gene	Sample_ID	compendium_version	drugs	rollup_cohort	Pathway_support_for_outlier
ACAD9	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
ADAM33	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
AHI1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
AHNAK2	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
AL132780.1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
AMPD2	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
ANKRD10	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
ARL17A	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
BCL6	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
BRPF3	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
BTG3	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
BZRAP1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CD46	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CDK9	TH34_1150_S02	v8	SCH 727965,ALVOCIDIB,SELICICLIB,SCH727965,Roniciclib,Flavopiridol,DINACICLIB,SNS-032,BMS-387032,BAY1000394	lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CDKN1B	TH34_1150_S02	v8	LAPATINIB	lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CEP57	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CEP95	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CH17-232I21.1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CIC	TH34_1150_S02	v8	SELUMETINIB (AZD6244),VEMURAFENIB,TRAMETINIB	lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CNOT2	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CTD-2270P14.1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
DAAM2	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
DDR1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
DDX42	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
DIDO1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
DMTF1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
DUSP22	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
DYNC2LI1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
DYNLL2	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
EFS	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
ELF2	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
EOGT	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
EPCAM	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
EWSR1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
EXOC6B	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
FAM219B	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
FBXO11	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
FNBP4	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
FPGS	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
FTSJ3	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
GOLGA8N	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
GOSR2	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
GREB1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
GREM1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
HHIP-AS1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
HIST1H2BG	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
HOXB8	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
IGLV3-25	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
KANSL1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
KIAA0907	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
LDB1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
LRCH3	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
LTBP3	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
LTBP4	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
LUC7L3	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
MAPK13	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
MEIS3	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
MFGE8	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
MIR124-2HG	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
MOXD1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
MRPL10	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
NAPSA	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
NME1-NME2	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
NOB1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
NPEPPS	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
NUDCD2	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
NUP93	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
PAGR1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
PAXBP1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
PCSK1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
PLEKHA7	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
PLEKHH2	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
PPFIA1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
PRDM2	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
PTPRR	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
RBBP6	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
RBL2	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
RCN2	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
RERG	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
RERGL	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
RHBDD3	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
RNA5SP187	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
RP11-156P1.3	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
RP11-575L7.8	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
RSAD1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
SCN1A	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
SCN3A	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
SFTPA1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
SFTPA2	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
SFTPB	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
SFTPC	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
SIAH3	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
SLC6A15	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
SLPI	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
SNHG1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
SNHG14	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
SNHG7	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
SNRPGP4	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
STAG3L1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
STAG3L2	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
STAG3L3	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
STON1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
STRADA	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
TBKBP1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
TCTEX1D1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
TLK2	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
TMEM161B-AS1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
TMEM164	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
TNRC6A	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
TTC21B	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
TUBB2B	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
USPL1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
VEZF1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
VSIG10	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
WSB1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
Y_RNA	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
ZBED5	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
ZBTB1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
ZBTB43	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
ZDHHC17	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
ZNF300P1	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
ZNF397	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
ZNF580	TH34_1150_S02	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
ABHD6	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
AC005943.6	TH34_1162_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACACB	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(11/478)
ACP5	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121)
ADGRG2	TH34_1162_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADPGK	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
ALG9	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
AP1B1	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121),REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION(9/91),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(18/933),REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING(5/60),REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS(4/53),REACTOME_LYSOSOME_VESICLE_BIOGENESIS(3/23),REACTOME_MEMBRANE_TRAFFICKING(5/129)
AP2S1	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION(9/91),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(18/933),HALLMARK_UV_RESPONSE_UP(7/158),REACTOME_DEVELOPMENTAL_BIOLOGY(8/396),HALLMARK_PROTEIN_SECRETION(4/96),REACTOME_AXON_GUIDANCE(6/251)
AP4B1	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121),REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING(5/60),REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS(4/53),REACTOME_MEMBRANE_TRAFFICKING(5/129)
APOC1	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_COMPLEMENT(10/200),HALLMARK_COAGULATION(5/138)
APOC4-APOC2	TH34_1162_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ARAP1	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_RHO_GTPASES(4/113)
ARFRP1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
ARHGAP17	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_RHO_GTPASES(4/113)
ARRB2	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(7/158),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(7/208),REACTOME_HEMOSTASIS(10/466)
ARTN	TH34_1162_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME_ASSOCIATED(12/753),NABA_MATRISOME(14/1028),REACTOME_DEVELOPMENTAL_BIOLOGY(8/396),REACTOME_AXON_GUIDANCE(6/251)
ASAH1	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121),REACTOME_GLYCOSPHINGOLIPID_METABOLISM(5/38),REACTOME_SPHINGOLIPID_METABOLISM(6/69),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(11/478),REACTOME_PHOSPHOLIPID_METABOLISM(7/198)
ASGR1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
ATG16L2	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
ATP1A1	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(10/413),HALLMARK_PROTEIN_SECRETION(4/96),KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION(3/42)
ATP5E	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
BLVRB	TH34_1162_S01	v7		lowstringency_pd_outliers	BIOCARTA_IL10_PATHWAY(4/17),REACTOME_METABOLISM_OF_PORPHYRINS(2/14)
C1orf162	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
C1orf61	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
C2	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_COMPLEMENT(10/200),REACTOME_IMMUNE_SYSTEM(18/933),HALLMARK_ALLOGRAFT_REJECTION(7/200),HALLMARK_COAGULATION(5/138),REACTOME_INNATE_IMMUNE_SYSTEM(6/279)
CCDC171	TH34_1162_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CCK	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(7/158)
CD14	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(18/933),HALLMARK_INFLAMMATORY_RESPONSE(7/200),KEGG_HEMATOPOIETIC_CELL_LINEAGE(4/88),HALLMARK_APOPTOSIS(5/161),REACTOME_INNATE_IMMUNE_SYSTEM(6/279),REACTOME_TOLL_RECEPTOR_CASCADES(4/118)
CD163	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
CD37	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(10/200),KEGG_HEMATOPOIETIC_CELL_LINEAGE(4/88)
CD52	TH34_1162_S01	v7	ALEMTUZUMAB,Alemtuzumab,CAMPATH	lowstringency_pd_outliers	NA
CD53	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
CD68	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121)
CDH23	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
CDH24	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
CEACAM21	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
CEACAM6	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
CECR1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
CES1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
CFD	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(18/933),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(7/208),REACTOME_HEMOSTASIS(10/466),HALLMARK_COAGULATION(5/138),REACTOME_INNATE_IMMUNE_SYSTEM(6/279)
CMTM3	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
COG7	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
COL9A3	TH34_1162_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(14/1028),REACTOME_DEVELOPMENTAL_BIOLOGY(8/396),REACTOME_AXON_GUIDANCE(6/251)
CORO1A	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
CORO7	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
CREG1	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(7/158)
CSF1R	TH34_1162_S01	v7	PLX3397,GW-2580,PEXIDARTINIB,Imatinib,PLX-3397,IMATINIB	lowstringency_pd_outliers	KEGG_HEMATOPOIETIC_CELL_LINEAGE(4/88),BIOCARTA_CBL_PATHWAY(2/13)
CSF3R	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_INFLAMMATORY_RESPONSE(7/200),KEGG_HEMATOPOIETIC_CELL_LINEAGE(4/88)
CSTB	TH34_1162_S01	v7		lowstringency_pd_outliers	NABA_ECM_REGULATORS(8/238),NABA_MATRISOME_ASSOCIATED(12/753),NABA_MATRISOME(14/1028)
CTC-575D19.1	TH34_1162_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTSA	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121),REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION(9/91),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(18/933),REACTOME_GLYCOSPHINGOLIPID_METABOLISM(5/38),REACTOME_SPHINGOLIPID_METABOLISM(6/69),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(11/478),NABA_ECM_REGULATORS(8/238),REACTOME_PHOSPHOLIPID_METABOLISM(7/198),NABA_MATRISOME_ASSOCIATED(12/753),NABA_MATRISOME(14/1028)
CTSB	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121),REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION(9/91),HALLMARK_COMPLEMENT(10/200),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(18/933),KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION(6/89),NABA_ECM_REGULATORS(8/238),REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR(3/14),NABA_MATRISOME_ASSOCIATED(12/753),NABA_MATRISOME(14/1028),HALLMARK_COAGULATION(5/138),REACTOME_INNATE_IMMUNE_SYSTEM(6/279),REACTOME_TOLL_RECEPTOR_CASCADES(4/118)
CTSD	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121),REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION(9/91),HALLMARK_COMPLEMENT(10/200),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(18/933),NABA_ECM_REGULATORS(8/238),HALLMARK_P53_PATHWAY(7/200),NABA_MATRISOME_ASSOCIATED(12/753),NABA_MATRISOME(14/1028)
CTSL	TH34_1162_S01	v7		lowstringency_pd_outliers	NABA_ECM_REGULATORS(8/238),NABA_MATRISOME_ASSOCIATED(12/753),NABA_MATRISOME(14/1028)
CTSS	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121),REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION(9/91),HALLMARK_COMPLEMENT(10/200),HALLMARK_KRAS_SIGNALING_UP(10/200),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(18/933),KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION(6/89),NABA_ECM_REGULATORS(8/238),HALLMARK_ALLOGRAFT_REJECTION(7/200),REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR(3/14),NABA_MATRISOME_ASSOCIATED(12/753),NABA_MATRISOME(14/1028),REACTOME_INNATE_IMMUNE_SYSTEM(6/279),REACTOME_TOLL_RECEPTOR_CASCADES(4/118)
CTSZ	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121),REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING(5/60),NABA_ECM_REGULATORS(8/238),NABA_MATRISOME_ASSOCIATED(12/753),REACTOME_LYSOSOME_VESICLE_BIOGENESIS(3/23),NABA_MATRISOME(14/1028),REACTOME_MEMBRANE_TRAFFICKING(5/129)
CYP1B1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
CYP26B1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
CYP4F22	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
D2HGDH	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
DAPK1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
DCHS2	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
DLG2	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
DUOX2	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
DUOXA2	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
FABP4	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(11/478),REACTOME_DEVELOPMENTAL_BIOLOGY(8/396)
FAM118A	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
FAM156B	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
FAM65C	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
FAM96A	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
FANCA	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
FCER1G	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_COMPLEMENT(10/200),HALLMARK_KRAS_SIGNALING_UP(10/200),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(7/208),REACTOME_HEMOSTASIS(10/466),KEGG_ASTHMA(3/30)
FCGRT	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
FEZF1-AS1	TH34_1162_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FPR3	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
FREM1	TH34_1162_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME_ASSOCIATED(12/753),NABA_MATRISOME(14/1028)
FRG2FP	TH34_1162_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FTL	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING(5/60),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(10/413),REACTOME_IRON_UPTAKE_AND_TRANSPORT(4/36),REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS(4/53),REACTOME_MEMBRANE_TRAFFICKING(5/129)
FUCA1	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121),HALLMARK_KRAS_SIGNALING_UP(10/200),HALLMARK_P53_PATHWAY(7/200),KEGG_OTHER_GLYCAN_DEGRADATION(3/16)
GLCE	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
GLG1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
GLUL	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
GM2A	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121),REACTOME_GLYCOSPHINGOLIPID_METABOLISM(5/38),REACTOME_SPHINGOLIPID_METABOLISM(6/69),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(11/478),HALLMARK_P53_PATHWAY(7/200),REACTOME_PHOSPHOLIPID_METABOLISM(7/198)
GMFG	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
GNG10	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(10/413),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(7/208),REACTOME_HEMOSTASIS(10/466)
GNPDA1	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM(4/44)
GPNMB	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(10/200)
GPR108	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
GPX1	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_APOPTOSIS(5/161)
GRN	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
GRP	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
HAP1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
HCST	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(18/933)
HEXA	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121),REACTOME_GLYCOSPHINGOLIPID_METABOLISM(5/38),REACTOME_SPHINGOLIPID_METABOLISM(6/69),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(11/478),REACTOME_PHOSPHOLIPID_METABOLISM(7/198),KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM(4/44),KEGG_OTHER_GLYCAN_DEGRADATION(3/16),HALLMARK_HYPOXIA(6/200)
HLA-DMA	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION(9/91),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(18/933),KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION(6/89),HALLMARK_ALLOGRAFT_REJECTION(7/200),HALLMARK_INTERFERON_GAMMA_RESPONSE(6/200),KEGG_LEISHMANIA_INFECTION(4/72),KEGG_ASTHMA(3/30)
HLA-DMB	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION(9/91),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(18/933),KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION(6/89),HALLMARK_ALLOGRAFT_REJECTION(7/200),KEGG_LEISHMANIA_INFECTION(4/72),KEGG_ASTHMA(3/30)
HMOX1	TH34_1162_S01	v7	SUNITINIB,SORAFENIB	lowstringency_pd_outliers	BIOCARTA_IL10_PATHWAY(4/17),HALLMARK_UV_RESPONSE_UP(7/158),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(10/413),REACTOME_IRON_UPTAKE_AND_TRANSPORT(4/36),HALLMARK_P53_PATHWAY(7/200),HALLMARK_HYPOXIA(6/200),HALLMARK_APOPTOSIS(5/161),REACTOME_METABOLISM_OF_PORPHYRINS(2/14)
HOXD10	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
HOXD11	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(10/200)
HOXD9	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
IFI30	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION(6/89),HALLMARK_P53_PATHWAY(7/200),HALLMARK_INTERFERON_GAMMA_RESPONSE(6/200)
IL10RA	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(10/200),BIOCARTA_IL10_PATHWAY(4/17),HALLMARK_INFLAMMATORY_RESPONSE(7/200),HALLMARK_INTERFERON_GAMMA_RESPONSE(6/200)
IL24	TH34_1162_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME_ASSOCIATED(12/753),NABA_MATRISOME(14/1028)
ITGAX	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(10/466)
ITM2A	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
JAK1	TH34_1162_S01	v7	RUXOLITINIB,Ruxolitinib,PEMBROLIZUMAB,ENZASTAURIN,INCB18424,AZD1480	lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(18/933),BIOCARTA_IL10_PATHWAY(4/17),KEGG_LEISHMANIA_INFECTION(4/72)
KCNE3	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
KDSR	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_SPHINGOLIPID_METABOLISM(6/69),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(11/478),REACTOME_PHOSPHOLIPID_METABOLISM(7/198)
KIAA1456	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
KMO	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
LAIR1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
LAMTOR4	TH34_1162_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LAPTM5	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121),HALLMARK_KRAS_SIGNALING_UP(10/200)
LGALS9	TH34_1162_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME_ASSOCIATED(12/753),NABA_MATRISOME(14/1028)
LGMN	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121),REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION(9/91),HALLMARK_COMPLEMENT(10/200),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(18/933),KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION(6/89),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(11/478),REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR(3/14),HALLMARK_COAGULATION(5/138),REACTOME_INNATE_IMMUNE_SYSTEM(6/279),REACTOME_TOLL_RECEPTOR_CASCADES(4/118)
LILRB4	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(18/933)
LIPA	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121),HALLMARK_COMPLEMENT(10/200)
LIPI	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
LL21NC02-1C16.2	TH34_1162_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LONRF1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
LOXHD1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
LRCH4	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
LST1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
MAN2B1	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121),KEGG_OTHER_GLYCAN_DEGRADATION(3/16)
MCOLN1	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(10/413),REACTOME_IRON_UPTAKE_AND_TRANSPORT(4/36)
MFSD1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
MGAT1	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(7/158)
MIER2	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
MPP1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
MS4A4A	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
MS4A6A	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
MS4A7	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
MSR1	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_INFLAMMATORY_RESPONSE(7/200)
MYO9B	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_RHO_GTPASES(4/113)
NAGK	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM(4/44),HALLMARK_HYPOXIA(6/200)
NEUROD6	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
NKX2-2	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(8/396)
NPC2	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121)
NPL	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM(4/44)
NPW	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
NR0B1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
NRD1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
ODF2L	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
P3H1	TH34_1162_S01	v7		lowstringency_pd_outliers	NABA_ECM_REGULATORS(8/238),NABA_MATRISOME_ASSOCIATED(12/753),NABA_MATRISOME(14/1028)
PARL	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
PAX7	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
PHKA2	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
PKP1	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_HYPOXIA(6/200)
PLA2G15	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121)
PLAUR	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_COMPLEMENT(10/200),HALLMARK_KRAS_SIGNALING_UP(10/200),HALLMARK_INFLAMMATORY_RESPONSE(7/200),REACTOME_HEMOSTASIS(10/466),HALLMARK_HYPOXIA(6/200)
PLD3	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(11/478),REACTOME_PHOSPHOLIPID_METABOLISM(7/198)
PLIN2	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(11/478),HALLMARK_HYPOXIA(6/200)
PPT1	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121),HALLMARK_UV_RESPONSE_UP(7/158),HALLMARK_APOPTOSIS(5/161),HALLMARK_PROTEIN_SECRETION(4/96)
PRKCB	TH34_1162_S01	v7	SOPHORETIN,ENZASTAURIN	lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(18/933),HALLMARK_ALLOGRAFT_REJECTION(7/200),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(7/208),REACTOME_HEMOSTASIS(10/466),KEGG_LEISHMANIA_INFECTION(4/72),KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION(3/42),BIOCARTA_CBL_PATHWAY(2/13)
PRND	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
PRRT4	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
PRSS35	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
PSAP	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121),REACTOME_GLYCOSPHINGOLIPID_METABOLISM(5/38),REACTOME_SPHINGOLIPID_METABOLISM(6/69),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(11/478),REACTOME_PHOSPHOLIPID_METABOLISM(7/198),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(7/208),REACTOME_HEMOSTASIS(10/466)
PTPN13	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
RASAL3	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
RBM11	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
RHOG	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_COMPLEMENT(10/200),HALLMARK_INFLAMMATORY_RESPONSE(7/200),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(7/208),REACTOME_HEMOSTASIS(10/466),REACTOME_DEVELOPMENTAL_BIOLOGY(8/396),REACTOME_AXON_GUIDANCE(6/251),REACTOME_SIGNALING_BY_RHO_GTPASES(4/113)
RNASE1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
RNASE6	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
RNF130	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
RNPEPL1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
RP11-1258F18.1	TH34_1162_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-343H5.4	TH34_1162_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-671J11.5	TH34_1162_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-734K23.9	TH34_1162_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP13-77O11.8	TH34_1162_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-765C7.2	TH34_1162_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SAMHD1	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_INTERFERON_GAMMA_RESPONSE(6/200)
SAT1	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(7/200),HALLMARK_APOPTOSIS(5/161)
SCNN1G	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION(3/42)
SH3BGRL3	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
SHANK1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
SIGLEC1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
SIM2	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
SIPA1	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(18/933)
SLC15A3	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(10/413),REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS(4/49),REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES(4/94)
SLC17A8	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(10/413),REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS(4/49),REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES(4/94)
SLC38A4	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(10/413),REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS(4/49),REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES(4/94)
SLC7A7	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(10/413),REACTOME_HEMOSTASIS(10/466),REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS(4/49),REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES(4/94)
SNX18	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
SPI1	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_ALLOGRAFT_REJECTION(7/200)
SPP1	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(10/200),NABA_MATRISOME(14/1028)
SRSF6	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
STAB1	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_INFLAMMATORY_RESPONSE(7/200),HALLMARK_ALLOGRAFT_REJECTION(7/200)
SYNPR	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
TAF6L	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
TCIRG1	TH34_1162_S01	v7		lowstringency_pd_outliers	KEGG_LYSOSOME(23/121),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(10/413),REACTOME_IRON_UPTAKE_AND_TRANSPORT(4/36)
TIAL1	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
TMEM91	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
TNFAIP2	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_INTERFERON_GAMMA_RESPONSE(6/200)
TRAPPC5	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
TRAV1-2	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
TREM2	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(8/396),REACTOME_AXON_GUIDANCE(6/251)
TRPM4	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
TSPAN8	TH34_1162_S01	v7		lowstringency_pd_outliers	HALLMARK_PROTEIN_SECRETION(4/96)
TYROBP	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(18/933),REACTOME_DEVELOPMENTAL_BIOLOGY(8/396),REACTOME_AXON_GUIDANCE(6/251)
UACA	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
UBXN11	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
UGT3A2	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
VAMP8	TH34_1162_S01	v7		lowstringency_pd_outliers	REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING(5/60),HALLMARK_P53_PATHWAY(7/200),REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS(4/53),REACTOME_LYSOSOME_VESICLE_BIOGENESIS(3/23),HALLMARK_INTERFERON_GAMMA_RESPONSE(6/200),REACTOME_MEMBRANE_TRAFFICKING(5/129)
XAGE1A	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
XAGE1B	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
XG	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
ZC3H13	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
ZDHHC3	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
ZNF276	TH34_1162_S01	v7		lowstringency_pd_outliers	NA
AC005062.2	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC079781.5	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADH1C	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
ADM	TH34_1163_S01	v7		lowstringency_pd_outliers	HALLMARK_HYPOXIA(8/200),PID_HIF1_TFPATHWAY(5/66)
ALG5	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
AP001065.15	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ARGLU1	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
BBS2	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
CARKD	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
CDC16	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
CFDP1	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
CHURC1	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
CNRIP1	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
CRYZL1	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
CSAG1	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
CSAG2	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
CSAG3	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
CUL4A	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
CXCL8	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
DIDO1	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
DNAJB11	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
EDNRA	TH34_1163_S01	v7	ZIBOTENTAN,ZD4054	lowstringency_pd_outliers	NA
ERCC5	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
ESD	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
F3	TH34_1163_S01	v7		lowstringency_pd_outliers	HALLMARK_HYPOXIA(8/200)
FABP7	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
FAR2P1	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FKBP5	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
FMO1	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
FP236383.7	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FP236383.8	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FP671120.2	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FRG1	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
FTH1	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
GTF2F2	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
GTSF1	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
HMOX1	TH34_1163_S01	v7	SUNITINIB,SORAFENIB	lowstringency_pd_outliers	HALLMARK_HYPOXIA(8/200),PID_HIF1_TFPATHWAY(5/66)
IFNGR2	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
ING1	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
JPX_1	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
KCNE4	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
KDM3A	TH34_1163_S01	v7		lowstringency_pd_outliers	HALLMARK_HYPOXIA(8/200)
LDHA	TH34_1163_S01	v7		lowstringency_pd_outliers	HALLMARK_HYPOXIA(8/200),PID_HIF1_TFPATHWAY(5/66)
LONRF1	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
MED4	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
MIR210HG	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
MME	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
MMP9	TH34_1163_S01	v7	BEVACIZUMAB	lowstringency_pd_outliers	NA
MRPS22	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
MRPS31	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
MRPS35	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
MT-RNR1	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT1E	TH34_1163_S01	v7		lowstringency_pd_outliers	HALLMARK_HYPOXIA(8/200)
MTA3	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
MTIF3	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
MYF5	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
MYH7B	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
NAMPT	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
NDRG1	TH34_1163_S01	v7		lowstringency_pd_outliers	HALLMARK_HYPOXIA(8/200),PID_HIF1_TFPATHWAY(5/66)
NECAP1	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
NHLRC3	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
NID2	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
NIFK	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NOB1	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
OSER1	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PCID2	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
PDGFRA	TH34_1163_S01	v7	MIDOSTAURIN,Nilotinib,SORAFENIB,MOTESANIB,CRENOLANIB,OLARATUMAB,NILOTINIB,IMC-3G3,MEDI-575,SUNITINIB,X-82,Crenolanib,Regorafenib,PAZOPANIB,SORAFENIB TOSYLATE,Ponatinib,TANDUTINIB,PONATINIB,MASITINIB,IMATINIB,AMUVATINIB,RAMUCIRUMAB,Sunitinib,Imatinib,Olaratumab,MP470,REGORAFENIB,NINTEDANIB,Pazopanib	lowstringency_pd_outliers	NA
PDK4	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
PDS5B	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
PGA3	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
PGA4	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
PGA5	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
PLIN2	TH34_1163_S01	v7		lowstringency_pd_outliers	HALLMARK_HYPOXIA(8/200),PID_HIF1_TFPATHWAY(5/66)
POMP	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
POP4	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
PRG4	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
PROCR	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
PTX3	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
RBM39	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
RNMT	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
RP11-138I1.4	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-229E13.4	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-452G18.2	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-467L13.4	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-765C7.2	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RPL23AP42	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
RPL41P2	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
S1PR3	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
SAP18	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
SCARA5	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
SF3B6	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SLC30A9	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
SMIM3	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SNHG7	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
SNORA27	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
SNORA51	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
SPG20	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
SRP9P1	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
STK24	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
SUPT20H	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TAF1D	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
TFPI	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
THOC2	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
TNMD	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
TP53I11	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
TPP2	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
TSPEAR-AS1	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TSPEAR-AS2	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
UBE2V1	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
UBXN8	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
UFM1	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
UTP11L	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
ZFAND2A	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
ZFAS1	TH34_1163_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZNF595	TH34_1163_S01	v7		lowstringency_pd_outliers	NA
ABCD4	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
ABHD2	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(7/200)
ABR	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK(4/43),REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING(5/81),REACTOME_SIGNALLING_BY_NGF(8/217),REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE(4/60)
AC005083.1	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC005307.3	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC006019.3	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC159540.1	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACAP3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
ACIN1	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_SPLICEOSOME(8/128)
ADAMTS2	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_MATRISOME_ASSOCIATED(23/753),REACTOME_COLLAGEN_FORMATION(4/58)
ADAMTSL2	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_MATRISOME_ASSOCIATED(23/753)
ADCY6	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_MELANOGENESIS(7/102),REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES(9/186),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(5/54),REACTOME_REGULATION_OF_INSULIN_SECRETION(6/93),REACTOME_NEURONAL_SYSTEM(10/279),REACTOME_GABA_B_RECEPTOR_ACTIVATION(4/38),REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS(4/44),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(6/120),REACTOME_SIGNALLING_BY_NGF(8/217),REACTOME_GABA_RECEPTOR_ACTIVATION(4/52),KEGG_GAP_JUNCTION(5/90),REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE(3/25),REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL(6/137),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(5/100),REACTOME_G_ALPHA_I_SIGNALLING_EVENTS(7/195),HALLMARK_ADIPOGENESIS(7/200)
ADGRA2	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AFAP1L2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
AGAP9	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
AHSA2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
AKAP8L	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
AL442127.1	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL662801.1	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ALB	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(9/208),REACTOME_HEMOSTASIS(12/466)
ALG13	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
AMBN	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),NABA_ECM_GLYCOPROTEINS(16/196),HALLMARK_KRAS_SIGNALING_DN(7/200)
ANKRD13D	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
AP003041.1	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
APBB3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
APCDD1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
ARHGEF17	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK(4/43),REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING(5/81),REACTOME_SIGNALLING_BY_NGF(8/217),REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE(4/60)
ARIH2	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(19/933)
ARMCX2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
ARVCF	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
ASCL5	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
ASPSCR1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
ATP11A	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
ATP6V0A1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
ATP6V0E2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
BAMBI	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
BBS2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
BEX1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
BGN	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(16/200),REACTOME_CS_DS_DEGRADATION(3/12),HALLMARK_HYPOXIA(8/200),HALLMARK_APOPTOSIS(7/161),REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM(4/52),REACTOME_METABOLISM_OF_CARBOHYDRATES(8/247)
BRD8	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
C1orf123	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
C1orf127	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
C1orf198	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
C1orf54	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
C2CD5	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
C7	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(19/933)
C9orf3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CADM1	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(16/200)
CADPS	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CALML3	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_MELANOGENESIS(7/102),KEGG_GLIOMA(5/65)
CALML5	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_MELANOGENESIS(7/102),KEGG_GLIOMA(5/65),HALLMARK_KRAS_SIGNALING_DN(7/200)
CAPRIN2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CCDC130	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CCDC14	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CCDC146	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CCDC159	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CCDC3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CCDC64	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CCDC84	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CCDC92	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CCNL2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CCS	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CD36	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_ECM_RECEPTOR_INTERACTION(10/84),REACTOME_DEVELOPMENTAL_BIOLOGY(18/396),HALLMARK_MYOGENESIS(10/200),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(9/208),REACTOME_IMMUNE_SYSTEM(19/933),REACTOME_HEMOSTASIS(12/466),HALLMARK_ADIPOGENESIS(7/200)
CDH13	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(10/200),HALLMARK_P53_PATHWAY(8/200)
CENPT	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CEP95	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CERK	TH34_1179_S01	v7		lowstringency_pd_outliers	ST_GRANULE_CELL_SURVIVAL_PATHWAY(3/27)
CFH	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(19/933),HALLMARK_KRAS_SIGNALING_UP(7/200)
CHGA	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CHGB	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CHKB	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CHRNA1	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(10/200),REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES(9/186),REACTOME_NEURONAL_SYSTEM(10/279),REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL(6/137)
CHRNA3	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES(9/186),REACTOME_NEURONAL_SYSTEM(10/279),REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL(6/137)
CIRBP	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CLASP2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CLEC11A	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_MATRISOME_ASSOCIATED(23/753)
CLK1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CLK2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CLSTN3	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_DN(7/200)
CNTN1	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(14/200),REACTOME_AXON_GUIDANCE(15/251),REACTOME_DEVELOPMENTAL_BIOLOGY(18/396),REACTOME_L1CAM_INTERACTIONS(7/86),REACTOME_SIGNALING_BY_NOTCH1(5/70),REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS(3/27),PID_NOTCH_PATHWAY(4/59)
COBL	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
COL16A1	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(16/200),HALLMARK_APICAL_JUNCTION(14/200),NABA_COLLAGENS(4/44),REACTOME_COLLAGEN_FORMATION(4/58)
COL18A1	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),NABA_BASEMENT_MEMBRANES(9/40),PID_INTEGRIN1_PATHWAY(7/66),PID_P53_DOWNSTREAM_PATHWAY(7/137),NABA_COLLAGENS(4/44)
COL4A1	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),KEGG_PATHWAYS_IN_CANCER(21/328),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(16/200),NABA_BASEMENT_MEMBRANES(9/40),KEGG_ECM_RECEPTOR_INTERACTION(10/84),REACTOME_AXON_GUIDANCE(15/251),REACTOME_DEVELOPMENTAL_BIOLOGY(18/396),KEGG_FOCAL_ADHESION(12/201),PID_INTEGRIN1_PATHWAY(7/66),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(7/79),KEGG_SMALL_CELL_LUNG_CANCER(7/84),NABA_COLLAGENS(4/44),BIOCARTA_AMI_PATHWAY(3/20),BIOCARTA_INTRINSIC_PATHWAY(3/23),REACTOME_COLLAGEN_FORMATION(4/58),HALLMARK_ADIPOGENESIS(7/200)
COL4A2	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),KEGG_PATHWAYS_IN_CANCER(21/328),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(16/200),NABA_BASEMENT_MEMBRANES(9/40),KEGG_ECM_RECEPTOR_INTERACTION(10/84),REACTOME_AXON_GUIDANCE(15/251),REACTOME_DEVELOPMENTAL_BIOLOGY(18/396),KEGG_FOCAL_ADHESION(12/201),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(7/79),KEGG_SMALL_CELL_LUNG_CANCER(7/84),HALLMARK_MYOGENESIS(10/200),NABA_COLLAGENS(4/44),BIOCARTA_AMI_PATHWAY(3/20),BIOCARTA_INTRINSIC_PATHWAY(3/23),REACTOME_COLLAGEN_FORMATION(4/58)
COLEC11	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_MATRISOME_ASSOCIATED(23/753)
CPLX2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CPSF7	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(10/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(9/140),REACTOME_MRNA_SPLICING(8/111),REACTOME_MRNA_3_END_PROCESSING(4/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(4/44)
CPT1B	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CPT1C	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CRABP2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
CRELD1	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),NABA_ECM_GLYCOPROTEINS(16/196)
CRLF1	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(16/200),NABA_MATRISOME_ASSOCIATED(23/753),NABA_SECRETED_FACTORS(10/344)
CRMP1	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_HEDGEHOG_SIGNALING(8/36),REACTOME_AXON_GUIDANCE(15/251),REACTOME_DEVELOPMENTAL_BIOLOGY(18/396),REACTOME_SEMAPHORIN_INTERACTIONS(5/68)
CSAD	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM(3/10)
CSNK1E	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_WNT_BETA_CATENIN_SIGNALING(7/42),PID_HEDGEHOG_GLI_PATHWAY(7/48),KEGG_HEDGEHOG_SIGNALING_PATHWAY(5/56),KEGG_WNT_SIGNALING_PATHWAY(7/151)
CST1	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_MATRISOME_ASSOCIATED(23/753)
CYGB	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
DAAM2	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_WNT_SIGNALING_PATHWAY(7/151)
DCAF8	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
DDHD2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
DDX17	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
DDX5	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_SPLICEOSOME(8/128),PID_P53_DOWNSTREAM_PATHWAY(7/137)
DEFA5	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(19/933)
DEFA6	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(19/933)
DENND4B	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
DKK1	TH34_1179_S01	v7	IRINOTECAN,L-FOLINIC ACID,5-FLUOROURACIL,OXALIPLATIN	lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(16/200),HALLMARK_WNT_BETA_CATENIN_SIGNALING(7/42),PID_BETA_CATENIN_NUC_PATHWAY(6/80),PID_P53_DOWNSTREAM_PATHWAY(7/137),KEGG_WNT_SIGNALING_PATHWAY(7/151),WNT_SIGNALING(5/89)
DKK3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
DKK4	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_WNT_BETA_CATENIN_SIGNALING(7/42),PID_BETA_CATENIN_NUC_PATHWAY(6/80),KEGG_WNT_SIGNALING_PATHWAY(7/151)
DLG4	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
DLX4	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
DMPK	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(10/200)
DMTF1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
DMXL2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
DNER	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_NOTCH1(5/70),REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS(3/27),PID_NOTCH_PATHWAY(4/59)
DNM1	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_AXON_GUIDANCE(15/251),REACTOME_DEVELOPMENTAL_BIOLOGY(18/396),REACTOME_L1CAM_INTERACTIONS(7/86),PID_THROMBIN_PAR1_PATHWAY(4/43),REACTOME_SIGNALLING_BY_NGF(8/217),REACTOME_IMMUNE_SYSTEM(19/933),PID_TXA2PATHWAY(4/57),PID_NOTCH_PATHWAY(4/59),PID_TRKR_PATHWAY(4/62)
DTX3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
EIF4G3	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(19/933)
ENG	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(7/200)
ENO2	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(16/200),HALLMARK_HYPOXIA(8/200),HALLMARK_APOPTOSIS(7/161),REACTOME_METABOLISM_OF_CARBOHYDRATES(8/247)
ENTPD4	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
EPB41L3	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(7/200)
ERCC3	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(10/161)
ERVMER34-1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
EVA1B	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
EXOC7	TH34_1179_S01	v7		lowstringency_pd_outliers	PID_ARF6_TRAFFICKING_PATHWAY(4/49)
F2R	TH34_1179_S01	v7		lowstringency_pd_outliers	BIOCARTA_SPPA_PATHWAY(4/22),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(9/208),HALLMARK_P53_PATHWAY(8/200),PID_THROMBIN_PAR1_PATHWAY(4/43),BIOCARTA_AMI_PATHWAY(3/20),HALLMARK_APOPTOSIS(7/161),KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(8/216),BIOCARTA_INTRINSIC_PATHWAY(3/23),REACTOME_HEMOSTASIS(12/466)
FAHD2B	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
FAM118A	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
FAM160B2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
FAM193B	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
FAM200B	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
FAM219B	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FAM3C	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
FAM95C	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FASLG	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),KEGG_PATHWAYS_IN_CANCER(21/328),NABA_MATRISOME_ASSOCIATED(23/753),KEGG_MAPK_SIGNALING_PATHWAY(11/267),HALLMARK_APOPTOSIS(7/161),NABA_SECRETED_FACTORS(10/344)
FBLN5	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(16/200),NABA_ECM_GLYCOPROTEINS(16/196)
FBLN7	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),NABA_ECM_GLYCOPROTEINS(16/196)
FBXO18	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
FBXW4	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_PROTEIN_FOLDING(5/53),WNT_SIGNALING(5/89),REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS(3/27)
FGD5	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
FGF19	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),KEGG_PATHWAYS_IN_CANCER(21/328),NABA_MATRISOME_ASSOCIATED(23/753),REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION(4/22),KEGG_MAPK_SIGNALING_PATHWAY(11/267),REACTOME_SHC_MEDIATED_CASCADE(4/28),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(5/54),REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE(6/87),REACTOME_FRS2_MEDIATED_CASCADE(4/36),REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING(4/37),KEGG_MELANOMA(5/71),REACTOME_SIGNALING_BY_INSULIN_RECEPTOR(6/108),KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(8/216),NABA_SECRETED_FACTORS(10/344),REACTOME_PI_3K_CASCADE(4/56),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(5/100)
FGF20	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),KEGG_PATHWAYS_IN_CANCER(21/328),NABA_MATRISOME_ASSOCIATED(23/753),REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION(4/22),KEGG_MAPK_SIGNALING_PATHWAY(11/267),REACTOME_SHC_MEDIATED_CASCADE(4/28),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(5/54),REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE(6/87),REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION(3/14),REACTOME_FRS2_MEDIATED_CASCADE(4/36),REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING(4/37),KEGG_MELANOMA(5/71),REACTOME_SIGNALING_BY_INSULIN_RECEPTOR(6/108),KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(8/216),NABA_SECRETED_FACTORS(10/344),REACTOME_PI_3K_CASCADE(4/56),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(5/100)
FGF3	TH34_1179_S01	v7	SORAFENIB	lowstringency_pd_outliers	NABA_MATRISOME(46/1028),KEGG_PATHWAYS_IN_CANCER(21/328),NABA_MATRISOME_ASSOCIATED(23/753),REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION(4/22),KEGG_MAPK_SIGNALING_PATHWAY(11/267),REACTOME_SHC_MEDIATED_CASCADE(4/28),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(5/54),REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE(6/87),REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION(3/14),REACTOME_FRS2_MEDIATED_CASCADE(4/36),REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING(4/37),KEGG_MELANOMA(5/71),REACTOME_SIGNALING_BY_INSULIN_RECEPTOR(6/108),KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(8/216),NABA_SECRETED_FACTORS(10/344),REACTOME_PI_3K_CASCADE(4/56),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(5/100)
FGFR1	TH34_1179_S01	v7	[Lucitanib],INFIGRATINIB,AZD-4547,BGJ-398,ORANTINIB,SU-6668,Regorafenib,LUCITANIB,PD173074,PONATINIB,MIDOSTAURIN,Ponatinib,Dovitinib,MASITINIB,AZD4547,Nintedanib,FGF/VEGF RECEPTOR TYROSINE KINASE INHIBITOR, PD173074,XL228,DOVITINIB,1058137-23-7,4-HYDROXYTAMOXIFEN,REGORAFENIB,NINTEDANIB,BGJ398,Lucitanib	lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(21/328),REACTOME_AXON_GUIDANCE(15/251),REACTOME_DEVELOPMENTAL_BIOLOGY(18/396),REACTOME_L1CAM_INTERACTIONS(7/86),REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION(4/22),KEGG_MAPK_SIGNALING_PATHWAY(11/267),REACTOME_SHC_MEDIATED_CASCADE(4/28),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(5/54),REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE(6/87),REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION(3/14),HALLMARK_ANGIOGENESIS(4/36),REACTOME_FRS2_MEDIATED_CASCADE(4/36),REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING(4/37),KEGG_MELANOMA(5/71),REACTOME_SIGNALING_BY_INSULIN_RECEPTOR(6/108),KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(8/216),KEGG_PROSTATE_CANCER(5/89),REACTOME_PI_3K_CASCADE(4/56),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(5/100)
FHOD3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
FLCN	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
FNBP4	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
FOXS1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
FRMPD1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
GABBR1	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES(9/186),REACTOME_NEURONAL_SYSTEM(10/279),REACTOME_GABA_B_RECEPTOR_ACTIVATION(4/38),REACTOME_GABA_RECEPTOR_ACTIVATION(4/52),REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL(6/137),REACTOME_G_ALPHA_I_SIGNALLING_EVENTS(7/195)
GAD1	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES(9/186),KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM(3/10),REACTOME_NEURONAL_SYSTEM(10/279),REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION(3/17)
GALNT2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
GAP43	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
GDI1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
GEM	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(16/200)
GGA1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
GGT5	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM(3/10)
GIMAP5	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
GNAI1	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(14/200),HALLMARK_WNT_BETA_CATENIN_SIGNALING(7/42),PID_HEDGEHOG_GLI_PATHWAY(7/48),BIOCARTA_SPPA_PATHWAY(4/22),KEGG_MELANOGENESIS(7/102),REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES(9/186),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(9/208),KEGG_AXON_GUIDANCE(7/129),REACTOME_REGULATION_OF_INSULIN_SECRETION(6/93),REACTOME_NEURONAL_SYSTEM(10/279),REACTOME_GABA_B_RECEPTOR_ACTIVATION(4/38),PID_THROMBIN_PAR1_PATHWAY(4/43),REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS(4/44),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(6/120),REACTOME_GABA_RECEPTOR_ACTIVATION(4/52),KEGG_GAP_JUNCTION(5/90),REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE(3/25),REACTOME_HEMOSTASIS(12/466),REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL(6/137),REACTOME_G_ALPHA_I_SIGNALLING_EVENTS(7/195)
GNG2	TH34_1179_S01	v7		lowstringency_pd_outliers	PID_HEDGEHOG_GLI_PATHWAY(7/48),REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES(9/186),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(9/208),REACTOME_REGULATION_OF_INSULIN_SECRETION(6/93),REACTOME_NEURONAL_SYSTEM(10/279),REACTOME_GABA_B_RECEPTOR_ACTIVATION(4/38),PID_THROMBIN_PAR1_PATHWAY(4/43),REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS(4/44),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(6/120),REACTOME_GABA_RECEPTOR_ACTIVATION(4/52),REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE(3/25),REACTOME_HEMOSTASIS(12/466),REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL(6/137),PID_TXA2PATHWAY(4/57),REACTOME_G_ALPHA_I_SIGNALLING_EVENTS(7/195)
GNL1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
GOLGA2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
GOLGA8A	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
GOLGA8B	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
GORASP1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
GRB10	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE(6/87),REACTOME_SIGNALING_BY_INSULIN_RECEPTOR(6/108)
GYG1	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_CARBOHYDRATES(8/247)
HDAC6	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_NOTCH1(5/70)
HERC2P2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
HES4	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
HEYL	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_NOTCH1(5/70)
HKR1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
HMCN1	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),NABA_ECM_GLYCOPROTEINS(16/196),NABA_BASEMENT_MEMBRANES(9/40)
HMP19	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
HNRNPH1	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(10/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(9/140),REACTOME_MRNA_SPLICING(8/111)
HOOK2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
HP1BP3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
HSBP1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
ID3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
IDS	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_CS_DS_DEGRADATION(3/12),HALLMARK_HYPOXIA(8/200),REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM(4/52),REACTOME_METABOLISM_OF_CARBOHYDRATES(8/247)
IGFBP7	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),NABA_ECM_GLYCOPROTEINS(16/196),HALLMARK_MYOGENESIS(10/200)
IGFN1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
ING4	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
INHBB	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_MATRISOME_ASSOCIATED(23/753),HALLMARK_P53_PATHWAY(8/200),NABA_SECRETED_FACTORS(10/344),HALLMARK_ESTROGEN_RESPONSE_EARLY(7/200)
INPPL1	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(14/200),REACTOME_IMMUNE_SYSTEM(19/933)
INTS3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
IP6K2	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(8/200),REACTOME_IMMUNE_SYSTEM(19/933)
IQSEC1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
ISYNA1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
ITGA1	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_ECM_RECEPTOR_INTERACTION(10/84),REACTOME_AXON_GUIDANCE(15/251),REACTOME_DEVELOPMENTAL_BIOLOGY(18/396),KEGG_FOCAL_ADHESION(12/201),PID_INTEGRIN1_PATHWAY(7/66),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(7/79),REACTOME_L1CAM_INTERACTIONS(7/86),BIOCARTA_SPPA_PATHWAY(4/22),REACTOME_SEMAPHORIN_INTERACTIONS(5/68),KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(8/216),PID_ARF6_TRAFFICKING_PATHWAY(4/49)
IVNS1ABP	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
JAG1	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_WNT_BETA_CATENIN_SIGNALING(7/42),HALLMARK_ANGIOGENESIS(4/36),REACTOME_SIGNALING_BY_NOTCH1(5/70),REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS(3/27),PID_NOTCH_PATHWAY(4/59)
KANK2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
KCNH2	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(14/200),HALLMARK_MYOGENESIS(10/200),REACTOME_NEURONAL_SYSTEM(10/279)
KIAA0195	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
KIAA0895L	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
KIF1A	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
KIFC3	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(10/200),REACTOME_PROTEIN_FOLDING(5/53),REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS(3/27)
KLC1	TH34_1179_S01	v7		lowstringency_pd_outliers	PID_ARF6_TRAFFICKING_PATHWAY(4/49),REACTOME_IMMUNE_SYSTEM(19/933),REACTOME_HEMOSTASIS(12/466)
KLC2	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(19/933),REACTOME_HEMOSTASIS(12/466)
KREMEN1	TH34_1179_S01	v7		lowstringency_pd_outliers	WNT_SIGNALING(5/89)
KRT5	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_DN(7/200)
KSR1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
LAMA2	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),KEGG_PATHWAYS_IN_CANCER(21/328),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(16/200),NABA_ECM_GLYCOPROTEINS(16/196),NABA_BASEMENT_MEMBRANES(9/40),KEGG_ECM_RECEPTOR_INTERACTION(10/84),KEGG_FOCAL_ADHESION(12/201),PID_INTEGRIN1_PATHWAY(7/66),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(7/79),KEGG_SMALL_CELL_LUNG_CANCER(7/84),HALLMARK_MYOGENESIS(10/200),PID_INTEGRIN4_PATHWAY(3/11),PID_A6B1_A6B4_INTEGRIN_PATHWAY(4/46)
LAMB1	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),KEGG_PATHWAYS_IN_CANCER(21/328),NABA_ECM_GLYCOPROTEINS(16/196),NABA_BASEMENT_MEMBRANES(9/40),KEGG_ECM_RECEPTOR_INTERACTION(10/84),REACTOME_AXON_GUIDANCE(15/251),REACTOME_DEVELOPMENTAL_BIOLOGY(18/396),KEGG_FOCAL_ADHESION(12/201),PID_INTEGRIN1_PATHWAY(7/66),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(7/79),KEGG_SMALL_CELL_LUNG_CANCER(7/84),REACTOME_L1CAM_INTERACTIONS(7/86),PID_INTEGRIN4_PATHWAY(3/11),PID_A6B1_A6B4_INTEGRIN_PATHWAY(4/46)
LAMB2	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),KEGG_PATHWAYS_IN_CANCER(21/328),NABA_ECM_GLYCOPROTEINS(16/196),NABA_BASEMENT_MEMBRANES(9/40),KEGG_ECM_RECEPTOR_INTERACTION(10/84),KEGG_FOCAL_ADHESION(12/201),PID_INTEGRIN1_PATHWAY(7/66),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(7/79),KEGG_SMALL_CELL_LUNG_CANCER(7/84),PID_INTEGRIN4_PATHWAY(3/11),PID_A6B1_A6B4_INTEGRIN_PATHWAY(4/46)
LAMC3	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),KEGG_PATHWAYS_IN_CANCER(21/328),NABA_ECM_GLYCOPROTEINS(16/196),NABA_BASEMENT_MEMBRANES(9/40),KEGG_ECM_RECEPTOR_INTERACTION(10/84),KEGG_FOCAL_ADHESION(12/201),KEGG_SMALL_CELL_LUNG_CANCER(7/84),PID_A6B1_A6B4_INTEGRIN_PATHWAY(4/46)
LCAT	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
LDB1	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_HEDGEHOG_SIGNALING(8/36)
LDB2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
LEF1	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(21/328),HALLMARK_WNT_BETA_CATENIN_SIGNALING(7/42),KEGG_BASAL_CELL_CARCINOMA(6/55),KEGG_MELANOGENESIS(7/102),PID_BETA_CATENIN_NUC_PATHWAY(6/80),KEGG_WNT_SIGNALING_PATHWAY(7/151),HALLMARK_APOPTOSIS(7/161),KEGG_PROSTATE_CANCER(5/89),WNT_SIGNALING(5/89)
LHFP	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
LINC00667	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01001	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01002	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01089	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01158	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINGO1	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING(5/81),REACTOME_SIGNALLING_BY_NGF(8/217)
LMBR1L	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
LMO2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
LRRC32	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
LTBP4	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),NABA_ECM_GLYCOPROTEINS(16/196)
LUC7L	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
LUC7L3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
LY6G6C	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
LZTR1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
MADD	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_APOPTOSIS(7/161)
MALAT1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
MAN2A2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
MAN2C1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
MAP3K12	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(11/267)
MAP6	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
MAPK8IP1	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(11/267),ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS(4/45),ST_GRANULE_CELL_SURVIVAL_PATHWAY(3/27)
MAPK8IP3	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(11/267),ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS(4/45),PID_ARF6_TRAFFICKING_PATHWAY(4/49),ST_GRANULE_CELL_SURVIVAL_PATHWAY(3/27)
MARK3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
MASP1	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_MATRISOME_ASSOCIATED(23/753),REACTOME_IMMUNE_SYSTEM(19/933)
MAST2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
MAU2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
MCF2L	TH34_1179_S01	v7		lowstringency_pd_outliers	PID_TRKR_PATHWAY(4/62)
MEG3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
METTL3	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(10/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(9/140)
MGEA5	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
MGP	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(16/200),NABA_ECM_GLYCOPROTEINS(16/196)
MIAT	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
MIAT_exon5_1	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MIR205HG	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MLLT6	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
MME	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
MPRIP	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
MSI2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
MT-ND4L	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND5	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTFR1L	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MXD4	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(8/200)
MYH7B	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
MZF1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
NAB1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
NDST2	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_HYPOXIA(8/200),REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM(4/52),REACTOME_METABOLISM_OF_CARBOHYDRATES(8/247)
NEIL1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
NELL2	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),NABA_ECM_GLYCOPROTEINS(16/196)
NFASC	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(14/200)
NGFR	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK(4/43),REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING(5/81),REACTOME_SIGNALLING_BY_NGF(8/217),REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE(4/60),PID_TRKR_PATHWAY(4/62)
NID1	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),NABA_ECM_GLYCOPROTEINS(16/196),NABA_BASEMENT_MEMBRANES(9/40),PID_INTEGRIN1_PATHWAY(7/66)
NISCH	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
NKTR	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
NLRP1	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(19/933)
NOL3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
NPIPA1	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NRCAM	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_HEDGEHOG_SIGNALING(8/36),REACTOME_AXON_GUIDANCE(15/251),REACTOME_DEVELOPMENTAL_BIOLOGY(18/396),REACTOME_L1CAM_INTERACTIONS(7/86)
NREP	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NRP1	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_HEDGEHOG_SIGNALING(8/36),REACTOME_AXON_GUIDANCE(15/251),REACTOME_DEVELOPMENTAL_BIOLOGY(18/396),REACTOME_L1CAM_INTERACTIONS(7/86),KEGG_AXON_GUIDANCE(7/129),HALLMARK_ANGIOGENESIS(4/36),REACTOME_SEMAPHORIN_INTERACTIONS(5/68),HALLMARK_KRAS_SIGNALING_UP(7/200)
NXPH3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
OAZ2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
OR51E1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
OVOS2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
P3H1	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_MATRISOME_ASSOCIATED(23/753)
P4HTM	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_MATRISOME_ASSOCIATED(23/753)
PACS1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PACS2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PAGE2B	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PAGE5	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PAM	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_HYPOXIA(8/200)
PAN2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PARP6	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PARVG	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(12/201)
PCBP4	TH34_1179_S01	v7		lowstringency_pd_outliers	PID_P53_DOWNSTREAM_PATHWAY(7/137)
PCF11	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(10/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(9/140),REACTOME_MRNA_SPLICING(8/111),REACTOME_MRNA_3_END_PROCESSING(4/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(4/44)
PCGF3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PCMTD2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PDGFRB	TH34_1179_S01	v7	SORAFENIB,MOTESANIB,Dasatinib,ORANTINIB,SUNITINIB,TELATINIB,X-82,Regorafenib,NILOTINIB,AXITINIB,TANDUTINIB,Sorafenib,MASITINIB,IMATINIB,XL-820,DASATINIB,Pazopanib,Sunitinib,LINIFANIB,XL820,Imatinib,SORAFENIB TOSYLATE,REGORAFENIB,NINTEDANIB,PAZOPANIB	lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(21/328),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(16/200),KEGG_FOCAL_ADHESION(12/201),KEGG_MAPK_SIGNALING_PATHWAY(11/267),KEGG_GLIOMA(5/65),KEGG_MELANOMA(5/71),HALLMARK_APOPTOSIS(7/161),KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(8/216),KEGG_PROSTATE_CANCER(5/89),KEGG_GAP_JUNCTION(5/90)
PDLIM3	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(7/200)
PEG10	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PHC1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PHF1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PHKA2	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_CARBOHYDRATES(8/247)
PHLDB1	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(7/200)
PHLDB3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PHYKPL	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PIAS3	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(21/328),KEGG_SMALL_CELL_LUNG_CANCER(7/84)
PIGG	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PILRB	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PIP5K1A	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(8/216)
PITX1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PKD1	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(14/200)
PKD1P6	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PLA2G6	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(11/267)
PLAC9	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PLB1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PLEKHG2	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK(4/43),REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING(5/81),REACTOME_SIGNALLING_BY_NGF(8/217),REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE(4/60)
PLK2	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(8/200)
PLXDC1	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_MATRISOME_ASSOCIATED(23/753)
PLXNB3	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),REACTOME_AXON_GUIDANCE(15/251),REACTOME_DEVELOPMENTAL_BIOLOGY(18/396),NABA_MATRISOME_ASSOCIATED(23/753),KEGG_AXON_GUIDANCE(7/129),REACTOME_SEMAPHORIN_INTERACTIONS(5/68)
PNISR	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PNMA1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
POGZ	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PON2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PPP6R2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PREB	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(7/200)
PRELP	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),REACTOME_METABOLISM_OF_CARBOHYDRATES(8/247)
PRKCQ	TH34_1179_S01	v7	SOPHORETIN	lowstringency_pd_outliers	REACTOME_AXON_GUIDANCE(15/251),REACTOME_DEVELOPMENTAL_BIOLOGY(18/396),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(9/208),REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS(4/44),REACTOME_IMMUNE_SYSTEM(19/933),REACTOME_HEMOSTASIS(12/466),PID_TXA2PATHWAY(4/57)
PRKCQ-AS1	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PRSS56	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
PSMA3-AS1	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PSTPIP1	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(19/933)
PTCD3	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(7/200)
PTCH1	TH34_1179_S01	v7	SONIDEGIB,Sonidegib,Vismodegib,VISMODEGIB	lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(21/328),HALLMARK_HEDGEHOG_SIGNALING(8/36),HALLMARK_WNT_BETA_CATENIN_SIGNALING(7/42),PID_HEDGEHOG_GLI_PATHWAY(7/48),KEGG_BASAL_CELL_CARCINOMA(6/55),KEGG_HEDGEHOG_SIGNALING_PATHWAY(5/56)
PTOV1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
QSOX2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
RAB24	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
RASL11B	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
RBM25	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_SPLICEOSOME(8/128)
RBM5	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(10/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(9/140),REACTOME_MRNA_SPLICING(8/111)
RBM6	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
RCAN2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
RGL3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
RGS11	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS(7/195),HALLMARK_KRAS_SIGNALING_DN(7/200)
RGS12	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS(7/195)
RGS5	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
RIMBP2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
RIMKLA	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
RNF11	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(7/200)
ROBO1	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_AXON_GUIDANCE(15/251),REACTOME_DEVELOPMENTAL_BIOLOGY(18/396),KEGG_AXON_GUIDANCE(7/129)
RP11-116G8.5	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-1212A22.1	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-20I20.4	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-350N15.4	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-394O4.5	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-401P9.4	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-449J21.3	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-734K23.9	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-809N8.5	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-669L17.10	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP5-857K21.11	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP5-857K21.7	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RPAIN	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
RRAGA	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
RTN1	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_HEDGEHOG_SIGNALING(8/36)
RUFY3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
RUNDC3A	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SAFB2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SAMD11	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SCG2	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(16/200),HALLMARK_HEDGEHOG_SIGNALING(8/36)
SCG3	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(9/208),REACTOME_HEMOSTASIS(12/466),HALLMARK_KRAS_SIGNALING_UP(7/200)
SCG5	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(7/200)
SDHAP1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SEC11C	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_REGULATION_OF_INSULIN_SECRETION(6/93),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(6/120)
SEMA4C	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_MATRISOME_ASSOCIATED(23/753),KEGG_AXON_GUIDANCE(7/129)
SEMA4D	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),REACTOME_AXON_GUIDANCE(15/251),REACTOME_DEVELOPMENTAL_BIOLOGY(18/396),NABA_MATRISOME_ASSOCIATED(23/753),KEGG_AXON_GUIDANCE(7/129),REACTOME_SEMAPHORIN_INTERACTIONS(5/68)
SEPT4	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SEPT5	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SERGEF	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SERPINI1	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_MATRISOME_ASSOCIATED(23/753)
SETD5	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SEZ6	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SF3B1	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(10/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(9/140),REACTOME_MRNA_SPLICING(8/111),KEGG_SPLICEOSOME(8/128)
SFI1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SGCE	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(14/200)
SGSM2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SHC2	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(12/201),REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE(6/87),KEGG_GLIOMA(5/65),REACTOME_SIGNALING_BY_INSULIN_RECEPTOR(6/108),REACTOME_SIGNALLING_BY_NGF(8/217),PID_TRKR_PATHWAY(4/62)
SHH	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),KEGG_PATHWAYS_IN_CANCER(21/328),HALLMARK_HEDGEHOG_SIGNALING(8/36),PID_HEDGEHOG_GLI_PATHWAY(7/48),NABA_MATRISOME_ASSOCIATED(23/753),KEGG_BASAL_CELL_CARCINOMA(6/55),KEGG_HEDGEHOG_SIGNALING_PATHWAY(5/56),NABA_SECRETED_FACTORS(10/344)
SIN3B	TH34_1179_S01	v7		lowstringency_pd_outliers	PID_HEDGEHOG_GLI_PATHWAY(7/48)
SLC12A4	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SLC25A27	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SLC34A2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SLC35E2B	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SLC39A13	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SLC7A6	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(12/466)
SLCO3A1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SMARCD3	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(18/396)
SNAP25	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES(9/186),REACTOME_REGULATION_OF_INSULIN_SECRETION(6/93),REACTOME_NEURONAL_SYSTEM(10/279),REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION(3/17),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(6/120),HALLMARK_KRAS_SIGNALING_UP(7/200)
SNHG25	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SNRNP70	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(10/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(9/140),REACTOME_MRNA_SPLICING(8/111),KEGG_SPLICEOSOME(8/128)
SORBS2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SP6	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SPIN1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SPPL2B	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SPRY4	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SREK1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SRPK2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SRSF10	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_SPLICEOSOME(8/128)
SRSF11	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(10/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(9/140),REACTOME_MRNA_SPLICING(8/111),REACTOME_MRNA_3_END_PROCESSING(4/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(4/44)
SRSF5	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(10/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(9/140),REACTOME_MRNA_SPLICING(8/111),KEGG_SPLICEOSOME(8/128),REACTOME_MRNA_3_END_PROCESSING(4/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(4/44)
SSTR1	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_G_ALPHA_I_SIGNALLING_EVENTS(7/195)
STAG3L5P	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
STAG3L5P-PVRIG2P-PILRB	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
STAP1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
STARD3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
STK36	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(21/328),PID_HEDGEHOG_GLI_PATHWAY(7/48),KEGG_BASAL_CELL_CARCINOMA(6/55),KEGG_HEDGEHOG_SIGNALING_PATHWAY(5/56)
STMN2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
STRA6	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SUGP2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
SVIL	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(10/200),HALLMARK_ESTROGEN_RESPONSE_EARLY(7/200)
SYK	TH34_1179_S01	v7	FOSTAMATINIB,R-788,PACLITAXEL	lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(14/200),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(7/79),BIOCARTA_SPPA_PATHWAY(4/22),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(9/208),REACTOME_IMMUNE_SYSTEM(19/933),REACTOME_HEMOSTASIS(12/466),PID_TXA2PATHWAY(4/57)
SYNPO	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_DN(7/200)
SYP	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
TAGLN3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
TAPT1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
TBC1D1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
TBX2	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
TCF4	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(18/396),PID_BETA_CATENIN_NUC_PATHWAY(6/80)
TCF7L2	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(21/328),KEGG_BASAL_CELL_CARCINOMA(6/55),KEGG_MELANOGENESIS(7/102),PID_BETA_CATENIN_NUC_PATHWAY(6/80),KEGG_WNT_SIGNALING_PATHWAY(7/151),KEGG_PROSTATE_CANCER(5/89)
TERF2IP	TH34_1179_S01	v7		lowstringency_pd_outliers	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS(4/45)
TGFA	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),KEGG_PATHWAYS_IN_CANCER(21/328),NABA_MATRISOME_ASSOCIATED(23/753),PID_P53_DOWNSTREAM_PATHWAY(7/137),KEGG_GLIOMA(5/65),HALLMARK_P53_PATHWAY(8/200),KEGG_PROSTATE_CANCER(5/89),NABA_SECRETED_FACTORS(10/344)
TGFB3	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),KEGG_PATHWAYS_IN_CANCER(21/328),NABA_MATRISOME_ASSOCIATED(23/753),KEGG_MAPK_SIGNALING_PATHWAY(11/267),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(9/208),HALLMARK_HYPOXIA(8/200),NABA_SECRETED_FACTORS(10/344),REACTOME_HEMOSTASIS(12/466)
THBS3	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),NABA_ECM_GLYCOPROTEINS(16/196),KEGG_ECM_RECEPTOR_INTERACTION(10/84),HALLMARK_APICAL_JUNCTION(14/200),KEGG_FOCAL_ADHESION(12/201)
TIA1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
TIAL1	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(14/200)
TM4SF4	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
TMEM132A	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
TMEM204	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
TMEM45A	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_HYPOXIA(8/200)
TMPRSS3	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(7/200)
TNFRSF11B	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(16/200),HALLMARK_APICAL_JUNCTION(14/200)
TNS2	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TNXB	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),NABA_ECM_GLYCOPROTEINS(16/196),KEGG_ECM_RECEPTOR_INTERACTION(10/84),KEGG_FOCAL_ADHESION(12/201)
TP53BP1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
TRA2A	TH34_1179_S01	v7		lowstringency_pd_outliers	KEGG_SPLICEOSOME(8/128)
TRDC	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
TRO	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(14/200)
TRPM8	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
TSPAN11	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
TSPAN32	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
TSPAN5	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
TSPYL2	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(8/200)
TTLL3	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
TUBA1A	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_PROTEIN_FOLDING(5/53),ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS(4/45),KEGG_GAP_JUNCTION(5/90)
TUBB2B	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_PROTEIN_FOLDING(5/53),KEGG_GAP_JUNCTION(5/90),HALLMARK_ESTROGEN_RESPONSE_EARLY(7/200)
TWIST1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
TXNDC15	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
TYK2	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(19/933)
UACA	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
UCHL1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
UNC119	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(7/200)
UNC5B	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_AXON_GUIDANCE(15/251),REACTOME_DEVELOPMENTAL_BIOLOGY(18/396),KEGG_AXON_GUIDANCE(7/129)
USP11	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_PROTEIN_FOLDING(5/53),REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS(3/27)
USP20	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
USP32P1	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
USP34	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
VAMP2	TH34_1179_S01	v7		lowstringency_pd_outliers	REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES(9/186),REACTOME_REGULATION_OF_INSULIN_SECRETION(6/93),REACTOME_NEURONAL_SYSTEM(10/279),REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION(3/17),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(6/120)
VASH1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
VCAN	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),NABA_CORE_MATRISOME(23/275),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(16/200),HALLMARK_APICAL_JUNCTION(14/200),PID_BETA_CATENIN_NUC_PATHWAY(6/80),REACTOME_CS_DS_DEGRADATION(3/12),HALLMARK_ANGIOGENESIS(4/36),PID_P53_DOWNSTREAM_PATHWAY(7/137),REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM(4/52),REACTOME_METABOLISM_OF_CARBOHYDRATES(8/247)
VGF	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
VGLL4	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
VOPP1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
VPS39	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
WASH5P	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
WBP1	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
WDR11	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
WDR27	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
WDR59	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
WDR6	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
WNT16	TH34_1179_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(46/1028),KEGG_PATHWAYS_IN_CANCER(21/328),NABA_MATRISOME_ASSOCIATED(23/753),KEGG_BASAL_CELL_CARCINOMA(6/55),KEGG_MELANOGENESIS(7/102),KEGG_HEDGEHOG_SIGNALING_PATHWAY(5/56),KEGG_WNT_SIGNALING_PATHWAY(7/151),WNT_SIGNALING(5/89),NABA_SECRETED_FACTORS(10/344),HALLMARK_KRAS_SIGNALING_DN(7/200)
WSB1	TH34_1179_S01	v7		lowstringency_pd_outliers	HALLMARK_HYPOXIA(8/200),REACTOME_IMMUNE_SYSTEM(19/933)
Y_RNA	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZACN	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
ZC3H11A	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
ZNF385A	TH34_1179_S01	v7		lowstringency_pd_outliers	PID_P53_DOWNSTREAM_PATHWAY(7/137)
ZNF532	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
ZNF692	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
ZNF76	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
ZNF83	TH34_1179_S01	v7		lowstringency_pd_outliers	NA
ZSWIM8	TH34_1179_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC006449.2	TH34_1238_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC011558.5	TH34_1238_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC019118.3	TH34_1238_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC091053.2	TH34_1238_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADAM23	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
AL162151.3	TH34_1238_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL662801.1	TH34_1238_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
APRT	TH34_1238_S01	v7		lowstringency_pd_outliers	HALLMARK_DNA_REPAIR(6/150),REACTOME_PURINE_METABOLISM(3/33)
ARL6IP4	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
ATP5I	TH34_1238_S01	v7		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(6/200),REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_(4/98)
AUP1	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
AURKAIP1	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
BBC3	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
BNIP3P41	TH34_1238_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
C11orf98	TH34_1238_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CCDC124	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
CCDC78	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
CCDC85B	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
CDC34	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
CDC37	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
CDHR3	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
DFNA5	TH34_1238_S01	v7		lowstringency_pd_outliers	HALLMARK_DNA_REPAIR(6/150)
DGUOK	TH34_1238_S01	v7		lowstringency_pd_outliers	HALLMARK_DNA_REPAIR(6/150),REACTOME_PURINE_METABOLISM(3/33)
DMPK	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
EDF1	TH34_1238_S01	v7		lowstringency_pd_outliers	HALLMARK_DNA_REPAIR(6/150)
EIF3G	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
EIF6	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
ELOF1	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
EME2	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
FAM150B	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
FCRLA	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
GAS6-AS1	TH34_1238_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GEMIN7	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
GIPR	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
GOLGA8A	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
HOXA3	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
HOXA5	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
HOXA9	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
HSD17B10	TH34_1238_S01	v7		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(6/200)
HSF4	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
HSPE1	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
IGHV3-20	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
IGLJ3	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
IGLV3-25	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
ITPA	TH34_1238_S01	v7		lowstringency_pd_outliers	HALLMARK_DNA_REPAIR(6/150)
KCNK9	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
KLRC4-KLRK1	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
KLRF2	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
LDLRAD2	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
LIMD2	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
MAPK12	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
MCOLN2	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
MEIS1	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
MPEG1	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
MRPL12	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
MRPL14	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
MRPL2	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
MRPL34	TH34_1238_S01	v7		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(6/200)
MRPL38	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
MRPL4	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
MRPL52	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
MRPS12	TH34_1238_S01	v7		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(6/200)
MRPS21	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
MRPS34	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
MYL5	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
NAA10	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
NAT9	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
NCBP2-AS2	TH34_1238_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NDUFA13	TH34_1238_S01	v7		lowstringency_pd_outliers	REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_(4/98)
NDUFA3	TH34_1238_S01	v7		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(6/200),REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_(4/98)
NDUFS6	TH34_1238_S01	v7		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(6/200),REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_(4/98)
NEAT1_1	TH34_1238_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NEIL1	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
NHP2L1	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
NOP16	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
NOSIP	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
NSMCE1	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
NT5C	TH34_1238_S01	v7		lowstringency_pd_outliers	HALLMARK_DNA_REPAIR(6/150),REACTOME_PURINE_METABOLISM(3/33)
NUDT1	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
OXLD1	TH34_1238_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
P2RY11	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
PAM16	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
PENK	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
PFDN6	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
PINLYP	TH34_1238_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PPP2R3B	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
PSME2	TH34_1238_S01	v7	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	NA
PSMG4	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
PTPRCAP	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
RAB24	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
RAB4B	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
REC8	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
RELL2	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
RFXANK	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
RP1-170O19.23	TH34_1238_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-291B21.2	TH34_1238_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-345J4.6	TH34_1238_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP5-1028K7.2	TH34_1238_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP5-887A10.1	TH34_1238_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RPL39P3	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
RPL8	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
RPS19BP1	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
SNHG9	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
SNORD22	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
SNRPD3	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
SNX22	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
SSNA1	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
SSSCA1	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
STIM2	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
TBC1D27	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
TBCB	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
TCL1B	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
TCTEX1D1	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
TM7SF2	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
TMEM160	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
TNFRSF13B	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
TRAPPC6A	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
TRMT1	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
UBALD1	TH34_1238_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
WBP1	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
WDR86	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
ZNF428	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
ZNF521	TH34_1238_S01	v7		lowstringency_pd_outliers	NA
ACP5	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
AL162151.3	TH34_1239_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL442127.1	TH34_1239_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL662801.1	TH34_1239_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ANXA3	TH34_1239_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(15/1028),NABA_MATRISOME_ASSOCIATED(13/753),NABA_ECM_AFFILIATED(6/171)
APOE	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
ARG1	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
ARTN	TH34_1239_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(15/1028),NABA_MATRISOME_ASSOCIATED(13/753),REACTOME_NCAM1_INTERACTIONS(3/39),REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH(3/64),REACTOME_AXON_GUIDANCE(4/251)
AURKAIP1	TH34_1239_S01	v7		lowstringency_pd_outliers	PID_AURORA_A_PATHWAY(2/31)
B3GNT7	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
BPI	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
C1QA	TH34_1239_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(16/933),NABA_MATRISOME(15/1028),NABA_MATRISOME_ASSOCIATED(13/753),REACTOME_INNATE_IMMUNE_SYSTEM(9/279),HALLMARK_COMPLEMENT(7/200),KEGG_PRION_DISEASES(4/35),NABA_ECM_AFFILIATED(6/171),REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS(3/10),BIOCARTA_CLASSIC_PATHWAY(3/14),REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT(3/16),BIOCARTA_COMP_PATHWAY(3/19),REACTOME_COMPLEMENT_CASCADE(3/32),HALLMARK_COAGULATION(4/138),KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS(4/140),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(3/69)
C1QB	TH34_1239_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(16/933),NABA_MATRISOME(15/1028),NABA_MATRISOME_ASSOCIATED(13/753),REACTOME_INNATE_IMMUNE_SYSTEM(9/279),KEGG_PRION_DISEASES(4/35),NABA_ECM_AFFILIATED(6/171),REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS(3/10),BIOCARTA_CLASSIC_PATHWAY(3/14),REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT(3/16),BIOCARTA_COMP_PATHWAY(3/19),REACTOME_COMPLEMENT_CASCADE(3/32),KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS(4/140),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(3/69)
C1QC	TH34_1239_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(16/933),NABA_MATRISOME(15/1028),NABA_MATRISOME_ASSOCIATED(13/753),REACTOME_INNATE_IMMUNE_SYSTEM(9/279),HALLMARK_COMPLEMENT(7/200),KEGG_PRION_DISEASES(4/35),NABA_ECM_AFFILIATED(6/171),REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS(3/10),BIOCARTA_CLASSIC_PATHWAY(3/14),REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT(3/16),BIOCARTA_COMP_PATHWAY(3/19),REACTOME_COMPLEMENT_CASCADE(3/32),KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS(4/140),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(3/69)
C9orf142	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
CAMP	TH34_1239_S01	v7		lowstringency_pd_outliers	REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS(2/33)
CD24	TH34_1239_S01	v7		lowstringency_pd_outliers	REACTOME_AXON_GUIDANCE(4/251)
CD247	TH34_1239_S01	v7		lowstringency_pd_outliers	HALLMARK_ALLOGRAFT_REJECTION(10/200),REACTOME_IMMUNE_SYSTEM(16/933),PID_IL12_2PATHWAY(6/63),PID_CD8_TCR_DOWNSTREAM_PATHWAY(6/65),KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY(6/137),REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL(5/70),PID_CD8_TCR_PATHWAY(4/53),BIOCARTA_CTL_PATHWAY(3/15),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(6/539),BIOCARTA_TCYTOTOXIC_PATHWAY(2/14),BIOCARTA_IL17_PATHWAY(2/17),PID_CXCR4_PATHWAY(3/102),KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY(3/108),REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS(2/28),PID_IL12_STAT4_PATHWAY(2/33)
CD7	TH34_1239_S01	v7		lowstringency_pd_outliers	HALLMARK_ALLOGRAFT_REJECTION(10/200),KEGG_HEMATOPOIETIC_CELL_LINEAGE(4/88)
CD8A	TH34_1239_S01	v7		lowstringency_pd_outliers	HALLMARK_ALLOGRAFT_REJECTION(10/200),REACTOME_IMMUNE_SYSTEM(16/933),PID_IL12_2PATHWAY(6/63),PID_CD8_TCR_DOWNSTREAM_PATHWAY(6/65),REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL(5/70),PID_CD8_TCR_PATHWAY(4/53),KEGG_CELL_ADHESION_MOLECULES_CAMS(5/134),KEGG_HEMATOPOIETIC_CELL_LINEAGE(4/88),KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION(4/89),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(6/539),BIOCARTA_TCYTOTOXIC_PATHWAY(2/14),BIOCARTA_IL17_PATHWAY(2/17),KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY(3/108),KEGG_PRIMARY_IMMUNODEFICIENCY(2/35)
CD8B	TH34_1239_S01	v7		lowstringency_pd_outliers	HALLMARK_ALLOGRAFT_REJECTION(10/200),REACTOME_IMMUNE_SYSTEM(16/933),PID_IL12_2PATHWAY(6/63),PID_CD8_TCR_DOWNSTREAM_PATHWAY(6/65),REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL(5/70),PID_CD8_TCR_PATHWAY(4/53),KEGG_CELL_ADHESION_MOLECULES_CAMS(5/134),KEGG_HEMATOPOIETIC_CELL_LINEAGE(4/88),KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION(4/89),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(6/539),KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY(3/108),REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS(2/28),KEGG_PRIMARY_IMMUNODEFICIENCY(2/35)
CEACAM1	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
CEACAM6	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
CEACAM8	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
CHI3L1	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
CHIT1	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
CLEC10A	TH34_1239_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(15/1028),NABA_MATRISOME_ASSOCIATED(13/753),NABA_ECM_AFFILIATED(6/171)
COL1A1	TH34_1239_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(15/1028),REACTOME_NCAM1_INTERACTIONS(3/39),REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH(3/64),PID_INTEGRIN1_PATHWAY(3/66),KEGG_ECM_RECEPTOR_INTERACTION(3/84),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(3/87),REACTOME_AXON_GUIDANCE(4/251)
CRISP3	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
CTD-3154N5.2	TH34_1239_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DEFA1	TH34_1239_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(16/933),REACTOME_INNATE_IMMUNE_SYSTEM(9/279),REACTOME_DEFENSINS(4/51)
DEFA1B	TH34_1239_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(16/933),REACTOME_INNATE_IMMUNE_SYSTEM(9/279),REACTOME_DEFENSINS(4/51)
DEFA3	TH34_1239_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(16/933),REACTOME_INNATE_IMMUNE_SYSTEM(9/279),REACTOME_DEFENSINS(4/51)
DEFA4	TH34_1239_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(16/933),REACTOME_INNATE_IMMUNE_SYSTEM(9/279),REACTOME_DEFENSINS(4/51)
FCGR3B	TH34_1239_S01	v7		lowstringency_pd_outliers	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY(6/137),KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS(4/140)
FLT3LG	TH34_1239_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(15/1028),NABA_MATRISOME_ASSOCIATED(13/753),KEGG_HEMATOPOIETIC_CELL_LINEAGE(4/88)
FOLR3	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
GNLY	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
GRIP1	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
GZMA	TH34_1239_S01	v7		lowstringency_pd_outliers	HALLMARK_ALLOGRAFT_REJECTION(10/200),PID_IL12_2PATHWAY(6/63),HALLMARK_COMPLEMENT(7/200),BIOCARTA_SET_PATHWAY(3/11),HALLMARK_INTERFERON_GAMMA_RESPONSE(5/200)
GZMB	TH34_1239_S01	v7		lowstringency_pd_outliers	HALLMARK_ALLOGRAFT_REJECTION(10/200),PID_IL12_2PATHWAY(6/63),PID_CD8_TCR_DOWNSTREAM_PATHWAY(6/65),HALLMARK_COMPLEMENT(7/200),KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY(6/137),BIOCARTA_SET_PATHWAY(3/11),BIOCARTA_CTL_PATHWAY(3/15),KEGG_ALLOGRAFT_REJECTION(3/38),KEGG_GRAFT_VERSUS_HOST_DISEASE(3/42),KEGG_TYPE_I_DIABETES_MELLITUS(3/44),KEGG_AUTOIMMUNE_THYROID_DISEASE(3/53),BIOCARTA_D4GDI_PATHWAY(2/13),SA_CASPASE_CASCADE(2/19),BIOCARTA_CASPASE_PATHWAY(2/23)
GZMH	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
HLA-B	TH34_1239_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(16/933),KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY(6/137),REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL(5/70),KEGG_CELL_ADHESION_MOLECULES_CAMS(5/134),KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION(4/89),HALLMARK_INTERFERON_GAMMA_RESPONSE(5/200),KEGG_ALLOGRAFT_REJECTION(3/38),KEGG_GRAFT_VERSUS_HOST_DISEASE(3/42),KEGG_TYPE_I_DIABETES_MELLITUS(3/44),KEGG_AUTOIMMUNE_THYROID_DISEASE(3/53),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(6/539)
HMOX1	TH34_1239_S01	v7	SUNITINIB,SORAFENIB	lowstringency_pd_outliers	PID_FRA_PATHWAY(2/37)
HOTAIRM1_1	TH34_1239_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HP	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
IL2RB	TH34_1239_S01	v7		lowstringency_pd_outliers	HALLMARK_ALLOGRAFT_REJECTION(10/200),REACTOME_IMMUNE_SYSTEM(16/933),PID_IL12_2PATHWAY(6/63),PID_CD8_TCR_DOWNSTREAM_PATHWAY(6/65),HALLMARK_INTERFERON_GAMMA_RESPONSE(5/200),PID_IL2_STAT5_PATHWAY(2/30)
IL32	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
ITGA7	TH34_1239_S01	v7		lowstringency_pd_outliers	PID_INTEGRIN1_PATHWAY(3/66),KEGG_ECM_RECEPTOR_INTERACTION(3/84),PID_CXCR4_PATHWAY(3/102)
KCNE5	TH34_1239_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
KLRK1	TH34_1239_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(16/933),KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY(6/137),REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL(5/70),HALLMARK_INTERFERON_GAMMA_RESPONSE(5/200),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(6/539)
LAMP5	TH34_1239_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LCN2	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
LGMN	TH34_1239_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(16/933),REACTOME_INNATE_IMMUNE_SYSTEM(9/279),HALLMARK_COMPLEMENT(7/200),KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION(4/89),HALLMARK_COAGULATION(4/138),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(6/539)
LTB	TH34_1239_S01	v7		lowstringency_pd_outliers	HALLMARK_ALLOGRAFT_REJECTION(10/200),NABA_MATRISOME(15/1028),NABA_MATRISOME_ASSOCIATED(13/753)
LTF	TH34_1239_S01	v7		lowstringency_pd_outliers	HALLMARK_COMPLEMENT(7/200),REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS(2/33)
METTL7B	TH34_1239_S01	v7		lowstringency_pd_outliers	HALLMARK_INTERFERON_GAMMA_RESPONSE(5/200)
MMP8	TH34_1239_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(15/1028),NABA_MATRISOME_ASSOCIATED(13/753),HALLMARK_COMPLEMENT(7/200),HALLMARK_COAGULATION(4/138),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(3/87),REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX(2/29)
MMP9	TH34_1239_S01	v7	BEVACIZUMAB	lowstringency_pd_outliers	HALLMARK_ALLOGRAFT_REJECTION(10/200),NABA_MATRISOME(15/1028),NABA_MATRISOME_ASSOCIATED(13/753),HALLMARK_COAGULATION(4/138),PID_FGF_PATHWAY(3/55),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(3/87),PID_CXCR4_PATHWAY(3/102),REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX(2/29),PID_FRA_PATHWAY(2/37)
MSLN	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
MVD	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
NCAM1	TH34_1239_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(16/933),KEGG_PRION_DISEASES(4/35),KEGG_CELL_ADHESION_MOLECULES_CAMS(5/134),REACTOME_NCAM1_INTERACTIONS(3/39),PID_FGF_PATHWAY(3/55),REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH(3/64),REACTOME_AXON_GUIDANCE(4/251)
OAZ1	TH34_1239_S01	v7		lowstringency_pd_outliers	PID_AURORA_A_PATHWAY(2/31)
OLFM4	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
ORM1	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
PGLYRP1	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
PITX1	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
PKIB	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
PRF1	TH34_1239_S01	v7		lowstringency_pd_outliers	HALLMARK_ALLOGRAFT_REJECTION(10/200),PID_CD8_TCR_DOWNSTREAM_PATHWAY(6/65),KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY(6/137),BIOCARTA_SET_PATHWAY(3/11),PID_CD8_TCR_PATHWAY(4/53),BIOCARTA_CTL_PATHWAY(3/15),KEGG_ALLOGRAFT_REJECTION(3/38),KEGG_GRAFT_VERSUS_HOST_DISEASE(3/42),KEGG_TYPE_I_DIABETES_MELLITUS(3/44),KEGG_AUTOIMMUNE_THYROID_DISEASE(3/53),BIOCARTA_D4GDI_PATHWAY(2/13),SA_CASPASE_CASCADE(2/19),BIOCARTA_CASPASE_PATHWAY(2/23),PID_IL2_STAT5_PATHWAY(2/30),PID_IL12_STAT4_PATHWAY(2/33)
RGL4	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
RP11-326C3.2	TH34_1239_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
S100B	TH34_1239_S01	v7		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(16/933),NABA_MATRISOME(15/1028),NABA_MATRISOME_ASSOCIATED(13/753),REACTOME_INNATE_IMMUNE_SYSTEM(9/279)
SDC2	TH34_1239_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(15/1028),NABA_MATRISOME_ASSOCIATED(13/753),NABA_ECM_AFFILIATED(6/171),KEGG_CELL_ADHESION_MOLECULES_CAMS(5/134),PID_FGF_PATHWAY(3/55),KEGG_ECM_RECEPTOR_INTERACTION(3/84)
SERINC2	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
SHOX2	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
SLPI	TH34_1239_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(15/1028),NABA_MATRISOME_ASSOCIATED(13/753)
TCN1	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
TGFBI	TH34_1239_S01	v7		lowstringency_pd_outliers	NABA_MATRISOME(15/1028),PID_INTEGRIN1_PATHWAY(3/66)
TMSB4XP6	TH34_1239_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TRDC	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
XAGE1B	TH34_1239_S01	v7		lowstringency_pd_outliers	NA
AC005943.6	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACTA1	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200),BIOCARTA_NO1_PATHWAY(3/33),PID_AP1_PATHWAY(3/70)
ACTC1	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200),KEGG_CARDIAC_MUSCLE_CONTRACTION(8/80),KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM(6/85),KEGG_DILATED_CARDIOMYOPATHY(6/92),HALLMARK_KRAS_SIGNALING_DN(6/200)
ADSL	TH34_1240_S01	v7		lowstringency_pd_outliers	KEGG_PURINE_METABOLISM(7/159),REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS(2/11),REACTOME_METABOLISM_OF_NUCLEOTIDES(3/72)
AIMP2	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(8/58),HALLMARK_MYC_TARGETS_V1(9/200)
AL132780.1	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL592211.1	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL662801.1	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ALG3	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(16/518)
ANKRD1	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
ANKRD2	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200)
ARMC6	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
ATAD3A	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
ATP1B3	TH34_1240_S01	v7		lowstringency_pd_outliers	KEGG_CARDIAC_MUSCLE_CONTRACTION(8/80),HALLMARK_ADIPOGENESIS(5/200)
ATP5D	TH34_1240_S01	v7		lowstringency_pd_outliers	KEGG_HUNTINGTONS_DISEASE(8/185),KEGG_OXIDATIVE_PHOSPHORYLATION(6/135),HALLMARK_OXIDATIVE_PHOSPHORYLATION(6/200),KEGG_PARKINSONS_DISEASE(5/133),KEGG_ALZHEIMERS_DISEASE(5/169),REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_(4/98),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(4/141)
ATP6V1F	TH34_1240_S01	v7		lowstringency_pd_outliers	KEGG_OXIDATIVE_PHOSPHORYLATION(6/135),HALLMARK_OXIDATIVE_PHOSPHORYLATION(6/200)
BOLA3	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
C7orf55	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
CA3	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
CAMKV	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
CASQ1	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200)
CBS	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
CCDC167	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
CD320	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
CDKN2A	TH34_1240_S01	v7	LETROZOLE,PALBOCICLIB,PALBOCICLIB (PD0332991),Letrozole,PD 0332991,PANITUMUMAB,PD0332991,Palbociclib	lowstringency_pd_outliers	BIOCARTA_ARF_PATHWAY(3/17),REACTOME_G1_PHASE(3/38),HALLMARK_E2F_TARGETS(5/200),REACTOME_MITOTIC_G1_G1_S_PHASES(4/137),PID_AP1_PATHWAY(3/70),REACTOME_CELL_CYCLE(6/421),BIOCARTA_CTCF_PATHWAY(2/23)
CKM	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200),HALLMARK_KRAS_SIGNALING_DN(6/200),KEGG_ARGININE_AND_PROLINE_METABOLISM(3/54)
COX6A2	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200),KEGG_CARDIAC_MUSCLE_CONTRACTION(8/80),KEGG_HUNTINGTONS_DISEASE(8/185),KEGG_OXIDATIVE_PHOSPHORYLATION(6/135),KEGG_PARKINSONS_DISEASE(5/133),KEGG_ALZHEIMERS_DISEASE(5/169)
CSRP3	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200)
CTA-29F11.1	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-2017F17.2	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DANCR	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DDT	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(5/200)
DDX56	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
DES	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200),REACTOME_STRIATED_MUSCLE_CONTRACTION(11/27),REACTOME_MUSCLE_CONTRACTION(11/48),KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM(6/85),KEGG_DILATED_CARDIOMYOPATHY(6/92)
DKC1	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(6/421)
DNAJC2	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
DPM3	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(16/518)
ENO3	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200)
FABP3	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200)
FAM136A	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
FAM195A	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
FAM207A	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
FOXP4-AS1	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GAL	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
GCAT	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
GNL2	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
GUK1	TH34_1240_S01	v7		lowstringency_pd_outliers	KEGG_PURINE_METABOLISM(7/159),HALLMARK_DNA_REPAIR(5/150),REACTOME_METABOLISM_OF_NUCLEOTIDES(3/72)
HIST1H4J	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_TRANSCRIPTION(5/210),REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION(4/122),REACTOME_CELL_CYCLE(6/421)
HSPB7	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
IMPDH1	TH34_1240_S01	v7		lowstringency_pd_outliers	KEGG_PURINE_METABOLISM(7/159),REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS(2/11),REACTOME_METABOLISM_OF_NUCLEOTIDES(3/72)
KIAA0020	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
KLHL41	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
KRT8	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
KRTCAP2	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
LDB3	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200)
LRFN4	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
LSM7	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(9/200)
MAP7D2	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
MB	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200)
MROH2A	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MRPL4	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
MRPS17	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
MRPS21	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
MRPS24	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
MRPS25	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
MT-CO2	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CO3	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND2	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND3	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND4	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTND2P28	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MUC6	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(16/518)
MUSTN1	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
MYBPC1	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_STRIATED_MUSCLE_CONTRACTION(11/27),REACTOME_MUSCLE_CONTRACTION(11/48)
MYC	TH34_1240_S01	v7	PREXASERTIB	lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(8/58),HALLMARK_MYC_TARGETS_V1(9/200),BIOCARTA_ARF_PATHWAY(3/17),REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION(3/27),REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER(3/38),HALLMARK_E2F_TARGETS(5/200),REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION(3/46),REACTOME_MITOTIC_G1_G1_S_PHASES(4/137),REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(3/63),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(3/65),PID_AP1_PATHWAY(3/70),REACTOME_SIGNALING_BY_NOTCH1(3/70),REACTOME_CELL_CYCLE(6/421),BIOCARTA_CTCF_PATHWAY(2/23)
MYH2	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200),KEGG_TIGHT_JUNCTION(4/134)
MYH7	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200),KEGG_CARDIAC_MUSCLE_CONTRACTION(8/80),KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM(6/85),KEGG_DILATED_CARDIOMYOPATHY(6/92),HALLMARK_KRAS_SIGNALING_DN(6/200),KEGG_TIGHT_JUNCTION(4/134)
MYL1	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200),REACTOME_STRIATED_MUSCLE_CONTRACTION(11/27),REACTOME_MUSCLE_CONTRACTION(11/48)
MYL2	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200),REACTOME_STRIATED_MUSCLE_CONTRACTION(11/27),REACTOME_MUSCLE_CONTRACTION(11/48),KEGG_CARDIAC_MUSCLE_CONTRACTION(8/80),KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM(6/85),KEGG_DILATED_CARDIOMYOPATHY(6/92),KEGG_TIGHT_JUNCTION(4/134)
MYL3	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200),REACTOME_STRIATED_MUSCLE_CONTRACTION(11/27),REACTOME_MUSCLE_CONTRACTION(11/48),KEGG_CARDIAC_MUSCLE_CONTRACTION(8/80),KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM(6/85),KEGG_DILATED_CARDIOMYOPATHY(6/92)
MYLPF	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200),KEGG_TIGHT_JUNCTION(4/134)
MYOT	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_DN(6/200)
MZB1	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
NCLN	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
NDUFB7	TH34_1240_S01	v7		lowstringency_pd_outliers	KEGG_HUNTINGTONS_DISEASE(8/185),KEGG_OXIDATIVE_PHOSPHORYLATION(6/135),HALLMARK_OXIDATIVE_PHOSPHORYLATION(6/200),KEGG_PARKINSONS_DISEASE(5/133),KEGG_ALZHEIMERS_DISEASE(5/169),REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_(4/98),HALLMARK_ADIPOGENESIS(5/200),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(4/141),REACTOME_RESPIRATORY_ELECTRON_TRANSPORT(3/79)
NDUFB9	TH34_1240_S01	v7		lowstringency_pd_outliers	KEGG_HUNTINGTONS_DISEASE(8/185),KEGG_OXIDATIVE_PHOSPHORYLATION(6/135),KEGG_PARKINSONS_DISEASE(5/133),KEGG_ALZHEIMERS_DISEASE(5/169),REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_(4/98),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(4/141),REACTOME_RESPIRATORY_ELECTRON_TRANSPORT(3/79)
NEB	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_STRIATED_MUSCLE_CONTRACTION(11/27),REACTOME_MUSCLE_CONTRACTION(11/48)
NOS3	TH34_1240_S01	v7		lowstringency_pd_outliers	BIOCARTA_NO1_PATHWAY(3/33),KEGG_ARGININE_AND_PROLINE_METABOLISM(3/54)
OTX2	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
PDIA2	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
PDIA5	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
PES1	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(8/58)
PET100	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PFDN2	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(16/518)
POLR1C	TH34_1240_S01	v7		lowstringency_pd_outliers	KEGG_PURINE_METABOLISM(7/159),KEGG_RNA_POLYMERASE(4/29),BIOCARTA_ARF_PATHWAY(3/17),REACTOME_RNA_POL_III_CHAIN_ELONGATION(3/17),REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION(3/19),REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER(3/23),REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER(3/26),HALLMARK_DNA_REPAIR(5/150),REACTOME_RNA_POL_III_TRANSCRIPTION(3/33),KEGG_PYRIMIDINE_METABOLISM(4/98),REACTOME_TRANSCRIPTION(5/210),REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION(4/122),REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION(2/22)
POLR2F	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION(12/169),REACTOME_INFLUENZA_LIFE_CYCLE(12/203),KEGG_HUNTINGTONS_DISEASE(8/185),KEGG_PURINE_METABOLISM(7/159),KEGG_RNA_POLYMERASE(4/29),REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS(3/14),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(4/45),REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE(5/104),REACTOME_RNA_POL_III_CHAIN_ELONGATION(3/17),REACTOME_DNA_REPAIR(5/112),REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION(3/19),HALLMARK_OXIDATIVE_PHOSPHORYLATION(6/200),REACTOME_HIV_LIFE_CYCLE(5/125),REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER(3/23),REACTOME_MICRORNA_MIRNA_BIOGENESIS(3/23),REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT(3/23),REACTOME_REGULATORY_RNA_PATHWAYS(3/26),REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER(3/26),HALLMARK_DNA_REPAIR(5/150),REACTOME_MRNA_CAPPING(3/30),REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX(3/30),REACTOME_ELONGATION_ARREST_AND_RECOVERY(3/32),REACTOME_RNA_POL_III_TRANSCRIPTION(3/33),REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX(3/34),KEGG_PYRIMIDINE_METABOLISM(4/98),REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING(3/41),REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER(3/45),REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_(3/45),REACTOME_MRNA_SPLICING(4/111),REACTOME_HIV_INFECTION(5/207),REACTOME_TRANSCRIPTION(5/210),REACTOME_NUCLEOTIDE_EXCISION_REPAIR(3/51),REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION(4/122),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(4/140),REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS(3/61),REACTOME_MRNA_PROCESSING(4/161)
POLR2H	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION(12/169),REACTOME_INFLUENZA_LIFE_CYCLE(12/203),KEGG_HUNTINGTONS_DISEASE(8/185),KEGG_PURINE_METABOLISM(7/159),KEGG_RNA_POLYMERASE(4/29),REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS(3/14),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(4/45),REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE(5/104),REACTOME_RNA_POL_III_CHAIN_ELONGATION(3/17),REACTOME_DNA_REPAIR(5/112),REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION(3/19),REACTOME_HIV_LIFE_CYCLE(5/125),REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER(3/23),REACTOME_MICRORNA_MIRNA_BIOGENESIS(3/23),REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT(3/23),REACTOME_REGULATORY_RNA_PATHWAYS(3/26),REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER(3/26),HALLMARK_DNA_REPAIR(5/150),REACTOME_MRNA_CAPPING(3/30),REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX(3/30),REACTOME_ELONGATION_ARREST_AND_RECOVERY(3/32),REACTOME_RNA_POL_III_TRANSCRIPTION(3/33),REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX(3/34),KEGG_PYRIMIDINE_METABOLISM(4/98),REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING(3/41),REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER(3/45),REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_(3/45),REACTOME_MRNA_SPLICING(4/111),REACTOME_HIV_INFECTION(5/207),REACTOME_TRANSCRIPTION(5/210),REACTOME_NUCLEOTIDE_EXCISION_REPAIR(3/51),REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION(4/122),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(4/140),REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS(3/61),REACTOME_MRNA_PROCESSING(4/161),REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION(2/22)
POLR2J	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION(12/169),REACTOME_INFLUENZA_LIFE_CYCLE(12/203),KEGG_HUNTINGTONS_DISEASE(8/185),KEGG_PURINE_METABOLISM(7/159),KEGG_RNA_POLYMERASE(4/29),REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS(3/14),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(4/45),REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE(5/104),REACTOME_DNA_REPAIR(5/112),REACTOME_HIV_LIFE_CYCLE(5/125),REACTOME_MICRORNA_MIRNA_BIOGENESIS(3/23),REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT(3/23),REACTOME_REGULATORY_RNA_PATHWAYS(3/26),HALLMARK_DNA_REPAIR(5/150),REACTOME_MRNA_CAPPING(3/30),REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX(3/30),REACTOME_ELONGATION_ARREST_AND_RECOVERY(3/32),REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX(3/34),KEGG_PYRIMIDINE_METABOLISM(4/98),REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING(3/41),REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER(3/45),REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_(3/45),REACTOME_MRNA_SPLICING(4/111),REACTOME_HIV_INFECTION(5/207),REACTOME_TRANSCRIPTION(5/210),REACTOME_NUCLEOTIDE_EXCISION_REPAIR(3/51),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(4/140),REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS(3/61),REACTOME_MRNA_PROCESSING(4/161)
POP7	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(5/200)
PPAN	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(8/58)
PPP1R27	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
PRDX4	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(9/200),HALLMARK_E2F_TARGETS(5/200)
PRR34-AS1	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PSMG3	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
PSMG4	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
PUSL1	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
PYGM	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200)
RHCG	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
RNU1-1	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
RNU1-28P	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RNU1-3	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
RNVU1-18	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP1-20B21.4	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-150O12.6	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-229E13.4	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-410L14.2	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-451G4.2	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-603J24.17	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP5-857K21.11	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP5-857K21.7	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP5-940J5.9	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP9	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
RPL18A	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION(12/169),REACTOME_INFLUENZA_LIFE_CYCLE(12/203),REACTOME_METABOLISM_OF_PROTEINS(16/518),KEGG_RIBOSOME(9/88),REACTOME_PEPTIDE_CHAIN_ELONGATION(9/153),REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION(9/176),REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX(9/176),REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE(9/179),REACTOME_TRANSLATION(9/222),REACTOME_METABOLISM_OF_MRNA(9/284),REACTOME_METABOLISM_OF_RNA(9/330)
RPL36	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION(12/169),REACTOME_INFLUENZA_LIFE_CYCLE(12/203),REACTOME_METABOLISM_OF_PROTEINS(16/518),KEGG_RIBOSOME(9/88),REACTOME_PEPTIDE_CHAIN_ELONGATION(9/153),REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION(9/176),REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX(9/176),REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE(9/179),REACTOME_TRANSLATION(9/222),REACTOME_METABOLISM_OF_MRNA(9/284),REACTOME_METABOLISM_OF_RNA(9/330)
RPLP1	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION(12/169),REACTOME_INFLUENZA_LIFE_CYCLE(12/203),REACTOME_METABOLISM_OF_PROTEINS(16/518),KEGG_RIBOSOME(9/88),REACTOME_PEPTIDE_CHAIN_ELONGATION(9/153),REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION(9/176),REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX(9/176),REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE(9/179),REACTOME_TRANSLATION(9/222),REACTOME_METABOLISM_OF_MRNA(9/284),REACTOME_METABOLISM_OF_RNA(9/330)
RPS10	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION(12/169),REACTOME_INFLUENZA_LIFE_CYCLE(12/203),REACTOME_METABOLISM_OF_PROTEINS(16/518),KEGG_RIBOSOME(9/88),REACTOME_PEPTIDE_CHAIN_ELONGATION(9/153),REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION(9/176),REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX(9/176),REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE(9/179),HALLMARK_MYC_TARGETS_V1(9/200),REACTOME_TRANSLATION(9/222),REACTOME_METABOLISM_OF_MRNA(9/284),REACTOME_METABOLISM_OF_RNA(9/330),REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX(5/74),REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S(5/84)
RPS15	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION(12/169),REACTOME_INFLUENZA_LIFE_CYCLE(12/203),REACTOME_METABOLISM_OF_PROTEINS(16/518),KEGG_RIBOSOME(9/88),REACTOME_PEPTIDE_CHAIN_ELONGATION(9/153),REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION(9/176),REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX(9/176),REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE(9/179),REACTOME_TRANSLATION(9/222),REACTOME_METABOLISM_OF_MRNA(9/284),REACTOME_METABOLISM_OF_RNA(9/330),REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX(5/74),REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S(5/84)
RPS17	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION(12/169),REACTOME_INFLUENZA_LIFE_CYCLE(12/203),REACTOME_METABOLISM_OF_PROTEINS(16/518),KEGG_RIBOSOME(9/88),REACTOME_PEPTIDE_CHAIN_ELONGATION(9/153),REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION(9/176),REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX(9/176),REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE(9/179),REACTOME_TRANSLATION(9/222),REACTOME_METABOLISM_OF_MRNA(9/284),REACTOME_METABOLISM_OF_RNA(9/330),REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX(5/74),REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S(5/84)
RPS27A	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION(12/169),REACTOME_INFLUENZA_LIFE_CYCLE(12/203),REACTOME_METABOLISM_OF_PROTEINS(16/518),KEGG_RIBOSOME(9/88),REACTOME_PEPTIDE_CHAIN_ELONGATION(9/153),REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION(9/176),REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX(9/176),REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE(9/179),REACTOME_TRANSLATION(9/222),REACTOME_METABOLISM_OF_MRNA(9/284),REACTOME_METABOLISM_OF_RNA(9/330),REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX(5/74),REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S(5/84),REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE(5/104),REACTOME_DNA_REPAIR(5/112),REACTOME_HIV_LIFE_CYCLE(5/125),REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION(3/27),REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER(3/38),REACTOME_G1_PHASE(3/38),REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION(2/9),REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION(3/46),REACTOME_HIV_INFECTION(5/207),REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS(2/10),REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL(2/11),REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY(2/11),REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING(2/12),REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES(2/12),REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR(2/12),REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING(2/14),REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX(2/14),REACTOME_P75NTR_SIGNALS_VIA_NFKB(2/14),REACTOME_MITOTIC_G1_G1_S_PHASES(4/137),REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON(2/14),REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX(2/14),REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(3/63),REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS(2/15),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(3/65),REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION(2/16),REACTOME_SIGNALING_BY_NOTCH1(3/70),REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR(2/18),REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA(2/18),REACTOME_CELL_CYCLE(6/421),REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY(2/20)
RPS28	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION(12/169),REACTOME_INFLUENZA_LIFE_CYCLE(12/203),REACTOME_METABOLISM_OF_PROTEINS(16/518),KEGG_RIBOSOME(9/88),REACTOME_PEPTIDE_CHAIN_ELONGATION(9/153),REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION(9/176),REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX(9/176),REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE(9/179),REACTOME_TRANSLATION(9/222),REACTOME_METABOLISM_OF_MRNA(9/284),REACTOME_METABOLISM_OF_RNA(9/330),REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX(5/74),REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S(5/84)
RRP9	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(8/58),HALLMARK_MYC_TARGETS_V1(9/200)
S100A1	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
SLC19A1	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(8/58),HALLMARK_ADIPOGENESIS(5/200)
SLIRP	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
SLN	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200)
SMIM4	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SMPX	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_DN(6/200)
SNHG19	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SNHG25	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SNHG9	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
SNORA76C	TH34_1240_S01	v7		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SRM	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(8/58),HALLMARK_MYC_TARGETS_V1(9/200),KEGG_ARGININE_AND_PROLINE_METABOLISM(3/54)
SSBP1	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(9/200)
TATDN1	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
TBRG4	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(8/58),HALLMARK_E2F_TARGETS(5/200)
TCAP	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200),REACTOME_STRIATED_MUSCLE_CONTRACTION(11/27),REACTOME_MUSCLE_CONTRACTION(11/48)
TG	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_DN(6/200)
THOC7	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
TIMM13	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(16/518),HALLMARK_OXIDATIVE_PHOSPHORYLATION(6/200),REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT(3/58)
TNNC1	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200),REACTOME_STRIATED_MUSCLE_CONTRACTION(11/27),REACTOME_MUSCLE_CONTRACTION(11/48),KEGG_CARDIAC_MUSCLE_CONTRACTION(8/80),KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM(6/85),KEGG_DILATED_CARDIOMYOPATHY(6/92)
TNNC2	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200),REACTOME_STRIATED_MUSCLE_CONTRACTION(11/27),REACTOME_MUSCLE_CONTRACTION(11/48)
TNNI1	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200),REACTOME_STRIATED_MUSCLE_CONTRACTION(11/27),REACTOME_MUSCLE_CONTRACTION(11/48),BIOCARTA_NO1_PATHWAY(3/33)
TNNI2	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(25/200),REACTOME_STRIATED_MUSCLE_CONTRACTION(11/27),REACTOME_MUSCLE_CONTRACTION(11/48)
TOMM5	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(16/518),REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT(3/58)
TOMM7	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(16/518),REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT(3/58)
TRAPPC5	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
TSSC2	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
TXNL4A	TH34_1240_S01	v7		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(9/200),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(4/45),REACTOME_MRNA_SPLICING(4/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(4/140),REACTOME_MRNA_PROCESSING(4/161)
UBA52	TH34_1240_S01	v7		lowstringency_pd_outliers	REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION(12/169),REACTOME_INFLUENZA_LIFE_CYCLE(12/203),REACTOME_METABOLISM_OF_PROTEINS(16/518),KEGG_RIBOSOME(9/88),REACTOME_PEPTIDE_CHAIN_ELONGATION(9/153),REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION(9/176),REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX(9/176),REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE(9/179),REACTOME_TRANSLATION(9/222),REACTOME_METABOLISM_OF_MRNA(9/284),REACTOME_METABOLISM_OF_RNA(9/330),REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE(5/104),REACTOME_DNA_REPAIR(5/112),REACTOME_HIV_LIFE_CYCLE(5/125),REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION(3/27),REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER(3/38),REACTOME_G1_PHASE(3/38),REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION(2/9),REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION(3/46),REACTOME_HIV_INFECTION(5/207),REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS(2/10),REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL(2/11),REACTOME_REGULATION_OF_THE_FANCONI_ANEMIA_PATHWAY(2/11),REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING(2/12),REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES(2/12),REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR(2/12),REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING(2/14),REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX(2/14),REACTOME_P75NTR_SIGNALS_VIA_NFKB(2/14),REACTOME_MITOTIC_G1_G1_S_PHASES(4/137),REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_EPSILON(2/14),REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX(2/14),REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(3/63),REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS(2/15),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(3/65),REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION(2/16),REACTOME_SIGNALING_BY_NOTCH1(3/70),REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR(2/18),REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA(2/18),REACTOME_CELL_CYCLE(6/421),REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY(2/20)
UNC93B1	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
UQCR11	TH34_1240_S01	v7		lowstringency_pd_outliers	KEGG_CARDIAC_MUSCLE_CONTRACTION(8/80),KEGG_HUNTINGTONS_DISEASE(8/185),KEGG_OXIDATIVE_PHOSPHORYLATION(6/135),HALLMARK_OXIDATIVE_PHOSPHORYLATION(6/200),KEGG_PARKINSONS_DISEASE(5/133),KEGG_ALZHEIMERS_DISEASE(5/169),REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_(4/98),HALLMARK_ADIPOGENESIS(5/200),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(4/141),REACTOME_RESPIRATORY_ELECTRON_TRANSPORT(3/79)
WDR18	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
WDR4	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
WDR46	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
XIRP2	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
YDJC	TH34_1240_S01	v7		lowstringency_pd_outliers	NA
AAMP	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ABCC4	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(17/466),HALLMARK_ANDROGEN_RESPONSE(5/101)
ABCC5	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(11/200)
AC004540.4	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC005154.6	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC006449.2	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC007620.3	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC132217.4	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACACB	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(16/478),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(6/120),KEGG_INSULIN_SIGNALING_PATHWAY(6/137)
ACIN1	TH34_1349_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(6/128)
ADCY2	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(6/54),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(7/100),REACTOME_SIGNALING_BY_FGFR(7/112),KEGG_PURINE_METABOLISM(8/159),REACTOME_SIGNALING_BY_PDGF(7/122),REACTOME_CA_DEPENDENT_EVENTS(4/30),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(7/127),REACTOME_SIGNALLING_BY_NGF(9/217),REACTOME_DAG_AND_IP3_SIGNALING(4/32),REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION(4/34),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(7/137),REACTOME_SIGNALING_BY_ERBB2(6/101),REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB(3/18),KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(6/115),REACTOME_PLC_BETA_MEDIATED_EVENTS(4/43),REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS(4/44),REACTOME_OPIOID_SIGNALLING(5/78),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(6/120),REACTOME_G_ALPHA_S_SIGNALLING_EVENTS(6/121),REACTOME_AQUAPORIN_MEDIATED_TRANSPORT(4/51),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(5/95)
ADGRA2	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADGRL2	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADRA1B	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(11/200),KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(6/115)
AES	TH34_1349_S01	v8		lowstringency_pd_outliers	PID_BETA_CATENIN_NUC_PATHWAY(5/80)
AFAP1L2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
AFMID	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
AGAP3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
AGFG2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
AHSA2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
AKAP8L	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
AKIP1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
AKTIP	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
AL162151.3	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL442127.1	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL662801.1	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ALCAM	TH34_1349_S01	v8	5-FLUOROURACIL	lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(13/200),KEGG_CELL_ADHESION_MOLECULES_CAMS(10/134),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(10/251),REACTOME_L1CAM_INTERACTIONS(6/86)
ALDH1A3	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(12/200),HALLMARK_ANDROGEN_RESPONSE(5/101),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(4/62)
ALDOC	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(9/200),REACTOME_GLYCOLYSIS(3/29),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(4/62)
AMPD2	TH34_1349_S01	v8		lowstringency_pd_outliers	KEGG_PURINE_METABOLISM(8/159)
AMPD3	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(9/200),KEGG_PURINE_METABOLISM(8/159)
AMT	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ANK3	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(10/251),REACTOME_L1CAM_INTERACTIONS(6/86)
ANKRA2	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(11/200)
ANKS1A	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ANKZF1	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(9/200)
ANO1	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(12/200)
ANXA3	TH34_1349_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028)
AP1S2	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(18/933)
APBB3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
APLN	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
APLP1	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(13/200),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(8/200)
APLP2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
APP	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(17/466),HALLMARK_MYOGENESIS(11/200),HALLMARK_P53_PATHWAY(11/200),BIOCARTA_PLATELETAPP_PATHWAY(3/14),PID_GLYPICAN_1PATHWAY(3/27),REACTOME_IMMUNE_SYSTEM(18/933)
ARGLU1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ARHGEF40	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ARMC9	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ARPC2	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(11/200)
ARRDC3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ARSB	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(16/478),REACTOME_PHOSPHOLIPID_METABOLISM(7/198)
ASIC3	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
BAZ2A	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
BBS1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
BCAP29	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
BDH2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
BMP2K	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(8/200)
BOD1L1	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
BRD8	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
C11orf58	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
C11orf84	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
C16orf45	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
C1QL1	TH34_1349_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028)
C1RL	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
C1orf54	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
C4A	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(18/933)
C4B	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
C5orf45	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
C5orf56	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CA11	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CA2	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(13/200),HALLMARK_KRAS_SIGNALING_UP(12/200),HALLMARK_ESTROGEN_RESPONSE_LATE(10/200),HALLMARK_HEME_METABOLISM(8/200),HALLMARK_UV_RESPONSE_UP(7/158)
CADM1	TH34_1349_S01	v8		lowstringency_pd_outliers	KEGG_CELL_ADHESION_MOLECULES_CAMS(10/134),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(8/200)
CALCOCO1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CBX7	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CCDC159	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CCKBR	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CCNJL	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CCNL2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CD200	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CD27-AS1	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CD34	TH34_1349_S01	v8		lowstringency_pd_outliers	KEGG_CELL_ADHESION_MOLECULES_CAMS(10/134),HALLMARK_APICAL_JUNCTION(11/200),REACTOME_IMMUNE_SYSTEM(18/933)
CD81	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(13/200),HALLMARK_P53_PATHWAY(11/200),PID_INTEGRIN1_PATHWAY(5/66),REACTOME_IMMUNE_SYSTEM(18/933)
CDC42EP2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CDH2	TH34_1349_S01	v8		lowstringency_pd_outliers	KEGG_CELL_ADHESION_MOLECULES_CAMS(10/134),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(8/200),PID_AJDISS_2PATHWAY(4/48)
CDK20	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CDKN1B	TH34_1349_S01	v8	LAPATINIB	lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_DN(9/144),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(7/100),REACTOME_SIGNALING_BY_FGFR(7/112),HALLMARK_HYPOXIA(9/200),REACTOME_SIGNALING_BY_PDGF(7/122),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(7/127),REACTOME_SIGNALLING_BY_NGF(9/217),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(7/137),REACTOME_SIGNALING_BY_ERBB2(6/101),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(5/95),REACTOME_IMMUNE_SYSTEM(18/933)
CES2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CH17-232I21.1	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CHD2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CHD3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CHN1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CHN2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CIRBP	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CLASP2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CLEC11A	TH34_1349_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028)
CLK3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CMSS1	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CNTN1	TH34_1349_S01	v8		lowstringency_pd_outliers	KEGG_CELL_ADHESION_MOLECULES_CAMS(10/134),HALLMARK_APICAL_JUNCTION(11/200),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(10/251),REACTOME_L1CAM_INTERACTIONS(6/86)
COG5	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
COL13A1	TH34_1349_S01	v8		lowstringency_pd_outliers	NABA_CORE_MATRISOME(14/275),NABA_MATRISOME(26/1028)
COL4A5	TH34_1349_S01	v8		lowstringency_pd_outliers	NABA_CORE_MATRISOME(14/275),NABA_MATRISOME(26/1028),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(10/251),REACTOME_SIGNALING_BY_PDGF(7/122),BIOCARTA_PLATELETAPP_PATHWAY(3/14),PID_INTEGRIN1_PATHWAY(5/66),REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH(4/64)
CPE	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(12/200),HALLMARK_ESTROGEN_RESPONSE_LATE(10/200)
CPED1	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CREBZF	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CRELD1	TH34_1349_S01	v8		lowstringency_pd_outliers	NABA_ECM_GLYCOPROTEINS(12/196),NABA_CORE_MATRISOME(14/275),NABA_MATRISOME(26/1028)
CREM	TH34_1349_S01	v8		lowstringency_pd_outliers	BIOCARTA_DREAM_PATHWAY(3/14)
CRMP1	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),HALLMARK_HEDGEHOG_SIGNALING(5/36),REACTOME_AXON_GUIDANCE(10/251)
CSAD	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CSRP2	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(9/200)
CTD-3064M3.3	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-3064M3.7	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTDSPL	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
CYP39A1	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(16/478)
CYP3A7	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
DAAM1	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(8/200)
DAB2IP	TH34_1349_S01	v8		lowstringency_pd_outliers	PID_RAS_PATHWAY(3/30)
DACT1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
DDX24	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
DDX26B	TH34_1349_S01	v8		lowstringency_pd_outliers	NABA_ECM_GLYCOPROTEINS(12/196),NABA_CORE_MATRISOME(14/275),NABA_MATRISOME(26/1028)
DDX5	TH34_1349_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(6/128)
DENR	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
DLG4	TH34_1349_S01	v8		lowstringency_pd_outliers	ST_GA12_PATHWAY(4/23),HALLMARK_UV_RESPONSE_UP(7/158),BIOCARTA_NOS1_PATHWAY(3/24)
DMAP1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
DMPK	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(11/200)
DNAJC1	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(10/200)
DOCK6	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(17/466),REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION(6/132)
DOCK9	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(17/466),REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION(6/132)
DPH1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
DPP10	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
DPP7	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
DZIP1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ECM1	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(13/200),NABA_ECM_GLYCOPROTEINS(12/196),NABA_CORE_MATRISOME(14/275),NABA_MATRISOME(26/1028),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(8/200)
EHBP1L1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
EID1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
EIF2B5	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ENO2	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(9/200),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(8/200),HALLMARK_UV_RESPONSE_UP(7/158),REACTOME_GLYCOLYSIS(3/29),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(4/62)
EPN2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ERP29	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ETV1	TH34_1349_S01	v8	TRAMETINIB	lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(12/200)
EXTL3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
F2RL2	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(13/200),REACTOME_HEMOSTASIS(17/466),ST_GA12_PATHWAY(4/23)
FABP4	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(16/478)
FAM131A	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
FAM156A	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
FAM193B	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
FAM219B	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FBXO9	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(8/200)
FCHSD1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
FENDRR	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FGD5	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
FGF4	TH34_1349_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(6/54),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(7/100),REACTOME_SIGNALING_BY_FGFR(7/112),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(7/127),PID_BETA_CATENIN_NUC_PATHWAY(5/80)
FGFR1	TH34_1349_S01	v8	[Lucitanib],INFIGRATINIB,AZD-4547,BGJ-398,ORANTINIB,SU-6668,Regorafenib,LUCITANIB,PD173074,PONATINIB,MIDOSTAURIN,Ponatinib,Dovitinib,MASITINIB,AZD4547,Nintedanib,FGF/VEGF RECEPTOR TYROSINE KINASE INHIBITOR, PD173074,XL228,DOVITINIB,1058137-23-7,4-HYDROXYTAMOXIFEN,REGORAFENIB,NINTEDANIB,BGJ398,Lucitanib	lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(6/54),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(7/100),REACTOME_SIGNALING_BY_FGFR(7/112),REACTOME_AXON_GUIDANCE(10/251),REACTOME_L1CAM_INTERACTIONS(6/86),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(7/127),PID_GLYPICAN_1PATHWAY(3/27),REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH(4/64)
FGL2	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(13/200),NABA_ECM_GLYCOPROTEINS(12/196),NABA_CORE_MATRISOME(14/275),NABA_MATRISOME(26/1028)
FHL2	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_DN(9/144),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(16/478)
FLYWCH1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
FOXF1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
FREM1	TH34_1349_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028)
FXYD6	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
FYN	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(17/466),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),HALLMARK_UV_RESPONSE_DN(9/144),REACTOME_AXON_GUIDANCE(10/251),PID_REELIN_PATHWAY(4/29),REACTOME_SIGNALING_BY_ERBB2(6/101),PID_AJDISS_2PATHWAY(4/48),PID_GLYPICAN_1PATHWAY(3/27),REACTOME_IMMUNE_SYSTEM(18/933),REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH(4/64)
GABBR1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
GALT	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
GBA2	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(16/478),REACTOME_PHOSPHOLIPID_METABOLISM(7/198)
GBP2	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(18/933)
GCLC	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(8/200)
GDF11	TH34_1349_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028)
GDI1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
GEM	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(8/200)
GFRA1	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(10/251),PID_AJDISS_2PATHWAY(4/48),REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH(4/64)
GNG2	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(17/466),REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION(4/34),REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS(4/44),REACTOME_OPIOID_SIGNALLING(5/78),REACTOME_PLATELET_HOMEOSTASIS(5/78),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(6/120),REACTOME_G_ALPHA_S_SIGNALLING_EVENTS(6/121),REACTOME_AQUAPORIN_MEDIATED_TRANSPORT(4/51)
GOLGA2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
GOLPH3L	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
GPR162	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
GPR20	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
GRAMD3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
GSTM2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
GUCY1A3	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(12/200),REACTOME_HEMOSTASIS(17/466),REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE(4/25),KEGG_PURINE_METABOLISM(8/159),KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(6/115),REACTOME_PLATELET_HOMEOSTASIS(5/78),HALLMARK_ANDROGEN_RESPONSE(5/101)
GUCY1B3	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(13/200),REACTOME_HEMOSTASIS(17/466),REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE(4/25),KEGG_PURINE_METABOLISM(8/159),KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(6/115),REACTOME_PLATELET_HOMEOSTASIS(5/78)
H19	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
HAGH	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(8/200)
HAND2	TH34_1349_S01	v8		lowstringency_pd_outliers	BIOCARTA_NFAT_PATHWAY(4/56)
HAND2-AS1	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HDHD2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
HERC2P2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
HERC2P3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
HIF1AN	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
HIGD1A	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
HNRNPH1	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(7/140),REACTOME_MRNA_SPLICING(6/111),REACTOME_MRNA_PROCESSING(7/161)
HNRNPH3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
HOTAIRM1	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HOTAIRM1_5	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HOXA-AS2	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HOXA3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
HOXA4	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
HOXA5	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
HOXB3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
HSD17B12	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(16/478)
HSPA4L	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(11/200),HALLMARK_ESTROGEN_RESPONSE_LATE(10/200)
IDUA	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
IFT57	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
IGF2	TH34_1349_S01	v8	CABAZITAXEL,DOCETAXEL,OSI-906 (LINSITINIB)	lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(12/200),NABA_MATRISOME(26/1028),PID_AJDISS_2PATHWAY(4/48)
IK	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
IKBKB	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(9/217),KEGG_INSULIN_SIGNALING_PATHWAY(6/137),REACTOME_IMMUNE_SYSTEM(18/933)
IL11RA	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
IL18BP	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
INPP1	TH34_1349_S01	v8		lowstringency_pd_outliers	KEGG_INOSITOL_PHOSPHATE_METABOLISM(5/54),KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM(5/76)
INPP5A	TH34_1349_S01	v8		lowstringency_pd_outliers	KEGG_INOSITOL_PHOSPHATE_METABOLISM(5/54),KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM(5/76)
INPPL1	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(11/200),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(16/478),KEGG_INOSITOL_PHOSPHATE_METABOLISM(5/54),KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM(5/76),REACTOME_PHOSPHOLIPID_METABOLISM(7/198),REACTOME_IMMUNE_SYSTEM(18/933)
IQGAP2	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_ANDROGEN_RESPONSE(5/101)
IRF1	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(17/466),HALLMARK_UV_RESPONSE_UP(7/158),REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION(6/132),REACTOME_IMMUNE_SYSTEM(18/933)
ISCU	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(11/200)
ISOC1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ITGA10	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(11/200),PID_INTEGRIN1_PATHWAY(5/66)
JAM2	TH34_1349_S01	v8		lowstringency_pd_outliers	KEGG_CELL_ADHESION_MOLECULES_CAMS(10/134),REACTOME_HEMOSTASIS(17/466),PID_INTEGRIN1_PATHWAY(5/66)
KANK2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
KCNK3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
KHDRBS3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
KIAA0895L	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
KIAA1109	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
KIDINS220	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(9/217),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(7/137)
KIT	TH34_1349_S01	v8	MIDOSTAURIN,PLX3397,4'-N-BENZOYLSTAUROSPORINE,Nilotinib,SORAFENIB,MOTESANIB,cabozantinib,PLX-3397,CABOZANTINIB,Dasatinib,IMATINIB,SUNITINIB,TELATINIB,Regorafenib,NILOTINIB,PLX108-01,AXITINIB,TANDUTINIB,Sorafenib,Motesanib,MASITINIB,Pazopanib,Midostaurin,XL-820,IMATINIB MESYLATE,DASATINIB,AMUVATINIB,PEXIDARTINIB,Sunitinib,XL820,Imatinib,MP470,REGORAFENIB,PAZOPANIB	lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_DN(9/144),BIOCARTA_BAD_PATHWAY(3/26)
LAMB1	TH34_1349_S01	v8		lowstringency_pd_outliers	NABA_ECM_GLYCOPROTEINS(12/196),NABA_CORE_MATRISOME(14/275),NABA_MATRISOME(26/1028),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(10/251),REACTOME_L1CAM_INTERACTIONS(6/86),PID_INTEGRIN1_PATHWAY(5/66)
LARGE	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(11/200),HALLMARK_ESTROGEN_RESPONSE_LATE(10/200),HALLMARK_HYPOXIA(9/200)
LBH	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
LDB1	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_HEDGEHOG_SIGNALING(5/36)
LENG8	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
LGI4	TH34_1349_S01	v8		lowstringency_pd_outliers	NABA_ECM_GLYCOPROTEINS(12/196),NABA_CORE_MATRISOME(14/275),NABA_MATRISOME(26/1028)
LINC01089	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01184	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LMBR1L	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
LMO2	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(8/200)
LRPAP1	TH34_1349_S01	v8		lowstringency_pd_outliers	PID_REELIN_PATHWAY(4/29),PID_LIS1_PATHWAY(3/28)
LRRC4B	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
LRRN4CL	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
LSAMP	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
LTBP3	TH34_1349_S01	v8		lowstringency_pd_outliers	NABA_ECM_GLYCOPROTEINS(12/196),NABA_CORE_MATRISOME(14/275),NABA_MATRISOME(26/1028)
LTBP4	TH34_1349_S01	v8		lowstringency_pd_outliers	NABA_ECM_GLYCOPROTEINS(12/196),NABA_CORE_MATRISOME(14/275),NABA_MATRISOME(26/1028)
LUC7L	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
MAGEH1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
MAGI2-AS3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
MAN2C1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
MAP1B	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_DN(9/144),PID_REELIN_PATHWAY(4/29),PID_LIS1_PATHWAY(3/28)
MAP3K12	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
MAPK12	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(11/200),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_SIGNALLING_BY_NGF(9/217),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(7/137),REACTOME_IMMUNE_SYSTEM(18/933)
MAPRE3	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(11/200)
MARCH11	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
MC1R	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_G_ALPHA_S_SIGNALLING_EVENTS(6/121)
MEG3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
MEIS1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
MEIS3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
METTL7A	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
MIR143HG	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
MIR99AHG	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MLLT6	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
MOCS2	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(10/200)
MORF4L1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
MORF4L1P1	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MOXD1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
MSL1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
MT-ATP6	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ATP8	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CO1	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CO2	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CO3	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CYB	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND4	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND4L	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTATP6P1	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTERF4	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTFR1L	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MYEF2	TH34_1349_S01	v8		lowstringency_pd_outliers	ST_GA12_PATHWAY(4/23)
N4BP2L1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
NAB2	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(10/200)
NDN	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
NEFL	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
NELL1	TH34_1349_S01	v8		lowstringency_pd_outliers	NABA_ECM_GLYCOPROTEINS(12/196),NABA_CORE_MATRISOME(14/275),NABA_MATRISOME(26/1028)
NES	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
NFASC	TH34_1349_S01	v8		lowstringency_pd_outliers	KEGG_CELL_ADHESION_MOLECULES_CAMS(10/134),HALLMARK_APICAL_JUNCTION(11/200)
NFATC4	TH34_1349_S01	v8		lowstringency_pd_outliers	BIOCARTA_NFAT_PATHWAY(4/56)
NISCH	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
NKX3-2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
NLGN2	TH34_1349_S01	v8		lowstringency_pd_outliers	KEGG_CELL_ADHESION_MOLECULES_CAMS(10/134),HALLMARK_APICAL_JUNCTION(11/200)
NLGN4Y	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
NPIPA1	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPP1	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPTX1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
NRCAM	TH34_1349_S01	v8		lowstringency_pd_outliers	KEGG_CELL_ADHESION_MOLECULES_CAMS(10/134),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),HALLMARK_HEDGEHOG_SIGNALING(5/36),REACTOME_AXON_GUIDANCE(10/251),REACTOME_L1CAM_INTERACTIONS(6/86)
NSUN5P1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
NUB1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
NXF1	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(7/140),HALLMARK_UV_RESPONSE_UP(7/158),REACTOME_MRNA_PROCESSING(7/161),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(4/54)
OBSCN	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(9/217)
P3H3	TH34_1349_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028)
PAGR1	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PAIP2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
PAM	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(9/200)
PARP10	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
PCDHB10	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
PCDHGC3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
PCSK1N	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(12/200)
PDE1A	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(17/466),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(6/54),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(7/100),REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE(4/25),REACTOME_SIGNALING_BY_FGFR(7/112),KEGG_PURINE_METABOLISM(8/159),REACTOME_SIGNALING_BY_PDGF(7/122),REACTOME_CA_DEPENDENT_EVENTS(4/30),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(7/127),REACTOME_SIGNALLING_BY_NGF(9/217),REACTOME_DAG_AND_IP3_SIGNALING(4/32),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(7/137),REACTOME_SIGNALING_BY_ERBB2(6/101),REACTOME_PLC_BETA_MEDIATED_EVENTS(4/43),REACTOME_OPIOID_SIGNALLING(5/78),REACTOME_PLATELET_HOMEOSTASIS(5/78),REACTOME_G_ALPHA_S_SIGNALLING_EVENTS(6/121),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(5/95)
PDE3A	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(17/466),REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE(4/25),KEGG_PURINE_METABOLISM(8/159),REACTOME_PLATELET_HOMEOSTASIS(5/78),REACTOME_G_ALPHA_S_SIGNALLING_EVENTS(6/121),KEGG_INSULIN_SIGNALING_PATHWAY(6/137)
PDE8A	TH34_1349_S01	v8		lowstringency_pd_outliers	KEGG_PURINE_METABOLISM(8/159),REACTOME_G_ALPHA_S_SIGNALLING_EVENTS(6/121)
PELO	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
PFKM	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(11/200),REACTOME_GLYCOLYSIS(3/29),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(4/62)
PGM5	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
PHC1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
PHF1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
PHPT1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
PIDD1	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PIP4K2A	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(16/478),KEGG_INOSITOL_PHOSPHATE_METABOLISM(5/54),KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM(5/76),REACTOME_PHOSPHOLIPID_METABOLISM(7/198)
PJA2	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(18/933)
PKD1	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(11/200)
PLA2G4C	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(16/478),REACTOME_PHOSPHOLIPID_METABOLISM(7/198)
PLA2G6	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(16/478),KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(6/115),REACTOME_PHOSPHOLIPID_METABOLISM(7/198)
PLAGL1	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(13/200)
PLAT	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(12/200),REACTOME_HEMOSTASIS(17/466),NABA_MATRISOME(26/1028),REACTOME_SIGNALING_BY_PDGF(7/122),BIOCARTA_PLATELETAPP_PATHWAY(3/14)
PLCE1	TH34_1349_S01	v8		lowstringency_pd_outliers	KEGG_INOSITOL_PHOSPHATE_METABOLISM(5/54),BIOCARTA_PLCE_PATHWAY(3/12),KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM(5/76),PID_RAS_PATHWAY(3/30)
PLD3	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(16/478),ST_GA12_PATHWAY(4/23),REACTOME_PHOSPHOLIPID_METABOLISM(7/198)
PLK2	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(11/200)
PLXDC1	TH34_1349_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028)
PNISR	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
PNMAL1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
PPM1A	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
PPP1CB	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(16/478),KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(6/115),KEGG_INSULIN_SIGNALING_PATHWAY(6/137)
PPP1R12C	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
PPP2R4	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
PPWD1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
PRKAR1A	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(17/466),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(6/54),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(7/100),REACTOME_SIGNALING_BY_FGFR(7/112),REACTOME_SIGNALING_BY_PDGF(7/122),BIOCARTA_PLCE_PATHWAY(3/12),REACTOME_CA_DEPENDENT_EVENTS(4/30),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(7/127),REACTOME_SIGNALLING_BY_NGF(9/217),REACTOME_DAG_AND_IP3_SIGNALING(4/32),BIOCARTA_DREAM_PATHWAY(3/14),REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION(4/34),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(7/137),REACTOME_SIGNALING_BY_ERBB2(6/101),BIOCARTA_SHH_PATHWAY(3/16),REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB(3/18),REACTOME_PLC_BETA_MEDIATED_EVENTS(4/43),REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS(4/44),REACTOME_OPIOID_SIGNALLING(5/78),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(6/120),REACTOME_AQUAPORIN_MEDIATED_TRANSPORT(4/51),BIOCARTA_NOS1_PATHWAY(3/24),REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION(6/132),KEGG_INSULIN_SIGNALING_PATHWAY(6/137),BIOCARTA_BAD_PATHWAY(3/26),BIOCARTA_NFAT_PATHWAY(4/56),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(5/95)
PRKAR2B	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(17/466),HALLMARK_UV_RESPONSE_DN(9/144),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(6/54),HALLMARK_ESTROGEN_RESPONSE_LATE(10/200),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(7/100),REACTOME_SIGNALING_BY_FGFR(7/112),REACTOME_SIGNALING_BY_PDGF(7/122),BIOCARTA_PLCE_PATHWAY(3/12),REACTOME_CA_DEPENDENT_EVENTS(4/30),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(7/127),REACTOME_SIGNALLING_BY_NGF(9/217),REACTOME_DAG_AND_IP3_SIGNALING(4/32),BIOCARTA_DREAM_PATHWAY(3/14),REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION(4/34),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(7/137),REACTOME_SIGNALING_BY_ERBB2(6/101),BIOCARTA_SHH_PATHWAY(3/16),REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB(3/18),REACTOME_PLC_BETA_MEDIATED_EVENTS(4/43),REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS(4/44),REACTOME_OPIOID_SIGNALLING(5/78),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(6/120),REACTOME_AQUAPORIN_MEDIATED_TRANSPORT(4/51),BIOCARTA_NOS1_PATHWAY(3/24),REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION(6/132),KEGG_INSULIN_SIGNALING_PATHWAY(6/137),BIOCARTA_BAD_PATHWAY(3/26),BIOCARTA_NFAT_PATHWAY(4/56),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(5/95)
PRRT2	TH34_1349_S01	v8	BRYOSTATIN	lowstringency_pd_outliers	NA
PTCH1	TH34_1349_S01	v8	SONIDEGIB,Sonidegib,Vismodegib,VISMODEGIB	lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(13/200),HALLMARK_HEDGEHOG_SIGNALING(5/36),BIOCARTA_SHH_PATHWAY(3/16)
PTP4A3	TH34_1349_S01	v8	CETUXIMAB	lowstringency_pd_outliers	HALLMARK_MYOGENESIS(11/200)
PTPN12	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
PTPRD	TH34_1349_S01	v8	JSI-124,R1507,CIXUTUMUMAB	lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(7/158)
PTPRM	TH34_1349_S01	v8		lowstringency_pd_outliers	KEGG_CELL_ADHESION_MOLECULES_CAMS(10/134),HALLMARK_UV_RESPONSE_DN(9/144)
PWWP2A	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
RAB24	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
RAB28	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
RABGAP1L	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(13/200),HALLMARK_KRAS_SIGNALING_UP(12/200)
RASGEF1B	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
RASSF2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
RBFOX2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
RBM5	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(7/140),HALLMARK_HEME_METABOLISM(8/200),REACTOME_MRNA_SPLICING(6/111),REACTOME_MRNA_PROCESSING(7/161)
RBM6	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
RBPMS	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_DN(9/144)
RCAN2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
RCBTB1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
REEP1	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(11/200)
REEP2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
RELN	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(12/200),NABA_ECM_GLYCOPROTEINS(12/196),NABA_CORE_MATRISOME(14/275),NABA_MATRISOME(26/1028),PID_REELIN_PATHWAY(4/29),PID_LIS1_PATHWAY(3/28)
RGL2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
RGS2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
RGS4	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_DN(9/144),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(8/200)
RGS5	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
RGS7BP	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
RHOBTB2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
RNA5SP216	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RNPC3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ROGDI	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
RP11-166D19.1	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-323N12.5	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-34P13.16	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-386G11.10	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-394O4.5	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-429A20.3	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-429A20.4	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-553L6.5	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-626H12.1	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-693N9.2	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-70C1.3	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-809N8.5	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-717I23.3	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RPAIN	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
RPL39P3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
RSPO3	TH34_1349_S01	v8		lowstringency_pd_outliers	NABA_ECM_GLYCOPROTEINS(12/196),NABA_CORE_MATRISOME(14/275),NABA_MATRISOME(26/1028)
RTN1	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_HEDGEHOG_SIGNALING(5/36)
RUFY3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
RXRB	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(7/158)
SAFB2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SAMD11	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SCRN2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SCUBE1	TH34_1349_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028)
SDR39U1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SEPT5	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SERTAD4	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SESN1	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(11/200)
SFRP1	TH34_1349_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(8/200)
SFSWAP	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SH2B1	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(17/466),HALLMARK_MYOGENESIS(11/200),REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION(6/132),REACTOME_IMMUNE_SYSTEM(18/933)
SHISA2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SIK2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SIL1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SIN3B	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(16/478)
SKAP2	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(11/200)
SKP1	TH34_1349_S01	v8		lowstringency_pd_outliers	PID_BETA_CATENIN_NUC_PATHWAY(5/80),REACTOME_IMMUNE_SYSTEM(18/933)
SLC12A2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SLC12A4	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SLC22A17	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SLC25A27	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SLC29A1	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(10/200)
SLC2A11	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SLTM	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SMARCD3	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(16/478)
SMIM3	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SMTN	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(11/200)
SMYD4	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SNRNP70	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(7/140),REACTOME_MRNA_SPLICING(6/111),REACTOME_MRNA_PROCESSING(7/161),KEGG_SPLICEOSOME(6/128)
SPACA6P	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SPARCL1	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(12/200),NABA_ECM_GLYCOPROTEINS(12/196),NABA_CORE_MATRISOME(14/275),NABA_MATRISOME(26/1028)
SPG20	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SPRED2	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(13/200)
SPRY4	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(13/200)
SPRY4-IT1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SPRY4-IT1_2	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SRRM2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SRSF11	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(7/140),REACTOME_MRNA_SPLICING(6/111),REACTOME_MRNA_PROCESSING(7/161),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(4/54)
SRSF4	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(7/140),REACTOME_MRNA_SPLICING(6/111),REACTOME_MRNA_PROCESSING(7/161),KEGG_SPLICEOSOME(6/128),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(4/54)
SRSF5	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(7/140),REACTOME_MRNA_SPLICING(6/111),REACTOME_MRNA_PROCESSING(7/161),KEGG_SPLICEOSOME(6/128),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(4/54)
SSFA2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ST5	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(11/200)
STAG3L5P	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
STAG3L5P-PVRIG2P-PILRB	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
STIM2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
STK17A	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
STRADA	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
STX11	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SUGP2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SUN1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SUPT7L	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SV2A	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
SYNGAP1	TH34_1349_S01	v8		lowstringency_pd_outliers	PID_RAS_PATHWAY(3/30)
SYNM	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
TAPBPL	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
TARBP1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
TBL1X	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(16/478),PID_BETA_CATENIN_NUC_PATHWAY(5/80)
TCF25	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
TECPR2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
TERF2IP	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
THOC5	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
THYN1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
TLE4	TH34_1349_S01	v8		lowstringency_pd_outliers	PID_BETA_CATENIN_NUC_PATHWAY(5/80)
TMEM132C	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
TMEM14C	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
TMEM163	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
TMEM30A	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
TMEM59L	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
TMOD1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
TNFAIP8	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_ANDROGEN_RESPONSE(5/101)
TNFRSF14	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(18/933)
TNS2	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TPBG	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(10/200),HALLMARK_HYPOXIA(9/200)
TRO	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(11/200)
TSC22D4	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
TSPAN12	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
TSPAN33	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
TSPYL1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
TSPYL2	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(11/200)
TTC1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
TUSC3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
UBA7	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(18/933)
USP53	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
VAMP2	TH34_1349_S01	v8		lowstringency_pd_outliers	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(6/120)
VPS11	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
WASH5P	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
WDR6	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
WWC3	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
XPC	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(11/200)
XPR1	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
Y_RNA	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZBTB16	TH34_1349_S01	v8		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(11/200),REACTOME_IMMUNE_SYSTEM(18/933)
ZBTB4	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ZFR2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ZFYVE21	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ZMAT2	TH34_1349_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(6/128)
ZNF638	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ZNF692	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ZNF711	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ZNF76	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ZRANB2	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ZSWIM6	TH34_1349_S01	v8		lowstringency_pd_outliers	NA
ZSWIM8	TH34_1349_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
A1BG	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
AAMP	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ABCC4	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(18/208),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(17/413)
AC004540.4	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC006449.2	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC007620.3	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC132217.4	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACAA1	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),KEGG_PPAR_SIGNALING_PATHWAY(13/69),KEGG_FATTY_ACID_METABOLISM(10/42),HALLMARK_FATTY_ACID_METABOLISM(11/158),HALLMARK_PEROXISOME(9/104),HALLMARK_UV_RESPONSE_UP(9/158),KEGG_PEROXISOME(6/78)
ACACB	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(15/168),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(8/120),KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY(6/67),KEGG_INSULIN_SIGNALING_PATHWAY(8/137)
ACAD11	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ACADVL	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),PID_HNF3B_PATHWAY(13/45),KEGG_FATTY_ACID_METABOLISM(10/42),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(15/168),HALLMARK_FATTY_ACID_METABOLISM(11/158)
ACIN1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ACOX2	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_COAGULATION(28/138),HALLMARK_XENOBIOTIC_METABOLISM(29/200),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),KEGG_PPAR_SIGNALING_PATHWAY(13/69),HALLMARK_ESTROGEN_RESPONSE_LATE(10/200),KEGG_PEROXISOME(6/78),REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM(4/27)
ACSL1	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),KEGG_PPAR_SIGNALING_PATHWAY(13/69),KEGG_FATTY_ACID_METABOLISM(10/42),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(15/168),HALLMARK_BILE_ACID_METABOLISM(12/112),REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION(11/104),HALLMARK_FATTY_ACID_METABOLISM(11/158),HALLMARK_PEROXISOME(9/104),KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY(6/67),KEGG_PEROXISOME(6/78),HALLMARK_MYOGENESIS(9/200)
ACSM2A	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ACSM2B	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_BIOLOGICAL_OXIDATIONS(25/139),REACTOME_PHASE_II_CONJUGATION(10/70)
ADCY5	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(17/413),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(6/54),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(8/120),REACTOME_AQUAPORIN_MEDIATED_TRANSPORT(5/51),REACTOME_SIGNALING_BY_GPCR(22/920),REACTOME_CA_DEPENDENT_EVENTS(4/30)
ADGRA2	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADH1A	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),REACTOME_BIOLOGICAL_OXIDATIONS(25/139),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(20/70),KEGG_RETINOL_METABOLISM(18/64),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(16/70),KEGG_TYROSINE_METABOLISM(11/42),KEGG_FATTY_ACID_METABOLISM(10/42),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(11/62),REACTOME_ETHANOL_OXIDATION(5/10),REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM(3/10)
ADH1B	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),REACTOME_BIOLOGICAL_OXIDATIONS(25/139),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(20/70),KEGG_RETINOL_METABOLISM(18/64),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(16/70),KEGG_TYROSINE_METABOLISM(11/42),KEGG_FATTY_ACID_METABOLISM(10/42),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(11/62),REACTOME_ETHANOL_OXIDATION(5/10)
ADH1C	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),HALLMARK_XENOBIOTIC_METABOLISM(29/200),REACTOME_BIOLOGICAL_OXIDATIONS(25/139),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(20/70),KEGG_RETINOL_METABOLISM(18/64),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(16/70),KEGG_TYROSINE_METABOLISM(11/42),KEGG_FATTY_ACID_METABOLISM(10/42),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(11/62),REACTOME_ETHANOL_OXIDATION(5/10),HALLMARK_FATTY_ACID_METABOLISM(11/158)
ADH4	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),REACTOME_BIOLOGICAL_OXIDATIONS(25/139),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(20/70),KEGG_RETINOL_METABOLISM(18/64),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(16/70),KEGG_TYROSINE_METABOLISM(11/42),KEGG_FATTY_ACID_METABOLISM(10/42),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(11/62),REACTOME_ETHANOL_OXIDATION(5/10)
ADH6	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),REACTOME_BIOLOGICAL_OXIDATIONS(25/139),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(20/70),KEGG_RETINOL_METABOLISM(18/64),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(16/70),KEGG_TYROSINE_METABOLISM(11/42),KEGG_FATTY_ACID_METABOLISM(10/42),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(11/62),REACTOME_ETHANOL_OXIDATION(5/10)
AFMID	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200)
AGAP3	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
AGFG2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
AGXT	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_BILE_ACID_METABOLISM(12/112),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM(6/31),KEGG_PEROXISOME(6/78)
AHCYL2	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_CYSTEINE_AND_METHIONINE_METABOLISM(6/34)
AHSA2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
AHSG	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
AKAP8L	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
AL162151.3	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL442127.1	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL603831.1	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL662801.1	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ALAS1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(29/200),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),PID_HNF3B_PATHWAY(13/45),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(15/168),REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION(11/104),KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM(6/31),KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM(6/41),HALLMARK_UV_RESPONSE_UP(9/158)
ALB	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),PID_HNF3B_PATHWAY(13/45),REACTOME_HEMOSTASIS(30/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(18/208),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),REACTOME_LIPOPROTEIN_METABOLISM(7/28),REACTOME_HDL_MEDIATED_LIPID_TRANSPORT(5/15),REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT(7/46),HALLMARK_PEROXISOME(9/104),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(17/413),REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM(4/27),REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS(3/11)
ALDH1A3	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(20/70),KEGG_TYROSINE_METABOLISM(11/42),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(11/62),HALLMARK_KRAS_SIGNALING_UP(16/200),KEGG_PHENYLALANINE_METABOLISM(5/18)
ALDH1L1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(9/200)
ALDOB	TH34_1349_S02	v8		lowstringency_pd_outliers	PID_HNF3B_PATHWAY(13/45),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(11/62),KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM(5/34),HALLMARK_HYPOXIA(10/200),REACTOME_METABOLISM_OF_CARBOHYDRATES(11/247)
AMBP	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),NABA_MATRISOME_ASSOCIATED(35/753)
AMPD3	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(10/200)
AMT	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM(6/31)
ANGPTL3	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(29/200),NABA_MATRISOME(51/1028),NABA_MATRISOME_ASSOCIATED(35/753)
ANK3	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(11/251)
ANKS1A	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ANO1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(16/200)
ANXA3	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_MATRISOME_ASSOCIATED(35/753)
AOX1	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),HALLMARK_XENOBIOTIC_METABOLISM(29/200),KEGG_TYROSINE_METABOLISM(11/42)
AP003041.1	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AP1S2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
APBB3	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
APCS	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_AMYLOIDS(6/83)
APLP1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(11/200)
APLP2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
APOA1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_COAGULATION(28/138),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),PID_HNF3B_PATHWAY(13/45),REACTOME_HEMOSTASIS(30/466),KEGG_PPAR_SIGNALING_PATHWAY(13/69),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(18/208),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(15/168),HALLMARK_BILE_ACID_METABOLISM(12/112),REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION(11/104),REACTOME_LIPOPROTEIN_METABOLISM(7/28),REACTOME_HDL_MEDIATED_LIPID_TRANSPORT(5/15),REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT(7/46),REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT(5/16),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(17/413),BIOCARTA_PPARA_PATHWAY(6/58),REACTOME_AMYLOIDS(6/83)
APOA2	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),KEGG_PPAR_SIGNALING_PATHWAY(13/69),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(15/168),REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION(11/104),REACTOME_LIPOPROTEIN_METABOLISM(7/28),REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT(7/46),REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT(5/16),BIOCARTA_PPARA_PATHWAY(6/58)
APOB	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),REACTOME_HEMOSTASIS(30/466),REACTOME_LIPOPROTEIN_METABOLISM(7/28),REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT(7/46),REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT(5/16),PID_AMB2_NEUTROPHILS_PATHWAY(5/41)
APOC1P1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
APOC2	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_COAGULATION(28/138),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),REACTOME_LIPOPROTEIN_METABOLISM(7/28),REACTOME_HDL_MEDIATED_LIPID_TRANSPORT(5/15),REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT(7/46),REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT(5/16)
APOC3	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_COAGULATION(28/138),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),KEGG_PPAR_SIGNALING_PATHWAY(13/69),REACTOME_LIPOPROTEIN_METABOLISM(7/28),REACTOME_HDL_MEDIATED_LIPID_TRANSPORT(5/15),REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT(7/46),REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT(5/16)
APOC4	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
APOC4-APOC2	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
APOH	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_ANGIOGENESIS(5/36)
APOM	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(9/158)
APP	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(18/208),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),BIOCARTA_PLATELETAPP_PATHWAY(5/14),REACTOME_INNATE_IMMUNE_SYSTEM(13/279),REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS(10/184),HALLMARK_ANGIOGENESIS(5/36),REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK(10/205),PID_GLYPICAN_1PATHWAY(4/27),REACTOME_SIGNALING_BY_GPCR(22/920),REACTOME_AMYLOIDS(6/83),HALLMARK_MYOGENESIS(9/200)
AQP9	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(29/200),HALLMARK_BILE_ACID_METABOLISM(12/112),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(17/413),REACTOME_AQUAPORIN_MEDIATED_TRANSPORT(5/51)
ARG1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(29/200),HALLMARK_KRAS_SIGNALING_UP(16/200),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200)
ARGLU1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ARRDC3	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ARSB	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),REACTOME_METABOLISM_OF_CARBOHYDRATES(11/247)
ASGR1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ASGR2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ASIC3	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ATM	TH34_1349_S02	v8	Olaparib,KU-0060648,NU7441,TRAMETINIB,SELUMETINIB (AZD6244),TEMOZOLOMIDE,Temozolomide,OLAPARIB	lowstringency_pd_outliers	NA
AZGP1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
BAAT	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),KEGG_PEROXISOME(6/78),REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM(4/27),REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS(3/11)
BAZ2A	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
BCAP29	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
BDH2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
BHMT	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM(6/31),KEGG_CYSTEINE_AND_METHIONINE_METABOLISM(6/34),REACTOME_SULFUR_AMINO_ACID_METABOLISM(4/24)
BHMT2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
BMPR1A	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_DN(8/144)
BOD1L1	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
BRD8	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
C11orf58	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
C1QL1	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_MATRISOME_ASSOCIATED(35/753)
C1RL	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
C4A	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),REACTOME_COMPLEMENT_CASCADE(10/32),BIOCARTA_LECTIN_PATHWAY(6/12),BIOCARTA_COMP_PATHWAY(6/19),BIOCARTA_CLASSIC_PATHWAY(5/14),REACTOME_INNATE_IMMUNE_SYSTEM(13/279),REACTOME_REGULATION_OF_COMPLEMENT_CASCADE(4/14)
C4B	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),BIOCARTA_LECTIN_PATHWAY(6/12),BIOCARTA_COMP_PATHWAY(6/19),BIOCARTA_CLASSIC_PATHWAY(5/14)
C4BPA	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),REACTOME_COMPLEMENT_CASCADE(10/32),REACTOME_INNATE_IMMUNE_SYSTEM(13/279),REACTOME_REGULATION_OF_COMPLEMENT_CASCADE(4/14)
C4BPB	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),REACTOME_COMPLEMENT_CASCADE(10/32),HALLMARK_COMPLEMENT(13/200),REACTOME_INNATE_IMMUNE_SYSTEM(13/279),REACTOME_REGULATION_OF_COMPLEMENT_CASCADE(4/14),HALLMARK_UV_RESPONSE_UP(9/158)
C6	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),REACTOME_COMPLEMENT_CASCADE(10/32),BIOCARTA_LECTIN_PATHWAY(6/12),BIOCARTA_COMP_PATHWAY(6/19),BIOCARTA_CLASSIC_PATHWAY(5/14),KEGG_PRION_DISEASES(6/35),REACTOME_INNATE_IMMUNE_SYSTEM(13/279)
C8A	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),HALLMARK_COAGULATION(28/138),REACTOME_COMPLEMENT_CASCADE(10/32),BIOCARTA_LECTIN_PATHWAY(6/12),BIOCARTA_COMP_PATHWAY(6/19),BIOCARTA_CLASSIC_PATHWAY(5/14),KEGG_PRION_DISEASES(6/35),REACTOME_INNATE_IMMUNE_SYSTEM(13/279)
C8B	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),HALLMARK_COAGULATION(28/138),REACTOME_COMPLEMENT_CASCADE(10/32),KEGG_PRION_DISEASES(6/35),REACTOME_INNATE_IMMUNE_SYSTEM(13/279)
C8G	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),HALLMARK_COAGULATION(28/138),REACTOME_COMPLEMENT_CASCADE(10/32),KEGG_PRION_DISEASES(6/35),REACTOME_INNATE_IMMUNE_SYSTEM(13/279)
C9	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),HALLMARK_COAGULATION(28/138),REACTOME_COMPLEMENT_CASCADE(10/32),BIOCARTA_LECTIN_PATHWAY(6/12),BIOCARTA_COMP_PATHWAY(6/19),HALLMARK_COMPLEMENT(13/200),BIOCARTA_CLASSIC_PATHWAY(5/14),KEGG_PRION_DISEASES(6/35),REACTOME_INNATE_IMMUNE_SYSTEM(13/279)
CA11	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
CA2	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(29/200),HALLMARK_KRAS_SIGNALING_UP(16/200),HALLMARK_COMPLEMENT(13/200),HALLMARK_FATTY_ACID_METABOLISM(11/158),HALLMARK_IL2_STAT5_SIGNALING(11/200),HALLMARK_UV_RESPONSE_UP(9/158),HALLMARK_ESTROGEN_RESPONSE_LATE(10/200),HALLMARK_HEME_METABOLISM(9/200)
CADM1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_PEROXISOME(9/104)
CBS	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM(6/31),KEGG_CYSTEINE_AND_METHIONINE_METABOLISM(6/34),REACTOME_SULFUR_AMINO_ACID_METABOLISM(4/24)
CCDC159	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
CCDC64	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
CCKBR	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS(10/184),REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK(10/205),REACTOME_SIGNALING_BY_GPCR(22/920)
CCNL2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
CD27-AS1	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CD34	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
CDK20	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
CEND1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
CES2	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_OTHER_ENZYMES(8/51)
CFHR1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
CFHR2	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(16/200)
CFHR3	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_COMPLEMENT_CASCADE(10/32),REACTOME_INNATE_IMMUNE_SYSTEM(13/279),REACTOME_REGULATION_OF_COMPLEMENT_CASCADE(4/14)
CHD3	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
CHKB	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478)
CHN1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
CHN2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
CIRBP	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
CITED2	TH34_1349_S02	v8		lowstringency_pd_outliers	BIOCARTA_PPARA_PATHWAY(6/58),HALLMARK_HYPOXIA(10/200),HALLMARK_UV_RESPONSE_DN(8/144)
CLASP2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
CLEC11A	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_MATRISOME_ASSOCIATED(35/753)
CNTN1	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(11/251)
COL13A1	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_CORE_MATRISOME(16/275)
COL4A5	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),BIOCARTA_AMI_PATHWAY(9/20),BIOCARTA_INTRINSIC_PATHWAY(9/23),NABA_CORE_MATRISOME(16/275),BIOCARTA_PLATELETAPP_PATHWAY(5/14),PID_INTEGRIN3_PATHWAY(6/43),PID_INTEGRIN1_PATHWAY(7/66),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(7/79),REACTOME_AXON_GUIDANCE(11/251)
CP	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_COMPLEMENT(13/200),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(17/413),KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM(6/41),HALLMARK_HYPOXIA(10/200)
CPB2	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),HALLMARK_COAGULATION(28/138),BIOCARTA_FIBRINOLYSIS_PATHWAY(7/12)
CPED1	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CPS1	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200)
CREBZF	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
CRELD1	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_ECM_GLYCOPROTEINS(14/196),NABA_CORE_MATRISOME(16/275)
CRMP1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_HEDGEHOG_SIGNALING(6/36),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(11/251)
CSAD	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(29/200),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),REACTOME_SULFUR_AMINO_ACID_METABOLISM(4/24)
CSRP2	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(10/200)
CTC-251I16.1	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-3064M3.3	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-3064M3.7	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTDSPL	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
CTSL	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),NABA_MATRISOME_ASSOCIATED(35/753)
CYP1A2	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),HALLMARK_XENOBIOTIC_METABOLISM(29/200),REACTOME_BIOLOGICAL_OXIDATIONS(25/139),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(20/70),KEGG_RETINOL_METABOLISM(18/64),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(16/70),REACTOME_XENOBIOTICS(9/16),REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE(10/51),KEGG_LINOLEIC_ACID_METABOLISM(8/29),REACTOME_PHASE_II_CONJUGATION(10/70)
CYP2A6	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),REACTOME_BIOLOGICAL_OXIDATIONS(25/139),KEGG_RETINOL_METABOLISM(18/64),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(16/70),REACTOME_XENOBIOTICS(9/16),REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE(10/51),KEGG_DRUG_METABOLISM_OTHER_ENZYMES(8/51)
CYP2B6	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),REACTOME_BIOLOGICAL_OXIDATIONS(25/139),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(20/70),KEGG_RETINOL_METABOLISM(18/64),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(16/70),REACTOME_XENOBIOTICS(9/16),REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE(10/51),KEGG_ARACHIDONIC_ACID_METABOLISM(7/58)
CYP2C8	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),REACTOME_BIOLOGICAL_OXIDATIONS(25/139),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(20/70),KEGG_RETINOL_METABOLISM(18/64),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(16/70),REACTOME_XENOBIOTICS(9/16),REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE(10/51),KEGG_LINOLEIC_ACID_METABOLISM(8/29),KEGG_ARACHIDONIC_ACID_METABOLISM(7/58)
CYP2C9	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),REACTOME_BIOLOGICAL_OXIDATIONS(25/139),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(20/70),KEGG_RETINOL_METABOLISM(18/64),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(16/70),REACTOME_XENOBIOTICS(9/16),REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE(10/51),KEGG_LINOLEIC_ACID_METABOLISM(8/29),KEGG_ARACHIDONIC_ACID_METABOLISM(7/58)
CYP2E1	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),HALLMARK_XENOBIOTIC_METABOLISM(29/200),REACTOME_BIOLOGICAL_OXIDATIONS(25/139),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(20/70),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(16/70),REACTOME_XENOBIOTICS(9/16),REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE(10/51),KEGG_LINOLEIC_ACID_METABOLISM(8/29),KEGG_ARACHIDONIC_ACID_METABOLISM(7/58)
CYP3A4	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),REACTOME_BIOLOGICAL_OXIDATIONS(25/139),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(20/70),KEGG_RETINOL_METABOLISM(18/64),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(16/70),REACTOME_XENOBIOTICS(9/16),REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE(10/51),KEGG_LINOLEIC_ACID_METABOLISM(8/29),KEGG_STEROID_HORMONE_BIOSYNTHESIS(9/55),KEGG_DRUG_METABOLISM_OTHER_ENZYMES(8/51)
CYP3A5	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),REACTOME_BIOLOGICAL_OXIDATIONS(25/139),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(20/70),KEGG_RETINOL_METABOLISM(18/64),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(16/70),REACTOME_XENOBIOTICS(9/16),REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE(10/51),KEGG_LINOLEIC_ACID_METABOLISM(8/29),KEGG_STEROID_HORMONE_BIOSYNTHESIS(9/55),KEGG_DRUG_METABOLISM_OTHER_ENZYMES(8/51)
CYP3A7	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),REACTOME_BIOLOGICAL_OXIDATIONS(25/139),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(20/70),KEGG_RETINOL_METABOLISM(18/64),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(16/70),REACTOME_XENOBIOTICS(9/16),REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE(10/51),KEGG_LINOLEIC_ACID_METABOLISM(8/29),KEGG_STEROID_HORMONE_BIOSYNTHESIS(9/55),KEGG_DRUG_METABOLISM_OTHER_ENZYMES(8/51)
CYP4A11	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_BIOLOGICAL_OXIDATIONS(25/139),KEGG_RETINOL_METABOLISM(18/64),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(16/70),KEGG_PPAR_SIGNALING_PATHWAY(13/69),KEGG_FATTY_ACID_METABOLISM(10/42),REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE(10/51),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(15/168),REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION(11/104),HALLMARK_FATTY_ACID_METABOLISM(11/158),KEGG_ARACHIDONIC_ACID_METABOLISM(7/58)
CYP4A22	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_RETINOL_METABOLISM(18/64),KEGG_PPAR_SIGNALING_PATHWAY(13/69),KEGG_FATTY_ACID_METABOLISM(10/42),HALLMARK_FATTY_ACID_METABOLISM(11/158),KEGG_ARACHIDONIC_ACID_METABOLISM(7/58)
DAAM1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(9/200)
DAAM2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
DAB2IP	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
DACT1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
DDX24	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
DDX5	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
DLG4	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_PEROXISOME(9/104),HALLMARK_UV_RESPONSE_UP(9/158),ST_GA12_PATHWAY(4/23)
DMAP1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
DOCK6	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466)
DOCK9	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),HALLMARK_COMPLEMENT(13/200)
DPH1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
DPP10	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
DPY19L4	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
DZIP1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
EDN3	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS(10/184),REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK(10/205),REACTOME_SIGNALING_BY_GPCR(22/920)
EID1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
EPN2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ETV1	TH34_1349_S02	v8	TRAMETINIB	lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(16/200)
F12	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),HALLMARK_COAGULATION(28/138),NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),REACTOME_HEMOSTASIS(30/466),NABA_MATRISOME_ASSOCIATED(35/753),BIOCARTA_INTRINSIC_PATHWAY(9/23),REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE(8/32)
F2	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),HALLMARK_COAGULATION(28/138),NABA_MATRISOME(51/1028),PID_HNF3B_PATHWAY(13/45),NABA_ECM_REGULATORS(23/238),REACTOME_HEMOSTASIS(30/466),NABA_MATRISOME_ASSOCIATED(35/753),BIOCARTA_AMI_PATHWAY(9/20),BIOCARTA_INTRINSIC_PATHWAY(9/23),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(18/208),BIOCARTA_FIBRINOLYSIS_PATHWAY(7/12),REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE(8/32),BIOCARTA_EXTRINSIC_PATHWAY(6/13),REACTOME_COMMON_PATHWAY(6/14),HALLMARK_COMPLEMENT(13/200),BIOCARTA_PLATELETAPP_PATHWAY(5/14),REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS(4/16),REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS(10/184),REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK(10/205),ST_GA12_PATHWAY(4/23),REACTOME_SIGNALING_BY_GPCR(22/920)
F2RL2	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_COAGULATION(28/138),REACTOME_HEMOSTASIS(30/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(18/208),HALLMARK_IL2_STAT5_SIGNALING(11/200),REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS(10/184),REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK(10/205),ST_GA12_PATHWAY(4/23),REACTOME_SIGNALING_BY_GPCR(22/920)
FABP1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(29/200),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),KEGG_PPAR_SIGNALING_PATHWAY(13/69),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(15/168),REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION(11/104),HALLMARK_FATTY_ACID_METABOLISM(11/158),BIOCARTA_PPARA_PATHWAY(6/58)
FAM101B	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
FAM126A	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
FAM193B	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
FAM219B	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FBP1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(29/200),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(11/62),KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM(5/34),HALLMARK_HYPOXIA(10/200),REACTOME_METABOLISM_OF_CARBOHYDRATES(11/247),KEGG_INSULIN_SIGNALING_PATHWAY(8/137)
FBXO9	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(9/200)
FCN3	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_MATRISOME_ASSOCIATED(35/753)
FENDRR	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FGA	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),HALLMARK_COAGULATION(28/138),NABA_MATRISOME(51/1028),REACTOME_HEMOSTASIS(30/466),BIOCARTA_AMI_PATHWAY(9/20),BIOCARTA_INTRINSIC_PATHWAY(9/23),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(18/208),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),BIOCARTA_FIBRINOLYSIS_PATHWAY(7/12),REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE(8/32),BIOCARTA_EXTRINSIC_PATHWAY(6/13),REACTOME_COMMON_PATHWAY(6/14),NABA_ECM_GLYCOPROTEINS(14/196),NABA_CORE_MATRISOME(16/275),PID_INTEGRIN2_PATHWAY(6/29),PID_INTEGRIN3_PATHWAY(6/43),PID_INTEGRIN1_PATHWAY(7/66),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(7/79),PID_UPA_UPAR_PATHWAY(5/42),REACTOME_AMYLOIDS(6/83),PID_EPHRINB_REV_PATHWAY(4/30)
FGB	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),NABA_MATRISOME(51/1028),REACTOME_HEMOSTASIS(30/466),BIOCARTA_AMI_PATHWAY(9/20),BIOCARTA_INTRINSIC_PATHWAY(9/23),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(18/208),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),BIOCARTA_FIBRINOLYSIS_PATHWAY(7/12),REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE(8/32),BIOCARTA_EXTRINSIC_PATHWAY(6/13),REACTOME_COMMON_PATHWAY(6/14),NABA_ECM_GLYCOPROTEINS(14/196),NABA_CORE_MATRISOME(16/275),PID_INTEGRIN2_PATHWAY(6/29),PID_INTEGRIN3_PATHWAY(6/43),PID_INTEGRIN1_PATHWAY(7/66),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(7/79),PID_UPA_UPAR_PATHWAY(5/42),PID_EPHRINB_REV_PATHWAY(4/30)
FGD5	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
FGF4	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_MATRISOME_ASSOCIATED(35/753),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(6/54)
FGFR1	TH34_1349_S02	v8	[Lucitanib],INFIGRATINIB,AZD-4547,BGJ-398,ORANTINIB,SU-6668,Regorafenib,LUCITANIB,PD173074,PONATINIB,MIDOSTAURIN,Ponatinib,Dovitinib,MASITINIB,AZD4547,Nintedanib,FGF/VEGF RECEPTOR TYROSINE KINASE INHIBITOR, PD173074,XL228,DOVITINIB,1058137-23-7,4-HYDROXYTAMOXIFEN,REGORAFENIB,NINTEDANIB,BGJ398,Lucitanib	lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(6/54),HALLMARK_ANGIOGENESIS(5/36),REACTOME_AXON_GUIDANCE(11/251),PID_GLYPICAN_1PATHWAY(4/27)
FGG	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),HALLMARK_COAGULATION(28/138),NABA_MATRISOME(51/1028),REACTOME_HEMOSTASIS(30/466),BIOCARTA_AMI_PATHWAY(9/20),BIOCARTA_INTRINSIC_PATHWAY(9/23),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(18/208),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),BIOCARTA_FIBRINOLYSIS_PATHWAY(7/12),REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE(8/32),BIOCARTA_EXTRINSIC_PATHWAY(6/13),REACTOME_COMMON_PATHWAY(6/14),NABA_ECM_GLYCOPROTEINS(14/196),NABA_CORE_MATRISOME(16/275),PID_INTEGRIN2_PATHWAY(6/29),PID_INTEGRIN3_PATHWAY(6/43),PID_INTEGRIN1_PATHWAY(7/66),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(7/79),PID_UPA_UPAR_PATHWAY(5/42),PID_EPHRINB_REV_PATHWAY(4/30)
FGL1	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_ECM_GLYCOPROTEINS(14/196),NABA_CORE_MATRISOME(16/275)
FGL2	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_ECM_GLYCOPROTEINS(14/196),NABA_CORE_MATRISOME(16/275),HALLMARK_IL2_STAT5_SIGNALING(11/200)
FHL2	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(15/168),REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION(11/104),HALLMARK_UV_RESPONSE_DN(8/144)
FLCN	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
FMO3	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),HALLMARK_XENOBIOTIC_METABOLISM(29/200),REACTOME_BIOLOGICAL_OXIDATIONS(25/139),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(16/70)
FOXF1	TH34_1349_S02	v8		lowstringency_pd_outliers	PID_HNF3B_PATHWAY(13/45)
FOXP1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
FTCD	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),HALLMARK_HEME_METABOLISM(9/200)
FYN	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_COAGULATION(28/138),REACTOME_HEMOSTASIS(30/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(18/208),HALLMARK_COMPLEMENT(13/200),KEGG_PRION_DISEASES(6/35),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(11/251),PID_AMB2_NEUTROPHILS_PATHWAY(5/41),HALLMARK_UV_RESPONSE_DN(8/144),PID_GLYPICAN_1PATHWAY(4/27),PID_EPHRINB_REV_PATHWAY(4/30)
G6PC	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(29/200),PID_HNF3B_PATHWAY(13/45),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(11/62),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(17/413),REACTOME_METABOLISM_OF_CARBOHYDRATES(11/247),KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY(6/67),KEGG_INSULIN_SIGNALING_PATHWAY(8/137)
GABBR1	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_GPCR(22/920)
GALT	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_CARBOHYDRATES(11/247)
GAMT	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM(6/31)
GBA2	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478)
GC	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),HALLMARK_BILE_ACID_METABOLISM(12/112)
GFRA1	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(11/251)
GLYAT	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_BIOLOGICAL_OXIDATIONS(25/139),REACTOME_PHASE_II_CONJUGATION(10/70)
GLYATL1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
GNG2	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(18/208),HALLMARK_COMPLEMENT(13/200),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(17/413),REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS(10/184),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(8/120),REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK(10/205),REACTOME_AQUAPORIN_MEDIATED_TRANSPORT(5/51),REACTOME_SIGNALING_BY_GPCR(22/920)
GOLGA2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
GOLPH3L	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
GOT2	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_TYROSINE_METABOLISM(11/42),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),KEGG_PHENYLALANINE_METABOLISM(5/18),KEGG_CYSTEINE_AND_METHIONINE_METABOLISM(6/34),REACTOME_METABOLISM_OF_CARBOHYDRATES(11/247)
GPATCH8	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
GPR162	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
GPR20	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
GPR52	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
GRAMD3	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
GSTA1	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),REACTOME_BIOLOGICAL_OXIDATIONS(25/139),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(20/70),REACTOME_PHASE_II_CONJUGATION(10/70)
GSTA2	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),REACTOME_BIOLOGICAL_OXIDATIONS(25/139),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(20/70),REACTOME_PHASE_II_CONJUGATION(10/70)
GSTM2	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(20/70)
H19	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
HAGH	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(9/200)
HAMP	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
HAND2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
HAND2-AS1	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HAO2	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(11/158),HALLMARK_PEROXISOME(9/104),KEGG_PEROXISOME(6/78)
HDAC6	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
HERC2P2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
HGD	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_TYROSINE_METABOLISM(11/42),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200)
HGFAC	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(29/200),NABA_MATRISOME(51/1028),NABA_MATRISOME_ASSOCIATED(35/753)
HIC1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
HMGCS2	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_COAGULATION(28/138),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),KEGG_PPAR_SIGNALING_PATHWAY(13/69),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(15/168),REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION(11/104),HALLMARK_FATTY_ACID_METABOLISM(11/158),HALLMARK_ESTROGEN_RESPONSE_LATE(10/200)
HNRNPH3	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
HOTAIRM1_5	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HOXA-AS2	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HOXA3	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
HOXA4	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
HOXA5	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
HOXB3	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
HP	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
HPD	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_TYROSINE_METABOLISM(11/42),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),KEGG_PHENYLALANINE_METABOLISM(5/18)
HPN	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_COAGULATION(28/138)
HPR	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
HPX	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_MATRISOME_ASSOCIATED(35/753)
HRG	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_COAGULATION(28/138),HALLMARK_XENOBIOTIC_METABOLISM(29/200),NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),REACTOME_HEMOSTASIS(30/466),NABA_MATRISOME_ASSOCIATED(35/753),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(18/208),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89)
HRH2	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_GPCR(22/920)
HSD11B1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(29/200),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),HALLMARK_KRAS_SIGNALING_UP(16/200),KEGG_STEROID_HORMONE_BIOSYNTHESIS(9/55)
HSD17B12	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(15/168),KEGG_STEROID_HORMONE_BIOSYNTHESIS(9/55)
HSD17B6	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_BILE_ACID_METABOLISM(12/112),KEGG_STEROID_HORMONE_BIOSYNTHESIS(9/55)
HULC	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
IDUA	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_CARBOHYDRATES(11/247)
IFT57	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
IGF2	TH34_1349_S02	v8	CABAZITAXEL,DOCETAXEL,OSI-906 (LINSITINIB)	lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_MATRISOME_ASSOCIATED(35/753),HALLMARK_KRAS_SIGNALING_UP(16/200),REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS(4/16)
IGFBP1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(29/200),NABA_MATRISOME(51/1028),PID_HNF3B_PATHWAY(13/45),NABA_ECM_GLYCOPROTEINS(14/196),NABA_CORE_MATRISOME(16/275),REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS(4/16),HALLMARK_HYPOXIA(10/200)
IL11RA	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
INPP1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
INPPL1	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478)
IQGAP2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ISCU	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_COAGULATION(28/138)
ITGA10	TH34_1349_S02	v8		lowstringency_pd_outliers	PID_INTEGRIN1_PATHWAY(7/66),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(7/79)
ITIH1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_COAGULATION(28/138),HALLMARK_XENOBIOTIC_METABOLISM(29/200),NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),NABA_MATRISOME_ASSOCIATED(35/753),HALLMARK_COMPLEMENT(13/200)
ITIH2	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),NABA_MATRISOME_ASSOCIATED(35/753)
ITIH3	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),NABA_MATRISOME_ASSOCIATED(35/753)
ITIH4	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(29/200),NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),NABA_MATRISOME_ASSOCIATED(35/753)
KANK2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
KCNK3	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
KCTD12	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
KHDRBS3	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
KHK	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM(5/34),REACTOME_METABOLISM_OF_CARBOHYDRATES(11/247)
KIAA0895L	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
KIF21B	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
KIT	TH34_1349_S02	v8	MIDOSTAURIN,PLX3397,4'-N-BENZOYLSTAUROSPORINE,Nilotinib,SORAFENIB,MOTESANIB,cabozantinib,PLX-3397,CABOZANTINIB,Dasatinib,IMATINIB,SUNITINIB,TELATINIB,Regorafenib,NILOTINIB,PLX108-01,AXITINIB,TANDUTINIB,Sorafenib,Motesanib,MASITINIB,Pazopanib,Midostaurin,XL-820,IMATINIB MESYLATE,DASATINIB,AMUVATINIB,PEXIDARTINIB,Sunitinib,XL820,Imatinib,MP470,REGORAFENIB,PAZOPANIB	lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_DN(8/144)
KNG1	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),REACTOME_HEMOSTASIS(30/466),NABA_MATRISOME_ASSOCIATED(35/753),BIOCARTA_INTRINSIC_PATHWAY(9/23),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(18/208),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE(8/32),PID_INTEGRIN2_PATHWAY(6/29),REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS(10/184),REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK(10/205),REACTOME_SIGNALING_BY_GPCR(22/920)
LAMB1	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_ECM_GLYCOPROTEINS(14/196),NABA_CORE_MATRISOME(16/275),PID_INTEGRIN3_PATHWAY(6/43),PID_INTEGRIN1_PATHWAY(7/66),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(7/79),REACTOME_AXON_GUIDANCE(11/251)
LCAT	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(29/200),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),REACTOME_LIPOPROTEIN_METABOLISM(7/28),REACTOME_HDL_MEDIATED_LIPID_TRANSPORT(5/15),REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT(7/46)
LDB1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_HEDGEHOG_SIGNALING(6/36)
LDB2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
LENG8	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
LGI4	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_ECM_GLYCOPROTEINS(14/196),NABA_CORE_MATRISOME(16/275)
LINC01089	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LMBR1L	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
LMO2	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(9/200)
LRRC4B	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
LSAMP	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
LSR	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(10/200)
LSS	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478)
LTBP4	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_ECM_GLYCOPROTEINS(14/196),NABA_CORE_MATRISOME(16/275)
LUC7L	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
MAGEH1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
MAGI2-AS3	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
MAN2C1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
MAP3K12	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
MAPRE3	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(9/200)
MASP2	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),HALLMARK_COAGULATION(28/138),NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),NABA_MATRISOME_ASSOCIATED(35/753),REACTOME_COMPLEMENT_CASCADE(10/32),BIOCARTA_LECTIN_PATHWAY(6/12),BIOCARTA_COMP_PATHWAY(6/19),REACTOME_INNATE_IMMUNE_SYSTEM(13/279)
MAT1A	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_BIOLOGICAL_OXIDATIONS(25/139),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),REACTOME_PHASE_II_CONJUGATION(10/70),KEGG_CYSTEINE_AND_METHIONINE_METABOLISM(6/34),REACTOME_SULFUR_AMINO_ACID_METABOLISM(4/24)
MEIS1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
MEIS3	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
METTL17	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
MIR143HG	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
MLXIPL	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(8/120)
MORF4L1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
MORF4L1P1	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MPDZ	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
MRFAP1L1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
MSL1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
MST1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_COAGULATION(28/138),NABA_MATRISOME(51/1028),NABA_MATRISOME_ASSOCIATED(35/753),PID_AMB2_NEUTROPHILS_PATHWAY(5/41)
MT-ATP6	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ATP8	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CO1	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CO2	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CO3	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CYB	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND4	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND4L	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT1G	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
MTATP6P1	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTERF4	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTFR1L	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MUM1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
N4BP2L1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
NBPF11	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
NDN	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
NEFL	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
NEK6	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
NELL1	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_ECM_GLYCOPROTEINS(14/196),NABA_CORE_MATRISOME(16/275)
NES	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
NFATC4	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
NINL	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
NISCH	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
NKX3-2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
NLGN4Y	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
NPIPP1	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NRBP2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
NRCAM	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_HEDGEHOG_SIGNALING(6/36),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(11/251)
NTN1	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_ECM_GLYCOPROTEINS(14/196),NABA_CORE_MATRISOME(16/275),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(11/251)
NXF1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(9/158)
NYNRIN	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
OBSCN	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_GPCR(22/920)
ORM1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ORM2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
P3H3	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),NABA_MATRISOME_ASSOCIATED(35/753)
PAGR1	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PAH	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),KEGG_PHENYLALANINE_METABOLISM(5/18)
PCK1	TH34_1349_S02	v8		lowstringency_pd_outliers	PID_HNF3B_PATHWAY(13/45),KEGG_PPAR_SIGNALING_PATHWAY(13/69),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(11/62),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),HALLMARK_HYPOXIA(10/200),REACTOME_METABOLISM_OF_CARBOHYDRATES(11/247),KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY(6/67),KEGG_INSULIN_SIGNALING_PATHWAY(8/137),REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM(3/10)
PCSK1N	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(16/200)
PDE1A	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(6/54),REACTOME_SIGNALING_BY_GPCR(22/920),REACTOME_CA_DEPENDENT_EVENTS(4/30)
PDE3A	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),KEGG_INSULIN_SIGNALING_PATHWAY(8/137),REACTOME_SIGNALING_BY_GPCR(22/920)
PDE8A	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_GPCR(22/920)
PEBP1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
PFKM	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_GLYCOLYSIS_GLUCONEOGENESIS(11/62),HALLMARK_BILE_ACID_METABOLISM(12/112),KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM(5/34),REACTOME_METABOLISM_OF_CARBOHYDRATES(11/247),HALLMARK_MYOGENESIS(9/200)
PHC1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
PHF1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
PHPT1	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM(5/34)
PIDD1	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PIP4K2A	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478)
PKD1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
PLA2G6	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),KEGG_LINOLEIC_ACID_METABOLISM(8/29),KEGG_ARACHIDONIC_ACID_METABOLISM(7/58)
PLAGL1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(11/200)
PLAT	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),HALLMARK_COAGULATION(28/138),NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),REACTOME_HEMOSTASIS(30/466),NABA_MATRISOME_ASSOCIATED(35/753),BIOCARTA_AMI_PATHWAY(9/20),BIOCARTA_FIBRINOLYSIS_PATHWAY(7/12),HALLMARK_KRAS_SIGNALING_UP(16/200),HALLMARK_COMPLEMENT(13/200),BIOCARTA_PLATELETAPP_PATHWAY(5/14),PID_INTEGRIN2_PATHWAY(6/29),PID_AMB2_NEUTROPHILS_PATHWAY(5/41)
PLD3	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),ST_GA12_PATHWAY(4/23)
PLG	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),HALLMARK_COAGULATION(28/138),HALLMARK_XENOBIOTIC_METABOLISM(29/200),NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),REACTOME_HEMOSTASIS(30/466),NABA_MATRISOME_ASSOCIATED(35/753),BIOCARTA_AMI_PATHWAY(9/20),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(18/208),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),BIOCARTA_FIBRINOLYSIS_PATHWAY(7/12),HALLMARK_COMPLEMENT(13/200),BIOCARTA_PLATELETAPP_PATHWAY(5/14),HALLMARK_HEDGEHOG_SIGNALING(6/36),REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS(4/16),PID_AMB2_NEUTROPHILS_PATHWAY(5/41),PID_UPA_UPAR_PATHWAY(5/42)
PNISR	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
PNMAL1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
PON1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
PON3	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
PPM1A	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
PPWD1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
PRAP1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
PRKAR1A	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(17/413),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(6/54),BIOCARTA_PPARA_PATHWAY(6/58),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(8/120),KEGG_INSULIN_SIGNALING_PATHWAY(8/137),REACTOME_AQUAPORIN_MEDIATED_TRANSPORT(5/51),REACTOME_SIGNALING_BY_GPCR(22/920),REACTOME_CA_DEPENDENT_EVENTS(4/30)
PRKAR2B	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(17/413),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(6/54),BIOCARTA_PPARA_PATHWAY(6/58),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(8/120),HALLMARK_ESTROGEN_RESPONSE_LATE(10/200),KEGG_INSULIN_SIGNALING_PATHWAY(8/137),HALLMARK_UV_RESPONSE_DN(8/144),REACTOME_AQUAPORIN_MEDIATED_TRANSPORT(5/51),REACTOME_SIGNALING_BY_GPCR(22/920),REACTOME_CA_DEPENDENT_EVENTS(4/30)
PRKCQ	TH34_1349_S02	v8	SOPHORETIN	lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(18/208),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS(10/184),REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK(10/205),REACTOME_AXON_GUIDANCE(11/251),KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY(6/67),REACTOME_SIGNALING_BY_GPCR(22/920)
PRKCQ-AS1	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PROC	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),HALLMARK_COAGULATION(28/138),REACTOME_HEMOSTASIS(30/466),BIOCARTA_AMI_PATHWAY(9/20),BIOCARTA_INTRINSIC_PATHWAY(9/23),REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE(8/32),BIOCARTA_EXTRINSIC_PATHWAY(6/13),REACTOME_COMMON_PATHWAY(6/14),PID_INTEGRIN2_PATHWAY(6/29)
PRRT2	TH34_1349_S02	v8	BRYOSTATIN	lowstringency_pd_outliers	NA
PSMA3-AS1	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PTCH1	TH34_1349_S02	v8	SONIDEGIB,Sonidegib,Vismodegib,VISMODEGIB	lowstringency_pd_outliers	HALLMARK_HEDGEHOG_SIGNALING(6/36),HALLMARK_IL2_STAT5_SIGNALING(11/200),REACTOME_SIGNALING_BY_GPCR(22/920)
PTH1R	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(11/200),REACTOME_SIGNALING_BY_GPCR(22/920)
PTN	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_MATRISOME_ASSOCIATED(35/753)
PTP4A3	TH34_1349_S02	v8	CETUXIMAB	lowstringency_pd_outliers	HALLMARK_MYOGENESIS(9/200)
PTPN12	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
PWWP2A	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
RAB28	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
RABGAP1L	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(16/200),HALLMARK_IL2_STAT5_SIGNALING(11/200)
RASGEF1B	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
RASSF2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
RBM5	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(9/200)
RBM6	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
RBP4	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(29/200),HALLMARK_KRAS_SIGNALING_UP(16/200)
RBPMS	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_DN(8/144)
REEP1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(9/200)
REEP2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
RELN	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),HALLMARK_KRAS_SIGNALING_UP(16/200),NABA_ECM_GLYCOPROTEINS(14/196),NABA_CORE_MATRISOME(16/275)
RGL2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
RGS2	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS(10/184),REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK(10/205),REACTOME_SIGNALING_BY_GPCR(22/920)
RGS4	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_DN(8/144),REACTOME_SIGNALING_BY_GPCR(22/920)
RGS5	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
RGS7BP	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
RNA5SP216	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RNF146	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
RNF24	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
RNPC3	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
RNU1-70P	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ROGDI	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
RP11-166D19.1	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-323N12.5	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-384F7.2	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-386G11.10	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-394O4.5	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-553L6.5	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-611O2.3	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-626H12.1	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-693N9.2	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-70C1.3	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-809N8.5	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-717I23.3	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RPL39P3	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
RTN1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_HEDGEHOG_SIGNALING(6/36)
RUFY3	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
RXRB	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_PPAR_SIGNALING_PATHWAY(13/69),HALLMARK_UV_RESPONSE_UP(9/158),KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY(6/67)
SAA1	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_INNATE_IMMUNE_SYSTEM(13/279),REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS(10/184),REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK(10/205),REACTOME_SIGNALING_BY_GPCR(22/920),REACTOME_AMYLOIDS(6/83)
SAA4	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
SAFB2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
SAMD11	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
SATB1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(16/200)
SCRN2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
SDR39U1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
SEPT5	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
SERPINA1	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),HALLMARK_COAGULATION(28/138),NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),REACTOME_HEMOSTASIS(30/466),NABA_MATRISOME_ASSOCIATED(35/753),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(18/208),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),HALLMARK_COMPLEMENT(13/200),HALLMARK_ESTROGEN_RESPONSE_LATE(10/200)
SERPINA11	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),NABA_MATRISOME_ASSOCIATED(35/753)
SERPINA3	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),NABA_MATRISOME_ASSOCIATED(35/753),HALLMARK_KRAS_SIGNALING_UP(16/200),HALLMARK_ESTROGEN_RESPONSE_LATE(10/200)
SERPINA4	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),NABA_MATRISOME_ASSOCIATED(35/753)
SERPINA5	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),NABA_MATRISOME_ASSOCIATED(35/753),HALLMARK_ANGIOGENESIS(5/36),HALLMARK_ESTROGEN_RESPONSE_LATE(10/200)
SERPINA6	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(29/200),NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),NABA_MATRISOME_ASSOCIATED(35/753),HALLMARK_BILE_ACID_METABOLISM(12/112),HALLMARK_PEROXISOME(9/104)
SERPINC1	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),HALLMARK_COAGULATION(28/138),NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),REACTOME_HEMOSTASIS(30/466),NABA_MATRISOME_ASSOCIATED(35/753),BIOCARTA_AMI_PATHWAY(9/20),BIOCARTA_INTRINSIC_PATHWAY(9/23),REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE(8/32),BIOCARTA_EXTRINSIC_PATHWAY(6/13),REACTOME_COMMON_PATHWAY(6/14),HALLMARK_COMPLEMENT(13/200),HALLMARK_IL2_STAT5_SIGNALING(11/200),PID_GLYPICAN_1PATHWAY(4/27)
SERPIND1	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),NABA_MATRISOME_ASSOCIATED(35/753)
SERPINF2	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(25/69),NABA_MATRISOME(51/1028),NABA_ECM_REGULATORS(23/238),REACTOME_HEMOSTASIS(30/466),NABA_MATRISOME_ASSOCIATED(35/753),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(18/208),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89)
SERTAD4	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
SFRP1	TH34_1349_S02	v8		lowstringency_pd_outliers	NABA_MATRISOME(51/1028),NABA_MATRISOME_ASSOCIATED(35/753)
SFSWAP	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
SH2B1	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),HALLMARK_MYOGENESIS(9/200)
SHC2	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_INSULIN_SIGNALING_PATHWAY(8/137)
SIN3B	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(15/168)
SLC12A2	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(17/413)
SLC12A4	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(29/200),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(17/413)
SLC13A5	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(17/413)
SLC22A1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(29/200),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(17/413),REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM(3/10)
SLC23A2	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_BILE_ACID_METABOLISM(12/112),HALLMARK_PEROXISOME(9/104)
SLC25A27	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
SLC25A47	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
SLC27A5	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),KEGG_PPAR_SIGNALING_PATHWAY(13/69),HALLMARK_BILE_ACID_METABOLISM(12/112),REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM(4/27),REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS(3/11)
SLC29A1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_BILE_ACID_METABOLISM(12/112),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(17/413),HALLMARK_ESTROGEN_RESPONSE_LATE(10/200)
SLC2A2	TH34_1349_S02	v8		lowstringency_pd_outliers	PID_HNF3B_PATHWAY(13/45),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(17/413),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(8/120),REACTOME_METABOLISM_OF_CARBOHYDRATES(11/247)
SMARCD3	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(15/168),REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION(11/104),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396)
SMTN	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(9/200)
SMYD4	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
SNRNP70	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
SPIN1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
SPRED2	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(11/200)
SPRY4	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(11/200)
SPRY4-IT1_2	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SRRM2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
SRSF11	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
SRSF4	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
SRSF5	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ST5	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(9/200)
ST7	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
STAG3L5P	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
STAG3L5P-PVRIG2P-PILRB	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
STIM2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
STK17A	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
SULT2A1	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_BIOLOGICAL_OXIDATIONS(25/139),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(15/168),REACTOME_PHASE_II_CONJUGATION(10/70),REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION(11/104)
SUPT7L	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
SYNGAP1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
SYNM	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
TAPBPL	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
TAT	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(29/200),PID_HNF3B_PATHWAY(13/45),KEGG_TYROSINE_METABOLISM(11/42),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),KEGG_PHENYLALANINE_METABOLISM(5/18),KEGG_CYSTEINE_AND_METHIONINE_METABOLISM(6/34)
TBL1X	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(34/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(15/168),REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION(11/104),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396)
TERF2IP	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
TF	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_COAGULATION(28/138),REACTOME_HEMOSTASIS(30/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(18/208),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(17/413)
TFR2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
THYN1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
TM4SF4	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
TMEM14C	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
TMEM163	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
TMEM30A	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
TMEM59L	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
TMOD1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
TNFRSF14	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
TNS2	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TPBG	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(10/200),HALLMARK_ESTROGEN_RESPONSE_LATE(10/200)
TRIB1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(16/200)
TRO	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
TSC22D4	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
TSPAN33	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
TSPYL1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
TSPYL2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
TTC1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
TTR	TH34_1349_S02	v8		lowstringency_pd_outliers	PID_HNF3B_PATHWAY(13/45),HALLMARK_BILE_ACID_METABOLISM(12/112),HALLMARK_PEROXISOME(9/104),REACTOME_AMYLOIDS(6/83)
TUSC3	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
UBA7	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_INNATE_IMMUNE_SYSTEM(13/279)
UGT1A1	TH34_1349_S02	v8	BELINOSTAT,Belinostat	lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),REACTOME_BIOLOGICAL_OXIDATIONS(25/139),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(20/70),KEGG_RETINOL_METABOLISM(18/64),REACTOME_PHASE_II_CONJUGATION(10/70),KEGG_STEROID_HORMONE_BIOSYNTHESIS(9/55),KEGG_DRUG_METABOLISM_OTHER_ENZYMES(8/51),KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM(6/41)
UGT2B4	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),REACTOME_BIOLOGICAL_OXIDATIONS(25/139),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(20/70),KEGG_RETINOL_METABOLISM(18/64),REACTOME_PHASE_II_CONJUGATION(10/70),KEGG_STEROID_HORMONE_BIOSYNTHESIS(9/55),KEGG_DRUG_METABOLISM_OTHER_ENZYMES(8/51),KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM(6/41)
UGT2B7	TH34_1349_S02	v8		lowstringency_pd_outliers	KEGG_DRUG_METABOLISM_CYTOCHROME_P450(23/72),REACTOME_BIOLOGICAL_OXIDATIONS(25/139),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(20/70),KEGG_RETINOL_METABOLISM(18/64),REACTOME_PHASE_II_CONJUGATION(10/70),KEGG_STEROID_HORMONE_BIOSYNTHESIS(9/55),KEGG_DRUG_METABOLISM_OTHER_ENZYMES(8/51),KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM(6/41)
UROD	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(11/158),KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM(6/41),HALLMARK_UV_RESPONSE_UP(9/158),HALLMARK_HEME_METABOLISM(9/200)
VAMP2	TH34_1349_S02	v8		lowstringency_pd_outliers	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(8/120)
VTN	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(29/200),NABA_MATRISOME(51/1028),NABA_ECM_GLYCOPROTEINS(14/196),NABA_CORE_MATRISOME(16/275),PID_INTEGRIN3_PATHWAY(6/43),PID_INTEGRIN1_PATHWAY(7/66),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(7/79),HALLMARK_ANGIOGENESIS(5/36),PID_UPA_UPAR_PATHWAY(5/42)
WDR6	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
WSB1	TH34_1349_S02	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(10/200)
WWC3	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
XPC	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
XPR1	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
Y_RNA	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZC3H7A	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ZCCHC11	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ZFYVE21	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ZMAT3	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ZNF638	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ZNF692	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ZNF711	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ZNF76	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ZRANB2	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ZSWIM6	TH34_1349_S02	v8		lowstringency_pd_outliers	NA
ZSWIM8	TH34_1349_S02	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ABI3	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
AC007192.6	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC009065.4	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC009950.1	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACP5	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
AL162151.3	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL662801.1	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ANXA11	TH34_1350_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(12/1028),NABA_MATRISOME_ASSOCIATED(10/753),NABA_ECM_AFFILIATED(4/171)
AP003041.1	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ARHGDIB	TH34_1350_S01	v8		lowstringency_pd_outliers	BIOCARTA_D4GDI_PATHWAY(2/13),BIOCARTA_CASPASE_PATHWAY(2/23)
ATF5	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
C19orf43	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
C1QA	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),BIOCARTA_CLASSIC_PATHWAY(5/14),REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT(5/16),HALLMARK_COMPLEMENT(9/200),BIOCARTA_COMP_PATHWAY(5/19),KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS(8/140),REACTOME_COMPLEMENT_CASCADE(5/32),REACTOME_INNATE_IMMUNE_SYSTEM(9/279),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(5/69),REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS(3/10),NABA_MATRISOME(12/1028),NABA_MATRISOME_ASSOCIATED(10/753),HALLMARK_COAGULATION(5/138),KEGG_PRION_DISEASES(3/35),NABA_ECM_AFFILIATED(4/171)
C1QB	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),BIOCARTA_CLASSIC_PATHWAY(5/14),REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT(5/16),BIOCARTA_COMP_PATHWAY(5/19),KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS(8/140),REACTOME_COMPLEMENT_CASCADE(5/32),REACTOME_INNATE_IMMUNE_SYSTEM(9/279),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(5/69),REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS(3/10),NABA_MATRISOME(12/1028),NABA_MATRISOME_ASSOCIATED(10/753),KEGG_PRION_DISEASES(3/35),NABA_ECM_AFFILIATED(4/171)
C1QC	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),BIOCARTA_CLASSIC_PATHWAY(5/14),REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT(5/16),HALLMARK_COMPLEMENT(9/200),BIOCARTA_COMP_PATHWAY(5/19),KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS(8/140),REACTOME_COMPLEMENT_CASCADE(5/32),REACTOME_INNATE_IMMUNE_SYSTEM(9/279),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(5/69),REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS(3/10),NABA_MATRISOME(12/1028),NABA_MATRISOME_ASSOCIATED(10/753),KEGG_PRION_DISEASES(3/35),NABA_ECM_AFFILIATED(4/171)
C2	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),BIOCARTA_CLASSIC_PATHWAY(5/14),REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT(5/16),HALLMARK_COMPLEMENT(9/200),HALLMARK_ALLOGRAFT_REJECTION(9/200),BIOCARTA_COMP_PATHWAY(5/19),KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS(8/140),REACTOME_COMPLEMENT_CASCADE(5/32),REACTOME_INNATE_IMMUNE_SYSTEM(9/279),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(5/69),HALLMARK_COAGULATION(5/138),BIOCARTA_LECTIN_PATHWAY(2/12),REACTOME_REGULATION_OF_COMPLEMENT_CASCADE(2/14)
C3	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),BIOCARTA_CLASSIC_PATHWAY(5/14),REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL(7/70),REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT(5/16),HALLMARK_COMPLEMENT(9/200),BIOCARTA_COMP_PATHWAY(5/19),KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS(8/140),REACTOME_COMPLEMENT_CASCADE(5/32),REACTOME_INNATE_IMMUNE_SYSTEM(9/279),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(10/539),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(5/69),HALLMARK_COAGULATION(5/138),KEGG_LEISHMANIA_INFECTION(4/72),BIOCARTA_LECTIN_PATHWAY(2/12),REACTOME_REGULATION_OF_COMPLEMENT_CASCADE(2/14),PID_INTEGRIN2_PATHWAY(2/29)
C6orf1	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
CAMK1	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
CAMP	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
CD177	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
CD300E	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
CD8A	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL(7/70),HALLMARK_ALLOGRAFT_REJECTION(9/200),PID_IL12_2PATHWAY(5/63),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(10/539),PID_CD8_TCR_DOWNSTREAM_PATHWAY(4/65),KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION(4/89),KEGG_CELL_ADHESION_MOLECULES_CAMS(4/134),PID_CD8_TCR_PATHWAY(3/53),KEGG_HEMATOPOIETIC_CELL_LINEAGE(3/88)
CD8B	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL(7/70),HALLMARK_ALLOGRAFT_REJECTION(9/200),PID_IL12_2PATHWAY(5/63),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(10/539),PID_CD8_TCR_DOWNSTREAM_PATHWAY(4/65),KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION(4/89),KEGG_CELL_ADHESION_MOLECULES_CAMS(4/134),PID_CD8_TCR_PATHWAY(3/53),KEGG_HEMATOPOIETIC_CELL_LINEAGE(3/88),REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS(2/21),REACTOME_HIV_INFECTION(4/207),REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS(2/28)
CEACAM1	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
CEACAM3	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
CEACAM8	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
CHI3L1	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
CHMP2A	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
COL17A1	TH34_1350_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(12/1028),HALLMARK_APICAL_JUNCTION(5/200),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(3/87)
COTL1	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
CTA-384D8.36	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-2006K23.1	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-3193O13.13	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CXCL16	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
CXCR2P1	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
DEDD2	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
DEFA1	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_INNATE_IMMUNE_SYSTEM(9/279)
DEFA4	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_INNATE_IMMUNE_SYSTEM(9/279)
DRAP1	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
EGR2	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
ELOF1	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
EPB41L3	TH34_1350_S01	v8		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(4/200)
EPSTI1	TH34_1350_S01	v8		lowstringency_pd_outliers	HALLMARK_INTERFERON_ALPHA_RESPONSE(7/97),HALLMARK_INTERFERON_GAMMA_RESPONSE(8/200)
FCGR2C	TH34_1350_S01	v8		lowstringency_pd_outliers	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS(8/140),KEGG_LEISHMANIA_INFECTION(4/72)
FCGR3A	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL(7/70),KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS(8/140),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(10/539),KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY(5/137),KEGG_LEISHMANIA_INFECTION(4/72)
FCGR3B	TH34_1350_S01	v8		lowstringency_pd_outliers	KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS(8/140),KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY(5/137),KEGG_LEISHMANIA_INFECTION(4/72)
FGFBP2	TH34_1350_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(12/1028),NABA_MATRISOME_ASSOCIATED(10/753)
FLT3LG	TH34_1350_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(12/1028),NABA_MATRISOME_ASSOCIATED(10/753),KEGG_HEMATOPOIETIC_CELL_LINEAGE(3/88)
GBP1	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_INTERFERON_SIGNALING(7/159),REACTOME_INTERFERON_GAMMA_SIGNALING(5/63),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(7/270)
GBP2	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),HALLMARK_ALLOGRAFT_REJECTION(9/200),HALLMARK_INTERFERON_ALPHA_RESPONSE(7/97),REACTOME_INTERFERON_SIGNALING(7/159),REACTOME_INTERFERON_GAMMA_SIGNALING(5/63),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(7/270),REACTOME_INTERFERON_ALPHA_BETA_SIGNALING(4/64)
GBP5	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_INTERFERON_SIGNALING(7/159),REACTOME_INTERFERON_GAMMA_SIGNALING(5/63),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(7/270)
GIMAP4	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
GIMAP5	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
GPBAR1	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
GPSM3	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
GZMB	TH34_1350_S01	v8		lowstringency_pd_outliers	HALLMARK_COMPLEMENT(9/200),HALLMARK_ALLOGRAFT_REJECTION(9/200),PID_IL12_2PATHWAY(5/63),KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY(5/137),PID_CD8_TCR_DOWNSTREAM_PATHWAY(4/65),KEGG_ALLOGRAFT_REJECTION(3/38),KEGG_GRAFT_VERSUS_HOST_DISEASE(3/42),KEGG_TYPE_I_DIABETES_MELLITUS(3/44),KEGG_AUTOIMMUNE_THYROID_DISEASE(3/53),BIOCARTA_D4GDI_PATHWAY(2/13),BIOCARTA_CTL_PATHWAY(2/15),BIOCARTA_CASPASE_PATHWAY(2/23)
GZMH	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
HLA-A	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL(7/70),HALLMARK_ALLOGRAFT_REJECTION(9/200),HALLMARK_INTERFERON_GAMMA_RESPONSE(8/200),REACTOME_INTERFERON_SIGNALING(7/159),PID_IL12_2PATHWAY(5/63),REACTOME_INTERFERON_GAMMA_SIGNALING(5/63),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(10/539),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(7/270),KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY(5/137),PID_CD8_TCR_DOWNSTREAM_PATHWAY(4/65),REACTOME_INTERFERON_ALPHA_BETA_SIGNALING(4/64),KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION(4/89),KEGG_ALLOGRAFT_REJECTION(3/38),KEGG_GRAFT_VERSUS_HOST_DISEASE(3/42),KEGG_TYPE_I_DIABETES_MELLITUS(3/44),REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY(2/9),KEGG_CELL_ADHESION_MOLECULES_CAMS(4/134),KEGG_AUTOIMMUNE_THYROID_DISEASE(3/53),PID_CD8_TCR_PATHWAY(3/53),REACTOME_ER_PHAGOSOME_PATHWAY(3/61),BIOCARTA_CTL_PATHWAY(2/15),PID_AP1_PATHWAY(3/70),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(3/76),REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS(2/21),REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC(2/21),REACTOME_HIV_INFECTION(4/207),REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS(2/28)
HLA-C	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL(7/70),HALLMARK_INTERFERON_ALPHA_RESPONSE(7/97),REACTOME_INTERFERON_SIGNALING(7/159),REACTOME_INTERFERON_GAMMA_SIGNALING(5/63),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(10/539),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(7/270),KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY(5/137),REACTOME_INTERFERON_ALPHA_BETA_SIGNALING(4/64),KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION(4/89),KEGG_ALLOGRAFT_REJECTION(3/38),KEGG_GRAFT_VERSUS_HOST_DISEASE(3/42),KEGG_TYPE_I_DIABETES_MELLITUS(3/44),REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY(2/9),KEGG_CELL_ADHESION_MOLECULES_CAMS(4/134),KEGG_AUTOIMMUNE_THYROID_DISEASE(3/53),REACTOME_ER_PHAGOSOME_PATHWAY(3/61),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(3/76),REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC(2/21)
HMOX1	TH34_1350_S01	v8	SUNITINIB,SORAFENIB	lowstringency_pd_outliers	NA
HSPA7	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
IFIT2	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),HALLMARK_INTERFERON_ALPHA_RESPONSE(7/97),HALLMARK_INTERFERON_GAMMA_RESPONSE(8/200),REACTOME_INTERFERON_SIGNALING(7/159),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(7/270),REACTOME_INTERFERON_ALPHA_BETA_SIGNALING(4/64)
LCN2	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
LILRA6	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
LILRB2	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL(7/70),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(10/539)
LINC01272	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LTF	TH34_1350_S01	v8		lowstringency_pd_outliers	HALLMARK_COMPLEMENT(9/200)
MAFB	TH34_1350_S01	v8		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(4/200)
MARCO	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
MEFV	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_INNATE_IMMUNE_SYSTEM(9/279)
MIR142	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
MMP24-AS1	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MMP8	TH34_1350_S01	v8		lowstringency_pd_outliers	HALLMARK_COMPLEMENT(9/200),NABA_MATRISOME(12/1028),NABA_MATRISOME_ASSOCIATED(10/753),HALLMARK_COAGULATION(5/138),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(3/87),REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX(2/29)
MMP9	TH34_1350_S01	v8	BEVACIZUMAB	lowstringency_pd_outliers	HALLMARK_ALLOGRAFT_REJECTION(9/200),NABA_MATRISOME(12/1028),NABA_MATRISOME_ASSOCIATED(10/753),HALLMARK_COAGULATION(5/138),HALLMARK_APICAL_JUNCTION(5/200),PID_AP1_PATHWAY(3/70),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(3/87),HALLMARK_KRAS_SIGNALING_UP(4/200),REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX(2/29)
MYOF	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
NEAT1_2	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NTAN1	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
PFN1	TH34_1350_S01	v8		lowstringency_pd_outliers	HALLMARK_COMPLEMENT(9/200),HALLMARK_APICAL_JUNCTION(5/200)
PGLYRP1	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
PILRA	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
PRELID1	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
PSMB9	TH34_1350_S01	v8	Carfilzomib,BORTEZOMIB,CARFILZOMIB	lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),HALLMARK_COMPLEMENT(9/200),HALLMARK_INTERFERON_ALPHA_RESPONSE(7/97),HALLMARK_INTERFERON_GAMMA_RESPONSE(8/200),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(10/539),REACTOME_ER_PHAGOSOME_PATHWAY(3/61),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(3/76),REACTOME_HIV_INFECTION(4/207)
RAB7A	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),PID_IL12_2PATHWAY(5/63),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(10/539)
RARRES3	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
RCN3	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
RGL4	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
RNA5SP216	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RNF167	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
ROGDI	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
RP11-361L15.3	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-362F19.1	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-386G11.10	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-3P17.5	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-466H18.1	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-478C6.4	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-498C9.3	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RRAS	TH34_1350_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(5/200)
SCO2	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
SECTM1	TH34_1350_S01	v8		lowstringency_pd_outliers	HALLMARK_INTERFERON_GAMMA_RESPONSE(8/200)
SHISA5	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
SIGLEC7	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
SLAMF7	TH34_1350_S01	v8	Elotuzumab,ELOTUZUMAB	lowstringency_pd_outliers	HALLMARK_INTERFERON_GAMMA_RESPONSE(8/200)
SLC2A6	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
SLPI	TH34_1350_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(12/1028),NABA_MATRISOME_ASSOCIATED(10/753),HALLMARK_KRAS_SIGNALING_UP(4/200)
SNAP29	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
SNORD89	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
SPI1	TH34_1350_S01	v8		lowstringency_pd_outliers	HALLMARK_ALLOGRAFT_REJECTION(9/200)
SSSCA1	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
TAF10	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_HIV_INFECTION(4/207)
TAGLN	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
TCF7L2	TH34_1350_S01	v8		lowstringency_pd_outliers	PID_AP1_PATHWAY(3/70)
TGFBI	TH34_1350_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(12/1028),HALLMARK_APICAL_JUNCTION(5/200),PID_INTEGRIN2_PATHWAY(2/29)
TMSB4XP6	TH34_1350_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TNFSF12	TH34_1350_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(12/1028),NABA_MATRISOME_ASSOCIATED(10/753)
TYMP	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
UBE2L6	TH34_1350_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),HALLMARK_INTERFERON_ALPHA_RESPONSE(7/97),REACTOME_INNATE_IMMUNE_SYSTEM(9/279),HALLMARK_INTERFERON_GAMMA_RESPONSE(8/200),REACTOME_INTERFERON_SIGNALING(7/159),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(10/539),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(7/270)
UBXN1	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
UNC119	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
WARS	TH34_1350_S01	v8		lowstringency_pd_outliers	HALLMARK_ALLOGRAFT_REJECTION(9/200),HALLMARK_INTERFERON_ALPHA_RESPONSE(7/97),HALLMARK_INTERFERON_GAMMA_RESPONSE(8/200)
WBP2	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
ZNF703	TH34_1350_S01	v8		lowstringency_pd_outliers	NA
AAAS	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(4/54)
ABCA3	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(8/200),HALLMARK_ESTROGEN_RESPONSE_LATE(8/200)
AC005154.6	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC159540.1	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACAN	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_CORE_MATRISOME(13/275)
ACE	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ACIN1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ACOT9	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ADAMTS10	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_MATRISOME_ASSOCIATED(19/753)
ADCY6	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(8/200)
ADH1B	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
AGER	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION(6/77),REACTOME_TOLL_RECEPTOR_CASCADES(7/118),REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE(6/83),REACTOME_ACTIVATED_TLR4_SIGNALLING(6/93),REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE(5/72),REACTOME_TRIF_MEDIATED_TLR3_SIGNALING(5/74),REACTOME_INNATE_IMMUNE_SYSTEM(9/279)
AGR2	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(8/200)
AGR3	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
AKAP10	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
AKAP8L	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
AKIRIN1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
AL132780.1	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL662801.1	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ALDH3A2	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(8/200)
ALKBH5	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ALPL	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ANAPC5	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(6/138)
ANKZF1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ANXA3	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_ECM_AFFILIATED(12/171),NABA_MATRISOME_ASSOCIATED(19/753)
AP003041.1	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AQP4	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ARGLU1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ARHGEF1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ASCC2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ASNA1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ATG4B	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ATHL1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ATP11A	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ATP8B2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ATPAF2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
B9D1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
BARX1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
BCS1L	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
BRIX1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
C11orf24	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
C16orf89	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
C19orf43	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
C19orf53	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
C19orf66	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
C19orf70	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
C1QTNF3	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_ECM_AFFILIATED(12/171),NABA_MATRISOME_ASSOCIATED(19/753)
C3orf58	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
C4BPA	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_INNATE_IMMUNE_SYSTEM(9/279)
C7orf55-LUC7L2	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
C8orf4	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
CALU	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
CCDC130	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
CCDC14	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
CCNL2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
CDC26	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(6/138)
CDC37	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
CDK10	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
CDKN2D	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
CEACAM6	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
CEP95	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
CES1	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(8/200)
CHN1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
CHTOP	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
CLDN18	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
CLDND1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
CLEC11A	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_ECM_AFFILIATED(12/171),NABA_MATRISOME_ASSOCIATED(19/753)
CLK2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
COL11A2	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_CORE_MATRISOME(13/275),NABA_COLLAGENS(6/44),REACTOME_COLLAGEN_FORMATION(6/58),PID_AVB3_INTEGRIN_PATHWAY(6/75),PID_SYNDECAN_1_PATHWAY(5/46),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(6/87)
COL13A1	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_CORE_MATRISOME(13/275),NABA_COLLAGENS(6/44),REACTOME_COLLAGEN_FORMATION(6/58),PID_AVB3_INTEGRIN_PATHWAY(6/75),PID_SYNDECAN_1_PATHWAY(5/46),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(6/87)
COL16A1	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_CORE_MATRISOME(13/275),NABA_COLLAGENS(6/44),REACTOME_COLLAGEN_FORMATION(6/58),PID_AVB3_INTEGRIN_PATHWAY(6/75),PID_SYNDECAN_1_PATHWAY(5/46),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(6/87)
COL27A1	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_CORE_MATRISOME(13/275),NABA_COLLAGENS(6/44),REACTOME_COLLAGEN_FORMATION(6/58),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(6/87)
COL2A1	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_CORE_MATRISOME(13/275),NABA_COLLAGENS(6/44),REACTOME_COLLAGEN_FORMATION(6/58),PID_AVB3_INTEGRIN_PATHWAY(6/75),PID_SYNDECAN_1_PATHWAY(5/46),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(6/87)
COL9A3	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_CORE_MATRISOME(13/275),NABA_COLLAGENS(6/44),REACTOME_COLLAGEN_FORMATION(6/58),PID_AVB3_INTEGRIN_PATHWAY(6/75),PID_SYNDECAN_1_PATHWAY(5/46),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(6/87)
COPA	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
COPS3	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
COPZ2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
COX10-AS1	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CRISPLD1	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_CORE_MATRISOME(13/275)
CSAD	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(8/200)
CSF3R	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
CTB-134H23.3	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-3252C9.4	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTSE	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_MATRISOME_ASSOCIATED(19/753)
CXCL17	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
CXCL2	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_MATRISOME_ASSOCIATED(19/753)
CYB5A	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(8/200)
CYP2B7P	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CYP4B1	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(8/200)
DANCR	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DCAF15	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
DCAF8	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
DDR2	TH34_1351_S01	v8	DASATINIB,REGORAFENIB,Dasatinib,Erlotinib,Regorafenib,ERLOTINIB	lowstringency_pd_outliers	NA
DDX1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
DDX17	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
DDX39A	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
DECR1	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(8/200)
DENND4B	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
DHPS	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(8/200)
DHRS7B	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(8/200)
DMTF1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
DNAJC21	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
DNM1L	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
DNM2	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_TOLL_RECEPTOR_CASCADES(7/118),REACTOME_INNATE_IMMUNE_SYSTEM(9/279)
DPH7	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DRG2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
DUSP12	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
DYNLT3	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(8/200),HALLMARK_ESTROGEN_RESPONSE_LATE(8/200)
DYRK4	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ECSIT	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION(6/77),REACTOME_TOLL_RECEPTOR_CASCADES(7/118),REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE(6/83),REACTOME_ACTIVATED_TLR4_SIGNALLING(6/93),REACTOME_INNATE_IMMUNE_SYSTEM(9/279)
EIF1AX	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ELAC2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ELF3	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(8/200)
ELOF1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ENOSF1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ENPP2	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(8/200)
ENTPD6	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
EPN2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
EXOSC10	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
F11R	TH34_1351_S01	v8		lowstringency_pd_outliers	PID_AVB3_INTEGRIN_PATHWAY(6/75)
FAM118A	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
FAM156A	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
FAM156B	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
FAM92A1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
FARSA	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
FASTKD1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
FBP1	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(8/200)
FKBP7	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
FLCN	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
FLII	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
FLRT2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
FNBP4	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
FTSJ1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
FXYD3	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
GADD45GIP1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
GAS7	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
GPBP1L1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
GPR153	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
GPRC5A	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
GYG2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
HAPLN1	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_CORE_MATRISOME(13/275)
HDAC6	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
HERC2P2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
HERC2P3	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
HOOK2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
HOPX	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
HP	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
HP1BP3	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
HPGD	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
HS3ST3A1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
IBSP	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_CORE_MATRISOME(13/275)
IFITM5	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
IGLV3-1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ILF3	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
IMPAD1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
INSC	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
INTS3	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
INTS8	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
IVD	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
IVNS1ABP	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
KAT2A	TH34_1351_S01	v8		lowstringency_pd_outliers	PID_MYC_PATHWAY(3/25)
KDM5C	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
KEAP1	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(6/138)
KIAA0907	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
KIRREL	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
KLC1	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933)
KRI1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
KRT18	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(8/200)
KRT19	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(8/200),HALLMARK_ESTROGEN_RESPONSE_LATE(8/200),PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY(4/38)
KRT7	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
KRT8	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(8/200),PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY(4/38)
LAMP3	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
LLGL1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
LPCAT1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
LRRC1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
LRRC75A-AS1	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LSM10	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(4/44)
LZTR1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
MAGI2-AS3	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
MALL	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
MAN2C1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
MAP2K3	TH34_1351_S01	v8	GDC-0973,AZD6244,BAY869766,MEK162,TRAMETINIB,SELUMETINIB,PD 0325901,DABRAFENIB MESYLATE	lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION(6/77),REACTOME_TOLL_RECEPTOR_CASCADES(7/118),REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE(6/83),REACTOME_ACTIVATED_TLR4_SIGNALLING(6/93),REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE(5/72),REACTOME_TRIF_MEDIATED_TLR3_SIGNALING(5/74),REACTOME_INNATE_IMMUNE_SYSTEM(9/279),BIOCARTA_MAPK_PATHWAY(5/87),REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE(4/50)
MAP2K4	TH34_1351_S01	v8	GDC-0973,AZD6244,BAY869766,MEK162,TRAMETINIB,SELUMETINIB,PD 0325901,DABRAFENIB MESYLATE	lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION(6/77),REACTOME_TOLL_RECEPTOR_CASCADES(7/118),REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE(6/83),REACTOME_ACTIVATED_TLR4_SIGNALLING(6/93),REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE(5/72),REACTOME_TRIF_MEDIATED_TLR3_SIGNALING(5/74),REACTOME_INNATE_IMMUNE_SYSTEM(9/279),BIOCARTA_MAPK_PATHWAY(5/87),REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE(4/50)
MAPK7	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION(6/77),REACTOME_TOLL_RECEPTOR_CASCADES(7/118),REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE(6/83),REACTOME_ACTIVATED_TLR4_SIGNALLING(6/93),REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE(5/72),REACTOME_TRIF_MEDIATED_TLR3_SIGNALING(5/74),REACTOME_INNATE_IMMUNE_SYSTEM(9/279),BIOCARTA_MAPK_PATHWAY(5/87),REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE(4/50)
MARCO	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
MARK3	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
MAST2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
MCOLN1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
MEF2A	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION(6/77),REACTOME_TOLL_RECEPTOR_CASCADES(7/118),REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE(6/83),REACTOME_ACTIVATED_TLR4_SIGNALLING(6/93),PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY(4/38),REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE(5/72),REACTOME_TRIF_MEDIATED_TLR3_SIGNALING(5/74),REACTOME_INNATE_IMMUNE_SYSTEM(9/279),BIOCARTA_MAPK_PATHWAY(5/87),REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE(4/50)
MIA	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
MKNK1	TH34_1351_S01	v8		lowstringency_pd_outliers	PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY(4/38),BIOCARTA_MAPK_PATHWAY(5/87)
MLLT1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
MLLT6	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
MLPH	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(8/200)
MPRIP	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
MRI1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
MRPS30	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
MSL3	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
MSTO1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
MTFR1L	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MUC1	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_ECM_AFFILIATED(12/171),NABA_MATRISOME_ASSOCIATED(19/753),HALLMARK_ESTROGEN_RESPONSE_EARLY(8/200)
MYO18A	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
N4BP2L2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
NADK2	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NAPSA	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
NBPF14	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
NCOR1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
NDNF	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_CORE_MATRISOME(13/275)
NDUFA11	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
NDUFS2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
NEAT1_1	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NEMF	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
NGEF	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
NIPBL	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
NKTR	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
NKX2-1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
NNT	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
NPIPA1	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB3	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPP1	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NRD1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
OGT	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
OMD	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_CORE_MATRISOME(13/275),HALLMARK_ADIPOGENESIS(8/200)
ORMDL1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
OXCT1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
P3H1	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_MATRISOME_ASSOCIATED(19/753)
PCDH18	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PDE4DIP	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PDHA1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PEBP4	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PEMT	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(8/200),HALLMARK_XENOBIOTIC_METABOLISM(8/200)
PET100	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PGC	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PHKA2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PHOSPHO1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PIGL	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PILRB	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PIN1	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),REACTOME_INNATE_IMMUNE_SYSTEM(9/279),PID_MYC_PATHWAY(3/25)
PKD1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PLAGL1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PLEKHA5	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PMP22	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PNN	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
POFUT2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
POLE3	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PON2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PPAN	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PRDX4	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PRKAA1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PRPF38B	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PRPSAP2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PRUNE	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PTCD3	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(8/200)
PTH1R	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
PTN	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_MATRISOME_ASSOCIATED(19/753)
PTPRS	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
QTRT1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
RABGGTB	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
RAD1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
RAD23A	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
RAI1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
RANBP3	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
RBBP6	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
RBM10	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
RCOR2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
REG1A	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_ECM_AFFILIATED(12/171),NABA_MATRISOME_ASSOCIATED(19/753),HALLMARK_XENOBIOTIC_METABOLISM(8/200)
RGS3	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
RHBDL2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
RMDN1	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RNASEH2A	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(8/200)
RP11-1212A22.4	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-231C14.4	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-488L18.4	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-706O15.1	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-734K23.9	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-765C7.2	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RPL13P12	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
RPL37	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
RPS28	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
RUNX2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
S100A13	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_MATRISOME_ASSOCIATED(19/753)
SAFB	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SAFB2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SCARF2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SCGB1A1	TH34_1351_S01	v8		lowstringency_pd_outliers	PID_HNF3A_PATHWAY(5/44)
SCGB3A1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SCGB3A2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SCO1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SELENBP1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SERPINA1	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_MATRISOME_ASSOCIATED(19/753),PID_HNF3A_PATHWAY(5/44),HALLMARK_ESTROGEN_RESPONSE_LATE(8/200)
SETDB1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SFPQ	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SFTA2	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_ECM_AFFILIATED(12/171),NABA_MATRISOME_ASSOCIATED(19/753)
SFTA3	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_ECM_AFFILIATED(12/171),NABA_MATRISOME_ASSOCIATED(19/753)
SFTPA1	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_ECM_AFFILIATED(12/171),NABA_MATRISOME_ASSOCIATED(19/753),PID_HNF3A_PATHWAY(5/44)
SFTPA2	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_ECM_AFFILIATED(12/171),NABA_MATRISOME_ASSOCIATED(19/753),PID_HNF3A_PATHWAY(5/44)
SFTPB	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_ECM_AFFILIATED(12/171),NABA_MATRISOME_ASSOCIATED(19/753)
SFTPC	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_ECM_AFFILIATED(12/171),NABA_MATRISOME_ASSOCIATED(19/753)
SFTPD	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_ECM_AFFILIATED(12/171),NABA_MATRISOME_ASSOCIATED(19/753),PID_HNF3A_PATHWAY(5/44)
SH3BP2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SH3KBP1	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933)
SH3YL1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SKP2	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(6/138),PID_MYC_PATHWAY(3/25)
SLC17A9	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SLC22A31	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SLC34A2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SLC39A8	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SNHG19	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SNHG3	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SNHG9	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SP7	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SPG7	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SPINT2	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(8/200)
SPTBN1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SRRM1	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(4/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(4/54)
SRSF10	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
SRSF11	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(4/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(4/54)
SRSF4	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(4/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(4/54)
STK36	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
STX10	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
STX8	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TACSTD2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TARBP1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TARDBP	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TARS	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TBX2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TECR	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
THBS3	TH34_1351_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(32/1028),NABA_CORE_MATRISOME(13/275)
THEM4	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933)
THOC1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TIMM44	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TMEM11	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TMEM119	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TMEM125	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TMEM263	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TMEM39A	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TMEM47	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TMTC2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TNNT3	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TNPO2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TOM1L2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TOP3A	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TRIM16	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TRMT1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TRO	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TSPAN13	TH34_1351_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(8/200)
TTC17	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TTC19	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
TVP23B	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TYK2	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933)
TYRO3	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
UBAP2L	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
UBE2G2	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(6/138)
UBE2V2	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933)
UFM1	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ULK2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
UPK3B	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
USP22	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
USP32P3	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
WASH5P	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
WDR45	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
WDR70	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
WDR83OS	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
WFDC2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
WIZ	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
WSB1	TH34_1351_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(21/933)
WWP2	TH34_1351_S01	v8		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(6/138)
Y_RNA	TH34_1351_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZCCHC11	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ZNF131	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ZNF18	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ZNF266	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ZNF280D	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ZNF286A	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ZNF287	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ZNF317	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ZNF559	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ZNF83	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ZRANB2	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
ZSWIM7	TH34_1351_S01	v8		lowstringency_pd_outliers	NA
AAAS	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(18/140),REACTOME_MRNA_PROCESSING(18/161),REACTOME_IMMUNE_SYSTEM(30/933),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(7/54),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(13/270),REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES(6/66),REACTOME_INTERFERON_SIGNALING(9/159),REACTOME_METABOLISM_OF_RNA(12/330)
ABCA8	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
AC005154.6	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC007620.3	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC093642.3	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC159540.1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACIN1	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(18/128)
ADGRA2	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADGRL1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AEBP2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
AFAP1L2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
AFP	TH34_1352_S01	v8		lowstringency_pd_outliers	PID_P53_DOWNSTREAM_PATHWAY(9/137)
AGER	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(30/933)
AHCY	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
AHI1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
AHSA2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
AKAP17A	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
AKAP8L	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
AL662801.1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ALB	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(18/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(9/208)
ALG13	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ALOX15	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
AMT	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ANKRD17	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ANKZF1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
AP003041.1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AP2A1	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(19/396),REACTOME_IMMUNE_SYSTEM(30/933),REACTOME_SIGNALLING_BY_NGF(12/217),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(9/137),REACTOME_NEURONAL_SYSTEM(13/279),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(8/109),REACTOME_AXON_GUIDANCE(12/251),REACTOME_L1CAM_INTERACTIONS(7/86),REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES(10/186),REACTOME_RECYCLING_PATHWAY_OF_L1(4/27),REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL(8/137),REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS(4/28),REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS(3/16),KEGG_ENDOCYTOSIS(8/183)
AP2A2	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(19/396),REACTOME_IMMUNE_SYSTEM(30/933),REACTOME_SIGNALLING_BY_NGF(12/217),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(9/137),REACTOME_NEURONAL_SYSTEM(13/279),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(8/109),REACTOME_AXON_GUIDANCE(12/251),REACTOME_L1CAM_INTERACTIONS(7/86),REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES(10/186),REACTOME_RECYCLING_PATHWAY_OF_L1(4/27),REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL(8/137),REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS(4/28),REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS(3/16),KEGG_ENDOCYTOSIS(8/183)
APBB3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
APPL1	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(16/328),PID_AR_PATHWAY(5/61)
ARHGAP21	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ARHGEF25	TH34_1352_S01	v8		lowstringency_pd_outliers	PID_CDC42_REG_PATHWAY(6/30)
ARHGEF40	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ARID1A	TH34_1352_S01	v8	DASATINIB,GSK126	lowstringency_pd_outliers	NA
ARSI	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ASIC1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ASNSD1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ASXL1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ATF7	TH34_1352_S01	v8		lowstringency_pd_outliers	PID_RB_1PATHWAY(5/65)
ATG16L1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ATG4B	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(14/200)
ATM	TH34_1352_S01	v8	Olaparib,KU-0060648,NU7441,TRAMETINIB,SELUMETINIB (AZD6244),TEMOZOLOMIDE,Temozolomide,OLAPARIB	lowstringency_pd_outliers	PID_NFKAPPAB_CANONICAL_PATHWAY(4/23),PID_TELOMERASE_PATHWAY(5/68)
ATN1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ATP2B4	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_DN(9/144)
ATP6V0A1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ATP8B4	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ATXN1	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_DN(9/144)
ATXN2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ATXN2L	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
BAMBI	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
BAZ2A	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
BCL9L	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
BCLAF1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
BIRC2	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(30/933),KEGG_PATHWAYS_IN_CANCER(16/328),KEGG_FOCAL_ADHESION(11/201),PID_NFKAPPAB_CANONICAL_PATHWAY(4/23),KEGG_SMALL_CELL_LUNG_CANCER(6/84)
BMP4	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(16/328),KEGG_TGF_BETA_SIGNALING_PATHWAY(6/86)
BOC	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(19/396)
BPTF	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
BRD8	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
BRINP1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
BRPF3	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(18/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(9/208)
BTBD19	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
C11orf57	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
C16orf45	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
C16orf89	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
C19orf43	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
C19orf66	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
C1orf52	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
C2CD2L	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
C7orf55-LUC7L2	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CACNG7	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(11/267)
CAMK1G	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CAMTA2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CAP2	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(19/396),HALLMARK_UV_RESPONSE_DN(9/144),REACTOME_AXON_GUIDANCE(12/251)
CAPRIN2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CASC3	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(12/330)
CASS4	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CBFA2T2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CBWD3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CBX1	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(16/200)
CCDC130	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CCDC184	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CCND2	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(11/201),PID_MYC_ACTIV_PATHWAY(7/79),PID_BETA_CATENIN_NUC_PATHWAY(6/80),PID_RB_1PATHWAY(5/65),HALLMARK_WNT_BETA_CATENIN_SIGNALING(4/42)
CCNL2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CCS	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CDK11A	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CDK5RAP3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CDKN3	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(16/200),HALLMARK_E2F_TARGETS(13/200)
CDON	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(19/396),HALLMARK_UV_RESPONSE_DN(9/144)
CENPT	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CEP164	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CEP170	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CEP250	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(14/200)
CEP44	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CEP95	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CFAP20	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CHD2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CHST1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CIC	TH34_1352_S01	v8	SELUMETINIB (AZD6244),VEMURAFENIB,TRAMETINIB	lowstringency_pd_outliers	NA
CIZ1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CLASRP	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CLEC11A	TH34_1352_S01	v8		lowstringency_pd_outliers	NABA_ECM_AFFILIATED(10/171)
CLIP3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CLK2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CNEP1R1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CNIH1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CNOT1	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_RNA_DEGRADATION(5/59)
CNOT2	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_RNA_DEGRADATION(5/59),REACTOME_METABOLISM_OF_RNA(12/330)
CNOT3	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_RNA_DEGRADATION(5/59),REACTOME_METABOLISM_OF_RNA(12/330)
COG7	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
COL21A1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
COL26A1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
COL27A1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
COX6B2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CPSF3L	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CPSF7	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(18/140),REACTOME_MRNA_SPLICING(16/111),REACTOME_MRNA_PROCESSING(18/161),REACTOME_MRNA_3_END_PROCESSING(8/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(8/44),REACTOME_RNA_POL_II_TRANSCRIPTION(8/105),REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS(3/14),REACTOME_TRANSCRIPTION(9/210)
CREBZF	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CRTAC1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CRTC2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CRYZL1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CSAD	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CSNK1G2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CTD-2545G14.4	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTXN1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CYB5B	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CYB5R2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
CYP26A1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
DAZAP1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
DBN1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
DCAF5	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
DCAF8	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
DDHD2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
DDX17	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
DDX42	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(18/128)
DDX5	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(18/128),PID_P53_DOWNSTREAM_PATHWAY(9/137)
DENND4B	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
DHX38	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(18/128),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(18/140),REACTOME_MRNA_SPLICING(16/111),REACTOME_MRNA_PROCESSING(18/161),REACTOME_MRNA_3_END_PROCESSING(8/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(8/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(7/54),REACTOME_RNA_POL_II_TRANSCRIPTION(8/105),REACTOME_TRANSCRIPTION(9/210)
DKFZp434J0226	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
DLG1	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(18/200),HALLMARK_MITOTIC_SPINDLE(14/200),REACTOME_DEVELOPMENTAL_BIOLOGY(19/396),REACTOME_NEURONAL_SYSTEM(13/279),HALLMARK_UV_RESPONSE_DN(9/144),REACTOME_AXON_GUIDANCE(12/251),REACTOME_L1CAM_INTERACTIONS(7/86),REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES(10/186),REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL(8/137),REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS(4/28)
DLG4	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
DMPK	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
DMTF1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
DMWD	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
DNM1L	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_ENDOCYTOSIS(8/183)
DNMT1	TH34_1352_S01	v8	DECITABINE,Decitabine	lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(13/200),PID_RB_1PATHWAY(5/65)
DOCK10	TH34_1352_S01	v8		lowstringency_pd_outliers	PID_CDC42_REG_PATHWAY(6/30),REACTOME_HEMOSTASIS(18/466),REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION(7/132)
DPAGT1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
DPH1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
DROSHA	TH34_1352_S01	v8		lowstringency_pd_outliers	PID_P53_DOWNSTREAM_PATHWAY(9/137)
DUXAP9	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
DVL3	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(16/328),PID_BETA_CATENIN_NUC_PATHWAY(6/80)
DZIP1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
EBF4	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
EED	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(13/200)
EID1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
EIF2B5	TH34_1352_S01	v8		lowstringency_pd_outliers	BIOCARTA_IGF1MTOR_PATHWAY(4/20)
EIF3G	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
EIF3M	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
EIF4E2	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(30/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(13/270),REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES(6/66),REACTOME_INTERFERON_SIGNALING(9/159),KEGG_INSULIN_SIGNALING_PATHWAY(7/137)
EIF4G3	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(30/933),BIOCARTA_MTOR_PATHWAY(5/23),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(13/270),REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES(6/66),REACTOME_INTERFERON_SIGNALING(9/159),BIOCARTA_EIF4_PATHWAY(4/24)
ELK1	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(30/933),REACTOME_SIGNALLING_BY_NGF(12/217),BIOCARTA_ERK_PATHWAY(5/28),KEGG_FOCAL_ADHESION(11/201),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(9/137),BIOCARTA_MAPK_PATHWAY(7/87),PID_PDGFRA_PATHWAY(4/22),ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS(5/45),KEGG_MAPK_SIGNALING_PATHWAY(11/267),BIOCARTA_PDGF_PATHWAY(4/32),BIOCARTA_AT1R_PATHWAY(4/36),BIOCARTA_MET_PATHWAY(4/37),BIOCARTA_NGF_PATHWAY(3/18),BIOCARTA_P38MAPK_PATHWAY(4/40),BIOCARTA_EPO_PATHWAY(3/19),KEGG_INSULIN_SIGNALING_PATHWAY(7/137),BIOCARTA_IL6_PATHWAY(3/22)
EML4	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ENPP2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ERBB2IP	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ERCC5	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ERF	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
EZH1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
FAIM2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
FAM107A	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
FAM133B	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
FAM156A	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
FAM160A2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
FAM178A	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
FAM193B	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
FAM20A	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
FAM214B	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FAM92A1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
FBRS	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
FBXL19	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
FER1L4	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
FEZ1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
FGFR1	TH34_1352_S01	v8	[Lucitanib],INFIGRATINIB,AZD-4547,BGJ-398,ORANTINIB,SU-6668,Regorafenib,LUCITANIB,PD173074,PONATINIB,MIDOSTAURIN,Ponatinib,Dovitinib,MASITINIB,AZD4547,Nintedanib,FGF/VEGF RECEPTOR TYROSINE KINASE INHIBITOR, PD173074,XL228,DOVITINIB,1058137-23-7,4-HYDROXYTAMOXIFEN,REGORAFENIB,NINTEDANIB,BGJ398,Lucitanib	lowstringency_pd_outliers	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(11/127),REACTOME_DEVELOPMENTAL_BIOLOGY(19/396),KEGG_PATHWAYS_IN_CANCER(16/328),REACTOME_SIGNALING_BY_FGFR(9/112),KEGG_ADHERENS_JUNCTION(7/75),PID_FGF_PATHWAY(6/55),REACTOME_AXON_GUIDANCE(12/251),REACTOME_L1CAM_INTERACTIONS(7/86),REACTOME_SIGNALING_BY_FGFR_MUTANTS(5/44),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(7/100),REACTOME_SIGNALING_BY_FGFR1_MUTANTS(4/30),KEGG_MAPK_SIGNALING_PATHWAY(11/267),REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING(4/37)
FGFR2	TH34_1352_S01	v8	BGJ-398,Regorafenib,XL228,Dovitinib,PD173074,Nintedanib,JNJ-42756493,Ponatinib,INFIGRATINIB,PONATINIB,DOVITINIB,AZD-4547,MASITINIB,PAZOPANIB,ERDAFITINIB,AZD4547,REGORAFENIB,NINTEDANIB,BGJ398	lowstringency_pd_outliers	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(11/127),KEGG_PATHWAYS_IN_CANCER(16/328),REACTOME_SIGNALING_BY_FGFR(9/112),PID_FGF_PATHWAY(6/55),REACTOME_SIGNALING_BY_FGFR_MUTANTS(5/44),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(7/100),KEGG_MAPK_SIGNALING_PATHWAY(11/267),REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING(4/37),KEGG_ENDOCYTOSIS(8/183)
FIP1L1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
FLCN	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
FNBP4	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
FNDC5	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
FREM1	TH34_1352_S01	v8		lowstringency_pd_outliers	NABA_ECM_AFFILIATED(10/171)
FUBP1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
FUBP3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
GABBR1	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_NEURONAL_SYSTEM(13/279),REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES(10/186),REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL(8/137)
GABPB1-AS1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GAS7	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
GATA6	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(18/466),REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION(7/132)
GATA6-AS1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GDF5	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_TGF_BETA_SIGNALING_PATHWAY(6/86)
GDI1	TH34_1352_S01	v8		lowstringency_pd_outliers	SIG_CHEMOTAXIS(5/45)
GGA1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
GLA	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
GNB4	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(18/466),REACTOME_NEURONAL_SYSTEM(13/279),REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES(10/186),REACTOME_ADP_SIGNALLING_THROUGH_P2RY1(4/25),REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL(8/137),REACTOME_SIGNAL_AMPLIFICATION(4/31),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(9/208),REACTOME_G_ALPHA1213_SIGNALLING_EVENTS(5/74)
GNG5	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(18/466),REACTOME_NEURONAL_SYSTEM(13/279),REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES(10/186),REACTOME_ADP_SIGNALLING_THROUGH_P2RY1(4/25),REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL(8/137),REACTOME_SIGNAL_AMPLIFICATION(4/31),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(9/208),REACTOME_G_ALPHA1213_SIGNALLING_EVENTS(5/74)
GNL2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
GNPDA1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
GOLGA2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
GOLGA8A	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
GOLGA8B	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
GPC3	TH34_1352_S01	v8		lowstringency_pd_outliers	NABA_ECM_AFFILIATED(10/171)
GPCPD1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
GPM6A	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
GRIN2D	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_NEURONAL_SYSTEM(13/279),REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES(10/186),REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL(8/137)
GRIP2	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_NEURONAL_SYSTEM(13/279),REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES(10/186),REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL(8/137),REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS(4/28),REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS(3/16)
GSDMA	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
GSTM2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
GTF2IP1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
GTPBP2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
GTPBP6	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
GULP1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
H19	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
HAND2-AS1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HDAC6	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(14/200),PID_HDAC_CLASSI_PATHWAY(5/66),REACTOME_SIGNALING_BY_NOTCH1(5/70)
HDC	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
HDGFRP2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
HERC2	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(30/933)
HERC2P2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
HERC2P9	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
HGF	TH34_1352_S01	v8	AMG 102,AMG-102,FICLATUZUMAB,RILOTUMUMAB	lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(30/933),KEGG_PATHWAYS_IN_CANCER(16/328),REACTOME_HEMOSTASIS(18/466),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(13/270),KEGG_FOCAL_ADHESION(11/201),PID_MET_PATHWAY(7/80),PID_P53_DOWNSTREAM_PATHWAY(9/137),PID_FGF_PATHWAY(6/55),BIOCARTA_MET_PATHWAY(4/37),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(9/208),PID_TCPTP_PATHWAY(4/43)
HGSNAT	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
HMGN3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
HNRNPA2B1	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(18/140),REACTOME_MRNA_SPLICING(16/111),REACTOME_MRNA_PROCESSING(18/161)
HNRNPC	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(18/128),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(18/140),REACTOME_MRNA_SPLICING(16/111),REACTOME_MRNA_PROCESSING(18/161),PID_TELOMERASE_PATHWAY(5/68)
HNRNPDL	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HNRNPH1	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(18/140),REACTOME_MRNA_SPLICING(16/111),REACTOME_MRNA_PROCESSING(18/161)
HNRNPH3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
HNRNPR	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(18/140),REACTOME_MRNA_SPLICING(16/111),REACTOME_MRNA_PROCESSING(18/161)
HNRNPUL1	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(18/140),REACTOME_MRNA_SPLICING(16/111),REACTOME_MRNA_PROCESSING(18/161)
HOXC6	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
HP1BP3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
HSPA9	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_RNA_DEGRADATION(5/59)
HUWE1	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(30/933),PID_MYC_ACTIV_PATHWAY(7/79)
IBTK	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ICAM5	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(18/200)
IGF2	TH34_1352_S01	v8	CABAZITAXEL,DOCETAXEL,OSI-906 (LINSITINIB)	lowstringency_pd_outliers	NA
IL4R	TH34_1352_S01	v8		lowstringency_pd_outliers	ST_INTERLEUKIN_4_PATHWAY(5/26),BIOCARTA_IL4_PATHWAY(3/11)
ILF3	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(16/200),HALLMARK_E2F_TARGETS(13/200)
ING5	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
INPPL1	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(18/200),REACTOME_IMMUNE_SYSTEM(30/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(13/270),PID_MET_PATHWAY(7/80),BIOCARTA_IGF1MTOR_PATHWAY(4/20),SIG_CHEMOTAXIS(5/45),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(5/67),PID_EPHA2_FWD_PATHWAY(3/19)
INTS3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
INTS8	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
IPO9	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
IRF2BPL	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
IRF3	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(30/933),REACTOME_HEMOSTASIS(18/466),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(13/270),REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES(6/66),REACTOME_INTERFERON_SIGNALING(9/159),REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION(7/132)
ITSN1	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(14/200),PID_CDC42_REG_PATHWAY(6/30),REACTOME_SIGNALLING_BY_NGF(12/217),REACTOME_G_ALPHA1213_SIGNALLING_EVENTS(5/74)
JPH4	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
KAT2A	TH34_1352_S01	v8		lowstringency_pd_outliers	PID_MYC_ACTIV_PATHWAY(7/79),PID_P53_DOWNSTREAM_PATHWAY(9/137),HALLMARK_WNT_BETA_CATENIN_SIGNALING(4/42),REACTOME_SIGNALING_BY_NOTCH1(5/70)
KCNC3	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_NEURONAL_SYSTEM(13/279)
KCNG1	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_NEURONAL_SYSTEM(13/279)
KCTD12	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
KIAA0368	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
KIAA0430	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
KIAA0907	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
KIF13A	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
KIFC2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
KIRREL	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
KLC1	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(14/200),REACTOME_IMMUNE_SYSTEM(30/933),REACTOME_HEMOSTASIS(18/466),REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION(7/132)
KLF16	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
KLHDC10	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
KMT2A	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
KMT2D	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
KXD1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LAMP3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
LARP1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
LCAT	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
LDB1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
LENG8	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
LIMA1	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(18/200)
LINC01002	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LOXL4	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
LPAR3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
LPPR4	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
LRP4	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
LSM6	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(18/128),KEGG_RNA_DEGRADATION(5/59),REACTOME_METABOLISM_OF_RNA(12/330)
LTBP4	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
LUC7L	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
LUC7L3	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(13/200)
LZTR1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MALAT1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MAML1	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_WNT_BETA_CATENIN_SIGNALING(4/42),REACTOME_SIGNALING_BY_NOTCH1(5/70)
MAP3K12	TH34_1352_S01	v8		lowstringency_pd_outliers	BIOCARTA_MAPK_PATHWAY(7/87),KEGG_MAPK_SIGNALING_PATHWAY(11/267)
MAP4K5	TH34_1352_S01	v8		lowstringency_pd_outliers	BIOCARTA_MAPK_PATHWAY(7/87)
MAPK15	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MAPK8IP3	TH34_1352_S01	v8		lowstringency_pd_outliers	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS(5/45),ST_INTEGRIN_SIGNALING_PATHWAY(6/82),KEGG_MAPK_SIGNALING_PATHWAY(11/267)
MARCH7	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MARCKS	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(16/200),HALLMARK_MITOTIC_SPINDLE(14/200)
MARK3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MATR3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MAU2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MBD1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MED25	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(19/396)
MEF2D	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(19/396),BIOCARTA_MAPK_PATHWAY(7/87),BIOCARTA_AT1R_PATHWAY(4/36),BIOCARTA_ERK5_PATHWAY(3/18),BIOCARTA_P38MAPK_PATHWAY(4/40)
MEG3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MEIS2	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(16/200)
MEOX2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MEST	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MIAT	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MIAT_exon5_1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MIIP	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MINK1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MKNK1	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(11/127),BIOCARTA_MTOR_PATHWAY(5/23),REACTOME_SIGNALING_BY_FGFR(9/112),BIOCARTA_ERK_PATHWAY(5/28),BIOCARTA_MAPK_PATHWAY(7/87),BIOCARTA_EIF4_PATHWAY(4/24),KEGG_MAPK_SIGNALING_PATHWAY(11/267),REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING(4/37),BIOCARTA_P38MAPK_PATHWAY(4/40),KEGG_INSULIN_SIGNALING_PATHWAY(7/137)
MLF1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MLXIP	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MMS19	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MNT	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MOK	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MRPL32	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MRPS5	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MSL1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MTA1	TH34_1352_S01	v8		lowstringency_pd_outliers	PID_MYC_ACTIV_PATHWAY(7/79),HALLMARK_UV_RESPONSE_DN(9/144)
MTERF4	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTMR11	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MYBBP1A	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
MYH10	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(18/200),HALLMARK_MITOTIC_SPINDLE(14/200),REACTOME_DEVELOPMENTAL_BIOLOGY(19/396),REACTOME_AXON_GUIDANCE(12/251)
MYO19	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
NAPSA	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
NASP	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(16/200),HALLMARK_E2F_TARGETS(13/200)
NCOR1	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(19/396),PID_HDAC_CLASSI_PATHWAY(5/66),REACTOME_SIGNALING_BY_NOTCH1(5/70)
NDEL1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
NDFIP1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
NEAT1_2	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NECAB3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
NEMF	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
NETO2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
NFKBIZ	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
NGEF	TH34_1352_S01	v8		lowstringency_pd_outliers	PID_CDC42_REG_PATHWAY(6/30),REACTOME_SIGNALLING_BY_NGF(12/217),REACTOME_G_ALPHA1213_SIGNALLING_EVENTS(5/74)
NISCH	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
NKX2-1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
NLGN2	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(18/200)
NMT1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
NOG	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_TGF_BETA_SIGNALING_PATHWAY(6/86)
NONO	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
NPIPA5	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPP1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NR2C1	TH34_1352_S01	v8		lowstringency_pd_outliers	PID_AR_TF_PATHWAY(5/53),PID_HDAC_CLASSI_PATHWAY(5/66)
NRBP2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
NSRP1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
NTAN1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
NTM	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
NUDCD2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
NUMB	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(19/396),PID_MET_PATHWAY(7/80),REACTOME_AXON_GUIDANCE(12/251),REACTOME_L1CAM_INTERACTIONS(7/86),REACTOME_RECYCLING_PATHWAY_OF_L1(4/27),HALLMARK_WNT_BETA_CATENIN_SIGNALING(4/42),REACTOME_SIGNALING_BY_NOTCH1(5/70)
NUP93	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(18/140),REACTOME_MRNA_PROCESSING(18/161),REACTOME_IMMUNE_SYSTEM(30/933),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(7/54),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(13/270),REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES(6/66),REACTOME_INTERFERON_SIGNALING(9/159),REACTOME_METABOLISM_OF_RNA(12/330)
NXPH2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
OAF	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ODF2	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(16/200)
OGG1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
OGT	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
OLFML1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
OR5E1P	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
OSR1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
P2RY1	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(18/466),REACTOME_ADP_SIGNALLING_THROUGH_P2RY1(4/25),REACTOME_SIGNAL_AMPLIFICATION(4/31),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(9/208)
PABPN1	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(18/140),REACTOME_MRNA_SPLICING(16/111),REACTOME_MRNA_PROCESSING(18/161),REACTOME_MRNA_3_END_PROCESSING(8/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(8/44),REACTOME_RNA_POL_II_TRANSCRIPTION(8/105),REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS(3/14),REACTOME_TRANSCRIPTION(9/210)
PAFAH1B1	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(16/200),HALLMARK_MITOTIC_SPINDLE(14/200)
PAGR1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PAN2	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(13/200)
PAX6	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(19/396)
PBX2	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(18/200)
PCED1A	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PCF11	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(18/140),REACTOME_MRNA_SPLICING(16/111),REACTOME_MRNA_PROCESSING(18/161),REACTOME_MRNA_3_END_PROCESSING(8/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(8/44),REACTOME_RNA_POL_II_TRANSCRIPTION(8/105),REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS(3/14),REACTOME_TRANSCRIPTION(9/210)
PCGF3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PDGFRA	TH34_1352_S01	v8	MIDOSTAURIN,Nilotinib,SORAFENIB,MOTESANIB,CRENOLANIB,OLARATUMAB,NILOTINIB,IMC-3G3,MEDI-575,SUNITINIB,X-82,Crenolanib,Regorafenib,PAZOPANIB,SORAFENIB TOSYLATE,Ponatinib,TANDUTINIB,PONATINIB,MASITINIB,IMATINIB,AMUVATINIB,RAMUCIRUMAB,Sunitinib,Imatinib,Olaratumab,MP470,REGORAFENIB,NINTEDANIB,Pazopanib	lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(16/328),BIOCARTA_ERK_PATHWAY(5/28),KEGG_FOCAL_ADHESION(11/201),PID_PDGFRA_PATHWAY(4/22),KEGG_MAPK_SIGNALING_PATHWAY(11/267),BIOCARTA_PDGF_PATHWAY(4/32),REACTOME_SIGNALING_BY_PDGF(7/122),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(6/95),KEGG_ENDOCYTOSIS(8/183)
PDHA1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PELP1	TH34_1352_S01	v8		lowstringency_pd_outliers	PID_AR_PATHWAY(5/61)
PHC1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PHF12	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PHF21A	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PHLDB1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PHLDB3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PHYKPL	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PIAS1	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(30/933),KEGG_PATHWAYS_IN_CANCER(16/328),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(13/270),REACTOME_INTERFERON_SIGNALING(9/159),PID_RANBP2_PATHWAY(3/11),KEGG_SMALL_CELL_LUNG_CANCER(6/84),PID_AR_PATHWAY(5/61),PID_TCPTP_PATHWAY(4/43)
PIAS3	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(16/328),HALLMARK_UV_RESPONSE_DN(9/144),KEGG_SMALL_CELL_LUNG_CANCER(6/84),PID_AR_PATHWAY(5/61)
PICALM	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PIP5K1A	TH34_1352_S01	v8		lowstringency_pd_outliers	PID_ECADHERIN_KERATINOCYTE_PATHWAY(3/21),KEGG_ENDOCYTOSIS(8/183)
PITX2	TH34_1352_S01	v8		lowstringency_pd_outliers	SIG_CHEMOTAXIS(5/45),PID_BETA_CATENIN_NUC_PATHWAY(6/80),KEGG_TGF_BETA_SIGNALING_PATHWAY(6/86),ST_G_ALPHA_I_PATHWAY(4/35)
PKD1	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(18/200)
PKD1P6	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PKDCC	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PKIG	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PLAGL1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PLCG1	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(18/200),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(11/127),REACTOME_DEVELOPMENTAL_BIOLOGY(19/396),PID_CDC42_REG_PATHWAY(6/30),REACTOME_IMMUNE_SYSTEM(30/933),KEGG_PATHWAYS_IN_CANCER(16/328),REACTOME_SIGNALING_BY_FGFR(9/112),REACTOME_SIGNALLING_BY_NGF(12/217),REACTOME_HEMOSTASIS(18/466),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(13/270),PID_MET_PATHWAY(7/80),PID_FGF_PATHWAY(6/55),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(9/137),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(8/109),REACTOME_AXON_GUIDANCE(12/251),PID_PDGFRA_PATHWAY(4/22),REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES(6/66),REACTOME_INTERFERON_SIGNALING(9/159),REACTOME_SIGNALING_BY_FGFR_MUTANTS(5/44),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(7/100),REACTOME_SIGNALING_BY_FGFR1_MUTANTS(4/30),ST_INTEGRIN_SIGNALING_PATHWAY(6/82),BIOCARTA_PDGF_PATHWAY(4/32),REACTOME_SIGNALING_BY_PDGF(7/122),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(6/95),BIOCARTA_NGF_PATHWAY(3/18),BIOCARTA_ERK5_PATHWAY(3/18),BIOCARTA_EPO_PATHWAY(3/19),REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS(3/19),REACTOME_SIGNALING_BY_ERBB2(6/101),PID_ECADHERIN_KERATINOCYTE_PATHWAY(3/21)
PLEKHG2	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(14/200),REACTOME_SIGNALLING_BY_NGF(12/217),REACTOME_G_ALPHA1213_SIGNALLING_EVENTS(5/74)
PLXNA3	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(19/396),NABA_ECM_AFFILIATED(10/171),REACTOME_AXON_GUIDANCE(12/251)
PMFBP1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PNISR	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PNKP	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PNN	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(13/200)
POGZ	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
POM121C	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PPAN	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PPFIA3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PPIL3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PPP1R10	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PPP5C	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(11/267)
PPWD1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PRAF2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PRKAR1A	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(11/127),REACTOME_SIGNALING_BY_FGFR(9/112),REACTOME_SIGNALLING_BY_NGF(12/217),REACTOME_HEMOSTASIS(18/466),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(9/137),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(8/109),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(7/100),REACTOME_SIGNALING_BY_PDGF(7/122),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(6/95),REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION(7/132),REACTOME_SIGNALING_BY_ERBB2(6/101),KEGG_INSULIN_SIGNALING_PATHWAY(7/137)
PRPF3	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(18/128)
PRPF38B	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(18/128)
PRPF39	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PRR14	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PRRT1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PRRT2	TH34_1352_S01	v8	BRYOSTATIN	lowstringency_pd_outliers	NA
PSD	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_ENDOCYTOSIS(8/183)
PSIP1	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(13/200)
PSMA3-AS1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PTCD3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PTEN	TH34_1352_S01	v8	AZD8186,LY294002,ENZALUTAMIDE,CETUXIMAB,EGFR INHIBITOR,1372540-25-4,AZD5363,EVEROLIMUS,PACLITAXEL,BKM120,Gefitinib,CARBOPLATIN,Cetuximab,TEMSIROLIMUS,BUPARLISIB,Everolimus,Paclitaxel,Trastuzumab,MK-2206,IPATASERTIB,PD184352,Temsirolimus,Ipatasertib,GEFITINIB,GSK2636771,MK2206,Enzalutamide,TRASTUZUMAB,ERLOTINIB	lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(18/200),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(11/127),REACTOME_IMMUNE_SYSTEM(30/933),KEGG_PATHWAYS_IN_CANCER(16/328),BIOCARTA_MTOR_PATHWAY(5/23),REACTOME_SIGNALING_BY_FGFR(9/112),REACTOME_SIGNALLING_BY_NGF(12/217),KEGG_FOCAL_ADHESION(11/201),PID_P53_DOWNSTREAM_PATHWAY(9/137),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(9/137),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(8/109),HALLMARK_UV_RESPONSE_DN(9/144),BIOCARTA_IGF1MTOR_PATHWAY(4/20),BIOCARTA_EIF4_PATHWAY(4/24),SIG_CHEMOTAXIS(5/45),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(7/100),ST_INTEGRIN_SIGNALING_PATHWAY(6/82),KEGG_SMALL_CELL_LUNG_CANCER(6/84),REACTOME_SIGNALING_BY_PDGF(7/122),BIOCARTA_MET_PATHWAY(4/37),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(6/95),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(5/67),REACTOME_SIGNALING_BY_ERBB2(6/101)
PTMS	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PTPRS	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
PVRL3	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(18/200),KEGG_ADHERENS_JUNCTION(7/75)
QRICH1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
R3HDM2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RABL2A	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RACGAP1	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(16/200),HALLMARK_MITOTIC_SPINDLE(14/200),HALLMARK_E2F_TARGETS(13/200),PID_CDC42_REG_PATHWAY(6/30),REACTOME_IMMUNE_SYSTEM(30/933),REACTOME_HEMOSTASIS(18/466),SIG_CHEMOTAXIS(5/45),REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION(7/132)
RAI1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RANBP9	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(14/200),REACTOME_DEVELOPMENTAL_BIOLOGY(19/396),PID_MET_PATHWAY(7/80),REACTOME_AXON_GUIDANCE(12/251),REACTOME_L1CAM_INTERACTIONS(7/86),PID_AR_PATHWAY(5/61)
RBBP6	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RBFOX2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RBM12	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RBM24	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RBM25	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(18/128)
RBM28	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RBM33	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RBM5	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(18/140),REACTOME_MRNA_SPLICING(16/111),REACTOME_MRNA_PROCESSING(18/161)
RBM6	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RCN1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RCOR3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RERE	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
REV1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RGL2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RGS2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RHOJ	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RNPC3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RNU6-476P	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ROBO3	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(19/396),REACTOME_AXON_GUIDANCE(12/251)
ROGDI	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RP11-1212A22.1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-166D19.1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-231C14.4	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-242D8.3	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-274B21.2	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-311C24.1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-350N15.4	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-394O4.5	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-466H18.1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-478C6.4	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-680F20.12	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-734K23.9	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-669L17.10	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-717I23.3	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-800G7.2	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RPF2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RPL11	TH34_1352_S01	v8		lowstringency_pd_outliers	PID_MYC_ACTIV_PATHWAY(7/79),REACTOME_METABOLISM_OF_RNA(12/330)
RPL21	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(12/330)
RPL26	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(12/330)
RPS25	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(12/330)
RPS6KB1	TH34_1352_S01	v8		lowstringency_pd_outliers	BIOCARTA_MTOR_PATHWAY(5/23),ST_INTERLEUKIN_4_PATHWAY(5/26),BIOCARTA_IGF1MTOR_PATHWAY(4/20),BIOCARTA_MAPK_PATHWAY(7/87),BIOCARTA_EIF4_PATHWAY(4/24),BIOCARTA_IL4_PATHWAY(3/11),KEGG_TGF_BETA_SIGNALING_PATHWAY(6/86),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(5/67),PID_TELOMERASE_PATHWAY(5/68),KEGG_INSULIN_SIGNALING_PATHWAY(7/137),PID_A6B1_A6B4_INTEGRIN_PATHWAY(4/46)
RRP7BP	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RSRC2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RTN2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RUFY3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
RXRB	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(16/328),PID_AR_TF_PATHWAY(5/53),KEGG_SMALL_CELL_LUNG_CANCER(6/84),PID_A6B1_A6B4_INTEGRIN_PATHWAY(4/46)
RXRG	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(16/328),PID_AR_TF_PATHWAY(5/53),KEGG_SMALL_CELL_LUNG_CANCER(6/84),PID_A6B1_A6B4_INTEGRIN_PATHWAY(4/46)
SAFB	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SAFB2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SAMD4A	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SART3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SCAF11	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SCGB3A2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SDCCAG3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SEC31A	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(30/933)
SENP2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SEPT5	TH34_1352_S01	v8		lowstringency_pd_outliers	BIOCARTA_PARKIN_PATHWAY(3/13)
SERINC5	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SETD5	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SEZ6	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SF1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SF3A2	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(18/128),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(18/140),REACTOME_MRNA_SPLICING(16/111),REACTOME_MRNA_PROCESSING(18/161)
SFPQ	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(16/200)
SFSWAP	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SFTA3	TH34_1352_S01	v8		lowstringency_pd_outliers	NABA_ECM_AFFILIATED(10/171)
SFTPA1	TH34_1352_S01	v8		lowstringency_pd_outliers	NABA_ECM_AFFILIATED(10/171),PID_HNF3A_PATHWAY(4/44)
SFTPA2	TH34_1352_S01	v8		lowstringency_pd_outliers	NABA_ECM_AFFILIATED(10/171),PID_HNF3A_PATHWAY(4/44)
SFTPB	TH34_1352_S01	v8		lowstringency_pd_outliers	NABA_ECM_AFFILIATED(10/171)
SFTPC	TH34_1352_S01	v8		lowstringency_pd_outliers	NABA_ECM_AFFILIATED(10/171)
SFTPD	TH34_1352_S01	v8		lowstringency_pd_outliers	NABA_ECM_AFFILIATED(10/171),PID_RB_1PATHWAY(5/65),PID_HNF3A_PATHWAY(4/44)
SGSM2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SH2B1	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(30/933),REACTOME_HEMOSTASIS(18/466),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(13/270),REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION(7/132)
SHC1	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(18/200),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(11/127),REACTOME_IMMUNE_SYSTEM(30/933),REACTOME_SIGNALING_BY_FGFR(9/112),ST_INTERLEUKIN_4_PATHWAY(5/26),REACTOME_SIGNALLING_BY_NGF(12/217),BIOCARTA_ERK_PATHWAY(5/28),REACTOME_HEMOSTASIS(18/466),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(13/270),KEGG_FOCAL_ADHESION(11/201),PID_MET_PATHWAY(7/80),PID_FGF_PATHWAY(6/55),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(9/137),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(8/109),BIOCARTA_MAPK_PATHWAY(7/87),PID_PDGFRA_PATHWAY(4/22),ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS(5/45),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(7/100),BIOCARTA_IL4_PATHWAY(3/11),ST_INTEGRIN_SIGNALING_PATHWAY(6/82),BIOCARTA_PDGF_PATHWAY(4/32),ST_G_ALPHA_I_PATHWAY(4/35),BIOCARTA_AT1R_PATHWAY(4/36),BIOCARTA_NGF_PATHWAY(3/18),BIOCARTA_ERK5_PATHWAY(3/18),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(9/208),BIOCARTA_P38MAPK_PATHWAY(4/40),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(5/67),BIOCARTA_EPO_PATHWAY(3/19),PID_EPHA2_FWD_PATHWAY(3/19),REACTOME_SIGNALING_BY_ERBB2(6/101),KEGG_INSULIN_SIGNALING_PATHWAY(7/137),PID_TCPTP_PATHWAY(4/43),BIOCARTA_IL6_PATHWAY(3/22),PID_A6B1_A6B4_INTEGRIN_PATHWAY(4/46)
SIDT2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SLC16A1	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(18/466)
SLC1A6	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_NEURONAL_SYSTEM(13/279),REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES(10/186)
SLC25A27	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SLC25A28	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SLC27A3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SLC35E2B	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SLC6A1	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_NEURONAL_SYSTEM(13/279),REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES(10/186)
SLTM	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SMARCC2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SMARCD3	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(19/396)
SMTN	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SNAI2	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_ADHERENS_JUNCTION(7/75),PID_P53_DOWNSTREAM_PATHWAY(9/137),HALLMARK_UV_RESPONSE_DN(9/144),PID_BETA_CATENIN_NUC_PATHWAY(6/80)
SNAP29	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SNORA40	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SNORA51	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SNRNP70	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(18/128),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(18/140),REACTOME_MRNA_SPLICING(16/111),REACTOME_MRNA_PROCESSING(18/161)
SNRPGP10	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SP9	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SPACA6P	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SPAG17	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SPECC1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SPEN	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SPG20	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SPPL2B	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SRC	TH34_1352_S01	v8	Dasatinib,XL228,AZD0530,DASATINIB,SARACATINIB,Saracatinib,KX2-391,XL-228	lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(18/200),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(11/127),REACTOME_DEVELOPMENTAL_BIOLOGY(19/396),REACTOME_IMMUNE_SYSTEM(30/933),REACTOME_SIGNALING_BY_FGFR(9/112),ST_INTERLEUKIN_4_PATHWAY(5/26),REACTOME_SIGNALLING_BY_NGF(12/217),BIOCARTA_ERK_PATHWAY(5/28),REACTOME_HEMOSTASIS(18/466),KEGG_ADHERENS_JUNCTION(7/75),KEGG_FOCAL_ADHESION(11/201),PID_MET_PATHWAY(7/80),PID_FGF_PATHWAY(6/55),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(9/137),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(8/109),REACTOME_AXON_GUIDANCE(12/251),REACTOME_L1CAM_INTERACTIONS(7/86),ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS(5/45),REACTOME_ADP_SIGNALLING_THROUGH_P2RY1(4/25),REACTOME_RECYCLING_PATHWAY_OF_L1(4/27),PID_AR_TF_PATHWAY(5/53),ST_INTEGRIN_SIGNALING_PATHWAY(6/82),REACTOME_SIGNAL_AMPLIFICATION(4/31),REACTOME_SIGNALING_BY_PDGF(7/122),ST_G_ALPHA_I_PATHWAY(4/35),BIOCARTA_AT1R_PATHWAY(4/36),BIOCARTA_MET_PATHWAY(4/37),REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING(4/37),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(6/95),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(9/208),PID_EPHA2_FWD_PATHWAY(3/19),REACTOME_SIGNALING_BY_ERBB2(6/101),PID_TCPTP_PATHWAY(4/43),PID_ECADHERIN_KERATINOCYTE_PATHWAY(3/21),KEGG_ENDOCYTOSIS(8/183)
SREK1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SRRM1	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(18/140),REACTOME_MRNA_SPLICING(16/111),REACTOME_MRNA_PROCESSING(18/161),REACTOME_MRNA_3_END_PROCESSING(8/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(8/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(7/54),REACTOME_RNA_POL_II_TRANSCRIPTION(8/105),REACTOME_TRANSCRIPTION(9/210)
SRRM2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SRRT	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SRSF10	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(18/128),HALLMARK_G2M_CHECKPOINT(16/200)
SRSF11	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(18/140),REACTOME_MRNA_SPLICING(16/111),REACTOME_MRNA_PROCESSING(18/161),REACTOME_MRNA_3_END_PROCESSING(8/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(8/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(7/54),REACTOME_RNA_POL_II_TRANSCRIPTION(8/105),REACTOME_TRANSCRIPTION(9/210)
SRSF4	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(18/128),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(18/140),REACTOME_MRNA_SPLICING(16/111),REACTOME_MRNA_PROCESSING(18/161),REACTOME_MRNA_3_END_PROCESSING(8/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(8/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(7/54),REACTOME_RNA_POL_II_TRANSCRIPTION(8/105),REACTOME_TRANSCRIPTION(9/210)
SRSF5	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(18/128),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(18/140),REACTOME_MRNA_SPLICING(16/111),REACTOME_MRNA_PROCESSING(18/161),REACTOME_MRNA_3_END_PROCESSING(8/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(8/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(7/54),REACTOME_RNA_POL_II_TRANSCRIPTION(8/105),REACTOME_TRANSCRIPTION(9/210)
SS18	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(16/200)
SSBP4	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SSX2IP	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_ADHERENS_JUNCTION(7/75)
ST13	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ST3GAL5	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
STIM2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
STK36	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(16/328)
STMN1	TH34_1352_S01	v8	PACLITAXEL	lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(16/200),HALLMARK_E2F_TARGETS(13/200),KEGG_MAPK_SIGNALING_PATHWAY(11/267)
STX16	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_NEURONAL_SYSTEM(13/279)
SUB1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SUGP2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SUMO1	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(30/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(13/270),REACTOME_INTERFERON_SIGNALING(9/159),PID_RANBP2_PATHWAY(3/11),BIOCARTA_PARKIN_PATHWAY(3/13),PID_HDAC_CLASSI_PATHWAY(5/66)
SUN1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SUPT20H	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SUPT7L	TH34_1352_S01	v8		lowstringency_pd_outliers	PID_MYC_ACTIV_PATHWAY(7/79)
SUV420H2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SVIL-AS1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SYNE2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SYNGAP1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
SYTL4	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TACC2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TAF1D	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TANK	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(30/933)
TAOK2	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(18/200),HALLMARK_MITOTIC_SPINDLE(14/200),KEGG_MAPK_SIGNALING_PATHWAY(11/267)
TARBP2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TBX1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TBX2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TBX5	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TCERG1	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(18/128)
TCF25	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TCF7L2	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(16/328),KEGG_ADHERENS_JUNCTION(7/75),PID_BETA_CATENIN_NUC_PATHWAY(6/80)
TERF2IP	TH34_1352_S01	v8		lowstringency_pd_outliers	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS(5/45),ST_INTEGRIN_SIGNALING_PATHWAY(6/82),ST_G_ALPHA_I_PATHWAY(4/35),PID_TELOMERASE_PATHWAY(5/68)
THBS3	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(18/200),KEGG_FOCAL_ADHESION(11/201),KEGG_TGF_BETA_SIGNALING_PATHWAY(6/86),REACTOME_SIGNALING_BY_PDGF(7/122)
THOC1	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(18/128)
THOC2	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(18/128)
THUMPD3-AS1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TIA1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TIAL1	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(18/200)
TIMM44	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TMCO6	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TMEM100	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TMEM259	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TMEM67	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TMPO	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(16/200),HALLMARK_E2F_TARGETS(13/200)
TNFAIP3	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(30/933),PID_NFKAPPAB_CANONICAL_PATHWAY(4/23)
TNPO2	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(16/200)
TNRC18	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TOP1MT	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TP53BP1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TP53BP2	TH34_1352_S01	v8		lowstringency_pd_outliers	PID_P53_DOWNSTREAM_PATHWAY(9/137)
TPT1-AS1	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TRA2A	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(18/128)
TRAF3IP3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TRAFD1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TRAK1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TRIM24	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(11/127),REACTOME_SIGNALING_BY_FGFR_MUTANTS(5/44),REACTOME_SIGNALING_BY_FGFR1_MUTANTS(4/30),PID_AR_TF_PATHWAY(5/53),REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS(3/19)
TRIM5	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TRIM6	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TRIM65	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TRO	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(18/200)
TSC2	TH34_1352_S01	v8	Everolimus,EVEROLIMUS	lowstringency_pd_outliers	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(11/127),REACTOME_IMMUNE_SYSTEM(30/933),BIOCARTA_MTOR_PATHWAY(5/23),REACTOME_SIGNALING_BY_FGFR(9/112),REACTOME_SIGNALLING_BY_NGF(12/217),PID_P53_DOWNSTREAM_PATHWAY(9/137),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(9/137),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(8/109),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(7/100),REACTOME_SIGNALING_BY_PDGF(7/122),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(6/95),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(5/67),REACTOME_SIGNALING_BY_ERBB2(6/101),KEGG_INSULIN_SIGNALING_PATHWAY(7/137)
TSPYL2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TTC17	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TTLL3	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TUBG2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TXNL4B	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
TYK2	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(30/933),ST_INTERLEUKIN_4_PATHWAY(5/26),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(13/270),REACTOME_INTERFERON_SIGNALING(9/159),BIOCARTA_IL6_PATHWAY(3/22)
UBAP2L	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
UBE2G2	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(30/933),BIOCARTA_PARKIN_PATHWAY(3/13)
UBTF	TH34_1352_S01	v8		lowstringency_pd_outliers	PID_MYC_ACTIV_PATHWAY(7/79),PID_RB_1PATHWAY(5/65),REACTOME_TRANSCRIPTION(9/210)
UCKL1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
UGP2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
UPF3A	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(12/330)
USP48	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
USP5	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
VAT1L	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
VCL	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(18/200),HALLMARK_MITOTIC_SPINDLE(14/200),REACTOME_HEMOSTASIS(18/466),KEGG_ADHERENS_JUNCTION(7/75),KEGG_FOCAL_ADHESION(11/201),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(9/208)
VPS52	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
VTN	TH34_1352_S01	v8		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(11/201),PID_HNF3A_PATHWAY(4/44)
WASH5P	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
WASH7P	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
WDR27	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
WDR59	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
WDR60	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
WHSC1L1	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
WSB1	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(30/933)
WT1	TH34_1352_S01	v8	CYTARABINE,DAUNORUBICIN	lowstringency_pd_outliers	PID_TELOMERASE_PATHWAY(5/68)
XPO1	TH34_1352_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(16/200),HALLMARK_E2F_TARGETS(13/200),PID_NFKAPPAB_CANONICAL_PATHWAY(4/23),PID_RANBP2_PATHWAY(3/11),PID_BETA_CATENIN_NUC_PATHWAY(6/80),REACTOME_METABOLISM_OF_RNA(12/330),PID_HDAC_CLASSI_PATHWAY(5/66)
YPEL2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
Y_RNA	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZC3H13	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ZC3H7A	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ZCCHC11	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ZDHHC17	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ZDHHC8	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ZFAND5	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ZMYM2	TH34_1352_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(11/127),REACTOME_SIGNALING_BY_FGFR_MUTANTS(5/44),REACTOME_SIGNALING_BY_FGFR1_MUTANTS(4/30),REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS(3/19)
ZMYND8	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ZNF217	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ZNF358	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ZNF384	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ZNF512	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ZNF638	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ZNF644	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ZNF783	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ZNF827	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ZNF83	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ZRANB2	TH34_1352_S01	v8		lowstringency_pd_outliers	NA
ZSWIM8	TH34_1352_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AAAS	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(19/140),REACTOME_MRNA_PROCESSING(19/161),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(17/241),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(9/54),REACTOME_METABOLISM_OF_CARBOHYDRATES(13/247),HALLMARK_DNA_REPAIR(9/150),REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY(4/27),REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE(7/104)
AARS	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ABCA3	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),HALLMARK_ESTROGEN_RESPONSE_LATE(13/200)
AC008753.4	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC132217.4	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACIN1	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(19/128)
ACSS2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ACSS3	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ACTN2	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(17/208),KEGG_FOCAL_ADHESION(13/201),HALLMARK_APICAL_JUNCTION(12/200),BIOCARTA_CELL2CELL_PATHWAY(4/14),HALLMARK_COMPLEMENT(10/200),KEGG_ADHERENS_JUNCTION(6/75)
ADCK3	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ADCY3	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413)
ADNP	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ADPGK	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ADSL	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(9/158)
AGAP3	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
AGAP9	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
AGER	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(13/200)
AGFG2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
AGPAT3	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),HALLMARK_ADIPOGENESIS(13/200),REACTOME_PHOSPHOLIPID_METABOLISM(12/198),KEGG_GLYCEROPHOSPHOLIPID_METABOLISM(7/77),REACTOME_SYNTHESIS_OF_PA(4/27)
AGR2	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(13/200)
AGT	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),NABA_ECM_REGULATORS(16/238),PID_PRL_SIGNALING_EVENTS_PATHWAY(4/23)
AGXT	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
AHCY	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(13/200),HALLMARK_XENOBIOTIC_METABOLISM(12/200)
AHSA2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
AHSG	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
AK6	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AKAP8L	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
AL132780.1	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ALB	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(17/208),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT(9/46),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(17/241),REACTOME_LIPOPROTEIN_METABOLISM(6/28),REACTOME_HDL_MEDIATED_LIPID_TRANSPORT(4/15)
ALDH1A2	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(12/200)
ALOX5	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_ARACHIDONIC_ACID_METABOLISM(6/58)
ALOX5AP	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
AMACR	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),HALLMARK_IL2_STAT5_SIGNALING(13/200)
AMBP	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_REGULATORS(16/238)
ANAPC7	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE_MITOTIC(16/325),REACTOME_CELL_CYCLE(17/421)
ANKLE2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ANKRD11	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ANPEP	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ANXA1	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_AFFILIATED(17/171),HALLMARK_APOPTOSIS(14/161),HALLMARK_COAGULATION(12/138)
AOC3	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(9/158)
AP003041.1	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
APCDD1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
APOA1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(17/208),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT(9/46),HALLMARK_COAGULATION(12/138),REACTOME_LIPOPROTEIN_METABOLISM(6/28),KEGG_PPAR_SIGNALING_PATHWAY(7/69),REACTOME_HDL_MEDIATED_LIPID_TRANSPORT(4/15),REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT(4/16)
APOA2	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT(9/46),REACTOME_LIPOPROTEIN_METABOLISM(6/28),KEGG_PPAR_SIGNALING_PATHWAY(7/69),REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT(4/16)
APOB	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT(9/46),REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL(11/91),REACTOME_LIPOPROTEIN_METABOLISM(6/28),PID_HNF3A_PATHWAY(6/44),REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT(4/16)
APOC1P1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
APOC3	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT(9/46),HALLMARK_COAGULATION(12/138),REACTOME_LIPOPROTEIN_METABOLISM(6/28),KEGG_PPAR_SIGNALING_PATHWAY(7/69),REACTOME_HDL_MEDIATED_LIPID_TRANSPORT(4/15),REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT(4/16)
APOC4	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
APOC4-APOC2	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
APOH	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_ANGIOGENESIS(7/36)
AQP9	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),HALLMARK_XENOBIOTIC_METABOLISM(12/200)
ARFGAP1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_UNFOLDED_PROTEIN_RESPONSE(8/113),REACTOME_MEMBRANE_TRAFFICKING(8/129),REACTOME_DIABETES_PATHWAYS(8/133)
ARGLU1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ARHGEF11	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(11/251)
ARHGEF2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ARPC2	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(12/200)
ASGR1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ASPSCR1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ASXL1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ATG4B	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ATG9A	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ATN1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ATXN2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
AXIN2	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(18/328),HALLMARK_WNT_BETA_CATENIN_SIGNALING(6/42),PID_BETA_CATENIN_NUC_PATHWAY(7/80)
BAMBI	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
BAZ2A	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(13/200)
BCS1L	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(23/518)
BMP4	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),KEGG_PATHWAYS_IN_CANCER(18/328)
BRD7	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
BRPF3	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(17/208),HALLMARK_COMPLEMENT(10/200)
BTG3	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(14/158),HALLMARK_APOPTOSIS(14/161),HALLMARK_ESTROGEN_RESPONSE_LATE(13/200)
C10orf2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
C16orf89	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
C1GALT1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(23/518)
C1orf115	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
C1orf162	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
C21orf59	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
C2orf72	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
C4BPA	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(11/69)
C4BPB	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(11/69),HALLMARK_UV_RESPONSE_UP(14/158),PID_HNF3A_PATHWAY(6/44),HALLMARK_COMPLEMENT(10/200)
C5	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(11/69)
C7orf49	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
CA4	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(9/158)
CALU	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(17/208)
CAPN15	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CAV1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT(9/46),HALLMARK_APOPTOSIS(14/161),REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL(11/91),HALLMARK_ESTROGEN_RESPONSE_LATE(13/200),KEGG_FOCAL_ADHESION(13/201),PID_VEGFR1_2_PATHWAY(6/69),PID_VEGFR1_PATHWAY(4/26)
CCAR1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(19/140),REACTOME_MRNA_PROCESSING(19/161),REACTOME_MRNA_SPLICING(15/111)
CCAR2	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CCDC130	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
CCDC59	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
CCL18	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753)
CCL25	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),HALLMARK_XENOBIOTIC_METABOLISM(12/200)
CCND2	TH34_1379_S01	v8		lowstringency_pd_outliers	PID_MYC_ACTIV_PATHWAY(11/79),HALLMARK_APOPTOSIS(14/161),HALLMARK_ANGIOGENESIS(7/36),HALLMARK_IL2_STAT5_SIGNALING(13/200),KEGG_FOCAL_ADHESION(13/201),REACTOME_CELL_CYCLE_MITOTIC(16/325),HALLMARK_KRAS_SIGNALING_UP(12/200),HALLMARK_WNT_BETA_CATENIN_SIGNALING(6/42),PID_RB_1PATHWAY(7/65),REACTOME_CELL_CYCLE(17/421),PID_BETA_CATENIN_NUC_PATHWAY(7/80),BIOCARTA_CELLCYCLE_PATHWAY(4/23)
CCNL1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
CCT3	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(16/200),REACTOME_METABOLISM_OF_PROTEINS(23/518),REACTOME_PROTEIN_FOLDING(8/53),REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS(4/27),REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC(4/28)
CCT8	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(23/518),REACTOME_PROTEIN_FOLDING(8/53),REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS(4/27),REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC(4/28)
CD163	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
CD52	TH34_1379_S01	v8	ALEMTUZUMAB,Alemtuzumab,CAMPATH	lowstringency_pd_outliers	NA
CD68	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_LYSOSOME(15/121)
CDC123	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
CDC42SE1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
CDK10	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
CDK2	TH34_1379_S01	v8	RONICICLIB,R-ROSCOVITINE,SCH 727965,ALVOCIDIB,FLAVOPIRIDOL,SCH727965,CARBOPLATIN,Roniciclib,Flavopiridol,DINACICLIB,ERIBULIN,SELICICLIB,SNS-032,BMS-387032,BAY1000394	lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),HALLMARK_MYC_TARGETS_V1(16/200),HALLMARK_UV_RESPONSE_UP(14/158),HALLMARK_APOPTOSIS(14/161),KEGG_PATHWAYS_IN_CANCER(18/328),REACTOME_CELL_CYCLE_MITOTIC(16/325),SA_REG_CASCADE_OF_CYCLIN_EXPR(4/13),PID_RB_1PATHWAY(7/65),REACTOME_CELL_CYCLE(17/421),REACTOME_MITOTIC_M_M_G1_PHASES(10/172),REACTOME_DNA_REPLICATION(10/192),BIOCARTA_CELLCYCLE_PATHWAY(4/23),PID_PRL_SIGNALING_EVENTS_PATHWAY(4/23),HALLMARK_PI3K_AKT_MTOR_SIGNALING(7/105)
CDK4	TH34_1379_S01	v8	CS1229,Ribociclib,PD 0332991,ALVOCIDIB,Flavopiridol,Abemaciclib,PALBOCICLIB (PD0332991),PD-0332991,PD-332991,LY2835219,ABEMACICLIB,Roniciclib,Palbociclib,LEE011,CID 5330286,RIBOCICLIB,BAY1000394,PD0332991,PALBOCICLIB	lowstringency_pd_outliers	PID_MYC_ACTIV_PATHWAY(11/79),HALLMARK_MYC_TARGETS_V1(16/200),KEGG_PATHWAYS_IN_CANCER(18/328),HALLMARK_G2M_CHECKPOINT(14/200),HALLMARK_MYC_TARGETS_V2(8/58),REACTOME_CELL_CYCLE_MITOTIC(16/325),HALLMARK_E2F_TARGETS(12/200),SA_REG_CASCADE_OF_CYCLIN_EXPR(4/13),PID_RB_1PATHWAY(7/65),REACTOME_CELL_CYCLE(17/421),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),BIOCARTA_CELLCYCLE_PATHWAY(4/23),HALLMARK_PI3K_AKT_MTOR_SIGNALING(7/105)
CEACAM6	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
CENPT	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE_MITOTIC(16/325),REACTOME_CELL_CYCLE(17/421),REACTOME_MITOTIC_M_M_G1_PHASES(10/172),REACTOME_DNA_REPLICATION(10/192)
CENPV	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
CERS2	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_PHOSPHOLIPID_METABOLISM(12/198),REACTOME_SPHINGOLIPID_METABOLISM(6/69)
CFD	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(11/69),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(17/208),HALLMARK_COAGULATION(12/138)
CHI3L1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
CKAP4	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(13/200)
CLASRP	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
CLDN18	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(12/200)
CLK2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
CLK3	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
COL27A1	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_CORE_MATRISOME(17/275)
COL2A1	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),HALLMARK_UV_RESPONSE_UP(14/158),NABA_CORE_MATRISOME(17/275),KEGG_FOCAL_ADHESION(13/201),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(8/79),PID_INTEGRIN1_PATHWAY(7/66),KEGG_ECM_RECEPTOR_INTERACTION(7/84),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(11/251)
COL9A3	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_CORE_MATRISOME(17/275),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(11/251)
COLEC11	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_AFFILIATED(17/171)
COLGALT1	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
COPS7B	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
CPA4	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
CPSF3L	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
CPSF4	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
CRELD1	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_CORE_MATRISOME(17/275),NABA_ECM_GLYCOPROTEINS(13/196)
CRLS1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_PHOSPHOLIPID_METABOLISM(12/198),REACTOME_ACYL_CHAIN_REMODELLING_OF_PG(4/16),KEGG_GLYCEROPHOSPHOLIPID_METABOLISM(7/77)
CS	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(23/518),HALLMARK_ADIPOGENESIS(13/200)
CSF3R	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(18/328)
CSNK1E	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE_MITOTIC(16/325),HALLMARK_WNT_BETA_CATENIN_SIGNALING(6/42),REACTOME_CELL_CYCLE(17/421)
CST4	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_REGULATORS(16/238)
CTBP2	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(18/328)
CTDSP2	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_DIABETES_PATHWAYS(8/133)
CTNNB1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_APOPTOSIS(14/161),KEGG_PATHWAYS_IN_CANCER(18/328),KEGG_FOCAL_ADHESION(13/201),HALLMARK_WNT_BETA_CATENIN_SIGNALING(6/42),BIOCARTA_CELL2CELL_PATHWAY(4/14),PID_BETA_CATENIN_NUC_PATHWAY(7/80),PID_ECADHERIN_KERATINOCYTE_PATHWAY(4/21),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),PID_VEGFR1_2_PATHWAY(6/69),PID_AJDISS_2PATHWAY(5/48),KEGG_ADHERENS_JUNCTION(6/75)
CTSC	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),KEGG_LYSOSOME(15/121),NABA_ECM_REGULATORS(16/238),HALLMARK_MTORC1_SIGNALING(14/200),HALLMARK_PROTEIN_SECRETION(8/96),HALLMARK_COMPLEMENT(10/200)
CTSL	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_REGULATORS(16/238)
CTSZ	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),KEGG_LYSOSOME(15/121),NABA_ECM_REGULATORS(16/238),HALLMARK_IL2_STAT5_SIGNALING(13/200),REACTOME_MEMBRANE_TRAFFICKING(8/129)
CX3CL1	TH34_1379_S01	v8	ATEZOLIZUMAB	lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),HALLMARK_APICAL_JUNCTION(12/200)
CXCL17	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
CYP4B1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(13/200)
CYP4F34P	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DAP3	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_APOPTOSIS(14/161)
DAZAP1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
DDX17	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
DDX23	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(19/128),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(19/140),REACTOME_MRNA_PROCESSING(19/161),REACTOME_MRNA_SPLICING(15/111),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(8/45)
DDX42	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(19/128)
DDX47	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
DEDD	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
DENND4B	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
DENR	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
DGKD	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(17/208),KEGG_GLYCEROPHOSPHOLIPID_METABOLISM(7/77)
DHX38	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(19/128),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(19/140),REACTOME_MRNA_PROCESSING(19/161),REACTOME_MRNA_SPLICING(15/111),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(9/54),REACTOME_TRANSCRIPTION(12/210),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(6/44),REACTOME_MRNA_3_END_PROCESSING(5/35),REACTOME_RNA_POL_II_TRANSCRIPTION(7/105)
DKC1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(14/200),REACTOME_CELL_CYCLE(17/421),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(8/113)
DLG5	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(13/200)
DLK1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
DMBT1	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_CORE_MATRISOME(17/275),NABA_ECM_GLYCOPROTEINS(13/196)
DMPK	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
DMTF1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
DNAJB6	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
DPEP1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
DRAM1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
DUSP16	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
DUSP9	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
E2F1	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(18/328),HALLMARK_G2M_CHECKPOINT(14/200),REACTOME_CELL_CYCLE_MITOTIC(16/325),SA_REG_CASCADE_OF_CYCLIN_EXPR(4/13),PID_RB_1PATHWAY(7/65),REACTOME_CELL_CYCLE(17/421),REACTOME_MITOTIC_M_M_G1_PHASES(10/172),REACTOME_DNA_REPLICATION(10/192),BIOCARTA_CELLCYCLE_PATHWAY(4/23),HALLMARK_PI3K_AKT_MTOR_SIGNALING(7/105)
E2F4	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(14/200),REACTOME_CELL_CYCLE_MITOTIC(16/325),SA_REG_CASCADE_OF_CYCLIN_EXPR(4/13),PID_RB_1PATHWAY(7/65),REACTOME_CELL_CYCLE(17/421)
EFNA4	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
EIF3B	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(16/200),REACTOME_METABOLISM_OF_PROTEINS(23/518)
EIF3H	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(23/518)
EIF4EBP2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ENC1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ENO2	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(14/158),HALLMARK_APOPTOSIS(14/161),REACTOME_METABOLISM_OF_CARBOHYDRATES(13/247),HALLMARK_FATTY_ACID_METABOLISM(9/158)
EPHX2	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(13/200),KEGG_ARACHIDONIC_ACID_METABOLISM(6/58)
ERVH48-1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ETV5	TH34_1379_S01	v8	TRAMETINIB	lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(12/200)
EWSR1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(14/200)
F2	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),REACTOME_HEMOSTASIS(30/466),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(11/69),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(17/208),HALLMARK_APOPTOSIS(14/161),REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL(11/91),NABA_ECM_REGULATORS(16/238),HALLMARK_COAGULATION(12/138),REACTOME_METABOLISM_OF_PROTEINS(23/518),BIOCARTA_EXTRINSIC_PATHWAY(4/13),REACTOME_COMMON_PATHWAY(4/14),BIOCARTA_INTRINSIC_PATHWAY(4/23),HALLMARK_COMPLEMENT(10/200),REACTOME_DIABETES_PATHWAYS(8/133)
F5	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(11/69),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(17/208),BIOCARTA_EXTRINSIC_PATHWAY(4/13),REACTOME_COMMON_PATHWAY(4/14),BIOCARTA_INTRINSIC_PATHWAY(4/23),HALLMARK_COMPLEMENT(10/200)
FABP1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),HALLMARK_XENOBIOTIC_METABOLISM(12/200),KEGG_PPAR_SIGNALING_PATHWAY(7/69),HALLMARK_FATTY_ACID_METABOLISM(9/158)
FABP4	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT(9/46),HALLMARK_ADIPOGENESIS(13/200),KEGG_PPAR_SIGNALING_PATHWAY(7/69),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396)
FABP5	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(13/200),KEGG_PPAR_SIGNALING_PATHWAY(7/69)
FAM160B2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
FAM171A1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
FAM178A	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
FAM189B	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
FAM192A	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
FAM193B	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
FAM210B	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FAM60A	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
FAT1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
FBRS	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
FBXO31	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
FCGR2A	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
FGFR1	TH34_1379_S01	v8	[Lucitanib],INFIGRATINIB,AZD-4547,BGJ-398,ORANTINIB,SU-6668,Regorafenib,LUCITANIB,PD173074,PONATINIB,MIDOSTAURIN,Ponatinib,Dovitinib,MASITINIB,AZD4547,Nintedanib,FGF/VEGF RECEPTOR TYROSINE KINASE INHIBITOR, PD173074,XL228,DOVITINIB,1058137-23-7,4-HYDROXYTAMOXIFEN,REGORAFENIB,NINTEDANIB,BGJ398,Lucitanib	lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(18/328),HALLMARK_ANGIOGENESIS(7/36),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(11/251),KEGG_ADHERENS_JUNCTION(6/75)
FGFR4	TH34_1379_S01	v8	BGJ-398,FGF/VEGF RECEPTOR TYROSINE KINASE INHIBITOR, PD173074,BGJ398,INFIGRATINIB,DOVITINIB	lowstringency_pd_outliers	NA
FGG	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),REACTOME_HEMOSTASIS(30/466),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(11/69),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(17/208),NABA_CORE_MATRISOME(17/275),HALLMARK_COAGULATION(12/138),NABA_ECM_GLYCOPROTEINS(13/196),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(8/79),BIOCARTA_EXTRINSIC_PATHWAY(4/13),PID_INTEGRIN1_PATHWAY(7/66),REACTOME_COMMON_PATHWAY(4/14),BIOCARTA_INTRINSIC_PATHWAY(4/23)
FKBP10	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
FMOD	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_CORE_MATRISOME(17/275),REACTOME_METABOLISM_OF_CARBOHYDRATES(13/247)
FNBP4	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
FOLR1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
FSCN1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(12/200)
FUBP3	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
FUS	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(19/140),REACTOME_MRNA_PROCESSING(19/161),REACTOME_MRNA_SPLICING(15/111),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(8/113)
FXYD3	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
GALNT2	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(23/518)
GALT	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_CARBOHYDRATES(13/247)
GATM	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
GBA2	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_PHOSPHOLIPID_METABOLISM(12/198),REACTOME_SPHINGOLIPID_METABOLISM(6/69)
GCN1L1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
GET4	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
GGA1	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_LYSOSOME(15/121)
GGA2	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_LYSOSOME(15/121),HALLMARK_MTORC1_SIGNALING(14/200)
GLMP	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GLT8D1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
GLUD1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
GOLGA2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
GORASP1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE_MITOTIC(16/325),REACTOME_CELL_CYCLE(17/421),REACTOME_MITOTIC_M_M_G1_PHASES(10/172),REACTOME_DNA_REPLICATION(10/192)
GPC3	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_AFFILIATED(17/171),REACTOME_METABOLISM_OF_CARBOHYDRATES(13/247)
GPR89A	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
GPRC5A	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
GSS	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(12/200)
GTF2IP1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
GTF2IP4	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GTF3C2	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSCRIPTION(12/210)
GTF3C5	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSCRIPTION(12/210),HALLMARK_DNA_REPAIR(9/150)
H2AFY2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
HABP4	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(17/208)
HBA1	TH34_1379_S01	v8		lowstringency_pd_outliers	BIOCARTA_AHSP_PATHWAY(3/13)
HBA2	TH34_1379_S01	v8		lowstringency_pd_outliers	BIOCARTA_AHSP_PATHWAY(3/13)
HBB	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),BIOCARTA_AHSP_PATHWAY(3/13)
HBG2	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466)
HMGCR	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),HALLMARK_MTORC1_SIGNALING(14/200)
HMOX1	TH34_1379_S01	v8	SUNITINIB,SORAFENIB	lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),HALLMARK_UV_RESPONSE_UP(14/158),HALLMARK_APOPTOSIS(14/161),HALLMARK_XENOBIOTIC_METABOLISM(12/200)
HNRNPA1	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(19/128),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(19/140),REACTOME_MRNA_PROCESSING(19/161),REACTOME_MRNA_SPLICING(15/111),HALLMARK_MYC_TARGETS_V1(16/200)
HNRNPDL	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HNRNPH1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(19/140),REACTOME_MRNA_PROCESSING(19/161),REACTOME_MRNA_SPLICING(15/111)
HNRNPH3	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
HOPX	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(13/200)
HS3ST4	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_CARBOHYDRATES(13/247)
HSDL1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
HSP90B1	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(18/328),HALLMARK_MTORC1_SIGNALING(14/200),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(8/113),REACTOME_DIABETES_PATHWAYS(8/133),HALLMARK_PI3K_AKT_MTOR_SIGNALING(7/105)
HSPD1	TH34_1379_S01	v8		lowstringency_pd_outliers	PID_MYC_ACTIV_PATHWAY(11/79),HALLMARK_MYC_TARGETS_V1(16/200),REACTOME_METABOLISM_OF_PROTEINS(23/518),HALLMARK_MTORC1_SIGNALING(14/200),HALLMARK_MYC_TARGETS_V2(8/58)
HSPE1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(16/200),HALLMARK_MTORC1_SIGNALING(14/200),HALLMARK_MYC_TARGETS_V2(8/58)
HSPH1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(9/158)
HYAL2	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),HALLMARK_UV_RESPONSE_UP(14/158),NABA_ECM_REGULATORS(16/238),REACTOME_METABOLISM_OF_CARBOHYDRATES(13/247)
ID2	TH34_1379_S01	v8		lowstringency_pd_outliers	PID_MYC_ACTIV_PATHWAY(11/79),HALLMARK_ESTROGEN_RESPONSE_LATE(13/200),HALLMARK_XENOBIOTIC_METABOLISM(12/200),HALLMARK_KRAS_SIGNALING_UP(12/200),PID_BETA_CATENIN_NUC_PATHWAY(7/80)
ID3	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
IDH3B	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(9/158)
IGF2	TH34_1379_S01	v8	CABAZITAXEL,DOCETAXEL,OSI-906 (LINSITINIB)	lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),HALLMARK_KRAS_SIGNALING_UP(12/200),REACTOME_DIABETES_PATHWAYS(8/133),PID_AJDISS_2PATHWAY(5/48)
IGF2R	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_LYSOSOME(15/121),HALLMARK_APOPTOSIS(14/161),HALLMARK_IL2_STAT5_SIGNALING(13/200),HALLMARK_PROTEIN_SECRETION(8/96),REACTOME_MEMBRANE_TRAFFICKING(8/129)
IKBKAP	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ILF3	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(14/200),HALLMARK_E2F_TARGETS(12/200)
IQGAP1	TH34_1379_S01	v8		lowstringency_pd_outliers	PID_VEGFR1_2_PATHWAY(6/69),PID_AJDISS_2PATHWAY(5/48),KEGG_ADHERENS_JUNCTION(6/75)
IRX3	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
IST1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ITIH2	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_REGULATORS(16/238)
ITIH5	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_REGULATORS(16/238),HALLMARK_ADIPOGENESIS(13/200),HALLMARK_IL2_STAT5_SIGNALING(13/200)
IVNS1ABP	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
KANK1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
KAT8	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
KCNJ5	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
KDM2B	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
KHDRBS3	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
KHSRP	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_UNFOLDED_PROTEIN_RESPONSE(8/113),REACTOME_DIABETES_PATHWAYS(8/133)
KIAA0907	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
KIFC3	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(23/518),REACTOME_PROTEIN_FOLDING(8/53),REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS(4/27)
KIZ	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
KLC1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466)
KMT2D	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
KNTC1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE_MITOTIC(16/325),REACTOME_CELL_CYCLE(17/421),REACTOME_MITOTIC_M_M_G1_PHASES(10/172),REACTOME_DNA_REPLICATION(10/192)
LAIR1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
LAMA5	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_CORE_MATRISOME(17/275),KEGG_PATHWAYS_IN_CANCER(18/328),NABA_ECM_GLYCOPROTEINS(13/196),KEGG_FOCAL_ADHESION(13/201),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(8/79),PID_INTEGRIN1_PATHWAY(7/66),KEGG_ECM_RECEPTOR_INTERACTION(7/84)
LAMB1	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_CORE_MATRISOME(17/275),KEGG_PATHWAYS_IN_CANCER(18/328),NABA_ECM_GLYCOPROTEINS(13/196),KEGG_FOCAL_ADHESION(13/201),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(8/79),PID_INTEGRIN1_PATHWAY(7/66),KEGG_ECM_RECEPTOR_INTERACTION(7/84),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(11/251)
LAMP3	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_LYSOSOME(15/121)
LDB1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
LEF1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_APOPTOSIS(14/161),KEGG_PATHWAYS_IN_CANCER(18/328),HALLMARK_WNT_BETA_CATENIN_SIGNALING(6/42),PID_BETA_CATENIN_NUC_PATHWAY(7/80),KEGG_ADHERENS_JUNCTION(6/75)
LENG8	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
LGALS8	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_AFFILIATED(17/171)
LINC00969	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01002	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01089	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LIPA	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_LYSOSOME(15/121),HALLMARK_COMPLEMENT(10/200)
LMBR1L	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
LONP1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(12/200)
LPCAT1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_PHOSPHOLIPID_METABOLISM(12/198),REACTOME_ACYL_CHAIN_REMODELLING_OF_PG(4/16),KEGG_GLYCEROPHOSPHOLIPID_METABOLISM(7/77),REACTOME_ACYL_CHAIN_REMODELLING_OF_PC(4/22),REACTOME_SYNTHESIS_OF_PA(4/27)
LTA4H	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_COAGULATION(12/138),HALLMARK_MTORC1_SIGNALING(14/200),KEGG_ARACHIDONIC_ACID_METABOLISM(6/58),HALLMARK_COMPLEMENT(10/200)
LUC7L	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
LUC7L3	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(12/200)
LYPLAL1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
LZTR1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
LZTS2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
M6PR	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_LYSOSOME(15/121),HALLMARK_MTORC1_SIGNALING(14/200),HALLMARK_PROTEIN_SECRETION(8/96),REACTOME_MEMBRANE_TRAFFICKING(8/129)
MACF1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MALAT1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MAP4K4	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MAPK8IP3	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MAPRE1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE_MITOTIC(16/325),REACTOME_CELL_CYCLE(17/421),REACTOME_MITOTIC_M_M_G1_PHASES(10/172),REACTOME_DNA_REPLICATION(10/192)
MARCO	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MATN3	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_CORE_MATRISOME(17/275),NABA_ECM_GLYCOPROTEINS(13/196)
MBD6	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MBTPS1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_DIABETES_PATHWAYS(8/133)
MCFD2	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(23/518)
MCM3AP	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MCM5	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(16/200),HALLMARK_G2M_CHECKPOINT(14/200),HALLMARK_MYC_TARGETS_V2(8/58),REACTOME_CELL_CYCLE_MITOTIC(16/325),HALLMARK_E2F_TARGETS(12/200),REACTOME_CELL_CYCLE(17/421),REACTOME_MITOTIC_M_M_G1_PHASES(10/172),REACTOME_DNA_REPLICATION(10/192)
MDFI	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MEG3	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MEST	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(13/200)
METTL9	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MFAP2	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_CORE_MATRISOME(17/275),NABA_ECM_GLYCOPROTEINS(13/196)
MFF	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MGEA5	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MGST2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MINK1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MKNK1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_PI3K_AKT_MTOR_SIGNALING(7/105)
MLEC	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(23/518)
MLLT6	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MME	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MORF4L2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MRC1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MRPL42	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MRS2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MS4A7	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MSL1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MSR1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MSRB2	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_COAGULATION(12/138)
MTA1	TH34_1379_S01	v8		lowstringency_pd_outliers	PID_MYC_ACTIV_PATHWAY(11/79)
MTG1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
MUC1	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_AFFILIATED(17/171),HALLMARK_IL2_STAT5_SIGNALING(13/200)
MUCL1	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_AFFILIATED(17/171),REACTOME_METABOLISM_OF_PROTEINS(23/518)
MYH7B	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
NAP1L1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(16/200),HALLMARK_E2F_TARGETS(12/200)
NAPSA	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_LYSOSOME(15/121)
NAT9	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
NCL	TH34_1379_S01	v8		lowstringency_pd_outliers	PID_MYC_ACTIV_PATHWAY(11/79),HALLMARK_G2M_CHECKPOINT(14/200)
NDN	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
NDUFA10	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
NDUFA6	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
NDUFS2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
NEAT1_2	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NECAB3	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
NELFCD	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NETO2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
NFE2L2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
NGFRAP1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
NID1	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_CORE_MATRISOME(17/275),NABA_ECM_GLYCOPROTEINS(13/196),PID_INTEGRIN1_PATHWAY(7/66)
NISCH	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
NKD1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_WNT_BETA_CATENIN_SIGNALING(6/42)
NMT1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(14/200),HALLMARK_ADIPOGENESIS(13/200),HALLMARK_XENOBIOTIC_METABOLISM(12/200),REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE(7/104)
NONO	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
NOP2	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(8/58),HALLMARK_IL2_STAT5_SIGNALING(13/200)
NOP56	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(16/200),REACTOME_METABOLISM_OF_PROTEINS(23/518),REACTOME_PROTEIN_FOLDING(8/53),HALLMARK_MYC_TARGETS_V2(8/58),HALLMARK_E2F_TARGETS(12/200),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(8/113),REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS(4/27)
NOP58	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
NOTUM	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
NOV	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_CORE_MATRISOME(17/275),NABA_ECM_GLYCOPROTEINS(13/196)
NPC2	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_LYSOSOME(15/121)
NPIPA1	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPA5	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB3	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB4	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB5	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPNT	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_CORE_MATRISOME(17/275),NABA_ECM_GLYCOPROTEINS(13/196),PID_INTEGRIN1_PATHWAY(7/66)
NR5A1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
NRBP1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
NRP1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_ANGIOGENESIS(7/36),HALLMARK_IL2_STAT5_SIGNALING(13/200),HALLMARK_KRAS_SIGNALING_UP(12/200),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),PID_VEGFR1_PATHWAY(4/26),REACTOME_AXON_GUIDANCE(11/251)
NRP2	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),PID_VEGFR1_PATHWAY(4/26),REACTOME_AXON_GUIDANCE(11/251)
NUDT4	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
NUDT5	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
NXF1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(19/140),REACTOME_MRNA_PROCESSING(19/161),HALLMARK_UV_RESPONSE_UP(14/158),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(9/54)
OAF	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ODAM	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
OGT	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
OLR1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL(11/91),HALLMARK_COAGULATION(12/138),HALLMARK_ANGIOGENESIS(7/36),KEGG_PPAR_SIGNALING_PATHWAY(7/69),HALLMARK_COMPLEMENT(10/200)
ORM1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(13/200)
ORMDL1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
P3H4	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PABPC1L	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
PAH	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
PAN2	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(12/200)
PBX2	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(12/200)
PCAT14	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PCP4	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(13/200),HALLMARK_KRAS_SIGNALING_UP(12/200)
PEBP1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
PECAM1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(17/208),REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL(11/91),HALLMARK_COAGULATION(12/138),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(8/79),HALLMARK_APICAL_JUNCTION(12/200),HALLMARK_KRAS_SIGNALING_UP(12/200),BIOCARTA_CELL2CELL_PATHWAY(4/14),REACTOME_PECAM1_INTERACTIONS(3/10)
PEG10	TH34_1379_S01	v8		lowstringency_pd_outliers	PID_MYC_ACTIV_PATHWAY(11/79)
PEG3	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(12/200)
PFDN4	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(23/518),REACTOME_PROTEIN_FOLDING(8/53),REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC(4/28)
PFKM	TH34_1379_S01	v8		lowstringency_pd_outliers	PID_MYC_ACTIV_PATHWAY(11/79),REACTOME_METABOLISM_OF_CARBOHYDRATES(13/247)
PGC	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
PIGQ	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(23/518)
PIP5K1A	TH34_1379_S01	v8		lowstringency_pd_outliers	PID_ECADHERIN_KERATINOCYTE_PATHWAY(4/21)
PKP4	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
PLA2G1B	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_PHOSPHOLIPID_METABOLISM(12/198),REACTOME_ACYL_CHAIN_REMODELLING_OF_PG(4/16),KEGG_GLYCEROPHOSPHOLIPID_METABOLISM(7/77),KEGG_ARACHIDONIC_ACID_METABOLISM(6/58),REACTOME_ACYL_CHAIN_REMODELLING_OF_PC(4/22),REACTOME_SYNTHESIS_OF_PA(4/27)
PLA2G2A	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_PHOSPHOLIPID_METABOLISM(12/198),REACTOME_ACYL_CHAIN_REMODELLING_OF_PG(4/16),KEGG_GLYCEROPHOSPHOLIPID_METABOLISM(7/77),KEGG_ARACHIDONIC_ACID_METABOLISM(6/58),REACTOME_ACYL_CHAIN_REMODELLING_OF_PC(4/22),REACTOME_SYNTHESIS_OF_PA(4/27)
PLA2G6	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_PHOSPHOLIPID_METABOLISM(12/198),KEGG_GLYCEROPHOSPHOLIPID_METABOLISM(7/77),KEGG_ARACHIDONIC_ACID_METABOLISM(6/58),REACTOME_ACYL_CHAIN_REMODELLING_OF_PC(4/22)
PLCG1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL(11/91),KEGG_PATHWAYS_IN_CANCER(18/328),HALLMARK_APICAL_JUNCTION(12/200),PID_ECADHERIN_KERATINOCYTE_PATHWAY(4/21),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),PID_VEGFR1_2_PATHWAY(6/69),REACTOME_PECAM1_INTERACTIONS(3/10),PID_VEGFR1_PATHWAY(4/26),REACTOME_AXON_GUIDANCE(11/251),HALLMARK_PI3K_AKT_MTOR_SIGNALING(7/105)
PLEKHB2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
PLLP	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
PLOD3	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_REGULATORS(16/238)
PLP1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
POGZ	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
POLR1D	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSCRIPTION(12/210),HALLMARK_DNA_REPAIR(9/150)
PON2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
POP5	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
PPOX	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
PPP1CC	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT(9/46),KEGG_FOCAL_ADHESION(13/201),REACTOME_CELL_CYCLE_MITOTIC(16/325),REACTOME_CELL_CYCLE(17/421),REACTOME_MITOTIC_M_M_G1_PHASES(10/172),REACTOME_DNA_REPLICATION(10/192)
PPP1R1B	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
PPT1	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_LYSOSOME(15/121),HALLMARK_UV_RESPONSE_UP(14/158),HALLMARK_APOPTOSIS(14/161),HALLMARK_PROTEIN_SECRETION(8/96)
PRAP1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
PRDX6	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(9/158)
PREB	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(23/518),HALLMARK_ADIPOGENESIS(13/200),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(8/113),REACTOME_MEMBRANE_TRAFFICKING(8/129),REACTOME_DIABETES_PATHWAYS(8/133)
PRMT2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
PROC	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(11/69),REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL(11/91),HALLMARK_COAGULATION(12/138),REACTOME_METABOLISM_OF_PROTEINS(23/518),BIOCARTA_EXTRINSIC_PATHWAY(4/13),REACTOME_COMMON_PATHWAY(4/14),BIOCARTA_INTRINSIC_PATHWAY(4/23)
PRPF3	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(19/128),HALLMARK_UV_RESPONSE_UP(14/158)
PRRC2B	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
PRRC2C	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
PSAP	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),KEGG_LYSOSOME(15/121),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(17/208),REACTOME_PHOSPHOLIPID_METABOLISM(12/198),REACTOME_SPHINGOLIPID_METABOLISM(6/69)
PSAT1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(14/200),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(8/113)
PSMD4	TH34_1379_S01	v8	BORTEZOMIB,TALAZOPARIB,CARFILZOMIB	lowstringency_pd_outliers	REACTOME_CELL_CYCLE_MITOTIC(16/325),REACTOME_CELL_CYCLE(17/421),REACTOME_MITOTIC_M_M_G1_PHASES(10/172),REACTOME_DNA_REPLICATION(10/192)
PTCD3	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(13/200)
PTK7	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
PTS	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(12/200),HALLMARK_FATTY_ACID_METABOLISM(9/158)
RAB4A	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
RABGGTB	TH34_1379_S01	v8		lowstringency_pd_outliers	PID_PRL_SIGNALING_EVENTS_PATHWAY(4/23)
RABL6	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RAE1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(19/140),REACTOME_MRNA_PROCESSING(19/161),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(17/241),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(9/54),REACTOME_METABOLISM_OF_CARBOHYDRATES(13/247),HALLMARK_DNA_REPAIR(9/150),REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY(4/27),REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE(7/104)
RAP1B	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(17/208),KEGG_FOCAL_ADHESION(13/201),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(8/79)
RBM17	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(19/128)
RBM25	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(19/128)
RBM39	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
RBM5	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(19/140),REACTOME_MRNA_PROCESSING(19/161),REACTOME_MRNA_SPLICING(15/111)
RBM6	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
RBMX	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(19/128),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(19/140),REACTOME_MRNA_PROCESSING(19/161),REACTOME_MRNA_SPLICING(15/111)
RBP4	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(12/200),HALLMARK_KRAS_SIGNALING_UP(12/200)
RELN	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_CORE_MATRISOME(17/275),NABA_ECM_GLYCOPROTEINS(13/196),KEGG_FOCAL_ADHESION(13/201),HALLMARK_KRAS_SIGNALING_UP(12/200),KEGG_ECM_RECEPTOR_INTERACTION(7/84)
RERE	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
RGCC	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RGL2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
RHBG	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
RHOBTB1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
RHOBTB2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
RHOT2	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_APOPTOSIS(14/161)
RNA5S9	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RNF145	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
RNF149	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
RNF19A	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
RNF43	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
RNY1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
RNY3	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ROBO1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),PID_AJDISS_2PATHWAY(5/48),REACTOME_AXON_GUIDANCE(11/251)
ROBO3	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(11/251)
RP11-1212A22.1	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-1212A22.4	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-231C14.4	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-488L18.4	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-568K15.1	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RPUSD3	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
RTFDC1	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
S100A8	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753)
SAFB	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SAMD1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SAMHD1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SCAMP3	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_PROTEIN_SECRETION(8/96)
SCARB1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT(9/46),REACTOME_LIPOPROTEIN_METABOLISM(6/28),HALLMARK_ADIPOGENESIS(13/200),HALLMARK_ESTROGEN_RESPONSE_LATE(13/200),REACTOME_HDL_MEDIATED_LIPID_TRANSPORT(4/15)
SCGB3A2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SDC2	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_AFFILIATED(17/171),REACTOME_METABOLISM_OF_CARBOHYDRATES(13/247),KEGG_ECM_RECEPTOR_INTERACTION(7/84)
SDCCAG3	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SEMA4C	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_AFFILIATED(17/171)
SEMA4G	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_AFFILIATED(17/171)
SEMA6B	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_AFFILIATED(17/171)
SEPHS1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SERINC5	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SERPINA5	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(11/69),NABA_ECM_REGULATORS(16/238),HALLMARK_ANGIOGENESIS(7/36),HALLMARK_ESTROGEN_RESPONSE_LATE(13/200)
SERPINA7	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_REGULATORS(16/238)
SERPIND1	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(11/69),NABA_ECM_REGULATORS(16/238)
SERPINF2	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),REACTOME_HEMOSTASIS(30/466),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(11/69),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(17/208),NABA_ECM_REGULATORS(16/238)
SERPINI1	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),PID_MYC_ACTIV_PATHWAY(11/79),NABA_ECM_REGULATORS(16/238)
SETDB1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SF1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SF3B1	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(19/128),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(19/140),REACTOME_MRNA_PROCESSING(19/161),REACTOME_MRNA_SPLICING(15/111),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(8/45)
SF3B3	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(19/128),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(19/140),REACTOME_MRNA_PROCESSING(19/161),REACTOME_MRNA_SPLICING(15/111),HALLMARK_MYC_TARGETS_V1(16/200),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(8/45)
SFPQ	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(14/200)
SFTA2	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_AFFILIATED(17/171)
SFTA3	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_AFFILIATED(17/171)
SFTPA1	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_AFFILIATED(17/171),PID_HNF3A_PATHWAY(6/44)
SFTPA2	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_AFFILIATED(17/171),PID_HNF3A_PATHWAY(6/44)
SFTPB	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_AFFILIATED(17/171)
SFTPC	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_AFFILIATED(17/171)
SFTPD	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753),NABA_ECM_AFFILIATED(17/171),PID_RB_1PATHWAY(7/65),PID_HNF3A_PATHWAY(6/44)
SGSH	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_LYSOSOME(15/121),REACTOME_METABOLISM_OF_CARBOHYDRATES(13/247)
SH2B1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466)
SH3BP4	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SHTN1	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SIGMAR1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(14/158)
SLC11A1	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_LYSOSOME(15/121),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(17/241),REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS(8/89),REACTOME_METAL_ION_SLC_TRANSPORTERS(4/22)
SLC13A3	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(17/241),REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS(8/89),REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS(3/11)
SLC13A5	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(17/241),REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS(8/89),REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS(3/11)
SLC16A1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(17/241),REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL(11/91),HALLMARK_ESTROGEN_RESPONSE_LATE(13/200),REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS(8/89),REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS(3/11)
SLC17A9	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SLC20A2	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(17/241)
SLC22A31	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SLC2A1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),PID_MYC_ACTIV_PATHWAY(11/79),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(17/241),KEGG_PATHWAYS_IN_CANCER(18/328),HALLMARK_MTORC1_SIGNALING(14/200),REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS(8/89),REACTOME_METABOLISM_OF_CARBOHYDRATES(13/247),HALLMARK_PI3K_AKT_MTOR_SIGNALING(7/105)
SLC30A3	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(17/241),HALLMARK_APICAL_JUNCTION(12/200),REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS(8/89),REACTOME_METAL_ION_SLC_TRANSPORTERS(4/22)
SLC34A2	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(17/241)
SLC35D2	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(17/241)
SLC39A5	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(17/241),REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS(8/89),REACTOME_METAL_ION_SLC_TRANSPORTERS(4/22)
SLC39A8	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(17/241),HALLMARK_IL2_STAT5_SIGNALING(13/200),REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS(8/89),REACTOME_METAL_ION_SLC_TRANSPORTERS(4/22)
SLC5A6	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(17/241),HALLMARK_ADIPOGENESIS(13/200)
SLC7A8	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(17/241),REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL(11/91)
SMAGP	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SMARCD1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SMARCD3	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396)
SMG5	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SMPD4	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_PHOSPHOLIPID_METABOLISM(12/198),REACTOME_SPHINGOLIPID_METABOLISM(6/69)
SMYD2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SNHG1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SNRPE	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(19/128),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(19/140),REACTOME_MRNA_PROCESSING(19/161),REACTOME_MRNA_SPLICING(15/111),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(8/45),REACTOME_TRANSCRIPTION(12/210),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(6/44),REACTOME_RNA_POL_II_TRANSCRIPTION(7/105)
SNX5	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_MEMBRANE_TRAFFICKING(8/129)
SON	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SOX13	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SP5	TH34_1379_S01	v8		lowstringency_pd_outliers	PID_BETA_CATENIN_NUC_PATHWAY(7/80)
SPG7	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SPI1	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(18/328),PID_RB_1PATHWAY(7/65)
SPPL2B	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SPTLC1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_PHOSPHOLIPID_METABOLISM(12/198),REACTOME_SPHINGOLIPID_METABOLISM(6/69)
SRC	TH34_1379_S01	v8	Dasatinib,XL228,AZD0530,DASATINIB,SARACATINIB,Saracatinib,KX2-391,XL-228	lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(17/208),REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL(11/91),KEGG_FOCAL_ADHESION(13/201),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(8/79),HALLMARK_APICAL_JUNCTION(12/200),BIOCARTA_CELL2CELL_PATHWAY(4/14),PID_ECADHERIN_KERATINOCYTE_PATHWAY(4/21),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),PID_PRL_SIGNALING_EVENTS_PATHWAY(4/23),HALLMARK_COMPLEMENT(10/200),PID_VEGFR1_2_PATHWAY(6/69),REACTOME_MEMBRANE_TRAFFICKING(8/129),REACTOME_PECAM1_INTERACTIONS(3/10),PID_AJDISS_2PATHWAY(5/48),REACTOME_AXON_GUIDANCE(11/251),KEGG_ADHERENS_JUNCTION(6/75)
SRRM2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SRRT	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
SRSF1	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(19/128),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(19/140),REACTOME_MRNA_PROCESSING(19/161),REACTOME_MRNA_SPLICING(15/111),HALLMARK_MYC_TARGETS_V1(16/200),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(9/54),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(8/45),HALLMARK_G2M_CHECKPOINT(14/200),HALLMARK_E2F_TARGETS(12/200),REACTOME_TRANSCRIPTION(12/210),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(6/44),REACTOME_MRNA_3_END_PROCESSING(5/35),REACTOME_RNA_POL_II_TRANSCRIPTION(7/105)
SRSF10	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(19/128),HALLMARK_G2M_CHECKPOINT(14/200)
SRSF2	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(19/128),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(19/140),REACTOME_MRNA_PROCESSING(19/161),REACTOME_MRNA_SPLICING(15/111),HALLMARK_MYC_TARGETS_V1(16/200),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(9/54),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(8/45),HALLMARK_G2M_CHECKPOINT(14/200),HALLMARK_E2F_TARGETS(12/200),REACTOME_TRANSCRIPTION(12/210),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(6/44),REACTOME_MRNA_3_END_PROCESSING(5/35),REACTOME_RNA_POL_II_TRANSCRIPTION(7/105)
SRSF6	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(19/128),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(19/140),REACTOME_MRNA_PROCESSING(19/161),REACTOME_MRNA_SPLICING(15/111),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(9/54),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(8/45),REACTOME_TRANSCRIPTION(12/210),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(6/44),REACTOME_MRNA_3_END_PROCESSING(5/35),HALLMARK_DNA_REPAIR(9/150),REACTOME_RNA_POL_II_TRANSCRIPTION(7/105)
SRSF7	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(19/128),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(19/140),REACTOME_MRNA_PROCESSING(19/161),REACTOME_MRNA_SPLICING(15/111),HALLMARK_MYC_TARGETS_V1(16/200),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(9/54),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(8/45),REACTOME_TRANSCRIPTION(12/210),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(6/44),REACTOME_MRNA_3_END_PROCESSING(5/35),REACTOME_RNA_POL_II_TRANSCRIPTION(7/105)
SSB	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(16/200),REACTOME_TRANSCRIPTION(12/210)
STAG3L5P-PVRIG2P-PILRB	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
STAR	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478)
STARD3	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(14/158)
STK25	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(14/158)
STK36	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(18/328)
STX16	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_PROTEIN_SECRETION(8/96)
SYTL2	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(14/200)
TAF1C	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSCRIPTION(12/210),HALLMARK_DNA_REPAIR(9/150)
TAF9	TH34_1379_S01	v8		lowstringency_pd_outliers	PID_MYC_ACTIV_PATHWAY(11/79),REACTOME_TRANSCRIPTION(12/210),HALLMARK_DNA_REPAIR(9/150),REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE(7/104),REACTOME_RNA_POL_II_TRANSCRIPTION(7/105)
TARBP1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
TARBP2	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_DNA_REPAIR(9/150)
TBCA	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(23/518),REACTOME_PROTEIN_FOLDING(8/53)
TBCE	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(23/518),REACTOME_PROTEIN_FOLDING(8/53)
TBRG4	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(8/58),HALLMARK_E2F_TARGETS(12/200)
TBX3	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
TCAF1	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TF	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(13/89),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(17/208),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),HALLMARK_COAGULATION(12/138)
THBS3	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_CORE_MATRISOME(17/275),NABA_ECM_GLYCOPROTEINS(13/196),KEGG_FOCAL_ADHESION(13/201),HALLMARK_APICAL_JUNCTION(12/200),KEGG_ECM_RECEPTOR_INTERACTION(7/84)
THOC2	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(19/128)
THUMPD3-AS1	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TIAL1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(12/200)
TM9SF4	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
TMEM106C	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
TMEM2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
TMEM261	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TNFSF13	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_MATRISOME_ASSOCIATED(40/753)
TNNI2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
TNPO2	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(14/200)
TOMM34	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
TOMM5	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(23/518)
TPCN1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
TPR	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(19/140),REACTOME_MRNA_PROCESSING(19/161),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(23/413),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(17/241),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(9/54),KEGG_PATHWAYS_IN_CANCER(18/328),REACTOME_METABOLISM_OF_CARBOHYDRATES(13/247),REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY(4/27),REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE(7/104)
TPSAB1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(13/200)
TRA2A	TH34_1379_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(19/128)
TRDC	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
TREM1	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(30/466),REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL(11/91)
TRH	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
TRIB2	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(12/200)
TRIM50	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
TRIP10	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
TRMU	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
TSG101	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_PROTEIN_SECRETION(8/96),HALLMARK_DNA_REPAIR(9/150),REACTOME_MEMBRANE_TRAFFICKING(8/129),REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE(7/104)
TTC17	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
TTLL4	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
TUBA1A	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(23/518),REACTOME_PROTEIN_FOLDING(8/53),REACTOME_CELL_CYCLE_MITOTIC(16/325),REACTOME_CELL_CYCLE(17/421),REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC(4/28)
UBAP2L	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
UBE2G2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
UCKL1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
UGCG	TH34_1379_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(27/478),REACTOME_PHOSPHOLIPID_METABOLISM(12/198),REACTOME_SPHINGOLIPID_METABOLISM(6/69)
UNC119B	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
UNG	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(14/200),HALLMARK_MYC_TARGETS_V2(8/58),HALLMARK_E2F_TARGETS(12/200)
USP22	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
USP34	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
UXS1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
VIM	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
VSIG4	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
VTN	TH34_1379_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(57/1028),NABA_CORE_MATRISOME(17/275),HALLMARK_ANGIOGENESIS(7/36),NABA_ECM_GLYCOPROTEINS(13/196),KEGG_FOCAL_ADHESION(13/201),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(8/79),HALLMARK_XENOBIOTIC_METABOLISM(12/200),PID_HNF3A_PATHWAY(6/44),PID_INTEGRIN1_PATHWAY(7/66),KEGG_ECM_RECEPTOR_INTERACTION(7/84),PID_VEGFR1_2_PATHWAY(6/69)
WASH3P	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
WASH5P	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
WASH6P	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
WASH7P	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
WDR59	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
WSB1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
WWP1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
XPO1	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(16/200),HALLMARK_G2M_CHECKPOINT(14/200),REACTOME_CELL_CYCLE_MITOTIC(16/325),HALLMARK_E2F_TARGETS(12/200),REACTOME_CELL_CYCLE(17/421),PID_BETA_CATENIN_NUC_PATHWAY(7/80),REACTOME_MITOTIC_M_M_G1_PHASES(10/172),REACTOME_DNA_REPLICATION(10/192),REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY(4/27),REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE(7/104)
YKT6	TH34_1379_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(14/158),HALLMARK_MTORC1_SIGNALING(14/200),HALLMARK_PROTEIN_SECRETION(8/96)
YY1AP1	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
Y_RNA	TH34_1379_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZC3H15	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ZCCHC11	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ZDHHC3	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ZDHHC6	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ZFAND2B	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ZMIZ2	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ZNF331	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ZNF384	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ZNF503	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ZNF638	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ZNF692	TH34_1379_S01	v8		lowstringency_pd_outliers	NA
ACOT8	TH34_1380_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(10/158)
ADAMTS10	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
ADCY3	TH34_1380_S01	v8		lowstringency_pd_outliers	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(5/115)
ADGRD1	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADSS	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
AL662801.1	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ANAPC5	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
ANO1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
ANO10	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
ARHGEF11	TH34_1380_S01	v8		lowstringency_pd_outliers	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(5/115),BIOCARTA_MYOSIN_PATHWAY(3/31),BIOCARTA_PAR1_PATHWAY(3/37)
ARHGEF17	TH34_1380_S01	v8		lowstringency_pd_outliers	BIOCARTA_MYOSIN_PATHWAY(3/31),BIOCARTA_PAR1_PATHWAY(3/37)
ASUN	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ATP1A2	TH34_1380_S01	v8		lowstringency_pd_outliers	KEGG_CARDIAC_MUSCLE_CONTRACTION(4/80)
ATP1B2	TH34_1380_S01	v8		lowstringency_pd_outliers	KEGG_CARDIAC_MUSCLE_CONTRACTION(4/80)
ATP2B4	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
BBS1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
BRD8	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
BTG2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
C1orf27	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
C1orf95	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
CAB39	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
CADPS	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
CALCR	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
CCDC102B	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
CCDC178	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CCDC68	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
CDH4	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
CDK18	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
CEBPA	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
CEBPG	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
CERS2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
CH17-232I21.1	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CHD6	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
CHST1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
CIRBP	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
CLUH	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
COL11A2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
COL5A3	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
COLCA1	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
COPA	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
COX4I2	TH34_1380_S01	v8		lowstringency_pd_outliers	KEGG_OXIDATIVE_PHOSPHORYLATION(6/135),KEGG_PARKINSONS_DISEASE(6/133),KEGG_CARDIAC_MUSCLE_CONTRACTION(4/80)
CPT1A	TH34_1380_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(12/200),HALLMARK_FATTY_ACID_METABOLISM(10/158)
CS	TH34_1380_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(12/200),KEGG_CITRATE_CYCLE_TCA_CYCLE(6/32),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(9/141),REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE(6/48),BIOCARTA_KREB_PATHWAY(3/8),REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE(4/26),HALLMARK_ADIPOGENESIS(6/200)
CTC-339O9.1	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-2228K2.7	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-2297D10.2	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-2521M24.5	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DAAM1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
DBNDD2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
DCAF6	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
DGKZ	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
DIMT1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
DIO3OS	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
DIRAS1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
DIS3L2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
DPY19L2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
DTX4	TH34_1380_S01	v8		lowstringency_pd_outliers	HALLMARK_NOTCH_SIGNALING(5/32),KEGG_NOTCH_SIGNALING_PATHWAY(4/47),REACTOME_SIGNALING_BY_NOTCH(5/103),REACTOME_SIGNALING_BY_NOTCH1(4/70)
EEF2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
EGFLAM	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
EIF2D	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
EIF3CL	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
EIF4EBP2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
FAM120A	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
FAM168A	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
FAM208B	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
FBN3	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
FBXO8	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
FCHSD2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
FH	TH34_1380_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(12/200),HALLMARK_FATTY_ACID_METABOLISM(10/158),KEGG_CITRATE_CYCLE_TCA_CYCLE(6/32),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(9/141),REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE(6/48),BIOCARTA_KREB_PATHWAY(3/8),REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE(4/26)
FMNL3	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
FMO1	TH34_1380_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(10/158)
FOCAD	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FRMD3	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
GABRB3	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
GATM	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
GBA2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
GLUL	TH34_1380_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(10/158)
GMNN	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
GSTM4	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
GUCY1A3	TH34_1380_S01	v8		lowstringency_pd_outliers	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(5/115)
GUCY1B3	TH34_1380_S01	v8		lowstringency_pd_outliers	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(5/115)
H19	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
HARS2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
HDHD2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
HEY2	TH34_1380_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_NOTCH(5/103),REACTOME_SIGNALING_BY_NOTCH1(4/70)
HEYL	TH34_1380_S01	v8		lowstringency_pd_outliers	HALLMARK_NOTCH_SIGNALING(5/32),REACTOME_SIGNALING_BY_NOTCH(5/103),REACTOME_SIGNALING_BY_NOTCH1(4/70)
HIPK2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
IDH1	TH34_1380_S01	v8	Olaparib,OLAPARIB	lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(12/200),HALLMARK_FATTY_ACID_METABOLISM(10/158),KEGG_CITRATE_CYCLE_TCA_CYCLE(6/32),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(9/141),REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE(6/48),HALLMARK_ADIPOGENESIS(6/200)
IDH2	TH34_1380_S01	v8	OLAPARIB	lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(12/200),KEGG_CITRATE_CYCLE_TCA_CYCLE(6/32),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(9/141),REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE(6/48),BIOCARTA_KREB_PATHWAY(3/8),REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE(4/26)
IMPA2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
INTS3	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
IQGAP2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
IRF6	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
JAG1	TH34_1380_S01	v8		lowstringency_pd_outliers	HALLMARK_NOTCH_SIGNALING(5/32),KEGG_NOTCH_SIGNALING_PATHWAY(4/47),REACTOME_SIGNALING_BY_NOTCH(5/103),REACTOME_SIGNALING_BY_NOTCH1(4/70)
KCNK2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
KCNK9	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
KCTD3	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
KDM2A	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
KIAA0907	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
KIRREL2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
KLHL14	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
KRBOX1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
LARP1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
LETMD1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
LIPG	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
LPGAT1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
LRIG3	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
LRRC8D	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
LRRN3	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
LYPLAL1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
MAN2A1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
MARC2	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MFSD2A	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
MIR199A2	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MKNK2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
MRPL21	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
MTRR	TH34_1380_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(12/200)
MVB12A	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MXD4	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
MYO19	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
MZF1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
NADK2	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NAV1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
NDRG2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
NDUFA5	TH34_1380_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(12/200),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(9/141),KEGG_OXIDATIVE_PHOSPHORYLATION(6/135),KEGG_PARKINSONS_DISEASE(6/133),HALLMARK_ADIPOGENESIS(6/200),REACTOME_RESPIRATORY_ELECTRON_TRANSPORT(4/79)
NDUFV1	TH34_1380_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(12/200),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(9/141),KEGG_OXIDATIVE_PHOSPHORYLATION(6/135),KEGG_PARKINSONS_DISEASE(6/133),REACTOME_RESPIRATORY_ELECTRON_TRANSPORT(4/79)
NET1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
NOTCH1	TH34_1380_S01	v8	REGN421,PF-03084014	lowstringency_pd_outliers	HALLMARK_NOTCH_SIGNALING(5/32),KEGG_NOTCH_SIGNALING_PATHWAY(4/47)
NOTCH3	TH34_1380_S01	v8	REGN421,PF-03084014	lowstringency_pd_outliers	HALLMARK_NOTCH_SIGNALING(5/32),KEGG_NOTCH_SIGNALING_PATHWAY(4/47),REACTOME_SIGNALING_BY_NOTCH(5/103)
NPHS1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
NPPC	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
NPY	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
NR2F6	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
NRARP	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
NRIP2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
NSUN2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
NTN5	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
OAZ2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
OPA1	TH34_1380_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(12/200)
ORAOV1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
P2RY11	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
PALD1	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PDCD4	TH34_1380_S01	v8	PACLITAXEL	lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(6/200)
PDHA1	TH34_1380_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(12/200),HALLMARK_FATTY_ACID_METABOLISM(10/158),KEGG_CITRATE_CYCLE_TCA_CYCLE(6/32),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(9/141),REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE(6/48)
PGA3	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
PGA4	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
PGA5	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
PKIG	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
PLD1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
PLXNA2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
POGK	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
POGZ	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
POLG2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
PP7080	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
PPA1	TH34_1380_S01	v8		lowstringency_pd_outliers	KEGG_OXIDATIVE_PHOSPHORYLATION(6/135)
PPFIBP2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
PPOX	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
PPP1R12B	TH34_1380_S01	v8		lowstringency_pd_outliers	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(5/115),BIOCARTA_MYOSIN_PATHWAY(3/31),BIOCARTA_PAR1_PATHWAY(3/37)
PPP1R1A	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
PPP6R3	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
PRKRIR	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
R3HDM2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
RABGGTB	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
RAD23B	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
RBMX	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
RCAN2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
RDH5	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
RIF1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
RNPC3	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
RNU6-689P	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-1055B8.4	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-116D17.3	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-1191J2.2	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-188P20.3	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-394O4.5	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-54O7.17	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-96L14.7	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SAMM50	TH34_1380_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(6/200)
SCD5	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
SDHAP1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
SDHC	TH34_1380_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(12/200),HALLMARK_FATTY_ACID_METABOLISM(10/158),KEGG_CITRATE_CYCLE_TCA_CYCLE(6/32),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(9/141),REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE(6/48),REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE(4/26),KEGG_OXIDATIVE_PHOSPHORYLATION(6/135),KEGG_PARKINSONS_DISEASE(6/133),HALLMARK_ADIPOGENESIS(6/200),REACTOME_RESPIRATORY_ELECTRON_TRANSPORT(4/79)
SEMA3G	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
SEPT5	TH34_1380_S01	v8		lowstringency_pd_outliers	KEGG_PARKINSONS_DISEASE(6/133)
SEPT8	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
SERINC3	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
SGSM2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
SLC22A23	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
SLC22A3	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
SLC25A26	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
SLC25A27	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
SLC25A29	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
SLC38A2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
SNHG25	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SNRK	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
SNX21	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
SOX13	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
SPPL3	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
SUV420H1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
TADA1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
TBCE	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
TBX3	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
TCTN1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
TDO2	TH34_1380_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(10/158)
TESC	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
TFCP2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
TMEM150C	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
TMEM263	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TMEM63A	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
TP53INP2	TH34_1380_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(10/158)
TPCN1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
TRIB1	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
TSPAN18	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
TTC19	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
UBA2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
UBR4	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
UQCRC2	TH34_1380_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(12/200),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(9/141),KEGG_OXIDATIVE_PHOSPHORYLATION(6/135),KEGG_PARKINSONS_DISEASE(6/133),KEGG_CARDIAC_MUSCLE_CONTRACTION(4/80),REACTOME_RESPIRATORY_ELECTRON_TRANSPORT(4/79)
URI1	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
VPS13D	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
VPS45	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
WNK2	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
Y_RNA	TH34_1380_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZAP70	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
ZC3H11A	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
ZNF266	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
ZNF326	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
ZNF333	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
ZNF496	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
ZNF561	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
ZNF587	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
ZNF608	TH34_1380_S01	v8		lowstringency_pd_outliers	NA
AAAS	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(19/54),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_HIV_INFECTION(24/207),HALLMARK_DNA_REPAIR(19/150),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(17/132),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
AARS	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(10/41),REACTOME_TRNA_AMINOACYLATION(10/42),REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION(7/24)
ABCA2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ABCB6	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(34/200)
ABCD4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ABCF3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ABI3BP	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200),NABA_CORE_MATRISOME(25/275)
AC006449.2	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC132217.4	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC159540.1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACADVL	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_UNFOLDED_PROTEIN_RESPONSE(19/80),REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S(14/46),REACTOME_DIABETES_PATHWAYS(21/133),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200)
ACAP3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ACBD3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ACBD6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ACIN1	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(42/128),REACTOME_APOPTOSIS(19/148)
ACKR1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACLY	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),HALLMARK_ADIPOGENESIS(20/200)
ACO2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200),HALLMARK_ADIPOGENESIS(20/200),REACTOME_METABOLISM_OF_PROTEINS(33/518)
ACP1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200)
ACSS1	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_GLYCOLYSIS_GLUCONEOGENESIS(13/62)
ACTR2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),PID_CDC42_PATHWAY(14/70),HALLMARK_PI3K_AKT_MTOR_SIGNALING(15/105),PID_ERBB1_DOWNSTREAM_PATHWAY(15/105),BIOCARTA_RHO_PATHWAY(8/32),ST_INTEGRIN_SIGNALING_PATHWAY(12/82),PID_PDGFRB_PATHWAY(15/129)
ACTR3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),PID_CDC42_PATHWAY(14/70),HALLMARK_PI3K_AKT_MTOR_SIGNALING(15/105),PID_ERBB1_DOWNSTREAM_PATHWAY(15/105),BIOCARTA_RHO_PATHWAY(8/32),ST_INTEGRIN_SIGNALING_PATHWAY(12/82),PID_PDGFRB_PATHWAY(15/129)
ADAM15	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(20/200)
ADAMTS16	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ADAR	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
ADCK3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ADD1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_UNFOLDED_PROTEIN_RESPONSE(19/80),REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S(14/46),REACTOME_DIABETES_PATHWAYS(21/133),REACTOME_APOPTOSIS(19/148),HALLMARK_APOPTOSIS(17/161)
ADGRA3	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADGRD1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADH5	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_GLYCOLYSIS_GLUCONEOGENESIS(13/62)
ADIPOR1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ADNP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ADRA2A	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(32/466)
ADSS	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
AGPAT6	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),HALLMARK_ADIPOGENESIS(20/200)
AGT	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478)
AHDC1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
AHSA2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
AIDA	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
AIFM3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_APOPTOSIS(17/161)
AK1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_DNA_REPAIR(19/150),HALLMARK_MYOGENESIS(22/200)
AKAP8L	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
AL162151.3	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL662801.1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ALDH18A1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_UNFOLDED_PROTEIN_RESPONSE(20/113)
ALDH9A1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(34/200),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(13/62)
ALDOA	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),HALLMARK_HYPOXIA(36/200),HALLMARK_GLYCOLYSIS(34/200),PID_HIF1_TFPATHWAY(17/66),REACTOME_GLYCOLYSIS(10/29),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(13/62),HALLMARK_UV_RESPONSE_UP(20/158),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),REACTOME_GLUCOSE_METABOLISM(12/69),HALLMARK_ADIPOGENESIS(20/200),REACTOME_HEMOSTASIS(32/466),KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM(8/34)
ALKBH5	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
AMPD2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ANAPC16	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ANAPC2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_CELL_CYCLE_CHECKPOINTS(18/124),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(14/73),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(18/138)
ANAPC5	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_CELL_CYCLE_CHECKPOINTS(18/124),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(14/73),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(18/138)
ANAPC7	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_CELL_CYCLE_CHECKPOINTS(18/124),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(14/73),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(18/138)
ANGEL2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ANGPTL4	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),HALLMARK_GLYCOLYSIS(34/200),REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),HALLMARK_ADIPOGENESIS(20/200)
ANKRD10	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ANKRD11	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ANKZF1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),HALLMARK_GLYCOLYSIS(34/200)
ANP32A	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(17/84),REACTOME_METABOLISM_OF_MRNA(26/284)
ANP32E	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(24/200)
AP003041.1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AP1G2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
AP1S2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_HIV_INFECTION(24/207),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(17/132)
APBB1	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_ALZHEIMERS_DISEASE(19/169)
APBB3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
APC2	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(34/328)
APH1A	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_ALZHEIMERS_DISEASE(19/169),REACTOME_SIGNALLING_BY_NGF(20/217)
APOA1BP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ARF1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_HIV_INFECTION(24/207),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(17/132),HALLMARK_PI3K_AKT_MTOR_SIGNALING(15/105)
ARF4	TH34_1381_S01	v8		lowstringency_pd_outliers	PID_ERBB1_DOWNSTREAM_PATHWAY(15/105)
ARFGAP1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_UNFOLDED_PROTEIN_RESPONSE(19/80),REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S(14/46),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(20/113),REACTOME_DIABETES_PATHWAYS(21/133)
ARGLU1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ARHGAP33	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ARHGEF1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(20/217),BIOCARTA_RHO_PATHWAY(8/32)
ARHGEF11	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251),HALLMARK_MITOTIC_SPINDLE(23/200),REACTOME_SIGNALLING_BY_NGF(20/217),BIOCARTA_RHO_PATHWAY(8/32)
ARHGEF7	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(23/200),PID_CDC42_PATHWAY(14/70),ST_INTEGRIN_SIGNALING_PATHWAY(12/82)
ARIH2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212)
ARL2BP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ARL4C	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ARL8A	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(23/200)
ARMC3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ARNT	TH34_1381_S01	v8		lowstringency_pd_outliers	PID_HIF1_TFPATHWAY(17/66),KEGG_PATHWAYS_IN_CANCER(34/328),BIOCARTA_VEGF_PATHWAY(10/29),REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN(7/25)
ARPC4	TH34_1381_S01	v8		lowstringency_pd_outliers	PID_CDC42_PATHWAY(14/70),PID_ERBB1_DOWNSTREAM_PATHWAY(15/105),BIOCARTA_RHO_PATHWAY(8/32),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(13/97),PID_PDGFRB_PATHWAY(15/129)
ARPC5	TH34_1381_S01	v8		lowstringency_pd_outliers	PID_CDC42_PATHWAY(14/70),PID_ERBB1_DOWNSTREAM_PATHWAY(15/105),BIOCARTA_RHO_PATHWAY(8/32),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(13/97),PID_PDGFRB_PATHWAY(15/129)
ARVCF	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ASXL1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ATAT1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ATF6B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ATG4B	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(23/200)
ATN1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ATP13A1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ATP1B1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200),REACTOME_HEMOSTASIS(32/466)
ATP1B2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(32/466)
ATP2A2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),KEGG_ALZHEIMERS_DISEASE(19/169),REACTOME_HEMOSTASIS(32/466)
ATP2B4	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(19/200)
ATP5E	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200),KEGG_ALZHEIMERS_DISEASE(19/169)
ATP8B2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
AUTS2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
AXIN2	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(34/328)
AZIN1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(10/49)
B4GALNT4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
B4GALT3	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),REACTOME_METABOLISM_OF_PROTEINS(33/518)
BAG6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
BAIAP3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
BBS1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
BCAN	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),NABA_CORE_MATRISOME(25/275),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247)
BCAR1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(23/200),PID_CDC42_PATHWAY(14/70),KEGG_FOCAL_ADHESION(20/201),REACTOME_HEMOSTASIS(32/466),ST_INTEGRIN_SIGNALING_PATHWAY(12/82),PID_PDGFRB_PATHWAY(15/129),BIOCARTA_CXCR4_PATHWAY(7/24)
BCCIP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
BCL6	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(20/200)
BCL9	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
BEX4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
BHLHE40	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),HALLMARK_HYPOXIA(36/200),PID_HIF1_TFPATHWAY(17/66),HALLMARK_MYOGENESIS(22/200),HALLMARK_ESTROGEN_RESPONSE_EARLY(19/200)
BMI1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
BNIP3	TH34_1381_S01	v8		lowstringency_pd_outliers	PID_HIF1_TFPATHWAY(17/66)
BNIP3L	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),HALLMARK_APOPTOSIS(17/161)
BOC	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396)
BOLA1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
BRD2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
BROX	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
C10orf105	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
C14orf159	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
C16orf58	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
C1QTNF3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
C1orf198	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
C1orf226	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
C1orf35	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
C1orf43	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
C4A	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933)
C4B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
C4orf3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
C5orf15	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
C5orf45	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
C5orf49	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
C6orf62	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
C7orf55-LUC7L2	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
C9orf24	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CA9	TH34_1381_S01	v8		lowstringency_pd_outliers	PID_HIF1_TFPATHWAY(17/66),REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN(7/25)
CABIN1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CACYBP	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200)
CADM1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200)
CALCOCO2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CALR	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_UNFOLDED_PROTEIN_RESPONSE(19/80),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(20/113),REACTOME_DIABETES_PATHWAYS(21/133),REACTOME_ER_PHAGOSOME_PATHWAY(13/61),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),HALLMARK_PI3K_AKT_MTOR_SIGNALING(15/105),REACTOME_METABOLISM_OF_PROTEINS(33/518)
CAMTA1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CANX	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),HALLMARK_MTORC1_SIGNALING(40/200),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_METABOLISM_OF_PROTEINS(33/518)
CAPN2	TH34_1381_S01	v8		lowstringency_pd_outliers	PID_ERBB1_DOWNSTREAM_PATHWAY(15/105),KEGG_ALZHEIMERS_DISEASE(19/169),KEGG_FOCAL_ADHESION(20/201)
CAPS	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CBX3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),REACTOME_TRANSCRIPTION(33/210)
CBX5	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(24/200),REACTOME_HEMOSTASIS(32/466)
CCAR1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111)
CCAR2	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CCDC114	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CCDC130	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CCDC14	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CCDC181	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CCDC37	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CCDC40	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CCDC57	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CCDC80	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CCDC85C	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CCNL1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CCNL2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CCT2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),REACTOME_METABOLISM_OF_PROTEINS(33/518)
CCT3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),REACTOME_METABOLISM_OF_PROTEINS(33/518)
CD36	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),HALLMARK_MYOGENESIS(22/200),KEGG_ECM_RECEPTOR_INTERACTION(14/84),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),HALLMARK_ADIPOGENESIS(20/200),REACTOME_HEMOSTASIS(32/466)
CD44	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(34/200),REACTOME_IMMUNE_SYSTEM(74/933),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200),KEGG_ECM_RECEPTOR_INTERACTION(14/84),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),HALLMARK_APOPTOSIS(17/161),HALLMARK_ESTROGEN_RESPONSE_EARLY(19/200),HALLMARK_ESTROGEN_RESPONSE_LATE(19/200),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
CD46	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933)
CDC123	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CDC16	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_CELL_CYCLE_CHECKPOINTS(18/124),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(14/73),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(18/138)
CDC42BPB	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CDC42SE1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CDH23	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CDIP1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CDK10	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CDK2	TH34_1381_S01	v8	RONICICLIB,R-ROSCOVITINE,SCH 727965,ALVOCIDIB,FLAVOPIRIDOL,SCH727965,CARBOPLATIN,Roniciclib,Flavopiridol,DINACICLIB,ERIBULIN,SELICICLIB,SNS-032,BMS-387032,BAY1000394	lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),KEGG_PATHWAYS_IN_CANCER(34/328),REACTOME_CELL_CYCLE_CHECKPOINTS(18/124),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),HALLMARK_UV_RESPONSE_UP(20/158),REACTOME_DNA_REPLICATION(21/192),HALLMARK_PI3K_AKT_MTOR_SIGNALING(15/105),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(11/57),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(10/48),REACTOME_HEMOSTASIS(32/466),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(11/65),HALLMARK_APOPTOSIS(17/161),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(11/67),REACTOME_MITOTIC_G2_G2_M_PHASES(12/81),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(10/56)
CDK5RAP2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),HALLMARK_MITOTIC_SPINDLE(23/200),REACTOME_MITOTIC_G2_G2_M_PHASES(12/81)
CDK5RAP3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CELF1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CENPF	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(28/200),HALLMARK_MITOTIC_SPINDLE(23/200)
CENPT	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),REACTOME_DNA_REPLICATION(21/192)
CEP170	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CEP95	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CERS1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CERS5	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478)
CETN2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),HALLMARK_DNA_REPAIR(19/150),REACTOME_MITOTIC_G2_G2_M_PHASES(12/81)
CFAP126	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFAP20	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFAP45	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFDP1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CH17-232I21.1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CHCHD7	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CHD1L	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CHID1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CHKA	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(20/158),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478)
CHKB	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478)
CHMP1A	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(28/200)
CHODL	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CHTF8	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CHTOP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CIAPIN1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CIART	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CIC	TH34_1381_S01	v8	SELUMETINIB (AZD6244),VEMURAFENIB,TRAMETINIB	lowstringency_pd_outliers	NA
CKAP4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CKAP5	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),HALLMARK_MITOTIC_SPINDLE(23/200),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),REACTOME_DNA_REPLICATION(21/192),REACTOME_MITOTIC_G2_G2_M_PHASES(12/81)
CKLF	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CLASRP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CLCN7	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CLK2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CLK3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CMTM4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CNIH4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CNN3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(22/200)
CNOT3	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_METABOLISM_OF_MRNA(26/284)
CNTN2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251)
COG2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(34/200)
COG4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
COL16A1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200),NABA_CORE_MATRISOME(25/275),HALLMARK_APICAL_JUNCTION(20/200)
COL27A1	TH34_1381_S01	v8		lowstringency_pd_outliers	NABA_CORE_MATRISOME(25/275)
COL2A1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251),HALLMARK_UV_RESPONSE_UP(20/158),KEGG_ECM_RECEPTOR_INTERACTION(14/84),NABA_CORE_MATRISOME(25/275),KEGG_FOCAL_ADHESION(20/201)
COL5A3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200),KEGG_ECM_RECEPTOR_INTERACTION(14/84),NABA_CORE_MATRISOME(25/275),KEGG_FOCAL_ADHESION(20/201)
COL9A2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251),NABA_CORE_MATRISOME(25/275)
COMMD3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
COMMD3-BMI1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
COMMD6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
COMT	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
COPA	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200)
COPB2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(34/200)
COPG1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
COPS8	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
COPZ1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
COQ9	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(20/200)
COX20	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
COX7A2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200),KEGG_ALZHEIMERS_DISEASE(19/169)
CPNE6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CPSF1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(19/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(19/54),REACTOME_MRNA_3_END_PROCESSING(16/35),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105)
CPSF3L	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CPSF4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CPXM1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CRB1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CRB2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CRELD1	TH34_1381_S01	v8		lowstringency_pd_outliers	NABA_CORE_MATRISOME(25/275)
CRELD2	TH34_1381_S01	v8		lowstringency_pd_outliers	NABA_CORE_MATRISOME(25/275)
CRTC2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CRYZL1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CSAD	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CSNK1E	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_MITOTIC_G2_G2_M_PHASES(12/81)
CTD-2228K2.7	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-2297D10.2	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTDSP2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_UNFOLDED_PROTEIN_RESPONSE(19/80),REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S(14/46),REACTOME_DIABETES_PATHWAYS(21/133)
CTTN	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(23/200),PID_PDGFRB_PATHWAY(15/129)
CUL9	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CXXC1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_UNFOLDED_PROTEIN_RESPONSE(19/80),REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S(14/46),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(20/113),REACTOME_DIABETES_PATHWAYS(21/133)
CXXC5	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CYB5R1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(20/158)
CYB5R3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200)
CYP4F12	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
CYTH2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(23/200)
DAD1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_DNA_REPAIR(19/150),REACTOME_METABOLISM_OF_PROTEINS(33/518)
DALRD3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DAP	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_APOPTOSIS(17/161)
DAP3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_APOPTOSIS(17/161)
DAPK3	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(34/328),REACTOME_APOPTOSIS(19/148),REACTOME_REGULATION_OF_APOPTOSIS(10/58)
DAW1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DAZAP1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DAZAP2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DBN1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DBNDD1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DCAF6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DCAF8	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DDIT3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),HALLMARK_HYPOXIA(36/200),REACTOME_UNFOLDED_PROTEIN_RESPONSE(19/80),REACTOME_DIABETES_PATHWAYS(21/133),HALLMARK_PI3K_AKT_MTOR_SIGNALING(15/105),HALLMARK_APOPTOSIS(17/161)
DDIT4	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),HALLMARK_HYPOXIA(36/200),HALLMARK_GLYCOLYSIS(34/200),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(20/113)
DDX1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DDX17	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DDX23	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),KEGG_SPLICEOSOME(42/128),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(16/45)
DDX39B	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(42/128)
DDX3X	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DDX41	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DDX5	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(42/128)
DEDD	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DEF8	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DEGS1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478)
DENND4B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DENND5A	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DENND6B	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DESI2	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DFNB31	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DGKD	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(32/466)
DHX15	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),KEGG_SPLICEOSOME(42/128)
DHX30	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DHX9	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111)
DLG5	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(19/200)
DMTF1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DMWD	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DNAH9	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DNAJB1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(20/158)
DNAJB11	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_UNFOLDED_PROTEIN_RESPONSE(19/80),REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S(14/46),REACTOME_DIABETES_PATHWAYS(21/133)
DNAJB6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DNAJC4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DNALI1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DOK5	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DPYSL4	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),HALLMARK_GLYCOLYSIS(34/200),REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251)
DPYSL5	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251),KEGG_AXON_GUIDANCE(16/129)
DTX3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DUSP12	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DUSP23	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
DUT	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),HALLMARK_E2F_TARGETS(24/200),HALLMARK_DNA_REPAIR(19/150)
DVL2	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(34/328)
DVL3	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(34/328)
DYNC1H1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),HALLMARK_MITOTIC_SPINDLE(23/200),REACTOME_MITOTIC_G2_G2_M_PHASES(12/81)
DYNC2LI1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539)
DYRK4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ECM2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200),NABA_CORE_MATRISOME(25/275)
EDC4	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(20/113),REACTOME_METABOLISM_OF_MRNA(26/284)
EFCAB1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
EFCAB2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
EFNB3	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_AXON_GUIDANCE(16/129)
EGLN1	TH34_1381_S01	v8		lowstringency_pd_outliers	PID_HIF1_TFPATHWAY(17/66),KEGG_PATHWAYS_IN_CANCER(34/328),REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN(7/25)
EHMT2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSCRIPTION(33/210)
EIF1AX	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),BIOCARTA_VEGF_PATHWAY(10/29),REACTOME_METABOLISM_OF_PROTEINS(33/518)
EIF1B	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_DNA_REPAIR(19/150)
EIF2D	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
EIF2S3	TH34_1381_S01	v8		lowstringency_pd_outliers	BIOCARTA_VEGF_PATHWAY(10/29),HALLMARK_UV_RESPONSE_UP(20/158),REACTOME_METABOLISM_OF_PROTEINS(33/518)
ELAVL1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(17/84),BIOCARTA_VEGF_PATHWAY(10/29),REACTOME_METABOLISM_OF_MRNA(26/284)
ELN	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200),NABA_CORE_MATRISOME(25/275)
ELP2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
EMP3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200)
ENAH	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251),PID_CDC42_PATHWAY(14/70)
ENO2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),HALLMARK_GLYCOLYSIS(34/200),REACTOME_GLYCOLYSIS(10/29),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(13/62),HALLMARK_UV_RESPONSE_UP(20/158),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),REACTOME_GLUCOSE_METABOLISM(12/69),HALLMARK_APOPTOSIS(17/161)
ENSA	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ENTPD6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
EPRS	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),HALLMARK_MTORC1_SIGNALING(40/200),KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(10/41),REACTOME_TRNA_AMINOACYLATION(10/42),REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION(7/24)
ERBB2	TH34_1381_S01	v8	CAPECITABINE,TYKERB,Capecitabine,MUBRITINIB,T-DM1,HERCEPTIN,Afatinib,ADO-TRASTUZUMAB EMTANSINE,trastuzumab,TAK165,AC480,TRASTUZUMAB EMTANSINE,HKI-272,Poziotinib,BMS-690514,CANERTINIB,BIBW 2992,Neratinib,Gefitinib,GW2016,PICTILISIB,IRINOTECAN,AEE788,DOCETAXEL,Lapatinib,ARRY-380,IRESSA,XL647,Trastuzumab emtansine,poziotinib,AEE-788,PLATINUM,Docetaxel,Canertinib,TESEVATINIB,BMS-599626,Ado-trastuzumab emtansine,LAPATINIB,PERTUZUMAB,Trastuzumab,Dacomitinib,AC-480,RAPAMYCIN (SIROLIMUS),trastuzumab emtansine,Cetuximab,CETUXIMAB,GDC-0941,NERATINIB,LAPATINIB DITOSYLATE,Pertuzumab,GEFITINIB,AFATINIB,Irbinitinib,TRASTUZUMAB,DACOMITINIB,Ado-Trastuzumab Emtansine,ARRY380,POZIOTINIB,PELITINIB	lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),KEGG_PATHWAYS_IN_CANCER(34/328),REACTOME_AXON_GUIDANCE(29/251),KEGG_FOCAL_ADHESION(20/201),HALLMARK_APOPTOSIS(17/161),PID_A6B1_A6B4_INTEGRIN_PATHWAY(9/46)
ERCC3	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105),REACTOME_HIV_INFECTION(24/207),HALLMARK_DNA_REPAIR(19/150)
ERF	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
EVL	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251),HALLMARK_APICAL_JUNCTION(20/200)
EWSR1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(28/200)
EXOC4	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DIABETES_PATHWAYS(21/133),HALLMARK_APICAL_JUNCTION(20/200)
EXOSC10	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_UNFOLDED_PROTEIN_RESPONSE(20/113)
FABP5	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(19/200)
FABP5P7	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
FAM162A	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),HALLMARK_GLYCOLYSIS(34/200)
FAM168B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
FAM179A	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
FAM189A2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
FAM192A	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
FAM193B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
FAM63A	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(19/200)
FAM81B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
FAM96B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
FBRS	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
FBXO44	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212)
FDPS	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(22/200),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),REACTOME_CHOLESTEROL_BIOSYNTHESIS(7/24)
FERMT2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200)
FEZ2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
FGD5-AS1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FGFR2	TH34_1381_S01	v8	BGJ-398,Regorafenib,XL228,Dovitinib,PD173074,Nintedanib,JNJ-42756493,Ponatinib,INFIGRATINIB,PONATINIB,DOVITINIB,AZD-4547,MASITINIB,PAZOPANIB,ERDAFITINIB,AZD4547,REGORAFENIB,NINTEDANIB,BGJ398	lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(34/328)
FGFRL1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
FH	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(34/328),HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200)
FHAD1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
FILIP1L	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
FIP1L1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
FKBP4	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(34/200),HALLMARK_UV_RESPONSE_UP(20/158),HALLMARK_ESTROGEN_RESPONSE_EARLY(19/200),HALLMARK_ESTROGEN_RESPONSE_LATE(19/200)
FLAD1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
FLII	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(22/200)
FMNL2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
FNBP1L	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
FNBP4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
FOXJ1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
FUBP1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
FXR1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GABARAPL2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(22/200)
GALNS	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GALNT2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(33/518)
GAPDH	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),HALLMARK_HYPOXIA(36/200),REACTOME_GLYCOLYSIS(10/29),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(13/62),KEGG_ALZHEIMERS_DISEASE(19/169),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),REACTOME_GLUCOSE_METABOLISM(12/69)
GAS5	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GAS8	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GBA2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478)
GCSH	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GDF1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396)
GDF10	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GDI1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GDPD2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GEM	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200)
GEMIN8	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GFAP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GGA2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200)
GGH	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(20/158)
GGPS1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),REACTOME_CHOLESTEROL_BIOSYNTHESIS(7/24)
GJA1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200),HALLMARK_ESTROGEN_RESPONSE_EARLY(19/200)
GLB1L2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GLMP	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GLOD4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GLYR1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GNAI2	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_AXON_GUIDANCE(16/129),HALLMARK_APICAL_JUNCTION(20/200),REACTOME_HEMOSTASIS(32/466)
GNB1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(32/466),BIOCARTA_CXCR4_PATHWAY(7/24)
GNL3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200)
GNPAT	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478)
GOLGA2P7	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GOLGA8A	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GOLGA8B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GON4L	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GORASP1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),REACTOME_DNA_REPLICATION(21/192)
GPI	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),HALLMARK_HYPOXIA(36/200),REACTOME_GLYCOLYSIS(10/29),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(13/62),HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),REACTOME_GLUCOSE_METABOLISM(12/69)
GPM6B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GPR162	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GPR89A	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GPSM2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GRAMD1A	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GRAMD2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GRIA4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GRSF1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GSTM1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_APOPTOSIS(17/161)
GSTM2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GSTM3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GSTM4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GSTM5	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GTF2A2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105),REACTOME_HIV_INFECTION(24/207),HALLMARK_DNA_REPAIR(19/150)
GTF2I	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GTF2IP1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GTF3C1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GTF3C2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSCRIPTION(33/210)
GTF3C6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
GYS1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),HALLMARK_GLYCOLYSIS(34/200),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),REACTOME_GLUCOSE_METABOLISM(12/69)
H1FX	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
H2AFZ	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),REACTOME_TRANSCRIPTION(33/210),REACTOME_CELL_CYCLE(42/421),HALLMARK_G2M_CHECKPOINT(28/200),HALLMARK_E2F_TARGETS(24/200)
H3F3A	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSCRIPTION(33/210),REACTOME_HEMOSTASIS(32/466)
H3F3AP4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
HAUS7	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
HAX1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(34/200)
HDAC2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),KEGG_PATHWAYS_IN_CANCER(34/328),REACTOME_HEMOSTASIS(32/466),PID_HDAC_CLASSI_PATHWAY(11/66),REACTOME_SIGNALLING_BY_NGF(20/217)
HDAC3	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),PID_HDAC_CLASSI_PATHWAY(11/66),REACTOME_SIGNALLING_BY_NGF(20/217)
HDAC6	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(23/200),PID_HDAC_CLASSI_PATHWAY(11/66)
HDGF	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),REACTOME_UNFOLDED_PROTEIN_RESPONSE(19/80),REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S(14/46),REACTOME_DIABETES_PATHWAYS(21/133)
HDHD2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
HDLBP	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),HALLMARK_GLYCOLYSIS(34/200)
HERPUD1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_UNFOLDED_PROTEIN_RESPONSE(19/80),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(20/113),REACTOME_DIABETES_PATHWAYS(21/133)
HIF1A	TH34_1381_S01	v8	NITROGLYCERIN	lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(28/200),PID_HIF1_TFPATHWAY(17/66),KEGG_PATHWAYS_IN_CANCER(34/328),BIOCARTA_VEGF_PATHWAY(10/29),REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN(7/25)
HIF3A	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN(7/25)
HILPDA	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HK1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),PID_HIF1_TFPATHWAY(17/66),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(13/62),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM(8/34)
HK2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),HALLMARK_HYPOXIA(36/200),HALLMARK_GLYCOLYSIS(34/200),PID_HIF1_TFPATHWAY(17/66),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(13/62),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM(8/34)
HKR1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
HMGB1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_APOPTOSIS(19/148)
HMGN1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
HMGN2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(28/200)
HMGXB3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
HN1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(28/200),HALLMARK_E2F_TARGETS(24/200)
HNRNPC	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),HALLMARK_MYC_TARGETS_V1(52/200),KEGG_SPLICEOSOME(42/128)
HNRNPDL	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HNRNPF	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111)
HNRNPH1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111)
HNRNPK	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),KEGG_SPLICEOSOME(42/128)
HNRNPL	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111)
HNRNPU	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),HALLMARK_MYC_TARGETS_V1(52/200),KEGG_SPLICEOSOME(42/128),HALLMARK_G2M_CHECKPOINT(28/200),HALLMARK_UV_RESPONSE_UP(20/158)
HNRNPU-AS1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
HOTAIRM1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HSD17B10	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200),KEGG_ALZHEIMERS_DISEASE(19/169)
HSD17B7	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),REACTOME_CHOLESTEROL_BIOSYNTHESIS(7/24)
HSP90B1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_UNFOLDED_PROTEIN_RESPONSE(19/80),KEGG_PATHWAYS_IN_CANCER(34/328),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(20/113),REACTOME_DIABETES_PATHWAYS(21/133),HALLMARK_PI3K_AKT_MTOR_SIGNALING(15/105)
HSPA1B	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(42/128),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(17/84),REACTOME_METABOLISM_OF_MRNA(26/284),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(10/53)
HTATSF1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
HUWE1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(18/138)
HYOU1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_UNFOLDED_PROTEIN_RESPONSE(19/80),REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S(14/46),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(20/113),REACTOME_DIABETES_PATHWAYS(21/133)
IARS2	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(10/41),REACTOME_TRNA_AMINOACYLATION(10/42)
ID2	TH34_1381_S01	v8		lowstringency_pd_outliers	PID_HIF1_TFPATHWAY(17/66),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200),HALLMARK_ESTROGEN_RESPONSE_LATE(19/200)
IDI1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),REACTOME_CHOLESTEROL_BIOSYNTHESIS(7/24)
IDUA	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(34/200),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247)
IFI27L2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
IFT140	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
IFT57	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
IGF2	TH34_1381_S01	v8	CABAZITAXEL,DOCETAXEL,OSI-906 (LINSITINIB)	lowstringency_pd_outliers	REACTOME_DIABETES_PATHWAYS(21/133)
IGSF1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(19/200)
IGSF8	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ILF2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200)
ILF3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(28/200),HALLMARK_E2F_TARGETS(24/200)
ING4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
INO80E	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
INPPL1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),HALLMARK_APICAL_JUNCTION(20/200),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
INTS3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
IP6K2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
IPO5	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
IPO9	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
IQCG	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
IRF2BP2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ISG20L2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(19/200)
IST1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ISYNA1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ITGA7	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(22/200),KEGG_ECM_RECEPTOR_INTERACTION(14/84),HALLMARK_ADIPOGENESIS(20/200),KEGG_FOCAL_ADHESION(20/201),ST_INTEGRIN_SIGNALING_PATHWAY(12/82)
ITGB1BP1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ITPA	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_DNA_REPAIR(19/150)
ITPKB	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
IVNS1ABP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
JAM2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(32/466)
JTB	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
KARS	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(10/41),REACTOME_TRNA_AMINOACYLATION(10/42),REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION(7/24)
KAT2A	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
KATNB1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(23/200)
KCNJ10	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
KCTD17	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
KCTD3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
KDM1A	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(32/466)
KDM3A	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200)
KDM3B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
KDM5B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
KDM5C	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
KHDRBS1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
KIAA0100	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
KIAA0895L	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
KIAA0907	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
KIF9	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(32/466)
KIFAP3	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),HALLMARK_MITOTIC_SPINDLE(23/200),REACTOME_HEMOSTASIS(32/466)
KLHDC9	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
KLHL12	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
KRTCAP2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LAMA1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),KEGG_PATHWAYS_IN_CANCER(34/328),REACTOME_AXON_GUIDANCE(29/251),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200),KEGG_ECM_RECEPTOR_INTERACTION(14/84),NABA_CORE_MATRISOME(25/275),KEGG_FOCAL_ADHESION(20/201),PID_A6B1_A6B4_INTEGRIN_PATHWAY(9/46)
LAMA5	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(34/328),KEGG_ECM_RECEPTOR_INTERACTION(14/84),NABA_CORE_MATRISOME(25/275),KEGG_FOCAL_ADHESION(20/201),PID_A6B1_A6B4_INTEGRIN_PATHWAY(9/46)
LAMB2	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(34/328),KEGG_ECM_RECEPTOR_INTERACTION(14/84),NABA_CORE_MATRISOME(25/275),KEGG_FOCAL_ADHESION(20/201),PID_A6B1_A6B4_INTEGRIN_PATHWAY(9/46)
LAMC1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),KEGG_PATHWAYS_IN_CANCER(34/328),REACTOME_AXON_GUIDANCE(29/251),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200),KEGG_ECM_RECEPTOR_INTERACTION(14/84),NABA_CORE_MATRISOME(25/275),KEGG_FOCAL_ADHESION(20/201),PID_A6B1_A6B4_INTEGRIN_PATHWAY(9/46)
LAMTOR2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LAMTOR3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LAPTM4B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LARS	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(10/41),REACTOME_TRNA_AMINOACYLATION(10/42),REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION(7/24)
LBR	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(28/200),HALLMARK_E2F_TARGETS(24/200),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),REACTOME_CHOLESTEROL_BIOSYNTHESIS(7/24)
LENG8	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LGALS8	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LGR6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LIMK2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251),PID_CDC42_PATHWAY(14/70),KEGG_AXON_GUIDANCE(16/129),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(13/97)
LINC00665	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC00969	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01002	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINGO1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(20/217)
LIX1L	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LLGL1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(23/200)
LMBR1L	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LMNA	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(42/421),REACTOME_UNFOLDED_PROTEIN_RESPONSE(19/80),REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S(14/46),REACTOME_DIABETES_PATHWAYS(21/133),REACTOME_APOPTOSIS(19/148),HALLMARK_APOPTOSIS(17/161)
LMO3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LRBA	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LRP10	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LRRC4B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LRRC71	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LRRN1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LRRN2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LSAMP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LSM14B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LUC7L	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LYPLA2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LYPLAL1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
LZTR1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
M6PR	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200)
MAB21L2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MAGED2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MAN2C1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MANF	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MAP1LC3A	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MAP3K12	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MAPK15	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MAPK1IP1L	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MAPK3	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_TRANSCRIPTION(33/210),REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),KEGG_PATHWAYS_IN_CANCER(34/328),REACTOME_AXON_GUIDANCE(29/251),PID_CDC42_PATHWAY(14/70),PID_ERBB1_DOWNSTREAM_PATHWAY(15/105),KEGG_ALZHEIMERS_DISEASE(19/169),KEGG_AXON_GUIDANCE(16/129),KEGG_FOCAL_ADHESION(20/201),REACTOME_HEMOSTASIS(32/466),REACTOME_SIGNALLING_BY_NGF(20/217),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(13/97),PID_PDGFRB_PATHWAY(15/129),BIOCARTA_CXCR4_PATHWAY(7/24),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
MAPK8IP3	TH34_1381_S01	v8		lowstringency_pd_outliers	ST_INTEGRIN_SIGNALING_PATHWAY(12/82)
MAPKAPK2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(17/84),REACTOME_METABOLISM_OF_MRNA(26/284),REACTOME_SIGNALLING_BY_NGF(20/217)
MAPRE1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),HALLMARK_MITOTIC_SPINDLE(23/200),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),REACTOME_DNA_REPLICATION(21/192),REACTOME_MITOTIC_G2_G2_M_PHASES(12/81)
MAPRE3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(22/200)
MARC2	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MARCH6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MARCKS	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(28/200),HALLMARK_MITOTIC_SPINDLE(23/200),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(13/97)
MARCKSL1	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(13/97)
MARK3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MARS	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(10/41),REACTOME_TRNA_AMINOACYLATION(10/42),REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION(7/24)
MAU2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MAZ	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MBD1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MBD6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MBTPS1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_UNFOLDED_PROTEIN_RESPONSE(19/80),REACTOME_DIABETES_PATHWAYS(21/133)
MCL1	TH34_1381_S01	v8		lowstringency_pd_outliers	PID_HIF1_TFPATHWAY(17/66),HALLMARK_APOPTOSIS(17/161)
MCM3AP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MCM4	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),HALLMARK_MTORC1_SIGNALING(40/200),REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),HALLMARK_E2F_TARGETS(24/200),REACTOME_CELL_CYCLE_CHECKPOINTS(18/124),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),REACTOME_DNA_REPLICATION(21/192),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(11/67)
MDM4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MEA1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MEAF6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MED24	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(34/200),REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),HALLMARK_ESTROGEN_RESPONSE_EARLY(19/200)
MEIS2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(28/200)
METTL13	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
METTL17	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
METTL3	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),HALLMARK_ESTROGEN_RESPONSE_LATE(19/200)
METTL5	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MEX3A	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MFGE8	TH34_1381_S01	v8		lowstringency_pd_outliers	NABA_CORE_MATRISOME(25/275)
MFI2-AS1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MFSD10	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MGEA5	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MGST1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MGST3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200),HALLMARK_ADIPOGENESIS(20/200)
MIA3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MIB2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MICAL3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MIF	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),HALLMARK_GLYCOLYSIS(34/200)
MKRN1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212)
MLF1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MLLT4	TH34_1381_S01	v8		lowstringency_pd_outliers	PID_PDGFRB_PATHWAY(15/129)
MLLT6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MMP17	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MMS19	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MOK	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MORF4L1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MOV10	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MOXD1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MPC2	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MPI	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(34/200),KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM(8/34),REACTOME_METABOLISM_OF_PROTEINS(33/518)
MPRIP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MPZL1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(20/200)
MRFAP1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MRFAP1L1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MRPL24	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MRPL3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MRPL51	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MRPL52	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MRPL55	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MRPL9	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200)
MRPS14	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MRPS25	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MRPS5	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MSH5	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MSI1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MSL1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MSMO1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),REACTOME_CHOLESTEROL_BIOSYNTHESIS(7/24)
MSN	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251),HALLMARK_APICAL_JUNCTION(20/200)
MSTO1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MSX1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(20/158),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200)
MTA1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MTCH2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(20/200)
MTG1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MTMR11	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MTND2P28	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTSS1L	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MTX1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(33/518)
MUC1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(19/200)
MUS81	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MVD	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),HALLMARK_APICAL_JUNCTION(20/200),REACTOME_CHOLESTEROL_BIOSYNTHESIS(7/24)
MXD4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MYEF2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
MYL6B	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(22/200)
MYO15B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NAA10	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NAE1	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_ALZHEIMERS_DISEASE(19/169)
NARS	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(10/41),REACTOME_TRNA_AMINOACYLATION(10/42),REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION(7/24)
NAV1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NBPF15	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NCALD	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NCAM1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251),HALLMARK_MYOGENESIS(22/200),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
NCAPD2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(24/200)
NCBP2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),HALLMARK_MYC_TARGETS_V1(52/200),KEGG_SPLICEOSOME(42/128),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(19/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(19/54),REACTOME_MRNA_3_END_PROCESSING(16/35),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(16/45),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_HIV_INFECTION(24/207),HALLMARK_DNA_REPAIR(19/150),REACTOME_METABOLISM_OF_MRNA(26/284)
NCSTN	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_ALZHEIMERS_DISEASE(19/169),REACTOME_SIGNALLING_BY_NGF(20/217)
NDUFA3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200),KEGG_ALZHEIMERS_DISEASE(19/169)
NDUFA8	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200),KEGG_ALZHEIMERS_DISEASE(19/169)
NDUFC1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200),KEGG_ALZHEIMERS_DISEASE(19/169)
NDUFS2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200),KEGG_ALZHEIMERS_DISEASE(19/169)
NDUFV1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200),KEGG_ALZHEIMERS_DISEASE(19/169)
NEK11	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NELFCD	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NENF	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NEO1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251)
NFASC	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(20/200)
NFATC4	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_AXON_GUIDANCE(16/129)
NFYC	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200)
NGFRAP1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(20/217)
NIPSNAP1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NIT1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NKAIN4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NLGN2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(20/200)
NLRP1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933)
NMB	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NME7	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NMT1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),REACTOME_HIV_INFECTION(24/207),REACTOME_APOPTOSIS(19/148),HALLMARK_ADIPOGENESIS(20/200)
NOC2L	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NONO	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NOP10	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NOP2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NOP56	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(20/113),HALLMARK_E2F_TARGETS(24/200),REACTOME_METABOLISM_OF_PROTEINS(33/518)
NOS1AP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NPEPPS	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212)
NPIPA1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB3	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB4	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB5	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPM1	TH34_1381_S01	v8	ALL-TRANS RETINOIC ACID	lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),REACTOME_CELL_CYCLE(42/421),PID_HIF1_TFPATHWAY(17/66),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(20/113),REACTOME_HIV_INFECTION(24/207),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(17/132)
NR2F1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NR2F1-AS1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NRBP2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NREP	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NSL1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),REACTOME_DNA_REPLICATION(21/192)
NSMF	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NSUN2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NSUN5P1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NTPCR	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NUCKS1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NUMA1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(42/421),HALLMARK_G2M_CHECKPOINT(28/200),REACTOME_CELL_CYCLE_MITOTIC(35/325),HALLMARK_MITOTIC_SPINDLE(23/200),REACTOME_MITOTIC_G2_G2_M_PHASES(12/81)
NUMBL	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NUP133	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(19/54),REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_HIV_INFECTION(24/207),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),REACTOME_DNA_REPLICATION(21/192),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(17/132),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
NUSAP1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(28/200),HALLMARK_MITOTIC_SPINDLE(23/200)
NUTF2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NVL	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
NXF1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(19/54),HALLMARK_UV_RESPONSE_UP(20/158)
OCIAD1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ODF3B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
OGT	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
OSGEP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
OXA1L	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200)
P4HA1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),HALLMARK_HYPOXIA(36/200),HALLMARK_GLYCOLYSIS(34/200)
PAAF1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PABPC1L	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PABPN1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(19/44),REACTOME_MRNA_3_END_PROCESSING(16/35),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105)
PACS2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PAGR1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PALM	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PAN2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(24/200)
PAQR6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PARP1	TH34_1381_S01	v8	Rucaparib,Olaparib,VELIPARIB,AZD 2281,NIRAPARIB,RUCAPARIB,ABT-888,OLAPARIB,INIPARIB,MK4827,KU-0059436,BSI-201,Veliparib,MK-4827	lowstringency_pd_outliers	NA
PARP2	TH34_1381_S01	v8	Rucaparib,Olaparib,Veliparib,AZD 2281,NIRAPARIB,MK-4827,OLAPARIB,MK4827,RUCAPARIB,VELIPARIB,ABT-888	lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(20/158)
PARP6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PAX3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PAX6	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),PID_CDC42_PATHWAY(14/70)
PBX1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PBX2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(20/200)
PCCB	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478)
PCED1A	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PCGF2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PCGF3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PCMTD2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PCNP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PCNXL4	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PCP4	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(19/200)
PDCD6IP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PDE4DIP	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(22/200)
PDE8A	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PDIA3	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ER_PHAGOSOME_PATHWAY(13/61),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),REACTOME_METABOLISM_OF_PROTEINS(33/518)
PDIA4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PDIA6	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_UNFOLDED_PROTEIN_RESPONSE(19/80),REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S(14/46),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(20/113),REACTOME_DIABETES_PATHWAYS(21/133)
PDLIM3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(20/158),HALLMARK_ESTROGEN_RESPONSE_EARLY(19/200),HALLMARK_ESTROGEN_RESPONSE_LATE(19/200)
PDXK	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PDZD4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PDZK1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(19/200),HALLMARK_ESTROGEN_RESPONSE_LATE(19/200)
PEA15	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_APOPTOSIS(17/161)
PER1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PEX11B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PEX19	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PFDN2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(33/518)
PFKFB3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),PID_HIF1_TFPATHWAY(17/66),REACTOME_GLYCOLYSIS(10/29),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),REACTOME_GLUCOSE_METABOLISM(12/69),HALLMARK_ADIPOGENESIS(20/200),KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM(8/34)
PFKFB4	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_GLYCOLYSIS(10/29),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),REACTOME_GLUCOSE_METABOLISM(12/69),KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM(8/34)
PFKM	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_GLYCOLYSIS(10/29),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(13/62),HALLMARK_MYOGENESIS(22/200),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),REACTOME_GLUCOSE_METABOLISM(12/69),KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM(8/34)
PFKP	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),HALLMARK_GLYCOLYSIS(34/200),REACTOME_GLYCOLYSIS(10/29),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(13/62),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),REACTOME_GLUCOSE_METABOLISM(12/69),KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM(8/34)
PFN2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200)
PGAM2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),HALLMARK_GLYCOLYSIS(34/200),REACTOME_GLYCOLYSIS(10/29),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(13/62),HALLMARK_MYOGENESIS(22/200),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),REACTOME_GLUCOSE_METABOLISM(12/69)
PGAP2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PGK1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),HALLMARK_MTORC1_SIGNALING(40/200),HALLMARK_HYPOXIA(36/200),HALLMARK_GLYCOLYSIS(34/200),PID_HIF1_TFPATHWAY(17/66),REACTOME_GLYCOLYSIS(10/29),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(13/62),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),REACTOME_GLUCOSE_METABOLISM(12/69)
PHC1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PHF1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PHF10	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PHLDA3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PHLDB1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(20/200)
PHYKPL	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PI4KAP2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PI4KB	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478)
PIAS3	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(34/328),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(18/138)
PID1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PIFO	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PIGC	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(33/518)
PIK3R1	TH34_1381_S01	v8	BEZ235,BUPARLISIB HYDROCHLORIDE,DACTOLISIB,SF1126,GSK2126458,SF-1126,BKM120,PF-4691502,SONOLISIB,PICTILISIB,PKI-587,PF-04691502,COPANLISIB,BUPARLISIB,BYL719,GDC-0980,APITOLISIB,OMIPALISIB,NVP-BEZ235,PX-866,XL765,GDC-0941,PF-05212384,GEDATOLISIB,XL-765,BAY80-6946,GSK2636771,VOXTALISIB,SOPHORETIN,XL147,PI-103	lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),KEGG_PATHWAYS_IN_CANCER(34/328),BIOCARTA_VEGF_PATHWAY(10/29),PID_CDC42_PATHWAY(14/70),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),PID_ERBB1_DOWNSTREAM_PATHWAY(15/105),KEGG_FOCAL_ADHESION(20/201),REACTOME_HEMOSTASIS(32/466),REACTOME_SIGNALLING_BY_NGF(20/217),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(13/97),PID_PDGFRB_PATHWAY(15/129),BIOCARTA_CXCR4_PATHWAY(7/24),PID_A6B1_A6B4_INTEGRIN_PATHWAY(9/46),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
PIP4K2B	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(13/97)
PIP5K1A	TH34_1381_S01	v8		lowstringency_pd_outliers	BIOCARTA_RHO_PATHWAY(8/32),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(13/97)
PITHD1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PITRM1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PKD1P6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PKM	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PKN1	TH34_1381_S01	v8	SOPHORETIN	lowstringency_pd_outliers	NA
PLA2G6	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(13/97)
PLCD1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PLCD3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PLCG1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),KEGG_PATHWAYS_IN_CANCER(34/328),REACTOME_AXON_GUIDANCE(29/251),BIOCARTA_VEGF_PATHWAY(10/29),HALLMARK_PI3K_AKT_MTOR_SIGNALING(15/105),HALLMARK_APICAL_JUNCTION(20/200),REACTOME_HEMOSTASIS(32/466),REACTOME_SIGNALLING_BY_NGF(20/217),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(13/97),ST_INTEGRIN_SIGNALING_PATHWAY(12/82),PID_PDGFRB_PATHWAY(15/129),BIOCARTA_CXCR4_PATHWAY(7/24),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
PLD2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),PID_ERBB1_DOWNSTREAM_PATHWAY(15/105),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(13/97)
PLEC	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_APOPTOSIS(19/148)
PLEKHA7	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PLEKHG4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PLEKHG5	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PLIN2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),PID_HIF1_TFPATHWAY(17/66),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),HALLMARK_ADIPOGENESIS(20/200)
PLOD2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),HALLMARK_GLYCOLYSIS(34/200),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200)
PLP2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PLXDC1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PLXNA2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251),KEGG_AXON_GUIDANCE(16/129)
PLXNA3	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251),KEGG_AXON_GUIDANCE(16/129)
PLXNB1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251),KEGG_AXON_GUIDANCE(16/129),HALLMARK_ESTROGEN_RESPONSE_LATE(19/200)
PLXNB2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(22/200),KEGG_AXON_GUIDANCE(16/129)
PMF1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),REACTOME_DNA_REPLICATION(21/192)
PNISR	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PNKP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PNN	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(24/200)
PNPLA7	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PODXL2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
POGK	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
POGZ	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
POLDIP3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
POLR2A	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(16/45),REACTOME_HIV_INFECTION(24/207),HALLMARK_DNA_REPAIR(19/150)
POLR2B	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(16/45),REACTOME_HIV_INFECTION(24/207)
POLR2J3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
POLR3C	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSCRIPTION(33/210),HALLMARK_DNA_REPAIR(19/150)
POMP	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_PROTEASOME(10/48)
POU3F3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PPFIA4	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),HALLMARK_GLYCOLYSIS(34/200),HALLMARK_MYOGENESIS(22/200)
PPIF	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(20/158),HALLMARK_ESTROGEN_RESPONSE_EARLY(19/200),HALLMARK_ESTROGEN_RESPONSE_LATE(19/200)
PPOX	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PPP1R10	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PPP1R12B	TH34_1381_S01	v8		lowstringency_pd_outliers	BIOCARTA_RHO_PATHWAY(8/32)
PPP1R15A	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),HALLMARK_HYPOXIA(36/200)
PPP1R1A	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PPP6R2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PRCC	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PRCP	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(32/466)
PRKDC	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(24/200)
PRKRIR	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PRMT5	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(28/200),REACTOME_METABOLISM_OF_RNA(34/330),PID_HDAC_CLASSI_PATHWAY(11/66)
PRMT7	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PRNP	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251),HALLMARK_MYOGENESIS(22/200)
PRODH	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PRPF3	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(42/128),HALLMARK_UV_RESPONSE_UP(20/158)
PRRC2A	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PRRC2C	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PRRT2	TH34_1381_S01	v8	BRYOSTATIN	lowstringency_pd_outliers	NA
PRUNE	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PSMA3	TH34_1381_S01	v8	BORTEZOMIB,CARFILZOMIB	lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(17/84),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_HIV_INFECTION(24/207),REACTOME_CELL_CYCLE_CHECKPOINTS(18/124),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_ER_PHAGOSOME_PATHWAY(13/61),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(14/73),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),REACTOME_APOPTOSIS(19/148),BIOCARTA_PROTEASOME_PATHWAY(9/28),REACTOME_METABOLISM_OF_MRNA(26/284),REACTOME_DNA_REPLICATION(21/192),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(17/132),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(11/57),KEGG_PROTEASOME(10/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(10/48),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(10/49),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(10/51),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(11/65),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(10/53),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(11/67),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(10/56),REACTOME_REGULATION_OF_APOPTOSIS(10/58)
PSMA4	TH34_1381_S01	v8	BORTEZOMIB,CARFILZOMIB	lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),HALLMARK_MTORC1_SIGNALING(40/200),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(17/84),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_HIV_INFECTION(24/207),REACTOME_CELL_CYCLE_CHECKPOINTS(18/124),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_ER_PHAGOSOME_PATHWAY(13/61),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(14/73),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),REACTOME_APOPTOSIS(19/148),BIOCARTA_PROTEASOME_PATHWAY(9/28),REACTOME_METABOLISM_OF_MRNA(26/284),REACTOME_DNA_REPLICATION(21/192),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(17/132),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(11/57),KEGG_PROTEASOME(10/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(10/48),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(10/49),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(10/51),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(11/65),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(10/53),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(11/67),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(10/56),REACTOME_REGULATION_OF_APOPTOSIS(10/58)
PSMB4	TH34_1381_S01	v8	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(17/84),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_HIV_INFECTION(24/207),REACTOME_CELL_CYCLE_CHECKPOINTS(18/124),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_ER_PHAGOSOME_PATHWAY(13/61),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(14/73),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),REACTOME_APOPTOSIS(19/148),BIOCARTA_PROTEASOME_PATHWAY(9/28),REACTOME_METABOLISM_OF_MRNA(26/284),REACTOME_DNA_REPLICATION(21/192),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(17/132),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(11/57),KEGG_PROTEASOME(10/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(10/48),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(10/49),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(10/51),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(11/65),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(10/53),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(11/67),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(10/56),REACTOME_REGULATION_OF_APOPTOSIS(10/58)
PSMC6	TH34_1381_S01	v8	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),HALLMARK_MTORC1_SIGNALING(40/200),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(17/84),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_HIV_INFECTION(24/207),REACTOME_CELL_CYCLE_CHECKPOINTS(18/124),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_ER_PHAGOSOME_PATHWAY(13/61),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(14/73),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),REACTOME_APOPTOSIS(19/148),BIOCARTA_PROTEASOME_PATHWAY(9/28),REACTOME_METABOLISM_OF_MRNA(26/284),REACTOME_DNA_REPLICATION(21/192),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(17/132),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(11/57),KEGG_PROTEASOME(10/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(10/48),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(10/49),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(10/51),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(11/65),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(10/53),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(11/67),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(10/56),REACTOME_REGULATION_OF_APOPTOSIS(10/58)
PSMD2	TH34_1381_S01	v8	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(17/84),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_HIV_INFECTION(24/207),REACTOME_CELL_CYCLE_CHECKPOINTS(18/124),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_ER_PHAGOSOME_PATHWAY(13/61),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(14/73),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),REACTOME_APOPTOSIS(19/148),REACTOME_METABOLISM_OF_MRNA(26/284),REACTOME_DNA_REPLICATION(21/192),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(17/132),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(11/57),KEGG_PROTEASOME(10/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(10/48),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(10/49),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(10/51),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(11/65),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(10/53),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(11/67),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(10/56),REACTOME_REGULATION_OF_APOPTOSIS(10/58)
PSMD4	TH34_1381_S01	v8	BORTEZOMIB,TALAZOPARIB,CARFILZOMIB	lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(17/84),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_HIV_INFECTION(24/207),REACTOME_CELL_CYCLE_CHECKPOINTS(18/124),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_ER_PHAGOSOME_PATHWAY(13/61),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(14/73),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),REACTOME_APOPTOSIS(19/148),REACTOME_METABOLISM_OF_MRNA(26/284),REACTOME_DNA_REPLICATION(21/192),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(17/132),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(11/57),KEGG_PROTEASOME(10/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(10/48),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(10/49),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(10/51),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(11/65),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(10/53),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(11/67),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(10/56),REACTOME_REGULATION_OF_APOPTOSIS(10/58)
PSMD6	TH34_1381_S01	v8	BORTEZOMIB,CARFILZOMIB	lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(17/84),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_HIV_INFECTION(24/207),REACTOME_CELL_CYCLE_CHECKPOINTS(18/124),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_ER_PHAGOSOME_PATHWAY(13/61),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(14/73),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),REACTOME_APOPTOSIS(19/148),BIOCARTA_PROTEASOME_PATHWAY(9/28),REACTOME_METABOLISM_OF_MRNA(26/284),REACTOME_DNA_REPLICATION(21/192),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(17/132),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(11/57),KEGG_PROTEASOME(10/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(10/48),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(10/49),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(10/51),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(11/65),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(10/53),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(11/67),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(10/56),REACTOME_REGULATION_OF_APOPTOSIS(10/58)
PSMD7	TH34_1381_S01	v8	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(17/84),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_HIV_INFECTION(24/207),REACTOME_CELL_CYCLE_CHECKPOINTS(18/124),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_ER_PHAGOSOME_PATHWAY(13/61),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(14/73),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),REACTOME_APOPTOSIS(19/148),REACTOME_METABOLISM_OF_MRNA(26/284),REACTOME_DNA_REPLICATION(21/192),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(17/132),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(11/57),KEGG_PROTEASOME(10/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(10/48),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(10/49),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(10/51),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(11/65),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(10/53),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(11/67),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(10/56),REACTOME_REGULATION_OF_APOPTOSIS(10/58)
PSMF1	TH34_1381_S01	v8	BORTEZOMIB,CARFILZOMIB	lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(17/84),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_HIV_INFECTION(24/207),REACTOME_CELL_CYCLE_CHECKPOINTS(18/124),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_ER_PHAGOSOME_PATHWAY(13/61),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(14/73),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),REACTOME_APOPTOSIS(19/148),REACTOME_METABOLISM_OF_MRNA(26/284),REACTOME_DNA_REPLICATION(21/192),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(17/132),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(11/57),KEGG_PROTEASOME(10/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(10/48),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(10/49),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(10/51),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(11/65),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(10/53),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(11/67),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(10/56),REACTOME_REGULATION_OF_APOPTOSIS(10/58)
PSRC1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PTCD3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(20/200)
PTGES3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200)
PTK2	TH34_1381_S01	v8	PF-00562271,MASITINIB,PF-562271,PF00562271	lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),KEGG_PATHWAYS_IN_CANCER(34/328),REACTOME_AXON_GUIDANCE(29/251),BIOCARTA_VEGF_PATHWAY(10/29),REACTOME_APOPTOSIS(19/148),KEGG_AXON_GUIDANCE(16/129),HALLMARK_APICAL_JUNCTION(20/200),KEGG_FOCAL_ADHESION(20/201),REACTOME_HEMOSTASIS(32/466),HALLMARK_APOPTOSIS(17/161),ST_INTEGRIN_SIGNALING_PATHWAY(12/82),BIOCARTA_CXCR4_PATHWAY(7/24)
PTMS	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PTN	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PTP4A1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PTPRF	TH34_1381_S01	v8	ERLOTINIB HYDROCHLORIDE	lowstringency_pd_outliers	NA
PTTG1IP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PYCR2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
PYGM	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),HALLMARK_MYOGENESIS(22/200),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),REACTOME_GLUCOSE_METABOLISM(12/69)
PYGO2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
QARS	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(10/41),REACTOME_TRNA_AMINOACYLATION(10/42),REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION(7/24)
QTRT1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
R3HDM2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RAB18	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RAB1A	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200)
RAB29	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RAB4A	TH34_1381_S01	v8		lowstringency_pd_outliers	PID_PDGFRB_PATHWAY(15/129)
RAB5B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RABAC1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RABL2A	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RABL2B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RAD21	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(42/421),HALLMARK_G2M_CHECKPOINT(28/200),REACTOME_CELL_CYCLE_MITOTIC(35/325),HALLMARK_E2F_TARGETS(24/200),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),REACTOME_DNA_REPLICATION(21/192)
RAF1	TH34_1381_S01	v8	Sorafenib,MLN-2480,Regorafenib,SORAFENIB TOSYLATE,LGX818,SORAFENIB,XL281,XL-281,REGORAFENIB,1096708-71-2	lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),KEGG_PATHWAYS_IN_CANCER(34/328),REACTOME_AXON_GUIDANCE(29/251),PID_CDC42_PATHWAY(14/70),HALLMARK_PI3K_AKT_MTOR_SIGNALING(15/105),PID_ERBB1_DOWNSTREAM_PATHWAY(15/105),KEGG_FOCAL_ADHESION(20/201),REACTOME_HEMOSTASIS(32/466),REACTOME_SIGNALLING_BY_NGF(20/217),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(13/97),ST_INTEGRIN_SIGNALING_PATHWAY(12/82),PID_PDGFRB_PATHWAY(15/129),BIOCARTA_CXCR4_PATHWAY(7/24),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
RALGDS	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(34/328),PID_ERBB1_DOWNSTREAM_PATHWAY(15/105),REACTOME_SIGNALLING_BY_NGF(20/217)
RAN	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),HALLMARK_E2F_TARGETS(24/200),REACTOME_HIV_INFECTION(24/207),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(17/132),PID_HDAC_CLASSI_PATHWAY(11/66)
RARA	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(34/328),HALLMARK_APOPTOSIS(17/161),HALLMARK_ESTROGEN_RESPONSE_EARLY(19/200)
RBCK1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),HALLMARK_GLYCOLYSIS(34/200),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212)
RBM17	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(42/128)
RBM23	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RBM25	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(42/128)
RBM34	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RBM39	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RBM4B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RBM5	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111)
RBM6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RBM8A	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),KEGG_SPLICEOSOME(42/128),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(19/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(19/54),REACTOME_MRNA_3_END_PROCESSING(16/35),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_METABOLISM_OF_MRNA(26/284)
RBMX	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),KEGG_SPLICEOSOME(42/128)
RCN1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RCOR3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
REC8	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(42/421)
REEP2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RELN	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_ECM_RECEPTOR_INTERACTION(14/84),NABA_CORE_MATRISOME(25/275),KEGG_FOCAL_ADHESION(20/201)
RERE	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RFWD2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_CHECKPOINTS(18/124),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(18/138),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(11/57),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(10/51)
RFX4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RFX5	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RGL1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RGL2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RGS11	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RHOBTB2	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(18/138)
RHOBTB3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(19/200)
RIMKLB	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RIT1	TH34_1381_S01	v8	SELUMETINIB (AZD6244),PICTILISIB	lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),HALLMARK_MYOGENESIS(22/200),HALLMARK_PI3K_AKT_MTOR_SIGNALING(15/105),REACTOME_SIGNALLING_BY_NGF(20/217)
RMST	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RMST_10	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RNF182	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212)
RNF187	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RNF2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RNF40	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RNF44	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RNH1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RNPEP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RNPS1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),HALLMARK_MYC_TARGETS_V1(52/200),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(19/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(19/54),REACTOME_MRNA_3_END_PROCESSING(16/35),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_METABOLISM_OF_MRNA(26/284)
ROBO3	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251),KEGG_AXON_GUIDANCE(16/129)
RP1-261G23.7	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-101E13.5	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-1212A22.1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-1212A22.4	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-14N7.2	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-231C14.4	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-263K19.4	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-386G11.10	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-488L18.4	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-565P22.6	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-632C17__A.1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-673C5.1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-734K23.9	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP3-467D16.3	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-669L17.10	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-781K5.2	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RPAIN	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RPL22	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_METABOLISM_OF_MRNA(26/284),REACTOME_METABOLISM_OF_PROTEINS(33/518)
RPL39P3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RPL7L1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RPN1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),HALLMARK_UV_RESPONSE_UP(20/158),BIOCARTA_PROTEASOME_PATHWAY(9/28),REACTOME_METABOLISM_OF_PROTEINS(33/518)
RPN2	TH34_1381_S01	v8		lowstringency_pd_outliers	BIOCARTA_PROTEASOME_PATHWAY(9/28),REACTOME_METABOLISM_OF_PROTEINS(33/518)
RPRD2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RRAGD	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),HALLMARK_GLYCOLYSIS(34/200)
RRNAD1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RSAD1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RSL24D1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RSPH1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RSPO2	TH34_1381_S01	v8		lowstringency_pd_outliers	NABA_CORE_MATRISOME(25/275)
RSPO4	TH34_1381_S01	v8		lowstringency_pd_outliers	NABA_CORE_MATRISOME(25/275)
RSRC2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RSRP1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RTFDC1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RTN1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
RTN4	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(20/217)
RUVBL1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(42/421)
RXRB	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(34/328),HALLMARK_UV_RESPONSE_UP(20/158),PID_A6B1_A6B4_INTEGRIN_PATHWAY(9/46)
S100A16	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SAFB	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SAFB2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SALL2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SAMD11	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SAP18	TH34_1381_S01	v8		lowstringency_pd_outliers	PID_HDAC_CLASSI_PATHWAY(11/66)
SAP30BP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SAR1A	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SARNP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SCAMP3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SCAP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SCCPDH	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SCNM1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SCOC	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SCRIB	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SDC3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),HALLMARK_GLYCOLYSIS(34/200),KEGG_ECM_RECEPTOR_INTERACTION(14/84),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),HALLMARK_APICAL_JUNCTION(20/200)
SDCBP	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251),HALLMARK_DNA_REPAIR(19/150)
SDCCAG3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SDCCAG8	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_MITOTIC_G2_G2_M_PHASES(12/81)
SDF2L1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200)
SDHC	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(34/200),HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200),KEGG_ALZHEIMERS_DISEASE(19/169),HALLMARK_ADIPOGENESIS(20/200)
SEC13	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),REACTOME_DNA_REPLICATION(21/192),REACTOME_METABOLISM_OF_PROTEINS(33/518)
SEC24C	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_METABOLISM_OF_PROTEINS(33/518)
SEC31A	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_UNFOLDED_PROTEIN_RESPONSE(19/80),REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S(14/46),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(20/113),REACTOME_DIABETES_PATHWAYS(21/133),REACTOME_METABOLISM_OF_PROTEINS(33/518)
SEC61A1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ER_PHAGOSOME_PATHWAY(13/61),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),HALLMARK_DNA_REPAIR(19/150),REACTOME_METABOLISM_OF_PROTEINS(33/518)
SEC61G	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ER_PHAGOSOME_PATHWAY(13/61),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),REACTOME_METABOLISM_OF_PROTEINS(33/518)
SEC63	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SELENBP1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200)
SEMA3B	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_AXON_GUIDANCE(16/129),HALLMARK_ESTROGEN_RESPONSE_EARLY(19/200),HALLMARK_ESTROGEN_RESPONSE_LATE(19/200)
SEMA5B	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_AXON_GUIDANCE(16/129)
SEMA6D	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251),KEGG_AXON_GUIDANCE(16/129),REACTOME_METABOLISM_OF_PROTEINS(33/518)
SENP6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SEP15	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SEPT2	TH34_1381_S01	v8		lowstringency_pd_outliers	PID_CDC42_PATHWAY(14/70)
SEPT5	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SERF1B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SERF2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SERP1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),REACTOME_UNFOLDED_PROTEIN_RESPONSE(19/80),REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S(14/46),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(20/113),REACTOME_DIABETES_PATHWAYS(21/133)
SETD5	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SETDB1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SF1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SF3A1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),HALLMARK_MYC_TARGETS_V1(52/200),KEGG_SPLICEOSOME(42/128)
SF3A3	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),KEGG_SPLICEOSOME(42/128),HALLMARK_DNA_REPAIR(19/150)
SF3B1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),KEGG_SPLICEOSOME(42/128),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(16/45)
SF3B3	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),HALLMARK_MYC_TARGETS_V1(52/200),KEGG_SPLICEOSOME(42/128),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(16/45)
SF3B4	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),KEGG_SPLICEOSOME(42/128),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(16/45)
SF3B6	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SFI1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SFPQ	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(28/200)
SFXN1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SGSM2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SGSM3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SH2B1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),HALLMARK_MYOGENESIS(22/200),REACTOME_HEMOSTASIS(32/466),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
SH3BP5L	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SHC1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_UNFOLDED_PROTEIN_RESPONSE(19/80),REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S(14/46),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(20/113),REACTOME_DIABETES_PATHWAYS(21/133),BIOCARTA_VEGF_PATHWAY(10/29),HALLMARK_APICAL_JUNCTION(20/200),KEGG_FOCAL_ADHESION(20/201),REACTOME_HEMOSTASIS(32/466),REACTOME_SIGNALLING_BY_NGF(20/217),ST_INTEGRIN_SIGNALING_PATHWAY(12/82),PID_PDGFRB_PATHWAY(15/129),PID_A6B1_A6B4_INTEGRIN_PATHWAY(9/46),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
SHISA4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SHMT2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200)
SIN3B	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),PID_HDAC_CLASSI_PATHWAY(11/66)
SIRT2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(22/200),PID_HDAC_CLASSI_PATHWAY(11/66)
SKIV2L	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SLC22A3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SLC25A3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200)
SLC25A36	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SLC25A37	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SLC25A44	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SLC29A1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(19/200)
SLC2A1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),HALLMARK_HYPOXIA(36/200),PID_HIF1_TFPATHWAY(17/66),KEGG_PATHWAYS_IN_CANCER(34/328),HALLMARK_PI3K_AKT_MTOR_SIGNALING(15/105),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),HALLMARK_ESTROGEN_RESPONSE_EARLY(19/200)
SLC35E2B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SLC38A5	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SLC39A1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SLC39A6	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(19/200)
SLC3A2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(32/466)
SLC41A1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SLC41A3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SLC4A3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SLC7A5	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),HALLMARK_G2M_CHECKPOINT(28/200),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(20/113),REACTOME_HEMOSTASIS(32/466),HALLMARK_ESTROGEN_RESPONSE_EARLY(19/200),HALLMARK_ESTROGEN_RESPONSE_LATE(19/200)
SLTM	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SMAD1	TH34_1381_S01	v8		lowstringency_pd_outliers	PID_ERBB1_DOWNSTREAM_PATHWAY(15/105)
SMARCC2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SMARCD1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SMARCD3	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478)
SMEK1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SMG5	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_METABOLISM_OF_MRNA(26/284),PID_HDAC_CLASSI_PATHWAY(11/66)
SMG7	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_METABOLISM_OF_MRNA(26/284)
SMO	TH34_1381_S01	v8	ARSENIC TRIOXIDE,Sonidegib,Arsenic trioxide,ERISMODEGIB,SONIDEGIB,TALADEGIB,Taladegib,GEFITINIB,VISMODEGIB,LY2940680,Gefitinib,SARIDEGIB,LDE225,Vismodegib,LDE 225	lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(34/328)
SMOC1	TH34_1381_S01	v8		lowstringency_pd_outliers	NABA_CORE_MATRISOME(25/275)
SMPD4	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478)
SMYD3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SNAP47	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SNAPIN	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SNRNP200	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),KEGG_SPLICEOSOME(42/128),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(16/45)
SNRNP27	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(42/128)
SNRNP70	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),KEGG_SPLICEOSOME(42/128)
SNRPB2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),HALLMARK_MYC_TARGETS_V1(52/200),KEGG_SPLICEOSOME(42/128)
SNRPD1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),HALLMARK_MYC_TARGETS_V1(52/200),KEGG_SPLICEOSOME(42/128),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(16/45),HALLMARK_G2M_CHECKPOINT(28/200),REACTOME_METABOLISM_OF_RNA(34/330)
SNRPD3	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),HALLMARK_MYC_TARGETS_V1(52/200),KEGG_SPLICEOSOME(42/128),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(19/44),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(16/45),REACTOME_METABOLISM_OF_RNA(34/330)
SNRPE	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),KEGG_SPLICEOSOME(42/128),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(19/44),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(16/45),REACTOME_METABOLISM_OF_RNA(34/330)
SNRPG	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),HALLMARK_MYC_TARGETS_V1(52/200),KEGG_SPLICEOSOME(42/128),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(19/44),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(16/45),REACTOME_METABOLISM_OF_RNA(34/330)
SNX1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SNX5	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SOCS2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
SORBS2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(23/200)
SPA17	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SPAG6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SPAG8	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SPATA17	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SPEG	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(22/200),HALLMARK_APICAL_JUNCTION(20/200)
SPG11	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SPG7	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SPOCK1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200),NABA_CORE_MATRISOME(25/275)
SPPL2B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SPRY2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SRGAP2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251),KEGG_AXON_GUIDANCE(16/129)
SRP9	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(33/518)
SRRM1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(19/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(19/54),REACTOME_MRNA_3_END_PROCESSING(16/35),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105)
SRRM2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SRSF1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),HALLMARK_MYC_TARGETS_V1(52/200),KEGG_SPLICEOSOME(42/128),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(19/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(19/54),REACTOME_MRNA_3_END_PROCESSING(16/35),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(16/45),HALLMARK_G2M_CHECKPOINT(28/200),HALLMARK_E2F_TARGETS(24/200)
SRSF10	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(42/128),HALLMARK_G2M_CHECKPOINT(28/200)
SRSF11	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(19/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(19/54),REACTOME_MRNA_3_END_PROCESSING(16/35),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105)
SRSF2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),HALLMARK_MYC_TARGETS_V1(52/200),KEGG_SPLICEOSOME(42/128),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(19/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(19/54),REACTOME_MRNA_3_END_PROCESSING(16/35),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(16/45),HALLMARK_G2M_CHECKPOINT(28/200),HALLMARK_E2F_TARGETS(24/200)
SRSF3	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),HALLMARK_MYC_TARGETS_V1(52/200),KEGG_SPLICEOSOME(42/128),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(19/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(19/54),REACTOME_MRNA_3_END_PROCESSING(16/35),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105)
SRSF4	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),KEGG_SPLICEOSOME(42/128),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(19/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(19/54),REACTOME_MRNA_3_END_PROCESSING(16/35),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105)
SRSF5	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),KEGG_SPLICEOSOME(42/128),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(19/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(19/54),REACTOME_MRNA_3_END_PROCESSING(16/35),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105)
SRSF6	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),KEGG_SPLICEOSOME(42/128),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(19/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(19/54),REACTOME_MRNA_3_END_PROCESSING(16/35),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(16/45),HALLMARK_DNA_REPAIR(19/150)
SRSF7	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),HALLMARK_MYC_TARGETS_V1(52/200),KEGG_SPLICEOSOME(42/128),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(19/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(19/54),REACTOME_MRNA_3_END_PROCESSING(16/35),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(16/45)
SRSF9	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),KEGG_SPLICEOSOME(42/128),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(19/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(19/54),REACTOME_MRNA_3_END_PROCESSING(16/35),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105)
SSB	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),REACTOME_TRANSCRIPTION(33/210)
SSBP3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SSR2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(33/518)
ST8SIA1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
STAC2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
STARD3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(20/158)
STARD7	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200)
STAT2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),HALLMARK_PI3K_AKT_MTOR_SIGNALING(15/105),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
STAT3	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),KEGG_PATHWAYS_IN_CANCER(34/328),PID_ERBB1_DOWNSTREAM_PATHWAY(15/105),PID_HDAC_CLASSI_PATHWAY(11/66),REACTOME_SIGNALLING_BY_NGF(20/217),PID_PDGFRB_PATHWAY(15/129),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
STAU1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(23/200)
STK11IP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
STK33	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
STK36	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(34/328)
STMN1	TH34_1381_S01	v8	PACLITAXEL	lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(34/200),HALLMARK_G2M_CHECKPOINT(28/200),HALLMARK_E2F_TARGETS(24/200)
STRADA	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
STRAP	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
STX18	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SUCO	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SUGP1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111)
SUGP2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SUMO2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SUMO3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SUN1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SUPT5H	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105),REACTOME_HIV_INFECTION(24/207),HALLMARK_DNA_REPAIR(19/150)
SUSD4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SYNCRIP	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),HALLMARK_G2M_CHECKPOINT(28/200),HALLMARK_E2F_TARGETS(24/200)
SYNGAP1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SYT11	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
SZRD1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TADA1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TADA3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TAF1C	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSCRIPTION(33/210),HALLMARK_DNA_REPAIR(19/150)
TAF1D	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TAGLN3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TARBP1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TARDBP	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200)
TARS2	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(10/41),REACTOME_TRNA_AMINOACYLATION(10/42)
TAZ	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478),REACTOME_METABOLISM_OF_PROTEINS(33/518)
TBC1D1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TBC1D9B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TBCD	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(23/200),REACTOME_METABOLISM_OF_PROTEINS(33/518)
TBCE	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(33/518)
TCEAL2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TCERG1	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(42/128)
TCF25	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TCF3	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396)
TCP1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),REACTOME_METABOLISM_OF_PROTEINS(33/518)
TCTEX1D1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TCTN1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TELO2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TERF2IP	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(42/421),ST_INTEGRIN_SIGNALING_PATHWAY(12/82)
TFDP1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),REACTOME_CELL_CYCLE(42/421),HALLMARK_G2M_CHECKPOINT(28/200),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_APOPTOSIS(19/148)
THBS3	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_ECM_RECEPTOR_INTERACTION(14/84),NABA_CORE_MATRISOME(25/275),HALLMARK_APICAL_JUNCTION(20/200),KEGG_FOCAL_ADHESION(20/201)
THBS4	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_ECM_RECEPTOR_INTERACTION(14/84),NABA_CORE_MATRISOME(25/275),KEGG_FOCAL_ADHESION(20/201)
THEM4	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),HALLMARK_PI3K_AKT_MTOR_SIGNALING(15/105),REACTOME_SIGNALLING_BY_NGF(20/217)
THOC1	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(42/128)
THOP1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
THRAP3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TIA1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TIAL1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(20/200)
TIMM17A	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200),REACTOME_METABOLISM_OF_PROTEINS(33/518)
TIMMDC1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TIPRL	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TKTL1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),HALLMARK_GLYCOLYSIS(34/200)
TMA7	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TMCO1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TMED10	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TMED2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_DNA_REPAIR(19/150)
TMED4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TMEM108	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TMEM132A	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TMEM161B-AS1	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TMEM175	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TMEM183A	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TMEM231	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TMEM50B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TMEM63A	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TMEM9	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TNC	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200),KEGG_ECM_RECEPTOR_INTERACTION(14/84),NABA_CORE_MATRISOME(25/275),KEGG_FOCAL_ADHESION(20/201)
TNFRSF10B	TH34_1381_S01	v8	APOMAB,DULANERMIN,LEXATUMUMAB,RHAPO2L/TRAIL,LBY135,CONATUMUMAB	lowstringency_pd_outliers	REACTOME_APOPTOSIS(19/148)
TNFRSF25	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TNIP1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TNK2	TH34_1381_S01	v8		lowstringency_pd_outliers	PID_CDC42_PATHWAY(14/70),ST_INTEGRIN_SIGNALING_PATHWAY(12/82)
TOB1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(20/200),HALLMARK_ESTROGEN_RESPONSE_EARLY(19/200),HALLMARK_ESTROGEN_RESPONSE_LATE(19/200)
TOB2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TOMM20	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(33/518)
TOP2B	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TOR1AIP1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TOR3A	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TP53BP2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TPD52L2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TPGS2	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TPPP3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TPR	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(19/54),KEGG_PATHWAYS_IN_CANCER(34/328),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_HIV_INFECTION(24/207),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(17/132),REACTOME_METABOLISM_OF_CARBOHYDRATES(23/247),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
TRA2A	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(42/128)
TRA2B	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),KEGG_SPLICEOSOME(42/128),HALLMARK_G2M_CHECKPOINT(28/200),HALLMARK_E2F_TARGETS(24/200)
TRAF7	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TRAPPC12	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TRAPPC2L	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TRIO	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(38/396),REACTOME_AXON_GUIDANCE(29/251),HALLMARK_MITOTIC_SPINDLE(23/200),REACTOME_SIGNALLING_BY_NGF(20/217)
TRO	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(20/200)
TSC22D3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TSC22D4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TSEN15	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TSN	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TSNAX	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TTC17	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TTC21A	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TTLL3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TTLL4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
TUBB	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),HALLMARK_E2F_TARGETS(24/200),REACTOME_MITOTIC_G2_G2_M_PHASES(12/81)
TYK2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
U2AF2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(50/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(47/140),REACTOME_MRNA_SPLICING(42/111),KEGG_SPLICEOSOME(42/128),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(19/44),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(19/54),REACTOME_MRNA_3_END_PROCESSING(16/35),REACTOME_TRANSCRIPTION(33/210),REACTOME_RNA_POL_II_TRANSCRIPTION(24/105)
UAP1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
UBA1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(18/138),BIOCARTA_PROTEASOME_PATHWAY(9/28)
UBA2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(18/138)
UBA7	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(18/138),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
UBAP2L	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
UBC	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(20/200)
UBE2A	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(18/138),BIOCARTA_PROTEASOME_PATHWAY(9/28)
UBE2D3	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(18/138),HALLMARK_PI3K_AKT_MTOR_SIGNALING(15/105),REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN(7/25)
UBE2E1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_CELL_CYCLE_CHECKPOINTS(18/124),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(14/73),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(18/138),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
UBE2G2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(18/138)
UBE2N	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(18/138),HALLMARK_PI3K_AKT_MTOR_SIGNALING(15/105),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
UBE2Q1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(18/138)
UBE2V1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
UBE2V2	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212)
UBQLN4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
UBR4	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212)
UBR5	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(18/138)
UBXN11	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
UCHL5	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200)
UCKL1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
UFC1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ULK3	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
UPF3A	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_METABOLISM_OF_MRNA(26/284)
UPK3BL	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
UQCR10	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200),KEGG_ALZHEIMERS_DISEASE(19/169),HALLMARK_ADIPOGENESIS(20/200)
UQCRC2	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(21/200),KEGG_ALZHEIMERS_DISEASE(19/169)
USF1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
USH1C	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
USP10	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
USP21	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
USP7	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
UTP6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
VANGL2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
VAPA	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(35/478)
VARS2	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(10/41),REACTOME_TRNA_AMINOACYLATION(10/42)
VEGFA	TH34_1381_S01	v8	AFLIBERCEPT,VEGF TRAP,BEVACIZUMAB,SORAFENIB TOSYLATE,Aflibercept,ZALTRAP,ZIV-AFLIBERCEPT,Bevacizumab	lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),HALLMARK_GLYCOLYSIS(34/200),PID_HIF1_TFPATHWAY(17/66),KEGG_PATHWAYS_IN_CANCER(34/328),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(20/113),BIOCARTA_VEGF_PATHWAY(10/29),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(22/200),KEGG_FOCAL_ADHESION(20/201),REACTOME_HEMOSTASIS(32/466),REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN(7/25)
VGLL4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
VIPR2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
VPS39	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
VPS45	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(32/466)
VPS52	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
VPS72	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
VSTM2L	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
VWA3A	TH34_1381_S01	v8		lowstringency_pd_outliers	NABA_CORE_MATRISOME(25/275)
WAC	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
WASH5P	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
WASH6P	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
WASH7P	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
WBP2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
WBP5	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
WBSCR22	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
WDR11	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
WDR26	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
WDR27	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
WDR59	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
WDR6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
WDR90	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(24/200)
WEE1	TH34_1381_S01	v8	PLATINUM,GEMCITABINE,AZD1775,AZD-1775,MK-1775,MK 1775	lowstringency_pd_outliers	REACTOME_CELL_CYCLE(42/421),REACTOME_CELL_CYCLE_MITOTIC(35/325),HALLMARK_E2F_TARGETS(24/200),REACTOME_CELL_CYCLE_CHECKPOINTS(18/124),REACTOME_HEMOSTASIS(32/466),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(11/65),HALLMARK_APOPTOSIS(17/161),REACTOME_MITOTIC_G2_G2_M_PHASES(12/81)
WNK2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
WNT11	TH34_1381_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(34/328)
WSB1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(41/251),HALLMARK_HYPOXIA(36/200),REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(32/212)
XBP1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(40/200),REACTOME_UNFOLDED_PROTEIN_RESPONSE(19/80),REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S(14/46),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(20/113),REACTOME_DIABETES_PATHWAYS(21/133),HALLMARK_ESTROGEN_RESPONSE_EARLY(19/200),HALLMARK_ESTROGEN_RESPONSE_LATE(19/200)
XIST	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
XPO1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(52/200),REACTOME_CELL_CYCLE(42/421),HALLMARK_G2M_CHECKPOINT(28/200),REACTOME_CELL_CYCLE_MITOTIC(35/325),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(17/84),HALLMARK_E2F_TARGETS(24/200),REACTOME_HIV_INFECTION(24/207),REACTOME_MITOTIC_M_M_G1_PHASES(21/172),REACTOME_METABOLISM_OF_MRNA(26/284),REACTOME_DNA_REPLICATION(21/192),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(17/132),PID_HDAC_CLASSI_PATHWAY(11/66),REACTOME_MITOTIC_G2_G2_M_PHASES(12/81)
XPO6	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
XPR1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
YTHDC1	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(28/200)
YWHAZ	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(74/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(54/539),REACTOME_METABOLISM_OF_RNA(34/330),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(20/113),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(17/84),REACTOME_METABOLISM_OF_MRNA(26/284),PID_ERBB1_DOWNSTREAM_PATHWAY(15/105),REACTOME_HEMOSTASIS(32/466),PID_PDGFRB_PATHWAY(15/129),PID_A6B1_A6B4_INTEGRIN_PATHWAY(9/46),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270)
YY1AP1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
Y_RNA	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZBTB18	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZC3H11A	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ZFP36	TH34_1381_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(36/200),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(17/84),REACTOME_METABOLISM_OF_MRNA(26/284),PID_ERBB1_DOWNSTREAM_PATHWAY(15/105),HALLMARK_ESTROGEN_RESPONSE_LATE(19/200)
ZFP36L1	TH34_1381_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(17/84),REACTOME_METABOLISM_OF_MRNA(26/284)
ZIC1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ZIC2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ZIC4	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ZMIZ1	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ZMIZ2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ZMYND10	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ZMYND11	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ZNF146	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ZNF384	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ZNF423	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ZNF496	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ZNF532	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ZNF638	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ZNF672	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ZNF687	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ZNF692	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ZNF76	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ZRANB2	TH34_1381_S01	v8		lowstringency_pd_outliers	NA
ZSWIM8	TH34_1381_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ABCA7	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ABCC5	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
AC005154.6	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC093323.3	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC093850.2	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC132217.4	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC159540.1	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACIN1	TH34_1399_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(13/128)
ADGRB1	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AIF1L	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
AKAP17A	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
AKAP8L	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
AL442127.1	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL603831.1	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL662801.1	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ALOX15	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
AMT	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ANKZF1	TH34_1399_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(9/200),HALLMARK_HYPOXIA(7/200)
ANXA3	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(16/753)
APBB3	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
APOA1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
APOD	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ARGLU1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ARHGAP21	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ARTN	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),HALLMARK_GLYCOLYSIS(9/200),NABA_MATRISOME_ASSOCIATED(16/753)
ATG4B	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ATP11A	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
B3GALT6	TH34_1399_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(9/200),HALLMARK_HYPOXIA(7/200)
BRD8	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
BTNL9	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
C11orf84	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
C11orf95	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
C17orf85	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
C1orf159	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
C20orf166-AS1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
C5orf45	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
CACNA2D2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
CADM1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
CALM1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
CAPN5	TH34_1399_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(9/200)
CCAR1	TH34_1399_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(9/140),REACTOME_MRNA_SPLICING(8/111),REACTOME_MRNA_PROCESSING(9/161)
CCDC109B	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
CCDC14	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
CCDC23	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
CCDC93	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
CCL25	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(16/753)
CCNL2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
CDC16	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
CEP95	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
CERS4	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
CFI	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
CH17-232I21.1	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CH507-513H4.1	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CH507-528H12.1	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CHD3	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
CHI3L1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
CHRD	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(16/753)
CHST1	TH34_1399_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(9/200)
CLDN6	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
CLSTN3	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
CNTROB	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
COL10A1	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_COLLAGENS(5/44),NABA_CORE_MATRISOME(10/275)
COL20A1	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_COLLAGENS(5/44),NABA_CORE_MATRISOME(10/275)
COL22A1	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_COLLAGENS(5/44),NABA_CORE_MATRISOME(10/275)
COL23A1	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_COLLAGENS(5/44),NABA_CORE_MATRISOME(10/275)
COL4A5	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_COLLAGENS(5/44),NABA_CORE_MATRISOME(10/275)
CTD-2007L18.5	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-2547H18.1	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTIF	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
CYP2S1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
DDX17	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
DDX18	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
DDX46	TH34_1399_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(13/128)
DIO3	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
DMPK	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
DMTF1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
DNM1L	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
DPP6	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
DUS3L	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ECEL1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
EGFL6	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(16/753)
EHMT1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
EIF2B5	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ENTPD6	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ENTPD8	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
EPCAM	TH34_1399_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(8/158)
ESYT2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
EXOSC8	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
FAM132A	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
FAM156A	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
FAM160B2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
FAM189A2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
FAM193B	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
FAM43A	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
FAM89A	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
FAM91A1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
FBN3	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_CORE_MATRISOME(10/275)
FBXO32	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
FENDRR	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FNBP1L	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
FNBP4	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
FTCD	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
GABBR1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
GAL	TH34_1399_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(8/158)
GALP	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
GBA2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
GCA	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
GJB2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
GJB6	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
GLS	TH34_1399_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(8/158)
GOLGA8B	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
GPBP1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
GRB10	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
GSTA1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
GUSB	TH34_1399_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(9/200)
HDAC6	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
HERC2P2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
HHEX	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
HILPDA	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HMGB1P1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
HNRNPH1	TH34_1399_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(9/140),REACTOME_MRNA_SPLICING(8/111),REACTOME_MRNA_PROCESSING(9/161)
HOPX	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
HP	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
HSBP1L1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
IGF2	TH34_1399_S01	v8	CABAZITAXEL,DOCETAXEL,OSI-906 (LINSITINIB)	lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(16/753)
IGSF10	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_CORE_MATRISOME(10/275)
IL3RA	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
INTS6	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
IP6K2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
IQCG	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
IRX2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ITGA1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ITIH2	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(16/753)
ITIH5	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(16/753)
KCNT1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
KCTD12	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
KDM3A	TH34_1399_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(7/200)
KDM6A	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
KIAA0907	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
KIDINS220	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
KLK6	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
KREMEN2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
KRT17	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
KRT18	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
KRT23	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
KRT8	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
LDB1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
LEF1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
LENG8	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
LINC00342	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
LINC00461	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
LINC00684	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC00969	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01001	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01002	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01089	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LIPG	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
LLNLF-173C4.1	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LMBR1L	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
LOXL3	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(16/753)
LPL	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
LRIG1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
LRRN1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
LSR	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
LSS	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
LUC7L3	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
LY6H	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
MAPK8IP3	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
MARCH6	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
MAST2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
MAT2A	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
MEIS3	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
METTL3	TH34_1399_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(9/140),REACTOME_MRNA_PROCESSING(9/161)
MGEA5	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
MINK1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
MIR503HG	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MLLT4	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
MLLT6	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
MOB2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
MPHOSPH8	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
MSLN	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
NADSYN1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
NEDD4L	TH34_1399_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(7/200)
NELFB	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NKTR	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
NPIPA1	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB3	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB5	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPP1	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NRBP2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
NRTN	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(16/753)
NSMF	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NSUN5P1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
NTNG2	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_CORE_MATRISOME(10/275)
ODF2L	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
OGT	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ONECUT3	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ORMDL1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
P4HA1	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),HALLMARK_GLYCOLYSIS(9/200),NABA_MATRISOME_ASSOCIATED(16/753),HALLMARK_HYPOXIA(7/200)
PABPC1L	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PAN2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PAPD4	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PAQR4	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PCF11	TH34_1399_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(9/140),REACTOME_MRNA_SPLICING(8/111),REACTOME_MRNA_PROCESSING(9/161)
PCGF3	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PCNX	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PDZD4	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PHYKPL	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PKD1P6	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PLB1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PLD2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PLK5	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PLXDC1	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(16/753)
PLXNA3	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(16/753)
PNCK	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PNISR	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PNN	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
POLI	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
POLR2H	TH34_1399_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(9/140),REACTOME_MRNA_SPLICING(8/111),REACTOME_MRNA_PROCESSING(9/161),HALLMARK_UV_RESPONSE_UP(8/158)
PON2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PPFIBP1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PPIL3	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PPP1R14C	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PPP1R1B	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PPP5C	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PPP6R3	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PPWD1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PRAME	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PRPF3	TH34_1399_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(13/128),HALLMARK_UV_RESPONSE_UP(8/158)
PRPF38B	TH34_1399_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(13/128)
PRR22	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PRR5L	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PSIP1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PSMA3-AS1	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PTAR1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PTDSS1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PTEN	TH34_1399_S01	v8	AZD8186,LY294002,ENZALUTAMIDE,CETUXIMAB,EGFR INHIBITOR,1372540-25-4,AZD5363,EVEROLIMUS,PACLITAXEL,BKM120,Gefitinib,CARBOPLATIN,Cetuximab,TEMSIROLIMUS,BUPARLISIB,Everolimus,Paclitaxel,Trastuzumab,MK-2206,IPATASERTIB,PD184352,Temsirolimus,Ipatasertib,GEFITINIB,GSK2636771,MK2206,Enzalutamide,TRASTUZUMAB,ERLOTINIB	lowstringency_pd_outliers	NA
PTPRQ	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
PYGB	TH34_1399_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(9/200)
RASGRF2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
RBFOX3	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
RBM25	TH34_1399_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(13/128)
RBM38	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
RBM39	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
RBM5	TH34_1399_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(9/140),REACTOME_MRNA_SPLICING(8/111),REACTOME_MRNA_PROCESSING(9/161)
RBM6	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
RGS12	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
RNF19A	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
RNF44	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
RP1-172N19.5	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-1212A22.4	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-20I20.4	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-231C14.4	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-394O4.5	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-488L18.4	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-496I9.1	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-673C5.1	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-734K23.9	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-89K21.1	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-669L17.10	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP5-902P8.12	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RPL39P3	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
RPP30	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
RPRD1B	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
RUFY3	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
SCG2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
SDHAP1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
SEMA6C	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(16/753)
SEPT11	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
SERPINB9	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(16/753)
SETDB1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
SF3B1	TH34_1399_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(13/128),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(9/140),REACTOME_MRNA_SPLICING(8/111),REACTOME_MRNA_PROCESSING(9/161)
SHOX2	TH34_1399_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(8/158)
SLC19A1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
SLC26A6	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
SLC29A4	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
SLC39A10	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
SLFN13	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
SLITRK2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
SMC5	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
SMOC1	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_CORE_MATRISOME(10/275)
SMURF2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
SNRNP70	TH34_1399_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(13/128),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(9/140),REACTOME_MRNA_SPLICING(8/111),REACTOME_MRNA_PROCESSING(9/161)
SPACA6P	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SPATC1L	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SPINT1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
SPINT2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
SREK1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
SRSF1	TH34_1399_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(13/128),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(9/140),REACTOME_MRNA_SPLICING(8/111),REACTOME_MRNA_PROCESSING(9/161)
STAG3L5P-PVRIG2P-PILRB	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
STK36	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
STX16	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
SUGP2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
SUPT20H	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TAGLN3	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
TCERG1	TH34_1399_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(13/128)
TCP11L2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
THOC1	TH34_1399_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(13/128)
THOC2	TH34_1399_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(13/128)
THUMPD3-AS1	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TIA1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
TIAL1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
TMEM2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
TMEM44	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
TMEM63C	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
TMX3	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
TNNT3	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
TOR4A	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TPT1-AS1	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TRA2A	TH34_1399_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(13/128)
TRIM29	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
TRIM67	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
TSPAN6	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
TTC17	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
TUBB8P12	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TUBBP5	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
TUG1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
TYRO3	TH34_1399_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(8/158)
U2SURP	TH34_1399_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(13/128)
UBE2G2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
UBR5	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
UFM1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
UNCX	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
VAV2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
VEGFA	TH34_1399_S01	v8	AFLIBERCEPT,VEGF TRAP,BEVACIZUMAB,SORAFENIB TOSYLATE,Aflibercept,ZALTRAP,ZIV-AFLIBERCEPT,Bevacizumab	lowstringency_pd_outliers	NABA_MATRISOME(26/1028),HALLMARK_GLYCOLYSIS(9/200),NABA_MATRISOME_ASSOCIATED(16/753),HALLMARK_HYPOXIA(7/200)
WDR19	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
WDR27	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
WISP1	TH34_1399_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_CORE_MATRISOME(10/275)
WIZ	TH34_1399_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(8/158)
WSB1	TH34_1399_S01	v8		lowstringency_pd_outliers	HALLMARK_HYPOXIA(7/200)
WSCD2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
YTHDC1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
Y_RNA	TH34_1399_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZFC3H1	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ZFYVE16	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ZMYM2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ZNF189	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ZNF302	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ZNF444	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ZNF561	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ZNF83	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
ZRANB2	TH34_1399_S01	v8		lowstringency_pd_outliers	NA
AC022007.5	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACACB	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(19/168),KEGG_PROPANOATE_METABOLISM(10/33),KEGG_PYRUVATE_METABOLISM(10/40),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(12/120),KEGG_INSULIN_SIGNALING_PATHWAY(10/137),KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY(7/67)
ACADM	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),HALLMARK_FATTY_ACID_METABOLISM(28/158),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(19/168),KEGG_PPAR_SIGNALING_PATHWAY(14/69),KEGG_PROPANOATE_METABOLISM(10/33),HALLMARK_OXIDATIVE_PHOSPHORYLATION(15/200),KEGG_FATTY_ACID_METABOLISM(9/42),KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION(9/44),REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION(6/14),KEGG_BETA_ALANINE_METABOLISM(4/22),REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION(6/104),PID_HNF3B_PATHWAY(4/45)
ACADS	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),HALLMARK_FATTY_ACID_METABOLISM(28/158),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(19/168),KEGG_FATTY_ACID_METABOLISM(9/42),KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION(9/44),REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION(6/14),KEGG_BUTANOATE_METABOLISM(6/34)
ACAT1	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(19/168),KEGG_PROPANOATE_METABOLISM(10/33),KEGG_PYRUVATE_METABOLISM(10/40),HALLMARK_OXIDATIVE_PHOSPHORYLATION(15/200),KEGG_FATTY_ACID_METABOLISM(9/42),KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION(9/44),KEGG_TRYPTOPHAN_METABOLISM(7/40),KEGG_BUTANOATE_METABOLISM(6/34),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(10/200),KEGG_LYSINE_DEGRADATION(4/44),REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM(3/17)
ACO1	TH34_1400_S01	v8		lowstringency_pd_outliers	KEGG_CITRATE_CYCLE_TCA_CYCLE(9/32),KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM(4/16)
ACSL1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(28/158),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(19/168),KEGG_PPAR_SIGNALING_PATHWAY(14/69),HALLMARK_MYOGENESIS(16/200),KEGG_FATTY_ACID_METABOLISM(9/42),REACTOME_TRIGLYCERIDE_BIOSYNTHESIS(7/38),KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY(7/67),HALLMARK_BILE_ACID_METABOLISM(7/112),REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION(6/104),KEGG_PEROXISOME(5/78),HALLMARK_PEROXISOME(5/104)
ACSS2	TH34_1400_S01	v8		lowstringency_pd_outliers	KEGG_PROPANOATE_METABOLISM(10/33),KEGG_PYRUVATE_METABOLISM(10/40),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(9/62),REACTOME_BIOLOGICAL_OXIDATIONS(11/139),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(8/70),REACTOME_ETHANOL_OXIDATION(4/10),HALLMARK_CHOLESTEROL_HOMEOSTASIS(7/74)
ADAM33	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
ADCK3	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
ADCY4	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(12/120),REACTOME_OPIOID_SIGNALLING(7/78),REACTOME_CA_DEPENDENT_EVENTS(5/30),REACTOME_DAG_AND_IP3_SIGNALING(5/32),REACTOME_PLC_BETA_MEDIATED_EVENTS(5/43),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(5/54),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(6/95),KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(6/115),REACTOME_SIGNALING_BY_PDGF(6/122),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(6/127),REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS(4/44),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(6/137),REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB(3/18),REACTOME_AQUAPORIN_MEDIATED_TRANSPORT(4/51),REACTOME_SIGNALLING_BY_NGF(7/217),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(5/100),KEGG_GNRH_SIGNALING_PATHWAY(5/101),REACTOME_SIGNALING_BY_ERBB2(5/101),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(5/109),REACTOME_SIGNALING_BY_FGFR(5/112),REACTOME_SIGNALING_BY_GPCR(14/920)
ADCY6	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(12/120),REACTOME_OPIOID_SIGNALLING(7/78),REACTOME_CA_DEPENDENT_EVENTS(5/30),REACTOME_DAG_AND_IP3_SIGNALING(5/32),REACTOME_PLC_BETA_MEDIATED_EVENTS(5/43),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(5/54),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(6/95),KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(6/115),REACTOME_SIGNALING_BY_PDGF(6/122),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(6/127),REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS(4/44),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(6/137),REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB(3/18),REACTOME_REGULATION_OF_INSULIN_SECRETION(5/93),REACTOME_AQUAPORIN_MEDIATED_TRANSPORT(4/51),REACTOME_SIGNALLING_BY_NGF(7/217),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(5/100),KEGG_GNRH_SIGNALING_PATHWAY(5/101),REACTOME_SIGNALING_BY_ERBB2(5/101),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(5/109),REACTOME_SIGNALING_BY_FGFR(5/112),REACTOME_SIGNALING_BY_GPCR(14/920)
ADH1B	TH34_1400_S01	v8		lowstringency_pd_outliers	KEGG_FATTY_ACID_METABOLISM(9/42),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(9/62),REACTOME_BIOLOGICAL_OXIDATIONS(11/139),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(8/70),KEGG_TYROSINE_METABOLISM(6/42),REACTOME_ETHANOL_OXIDATION(4/10),KEGG_RETINOL_METABOLISM(6/64),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(6/70),KEGG_DRUG_METABOLISM_CYTOCHROME_P450(6/72)
ADH1C	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(28/158),HALLMARK_XENOBIOTIC_METABOLISM(19/200),KEGG_FATTY_ACID_METABOLISM(9/42),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(9/62),REACTOME_BIOLOGICAL_OXIDATIONS(11/139),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(8/70),KEGG_TYROSINE_METABOLISM(6/42),REACTOME_ETHANOL_OXIDATION(4/10),KEGG_RETINOL_METABOLISM(6/64),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(6/70),KEGG_DRUG_METABOLISM_CYTOCHROME_P450(6/72)
ADHFE1	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE(7/48),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(9/141)
ADIPOQ	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),KEGG_PPAR_SIGNALING_PATHWAY(14/69),REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION(10/72),KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY(7/67),REACTOME_DEVELOPMENTAL_BIOLOGY(12/396),KEGG_TYPE_II_DIABETES_MELLITUS(4/47)
ADIRF	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADRA2A	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(12/120),REACTOME_HEMOSTASIS(15/466),REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS(4/44),REACTOME_REGULATION_OF_INSULIN_SECRETION(5/93),REACTOME_SIGNALING_BY_GPCR(14/920)
AGPAT2	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(19/168),REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS(9/82),REACTOME_TRIGLYCERIDE_BIOSYNTHESIS(7/38),REACTOME_PHOSPHOLIPID_METABOLISM(10/198),KEGG_GLYCEROLIPID_METABOLISM(6/49),REACTOME_SYNTHESIS_OF_PA(4/27),KEGG_GLYCEROPHOSPHOLIPID_METABOLISM(5/77)
AHSA2	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
AIFM2	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
AKAP1	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(15/466)
AKR1C1	TH34_1400_S01	v8		lowstringency_pd_outliers	KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(6/70)
AKR1C2	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(19/200),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(6/70)
ALAD	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(28/158),HALLMARK_HEME_METABOLISM(7/200)
ALDH1L1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(7/200)
ALDH2	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),HALLMARK_XENOBIOTIC_METABOLISM(19/200),KEGG_PROPANOATE_METABOLISM(10/33),KEGG_PYRUVATE_METABOLISM(10/40),KEGG_FATTY_ACID_METABOLISM(9/42),KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION(9/44),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(9/62),REACTOME_BIOLOGICAL_OXIDATIONS(11/139),KEGG_TRYPTOPHAN_METABOLISM(7/40),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(8/70),KEGG_BUTANOATE_METABOLISM(6/34),REACTOME_ETHANOL_OXIDATION(4/10),KEGG_GLYCEROLIPID_METABOLISM(6/49),KEGG_BETA_ALANINE_METABOLISM(4/22),KEGG_LYSINE_DEGRADATION(4/44),KEGG_HISTIDINE_METABOLISM(3/29)
ALDH6A1	TH34_1400_S01	v8		lowstringency_pd_outliers	KEGG_PROPANOATE_METABOLISM(10/33),HALLMARK_OXIDATIVE_PHOSPHORYLATION(15/200),KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION(9/44),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(10/200),REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM(3/17),HALLMARK_HEME_METABOLISM(7/200)
ALDOC	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_GLUCOSE_METABOLISM(10/69),REACTOME_METABOLISM_OF_CARBOHYDRATES(15/247),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(9/62),HALLMARK_CHOLESTEROL_HOMEOSTASIS(7/74),REACTOME_GLUCONEOGENESIS(5/34),KEGG_PENTOSE_PHOSPHATE_PATHWAY(3/27),REACTOME_GLYCOLYSIS(3/29)
AMY2B	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_CARBOHYDRATES(15/247),KEGG_STARCH_AND_SUCROSE_METABOLISM(4/52)
ANG	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(9/200)
AOC3	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(28/158),KEGG_TYROSINE_METABOLISM(6/42),KEGG_BETA_ALANINE_METABOLISM(4/22),KEGG_PHENYLALANINE_METABOLISM(3/18),KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM(3/31)
AQP7	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(28/158),KEGG_PPAR_SIGNALING_PATHWAY(14/69),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413),REACTOME_AQUAPORIN_MEDIATED_TRANSPORT(4/51)
ASPH	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
ATP1A2	TH34_1400_S01	v8		lowstringency_pd_outliers	KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION(5/23),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413)
ATPAF1	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
AZGP1	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
BHMT2	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
BNIP3	TH34_1400_S01	v8		lowstringency_pd_outliers	PID_HIF1_TFPATHWAY(6/66)
BPHL	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(28/158),HALLMARK_XENOBIOTIC_METABOLISM(19/200)
BTD	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
BTNL9	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
C14orf180	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
C19orf12	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
C1orf115	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
C2CD2	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
C6	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
CA3	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
CA4	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(28/158),KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION(5/23)
CALB2	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
CALCOCO1	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
CAT	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),HALLMARK_XENOBIOTIC_METABOLISM(19/200),KEGG_TRYPTOPHAN_METABOLISM(7/40),HALLMARK_BILE_ACID_METABOLISM(7/112),KEGG_PEROXISOME(5/78),HALLMARK_HEME_METABOLISM(7/200),HALLMARK_PEROXISOME(5/104)
CAV2	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
CBX7	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
CCDC69	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
CD300LG	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
CD36	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),HALLMARK_FATTY_ACID_METABOLISM(28/158),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(19/168),KEGG_PPAR_SIGNALING_PATHWAY(14/69),HALLMARK_XENOBIOTIC_METABOLISM(19/200),HALLMARK_MYOGENESIS(16/200),REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION(10/72),REACTOME_HEMOSTASIS(15/466),KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY(7/67),REACTOME_DEVELOPMENTAL_BIOLOGY(12/396),BIOCARTA_PPARA_PATHWAY(5/58),REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION(6/104)
CDKN2C	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200)
CDO1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(19/200),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(10/200),HALLMARK_UV_RESPONSE_UP(8/158),REACTOME_SULFUR_AMINO_ACID_METABOLISM(4/24)
CEBPA	TH34_1400_S01	v8		lowstringency_pd_outliers	PID_HNF3B_PATHWAY(4/45)
CFD	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(16/200),REACTOME_HEMOSTASIS(15/466)
CFLAR	TH34_1400_S01	v8	BICALUTAMIDE	lowstringency_pd_outliers	NA
CHP1	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CIDEA	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),HALLMARK_FATTY_ACID_METABOLISM(28/158)
CIDEC	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
CISH	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING(3/24)
CNTFR	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
CPM	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
CRYAB	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(16/200)
CS	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),KEGG_CITRATE_CYCLE_TCA_CYCLE(9/32),HALLMARK_OXIDATIVE_PHOSPHORYLATION(15/200),REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE(7/48),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(9/141),KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM(4/16),BIOCARTA_KREB_PATHWAY(3/8),REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE(3/26)
CSAD	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(19/200),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(10/200),REACTOME_SULFUR_AMINO_ACID_METABOLISM(4/24)
CTIF	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
CYB5A	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(19/200),HALLMARK_OXIDATIVE_PHOSPHORYLATION(15/200),REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS(6/51),HALLMARK_GLYCOLYSIS(9/200)
CYP4B1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),REACTOME_BIOLOGICAL_OXIDATIONS(11/139),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(8/70)
CYSTM1	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DAPK2	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(16/200)
DBI	TH34_1400_S01	v8		lowstringency_pd_outliers	KEGG_PPAR_SIGNALING_PATHWAY(14/69)
DECR1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),HALLMARK_FATTY_ACID_METABOLISM(28/158),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(19/168),HALLMARK_OXIDATIVE_PHOSPHORYLATION(15/200),REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION(6/14)
DGAT1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(19/168),REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS(9/82),REACTOME_TRIGLYCERIDE_BIOSYNTHESIS(7/38),REACTOME_PHOSPHOLIPID_METABOLISM(10/198),KEGG_GLYCEROLIPID_METABOLISM(6/49),KEGG_RETINOL_METABOLISM(6/64),HALLMARK_UV_RESPONSE_UP(8/158)
DGAT2	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(19/168),REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS(9/82),REACTOME_TRIGLYCERIDE_BIOSYNTHESIS(7/38),REACTOME_PHOSPHOLIPID_METABOLISM(10/198),KEGG_GLYCEROLIPID_METABOLISM(6/49),KEGG_RETINOL_METABOLISM(6/64)
DHDDS	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
DHRS11	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
DMTN	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
EBF1	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION(10/72),REACTOME_DEVELOPMENTAL_BIOLOGY(12/396)
ECHDC2	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
ECHDC3	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
ECHS1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),HALLMARK_FATTY_ACID_METABOLISM(28/158),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(19/168),KEGG_PROPANOATE_METABOLISM(10/33),HALLMARK_OXIDATIVE_PHOSPHORYLATION(15/200),KEGG_FATTY_ACID_METABOLISM(9/42),KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION(9/44),REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION(6/14),KEGG_TRYPTOPHAN_METABOLISM(7/40),KEGG_BUTANOATE_METABOLISM(6/34),KEGG_BETA_ALANINE_METABOLISM(4/22),KEGG_LYSINE_DEGRADATION(4/44)
ECM2	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
EEPD1	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
ELMOD3	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200)
EMC3	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ENGASE	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
ENOSF1	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
EPHX1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(28/158),HALLMARK_XENOBIOTIC_METABOLISM(19/200),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(6/70),HALLMARK_UV_RESPONSE_UP(8/158)
ESYT1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200)
ETFA	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(15/200),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(9/141)
ETFDH	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(28/158),HALLMARK_XENOBIOTIC_METABOLISM(19/200),HALLMARK_OXIDATIVE_PHOSPHORYLATION(15/200),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(9/141)
EZH1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(7/200)
FABP4	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),KEGG_PPAR_SIGNALING_PATHWAY(14/69),REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION(10/72),REACTOME_DEVELOPMENTAL_BIOLOGY(12/396),REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS(3/13),REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT(4/46)
FADS3	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
FAH	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),HALLMARK_XENOBIOTIC_METABOLISM(19/200),KEGG_TYROSINE_METABOLISM(6/42),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(10/200)
FAM213A	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FAM219B	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FAM47E-STBD1	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FAM89A	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
FASN	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(28/158),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(19/168),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(12/120),REACTOME_TRIGLYCERIDE_BIOSYNTHESIS(7/38),KEGG_INSULIN_SIGNALING_PATHWAY(10/137),BIOCARTA_CHREBP2_PATHWAY(6/42),HALLMARK_CHOLESTEROL_HOMEOSTASIS(7/74),REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS(6/51)
FERMT2	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
FGFRL1	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
FHL1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(16/200)
FMO2	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_BIOLOGICAL_OXIDATIONS(11/139),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(8/70),KEGG_DRUG_METABOLISM_CYTOCHROME_P450(6/72)
FZD4	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),REACTOME_SIGNALING_BY_GPCR(14/920)
G0S2	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(28/158),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(19/168),REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION(6/104)
GABRE	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
GDPD5	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
GHR	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING(3/24),BIOCARTA_GH_PATHWAY(3/28)
GLYAT	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_BIOLOGICAL_OXIDATIONS(11/139)
GPAM	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(19/168),REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS(9/82),REACTOME_TRIGLYCERIDE_BIOSYNTHESIS(7/38),REACTOME_PHOSPHOLIPID_METABOLISM(10/198),KEGG_GLYCEROLIPID_METABOLISM(6/49),REACTOME_SYNTHESIS_OF_PA(4/27),KEGG_GLYCEROPHOSPHOLIPID_METABOLISM(5/77)
GPD1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(28/158),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(19/168),REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS(9/82),REACTOME_TRIGLYCERIDE_BIOSYNTHESIS(7/38),REACTOME_PHOSPHOLIPID_METABOLISM(10/198),REACTOME_SYNTHESIS_OF_PA(4/27),KEGG_GLYCEROPHOSPHOLIPID_METABOLISM(5/77)
GPR146	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
GPT	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(10/200)
GPT2	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(10/200)
GSDMB	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
GSN	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(16/200)
GYG2	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_GLUCOSE_METABOLISM(10/69),REACTOME_METABOLISM_OF_CARBOHYDRATES(15/247)
HACD2	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HADH	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),HALLMARK_FATTY_ACID_METABOLISM(28/158),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(19/168),KEGG_FATTY_ACID_METABOLISM(9/42),KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION(9/44),REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION(6/14),KEGG_TRYPTOPHAN_METABOLISM(7/40),KEGG_BUTANOATE_METABOLISM(6/34),KEGG_LYSINE_DEGRADATION(4/44),PID_HNF3B_PATHWAY(4/45)
HCAR2	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_GPCR(14/920)
HEBP2	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
HECTD3	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
HK2	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_CARBOHYDRATES(15/247),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(9/62),KEGG_INSULIN_SIGNALING_PATHWAY(10/137),PID_HIF1_TFPATHWAY(6/66),HALLMARK_GLYCOLYSIS(9/200),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413),KEGG_TYPE_II_DIABETES_MELLITUS(4/47),KEGG_STARCH_AND_SUCROSE_METABOLISM(4/52),KEGG_GALACTOSE_METABOLISM(3/26)
HMGN2P15	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HOOK2	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
HRASLS5	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
HSDL2	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(28/158)
HSPB7	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
IDH1	TH34_1400_S01	v8	Olaparib,OLAPARIB	lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),HALLMARK_FATTY_ACID_METABOLISM(28/158),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),HALLMARK_XENOBIOTIC_METABOLISM(19/200),KEGG_CITRATE_CYCLE_TCA_CYCLE(9/32),HALLMARK_OXIDATIVE_PHOSPHORYLATION(15/200),REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE(7/48),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(9/141),HALLMARK_GLYCOLYSIS(9/200),HALLMARK_BILE_ACID_METABOLISM(7/112),KEGG_PEROXISOME(5/78),HALLMARK_PEROXISOME(5/104)
INPP5K	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),KEGG_INSULIN_SIGNALING_PATHWAY(10/137),REACTOME_PHOSPHOLIPID_METABOLISM(10/198)
ITGA7	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),HALLMARK_MYOGENESIS(16/200)
ITGB1BP1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_PEROXISOME(5/104)
ITPK1	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(15/466)
ITSN1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),REACTOME_SIGNALLING_BY_NGF(7/217),REACTOME_SIGNALING_BY_GPCR(14/920)
JAM2	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(15/466)
KCNIP2	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
LDHD	TH34_1400_S01	v8		lowstringency_pd_outliers	KEGG_PYRUVATE_METABOLISM(10/40)
LENG8	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
LEP	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(12/120),REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION(10/72),KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY(7/67),PID_HIF1_TFPATHWAY(6/66),REACTOME_DEVELOPMENTAL_BIOLOGY(12/396),REACTOME_REGULATION_OF_INSULIN_SECRETION(5/93)
LGALS12	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
LGI4	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
LINC01002	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01089	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01140	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01485	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LIPE	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),KEGG_INSULIN_SIGNALING_PATHWAY(10/137),HALLMARK_BILE_ACID_METABOLISM(7/112),REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS(3/13),REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT(4/46)
LPL	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),KEGG_PPAR_SIGNALING_PATHWAY(14/69),REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION(10/72),HALLMARK_CHOLESTEROL_HOMEOSTASIS(7/74),KEGG_GLYCEROLIPID_METABOLISM(6/49),REACTOME_DEVELOPMENTAL_BIOLOGY(12/396),BIOCARTA_PPARA_PATHWAY(5/58),REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT(4/46)
LVRN	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LYVE1	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_CARBOHYDRATES(15/247)
MALAT1	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
MAN2C1	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
MAOA	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(28/158),HALLMARK_XENOBIOTIC_METABOLISM(19/200),REACTOME_BIOLOGICAL_OXIDATIONS(11/139),KEGG_TRYPTOPHAN_METABOLISM(7/40),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(8/70),KEGG_TYROSINE_METABOLISM(6/42),KEGG_DRUG_METABOLISM_CYTOCHROME_P450(6/72),HALLMARK_UV_RESPONSE_UP(8/158),KEGG_PHENYLALANINE_METABOLISM(3/18),KEGG_HISTIDINE_METABOLISM(3/29),KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM(3/31)
MAOB	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(15/200),REACTOME_BIOLOGICAL_OXIDATIONS(11/139),KEGG_TRYPTOPHAN_METABOLISM(7/40),REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS(8/70),KEGG_TYROSINE_METABOLISM(6/42),KEGG_DRUG_METABOLISM_CYTOCHROME_P450(6/72),KEGG_PHENYLALANINE_METABOLISM(3/18),KEGG_HISTIDINE_METABOLISM(3/29),KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM(3/31)
MARC1	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MARC2	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MCCC1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION(9/44),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(10/200),REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM(3/17)
MDH1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(28/158),KEGG_PYRUVATE_METABOLISM(10/40),KEGG_CITRATE_CYCLE_TCA_CYCLE(9/32),HALLMARK_OXIDATIVE_PHOSPHORYLATION(15/200),REACTOME_GLUCOSE_METABOLISM(10/69),REACTOME_METABOLISM_OF_CARBOHYDRATES(15/247),KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION(5/23),REACTOME_GLUCONEOGENESIS(5/34),KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM(4/16),HALLMARK_GLYCOLYSIS(9/200),BIOCARTA_KREB_PATHWAY(3/8)
ME1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),HALLMARK_FATTY_ACID_METABOLISM(28/158),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(19/168),KEGG_PPAR_SIGNALING_PATHWAY(14/69),KEGG_PYRUVATE_METABOLISM(10/40),HALLMARK_GLYCOLYSIS(9/200),BIOCARTA_PPARA_PATHWAY(5/58),REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION(6/104)
MEOX2	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
MESP1	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
METTL5	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
MGST1	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_BIOLOGICAL_OXIDATIONS(11/139),KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450(6/70),KEGG_DRUG_METABOLISM_CYTOCHROME_P450(6/72)
MLLT6	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
MLX	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(12/120),BIOCARTA_CHREBP2_PATHWAY(6/42)
MLXIPL	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(12/120),BIOCARTA_CHREBP2_PATHWAY(6/42)
MMD	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
MOCS1	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS(6/51)
MRAP	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200)
MRAS	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(16/200)
MT-ATP6	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ATP8	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CO1	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CO2	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CO3	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CYB	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND1	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND2	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND3	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND4	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND4L	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND5	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTATP6P1	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTHFD1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(19/200),REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS(6/51),KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM(4/16)
MTND2P28	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTURN	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MUSTN1	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
MYH11	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(16/200),REACTOME_DEVELOPMENTAL_BIOLOGY(12/396),KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(6/115)
MYO1C	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(16/200)
MYOC	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
MYZAP	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
NAT8L	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
NDRG2	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(19/200)
NEAT1	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
NEIL1	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
NFU1	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
NMB	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_GPCR(14/920)
NOSTRIN	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
NPIPB3	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB5	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NRBP2	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
NSMCE4A	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
ORMDL3	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
PALMD	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
PC	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(19/200),KEGG_PYRUVATE_METABOLISM(10/40),HALLMARK_MYOGENESIS(16/200),KEGG_CITRATE_CYCLE_TCA_CYCLE(9/32),REACTOME_GLUCOSE_METABOLISM(10/69),REACTOME_METABOLISM_OF_CARBOHYDRATES(15/247),REACTOME_GLUCONEOGENESIS(5/34),HALLMARK_GLYCOLYSIS(9/200),HALLMARK_HEME_METABOLISM(7/200)
PCCA	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(19/168),KEGG_PROPANOATE_METABOLISM(10/33),KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION(9/44),REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION(6/14)
PCK1	TH34_1400_S01	v8		lowstringency_pd_outliers	KEGG_PPAR_SIGNALING_PATHWAY(14/69),KEGG_PYRUVATE_METABOLISM(10/40),KEGG_CITRATE_CYCLE_TCA_CYCLE(9/32),REACTOME_GLUCOSE_METABOLISM(10/69),REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION(10/72),REACTOME_METABOLISM_OF_CARBOHYDRATES(15/247),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(9/62),KEGG_INSULIN_SIGNALING_PATHWAY(10/137),KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY(7/67),KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION(5/23),REACTOME_GLUCONEOGENESIS(5/34),REACTOME_DEVELOPMENTAL_BIOLOGY(12/396),PID_HNF3B_PATHWAY(4/45)
PDE1B	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(15/466),REACTOME_OPIOID_SIGNALLING(7/78),REACTOME_CA_DEPENDENT_EVENTS(5/30),REACTOME_DAG_AND_IP3_SIGNALING(5/32),REACTOME_PLC_BETA_MEDIATED_EVENTS(5/43),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(5/54),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(6/95),REACTOME_SIGNALING_BY_PDGF(6/122),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(6/127),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(6/137),REACTOME_SIGNALLING_BY_NGF(7/217),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(5/100),REACTOME_SIGNALING_BY_ERBB2(5/101),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(5/109),REACTOME_SIGNALING_BY_FGFR(5/112),REACTOME_SIGNALING_BY_GPCR(14/920)
PDE2A	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(15/466),REACTOME_SIGNALING_BY_GPCR(14/920)
PDHA1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(28/158),KEGG_PYRUVATE_METABOLISM(10/40),KEGG_CITRATE_CYCLE_TCA_CYCLE(9/32),HALLMARK_OXIDATIVE_PHOSPHORYLATION(15/200),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(9/62),REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE(7/48),KEGG_BUTANOATE_METABOLISM(6/34),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(9/141)
PDK2	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE(7/48),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(9/141)
PDXK	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS(6/51)
PECR	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_BILE_ACID_METABOLISM(7/112),KEGG_PEROXISOME(5/78)
PEX19	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_BILE_ACID_METABOLISM(7/112),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413),KEGG_PEROXISOME(5/78)
PFKFB3	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),REACTOME_GLUCOSE_METABOLISM(10/69),REACTOME_METABOLISM_OF_CARBOHYDRATES(15/247),PID_HIF1_TFPATHWAY(6/66),REACTOME_GLYCOLYSIS(3/29)
PGM1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),REACTOME_GLUCOSE_METABOLISM(10/69),REACTOME_METABOLISM_OF_CARBOHYDRATES(15/247),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(9/62),PID_HIF1_TFPATHWAY(6/66),KEGG_STARCH_AND_SUCROSE_METABOLISM(4/52),KEGG_GALACTOSE_METABOLISM(3/26),KEGG_PENTOSE_PHOSPHATE_PATHWAY(3/27)
PHLDB1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200)
PHYKPL	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PLA2G16	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS(9/82),REACTOME_PHOSPHOLIPID_METABOLISM(10/198),REACTOME_ACYL_CHAIN_REMODELLING_OF_PE(3/21),REACTOME_ACYL_CHAIN_REMODELLING_OF_PC(3/22)
PLA2G2A	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS(9/82),REACTOME_PHOSPHOLIPID_METABOLISM(10/198),REACTOME_SYNTHESIS_OF_PA(4/27),KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(6/115),KEGG_GLYCEROPHOSPHOLIPID_METABOLISM(5/77),REACTOME_ACYL_CHAIN_REMODELLING_OF_PE(3/21),REACTOME_ACYL_CHAIN_REMODELLING_OF_PC(3/22),KEGG_GNRH_SIGNALING_PATHWAY(5/101)
PLA2G6	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS(9/82),REACTOME_PHOSPHOLIPID_METABOLISM(10/198),KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(6/115),KEGG_GLYCEROPHOSPHOLIPID_METABOLISM(5/77),REACTOME_ACYL_CHAIN_REMODELLING_OF_PE(3/21),REACTOME_ACYL_CHAIN_REMODELLING_OF_PC(3/22),KEGG_GNRH_SIGNALING_PATHWAY(5/101)
PLIN1	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),KEGG_PPAR_SIGNALING_PATHWAY(14/69),REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION(10/72),REACTOME_DEVELOPMENTAL_BIOLOGY(12/396),REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS(3/13),REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT(4/46)
PLIN4	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
PLIN5	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
PNPLA2	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS(9/82),REACTOME_PHOSPHOLIPID_METABOLISM(10/198)
PPARG	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM(19/168),KEGG_PPAR_SIGNALING_PATHWAY(14/69),REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION(10/72),HALLMARK_CHOLESTEROL_HOMEOSTASIS(7/74),REACTOME_DEVELOPMENTAL_BIOLOGY(12/396),REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION(6/104)
PPP1R16A	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
PPP1R1A	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
PPP1R1B	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_OPIOID_SIGNALLING(7/78),REACTOME_DARPP_32_EVENTS(3/25),REACTOME_SIGNALING_BY_GPCR(14/920)
PPP2R1B	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(12/120),REACTOME_GLUCOSE_METABOLISM(10/69),REACTOME_METABOLISM_OF_CARBOHYDRATES(15/247),REACTOME_HEMOSTASIS(15/466),BIOCARTA_CHREBP2_PATHWAY(6/42),REACTOME_OPIOID_SIGNALLING(7/78),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(6/137),REACTOME_SIGNALLING_BY_NGF(7/217),REACTOME_DARPP_32_EVENTS(3/25),REACTOME_GLYCOLYSIS(3/29),REACTOME_SIGNALING_BY_GPCR(14/920)
PPP2R5A	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(15/466),BIOCARTA_CHREBP2_PATHWAY(6/42)
PRKAR2B	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(12/120),KEGG_INSULIN_SIGNALING_PATHWAY(10/137),REACTOME_HEMOSTASIS(15/466),BIOCARTA_CHREBP2_PATHWAY(6/42),REACTOME_OPIOID_SIGNALLING(7/78),REACTOME_CA_DEPENDENT_EVENTS(5/30),REACTOME_DAG_AND_IP3_SIGNALING(5/32),REACTOME_PLC_BETA_MEDIATED_EVENTS(5/43),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(5/54),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(6/95),BIOCARTA_PPARA_PATHWAY(5/58),REACTOME_SIGNALING_BY_PDGF(6/122),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(6/127),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(6/137),REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB(3/18),REACTOME_REGULATION_OF_INSULIN_SECRETION(5/93),REACTOME_AQUAPORIN_MEDIATED_TRANSPORT(4/51),REACTOME_SIGNALLING_BY_NGF(7/217),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(5/100),REACTOME_SIGNALING_BY_ERBB2(5/101),REACTOME_DARPP_32_EVENTS(3/25),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(5/109),REACTOME_SIGNALING_BY_FGFR(5/112),REACTOME_SIGNALING_BY_GPCR(14/920)
PRKCD	TH34_1400_S01	v8	SOPHORETIN	lowstringency_pd_outliers	REACTOME_HEMOSTASIS(15/466),REACTOME_OPIOID_SIGNALLING(7/78),REACTOME_CA_DEPENDENT_EVENTS(5/30),REACTOME_DAG_AND_IP3_SIGNALING(5/32),HALLMARK_UV_RESPONSE_UP(8/158),REACTOME_PLC_BETA_MEDIATED_EVENTS(5/43),REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE(5/54),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(6/95),KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(6/115),REACTOME_SIGNALING_BY_PDGF(6/122),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(6/127),REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS(4/44),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(6/137),KEGG_TYPE_II_DIABETES_MELLITUS(4/47),REACTOME_SIGNALLING_BY_NGF(7/217),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(5/100),KEGG_GNRH_SIGNALING_PATHWAY(5/101),REACTOME_SIGNALING_BY_ERBB2(5/101),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(5/109),REACTOME_SIGNALING_BY_FGFR(5/112),REACTOME_SIGNALING_BY_GPCR(14/920)
PRPF3	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(8/158)
PRRT4	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
PTGER3	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),REACTOME_SIGNALING_BY_GPCR(14/920)
PTPRS	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
RAPGEF3	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(12/120),REACTOME_HEMOSTASIS(15/466),REACTOME_REGULATION_OF_INSULIN_SECRETION(5/93)
RASA4	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
RBP4	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(19/200)
RDH5	TH34_1400_S01	v8		lowstringency_pd_outliers	KEGG_RETINOL_METABOLISM(6/64)
RETSAT	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),HALLMARK_FATTY_ACID_METABOLISM(28/158),HALLMARK_XENOBIOTIC_METABOLISM(19/200),HALLMARK_OXIDATIVE_PHOSPHORYLATION(15/200),KEGG_RETINOL_METABOLISM(6/64),HALLMARK_BILE_ACID_METABOLISM(7/112),HALLMARK_PEROXISOME(5/104)
RHOQ	TH34_1400_S01	v8		lowstringency_pd_outliers	KEGG_INSULIN_SIGNALING_PATHWAY(10/137)
RNA5SP216	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RNASE4	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
RP1-28O10.1	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-162P23.2	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-231C14.4	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-369J21.13	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-394O4.5	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-681H18.2	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-903H12.5	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RTN3	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200)
S100B	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
SCARA5	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
SCD	TH34_1400_S01	v8		lowstringency_pd_outliers	KEGG_PPAR_SIGNALING_PATHWAY(14/69),HALLMARK_MYOGENESIS(16/200),HALLMARK_CHOLESTEROL_HOMEOSTASIS(7/74)
SCRN2	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
SEMA3G	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
SGCG	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(16/200)
SHANK3	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
SIK2	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
SLC19A3	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS(6/51)
SLC25A10	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),REACTOME_GLUCOSE_METABOLISM(10/69),REACTOME_METABOLISM_OF_CARBOHYDRATES(15/247),KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION(5/23),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(10/200),REACTOME_GLUCONEOGENESIS(5/34),HALLMARK_GLYCOLYSIS(9/200),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413),REACTOME_SULFUR_AMINO_ACID_METABOLISM(4/24)
SLC25A27	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
SLC29A4	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413)
SLC2A4	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION(10/72),REACTOME_METABOLISM_OF_CARBOHYDRATES(15/247),KEGG_INSULIN_SIGNALING_PATHWAY(10/137),KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY(7/67),REACTOME_DEVELOPMENTAL_BIOLOGY(12/396),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413),KEGG_TYPE_II_DIABETES_MELLITUS(4/47),BIOCARTA_GH_PATHWAY(3/28)
SLC7A10	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(15/466),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413)
SNCG	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200)
SNX21	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
SORBS1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),KEGG_PPAR_SIGNALING_PATHWAY(14/69),HALLMARK_MYOGENESIS(16/200),KEGG_INSULIN_SIGNALING_PATHWAY(10/137)
SPTBN1	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(12/396)
ST6GALNAC6	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
STAT5A	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(6/95),BIOCARTA_PPARA_PATHWAY(5/58),REACTOME_SIGNALING_BY_PDGF(6/122),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(6/127),REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING(3/24),BIOCARTA_GH_PATHWAY(3/28)
SUCLA2	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(28/158),KEGG_PROPANOATE_METABOLISM(10/33),KEGG_CITRATE_CYCLE_TCA_CYCLE(9/32),HALLMARK_OXIDATIVE_PHOSPHORYLATION(15/200),REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE(7/48),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(9/141),BIOCARTA_KREB_PATHWAY(3/8),REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE(3/26)
SUCLG2	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(28/158),KEGG_PROPANOATE_METABOLISM(10/33),KEGG_CITRATE_CYCLE_TCA_CYCLE(9/32),REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE(7/48),REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_TRANSPORT(9/141),REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE(3/26)
TF	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(15/466),PID_HIF1_TFPATHWAY(6/66),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413)
THRSP	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
TIMP4	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
TK2	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
TKT	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),REACTOME_INTEGRATION_OF_ENERGY_METABOLISM(12/120),REACTOME_METABOLISM_OF_CARBOHYDRATES(15/247),KEGG_PENTOSE_PHOSPHATE_PATHWAY(3/27)
TM7SF2	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(30/478),HALLMARK_CHOLESTEROL_HOMEOSTASIS(7/74)
TMEM132C	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
TMEM37	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
TMEM63A	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
TMEM80	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
TNNT3	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(16/200)
TNS1	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(7/200)
TNS2	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TNXB	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
TP53I13	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
TRHDE-AS1	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TSPAN3	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
TST	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(43/200),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(10/200),HALLMARK_UV_RESPONSE_UP(8/158),REACTOME_SULFUR_AMINO_ACID_METABOLISM(4/24)
TTC38	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
TUSC5	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
TYRO3	TH34_1400_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(8/158)
UGP2	TH34_1400_S01	v8		lowstringency_pd_outliers	REACTOME_GLUCOSE_METABOLISM(10/69),REACTOME_METABOLISM_OF_CARBOHYDRATES(15/247),REACTOME_BIOLOGICAL_OXIDATIONS(11/139),HALLMARK_GLYCOLYSIS(9/200),KEGG_STARCH_AND_SUCROSE_METABOLISM(4/52),KEGG_GALACTOSE_METABOLISM(3/26)
VKORC1L1	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
WASH5P	TH34_1400_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZBTB7B	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
ZNF219	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
ZNF83	TH34_1400_S01	v8		lowstringency_pd_outliers	NA
ABCA5	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ABI1	TH34_1412_S01	v8		lowstringency_pd_outliers	PID_RAC1_REG_PATHWAY(5/38),PID_ECADHERIN_NASCENT_AJ_PATHWAY(5/39),PID_ECADHERIN_STABILIZATION_PATHWAY(5/42),PID_PDGFRB_PATHWAY(7/129),PID_RAC1_PATHWAY(4/54),PID_ERBB1_DOWNSTREAM_PATHWAY(5/105)
ABO	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
AC005256.1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC093323.3	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC104809.4	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC138035.2	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACCS	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ADAMTS17	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(20/753),NABA_ECM_REGULATORS(8/238)
ADAMTSL5	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(20/753),NABA_ECM_REGULATORS(8/238)
ADGRB1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADGRF5	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADGRG2	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADIRF-AS1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AFF4	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
AGR2	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(9/200)
AIF1L	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
AKAP17A	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
AKAP8L	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
AL603831.1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ALOX15	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ALS2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ANK3	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(10/251),REACTOME_L1CAM_INTERACTIONS(5/86)
ANO9	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ANXA3	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(20/753),NABA_ECM_AFFILIATED(7/171)
AP000275.65	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AP004550.1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AP2A2	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(10/251),REACTOME_L1CAM_INTERACTIONS(5/86),REACTOME_IMMUNE_SYSTEM(18/933),REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL(6/137),REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS(3/28)
APOA1	TH34_1412_S01	v8		lowstringency_pd_outliers	BIOCARTA_PPARA_PATHWAY(4/58)
APPL1	TH34_1412_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(10/328),KEGG_COLORECTAL_CANCER(4/62)
ARF3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ARHGAP35	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),KEGG_FOCAL_ADHESION(9/201),REACTOME_AXON_GUIDANCE(10/251),PID_PDGFRB_PATHWAY(7/129),PID_SHP2_PATHWAY(5/58),PID_EPHA2_FWD_PATHWAY(3/19),ST_INTEGRIN_SIGNALING_PATHWAY(5/82)
ARL8A	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ARTN	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),NABA_MATRISOME_ASSOCIATED(20/753),REACTOME_AXON_GUIDANCE(10/251),HALLMARK_GLYCOLYSIS(8/200)
ASNSD1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ATF7	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ATF7IP2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ATP2B2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ATXN2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ATXN3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
B3GAT1	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(8/200)
B3GNT6	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS(4/59)
BAIAP3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
BCL9L	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
BTNL9	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
C11orf30	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
C11orf57	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
C11orf80	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
C11orf84	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
C16orf89	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
C1QTNF7	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(20/753),NABA_ECM_AFFILIATED(7/171)
C1orf159	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
C21orf59	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
C5orf30	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CACNA2D1	TH34_1412_S01	v8		lowstringency_pd_outliers	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC(5/76)
CACNA2D2	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(9/200),KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC(5/76)
CADM1	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS(4/27),REACTOME_CELL_CELL_JUNCTION_ORGANIZATION(5/56),KEGG_CELL_ADHESION_MOLECULES_CAMS(7/134),REACTOME_CELL_JUNCTION_ORGANIZATION(5/78),REACTOME_CELL_CELL_COMMUNICATION(6/120)
CALM1	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR(4/17),BIOCARTA_BIOPEPTIDES_PATHWAY(5/45),REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS(4/27),BIOCARTA_NFAT_PATHWAY(5/56),BIOCARTA_PYK2_PATHWAY(4/31),KEGG_INSULIN_SIGNALING_PATHWAY(7/137),BIOCARTA_NO1_PATHWAY(4/33),REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS(4/33),KEGG_MELANOGENESIS(6/102),KEGG_GLIOMA(5/65),BIOCARTA_AT1R_PATHWAY(4/36),REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII(3/15),REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS(4/37),BIOCARTA_CACAM_PATHWAY(3/16),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(6/126),REACTOME_IMMUNE_SYSTEM(18/933),REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL(6/137),REACTOME_DARPP_32_EVENTS(3/25),BIOCARTA_PGC1A_PATHWAY(3/26),KEGG_GNRH_SIGNALING_PATHWAY(5/101),REACTOME_SIGNALING_BY_ERBB2(5/101)
CAMK2A	TH34_1412_S01	v8		lowstringency_pd_outliers	KEGG_ERBB_SIGNALING_PATHWAY(8/87),PID_TGFBR_PATHWAY(7/55),BIOCARTA_CREB_PATHWAY(5/27),REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR(4/17),ST_WNT_CA2_CYCLIC_GMP_PATHWAY(4/20),BIOCARTA_BIOPEPTIDES_PATHWAY(5/45),REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS(4/27),PID_NETRIN_PATHWAY(4/32),REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS(4/33),KEGG_MELANOGENESIS(6/102),KEGG_GLIOMA(5/65),REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII(3/15),REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS(4/37),KEGG_WNT_SIGNALING_PATHWAY(7/151),BIOCARTA_CACAM_PATHWAY(3/16),PID_IFNG_PATHWAY(4/40),BIOCARTA_STATHMIN_PATHWAY(3/19),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(6/126),REACTOME_IMMUNE_SYSTEM(18/933),REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL(6/137),PID_FGF_PATHWAY(4/55),BIOCARTA_PGC1A_PATHWAY(3/26),KEGG_GNRH_SIGNALING_PATHWAY(5/101),REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS(3/28),REACTOME_INTERFERON_GAMMA_SIGNALING(4/63),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(8/270)
CAMK2B	TH34_1412_S01	v8		lowstringency_pd_outliers	KEGG_ERBB_SIGNALING_PATHWAY(8/87),BIOCARTA_CREB_PATHWAY(5/27),REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR(4/17),ST_WNT_CA2_CYCLIC_GMP_PATHWAY(4/20),BIOCARTA_BIOPEPTIDES_PATHWAY(5/45),REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS(4/27),REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS(4/33),KEGG_MELANOGENESIS(6/102),KEGG_GLIOMA(5/65),REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII(3/15),REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS(4/37),KEGG_WNT_SIGNALING_PATHWAY(7/151),BIOCARTA_CACAM_PATHWAY(3/16),PID_IFNG_PATHWAY(4/40),BIOCARTA_STATHMIN_PATHWAY(3/19),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(6/126),REACTOME_IMMUNE_SYSTEM(18/933),REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL(6/137),BIOCARTA_PGC1A_PATHWAY(3/26),KEGG_GNRH_SIGNALING_PATHWAY(5/101),REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS(3/28),REACTOME_INTERFERON_GAMMA_SIGNALING(4/63),PID_RAS_PATHWAY(3/30),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(8/270)
CAPN5	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(8/200)
CBLL1	TH34_1412_S01	v8		lowstringency_pd_outliers	PID_AJDISS_2PATHWAY(4/48)
CBLN1	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(20/753)
CBWD1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CCDC40	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CCDC68	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CCK	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(6/158)
CCL25	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(20/753)
CCNK	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CDH1	TH34_1412_S01	v8		lowstringency_pd_outliers	KEGG_ENDOMETRIAL_CANCER(7/52),PID_CDC42_PATHWAY(7/70),KEGG_ADHERENS_JUNCTION(7/75),PID_ECADHERIN_NASCENT_AJ_PATHWAY(5/39),PID_ECADHERIN_STABILIZATION_PATHWAY(5/42),HALLMARK_ESTROGEN_RESPONSE_LATE(9/200),HALLMARK_APICAL_JUNCTION(9/200),PID_MET_PATHWAY(6/80),REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS(4/27),PID_NECTIN_PATHWAY(4/30),REACTOME_CELL_CELL_JUNCTION_ORGANIZATION(5/56),KEGG_CELL_ADHESION_MOLECULES_CAMS(7/134),KEGG_PATHWAYS_IN_CANCER(10/328),REACTOME_CELL_JUNCTION_ORGANIZATION(5/78),REACTOME_CELL_CELL_COMMUNICATION(6/120),PID_A6B1_A6B4_INTEGRIN_PATHWAY(4/46),PID_AJDISS_2PATHWAY(4/48),REACTOME_IMMUNE_SYSTEM(18/933),HALLMARK_TGF_BETA_SIGNALING(4/54),PID_RAC1_PATHWAY(4/54),PID_FGF_PATHWAY(4/55),KEGG_THYROID_CANCER(3/29)
CDH4	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),HALLMARK_APICAL_JUNCTION(9/200),REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS(4/27),REACTOME_CELL_CELL_JUNCTION_ORGANIZATION(5/56),KEGG_CELL_ADHESION_MOLECULES_CAMS(7/134),REACTOME_CELL_JUNCTION_ORGANIZATION(5/78),REACTOME_CELL_CELL_COMMUNICATION(6/120)
CELSR1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CELSR3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CERS4	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CH17-232I21.1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CH507-254M2.1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CH507-513H4.1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CH507-528H12.1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CHD2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CHD3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CHD8	TH34_1412_S01	v8		lowstringency_pd_outliers	KEGG_WNT_SIGNALING_PATHWAY(7/151)
CHI3L1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CHRNA4	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL(6/137)
CIZ1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CLDN3	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION(5/56),KEGG_CELL_ADHESION_MOLECULES_CAMS(7/134),HALLMARK_GLYCOLYSIS(8/200),REACTOME_CELL_JUNCTION_ORGANIZATION(5/78),REACTOME_CELL_CELL_COMMUNICATION(6/120)
CLK3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CLNS1A	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(7/200)
CLPTM1L	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CLSTN3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CMTM4	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CNOT3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
COG5	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
COL20A1	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028)
COL23A1	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028)
CP	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CPLX1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CPSF7	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CRTC1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CRTC2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CRTC3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CTD-2007L18.5	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-2193P3.2	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-2547H18.1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-3193O13.11	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTNNA1	TH34_1412_S01	v8		lowstringency_pd_outliers	KEGG_ENDOMETRIAL_CANCER(7/52),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),PID_CDC42_PATHWAY(7/70),KEGG_ADHERENS_JUNCTION(7/75),PID_ECADHERIN_NASCENT_AJ_PATHWAY(5/39),PID_ECADHERIN_STABILIZATION_PATHWAY(5/42),HALLMARK_APICAL_JUNCTION(9/200),PID_MET_PATHWAY(6/80),REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS(4/27),PID_NECTIN_PATHWAY(4/30),REACTOME_CELL_CELL_JUNCTION_ORGANIZATION(5/56),KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC(5/76),KEGG_PATHWAYS_IN_CANCER(10/328),REACTOME_CELL_JUNCTION_ORGANIZATION(5/78),REACTOME_CELL_CELL_COMMUNICATION(6/120),PID_AJDISS_2PATHWAY(4/48),PID_RAC1_PATHWAY(4/54)
CTTNBP2NL	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CWC27	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
CXXC4	TH34_1412_S01	v8		lowstringency_pd_outliers	KEGG_WNT_SIGNALING_PATHWAY(7/151),WNT_SIGNALING(5/89)
CYP2S1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
DDX18	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(7/200)
DDX5	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
DDX6	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
DHX16	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(9/200)
DIS3L2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
DLX1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
DNAJB6	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
DPCD	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
DPF1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
DPP6	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
DROSHA	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
DYNC2LI1	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(18/933)
ECEL1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
EFHD1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
EHF	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
EHMT1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
EIF2B1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
EIF4G2	TH34_1412_S01	v8		lowstringency_pd_outliers	BIOCARTA_EIF4_PATHWAY(4/24),BIOCARTA_MTOR_PATHWAY(3/23),REACTOME_IMMUNE_SYSTEM(18/933),HALLMARK_MYC_TARGETS_V1(7/200),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(8/270)
EMC6	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ENTPD6	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
EPCAM	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(6/158)
EPM2AIP1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
EPS8L1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ERBB2	TH34_1412_S01	v8	CAPECITABINE,TYKERB,Capecitabine,MUBRITINIB,T-DM1,HERCEPTIN,Afatinib,ADO-TRASTUZUMAB EMTANSINE,trastuzumab,TAK165,AC480,TRASTUZUMAB EMTANSINE,HKI-272,Poziotinib,BMS-690514,CANERTINIB,BIBW 2992,Neratinib,Gefitinib,GW2016,PICTILISIB,IRINOTECAN,AEE788,DOCETAXEL,Lapatinib,ARRY-380,IRESSA,XL647,Trastuzumab emtansine,poziotinib,AEE-788,PLATINUM,Docetaxel,Canertinib,TESEVATINIB,BMS-599626,Ado-trastuzumab emtansine,LAPATINIB,PERTUZUMAB,Trastuzumab,Dacomitinib,AC-480,RAPAMYCIN (SIROLIMUS),trastuzumab emtansine,Cetuximab,CETUXIMAB,GDC-0941,NERATINIB,LAPATINIB DITOSYLATE,Pertuzumab,GEFITINIB,AFATINIB,Irbinitinib,TRASTUZUMAB,DACOMITINIB,Ado-Trastuzumab Emtansine,ARRY380,POZIOTINIB,PELITINIB	lowstringency_pd_outliers	KEGG_ERBB_SIGNALING_PATHWAY(8/87),KEGG_ENDOMETRIAL_CANCER(7/52),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),KEGG_ADHERENS_JUNCTION(7/75),KEGG_FOCAL_ADHESION(9/201),REACTOME_AXON_GUIDANCE(10/251),KEGG_PATHWAYS_IN_CANCER(10/328),PID_A6B1_A6B4_INTEGRIN_PATHWAY(4/46),REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING(3/22),KEGG_PROSTATE_CANCER(5/89),REACTOME_SIGNALING_BY_ERBB2(5/101)
ERBB2IP	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ERP27	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ESRP1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ESRP2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ESYT2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
FAM103A2P	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
FAM111A	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
FAM124A	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
FAM132A	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
FAM133B	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
FAM153A	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
FAM153B	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
FAM189A1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
FAM193B	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
FAM214A	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FBRS	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
FBXO38	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
FBXW4	TH34_1412_S01	v8		lowstringency_pd_outliers	WNT_SIGNALING(5/89)
FCHO2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
FIP1L1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
FKBP2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
FOXA2	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396)
FOXC2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
FOXJ3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
FOXL1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
FTCD	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
FTCD-AS1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GAL	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(9/200),HALLMARK_UV_RESPONSE_UP(6/158)
GALP	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
GCA	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
GCLC	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(8/200)
GIT1	TH34_1412_S01	v8		lowstringency_pd_outliers	PID_ECADHERIN_STABILIZATION_PATHWAY(5/42),PID_CDC42_REG_PATHWAY(3/30)
GJB2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
GJB6	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
GNRHR2P1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GSK3B	TH34_1412_S01	v8		lowstringency_pd_outliers	KEGG_ERBB_SIGNALING_PATHWAY(8/87),KEGG_ENDOMETRIAL_CANCER(7/52),PID_CDC42_PATHWAY(7/70),KEGG_FOCAL_ADHESION(9/201),BIOCARTA_NFAT_PATHWAY(5/56),KEGG_INSULIN_SIGNALING_PATHWAY(7/137),KEGG_MELANOGENESIS(6/102),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(5/67),KEGG_WNT_SIGNALING_PATHWAY(7/151),KEGG_PATHWAYS_IN_CANCER(10/328),BIOCARTA_IGF1MTOR_PATHWAY(3/20),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(6/126),KEGG_PROSTATE_CANCER(5/89),BIOCARTA_PTDINS_PATHWAY(3/23),WNT_SIGNALING(5/89),SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES(4/51),PID_KIT_PATHWAY(4/52),SIG_IL4RECEPTOR_IN_B_LYPHOCYTES(3/27),KEGG_COLORECTAL_CANCER(4/62),KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY(5/108)
GTF2IP1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
GUSBP3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
HACD3	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HDHD2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
HEXIM1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
HGFAC	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(20/753)
HHEX	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
HIBCH	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
HIPK2	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_TGF_BETA_SIGNALING(4/54)
HMGB1P1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
HNRNPR	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(7/200)
HOXB3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
HP09025	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HSD17B4	TH34_1412_S01	v8		lowstringency_pd_outliers	BIOCARTA_PPARA_PATHWAY(4/58)
HSPA9	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
HUWE1	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(18/933)
IGSF10	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028)
IL2RB	TH34_1412_S01	v8		lowstringency_pd_outliers	PID_SHP2_PATHWAY(5/58),BIOCARTA_IL2RB_PATHWAY(4/38),BIOCARTA_IL2_PATHWAY(3/22),REACTOME_IMMUNE_SYSTEM(18/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(8/270)
INSIG1	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(9/200),HALLMARK_ANDROGEN_RESPONSE(5/101)
INTS6	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
IQCG	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
IRX4	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ISM1	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(20/753)
ITGA6	TH34_1412_S01	v8		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(9/201),KEGG_CELL_ADHESION_MOLECULES_CAMS(7/134),KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC(5/76),KEGG_PATHWAYS_IN_CANCER(10/328),PID_A6B1_A6B4_INTEGRIN_PATHWAY(4/46),ST_INTEGRIN_SIGNALING_PATHWAY(5/82)
ITIH2	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(20/753),NABA_ECM_REGULATORS(8/238)
ITIH5	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(20/753),NABA_ECM_REGULATORS(8/238)
KCNT1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
KDM4B	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
KDR	TH34_1412_S01	v8	Vandetanib,RAF265,VANDETANIB,MGCD-265,PTK787/ZK 222584,SORAFENIB,BRIVANIB,XL880,CHIR-265,ABT-869,ENMD 2076,BMS-690514,CABOZANTINIB,ORANTINIB,Vatalanib,LENVATINIB,TESEVATINIB,Axitinib,SUNITINIB,TELATINIB,BAY-57-9352,FORETINIB,AEE788,X-82,ENMD-2076,MGCD265,Regorafenib,XL647,IMC-1121B,AEE-788,SU-6668,AXITINIB,Ponatinib,MIDOSTAURIN,PONATINIB,Sorafenib,Motesanib,1058137-23-7,PAZOPANIB,Nintedanib,CEDIRANIB,XL-820,Cabozantinib,MOTESANIB,RAMUCIRUMAB,VATALANIB,TIVOZANIB,Sunitinib,LINIFANIB,XL820,LUCITANIB,SORAFENIB TOSYLATE,Ramucirumab,E 7080,REGORAFENIB,NINTEDANIB,Lucitanib,Pazopanib	lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(9/201),PID_SHP2_PATHWAY(5/58),BIOCARTA_NO1_PATHWAY(4/33)
KIAA0319L	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
KIAA0355	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
KIAA0368	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
KIAA0430	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
KIAA1191	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
KLHL25	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
KLK6	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
KMT2C	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
KRT10	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
KRT8	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_ANDROGEN_RESPONSE(5/101)
KRTAP5-4	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
LARP1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
LEF1	TH34_1412_S01	v8		lowstringency_pd_outliers	KEGG_ENDOMETRIAL_CANCER(7/52),KEGG_ADHERENS_JUNCTION(7/75),KEGG_MELANOGENESIS(6/102),KEGG_WNT_SIGNALING_PATHWAY(7/151),KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC(5/76),KEGG_PATHWAYS_IN_CANCER(10/328),KEGG_PROSTATE_CANCER(5/89),WNT_SIGNALING(5/89),KEGG_ACUTE_MYELOID_LEUKEMIA(4/60),KEGG_COLORECTAL_CANCER(4/62),KEGG_THYROID_CANCER(3/29)
LEPROTL1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
LGALS2	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(20/753),NABA_ECM_AFFILIATED(7/171)
LGALS8	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(20/753),NABA_ECM_AFFILIATED(7/171)
LINC00165	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
LINC00261	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
LINC00684	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01002	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01420	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LL22NC03-N95F10.1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LLNLF-173C4.2	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LLNLF-176F2.1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LMO7	TH34_1412_S01	v8		lowstringency_pd_outliers	KEGG_ADHERENS_JUNCTION(7/75)
LOXL3	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(20/753),NABA_ECM_REGULATORS(8/238)
LRRC55	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
LSR	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(9/200)
MAL2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
MAML1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
MAP7	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_ANDROGEN_RESPONSE(5/101)
MAPK1IP1L	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
MAPK3	TH34_1412_S01	v8		lowstringency_pd_outliers	KEGG_ERBB_SIGNALING_PATHWAY(8/87),KEGG_ENDOMETRIAL_CANCER(7/52),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),PID_CDC42_PATHWAY(7/70),BIOCARTA_CREB_PATHWAY(5/27),KEGG_ADHERENS_JUNCTION(7/75),BIOCARTA_BIOPEPTIDES_PATHWAY(5/45),KEGG_FOCAL_ADHESION(9/201),BIOCARTA_EIF4_PATHWAY(4/24),REACTOME_AXON_GUIDANCE(10/251),PID_MET_PATHWAY(6/80),BIOCARTA_NFAT_PATHWAY(5/56),PID_PDGFRB_PATHWAY(7/129),BIOCARTA_PYK2_PATHWAY(4/31),PID_NETRIN_PATHWAY(4/32),KEGG_INSULIN_SIGNALING_PATHWAY(7/137),KEGG_MELANOGENESIS(6/102),KEGG_GLIOMA(5/65),BIOCARTA_AT1R_PATHWAY(4/36),BIOCARTA_IL2RB_PATHWAY(4/38),PID_EPHB_FWD_PATHWAY(4/40),PID_IFNG_PATHWAY(4/40),BIOCARTA_PTEN_PATHWAY(3/18),KEGG_PATHWAYS_IN_CANCER(10/328),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(6/126),BIOCARTA_IL2_PATHWAY(3/22),REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING(3/22),REACTOME_L1CAM_INTERACTIONS(5/86),KEGG_PROSTATE_CANCER(5/89),BIOCARTA_IGF1R_PATHWAY(3/23),SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES(4/51),REACTOME_IMMUNE_SYSTEM(18/933),PID_KIT_PATHWAY(4/52),SA_B_CELL_RECEPTOR_COMPLEXES(3/24),PID_FGF_PATHWAY(4/55),BIOCARTA_PPARA_PATHWAY(4/58),SIG_IL4RECEPTOR_IN_B_LYPHOCYTES(3/27),KEGG_GNRH_SIGNALING_PATHWAY(5/101),KEGG_ACUTE_MYELOID_LEUKEMIA(4/60),REACTOME_SIGNALING_BY_ERBB2(5/101),KEGG_COLORECTAL_CANCER(4/62),KEGG_THYROID_CANCER(3/29),PID_ERBB1_DOWNSTREAM_PATHWAY(5/105),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(8/270),KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY(5/108)
MATR3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
MBD4	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
MERTK	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(8/200),HALLMARK_ANDROGEN_RESPONSE(5/101)
MIA3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
MILR1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
MLLT10	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
MLLT4	TH34_1412_S01	v8		lowstringency_pd_outliers	KEGG_ADHERENS_JUNCTION(7/75),PID_ECADHERIN_NASCENT_AJ_PATHWAY(5/39),PID_ECADHERIN_STABILIZATION_PATHWAY(5/42),PID_NECTIN_PATHWAY(4/30),PID_PDGFRB_PATHWAY(7/129),PID_SHP2_PATHWAY(5/58)
MLLT6	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
MLXIP	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
MNT	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
MOB2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
MSLN	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
MT-ATP8	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND2	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTATP6P1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTERF4	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTRR	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
MUC2	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(20/753),NABA_ECM_AFFILIATED(7/171),REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS(3/24),REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS(4/59)
MUC6	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(20/753),NABA_ECM_AFFILIATED(7/171),REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS(3/24),REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS(4/59)
MYO16	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
NACC1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
NCOA2	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396)
NECAP1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
NEDD1	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES(4/59)
NEDD4L	TH34_1412_S01	v8		lowstringency_pd_outliers	PID_TGFBR_PATHWAY(7/55)
NGB	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
NMT1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
NOLC1	TH34_1412_S01	v8		lowstringency_pd_outliers	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(5/67),HALLMARK_MYC_TARGETS_V1(7/200)
NOMO3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
NRXN1	TH34_1412_S01	v8		lowstringency_pd_outliers	KEGG_CELL_ADHESION_MOLECULES_CAMS(7/134)
NSMF	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NT5C2	TH34_1412_S01	v8	6-THIOGUANINE,6-MERCAPTOPURINE	lowstringency_pd_outliers	NA
NTNG2	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028)
NUFIP2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
NUMB	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(10/251),PID_MET_PATHWAY(6/80),REACTOME_L1CAM_INTERACTIONS(5/86)
ONECUT3	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396)
OSBPL9	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PABPC1L2B-AS1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PABPN1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PAK1	TH34_1412_S01	v8		lowstringency_pd_outliers	KEGG_ERBB_SIGNALING_PATHWAY(8/87),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),PID_CDC42_PATHWAY(7/70),KEGG_FOCAL_ADHESION(9/201),REACTOME_AXON_GUIDANCE(10/251),PID_MET_PATHWAY(6/80),PID_PDGFRB_PATHWAY(7/129),BIOCARTA_PYK2_PATHWAY(4/31),PID_NETRIN_PATHWAY(4/32),BIOCARTA_AT1R_PATHWAY(4/36),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(5/67),PID_EPHB_FWD_PATHWAY(4/40),PID_EPHA2_FWD_PATHWAY(3/19),REACTOME_CELL_CELL_COMMUNICATION(6/120),ST_INTEGRIN_SIGNALING_PATHWAY(5/82),REACTOME_L1CAM_INTERACTIONS(5/86),REACTOME_IMMUNE_SYSTEM(18/933),PID_RAC1_PATHWAY(4/54),KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY(5/108)
PANK1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PAPLN	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028)
PCDHB14	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PCDHB5	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PCGF2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PCNX	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PDE8B	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PDK2	TH34_1412_S01	v8		lowstringency_pd_outliers	BIOCARTA_EIF4_PATHWAY(4/24),BIOCARTA_PTEN_PATHWAY(3/18),BIOCARTA_IGF1MTOR_PATHWAY(3/20),BIOCARTA_MTOR_PATHWAY(3/23)
PHLDB3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PIAS1	TH34_1412_S01	v8		lowstringency_pd_outliers	PID_IFNG_PATHWAY(4/40),KEGG_PATHWAYS_IN_CANCER(10/328),REACTOME_IMMUNE_SYSTEM(18/933),HALLMARK_ANDROGEN_RESPONSE(5/101),REACTOME_INTERFERON_GAMMA_SIGNALING(4/63),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(8/270)
PLB1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PLCH2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PLEKHA6	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PLK5	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PNCK	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
POLG2	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(6/158)
POM121C	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
POMT2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PPAPDC2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PPIP5K2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PPP1R1B	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_DARPP_32_EVENTS(3/25)
PPP2R2A	TH34_1412_S01	v8		lowstringency_pd_outliers	PID_TGFBR_PATHWAY(7/55),BIOCARTA_CHREBP2_PATHWAY(4/42),PID_ERBB1_DOWNSTREAM_PATHWAY(5/105)
PPP2R2C	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(9/200),BIOCARTA_CHREBP2_PATHWAY(4/42)
PPP6R3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PRG4	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028)
PRICKLE4	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PRKAB1	TH34_1412_S01	v8		lowstringency_pd_outliers	KEGG_INSULIN_SIGNALING_PATHWAY(7/137),BIOCARTA_CHREBP2_PATHWAY(4/42)
PRKAR2B	TH34_1412_S01	v8		lowstringency_pd_outliers	BIOCARTA_CREB_PATHWAY(5/27),HALLMARK_ESTROGEN_RESPONSE_LATE(9/200),BIOCARTA_NFAT_PATHWAY(5/56),KEGG_INSULIN_SIGNALING_PATHWAY(7/137),BIOCARTA_NO1_PATHWAY(4/33),BIOCARTA_CHREBP2_PATHWAY(4/42),BIOCARTA_STATHMIN_PATHWAY(3/19),BIOCARTA_IGF1R_PATHWAY(3/23),REACTOME_DARPP_32_EVENTS(3/25),BIOCARTA_PPARA_PATHWAY(4/58),REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES(4/59),REACTOME_SIGNALING_BY_ERBB2(5/101)
PRR36	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PRR5L	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PSIP1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PTPRN2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PTPRQ	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
PUM1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
R3HDM2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
RAB18	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
RAB6A	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
RAB7A	TH34_1412_S01	v8		lowstringency_pd_outliers	PID_AJDISS_2PATHWAY(4/48),REACTOME_IMMUNE_SYSTEM(18/933)
RAB8B	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
RAD17	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
RAP1GAP2	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(18/933)
RAPGEF2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
RASGRF2	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR(4/17),PID_RAC1_REG_PATHWAY(5/38),REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS(4/27),REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS(4/33),REACTOME_ACTIVATION_OF_NMDA_RECEPTOR_UPON_GLUTAMATE_BINDING_AND_POSTSYNAPTIC_EVENTS(4/37),ST_INTEGRIN_SIGNALING_PATHWAY(5/82),REACTOME_NEUROTRANSMITTER_RECEPTOR_BINDING_AND_DOWNSTREAM_TRANSMISSION_IN_THE_POSTSYNAPTIC_CELL(6/137),PID_RAS_PATHWAY(3/30)
RBFOX3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
RBM12	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
REXO1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
RFC1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
RFC5	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
RGS12	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
RGS5	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
RIC8B	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
RNPC3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
RP1-172N19.5	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP1-69M21.2	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-1277A3.2	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-158M2.3	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-242D8.3	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-417N10.4	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-423H2.1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-497H16.5	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-554I8.1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-61A14.1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-69E11.4	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-844P9.2	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-613B23.5	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RPL23AP3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
RPL29P11	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RPS6KB1	TH34_1412_S01	v8		lowstringency_pd_outliers	KEGG_ERBB_SIGNALING_PATHWAY(8/87),PID_TGFBR_PATHWAY(7/55),PID_CDC42_PATHWAY(7/70),BIOCARTA_EIF4_PATHWAY(4/24),BIOCARTA_NFAT_PATHWAY(5/56),KEGG_INSULIN_SIGNALING_PATHWAY(7/137),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(5/67),BIOCARTA_IL2RB_PATHWAY(4/38),BIOCARTA_IGF1MTOR_PATHWAY(3/20),PID_A6B1_A6B4_INTEGRIN_PATHWAY(4/46),BIOCARTA_MTOR_PATHWAY(3/23),BIOCARTA_PTDINS_PATHWAY(3/23),SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES(4/51),PID_KIT_PATHWAY(4/52),KEGG_ACUTE_MYELOID_LEUKEMIA(4/60)
RSRC1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
RSRC2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
RTP5	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SCAMP1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SCAP	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SDC3	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(20/753),HALLMARK_APICAL_JUNCTION(9/200),KEGG_CELL_ADHESION_MOLECULES_CAMS(7/134),HALLMARK_GLYCOLYSIS(8/200),NABA_ECM_AFFILIATED(7/171)
SDCCAG8	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES(4/59)
SENP2	TH34_1412_S01	v8		lowstringency_pd_outliers	KEGG_WNT_SIGNALING_PATHWAY(7/151),WNT_SIGNALING(5/89)
SEPT3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SERINC5	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SERPINB1	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(20/753),NABA_ECM_REGULATORS(8/238)
SERPINB9	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(20/753),NABA_ECM_REGULATORS(8/238)
SF3A1	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(7/200)
SIMC1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SLC19A1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SLC22A23	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SLC25A27	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SLC26A6	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SLC6A13	TH34_1412_S01	v8		lowstringency_pd_outliers	ST_WNT_CA2_CYCLIC_GMP_PATHWAY(4/20)
SLC7A1	TH34_1412_S01	v8		lowstringency_pd_outliers	BIOCARTA_NO1_PATHWAY(4/33)
SLC8A2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SLFN13	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SLITRK2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SLTM	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SMN1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SMN2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SMPDL3B	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SMURF2	TH34_1412_S01	v8		lowstringency_pd_outliers	PID_TGFBR_PATHWAY(7/55),REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY(3/20),REACTOME_IMMUNE_SYSTEM(18/933),HALLMARK_TGF_BETA_SIGNALING(4/54)
SNAP29	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SNORA22	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SNORA51	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SOS1	TH34_1412_S01	v8		lowstringency_pd_outliers	KEGG_ERBB_SIGNALING_PATHWAY(8/87),KEGG_ENDOMETRIAL_CANCER(7/52),PID_TGFBR_PATHWAY(7/55),REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),BIOCARTA_CREB_PATHWAY(5/27),PID_RAC1_REG_PATHWAY(5/38),BIOCARTA_BIOPEPTIDES_PATHWAY(5/45),KEGG_FOCAL_ADHESION(9/201),REACTOME_AXON_GUIDANCE(10/251),PID_MET_PATHWAY(6/80),PID_PDGFRB_PATHWAY(7/129),BIOCARTA_PYK2_PATHWAY(4/31),PID_SHP2_PATHWAY(5/58),KEGG_INSULIN_SIGNALING_PATHWAY(7/137),KEGG_GLIOMA(5/65),BIOCARTA_AT1R_PATHWAY(4/36),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(5/67),BIOCARTA_IL2RB_PATHWAY(4/38),BIOCARTA_PTEN_PATHWAY(3/18),KEGG_PATHWAYS_IN_CANCER(10/328),ST_INTEGRIN_SIGNALING_PATHWAY(5/82),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(6/126),BIOCARTA_IL2_PATHWAY(3/22),REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING(3/22),KEGG_PROSTATE_CANCER(5/89),BIOCARTA_IGF1R_PATHWAY(3/23),SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES(4/51),REACTOME_IMMUNE_SYSTEM(18/933),PID_KIT_PATHWAY(4/52),SA_B_CELL_RECEPTOR_COMPLEXES(3/24),PID_FGF_PATHWAY(4/55),SIG_IL4RECEPTOR_IN_B_LYPHOCYTES(3/27),KEGG_GNRH_SIGNALING_PATHWAY(5/101),KEGG_ACUTE_MYELOID_LEUKEMIA(4/60),REACTOME_SIGNALING_BY_ERBB2(5/101),PID_ERBB1_DOWNSTREAM_PATHWAY(5/105),PID_RAS_PATHWAY(3/30),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(8/270),KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY(5/108)
SOX2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SOX21	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SPATA13	TH34_1412_S01	v8		lowstringency_pd_outliers	PID_RAC1_REG_PATHWAY(5/38),PID_CDC42_REG_PATHWAY(3/30)
SPATC1L	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SPINT1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SPTLC1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SRPK1	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(7/200)
SRSF5	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SSTR3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ST14	TH34_1412_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(26/1028),NABA_MATRISOME_ASSOCIATED(20/753),HALLMARK_ESTROGEN_RESPONSE_LATE(9/200),NABA_ECM_REGULATORS(8/238)
ST3GAL3	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS(3/24),REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS(4/59)
STK24	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SUMO1	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(18/933),REACTOME_INTERFERON_GAMMA_SIGNALING(4/63),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(8/270)
SUOX	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SYBU	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
SYNJ1	TH34_1412_S01	v8		lowstringency_pd_outliers	PID_EPHB_FWD_PATHWAY(4/40)
Six3os1_2	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TC2N	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
TCP11L2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
TF	TH34_1412_S01	v8		lowstringency_pd_outliers	ST_WNT_CA2_CYCLIC_GMP_PATHWAY(4/20),PID_EPHB_FWD_PATHWAY(4/40)
TGFBR3L	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TGIF2	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY(3/20)
TH	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(9/200)
THOC3	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
TMCO6	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
TMEM2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
TMEM63C	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
TMEM8B	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(9/200)
TOR4A	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TP53BP2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
TRIM24	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
TRIM29	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(9/200)
TRIM33	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY(3/20),HALLMARK_TGF_BETA_SIGNALING(4/54)
TRIM67	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
TRPM2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
TTC13	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
TTC8	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
TUBB2A	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
TUBB4B	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES(4/59)
TUBB8P12	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TUBBP5	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
TUSC1	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
TYRO3	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(6/158)
UBAP2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
UBAP2L	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
UBE2E2	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(18/933)
UNC5A	TH34_1412_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(15/396),REACTOME_AXON_GUIDANCE(10/251),PID_NETRIN_PATHWAY(4/32)
UNC5B-AS1	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
UNCX	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
UQCR10	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
USP10	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
USP53	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
USP54	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
VAV2	TH34_1412_S01	v8		lowstringency_pd_outliers	PID_CDC42_PATHWAY(7/70),PID_RAC1_REG_PATHWAY(5/38),PID_ECADHERIN_NASCENT_AJ_PATHWAY(5/39),HALLMARK_APICAL_JUNCTION(9/200),KEGG_FOCAL_ADHESION(9/201),PID_NECTIN_PATHWAY(4/30),PID_PDGFRB_PATHWAY(7/129),PID_EPHA2_FWD_PATHWAY(3/19),BIOCARTA_PTDINS_PATHWAY(3/23),SA_B_CELL_RECEPTOR_COMPLEXES(3/24),PID_ERBB1_DOWNSTREAM_PATHWAY(5/105),PID_CDC42_REG_PATHWAY(3/30),KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY(5/108)
VIPAS39	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
WDR11	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
WDR60	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
WIPF2	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
WIZ	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(6/158)
XKR8	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
XXbac-BPG252P9.9	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
Y_RNA	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZDHHC22	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ZFR	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ZFYVE16	TH34_1412_S01	v8		lowstringency_pd_outliers	PID_TGFBR_PATHWAY(7/55)
ZMYND11	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ZNF189	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ZNF292	TH34_1412_S01	v8		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(8/200)
ZNF444	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ZNF641	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ZNF644	TH34_1412_S01	v8		lowstringency_pd_outliers	NA
ZNF815P	TH34_1412_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC066694.1	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
AGAP2-AS1	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
AKR7A3	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
AL109927.1	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
AL132780.1	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
AL662801.1	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
ANKRD52	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
ANKRD6	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
AP003041.1	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
ARHGEF25	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
ARMCX6	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CCER2	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CDK4	TH34_1414_S01	v8	CS1229,Ribociclib,PD 0332991,ALVOCIDIB,Flavopiridol,Abemaciclib,PALBOCICLIB (PD0332991),PD-0332991,PD-332991,LY2835219,ABEMACICLIB,Roniciclib,Palbociclib,LEE011,CID 5330286,RIBOCICLIB,BAY1000394,PD0332991,PALBOCICLIB	lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CELA2B	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CNPY2	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
COQ10A	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CPA4	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CS	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CSAG1	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CSAG3	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CTAG1A	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CTAG1B	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CTAG2	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
CTD-2314G24.2	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
DAPL1	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
DCTN1	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
DCTN2	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
DDIT3	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
DRGX	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
DTX3	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
DYNLRB1	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
EIF3I	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
EPHA8	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
EXOC7	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
FAM110A	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
FAM127B	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
FAM192A	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
FAM200B	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
GNB1	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
GOLGA7	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
GRM2	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
IGHV1-18	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
IGHV3-49	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
IGHV4-59	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
IGHV6-1	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
IGKV1-27	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
IGLV1-44	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
KCND3	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
KIAA0556	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
KIF19	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
KIZ	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
LA16c-312E8.4	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
LINC01082	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
MAPK1IP1L	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
MARCH9	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
MBD6	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
ME2	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
METTL1	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
METTL21B	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
MIEN1	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
MT-ATP8	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
MTND2P28	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
MYL6	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
NABP2	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
NEAT1_2	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
NEK6	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
NMT1	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
NOS1	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
NUTF2	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
OST4	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
PAN2	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
PDZD11	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
PEA15	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
PIP4K2C	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
PIPOX	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
PLEKHH1	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
PRDM12	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
PRL	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
PSMB2	TH34_1414_S01	v8	BORTEZOMIB,CARFILZOMIB,Carfilzomib	lowstringency_pd_outliers	NO_OVERLAPS_FOUND
RBMX2	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
RN7SK	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
RNF41	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
RNU6-112P	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
RP11-478C6.4	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
RP11-632C17__A.1	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
RP11-977G19.5	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
SH2D5	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
SLC6A1	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
SLC6A3	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
SMARCC2	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
SNAP29	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
SNHG25	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
STAT2	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
THY1	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
TMSB10	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
TPGS2	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
TSFM	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
TSPAN31	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
TTC39C	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
TUBGCP3	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
ZDHHC22	TH34_1414_S01	v8		lowstringency_pd_outliers	NO_OVERLAPS_FOUND
ABCC8	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
ABTB1	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
ADAMTS10	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),NABA_ECM_REGULATORS(8/238)
ADD3	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
ADGRA2	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADGRB1	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AGER	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
AL132780.1	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL662801.1	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ANGPT2	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),NABA_SECRETED_FACTORS(7/344),REACTOME_HEMOSTASIS(7/466)
AP003041.1	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AP1M2	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
BCHE	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
BCL2A1	TH34_1415_S01	v8		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(7/200)
C5orf46	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
CBLN2	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),NABA_SECRETED_FACTORS(7/344)
CCAR1	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
CCDC3	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
CCDC80	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
CCL18	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(8/267),NABA_SECRETED_FACTORS(7/344)
CEMIP	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CH17-232I21.1	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CLDN7	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
CLEC11A	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),NABA_ECM_AFFILIATED(9/171)
COL5A3	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(4/87),KEGG_FOCAL_ADHESION(5/201),REACTOME_COLLAGEN_FORMATION(3/58)
COL9A1	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(4/87),REACTOME_COLLAGEN_FORMATION(3/58)
COLEC11	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),NABA_ECM_AFFILIATED(9/171)
CRH	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
CROCC	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
CSF3R	TH34_1415_S01	v8		lowstringency_pd_outliers	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(8/267),HALLMARK_INFLAMMATORY_RESPONSE(7/200),HALLMARK_IL6_JAK_STAT3_SIGNALING(4/87)
CTB-134H23.3	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-2308N23.2	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-3214H19.16	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTSL	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),NABA_ECM_REGULATORS(8/238)
CXCL17	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
CXCL2	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(8/267),HALLMARK_TNFA_SIGNALING_VIA_NFKB(7/200),NABA_SECRETED_FACTORS(7/344),HALLMARK_UV_RESPONSE_UP(5/158)
CXCL8	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),NABA_SECRETED_FACTORS(7/344)
CYGB	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
DIO3	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
DIO3OS	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
DLK1	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
DLL4	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
EHD3	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
EME2	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
ETV4	TH34_1415_S01	v8	TRAMETINIB	lowstringency_pd_outliers	NA
ETV5	TH34_1415_S01	v8	TRAMETINIB	lowstringency_pd_outliers	NA
EVA1B	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FAM213A	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FBP1	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
FLRT2	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
FLT4	TH34_1415_S01	v8	MGCD265,MGCD-265,SORAFENIB,MOTESANIB,ABT-869,ENMD 2076,ORANTINIB,Vatalanib,LENVATINIB,TESEVATINIB,Axitinib,SUNITINIB,TELATINIB,FORETINIB,ENMD-2076,Regorafenib,XL647,LUCITANIB,AXITINIB,X-82,Sorafenib,PAZOPANIB,Nintedanib,VATALANIB,VANDETANIB,TIVOZANIB,Sunitinib,LINIFANIB,SORAFENIB TOSYLATE,1058137-23-7,REGORAFENIB,NINTEDANIB,Pazopanib	lowstringency_pd_outliers	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(8/267),KEGG_FOCAL_ADHESION(5/201),PID_VEGF_VEGFR_PATHWAY(2/10),REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS(2/10)
GK	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
HBA1	TH34_1415_S01	v8		lowstringency_pd_outliers	BIOCARTA_AHSP_PATHWAY(3/13)
HBA2	TH34_1415_S01	v8		lowstringency_pd_outliers	BIOCARTA_AHSP_PATHWAY(3/13)
HBB	TH34_1415_S01	v8		lowstringency_pd_outliers	BIOCARTA_AHSP_PATHWAY(3/13),REACTOME_HEMOSTASIS(7/466)
HBG2	TH34_1415_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(7/466)
HMOX1	TH34_1415_S01	v8	SUNITINIB,SORAFENIB	lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(5/158),HALLMARK_IL6_JAK_STAT3_SIGNALING(4/87)
HP	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
ICOSLG	TH34_1415_S01	v8		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(7/200),HALLMARK_INFLAMMATORY_RESPONSE(7/200)
IFFO1	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
IGHA2	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
IGHV3-7	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
IGKV1D-13	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
IGLC7	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
IGLV2-8	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
IL6	TH34_1415_S01	v8	SILTUXIMAB,Siltuximab	lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200),KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(8/267),HALLMARK_TNFA_SIGNALING_VIA_NFKB(7/200),HALLMARK_INFLAMMATORY_RESPONSE(7/200),NABA_SECRETED_FACTORS(7/344),HALLMARK_UV_RESPONSE_UP(5/158),HALLMARK_IL6_JAK_STAT3_SIGNALING(4/87)
KCNJ8	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
KIZ	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
KLF2	TH34_1415_S01	v8		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(7/200)
KRT19	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
LA16c-361A3.3	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LAMA4	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),KEGG_FOCAL_ADHESION(5/201)
LINC01164	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01272	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01393	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LOXL2	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200),NABA_ECM_REGULATORS(8/238)
LUC7L3	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
LXN	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
MAP2	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
MAPK8IP3	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
MARCO	TH34_1415_S01	v8		lowstringency_pd_outliers	HALLMARK_INFLAMMATORY_RESPONSE(7/200)
MCC	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
MEG3	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
MIR671	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MIRLET7D	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
MMP12	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),NABA_ECM_REGULATORS(8/238)
MMP23B	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),NABA_ECM_REGULATORS(8/238)
MT-ATP6	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND4	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTATP6P1	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MYBPC2	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
NAPSA	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
NDUFA4L2	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
NEAT1_2	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NID2	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200)
NMT1	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
NPIPB3	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB4	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPTX2	TH34_1415_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(5/158)
PCDH18	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
PCSK6	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),NABA_ECM_REGULATORS(8/238)
PDE8B	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
PEAR1	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
PHLDA2	TH34_1415_S01	v8		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(7/200)
PITPNC1	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
PLA2G2A	TH34_1415_S01	v8		lowstringency_pd_outliers	HALLMARK_IL6_JAK_STAT3_SIGNALING(4/87)
PLAC9	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
PLOD1	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200),NABA_ECM_REGULATORS(8/238),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(4/87),REACTOME_COLLAGEN_FORMATION(3/58)
PLXDC1	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),NABA_ECM_AFFILIATED(9/171)
POLE	TH34_1415_S01	v8	PEMBROLIZUMAB	lowstringency_pd_outliers	NA
PPP1R12A	TH34_1415_S01	v8		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(5/201)
PTGIR	TH34_1415_S01	v8		lowstringency_pd_outliers	HALLMARK_INFLAMMATORY_RESPONSE(7/200),REACTOME_HEMOSTASIS(7/466)
PTGIS	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
PTX3	TH34_1415_S01	v8		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200),HALLMARK_TNFA_SIGNALING_VIA_NFKB(7/200)
RGS4	TH34_1415_S01	v8		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200)
RGS5	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
ROBO1	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
RP11-1212A22.4	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-166D19.1	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-323N12.5	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-343H5.4	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-82L18.2	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-765C7.2	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SCARA5	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
SCGB1A1	TH34_1415_S01	v8		lowstringency_pd_outliers	PID_HNF3A_PATHWAY(4/44)
SCGB3A2	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
SEPT4	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
SFTA2	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),NABA_ECM_AFFILIATED(9/171)
SFTPA1	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),NABA_ECM_AFFILIATED(9/171),PID_HNF3A_PATHWAY(4/44)
SFTPA2	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),NABA_ECM_AFFILIATED(9/171),PID_HNF3A_PATHWAY(4/44)
SFTPB	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),NABA_ECM_AFFILIATED(9/171)
SFTPC	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),NABA_ECM_AFFILIATED(9/171)
SFTPD	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),NABA_ECM_AFFILIATED(9/171),PID_HNF3A_PATHWAY(4/44)
SHISA3	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
SLC11A1	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
SLC1A6	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
SLC26A6	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
SLC34A2	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
SNHG25	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
STAB1	TH34_1415_S01	v8		lowstringency_pd_outliers	HALLMARK_INFLAMMATORY_RESPONSE(7/200)
STXBP5-AS1	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SULT1A1	TH34_1415_S01	v8		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(5/158),KEGG_SULFUR_METABOLISM(2/13),REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES(2/14)
SULT1E1	TH34_1415_S01	v8		lowstringency_pd_outliers	KEGG_SULFUR_METABOLISM(2/13),REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES(2/14)
SYCE1L	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
TFPI2	TH34_1415_S01	v8		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200)
TIMP1	TH34_1415_S01	v8		lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200),NABA_ECM_REGULATORS(8/238),HALLMARK_INFLAMMATORY_RESPONSE(7/200),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(4/87),REACTOME_HEMOSTASIS(7/466)
TNFRSF11B	TH34_1415_S01	v8		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200),KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(8/267)
TNFRSF6B	TH34_1415_S01	v8		lowstringency_pd_outliers	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(8/267)
TREM1	TH34_1415_S01	v8		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(7/466)
TRH	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
UACA	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
VEGFC	TH34_1415_S01	v8	SORAFENIB TOSYLATE	lowstringency_pd_outliers	NABA_MATRISOME(28/1028),NABA_MATRISOME_ASSOCIATED(24/753),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200),KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(8/267),NABA_SECRETED_FACTORS(7/344),KEGG_FOCAL_ADHESION(5/201),REACTOME_HEMOSTASIS(7/466),PID_VEGF_VEGFR_PATHWAY(2/10),REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS(2/10)
VGF	TH34_1415_S01	v8		lowstringency_pd_outliers	NA
Y_RNA	TH34_1415_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AAAS	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_PROCESSING(26/161),REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(10/54),REACTOME_METABOLISM_OF_RNA(21/330),REACTOME_INTERFERON_SIGNALING(14/159)
AAK1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ABAT	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ABCD4	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ABCF3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ABI1	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(22/200),PID_PDGFRB_PATHWAY(16/129),PID_ERBB1_DOWNSTREAM_PATHWAY(13/105)
ABI2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ABI3BP	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
AC010641.1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC093838.4	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC138035.2	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACIN1	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(21/128)
ACOX2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ACP2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ACSF2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ACSF3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ACSS1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ADAM9	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(16/200)
ADCY9	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_SIGNALING_BY_PDGF(21/122),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(16/95),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(17/137),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(15/109),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(16/127),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(14/100),REACTOME_SIGNALING_BY_ERBB2(14/101),REACTOME_SIGNALING_BY_FGFR(14/112),PID_ENDOTHELIN_PATHWAY(10/63)
ADGRA3	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADGRF5	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADIPOR1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
AGAP3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
AHDC1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
AKAP17A	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
AKAP8L	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
AKT1	TH34_1444_S01	v8	Everolimus,MK-2206,GSK2126458,PERIFOSINE,AZD5363,AZD-5363,MK2206,IPATASERTIB,Vemurafenib,VEMURAFENIB,Perifosine,EVEROLIMUS,AZD4547,GDC-0068,Ipatasertib	lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_IMMUNE_SYSTEM(55/933),KEGG_PATHWAYS_IN_CANCER(32/328),REACTOME_SIGNALING_BY_PDGF(21/122),REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),PID_MET_PATHWAY(15/80),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(16/95),KEGG_ACUTE_MYELOID_LEUKEMIA(13/60),KEGG_PROSTATE_CANCER(15/89),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(13/67),PID_SMAD2_3NUCLEAR_PATHWAY(14/82),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(17/137),KEGG_FOCAL_ADHESION(20/201),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(16/126),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(15/109),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(16/127),REACTOME_SIGNALING_BY_SCF_KIT(13/78),KEGG_MTOR_SIGNALING_PATHWAY(11/52),ST_INTEGRIN_SIGNALING_PATHWAY(13/82),KEGG_INSULIN_SIGNALING_PATHWAY(16/137),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(14/100),KEGG_SMALL_CELL_LUNG_CANCER(13/84),REACTOME_SIGNALING_BY_ERBB2(14/101),KEGG_PANCREATIC_CANCER(12/70),KEGG_CHRONIC_MYELOID_LEUKEMIA(12/73),REACTOME_SIGNALING_BY_ERBB4(13/90),KEGG_COLORECTAL_CANCER(11/62),PID_FCER1_PATHWAY(11/62),PID_CERAMIDE_PATHWAY(10/48),REACTOME_SIGNALING_BY_FGFR(14/112),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(13/97),REACTOME_PI3K_AKT_ACTIVATION(9/38),SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES(10/51),PID_REG_GR_PATHWAY(12/82),KEGG_ENDOMETRIAL_CANCER(10/52),PID_VEGFR1_2_PATHWAY(11/69),REACTOME_PIP3_ACTIVATES_AKT_SIGNALING(8/29),KEGG_RENAL_CELL_CARCINOMA(11/70),PID_ERBB1_DOWNSTREAM_PATHWAY(13/105),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(14/126),PID_P53_REGULATION_PATHWAY(10/59),SIG_BCR_SIGNALING_PATHWAY(9/46),BIOCARTA_GLEEVEC_PATHWAY(7/23),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(12/97),PID_ENDOTHELIN_PATHWAY(10/63),PID_BCR_5PATHWAY(10/65),REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING(8/38),REACTOME_GAB1_SIGNALOSOME(8/38),REACTOME_METABOLISM_OF_RNA(21/330),KEGG_ERBB_SIGNALING_PATHWAY(11/87),BIOCARTA_HCMV_PATHWAY(6/17),SIG_IL4RECEPTOR_IN_B_LYPHOCYTES(7/27),PID_IFNG_PATHWAY(8/40),BIOCARTA_PTEN_PATHWAY(6/18),PID_IGF1_PATHWAY(7/30)
AKT1S1	TH34_1444_S01	v8	OSI-027,AZD8055,MLN0128	lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_SIGNALING_BY_PDGF(21/122),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),PID_MET_PATHWAY(15/80),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(16/95),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(17/137),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(16/126),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(15/109),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(16/127),REACTOME_SIGNALING_BY_SCF_KIT(13/78),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(14/100),REACTOME_SIGNALING_BY_ERBB2(14/101),REACTOME_SIGNALING_BY_ERBB4(13/90),REACTOME_SIGNALING_BY_FGFR(14/112),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(13/97),REACTOME_PI3K_AKT_ACTIVATION(9/38),REACTOME_PIP3_ACTIVATES_AKT_SIGNALING(8/29),PID_LKB1_PATHWAY(9/47),REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING(8/38),REACTOME_GAB1_SIGNALOSOME(8/38)
AKT2	TH34_1444_S01	v8	MK-2206,GSK2126458,IPATASERTIB,MK2206,TRASTUZUMAB,AZD4547,GDC-0068,EVEROLIMUS	lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_IMMUNE_SYSTEM(55/933),KEGG_PATHWAYS_IN_CANCER(32/328),REACTOME_SIGNALING_BY_PDGF(21/122),REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),PID_MET_PATHWAY(15/80),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(16/95),KEGG_ACUTE_MYELOID_LEUKEMIA(13/60),KEGG_PROSTATE_CANCER(15/89),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(13/67),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(17/137),KEGG_FOCAL_ADHESION(20/201),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(16/126),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(15/109),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(16/127),REACTOME_SIGNALING_BY_SCF_KIT(13/78),KEGG_MTOR_SIGNALING_PATHWAY(11/52),ST_INTEGRIN_SIGNALING_PATHWAY(13/82),KEGG_INSULIN_SIGNALING_PATHWAY(16/137),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(14/100),KEGG_SMALL_CELL_LUNG_CANCER(13/84),REACTOME_SIGNALING_BY_ERBB2(14/101),KEGG_PANCREATIC_CANCER(12/70),KEGG_CHRONIC_MYELOID_LEUKEMIA(12/73),REACTOME_SIGNALING_BY_ERBB4(13/90),KEGG_COLORECTAL_CANCER(11/62),REACTOME_SIGNALING_BY_FGFR(14/112),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(13/97),REACTOME_PI3K_AKT_ACTIVATION(9/38),SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES(10/51),KEGG_ENDOMETRIAL_CANCER(10/52),REACTOME_PIP3_ACTIVATES_AKT_SIGNALING(8/29),KEGG_RENAL_CELL_CARCINOMA(11/70),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(14/126),SIG_BCR_SIGNALING_PATHWAY(9/46),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(12/97),REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING(8/38),REACTOME_GAB1_SIGNALOSOME(8/38),KEGG_ERBB_SIGNALING_PATHWAY(11/87),SIG_IL4RECEPTOR_IN_B_LYPHOCYTES(7/27),HALLMARK_APICAL_JUNCTION(16/200)
AL442127.1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL662801.1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ALAD	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ALAS1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ALG13	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ALG3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ANAPC5	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),REACTOME_CELL_CYCLE(26/421),KEGG_CELL_CYCLE(14/128),REACTOME_CELL_CYCLE_MITOTIC(22/325),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(14/138)
ANAPC7	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),REACTOME_CELL_CYCLE(26/421),KEGG_CELL_CYCLE(14/128),REACTOME_CELL_CYCLE_MITOTIC(22/325),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(14/138)
ANK3	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),REACTOME_AXON_GUIDANCE(19/251)
ANKRD11	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ANKZF1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
AP003041.1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AP1G2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
AP2A1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(17/137),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(15/109),REACTOME_AXON_GUIDANCE(19/251)
APBB2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
APCDD1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
APEX1	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(18/200)
AREL1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ARFGAP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ARHGAP22	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_RHO_GTPASES(14/113)
ARHGAP24	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_RHO_GTPASES(14/113)
ARHGAP27	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(22/200)
ARHGAP35	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),KEGG_FOCAL_ADHESION(20/201),PID_FAK_PATHWAY(12/59),PID_PDGFRB_PATHWAY(16/129),ST_INTEGRIN_SIGNALING_PATHWAY(13/82),REACTOME_SIGNALING_BY_RHO_GTPASES(14/113),REACTOME_AXON_GUIDANCE(19/251)
ARHGAP8	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_RHO_GTPASES(14/113)
ARHGAP9	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ARHGEF10	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ARHGEF17	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_SIGNALING_BY_RHO_GTPASES(14/113),REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK(8/43)
ARHGEF19	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ARHGEF2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),HALLMARK_MITOTIC_SPINDLE(22/200),REACTOME_SIGNALING_BY_RHO_GTPASES(14/113),REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK(8/43)
ARHGEF7	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(22/200),PID_FAK_PATHWAY(12/59),ST_INTEGRIN_SIGNALING_PATHWAY(13/82)
ARHGEF9	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_SIGNALING_BY_RHO_GTPASES(14/113),REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK(8/43)
ARID1A	TH34_1444_S01	v8	DASATINIB,GSK126	lowstringency_pd_outliers	NA
ARID3A	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_P53_DOWNSTREAM_PATHWAY(17/137)
ARIH2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539)
ARL8A	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(22/200)
ARRDC1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ASAP2	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(12/97)
ASL	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ASPSCR1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ATF5	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200)
ATF6B	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ATG16L2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ATG4B	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(22/200)
ATN1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ATP13A1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ATP6V0C	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ATXN2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ATXN2L	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
AUTS2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
BABAM1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
BAZ2A	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
BCAR1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_PDGF(21/122),HALLMARK_MITOTIC_SPINDLE(22/200),PID_MET_PATHWAY(15/80),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(16/95),KEGG_FOCAL_ADHESION(20/201),PID_FAK_PATHWAY(12/59),BIOCARTA_INTEGRIN_PATHWAY(10/38),PID_PDGFRB_PATHWAY(16/129),ST_INTEGRIN_SIGNALING_PATHWAY(13/82),PID_ENDOTHELIN_PATHWAY(10/63),BIOCARTA_CXCR4_PATHWAY(7/24),BIOCARTA_PTEN_PATHWAY(6/18),PID_IGF1_PATHWAY(7/30)
BCL9	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
BCL9L	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
BCLAF1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
BCOR	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
BCR	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(32/328),HALLMARK_MITOTIC_SPINDLE(22/200),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(16/127),BIOCARTA_INTEGRIN_PATHWAY(10/38),KEGG_CHRONIC_MYELOID_LEUKEMIA(12/73),REACTOME_SIGNALING_BY_RHO_GTPASES(14/113),SIG_BCR_SIGNALING_PATHWAY(9/46),BIOCARTA_GLEEVEC_PATHWAY(7/23)
BDH1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
BEND7	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
BLNK	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(16/126),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),SIG_BCR_SIGNALING_PATHWAY(9/46),PID_BCR_5PATHWAY(10/65)
BMF	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
BMP7	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_TGF_BETA_SIGNALING_PATHWAY(11/86)
BOP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
BPTF	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
BRD2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
BRD4	TH34_1444_S01	v8		lowstringency_pd_outliers	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES(10/51)
BRPF3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
BTNL9	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
C19orf43	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
C20orf27	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
C5orf15	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CABIN1	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_NFAT_3PATHWAY(9/54)
CACYBP	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_WNT_SIGNALING_PATHWAY(15/151)
CAMTA2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CARD8	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CASC3	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(21/330)
CCDC130	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CCDC14	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CCDC57	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CCDC93	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CCNK	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_P53_DOWNSTREAM_PATHWAY(17/137)
CCNL1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CDC27	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),HALLMARK_MITOTIC_SPINDLE(22/200),REACTOME_CELL_CYCLE(26/421),KEGG_CELL_CYCLE(14/128),REACTOME_CELL_CYCLE_MITOTIC(22/325),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(14/138)
CDCA7L	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CDIP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CDK16	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CELF1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CENPT	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(26/421),REACTOME_CELL_CYCLE_MITOTIC(22/325)
CENPV	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CERCAM	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(16/200)
CERS4	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CGN	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(14/63)
CHD2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CHD8	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_WNT_SIGNALING_PATHWAY(15/151)
CHERP	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(21/128)
CIC	TH34_1444_S01	v8	SELUMETINIB (AZD6244),VEMURAFENIB,TRAMETINIB	lowstringency_pd_outliers	NA
CIZ1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CLASRP	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CLK2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CLK3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CLPP	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CLUH	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CNNM4	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CNOT1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CNOT11	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CNOT2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(21/330)
CNOT3	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(21/330)
CNOT7	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(21/330)
CNTD2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CNTFR	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
COASY	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
COL4A2	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(32/328),REACTOME_SIGNALING_BY_PDGF(21/122),REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),KEGG_FOCAL_ADHESION(20/201),KEGG_SMALL_CELL_LUNG_CANCER(13/84),REACTOME_AXON_GUIDANCE(19/251)
COL6A1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_PDGF(21/122),REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),KEGG_FOCAL_ADHESION(20/201),REACTOME_AXON_GUIDANCE(19/251)
COL9A3	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_PDGF(21/122),REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),REACTOME_AXON_GUIDANCE(19/251)
COPS7B	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
COQ4	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CPNE2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CPSF3L	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CPSF6	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(16/127)
CPSF7	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161),REACTOME_MRNA_3_END_PROCESSING(11/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),REACTOME_TRANSCRIPTION(19/210),REACTOME_RNA_POL_II_TRANSCRIPTION(12/105)
CRACR2B	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CREB1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_SIGNALING_BY_PDGF(21/122),REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(16/95),KEGG_PROSTATE_CANCER(15/89),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(13/67),PID_SMAD2_3NUCLEAR_PATHWAY(14/82),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(17/137),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(16/126),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(15/109),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(16/127),REACTOME_SIGNALING_BY_SCF_KIT(13/78),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(14/100),REACTOME_SIGNALING_BY_ERBB2(14/101),REACTOME_SIGNALING_BY_ERBB4(13/90),REACTOME_SIGNALING_BY_FGFR(14/112),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(13/97),REACTOME_PI3K_AKT_ACTIVATION(9/38),PID_REG_GR_PATHWAY(12/82),REACTOME_PIP3_ACTIVATES_AKT_SIGNALING(8/29),PID_ERBB1_DOWNSTREAM_PATHWAY(13/105),BIOCARTA_MAPK_PATHWAY(12/87),REACTOME_AXON_GUIDANCE(19/251),PID_LKB1_PATHWAY(9/47),REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING(8/38),REACTOME_GAB1_SIGNALOSOME(8/38),BIOCARTA_HCMV_PATHWAY(6/17)
CREBBP	TH34_1444_S01	v8	C646	lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),KEGG_PATHWAYS_IN_CANCER(32/328),REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),KEGG_PROSTATE_CANCER(15/89),PID_SMAD2_3NUCLEAR_PATHWAY(14/82),PID_P53_DOWNSTREAM_PATHWAY(17/137),REACTOME_SIGNALING_BY_NOTCH(15/103),PID_REG_GR_PATHWAY(12/82),KEGG_RENAL_CELL_CARCINOMA(11/70),KEGG_CELL_CYCLE(14/128),KEGG_WNT_SIGNALING_PATHWAY(15/151),PID_P53_REGULATION_PATHWAY(10/59),PID_HES_HEY_PATHWAY(9/48),KEGG_TGF_BETA_SIGNALING_PATHWAY(11/86),REACTOME_SIGNALING_BY_NOTCH1(10/70),PID_NFAT_3PATHWAY(9/54),PID_IFNG_PATHWAY(8/40),REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION(7/29),KEGG_ADHERENS_JUNCTION(10/75)
CRTC2	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_LKB1_PATHWAY(9/47)
CS	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CSNK1G2	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_P53_REGULATION_PATHWAY(10/59)
CSRP2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CTC-435M10.3	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTDSP1	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_SMAD2_3PATHWAY(6/17)
CWH43	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CXXC1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CYB5R3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CYTH1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
CYTH3	TH34_1444_S01	v8		lowstringency_pd_outliers	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(13/67),SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES(10/51)
DAZAP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
DCAF5	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
DCBLD2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
DCTN1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),REACTOME_CELL_CYCLE(26/421),REACTOME_CELL_CYCLE_MITOTIC(22/325)
DDX17	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
DDX23	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161),KEGG_SPLICEOSOME(21/128)
DDX42	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(21/128)
DDX5	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(21/128),PID_P53_DOWNSTREAM_PATHWAY(17/137)
DEK	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(20/200),HALLMARK_MYC_TARGETS_V1(18/200)
DGKZ	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
DICER1	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_TAP63_PATHWAY(9/54)
DKC1	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),REACTOME_CELL_CYCLE(26/421)
DLG3	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),REACTOME_AXON_GUIDANCE(19/251)
DLG5	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
DLST	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
DMAP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
DMPK	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
DMTF1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
DMTN	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DNM2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(17/137),PID_PDGFRB_PATHWAY(16/129),PID_VEGFR1_2_PATHWAY(11/69),REACTOME_AXON_GUIDANCE(19/251),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(12/97)
DNMT1	TH34_1444_S01	v8	DECITABINE,Decitabine	lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(20/200)
DPH1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
DVL3	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(32/328),KEGG_WNT_SIGNALING_PATHWAY(15/151)
DYNC1LI2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539)
DYRK1B	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
E2F4	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(14/63),PID_SMAD2_3NUCLEAR_PATHWAY(14/82),REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER(10/38),REACTOME_CELL_CYCLE(26/421),KEGG_CELL_CYCLE(14/128),REACTOME_CELL_CYCLE_MITOTIC(22/325),KEGG_TGF_BETA_SIGNALING_PATHWAY(11/86),REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION(7/27)
EBF4	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ECHDC2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
EDC4	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(21/330)
EHMT1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
EIF2B2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
EIF4E2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),KEGG_MTOR_SIGNALING_PATHWAY(11/52),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),KEGG_INSULIN_SIGNALING_PATHWAY(16/137),REACTOME_INTERFERON_SIGNALING(14/159)
EIF4ENIF1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
EIF4G2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),HALLMARK_MYC_TARGETS_V1(18/200),REACTOME_INTERFERON_SIGNALING(14/159)
EIF4G3	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),REACTOME_INTERFERON_SIGNALING(14/159)
EMID1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ENSA	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ENTHD2	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ENTPD6	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
EP300	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),KEGG_PATHWAYS_IN_CANCER(32/328),REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),KEGG_PROSTATE_CANCER(15/89),PID_SMAD2_3NUCLEAR_PATHWAY(14/82),PID_P53_DOWNSTREAM_PATHWAY(17/137),REACTOME_SIGNALING_BY_NOTCH(15/103),PID_REG_GR_PATHWAY(12/82),KEGG_RENAL_CELL_CARCINOMA(11/70),KEGG_CELL_CYCLE(14/128),KEGG_WNT_SIGNALING_PATHWAY(15/151),PID_P53_REGULATION_PATHWAY(10/59),PID_HES_HEY_PATHWAY(9/48),KEGG_TGF_BETA_SIGNALING_PATHWAY(11/86),REACTOME_SIGNALING_BY_NOTCH1(10/70),PID_NFAT_3PATHWAY(9/54),PID_TAP63_PATHWAY(9/54),PID_IFNG_PATHWAY(8/40),REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION(7/29),KEGG_ADHERENS_JUNCTION(10/75)
EPS8L2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ESRP2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
EVPL	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_TAP63_PATHWAY(9/54)
EWSR1	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200)
EXOC7	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_INSULIN_SIGNALING_PATHWAY(16/137)
EXT1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
F11R	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(14/63)
FAM111A	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FAM133B	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FAM160A2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FAM160B2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FAM168B	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FAM189A2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FAM192A	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FAM193B	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FAM49A	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FAM63A	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FAR2P1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FARSA	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FBF1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FBRS	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FBRSL1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FIP1L1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FKBP1A	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(14/63),PID_NFAT_3PATHWAY(9/54)
FNBP4	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FNDC3B	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FOXE1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FOXK2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FOXP4	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FPGS	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FUBP3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FURIN	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_SIGNALING_BY_PDGF(21/122),REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(14/63),REACTOME_SIGNALING_BY_NOTCH(15/103)
FXR2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
FXYD6	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
G6PD	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GAA	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_HES_HEY_PATHWAY(9/48)
GALNT10	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GARS	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GART	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GBA2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GCLC	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GCN1L1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GFER	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GGA2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GIGYF1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GLB1L2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GLYR1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GNA11	TH34_1444_S01	v8	CABOZANTINIB,PD0325901	lowstringency_pd_outliers	PID_ENDOTHELIN_PATHWAY(10/63)
GOLGA7	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GOLGA8M	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GOLGA8N	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GOLGA8O	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GOLGA8Q	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GOLGA8R	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GORASP1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(26/421),REACTOME_CELL_CYCLE_MITOTIC(22/325)
GPR137	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GRAMD4	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GSE1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GSK3A	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_SIGNALING_BY_PDGF(21/122),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(16/95),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(13/67),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(17/137),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(16/126),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(15/109),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(16/127),REACTOME_SIGNALING_BY_SCF_KIT(13/78),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(14/100),REACTOME_SIGNALING_BY_ERBB2(14/101),REACTOME_SIGNALING_BY_ERBB4(13/90),REACTOME_SIGNALING_BY_FGFR(14/112),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(13/97),REACTOME_PI3K_AKT_ACTIVATION(9/38),SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES(10/51),REACTOME_PIP3_ACTIVATES_AKT_SIGNALING(8/29),SIG_BCR_SIGNALING_PATHWAY(9/46),REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING(8/38),REACTOME_GAB1_SIGNALOSOME(8/38),SIG_IL4RECEPTOR_IN_B_LYPHOCYTES(7/27)
GSTM2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GSTM4	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GTF2I	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GTF2IP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GTF3C2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSCRIPTION(19/210)
GTF3C5	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSCRIPTION(19/210)
GTPBP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GTPBP2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GUSB	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
GYLTL1B	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
H1F0	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
H1FX	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
H2AFX	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),HALLMARK_E2F_TARGETS(20/200),REACTOME_TRANSCRIPTION(19/210),REACTOME_CELL_CYCLE(26/421)
H2AFY	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
H2AFY2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
HAAO	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
HBA1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
HBA2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
HDAC6	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(22/200),REACTOME_SIGNALING_BY_NOTCH(15/103),REACTOME_SIGNALING_BY_NOTCH1(10/70)
HECTD4	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HIF1A	TH34_1444_S01	v8	NITROGLYCERIN	lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),KEGG_PATHWAYS_IN_CANCER(32/328),REACTOME_SIGNALING_BY_NOTCH(15/103),KEGG_MTOR_SIGNALING_PATHWAY(11/52),KEGG_RENAL_CELL_CARCINOMA(11/70),PID_HES_HEY_PATHWAY(9/48),REACTOME_SIGNALING_BY_NOTCH1(10/70)
HIF3A	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
HN1L	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
HNRNPD	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),HALLMARK_G2M_CHECKPOINT(29/200),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161),HALLMARK_E2F_TARGETS(20/200),HALLMARK_MYC_TARGETS_V1(18/200),REACTOME_METABOLISM_OF_RNA(21/330)
HNRNPH1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161)
HNRNPH3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
HNRNPUL1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161)
HP1BP3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
HTT	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_P53_DOWNSTREAM_PATHWAY(17/137)
HUWE1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),PID_P53_REGULATION_PATHWAY(10/59),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(14/138)
IDH2	TH34_1444_S01	v8	OLAPARIB	lowstringency_pd_outliers	NA
IFFO2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
IFNGR2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),REACTOME_INTERFERON_SIGNALING(14/159)
IFT122	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
IGDCC3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
IGF2BP2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
IKBKB	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_IMMUNE_SYSTEM(55/933),KEGG_PATHWAYS_IN_CANCER(32/328),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),KEGG_ACUTE_MYELOID_LEUKEMIA(13/60),KEGG_PROSTATE_CANCER(15/89),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(16/126),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),KEGG_INSULIN_SIGNALING_PATHWAY(16/137),KEGG_SMALL_CELL_LUNG_CANCER(13/84),KEGG_PANCREATIC_CANCER(12/70),KEGG_CHRONIC_MYELOID_LEUKEMIA(12/73),BIOCARTA_KERATINOCYTE_PATHWAY(10/46),PID_FCER1_PATHWAY(11/62),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(13/97),BIOCARTA_MAPK_PATHWAY(12/87),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(14/126),PID_BCR_5PATHWAY(10/65),PID_TAP63_PATHWAY(9/54)
IKZF4	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
IL22RA1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ILF3	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),HALLMARK_E2F_TARGETS(20/200)
INCENP	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),HALLMARK_MITOTIC_SPINDLE(22/200),REACTOME_CELL_CYCLE(26/421),REACTOME_CELL_CYCLE_MITOTIC(22/325)
INO80E	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
INPPL1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),PID_MET_PATHWAY(15/80),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(13/67),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES(10/51),HALLMARK_APICAL_JUNCTION(16/200)
INTS3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
IP6K2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),REACTOME_INTERFERON_SIGNALING(14/159)
IPO13	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
IPO9	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
IRF2BP2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
IRX2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ISG20L2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ITFG2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ITGB1P1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
JAZF1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
KALRN	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_SIGNALING_BY_RHO_GTPASES(14/113),REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK(8/43)
KANSL1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
KCNK3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
KCTD3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
KDM2A	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
KHNYN	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
KHSRP	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(21/330)
KIAA0195	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
KIAA0368	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
KIAA0430	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
KIAA0907	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
KIAA1191	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
KIT	TH34_1444_S01	v8	MIDOSTAURIN,PLX3397,4'-N-BENZOYLSTAUROSPORINE,Nilotinib,SORAFENIB,MOTESANIB,cabozantinib,PLX-3397,CABOZANTINIB,Dasatinib,IMATINIB,SUNITINIB,TELATINIB,Regorafenib,NILOTINIB,PLX108-01,AXITINIB,TANDUTINIB,Sorafenib,Motesanib,MASITINIB,Pazopanib,Midostaurin,XL-820,IMATINIB MESYLATE,DASATINIB,AMUVATINIB,PEXIDARTINIB,Sunitinib,XL820,Imatinib,MP470,REGORAFENIB,PAZOPANIB	lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(32/328),KEGG_ACUTE_MYELOID_LEUKEMIA(13/60),REACTOME_SIGNALING_BY_SCF_KIT(13/78)
KLF13	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
KLHDC4	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
KMT2C	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
KMT2D	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
KMT2E	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
KRT78	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
KSR1	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_PDGFRB_PATHWAY(16/129),PID_CERAMIDE_PATHWAY(10/48),PID_ERBB1_DOWNSTREAM_PATHWAY(13/105)
KXD1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LAMC1	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(32/328),REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),PID_SMAD2_3NUCLEAR_PATHWAY(14/82),KEGG_FOCAL_ADHESION(20/201),KEGG_SMALL_CELL_LUNG_CANCER(13/84),REACTOME_AXON_GUIDANCE(19/251)
LARP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
LDB1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
LENG8	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
LINC00665	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC00969	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01001	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01002	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01420	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LMBR1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
LRCH4	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
LRP5	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_WNT_SIGNALING_PATHWAY(15/151)
LRP5L	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
LSM14B	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
LTBP3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
LUC7L2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
LUC7L3	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(20/200)
LYPLA1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
M6PR	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MAEA	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MAGI1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MAML1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_NOTCH(15/103),PID_HES_HEY_PATHWAY(9/48),REACTOME_SIGNALING_BY_NOTCH1(10/70),REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION(7/29)
MAN2A2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MAP3K1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),PID_MET_PATHWAY(15/80),BIOCARTA_KERATINOCYTE_PATHWAY(10/46),PID_FCER1_PATHWAY(11/62),PID_CERAMIDE_PATHWAY(10/48),PID_ERBB1_DOWNSTREAM_PATHWAY(13/105),BIOCARTA_MAPK_PATHWAY(12/87),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(14/126),BIOCARTA_GLEEVEC_PATHWAY(7/23),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(14/138),PID_BCR_5PATHWAY(10/65),BIOCARTA_HCMV_PATHWAY(6/17),PID_SMAD2_3PATHWAY(6/17),PID_NFAT_3PATHWAY(9/54),PID_IFNG_PATHWAY(8/40)
MAP4K4	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_P53_DOWNSTREAM_PATHWAY(17/137),PID_CERAMIDE_PATHWAY(10/48),BIOCARTA_MAPK_PATHWAY(12/87)
MAPK1IP1L	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MAPK3	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_IMMUNE_SYSTEM(55/933),KEGG_PATHWAYS_IN_CANCER(32/328),REACTOME_SIGNALING_BY_PDGF(21/122),REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),PID_MET_PATHWAY(15/80),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(16/95),KEGG_ACUTE_MYELOID_LEUKEMIA(13/60),KEGG_PROSTATE_CANCER(15/89),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(17/137),KEGG_FOCAL_ADHESION(20/201),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(15/109),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(16/127),BIOCARTA_INTEGRIN_PATHWAY(10/38),PID_PDGFRB_PATHWAY(16/129),REACTOME_SIGNALING_BY_SCF_KIT(13/78),KEGG_MTOR_SIGNALING_PATHWAY(11/52),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),KEGG_INSULIN_SIGNALING_PATHWAY(16/137),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(14/100),REACTOME_SIGNALING_BY_ERBB2(14/101),KEGG_PANCREATIC_CANCER(12/70),REACTOME_TRANSCRIPTION(19/210),KEGG_CHRONIC_MYELOID_LEUKEMIA(12/73),REACTOME_SIGNALING_BY_ERBB4(13/90),BIOCARTA_KERATINOCYTE_PATHWAY(10/46),KEGG_COLORECTAL_CANCER(11/62),PID_FCER1_PATHWAY(11/62),PID_CERAMIDE_PATHWAY(10/48),REACTOME_SIGNALING_BY_FGFR(14/112),SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES(10/51),PID_REG_GR_PATHWAY(12/82),KEGG_ENDOMETRIAL_CANCER(10/52),PID_VEGFR1_2_PATHWAY(11/69),KEGG_RENAL_CELL_CARCINOMA(11/70),PID_ERBB1_DOWNSTREAM_PATHWAY(13/105),BIOCARTA_MAPK_PATHWAY(12/87),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(14/126),REACTOME_AXON_GUIDANCE(19/251),SIG_BCR_SIGNALING_PATHWAY(9/46),BIOCARTA_GLEEVEC_PATHWAY(7/23),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(12/97),PID_ENDOTHELIN_PATHWAY(10/63),BIOCARTA_CXCR4_PATHWAY(7/24),PID_BCR_5PATHWAY(10/65),KEGG_TGF_BETA_SIGNALING_PATHWAY(11/86),KEGG_ERBB_SIGNALING_PATHWAY(11/87),BIOCARTA_HCMV_PATHWAY(6/17),SIG_IL4RECEPTOR_IN_B_LYPHOCYTES(7/27),PID_SMAD2_3PATHWAY(6/17),PID_NFAT_3PATHWAY(9/54),PID_IFNG_PATHWAY(8/40),BIOCARTA_PTEN_PATHWAY(6/18),KEGG_ADHERENS_JUNCTION(10/75),REACTOME_INTERFERON_SIGNALING(14/159)
MAPK8	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_IMMUNE_SYSTEM(55/933),KEGG_PATHWAYS_IN_CANCER(32/328),PID_MET_PATHWAY(15/80),KEGG_FOCAL_ADHESION(20/201),PID_FAK_PATHWAY(12/59),BIOCARTA_INTEGRIN_PATHWAY(10/38),PID_PDGFRB_PATHWAY(16/129),ST_INTEGRIN_SIGNALING_PATHWAY(13/82),KEGG_INSULIN_SIGNALING_PATHWAY(16/137),KEGG_PANCREATIC_CANCER(12/70),BIOCARTA_KERATINOCYTE_PATHWAY(10/46),KEGG_COLORECTAL_CANCER(11/62),PID_FCER1_PATHWAY(11/62),PID_CERAMIDE_PATHWAY(10/48),PID_REG_GR_PATHWAY(12/82),PID_ERBB1_DOWNSTREAM_PATHWAY(13/105),BIOCARTA_MAPK_PATHWAY(12/87),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(14/126),KEGG_WNT_SIGNALING_PATHWAY(15/151),PID_P53_REGULATION_PATHWAY(10/59),BIOCARTA_GLEEVEC_PATHWAY(7/23),PID_ENDOTHELIN_PATHWAY(10/63),PID_BCR_5PATHWAY(10/65),KEGG_ERBB_SIGNALING_PATHWAY(11/87),PID_NFAT_3PATHWAY(9/54),REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK(8/43)
MAPK8IP3	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_FAK_PATHWAY(12/59),ST_INTEGRIN_SIGNALING_PATHWAY(13/82)
MAPKBP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MARK2	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_LKB1_PATHWAY(9/47)
MARK3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MARVELD2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MAU2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MAZ	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MBD1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MBD6	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MBP	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MCM2	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),HALLMARK_E2F_TARGETS(20/200),HALLMARK_MYC_TARGETS_V1(18/200),REACTOME_CELL_CYCLE(26/421),KEGG_CELL_CYCLE(14/128),REACTOME_CELL_CYCLE_MITOTIC(22/325)
MCM4	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(20/200),HALLMARK_MYC_TARGETS_V1(18/200),REACTOME_CELL_CYCLE(26/421),KEGG_CELL_CYCLE(14/128),REACTOME_CELL_CYCLE_MITOTIC(22/325)
MCM5	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),HALLMARK_E2F_TARGETS(20/200),HALLMARK_MYC_TARGETS_V1(18/200),REACTOME_CELL_CYCLE(26/421),KEGG_CELL_CYCLE(14/128),REACTOME_CELL_CYCLE_MITOTIC(22/325)
MED14	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(34/396)
MED24	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(34/396)
MED25	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(34/396)
MEN1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(14/63),REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER(10/38),REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION(7/27)
MEST	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
METTL17	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MGRN1	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(14/138)
MIA3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MIB2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_NOTCH(15/103),REACTOME_SIGNALING_BY_NOTCH1(10/70)
MIER2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MINK1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MKNK2	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_INSULIN_SIGNALING_PATHWAY(16/137),BIOCARTA_MAPK_PATHWAY(12/87)
MLLT1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MLLT4	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_PDGFRB_PATHWAY(16/129),KEGG_ADHERENS_JUNCTION(10/75)
MLXIP	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MOGS	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MOV10	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_NOTCH(15/103),REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION(7/29)
MPDU1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MPRIP	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MROH1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MROH6	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MRPL38	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MSL1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MT1H	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MTA1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MTATP6P1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTDH	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MTERF4	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTG1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MTMR3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MVD	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(16/200)
MYO19	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
MZF1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
NACC1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
NADK	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
NADSYN1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
NAGK	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
NASP	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),HALLMARK_E2F_TARGETS(20/200)
NBEAL2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
NCOR1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(14/63),PID_SMAD2_3NUCLEAR_PATHWAY(14/82),REACTOME_SIGNALING_BY_NOTCH(15/103),REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER(10/38),REACTOME_SIGNALING_BY_ERBB4(13/90),PID_HES_HEY_PATHWAY(9/48),REACTOME_SIGNALING_BY_NOTCH1(10/70)
NCOR2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(14/63),REACTOME_SIGNALING_BY_NOTCH(15/103),REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER(10/38),PID_HES_HEY_PATHWAY(9/48),REACTOME_SIGNALING_BY_NOTCH1(10/70)
NECAB3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
NECAP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
NET1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),HALLMARK_MITOTIC_SPINDLE(22/200),REACTOME_SIGNALING_BY_RHO_GTPASES(14/113),REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK(8/43)
NF1	TH34_1444_S01	v8	Sirolimus,Vemurafenib,DABRAFENIB,Selumetinib,SELUMETINIB (AZD6244),VEMURAFENIB,SELUMETINIB,RAPAMYCIN (SIROLIMUS),PD-325901,PD0325901	lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(22/200),HALLMARK_APICAL_JUNCTION(16/200)
NFE2L1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
NFYC	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_P53_DOWNSTREAM_PATHWAY(17/137)
NID2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
NKIRAS2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
NMT1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
NOL4L	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NOLC1	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(13/67),HALLMARK_E2F_TARGETS(20/200),HALLMARK_MYC_TARGETS_V1(18/200)
NOMO1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
NONO	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
NPEPPS	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539)
NPIPB3	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB4	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB5	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NR2F6	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
NRBP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
NREP	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NUDT21	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161),REACTOME_MRNA_3_END_PROCESSING(11/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),HALLMARK_E2F_TARGETS(20/200),REACTOME_TRANSCRIPTION(19/210),REACTOME_RNA_POL_II_TRANSCRIPTION(12/105)
NUFIP2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
NUMA1	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),HALLMARK_MITOTIC_SPINDLE(22/200),REACTOME_CELL_CYCLE(26/421),REACTOME_CELL_CYCLE_MITOTIC(22/325)
NUMB	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),PID_MET_PATHWAY(15/80),REACTOME_SIGNALING_BY_NOTCH(15/103),REACTOME_AXON_GUIDANCE(19/251),REACTOME_SIGNALING_BY_NOTCH1(10/70)
NUP62	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_PROCESSING(26/161),REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(10/54),REACTOME_METABOLISM_OF_RNA(21/330),REACTOME_INTERFERON_SIGNALING(14/159)
NUP98	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200)
NUTF2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
NYNRIN	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
OBSL1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
OGFOD3	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
OGG1	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_TAP63_PATHWAY(9/54)
OSBP2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
OXA1L	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PABPC1	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(18/200),REACTOME_METABOLISM_OF_RNA(21/330)
PABPN1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161),REACTOME_MRNA_3_END_PROCESSING(11/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),REACTOME_TRANSCRIPTION(19/210),REACTOME_RNA_POL_II_TRANSCRIPTION(12/105)
PAK4	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),PID_MET_PATHWAY(15/80),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(13/67),KEGG_FOCAL_ADHESION(20/201),ST_INTEGRIN_SIGNALING_PATHWAY(13/82),KEGG_RENAL_CELL_CARCINOMA(11/70),REACTOME_AXON_GUIDANCE(19/251),KEGG_ERBB_SIGNALING_PATHWAY(11/87)
PAPOLA	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161),REACTOME_MRNA_3_END_PROCESSING(11/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),REACTOME_TRANSCRIPTION(19/210),REACTOME_RNA_POL_II_TRANSCRIPTION(12/105)
PARP10	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PARP6	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PAWR	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_CERAMIDE_PATHWAY(10/48)
PAX8	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(32/328)
PAX8-AS1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PBX2	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(16/200)
PCGF2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PCMTD2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PCNXL3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PDHA1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PELP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PHC1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PHF12	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PHF21A	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PHF23	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PHYKPL	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PI4KAP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PI4KAP2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PIAS1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),KEGG_PATHWAYS_IN_CANCER(32/328),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),KEGG_SMALL_CELL_LUNG_CANCER(13/84),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(14/138),PID_IFNG_PATHWAY(8/40),REACTOME_INTERFERON_SIGNALING(14/159)
PIAS4	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(32/328),PID_SMAD2_3NUCLEAR_PATHWAY(14/82),KEGG_SMALL_CELL_LUNG_CANCER(13/84),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(14/138),PID_SMAD2_3PATHWAY(6/17),PID_IFNG_PATHWAY(8/40)
PIGL	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PIK3R2	TH34_1444_S01	v8	BEZ235,BUPARLISIB HYDROCHLORIDE,DACTOLISIB,SF1126,GSK2126458,SF-1126,BKM120,PF-4691502,SONOLISIB,PICTILISIB,PKI-587,PF-04691502,COPANLISIB,BUPARLISIB,BYL719,GDC-0980,APITOLISIB,OMIPALISIB,PX-866,GDC-0941,GEDATOLISIB,XL-765,BAY80-6946,GSK2636771,VOXTALISIB,SOPHORETIN,XL147,PI-103	lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_IMMUNE_SYSTEM(55/933),KEGG_PATHWAYS_IN_CANCER(32/328),REACTOME_SIGNALING_BY_PDGF(21/122),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(16/95),KEGG_ACUTE_MYELOID_LEUKEMIA(13/60),KEGG_PROSTATE_CANCER(15/89),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(17/137),KEGG_FOCAL_ADHESION(20/201),PID_PDGFRB_PATHWAY(16/129),REACTOME_SIGNALING_BY_SCF_KIT(13/78),KEGG_MTOR_SIGNALING_PATHWAY(11/52),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),KEGG_INSULIN_SIGNALING_PATHWAY(16/137),KEGG_SMALL_CELL_LUNG_CANCER(13/84),KEGG_PANCREATIC_CANCER(12/70),KEGG_CHRONIC_MYELOID_LEUKEMIA(12/73),KEGG_COLORECTAL_CANCER(11/62),REACTOME_SIGNALING_BY_RHO_GTPASES(14/113),REACTOME_PI3K_AKT_ACTIVATION(9/38),KEGG_ENDOMETRIAL_CANCER(10/52),KEGG_RENAL_CELL_CARCINOMA(11/70),PID_ERBB1_DOWNSTREAM_PATHWAY(13/105),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(14/126),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(12/97),KEGG_ERBB_SIGNALING_PATHWAY(11/87)
PILRB	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PITPNM1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PKNOX1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PKNOX2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PLA2G6	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(12/97)
PLCG1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_IMMUNE_SYSTEM(55/933),KEGG_PATHWAYS_IN_CANCER(32/328),REACTOME_SIGNALING_BY_PDGF(21/122),REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),PID_MET_PATHWAY(15/80),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(16/95),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(17/137),PID_FAK_PATHWAY(12/59),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(16/126),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(15/109),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(16/127),PID_PDGFRB_PATHWAY(16/129),ST_INTEGRIN_SIGNALING_PATHWAY(13/82),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(14/100),REACTOME_SIGNALING_BY_ERBB2(14/101),PID_FCER1_PATHWAY(11/62),REACTOME_SIGNALING_BY_FGFR(14/112),PID_VEGFR1_2_PATHWAY(11/69),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(14/126),REACTOME_AXON_GUIDANCE(19/251),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(12/97),BIOCARTA_CXCR4_PATHWAY(7/24),KEGG_ERBB_SIGNALING_PATHWAY(11/87),HALLMARK_APICAL_JUNCTION(16/200),REACTOME_INTERFERON_SIGNALING(14/159)
PLEKHG2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),HALLMARK_MITOTIC_SPINDLE(22/200),REACTOME_SIGNALING_BY_RHO_GTPASES(14/113),REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK(8/43)
PLEKHH1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PLSCR1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PML	TH34_1444_S01	v8	Arsenic Trioxide,TRETINOIN,Tretinoin,ALL-TRANS RETINOIC ACID,ARSENIC TRIOXIDE	lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),REACTOME_IMMUNE_SYSTEM(55/933),KEGG_PATHWAYS_IN_CANCER(32/328),KEGG_ACUTE_MYELOID_LEUKEMIA(13/60),PID_P53_DOWNSTREAM_PATHWAY(17/137),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(14/138),PID_TAP63_PATHWAY(9/54),REACTOME_INTERFERON_SIGNALING(14/159)
PNISR	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PNKP	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PNN	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(20/200)
POGZ	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
POLD2	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(20/200),HALLMARK_MYC_TARGETS_V1(18/200),REACTOME_CELL_CYCLE(26/421),REACTOME_CELL_CYCLE_MITOTIC(22/325)
POLR2A	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161),REACTOME_TRANSCRIPTION(19/210),REACTOME_RNA_POL_II_TRANSCRIPTION(12/105)
POLR3E	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSCRIPTION(19/210)
POM121	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_PROCESSING(26/161),REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(10/54),REACTOME_METABOLISM_OF_RNA(21/330),REACTOME_INTERFERON_SIGNALING(14/159)
POM121C	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PPFIBP2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PPIL2	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(14/138)
PPP1R10	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PPP1R12A	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(20/201)
PPP1R12C	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PPP1R13B	TH34_1444_S01	v8		lowstringency_pd_outliers	SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(13/67),PID_P53_DOWNSTREAM_PATHWAY(17/137),SIG_BCR_SIGNALING_PATHWAY(9/46),SIG_IL4RECEPTOR_IN_B_LYPHOCYTES(7/27)
PPP1R2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PPP1R37	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PPP2R5C	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),REACTOME_CELL_CYCLE(26/421),REACTOME_CELL_CYCLE_MITOTIC(22/325),KEGG_WNT_SIGNALING_PATHWAY(15/151)
PPP4R1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PPP5C	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_REG_GR_PATHWAY(12/82),PID_ERBB1_DOWNSTREAM_PATHWAY(13/105)
PPP6R1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PPP6R3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PRAME	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PRCC	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PRDM2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PRELID1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PRKAA1	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_MTOR_SIGNALING_PATHWAY(11/52),KEGG_INSULIN_SIGNALING_PATHWAY(16/137),PID_VEGFR1_2_PATHWAY(11/69),PID_LKB1_PATHWAY(9/47)
PRKAB1	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_P53_DOWNSTREAM_PATHWAY(17/137),KEGG_INSULIN_SIGNALING_PATHWAY(16/137),PID_VEGFR1_2_PATHWAY(11/69),PID_LKB1_PATHWAY(9/47)
PRKCD	TH34_1444_S01	v8	SOPHORETIN	lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_SIGNALING_BY_PDGF(21/122),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(16/95),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(17/137),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(15/109),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(16/127),PID_PDGFRB_PATHWAY(16/129),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(14/100),REACTOME_SIGNALING_BY_ERBB2(14/101),BIOCARTA_KERATINOCYTE_PATHWAY(10/46),PID_CERAMIDE_PATHWAY(10/48),REACTOME_SIGNALING_BY_FGFR(14/112),PID_VEGFR1_2_PATHWAY(11/69),PID_ERBB1_DOWNSTREAM_PATHWAY(13/105),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(14/126),PID_P53_REGULATION_PATHWAY(10/59),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(12/97),PID_ENDOTHELIN_PATHWAY(10/63),REACTOME_METABOLISM_OF_RNA(21/330),PID_NFAT_3PATHWAY(9/54),PID_TAP63_PATHWAY(9/54),PID_IFNG_PATHWAY(8/40),REACTOME_INTERFERON_SIGNALING(14/159),PID_IGF1_PATHWAY(7/30)
PRKCH	TH34_1444_S01	v8	SOPHORETIN	lowstringency_pd_outliers	BIOCARTA_KERATINOCYTE_PATHWAY(10/46),PID_ENDOTHELIN_PATHWAY(10/63),PID_NFAT_3PATHWAY(9/54)
PRMT7	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PROM2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PROSER1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PRPF3	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(21/128)
PRPSAP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PRR14	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PRRC2C	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PRUNE	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PSMB2	TH34_1444_S01	v8	BORTEZOMIB,CARFILZOMIB,Carfilzomib	lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(16/126),HALLMARK_MYC_TARGETS_V1(18/200),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(13/97),REACTOME_CELL_CYCLE(26/421),REACTOME_CELL_CYCLE_MITOTIC(22/325),REACTOME_METABOLISM_OF_RNA(21/330)
PSMC6	TH34_1444_S01	v8	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(16/126),HALLMARK_MYC_TARGETS_V1(18/200),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(13/97),REACTOME_CELL_CYCLE(26/421),REACTOME_CELL_CYCLE_MITOTIC(22/325),REACTOME_METABOLISM_OF_RNA(21/330)
PSMF1	TH34_1444_S01	v8	BORTEZOMIB,CARFILZOMIB	lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(16/126),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(13/97),REACTOME_CELL_CYCLE(26/421),REACTOME_CELL_CYCLE_MITOTIC(22/325),REACTOME_METABOLISM_OF_RNA(21/330)
PTBP1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161)
PTEN	TH34_1444_S01	v8	AZD8186,LY294002,ENZALUTAMIDE,CETUXIMAB,EGFR INHIBITOR,1372540-25-4,AZD5363,EVEROLIMUS,PACLITAXEL,BKM120,Gefitinib,CARBOPLATIN,Cetuximab,TEMSIROLIMUS,BUPARLISIB,Everolimus,Paclitaxel,Trastuzumab,MK-2206,IPATASERTIB,PD184352,Temsirolimus,Ipatasertib,GEFITINIB,GSK2636771,MK2206,Enzalutamide,TRASTUZUMAB,ERLOTINIB	lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_IMMUNE_SYSTEM(55/933),KEGG_PATHWAYS_IN_CANCER(32/328),REACTOME_SIGNALING_BY_PDGF(21/122),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(16/95),KEGG_PROSTATE_CANCER(15/89),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(13/67),PID_P53_DOWNSTREAM_PATHWAY(17/137),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(17/137),KEGG_FOCAL_ADHESION(20/201),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(16/126),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(15/109),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(16/127),PID_PDGFRB_PATHWAY(16/129),REACTOME_SIGNALING_BY_SCF_KIT(13/78),ST_INTEGRIN_SIGNALING_PATHWAY(13/82),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(14/100),KEGG_SMALL_CELL_LUNG_CANCER(13/84),REACTOME_SIGNALING_BY_ERBB2(14/101),REACTOME_SIGNALING_BY_ERBB4(13/90),REACTOME_SIGNALING_BY_FGFR(14/112),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(13/97),REACTOME_PI3K_AKT_ACTIVATION(9/38),SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES(10/51),KEGG_ENDOMETRIAL_CANCER(10/52),REACTOME_PIP3_ACTIVATES_AKT_SIGNALING(8/29),PID_BCR_5PATHWAY(10/65),REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING(8/38),REACTOME_GAB1_SIGNALOSOME(8/38),HALLMARK_APICAL_JUNCTION(16/200),BIOCARTA_PTEN_PATHWAY(6/18)
PTK2	TH34_1444_S01	v8	PF-00562271,MASITINIB,PF-562271,PF00562271	lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(32/328),REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),PID_MET_PATHWAY(15/80),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(13/67),KEGG_FOCAL_ADHESION(20/201),PID_FAK_PATHWAY(12/59),BIOCARTA_INTEGRIN_PATHWAY(10/38),ST_INTEGRIN_SIGNALING_PATHWAY(13/82),KEGG_SMALL_CELL_LUNG_CANCER(13/84),PID_FCER1_PATHWAY(11/62),PID_VEGFR1_2_PATHWAY(11/69),REACTOME_AXON_GUIDANCE(19/251),BIOCARTA_CXCR4_PATHWAY(7/24),KEGG_ERBB_SIGNALING_PATHWAY(11/87),HALLMARK_APICAL_JUNCTION(16/200),BIOCARTA_PTEN_PATHWAY(6/18),PID_IGF1_PATHWAY(7/30)
PTOV1-AS2	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PTPN18	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PTRHD1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
PUF60	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(21/128)
PXN	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(22/200),PID_MET_PATHWAY(15/80),KEGG_FOCAL_ADHESION(20/201),PID_FAK_PATHWAY(12/59),BIOCARTA_INTEGRIN_PATHWAY(10/38),PID_FCER1_PATHWAY(11/62),PID_VEGFR1_2_PATHWAY(11/69),BIOCARTA_CXCR4_PATHWAY(7/24),PID_IGF1_PATHWAY(7/30)
PYY2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
QKI	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
QRICH1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
QTRT1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
R3HDM1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
R3HDM2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RAB15	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RAB7A	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539)
RAB8A	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RABL6	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RAD23A	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RAF1	TH34_1444_S01	v8	Sorafenib,MLN-2480,Regorafenib,SORAFENIB TOSYLATE,LGX818,SORAFENIB,XL281,XL-281,REGORAFENIB,1096708-71-2	lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_IMMUNE_SYSTEM(55/933),KEGG_PATHWAYS_IN_CANCER(32/328),REACTOME_SIGNALING_BY_PDGF(21/122),REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),PID_MET_PATHWAY(15/80),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(16/95),KEGG_ACUTE_MYELOID_LEUKEMIA(13/60),KEGG_PROSTATE_CANCER(15/89),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(17/137),KEGG_FOCAL_ADHESION(20/201),PID_FAK_PATHWAY(12/59),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(15/109),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(16/127),BIOCARTA_INTEGRIN_PATHWAY(10/38),PID_PDGFRB_PATHWAY(16/129),REACTOME_SIGNALING_BY_SCF_KIT(13/78),ST_INTEGRIN_SIGNALING_PATHWAY(13/82),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),KEGG_INSULIN_SIGNALING_PATHWAY(16/137),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(14/100),REACTOME_SIGNALING_BY_ERBB2(14/101),KEGG_PANCREATIC_CANCER(12/70),KEGG_CHRONIC_MYELOID_LEUKEMIA(12/73),REACTOME_SIGNALING_BY_ERBB4(13/90),BIOCARTA_KERATINOCYTE_PATHWAY(10/46),KEGG_COLORECTAL_CANCER(11/62),PID_FCER1_PATHWAY(11/62),PID_CERAMIDE_PATHWAY(10/48),REACTOME_SIGNALING_BY_FGFR(14/112),SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES(10/51),KEGG_ENDOMETRIAL_CANCER(10/52),PID_VEGFR1_2_PATHWAY(11/69),KEGG_RENAL_CELL_CARCINOMA(11/70),PID_ERBB1_DOWNSTREAM_PATHWAY(13/105),BIOCARTA_MAPK_PATHWAY(12/87),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(14/126),REACTOME_AXON_GUIDANCE(19/251),SIG_BCR_SIGNALING_PATHWAY(9/46),BIOCARTA_GLEEVEC_PATHWAY(7/23),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(12/97),PID_ENDOTHELIN_PATHWAY(10/63),BIOCARTA_CXCR4_PATHWAY(7/24),PID_BCR_5PATHWAY(10/65),KEGG_ERBB_SIGNALING_PATHWAY(11/87),SIG_IL4RECEPTOR_IN_B_LYPHOCYTES(7/27),PID_IGF1_PATHWAY(7/30)
RAI1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RAPGEF2	TH34_1444_S01	v8		lowstringency_pd_outliers	BIOCARTA_MAPK_PATHWAY(12/87)
RASSF4	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RBM12	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RBM14	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200)
RBM23	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RBM25	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(21/128)
RBM5	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161)
RBM6	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RBPMS	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RCOR3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RDX	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),REACTOME_AXON_GUIDANCE(19/251)
RELA	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_IMMUNE_SYSTEM(55/933),KEGG_PATHWAYS_IN_CANCER(32/328),REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),KEGG_ACUTE_MYELOID_LEUKEMIA(13/60),KEGG_PROSTATE_CANCER(15/89),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(16/126),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),KEGG_SMALL_CELL_LUNG_CANCER(13/84),KEGG_PANCREATIC_CANCER(12/70),KEGG_CHRONIC_MYELOID_LEUKEMIA(12/73),BIOCARTA_KERATINOCYTE_PATHWAY(10/46),PID_FCER1_PATHWAY(11/62),PID_CERAMIDE_PATHWAY(10/48),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(13/97),PID_REG_GR_PATHWAY(12/82),BIOCARTA_MAPK_PATHWAY(12/87),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(14/126),BIOCARTA_CXCR4_PATHWAY(7/24),PID_BCR_5PATHWAY(10/65),BIOCARTA_HCMV_PATHWAY(6/17)
REPIN1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RERE	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RGAG4	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RGL2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RHNO1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RHOT1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_RHO_GTPASES(14/113)
RMND5B	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RNF167	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RNF25	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539)
RNF31	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RNF4	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539)
RNF44	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RNPC3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ROGDI	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RP11-1000B6.3	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-1212A22.4	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-192N10.2	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-206L10.1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-231C14.4	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-274B21.2	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-295P9.3	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-34P13.15	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-386G11.10	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-589N15.2	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-632K20.8	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-65I12.1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-680F20.12	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-793H13.8	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-834C11.4	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-555D20.1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-669L17.10	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-669L17.8	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RPH3AL	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RPS6KB2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_SIGNALING_BY_PDGF(21/122),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(16/95),KEGG_ACUTE_MYELOID_LEUKEMIA(13/60),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(17/137),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(16/126),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(15/109),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(16/127),REACTOME_SIGNALING_BY_SCF_KIT(13/78),KEGG_MTOR_SIGNALING_PATHWAY(11/52),KEGG_INSULIN_SIGNALING_PATHWAY(16/137),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(14/100),REACTOME_SIGNALING_BY_ERBB2(14/101),REACTOME_SIGNALING_BY_ERBB4(13/90),REACTOME_SIGNALING_BY_FGFR(14/112),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(13/97),REACTOME_PI3K_AKT_ACTIVATION(9/38),REACTOME_PIP3_ACTIVATES_AKT_SIGNALING(8/29),BIOCARTA_MAPK_PATHWAY(12/87),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(12/97),REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING(8/38),REACTOME_GAB1_SIGNALOSOME(8/38),KEGG_TGF_BETA_SIGNALING_PATHWAY(11/86),KEGG_ERBB_SIGNALING_PATHWAY(11/87)
RSPRY1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
RSRC2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SAFB	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SARS2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SBNO2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SCAMP2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SCAP	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SCGB1A1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SCMH1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SCUBE3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SEC23IP	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SEMA3D	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SEMA4B	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SENP2	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_WNT_SIGNALING_PATHWAY(15/151)
SEPT8	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SETD5	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SETD8	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),PID_P53_REGULATION_PATHWAY(10/59)
SF1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SF3A1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161),KEGG_SPLICEOSOME(21/128),HALLMARK_MYC_TARGETS_V1(18/200)
SF3A2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161),KEGG_SPLICEOSOME(21/128)
SF3B4	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161),KEGG_SPLICEOSOME(21/128)
SFRP1	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_WNT_SIGNALING_PATHWAY(15/151)
SFSWAP	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SGIP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SGSM3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SGTA	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SH2B1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),REACTOME_SIGNALING_BY_ERBB4(13/90),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(14/126)
SH3D19	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SH3D21	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SH3GL1	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_FAK_PATHWAY(12/59)
SH3GLB2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SH3RF2	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SHKBP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SIDT2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SIGLEC7	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SIPA1L3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SIRT2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SKA2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(26/421),REACTOME_CELL_CYCLE_MITOTIC(22/325)
SLAIN2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SLC12A6	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SLC16A11	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SLC20A2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SLC25A27	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SLC25A29	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SLC29A4	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SLC35D2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SLC38A2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SLC39A13	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SLC39A14	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SLC44A2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SLC4A5	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SLC9A3R1	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_PDGFRB_PATHWAY(16/129)
SLTM	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SMAD3	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),KEGG_PATHWAYS_IN_CANCER(32/328),REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(14/63),PID_SMAD2_3NUCLEAR_PATHWAY(14/82),REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER(10/38),KEGG_PANCREATIC_CANCER(12/70),KEGG_CHRONIC_MYELOID_LEUKEMIA(12/73),KEGG_COLORECTAL_CANCER(11/62),KEGG_CELL_CYCLE(14/128),KEGG_WNT_SIGNALING_PATHWAY(15/151),KEGG_TGF_BETA_SIGNALING_PATHWAY(11/86),PID_SMAD2_3PATHWAY(6/17),REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION(7/27),KEGG_ADHERENS_JUNCTION(10/75)
SMAD4	TH34_1444_S01	v8	5-FLUOROURACIL,CETUXIMAB	lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(32/328),REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(14/63),PID_SMAD2_3NUCLEAR_PATHWAY(14/82),REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER(10/38),KEGG_PANCREATIC_CANCER(12/70),KEGG_CHRONIC_MYELOID_LEUKEMIA(12/73),KEGG_COLORECTAL_CANCER(11/62),KEGG_CELL_CYCLE(14/128),KEGG_WNT_SIGNALING_PATHWAY(15/151),PID_LKB1_PATHWAY(9/47),KEGG_TGF_BETA_SIGNALING_PATHWAY(11/86),PID_SMAD2_3PATHWAY(6/17),REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION(7/27),KEGG_ADHERENS_JUNCTION(10/75)
SMARCC1	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),HALLMARK_MYC_TARGETS_V1(18/200),PID_REG_GR_PATHWAY(12/82)
SMARCC2	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_REG_GR_PATHWAY(12/82)
SMARCD2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SMARCE1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SMG7	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(21/330)
SMIM1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SMN1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(21/330)
SMN2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(21/330)
SMOC1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SMPD4	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SMTN	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SNRNP70	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161),KEGG_SPLICEOSOME(21/128)
SNX12	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SNX8	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SORBS2	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(22/200)
SOS1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_IMMUNE_SYSTEM(55/933),KEGG_PATHWAYS_IN_CANCER(32/328),REACTOME_SIGNALING_BY_PDGF(21/122),REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),HALLMARK_MITOTIC_SPINDLE(22/200),PID_MET_PATHWAY(15/80),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(16/95),KEGG_ACUTE_MYELOID_LEUKEMIA(13/60),KEGG_PROSTATE_CANCER(15/89),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(13/67),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(17/137),KEGG_FOCAL_ADHESION(20/201),PID_FAK_PATHWAY(12/59),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(16/126),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(15/109),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(16/127),BIOCARTA_INTEGRIN_PATHWAY(10/38),PID_PDGFRB_PATHWAY(16/129),REACTOME_SIGNALING_BY_SCF_KIT(13/78),ST_INTEGRIN_SIGNALING_PATHWAY(13/82),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),KEGG_INSULIN_SIGNALING_PATHWAY(16/137),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(14/100),REACTOME_SIGNALING_BY_ERBB2(14/101),KEGG_CHRONIC_MYELOID_LEUKEMIA(12/73),REACTOME_SIGNALING_BY_ERBB4(13/90),PID_FCER1_PATHWAY(11/62),REACTOME_SIGNALING_BY_FGFR(14/112),REACTOME_SIGNALING_BY_RHO_GTPASES(14/113),SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES(10/51),KEGG_ENDOMETRIAL_CANCER(10/52),KEGG_RENAL_CELL_CARCINOMA(11/70),PID_ERBB1_DOWNSTREAM_PATHWAY(13/105),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(14/126),REACTOME_AXON_GUIDANCE(19/251),SIG_BCR_SIGNALING_PATHWAY(9/46),BIOCARTA_GLEEVEC_PATHWAY(7/23),PID_BCR_5PATHWAY(10/65),KEGG_ERBB_SIGNALING_PATHWAY(11/87),SIG_IL4RECEPTOR_IN_B_LYPHOCYTES(7/27),BIOCARTA_PTEN_PATHWAY(6/18),REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK(8/43),PID_IGF1_PATHWAY(7/30)
SP1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(14/63),PID_SMAD2_3NUCLEAR_PATHWAY(14/82),PID_P53_DOWNSTREAM_PATHWAY(17/137),REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER(10/38),BIOCARTA_KERATINOCYTE_PATHWAY(10/46),BIOCARTA_MAPK_PATHWAY(12/87),KEGG_TGF_BETA_SIGNALING_PATHWAY(11/86),BIOCARTA_HCMV_PATHWAY(6/17),REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION(7/27),PID_TAP63_PATHWAY(9/54)
SPEN	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_HES_HEY_PATHWAY(9/48)
SPIRE2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SPPL2B	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SRCAP	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SREBF2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SREK1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SRRM1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161),REACTOME_MRNA_3_END_PROCESSING(11/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),REACTOME_TRANSCRIPTION(19/210),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(10/54),REACTOME_RNA_POL_II_TRANSCRIPTION(12/105)
SRRM2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SRRT	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SRSF10	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),KEGG_SPLICEOSOME(21/128)
SRSF11	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161),REACTOME_MRNA_3_END_PROCESSING(11/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),REACTOME_TRANSCRIPTION(19/210),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(10/54),REACTOME_RNA_POL_II_TRANSCRIPTION(12/105)
SRSF2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),HALLMARK_G2M_CHECKPOINT(29/200),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161),KEGG_SPLICEOSOME(21/128),REACTOME_MRNA_3_END_PROCESSING(11/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),HALLMARK_E2F_TARGETS(20/200),REACTOME_TRANSCRIPTION(19/210),HALLMARK_MYC_TARGETS_V1(18/200),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(10/54),REACTOME_RNA_POL_II_TRANSCRIPTION(12/105)
SRSF4	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161),KEGG_SPLICEOSOME(21/128),REACTOME_MRNA_3_END_PROCESSING(11/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),REACTOME_TRANSCRIPTION(19/210),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(10/54),REACTOME_RNA_POL_II_TRANSCRIPTION(12/105)
SRSF5	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161),KEGG_SPLICEOSOME(21/128),REACTOME_MRNA_3_END_PROCESSING(11/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),REACTOME_TRANSCRIPTION(19/210),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(10/54),REACTOME_RNA_POL_II_TRANSCRIPTION(12/105)
SRSF6	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161),KEGG_SPLICEOSOME(21/128),REACTOME_MRNA_3_END_PROCESSING(11/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),REACTOME_TRANSCRIPTION(19/210),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(10/54),REACTOME_RNA_POL_II_TRANSCRIPTION(12/105)
SS18	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200)
SSBP3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ST14	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ST5	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
STAG3L5P-PVRIG2P-PILRB	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
STARD3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
STK25	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
STK36	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(32/328)
STRN4	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SUGP1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161)
SUOX	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SUPT20H	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SUPT6H	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
SYMPK	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(16/200)
SYNE2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(26/421)
SYTL3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TAF1C	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSCRIPTION(19/210)
TAOK2	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(22/200),HALLMARK_APICAL_JUNCTION(16/200)
TARBP2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TBC1D10C	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TBC1D4	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TBC1D9B	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TBX22	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TCF12	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(34/396)
TCF3	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),PID_SMAD2_3NUCLEAR_PATHWAY(14/82),PID_HES_HEY_PATHWAY(9/48)
TCF7L1	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(32/328),KEGG_ACUTE_MYELOID_LEUKEMIA(13/60),KEGG_PROSTATE_CANCER(15/89),KEGG_COLORECTAL_CANCER(11/62),KEGG_ENDOMETRIAL_CANCER(10/52),KEGG_WNT_SIGNALING_PATHWAY(15/151),KEGG_ADHERENS_JUNCTION(10/75)
TCF7L2	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(32/328),KEGG_ACUTE_MYELOID_LEUKEMIA(13/60),KEGG_PROSTATE_CANCER(15/89),KEGG_COLORECTAL_CANCER(11/62),KEGG_ENDOMETRIAL_CANCER(10/52),KEGG_WNT_SIGNALING_PATHWAY(15/151),KEGG_ADHERENS_JUNCTION(10/75)
TEAD3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TESK1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TEX2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TFDP1	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(14/63),PID_SMAD2_3NUCLEAR_PATHWAY(14/82),PID_P53_DOWNSTREAM_PATHWAY(17/137),REACTOME_SIGNALING_BY_NOTCH(15/103),REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER(10/38),HALLMARK_MYC_TARGETS_V1(18/200),REACTOME_CELL_CYCLE(26/421),KEGG_CELL_CYCLE(14/128),REACTOME_CELL_CYCLE_MITOTIC(22/325),KEGG_TGF_BETA_SIGNALING_PATHWAY(11/86),REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION(7/27),REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION(7/29)
TFDP2	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_CELL_CYCLE(14/128)
TGIF2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(14/63),PID_SMAD2_3NUCLEAR_PATHWAY(14/82),REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER(10/38),REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION(7/27)
THAP9-AS1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
THBS3	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_PDGF(21/122),KEGG_FOCAL_ADHESION(20/201),KEGG_TGF_BETA_SIGNALING_PATHWAY(11/86),HALLMARK_APICAL_JUNCTION(16/200)
THOC2	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(21/128)
TIA1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TIE1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TKT	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TLE2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_NOTCH(15/103),REACTOME_SIGNALING_BY_NOTCH1(10/70)
TLE6	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TMEM11	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TMEM175	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TMEM180	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TMEM183A	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TMEM184B	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TMEM189	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TMEM254	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TMEM259	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TMEM8B	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(16/200)
TNFRSF1B	TH34_1444_S01	v8		lowstringency_pd_outliers	BIOCARTA_KERATINOCYTE_PATHWAY(10/46)
TNIP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TNPO1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(21/330)
TNRC18	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TNRC6A	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_NOTCH(15/103),REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION(7/29)
TNS1	TH34_1444_S01	v8		lowstringency_pd_outliers	BIOCARTA_INTEGRIN_PATHWAY(10/38)
TOM1L2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TOP2A	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),HALLMARK_MITOTIC_SPINDLE(22/200),HALLMARK_E2F_TARGETS(20/200)
TOX4	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TP53	TH34_1444_S01	v8	CAPECITABINE,CETUXIMAB,DOXORUBICIN,Docetaxel,TAMOXIFEN,Selumetinib,CARBOPLATIN,SELUMETINIB (AZD6244),Doxorubicin,Oxaliplatin,Carboplatin,DOCETAXEL,OXALIPLATIN	lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(32/328),KEGG_PROSTATE_CANCER(15/89),PID_P53_DOWNSTREAM_PATHWAY(17/137),HALLMARK_E2F_TARGETS(20/200),REACTOME_SIGNALING_BY_NOTCH(15/103),KEGG_SMALL_CELL_LUNG_CANCER(13/84),KEGG_PANCREATIC_CANCER(12/70),KEGG_CHRONIC_MYELOID_LEUKEMIA(12/73),KEGG_COLORECTAL_CANCER(11/62),PID_REG_GR_PATHWAY(12/82),REACTOME_CELL_CYCLE(26/421),KEGG_ENDOMETRIAL_CANCER(10/52),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(14/126),KEGG_CELL_CYCLE(14/128),KEGG_WNT_SIGNALING_PATHWAY(15/151),PID_P53_REGULATION_PATHWAY(10/59),PID_LKB1_PATHWAY(9/47),REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION(7/29)
TP53BP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TP53I11	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TPM2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TRA2B	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),KEGG_SPLICEOSOME(21/128),HALLMARK_E2F_TARGETS(20/200),HALLMARK_MYC_TARGETS_V1(18/200)
TRAF4	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(32/328),KEGG_SMALL_CELL_LUNG_CANCER(13/84),PID_TAP63_PATHWAY(9/54)
TRAF7	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TRAK1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TRIM33	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(14/63),REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER(10/38)
TRIP10	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_INSULIN_SIGNALING_PATHWAY(16/137)
TRMT2A	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TRPC6	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(34/396),REACTOME_AXON_GUIDANCE(19/251),PID_ENDOTHELIN_PATHWAY(10/63)
TSC2	TH34_1444_S01	v8	Everolimus,EVEROLIMUS	lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(27/217),REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_SIGNALING_BY_PDGF(21/122),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(16/95),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(13/67),PID_P53_DOWNSTREAM_PATHWAY(17/137),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(17/137),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(16/126),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(15/109),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(16/127),REACTOME_SIGNALING_BY_SCF_KIT(13/78),KEGG_MTOR_SIGNALING_PATHWAY(11/52),KEGG_INSULIN_SIGNALING_PATHWAY(16/137),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(14/100),REACTOME_SIGNALING_BY_ERBB2(14/101),REACTOME_SIGNALING_BY_ERBB4(13/90),REACTOME_SIGNALING_BY_FGFR(14/112),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(13/97),REACTOME_PI3K_AKT_ACTIVATION(9/38),REACTOME_PIP3_ACTIVATES_AKT_SIGNALING(8/29),PID_LKB1_PATHWAY(9/47),REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING(8/38),REACTOME_GAB1_SIGNALOSOME(8/38)
TSG101	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_REG_GR_PATHWAY(12/82)
TSPAN14	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TTC17	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TTYH2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TTYH3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TUBA1B	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TUBG1	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(20/200),REACTOME_CELL_CYCLE(26/421),REACTOME_CELL_CYCLE_MITOTIC(22/325),HALLMARK_APICAL_JUNCTION(16/200)
TUG1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
TYK2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(22/270),REACTOME_INTERFERON_SIGNALING(14/159)
TYMS	TH34_1444_S01	v8	Fluorouracil,5-FLUOROURACIL,IRINOTECAN,METHOTREXATE,PEMETREXED,FLUOROURACIL	lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(18/200),REACTOME_CELL_CYCLE(26/421),REACTOME_CELL_CYCLE_MITOTIC(22/325)
U2AF2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(26/140),REACTOME_MRNA_SPLICING(23/111),REACTOME_MRNA_PROCESSING(26/161),KEGG_SPLICEOSOME(21/128),REACTOME_MRNA_3_END_PROCESSING(11/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),REACTOME_TRANSCRIPTION(19/210),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(10/54),REACTOME_RNA_POL_II_TRANSCRIPTION(12/105)
U2SURP	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_SPLICEOSOME(21/128)
UBALD1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
UBALD2	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
UBAP2L	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
UBE2G2	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(14/138)
UBE2O	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(14/138)
UBE2Q1	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(14/138)
UBE2S	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200),REACTOME_IMMUNE_SYSTEM(55/933),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(36/539),HALLMARK_E2F_TARGETS(20/200),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(14/138)
UBE2V1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
UBP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
UBTF	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_TRANSCRIPTION(19/210)
UCKL1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ULK3	TH34_1444_S01	v8		lowstringency_pd_outliers	KEGG_MTOR_SIGNALING_PATHWAY(11/52)
UPF3A	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(21/330)
USP10	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
USP32P1	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
USP5	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
USP7	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_P53_REGULATION_PATHWAY(10/59)
VAMP2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
VCL	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(22/200),KEGG_FOCAL_ADHESION(20/201),PID_FAK_PATHWAY(12/59),BIOCARTA_INTEGRIN_PATHWAY(10/38),PID_VEGFR1_2_PATHWAY(11/69),HALLMARK_APICAL_JUNCTION(16/200),KEGG_ADHERENS_JUNCTION(10/75)
VEGFC	TH34_1444_S01	v8	SORAFENIB TOSYLATE	lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(32/328),KEGG_FOCAL_ADHESION(20/201),KEGG_MTOR_SIGNALING_PATHWAY(11/52),KEGG_PANCREATIC_CANCER(12/70),KEGG_RENAL_CELL_CARCINOMA(11/70)
VGLL4	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
VLDLR	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
VPS37B	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
VPS52	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
WAC	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
WASF2	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(22/200),PID_PDGFRB_PATHWAY(16/129),PID_ERBB1_DOWNSTREAM_PATHWAY(13/105),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(12/97),KEGG_ADHERENS_JUNCTION(10/75)
WASH5P	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
WASH6P	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
WASH7P	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
WDR11	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
WDR59	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
WDR6	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
WHSC1	TH34_1444_S01	v8		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(29/200)
WIPI2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
WNK1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
XPNPEP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
XPR1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
XXbac-BPG252P9.9	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
YY1AP1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
Y_RNA	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZBED5	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZBTB7B	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZC3H14	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZC3H18	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZC3H3	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZCCHC11	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZDHHC12	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZDHHC18	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZDHHC8	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZFR	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZMIZ2	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZMYND11	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZNF207	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZNF219	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZNF362	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZNF384	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZNF385A	TH34_1444_S01	v8		lowstringency_pd_outliers	PID_P53_DOWNSTREAM_PATHWAY(17/137)
ZNF444	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZNF580	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZNF608	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZNF692	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZNF76	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZNRF1	TH34_1444_S01	v8		lowstringency_pd_outliers	NA
ZSWIM8	TH34_1444_S01	v8		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZWINT	TH34_1444_S01	v8		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(26/421),REACTOME_CELL_CYCLE_MITOTIC(22/325)
AC132217.4	TH34_1445_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACSF2	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
ACTG1	TH34_1445_S02	v9		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(6/201)
AGAP1	TH34_1445_S02	v9		lowstringency_pd_outliers	KEGG_ENDOCYTOSIS(6/183)
AL603831.1	TH34_1445_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL662801.1	TH34_1445_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ALDH1A3	TH34_1445_S02	v9		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(6/200)
ANKRD11	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
AP003041.1	TH34_1445_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AP2A2	TH34_1445_S02	v9		lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(13/539),REACTOME_SIGNALLING_BY_NGF(8/217),REACTOME_IMMUNE_SYSTEM(15/933),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(5/109),KEGG_ENDOCYTOSIS(6/183),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(5/137),REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION(4/91),REACTOME_HIV_INFECTION(5/207),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(4/132)
ARHGAP17	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
ARHGDIA	TH34_1445_S02	v9		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(8/217),HALLMARK_PI3K_AKT_MTOR_SIGNALING(4/105),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(4/126),PID_CDC42_PATHWAY(3/70)
ARL8A	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
ARRDC3	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
ASAP1	TH34_1445_S02	v9		lowstringency_pd_outliers	ST_INTEGRIN_SIGNALING_PATHWAY(5/82),PID_ARF_3PATHWAY(3/19),KEGG_ENDOCYTOSIS(6/183)
ASNSD1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
ATXN2	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
BAZ2A	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
BCL9L	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
BCLAF1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
BMI1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
BPTF	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
BRD4	TH34_1445_S02	v9		lowstringency_pd_outliers	SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES(4/51)
CACNG5	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
CAPN5	TH34_1445_S02	v9		lowstringency_pd_outliers	HALLMARK_COAGULATION(4/138)
CBWD3	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
CBX4	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
CCDC82	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
CDC42SE1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
CDH19	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
CEP95	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
CHAD	TH34_1445_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(14/1028),KEGG_FOCAL_ADHESION(6/201),NABA_CORE_MATRISOME(6/275)
CIC	TH34_1445_S02	v9	SELUMETINIB (AZD6244),VEMURAFENIB,TRAMETINIB	lowstringency_pd_outliers	NA
CIZ1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
CLEC2B	TH34_1445_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(14/1028)
CLK2	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
CLK3	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
CNOT2	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
COL13A1	TH34_1445_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(14/1028),PID_AVB3_INTEGRIN_PATHWAY(4/75),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(4/87),NABA_CORE_MATRISOME(6/275),REACTOME_COLLAGEN_FORMATION(3/58)
COL9A1	TH34_1445_S02	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_PDGF(6/122),NABA_MATRISOME(14/1028),PID_AVB3_INTEGRIN_PATHWAY(4/75),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(4/87),NABA_CORE_MATRISOME(6/275),REACTOME_COLLAGEN_FORMATION(3/58)
CRTC2	TH34_1445_S02	v9		lowstringency_pd_outliers	PID_LKB1_PATHWAY(3/47)
CTHRC1	TH34_1445_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(14/1028),NABA_CORE_MATRISOME(6/275),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(5/200)
CTSB	TH34_1445_S02	v9		lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(13/539),REACTOME_IMMUNE_SYSTEM(15/933),NABA_MATRISOME(14/1028),KEGG_LYSOSOME(5/121),HALLMARK_COMPLEMENT(6/200),REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION(4/91),HALLMARK_COAGULATION(4/138)
CTSD	TH34_1445_S02	v9		lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(13/539),REACTOME_IMMUNE_SYSTEM(15/933),NABA_MATRISOME(14/1028),KEGG_LYSOSOME(5/121),HALLMARK_COMPLEMENT(6/200),REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION(4/91),PID_LKB1_PATHWAY(3/47)
CTSL	TH34_1445_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(14/1028)
DBN1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
DDX3X	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
DDX42	TH34_1445_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(9/128)
DDX5	TH34_1445_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(9/128)
DENND4B	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
DGKA	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
DMWD	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
EIF4E2	TH34_1445_S02	v9		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(15/933),KEGG_MTOR_SIGNALING_PATHWAY(4/52),KEGG_INSULIN_SIGNALING_PATHWAY(5/137)
EMC6	TH34_1445_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
EPHB2	TH34_1445_S02	v9		lowstringency_pd_outliers	ST_INTEGRIN_SIGNALING_PATHWAY(5/82),HALLMARK_KRAS_SIGNALING_UP(6/200)
EPN2	TH34_1445_S02	v9		lowstringency_pd_outliers	KEGG_ENDOCYTOSIS(6/183)
ERF	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
ERO1L	TH34_1445_S02	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(7/200),HALLMARK_KRAS_SIGNALING_UP(6/200)
EXOC7	TH34_1445_S02	v9		lowstringency_pd_outliers	KEGG_INSULIN_SIGNALING_PATHWAY(5/137),PID_INSULIN_PATHWAY(3/45),PID_CDC42_PATHWAY(3/70)
FAM104A	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
FAM127B	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
FAM133B	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
FAM193B	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
FAM95B1	TH34_1445_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FBRS	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
FCRLA	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
FIP1L1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
FKBP2	TH34_1445_S02	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(7/200)
FNBP4	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
FOXK2	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
FPGS	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
FTSJ3	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
GATAD2A	TH34_1445_S02	v9		lowstringency_pd_outliers	PID_HDAC_CLASSI_PATHWAY(3/66)
GGA2	TH34_1445_S02	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(7/200),KEGG_LYSOSOME(5/121)
GGA3	TH34_1445_S02	v9		lowstringency_pd_outliers	PID_ARF_3PATHWAY(3/19),KEGG_LYSOSOME(5/121)
GOLGA2	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
GON4L	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
GRB2	TH34_1445_S02	v9		lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(13/539),REACTOME_SIGNALLING_BY_NGF(8/217),REACTOME_IMMUNE_SYSTEM(15/933),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(6/126),REACTOME_SIGNALING_BY_PDGF(6/122),ST_INTEGRIN_SIGNALING_PATHWAY(5/82),BIOCARTA_MAPK_PATHWAY(5/87),SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES(4/51),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(5/109),HALLMARK_COMPLEMENT(6/200),KEGG_FOCAL_ADHESION(6/201),REACTOME_PI3K_CASCADE(4/71),KEGG_INSULIN_SIGNALING_PATHWAY(5/137),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(5/137),PID_IL2_PI3K_PATHWAY(3/34),REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE(4/87),ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY(3/37),REACTOME_GAB1_SIGNALOSOME(3/38),BIOCARTA_P38MAPK_PATHWAY(3/40),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(4/95),REACTOME_SIGNALING_BY_ERBB2(4/101),REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING(3/44),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(4/100),PID_INSULIN_PATHWAY(3/45),HALLMARK_PI3K_AKT_MTOR_SIGNALING(4/105),BIOCARTA_IL4_PATHWAY(2/11),REACTOME_SIGNALING_BY_INSULIN_RECEPTOR(4/108),PID_ANGIOPOIETIN_RECEPTOR_PATHWAY(3/50),REACTOME_SIGNALING_BY_FGFR(4/112),PID_KIT_PATHWAY(3/52),REACTOME_PI_3K_CASCADE(3/56),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(4/126),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(4/127),KEGG_ACUTE_MYELOID_LEUKEMIA(3/60),SA_PTEN_PATHWAY(2/17),SA_TRKA_RECEPTOR(2/17),PID_FCER1_PATHWAY(3/62),BIOCARTA_NGF_PATHWAY(2/18),BIOCARTA_PTEN_PATHWAY(2/18),BIOCARTA_ERK5_PATHWAY(2/18),PID_BCR_5PATHWAY(3/65),PID_IL4_2PATHWAY(3/65),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(3/67)
GTPBP2	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
H19	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
HILPDA	TH34_1445_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HMGA1	TH34_1445_S02	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(6/200),REACTOME_HIV_INFECTION(5/207),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(4/132),PID_IL4_2PATHWAY(3/65)
HMGN1	TH34_1445_S02	v9		lowstringency_pd_outliers	BIOCARTA_P38MAPK_PATHWAY(3/40)
HNRNPH1	TH34_1445_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(6/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(6/140),REACTOME_MRNA_PROCESSING(6/161)
HSPA1A	TH34_1445_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(9/128),KEGG_ENDOCYTOSIS(6/183),HALLMARK_COMPLEMENT(6/200),BIOCARTA_PPARA_PATHWAY(3/58),BIOCARTA_TID_PATHWAY(2/19)
IGF2	TH34_1445_S02	v9	CABAZITAXEL,DOCETAXEL,OSI-906 (LINSITINIB)	lowstringency_pd_outliers	NABA_MATRISOME(14/1028),HALLMARK_KRAS_SIGNALING_UP(6/200)
IGSF9B	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
ING1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
INTS3	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
IPO9	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
ISG20L2	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
KCTD13	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
KIAA0907	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
LENG8	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
LGALS8	TH34_1445_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(14/1028)
LGI4	TH34_1445_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(14/1028),NABA_CORE_MATRISOME(6/275)
LINC01002	TH34_1445_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LMO1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
LPAR2	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
LTBR	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
LUC7L3	TH34_1445_S02	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(6/200)
M6PR	TH34_1445_S02	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(7/200),KEGG_LYSOSOME(5/121)
MAGEC2	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
MAP3K12	TH34_1445_S02	v9		lowstringency_pd_outliers	BIOCARTA_MAPK_PATHWAY(5/87)
MAPK1IP1L	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
MARK3	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
MBD6	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
MEF2D	TH34_1445_S02	v9		lowstringency_pd_outliers	BIOCARTA_MAPK_PATHWAY(5/87),BIOCARTA_P38MAPK_PATHWAY(3/40),BIOCARTA_ERK5_PATHWAY(2/18)
MEG3	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
METRNL	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
MIA3	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
MMP15	TH34_1445_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(14/1028),HALLMARK_COMPLEMENT(6/200),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(4/87),HALLMARK_COAGULATION(4/138)
MORF4L1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
MSTO1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
MTMR4	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
MTRR	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
NACC1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
NGFR	TH34_1445_S02	v9		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(8/217),REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR(2/10),REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL(2/11),REACTOME_P75NTR_SIGNALS_VIA_NFKB(2/14),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(4/126),SA_TRKA_RECEPTOR(2/17),BIOCARTA_NGF_PATHWAY(2/18)
NKX2-2-AS1	TH34_1445_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NMT1	TH34_1445_S02	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(7/200),REACTOME_HIV_INFECTION(5/207)
NPLOC4	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
NRP1	TH34_1445_S02	v9		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(6/200),PID_VEGF_VEGFR_PATHWAY(2/10),REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS(2/10)
NSRP1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
NT5C	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
ODF2	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
P4HB	TH34_1445_S02	v9		lowstringency_pd_outliers	ST_INTEGRIN_SIGNALING_PATHWAY(5/82),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(4/87),BIOCARTA_HIF_PATHWAY(2/15),REACTOME_COLLAGEN_FORMATION(3/58)
PCBP1-AS1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
PDLIM7	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
PGS1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
PHF23	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
PIP5K1A	TH34_1445_S02	v9		lowstringency_pd_outliers	PID_ARF_3PATHWAY(3/19),KEGG_ENDOCYTOSIS(6/183)
PITPNM1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
PKDCC	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
PMEPA1	TH34_1445_S02	v9		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(5/200)
PNN	TH34_1445_S02	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(6/200)
POGZ	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
PPP1R2	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
PPP1R9B	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
PRKAR1A	TH34_1445_S02	v9		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(8/217),REACTOME_SIGNALING_BY_PDGF(6/122),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(5/109),KEGG_INSULIN_SIGNALING_PATHWAY(5/137),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(5/137),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(4/95),REACTOME_SIGNALING_BY_ERBB2(4/101),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(4/100),REACTOME_SIGNALING_BY_FGFR(4/112),BIOCARTA_PPARA_PATHWAY(3/58),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(4/127)
PRRC2C	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
PSMC6	TH34_1445_S02	v9	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(13/539),REACTOME_IMMUNE_SYSTEM(15/933),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(6/126),HALLMARK_MTORC1_SIGNALING(7/200),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(5/97),REACTOME_HIV_INFECTION(5/207),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(5/212),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(4/132),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(3/64)
PSMD12	TH34_1445_S02	v9	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(13/539),REACTOME_IMMUNE_SYSTEM(15/933),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(6/126),HALLMARK_MTORC1_SIGNALING(7/200),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(5/97),REACTOME_HIV_INFECTION(5/207),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(5/212),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(4/132),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(3/64)
PTEN	TH34_1445_S02	v9	AZD8186,LY294002,ENZALUTAMIDE,CETUXIMAB,EGFR INHIBITOR,1372540-25-4,AZD5363,EVEROLIMUS,PACLITAXEL,BKM120,Gefitinib,CARBOPLATIN,Cetuximab,TEMSIROLIMUS,BUPARLISIB,Everolimus,Paclitaxel,Trastuzumab,MK-2206,IPATASERTIB,PD184352,Temsirolimus,Ipatasertib,GEFITINIB,GSK2636771,MK2206,Enzalutamide,TRASTUZUMAB,ERLOTINIB	lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(13/539),REACTOME_SIGNALLING_BY_NGF(8/217),REACTOME_IMMUNE_SYSTEM(15/933),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(6/126),REACTOME_SIGNALING_BY_PDGF(6/122),ST_INTEGRIN_SIGNALING_PATHWAY(5/82),SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES(4/51),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(5/97),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(5/109),KEGG_FOCAL_ADHESION(6/201),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(5/137),ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY(3/37),REACTOME_GAB1_SIGNALOSOME(3/38),REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK(2/9),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(4/95),REACTOME_SIGNALING_BY_ERBB2(4/101),REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING(3/44),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(4/100),HALLMARK_PI3K_AKT_MTOR_SIGNALING(4/105),REACTOME_SIGNALING_BY_FGFR(4/112),PID_KIT_PATHWAY(3/52),REACTOME_PI_3K_CASCADE(3/56),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(4/127),SA_PTEN_PATHWAY(2/17),BIOCARTA_PTEN_PATHWAY(2/18),PID_BCR_5PATHWAY(3/65),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(3/67),BIOCARTA_IGF1MTOR_PATHWAY(2/20)
PTPN12	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
RAB7A	TH34_1445_S02	v9		lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(13/539),REACTOME_IMMUNE_SYSTEM(15/933),REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION(4/91)
RAB8B	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
RABL2B	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
RAD51C	TH34_1445_S02	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(6/200)
RBM12	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
RBM8A	TH34_1445_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(9/128),REACTOME_MRNA_SPLICING(6/111),REACTOME_MRNA_3_END_PROCESSING(4/35),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(6/140),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(4/44),REACTOME_MRNA_PROCESSING(6/161),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(4/54),REACTOME_RNA_POL_II_TRANSCRIPTION(4/105)
RCOR3	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
RELA	TH34_1445_S02	v9		lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(13/539),REACTOME_SIGNALLING_BY_NGF(8/217),REACTOME_IMMUNE_SYSTEM(15/933),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(6/126),BIOCARTA_MAPK_PATHWAY(5/87),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(5/97),PID_IL2_PI3K_PATHWAY(3/34),REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR(2/10),REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL(2/11),PID_ANGIOPOIETIN_RECEPTOR_PATHWAY(3/50),REACTOME_P75NTR_SIGNALS_VIA_NFKB(2/14),BIOCARTA_PPARA_PATHWAY(3/58),KEGG_NEUROTROPHIN_SIGNALING_PATHWAY(4/126),KEGG_ACUTE_MYELOID_LEUKEMIA(3/60),PID_FCER1_PATHWAY(3/62),PID_BCR_5PATHWAY(3/65),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(3/64),PID_HDAC_CLASSI_PATHWAY(3/66),BIOCARTA_TID_PATHWAY(2/19)
RIC3	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
RNF31	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
RP1-261G23.7	TH34_1445_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-159D12.5	TH34_1445_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-274B21.2	TH34_1445_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RPS6KB1	TH34_1445_S02	v9		lowstringency_pd_outliers	BIOCARTA_MAPK_PATHWAY(5/87),KEGG_MTOR_SIGNALING_PATHWAY(4/52),SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES(4/51),REACTOME_PI3K_CASCADE(4/71),KEGG_INSULIN_SIGNALING_PATHWAY(5/137),PID_AVB3_INTEGRIN_PATHWAY(4/75),PID_IL2_PI3K_PATHWAY(3/34),REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE(4/87),ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY(3/37),PID_INSULIN_PATHWAY(3/45),BIOCARTA_IL4_PATHWAY(2/11),REACTOME_SIGNALING_BY_INSULIN_RECEPTOR(4/108),PID_ANGIOPOIETIN_RECEPTOR_PATHWAY(3/50),PID_KIT_PATHWAY(3/52),KEGG_ACUTE_MYELOID_LEUKEMIA(3/60),PID_IL4_2PATHWAY(3/65),SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES(3/67),BIOCARTA_IGF1MTOR_PATHWAY(2/20),PID_CDC42_PATHWAY(3/70)
RSRC2	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
SATB1	TH34_1445_S02	v9		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(6/200)
SDK2	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
SENP2	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
SETDB1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
SF1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
SF3B4	TH34_1445_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(9/128),REACTOME_MRNA_SPLICING(6/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(6/140),REACTOME_MRNA_PROCESSING(6/161)
SFXN3	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
SLTM	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
SMG7	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
SMTN	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
SNX12	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
SPG20	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
SPRED3	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
SREK1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
SRSF1	TH34_1445_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(9/128),REACTOME_MRNA_SPLICING(6/111),REACTOME_MRNA_3_END_PROCESSING(4/35),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(6/140),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(4/44),REACTOME_MRNA_PROCESSING(6/161),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(4/54),HALLMARK_E2F_TARGETS(6/200),REACTOME_RNA_POL_II_TRANSCRIPTION(4/105)
SRSF11	TH34_1445_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(6/111),REACTOME_MRNA_3_END_PROCESSING(4/35),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(6/140),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(4/44),REACTOME_MRNA_PROCESSING(6/161),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(4/54),REACTOME_RNA_POL_II_TRANSCRIPTION(4/105)
SRSF5	TH34_1445_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(9/128),REACTOME_MRNA_SPLICING(6/111),REACTOME_MRNA_3_END_PROCESSING(4/35),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(6/140),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(4/44),REACTOME_MRNA_PROCESSING(6/161),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(4/54),REACTOME_RNA_POL_II_TRANSCRIPTION(4/105)
STRADA	TH34_1445_S02	v9		lowstringency_pd_outliers	KEGG_MTOR_SIGNALING_PATHWAY(4/52),REACTOME_PI3K_CASCADE(4/71),REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE(4/87),PID_LKB1_PATHWAY(3/47),REACTOME_SIGNALING_BY_INSULIN_RECEPTOR(4/108)
SUMO1	TH34_1445_S02	v9		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(15/933),PID_HDAC_CLASSI_PATHWAY(3/66)
SUPT6H	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
TANC2	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
TESK1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
THBS1	TH34_1445_S02	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_PDGF(6/122),NABA_MATRISOME(14/1028),KEGG_FOCAL_ADHESION(6/201),NABA_CORE_MATRISOME(6/275),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(5/200),HALLMARK_COAGULATION(4/138)
THEM4	TH34_1445_S02	v9		lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(13/539),REACTOME_SIGNALLING_BY_NGF(8/217),REACTOME_IMMUNE_SYSTEM(15/933),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(6/126),REACTOME_SIGNALING_BY_PDGF(6/122),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(5/97),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(5/109),REACTOME_PI3K_CASCADE(4/71),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(5/137),REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE(4/87),REACTOME_GAB1_SIGNALOSOME(3/38),REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK(2/9),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(4/95),REACTOME_SIGNALING_BY_ERBB2(4/101),REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING(3/44),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(4/100),HALLMARK_PI3K_AKT_MTOR_SIGNALING(4/105),REACTOME_SIGNALING_BY_INSULIN_RECEPTOR(4/108),REACTOME_SIGNALING_BY_FGFR(4/112),REACTOME_PI_3K_CASCADE(3/56),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(4/127)
TLK2	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
TP53BP1	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
TRA2A	TH34_1445_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(9/128)
TRA2B	TH34_1445_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(9/128),HALLMARK_E2F_TARGETS(6/200)
TRIP12	TH34_1445_S02	v9		lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(13/539),REACTOME_IMMUNE_SYSTEM(15/933),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(5/212)
TRPM8	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
UBAP2L	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
UBE2Q1	TH34_1445_S02	v9		lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(13/539),REACTOME_IMMUNE_SYSTEM(15/933),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(5/212)
UBE2Z	TH34_1445_S02	v9		lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(13/539),REACTOME_IMMUNE_SYSTEM(15/933),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(5/212)
USP5	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
VEGFA	TH34_1445_S02	v9	AFLIBERCEPT,VEGF TRAP,BEVACIZUMAB,SORAFENIB TOSYLATE,Aflibercept,ZALTRAP,ZIV-AFLIBERCEPT,Bevacizumab	lowstringency_pd_outliers	KEGG_MTOR_SIGNALING_PATHWAY(4/52),NABA_MATRISOME(14/1028),KEGG_FOCAL_ADHESION(6/201),PID_AVB3_INTEGRIN_PATHWAY(4/75),PID_VEGF_VEGFR_PATHWAY(2/10),REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS(2/10),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(5/200),BIOCARTA_HIF_PATHWAY(2/15)
WIPF1	TH34_1445_S02	v9		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(5/200),PID_FCER1_PATHWAY(3/62)
XPNPEP1	TH34_1445_S02	v9		lowstringency_pd_outliers	HALLMARK_COMPLEMENT(6/200)
ZC3H7A	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
ZNF337	TH34_1445_S02	v9		lowstringency_pd_outliers	NA
ZSWIM8	TH34_1445_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL132780.1	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL442127.1	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL662801.1	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ALDH1A3	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
AP003041.1	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
APOD	TH34_1446_S01	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(6/200)
AQP7P1	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
ARHGAP32	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
C2orf82	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
CC2D1A	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
CD55	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
CDH13	TH34_1446_S01	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(6/200)
CHRDL1	TH34_1446_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(12/1028),NABA_SECRETED_FACTORS(4/344)
CNIH3	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
CNTNAP3B	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
COL12A1	TH34_1446_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(12/1028),NABA_CORE_MATRISOME(7/275),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(6/200),NABA_COLLAGENS(3/44),REACTOME_COLLAGEN_FORMATION(3/58),PID_AVB3_INTEGRIN_PATHWAY(3/75),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(3/87)
COL13A1	TH34_1446_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(12/1028),NABA_CORE_MATRISOME(7/275),NABA_COLLAGENS(3/44),REACTOME_COLLAGEN_FORMATION(3/58),PID_AVB3_INTEGRIN_PATHWAY(3/75),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(3/87)
COL22A1	TH34_1446_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(12/1028),NABA_CORE_MATRISOME(7/275),NABA_COLLAGENS(3/44),REACTOME_COLLAGEN_FORMATION(3/58),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(3/87)
CRLF1	TH34_1446_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(12/1028),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(6/200),NABA_SECRETED_FACTORS(4/344)
CTC-575D19.1	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTHRC1	TH34_1446_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(12/1028),NABA_CORE_MATRISOME(7/275),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(6/200),PID_WNT_SIGNALING_PATHWAY(2/28)
DKK1	TH34_1446_S01	v9	IRINOTECAN,L-FOLINIC ACID,5-FLUOROURACIL,OXALIPLATIN	lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(6/200),PID_WNT_SIGNALING_PATHWAY(2/28)
EHBP1L1	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
EPHA3	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
FCRLA	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
FP325317.1	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FST	TH34_1446_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(12/1028),HALLMARK_MYOGENESIS(6/200),NABA_SECRETED_FACTORS(4/344)
FXYD5	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
GDNF	TH34_1446_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(12/1028),NABA_SECRETED_FACTORS(4/344)
GSN	TH34_1446_S01	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(6/200),HALLMARK_COAGULATION(3/138),PID_AVB3_OPN_PATHWAY(2/31)
ITGB3	TH34_1446_S01	v9		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(6/200),PID_AVB3_INTEGRIN_PATHWAY(3/75),PID_S1P_S1P1_PATHWAY(2/21),BIOCARTA_EDG1_PATHWAY(2/27),HALLMARK_COAGULATION(3/138),PID_AVB3_OPN_PATHWAY(2/31)
KLF2	TH34_1446_S01	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(4/200)
LGI4	TH34_1446_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(12/1028),NABA_CORE_MATRISOME(7/275)
MFI2	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
MIA	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
MICALL2	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
MIR671	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MRPS6	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
MT-ATP6	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ATP8	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CO1	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CO2	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CO3	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CYB	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND1	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND2	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND3	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND4	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND4L	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND5	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND6	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTATP6P1	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTND1P23	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NEAT1	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
NEAT1_1	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PHLDA2	TH34_1446_S01	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(4/200)
PLAC9	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
PLEKHG4	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
PODNL1	TH34_1446_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(12/1028),NABA_CORE_MATRISOME(7/275)
PODXL	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
PPFIBP1	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
RNA5SP244	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-156L14.1	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-323N12.5	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-380M21.2	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-3L21.2	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-698N11.2	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-809N8.5	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP5-857K21.11	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP5-857K21.7	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SERPINB2	TH34_1446_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(12/1028),HALLMARK_TNFA_SIGNALING_VIA_NFKB(4/200),HALLMARK_COAGULATION(3/138)
SLC26A2	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
SLCO4A1-AS1	TH34_1446_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SNTB1	TH34_1446_S01	v9		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(6/200)
SNX1	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
SOD3	TH34_1446_S01	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(6/200)
SPHK1	TH34_1446_S01	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(6/200),HALLMARK_TNFA_SIGNALING_VIA_NFKB(4/200),PID_S1P_S1P1_PATHWAY(2/21),BIOCARTA_EDG1_PATHWAY(2/27)
ST8SIA5	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
TESC	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
THBS4	TH34_1446_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(12/1028),NABA_CORE_MATRISOME(7/275)
TRPM8	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
TRPV4	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
UCN2	TH34_1446_S01	v9		lowstringency_pd_outliers	NA
AAMP	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ABCF1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ABCF2	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(23/200)
AC006011.4	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC011558.5	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC132217.4	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACIN1	TH34_1447_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(29/128),REACTOME_APOPTOSIS(18/148)
ACOT13	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ACP1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200)
ADAT1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ADGRA2	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADORA3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
AFG3L2	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(13/200)
AGBL5	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
AKIRIN2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ALDH1A2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ALG13	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(31/518)
ALKBH5	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ANP32B	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ANP32E	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200)
AP1G2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
APEX1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_DNA_REPAIR(8/112),BIOCARTA_SET_PATHWAY(3/11)
APOC4-APOC2	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ARF1	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_HIV_INFECTION(25/207),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(18/132),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_IMMUNE_SYSTEM(33/933),REACTOME_MEMBRANE_TRAFFICKING(9/129)
ARHGAP4	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ARL16	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ASH2L	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ATAD3A	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ATAD3B	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ATG4B	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ATIC	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_NUCLEOTIDES(7/72),KEGG_PURINE_METABOLISM(9/159),REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS(3/11)
ATPAF2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
B4GALT3	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(31/518)
BAZ1A	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
BCLAF1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
BLMH	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(20/212),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_IMMUNE_SYSTEM(33/933)
BOD1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
BPHL	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
BRAT1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
BRD9	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
BRE	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
BRIX1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
BRMS1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
BUB1B	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200),REACTOME_MITOTIC_M_M_G1_PHASES(22/172),REACTOME_CELL_CYCLE_CHECKPOINTS(19/124),REACTOME_DNA_REPLICATION(22/192),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(15/73),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_CELL_CYCLE(27/421)
C11orf24	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
C14orf119	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
C14orf166	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
C1orf35	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CABYR	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CACYBP	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(23/200)
CAD	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),PID_MYC_ACTIV_PATHWAY(13/79),REACTOME_METABOLISM_OF_NUCLEOTIDES(7/72),KEGG_PYRIMIDINE_METABOLISM(7/98)
CARM1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CBWD1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CBWD2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CBWD3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CBWD5	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CBWD7	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CBX2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CCAR1	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(28/111),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140)
CCDC58	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CCDC59	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CCDC86	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CCNC	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION(5/46)
CCNE1	TH34_1447_S01	v9	MK-2206,PALBOCICLIB (PD0332991),DINACICLIB	lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(17/65),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(16/56),REACTOME_S_PHASE(19/109),REACTOME_G1_S_TRANSITION(19/112),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(15/57),REACTOME_CELL_CYCLE_CHECKPOINTS(19/124),REACTOME_MITOTIC_G1_G1_S_PHASES(19/137),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_CELL_CYCLE(27/421),BIOCARTA_P27_PATHWAY(4/13),HALLMARK_UV_RESPONSE_UP(9/158)
CCT3	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS(4/27)
CCT6A	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(23/200),REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS(4/27)
CD163L1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CD2BP2	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(28/111),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140)
CDC37	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CDK11A	TH34_1447_S01	v9		lowstringency_pd_outliers	BIOCARTA_HIVNEF_PATHWAY(6/58)
CDK11B	TH34_1447_S01	v9		lowstringency_pd_outliers	BIOCARTA_HIVNEF_PATHWAY(6/58)
CENPN	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MITOTIC_M_M_G1_PHASES(22/172),REACTOME_DNA_REPLICATION(22/192),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_CELL_CYCLE(27/421)
CENPW	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CFDP1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CFH	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(33/933)
CHCHD3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CHD1L	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CHD8	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CHMP2A	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MEMBRANE_TRAFFICKING(9/129)
CHMP4A	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MEMBRANE_TRAFFICKING(9/129)
CHTF8	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CHTOP	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CIAPIN1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CIRH1A	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CKS1B	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(17/65),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(16/56),HALLMARK_G2M_CHECKPOINT(25/200),REACTOME_S_PHASE(19/109),REACTOME_G1_S_TRANSITION(19/112),REACTOME_MITOTIC_G1_G1_S_PHASES(19/137),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_CELL_CYCLE(27/421),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(11/113),BIOCARTA_P27_PATHWAY(4/13)
CLINT1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CLK2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CLPTM1L	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CNOT1	TH34_1447_S01	v9		lowstringency_pd_outliers	KEGG_RNA_DEGRADATION(10/59)
CNOT11	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CNOT3	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_METABOLISM_OF_MRNA(28/284),KEGG_RNA_DEGRADATION(10/59),REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY(7/48)
CNOT7	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_METABOLISM_OF_MRNA(28/284),KEGG_RNA_DEGRADATION(10/59),REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY(7/48)
COA1	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
COL12A1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
COL2A1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(9/158)
COMMD9	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
COPS3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
COPS7B	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
COX5B	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(13/200)
CPSF2	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(28/111),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),REACTOME_RNA_POL_II_TRANSCRIPTION(17/105),REACTOME_TRANSCRIPTION(21/210),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),REACTOME_MRNA_3_END_PROCESSING(9/35),REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA(7/23),REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS(5/14),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(7/54)
CPSF3	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(28/111),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),REACTOME_RNA_POL_II_TRANSCRIPTION(17/105),REACTOME_TRANSCRIPTION(21/210),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),REACTOME_MRNA_3_END_PROCESSING(9/35),REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA(7/23),REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS(5/14),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(7/54)
CPSF6	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CRABP2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CSNK2B	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CTPS1	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTSL	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CXorf56	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
CYCS	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_APOPTOSIS(18/148),HALLMARK_OXIDATIVE_PHOSPHORYLATION(13/200),BIOCARTA_HIVNEF_PATHWAY(6/58),BIOCARTA_CASPASE_PATHWAY(4/23)
DACT1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
DAZAP1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
DBNL	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_APOPTOSIS(18/148)
DCUN1D5	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
DDX1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
DDX10	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_UNFOLDED_PROTEIN_RESPONSE(11/113)
DDX18	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),HALLMARK_MYC_TARGETS_V2(14/58),PID_MYC_ACTIV_PATHWAY(13/79)
DDX19A	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
DDX19B	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
DDX27	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
DDX5	TH34_1447_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(29/128)
DDX56	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
DES	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
DFFA	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_APOPTOSIS(18/148),BIOCARTA_HIVNEF_PATHWAY(6/58),BIOCARTA_CASPASE_PATHWAY(4/23),BIOCARTA_SET_PATHWAY(3/11)
DHX16	TH34_1447_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(29/128)
DKC1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(25/200),REACTOME_CELL_CYCLE(27/421),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(11/113),PID_TELOMERASE_PATHWAY(7/68)
DMKN	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
DNAAF5	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DNAJC11	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
DNAJC2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
DNAJC7	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
DNMT3A	TH34_1447_S01	v9	IDARUBICIN,DECITABINE,Decitabine	lowstringency_pd_outliers	NA
DPAGT1	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(31/518)
DRG2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
DUS1L	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
DUSP12	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
DUXAP8	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
DUXAP9	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
EAPP	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
EBNA1BP2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ECHDC1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ECI2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
EDC4	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_METABOLISM_OF_MRNA(28/284),KEGG_RNA_DEGRADATION(10/59),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(11/113),REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY(7/48)
EEF1E1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(23/200),REACTOME_TRNA_AMINOACYLATION(9/42),REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION(6/24)
EIF2B4	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_TRANSLATION(11/222)
EIF2S2	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),HALLMARK_MTORC1_SIGNALING(23/200),REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_TRANSLATION(11/222)
EIF3B	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_TRANSLATION(11/222)
EIF3G	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_TRANSLATION(11/222)
EIF3M	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
EIF4A3	TH34_1447_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(29/128),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_IMMUNE_SYSTEM(33/933),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(11/113),REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY(7/48)
EIF4E2	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(33/933)
EIF4EBP1	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(31/518),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(11/113),REACTOME_TRANSLATION(11/222)
EIF5B	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_TRANSLATION(11/222)
ELAC2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ELAVL1	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(18/84),REACTOME_METABOLISM_OF_MRNA(28/284)
ELFN1-AS1	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ELP2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ELP3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
EMC9	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
EME1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ENSA	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
EPHB4	TH34_1447_S01	v9	TESEVATINIB,XL647	lowstringency_pd_outliers	NA
EPN1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ERAL1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ERVK3-1	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
EXOSC1	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(18/84),REACTOME_METABOLISM_OF_MRNA(28/284),KEGG_RNA_DEGRADATION(10/59),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(11/113),REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY(7/48)
EXOSC3	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(18/84),REACTOME_METABOLISM_OF_MRNA(28/284),KEGG_RNA_DEGRADATION(10/59),REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY(7/48)
FAM126A	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
FAM136A	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
FAM177A1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
FAM192A	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
FAM50A	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
FAM98A	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
FANCA	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_DNA_REPAIR(8/112)
FARSB	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_TRNA_AMINOACYLATION(9/42),KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(8/41),REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION(6/24)
FBLIM1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
FBRS	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
FHOD1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
FIP1L1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
FKBP4	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(9/158)
FKBP7	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
FLAD1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
FLII	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
FOXC1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
FOXP4	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
FTSJ1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
FTSJ2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
FTSJ3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
GALE	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
GARS	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_TRNA_AMINOACYLATION(9/42),KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(8/41),REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION(6/24),REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION(4/21)
GEMIN2	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_METABOLISM_OF_NON_CODING_RNA(6/49)
GET4	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
GFAP	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
GGA2	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(23/200)
GGCT	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
GMPR2	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_DNA_REPAIR(11/150),REACTOME_METABOLISM_OF_NUCLEOTIDES(7/72),KEGG_PURINE_METABOLISM(9/159)
GMPS	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(23/200),REACTOME_METABOLISM_OF_NUCLEOTIDES(7/72),KEGG_PURINE_METABOLISM(9/159),REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS(3/11)
GNB2L1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200)
GNL2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
GNL3	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),HALLMARK_MYC_TARGETS_V2(14/58)
GNPAT	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
GNPDA1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
GOLGA2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
GOLGA7	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
GPATCH4	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
GPBP1L1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
GPC3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
GPN1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
GRPEL1	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT(8/58),HALLMARK_OXIDATIVE_PHOSPHORYLATION(13/200),HALLMARK_UV_RESPONSE_UP(9/158)
GTF2E2	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_HIV_INFECTION(25/207),REACTOME_RNA_POL_II_TRANSCRIPTION(17/105),REACTOME_TRANSCRIPTION(21/210),REACTOME_HIV_LIFE_CYCLE(10/125),REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS(6/61),REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING(5/41),REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE(7/104)
GTF2H4	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(31/161),REACTOME_HIV_INFECTION(25/207),REACTOME_RNA_POL_II_TRANSCRIPTION(17/105),REACTOME_TRANSCRIPTION(21/210),REACTOME_HIV_LIFE_CYCLE(10/125),REACTOME_DNA_REPAIR(8/112),REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS(6/61),REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING(5/41),REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE(7/104)
GTF3C2	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_TRANSCRIPTION(21/210)
GTF3C6	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
GTPBP4	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
HARS2	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_TRNA_AMINOACYLATION(9/42),KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(8/41),REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION(4/21)
HBS1L	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
HDAC2	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),PID_TELOMERASE_PATHWAY(7/68),REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION(5/46)
HDAC3	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION(5/46)
HDLBP	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
HEIH	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HMGA1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200),HALLMARK_G2M_CHECKPOINT(25/200),REACTOME_HIV_INFECTION(25/207),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(18/132),PID_MYC_ACTIV_PATHWAY(13/79),REACTOME_HIV_LIFE_CYCLE(10/125)
HMGA2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
HMGB3	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200),HALLMARK_G2M_CHECKPOINT(25/200)
HMGN1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
HMGN3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
HMHA1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
HN1L	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
HNRNPA2B1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_MRNA_SPLICING(28/111),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140)
HNRNPA3	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_MRNA_SPLICING(28/111),KEGG_SPLICEOSOME(29/128),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140)
HNRNPAB	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
HNRNPC	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_MRNA_SPLICING(28/111),KEGG_SPLICEOSOME(29/128),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),PID_TELOMERASE_PATHWAY(7/68)
HNRNPD	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_MRNA_SPLICING(28/111),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),HALLMARK_E2F_TARGETS(29/200),REACTOME_METABOLISM_OF_RNA(34/330),HALLMARK_G2M_CHECKPOINT(25/200),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(18/84),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(15/53)
HNRNPH1	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(28/111),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140)
HNRNPR	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_MRNA_SPLICING(28/111),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140)
HNRNPU	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_MRNA_SPLICING(28/111),KEGG_SPLICEOSOME(29/128),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),HALLMARK_G2M_CHECKPOINT(25/200),HALLMARK_UV_RESPONSE_UP(9/158)
HOXA-AS2	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HOXA9	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
HSPA4	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(23/200),PID_MYC_ACTIV_PATHWAY(13/79)
HSPD1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),HALLMARK_MTORC1_SIGNALING(23/200),HALLMARK_MYC_TARGETS_V2(14/58),REACTOME_METABOLISM_OF_PROTEINS(31/518),PID_MYC_ACTIV_PATHWAY(13/79),KEGG_RNA_DEGRADATION(10/59),REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT(8/58)
HSPE1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),HALLMARK_MTORC1_SIGNALING(23/200),HALLMARK_MYC_TARGETS_V2(14/58)
HUWE1	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(20/212),PID_MYC_ACTIV_PATHWAY(13/79),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_IMMUNE_SYSTEM(33/933)
IAH1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ICT1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ID2	TH34_1447_S01	v9		lowstringency_pd_outliers	PID_MYC_ACTIV_PATHWAY(13/79)
ID2-AS1	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
IGF2	TH34_1447_S01	v9	CABAZITAXEL,DOCETAXEL,OSI-906 (LINSITINIB)	lowstringency_pd_outliers	NA
IGF2BP3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
IK	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ILF2	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200)
IMP4	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(14/58)
INO80E	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
INPP5F	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
IPO4	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(14/58)
IPO9	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ISOC2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ISYNA1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ITFG2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
IVNS1ABP	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
JUP	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
KDM1A	TH34_1447_S01	v9		lowstringency_pd_outliers	PID_HES_HEY_PATHWAY(5/48)
KDM5B	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
KIAA0020	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
KIAA0586	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
KIAA0907	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
KIF22	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200),HALLMARK_G2M_CHECKPOINT(25/200),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_IMMUNE_SYSTEM(33/933)
KLHL7	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
KPNA2	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),HALLMARK_E2F_TARGETS(29/200),HALLMARK_G2M_CHECKPOINT(25/200),REACTOME_IMMUNE_SYSTEM(33/933)
KRI1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
LARP1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
LARS	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_TRNA_AMINOACYLATION(9/42),KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(8/41),REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION(6/24),KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS(3/11)
LBR	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200),HALLMARK_G2M_CHECKPOINT(25/200)
LIMD2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
LINC01296	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01420	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LMNB2	TH34_1447_S01	v9		lowstringency_pd_outliers	BIOCARTA_HIVNEF_PATHWAY(6/58),BIOCARTA_CASPASE_PATHWAY(4/23)
LRCH4	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
LRP5	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
LRRC59	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
LSM5	TH34_1447_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(29/128),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_METABOLISM_OF_MRNA(28/284),KEGG_RNA_DEGRADATION(10/59),REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY(7/48)
LSM8	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LTV1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
LYAR	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200)
LYPLA2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
LZTS2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MAD1L1	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MITOTIC_M_M_G1_PHASES(22/172),REACTOME_CELL_CYCLE_CHECKPOINTS(19/124),REACTOME_DNA_REPLICATION(22/192),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_CELL_CYCLE(27/421)
MAGEA9B	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MAGED2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MAGI2-AS3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MALSU1	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MBIP	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MBP	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MCM3	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200),HALLMARK_G2M_CHECKPOINT(25/200),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(16/65),REACTOME_S_PHASE(19/109),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(16/67),REACTOME_G1_S_TRANSITION(19/112),REACTOME_MITOTIC_M_M_G1_PHASES(22/172),REACTOME_CELL_CYCLE_CHECKPOINTS(19/124),REACTOME_M_G1_TRANSITION(16/81),REACTOME_DNA_REPLICATION(22/192),REACTOME_MITOTIC_G1_G1_S_PHASES(19/137),REACTOME_SYNTHESIS_OF_DNA(16/92),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_CELL_CYCLE(27/421),KEGG_DNA_REPLICATION(5/36)
MCM6	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),HALLMARK_E2F_TARGETS(29/200),HALLMARK_G2M_CHECKPOINT(25/200),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(16/65),REACTOME_S_PHASE(19/109),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(16/67),REACTOME_G1_S_TRANSITION(19/112),REACTOME_MITOTIC_M_M_G1_PHASES(22/172),REACTOME_CELL_CYCLE_CHECKPOINTS(19/124),REACTOME_M_G1_TRANSITION(16/81),REACTOME_DNA_REPLICATION(22/192),REACTOME_MITOTIC_G1_G1_S_PHASES(19/137),REACTOME_SYNTHESIS_OF_DNA(16/92),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_CELL_CYCLE(27/421),KEGG_DNA_REPLICATION(5/36)
MCTS1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MDC1	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_DNA_REPAIR(8/112)
MEG3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MEIS1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(25/200)
MEIS2	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(25/200)
METTL17	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
METTL5	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MFAP2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MFF	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MIA3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MIR503HG	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MITD1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MNAT1	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(31/161),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(17/65),HALLMARK_G2M_CHECKPOINT(25/200),REACTOME_HIV_INFECTION(25/207),REACTOME_S_PHASE(19/109),REACTOME_G1_S_TRANSITION(19/112),REACTOME_MITOTIC_G1_G1_S_PHASES(19/137),REACTOME_RNA_POL_II_TRANSCRIPTION(17/105),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_TRANSCRIPTION(21/210),REACTOME_CELL_CYCLE(27/421),REACTOME_HIV_LIFE_CYCLE(10/125),REACTOME_DNA_REPAIR(8/112),REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS(6/61),REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING(5/41),REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE(7/104)
MORF4L2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MPHOSPH6	TH34_1447_S01	v9		lowstringency_pd_outliers	KEGG_RNA_DEGRADATION(10/59)
MPV17	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MRPL11	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(13/200)
MRPL15	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(13/200)
MRPL2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MRPL22	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MRPL3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MRPL30	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MRPL32	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MRPL45	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MRPL52	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MRPL9	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200)
MRPS5	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MRPS9	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MSH5	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MSTO1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MT-CO2	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTA3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MTERF4	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTX2	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT(8/58),HALLMARK_OXIDATIVE_PHOSPHORYLATION(13/200)
MX2	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(33/933)
MXRA8	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MYADM	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
MYO19	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NAA10	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NANS	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NASP	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200),HALLMARK_G2M_CHECKPOINT(25/200)
NCAPD2	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200)
NCL	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(25/200),PID_MYC_ACTIV_PATHWAY(13/79),PID_TELOMERASE_PATHWAY(7/68)
NCOR1	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION(5/46),PID_HES_HEY_PATHWAY(5/48)
NDUFS6	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(13/200)
NDUFV2	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(13/200)
NECAP1	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MEMBRANE_TRAFFICKING(9/129)
NEDD8	TH34_1447_S01	v9		lowstringency_pd_outliers	BIOCARTA_P27_PATHWAY(4/13)
NELFE	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NFATC4	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NGDN	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NIF3L1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NIFK	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NKIRAS2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NME1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),HALLMARK_E2F_TARGETS(29/200),PID_MYC_ACTIV_PATHWAY(13/79),HALLMARK_DNA_REPAIR(11/150),REACTOME_METABOLISM_OF_NUCLEOTIDES(7/72),KEGG_PURINE_METABOLISM(9/159),KEGG_PYRIMIDINE_METABOLISM(7/98),BIOCARTA_SET_PATHWAY(3/11)
NOB1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NOC2L	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NOL10	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NOL11	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NOL7	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NOL8	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NONO	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NOP16	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),HALLMARK_MYC_TARGETS_V2(14/58)
NOP56	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),HALLMARK_E2F_TARGETS(29/200),HALLMARK_MYC_TARGETS_V2(14/58),REACTOME_METABOLISM_OF_PROTEINS(31/518),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(11/113),REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS(4/27)
NOP58	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NRBP1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NSRP1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NT5C3B	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NTS	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NUB1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NUCKS1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NUDT1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
NUDT21	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(28/111),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),HALLMARK_E2F_TARGETS(29/200),REACTOME_RNA_POL_II_TRANSCRIPTION(17/105),REACTOME_TRANSCRIPTION(21/210),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),REACTOME_MRNA_3_END_PROCESSING(9/35),REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA(7/23),REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS(5/14),HALLMARK_DNA_REPAIR(11/150)
NUP93	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_HIV_INFECTION(25/207),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(18/132),REACTOME_IMMUNE_SYSTEM(33/933),REACTOME_HIV_LIFE_CYCLE(10/125),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(7/54),REACTOME_METABOLISM_OF_NON_CODING_RNA(6/49),REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE(7/104)
NUTF2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
OARD1	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ODC1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),HALLMARK_G2M_CHECKPOINT(25/200),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(15/49),PID_MYC_ACTIV_PATHWAY(13/79),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200)
ODF2	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(25/200)
OSGEP	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
OXA1L	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(13/200)
P3H1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
P3H3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PAAF1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PABPN1	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(28/111),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),REACTOME_RNA_POL_II_TRANSCRIPTION(17/105),REACTOME_TRANSCRIPTION(21/210),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),REACTOME_MRNA_3_END_PROCESSING(9/35),REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA(7/23),REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS(5/14)
PAICS	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200),REACTOME_METABOLISM_OF_NUCLEOTIDES(7/72),KEGG_PURINE_METABOLISM(9/159),REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS(3/11)
PAK1IP1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PAPOLA	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(28/111),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),REACTOME_RNA_POL_II_TRANSCRIPTION(17/105),REACTOME_TRANSCRIPTION(21/210),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),REACTOME_MRNA_3_END_PROCESSING(9/35),KEGG_RNA_DEGRADATION(10/59),REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA(7/23),REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS(5/14)
PARP1	TH34_1447_S01	v9	Rucaparib,Olaparib,VELIPARIB,AZD 2281,NIRAPARIB,RUCAPARIB,ABT-888,OLAPARIB,INIPARIB,MK4827,KU-0059436,BSI-201,Veliparib,MK-4827	lowstringency_pd_outliers	BIOCARTA_HIVNEF_PATHWAY(6/58),BIOCARTA_CASPASE_PATHWAY(4/23),PID_HES_HEY_PATHWAY(5/48)
PARP2	TH34_1447_S01	v9	Rucaparib,Olaparib,Veliparib,AZD 2281,NIRAPARIB,MK-4827,OLAPARIB,MK4827,RUCAPARIB,VELIPARIB,ABT-888	lowstringency_pd_outliers	PID_TELOMERASE_PATHWAY(7/68),HALLMARK_UV_RESPONSE_UP(9/158)
PBDC1	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PBX2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PCDH18	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PCOLCE	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PDCD2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PDCL3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PDGFRB	TH34_1447_S01	v9	SORAFENIB,MOTESANIB,Dasatinib,ORANTINIB,SUNITINIB,TELATINIB,X-82,Regorafenib,NILOTINIB,AXITINIB,TANDUTINIB,Sorafenib,MASITINIB,IMATINIB,XL-820,DASATINIB,Pazopanib,Sunitinib,LINIFANIB,XL820,Imatinib,SORAFENIB TOSYLATE,REGORAFENIB,NINTEDANIB,PAZOPANIB	lowstringency_pd_outliers	NA
PDHA1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_OXIDATIVE_PHOSPHORYLATION(13/200),KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS(3/11)
PDIA6	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_UNFOLDED_PROTEIN_RESPONSE(11/113)
PFDN6	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(31/518)
PIGC	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(31/518)
PIP5K1A	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PKDCC	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PLAGL1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PLP1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PNN	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200)
POLB	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_DNA_REPAIR(11/150),REACTOME_DNA_REPAIR(8/112)
POLR1C	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_TRANSCRIPTION(21/210),HALLMARK_DNA_REPAIR(11/150),KEGG_PURINE_METABOLISM(9/159),KEGG_PYRIMIDINE_METABOLISM(7/98)
POLR2D	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(28/111),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),REACTOME_HIV_INFECTION(25/207),REACTOME_RNA_POL_II_TRANSCRIPTION(17/105),REACTOME_TRANSCRIPTION(21/210),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(7/45),HALLMARK_DNA_REPAIR(11/150),REACTOME_HIV_LIFE_CYCLE(10/125),REACTOME_DNA_REPAIR(8/112),REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS(6/61),REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING(5/41),KEGG_PURINE_METABOLISM(9/159),KEGG_PYRIMIDINE_METABOLISM(7/98),REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE(7/104)
POLR3D	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_TRANSCRIPTION(21/210),PID_MYC_ACTIV_PATHWAY(13/79),KEGG_PURINE_METABOLISM(9/159),KEGG_PYRIMIDINE_METABOLISM(7/98)
PPAN	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(14/58)
PPIA	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_HIV_INFECTION(25/207),HALLMARK_MTORC1_SIGNALING(23/200),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(18/132),REACTOME_HIV_LIFE_CYCLE(10/125)
PPID	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PPIG	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PPIH	TH34_1447_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(29/128)
PPIL1	TH34_1447_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(29/128)
PPM1G	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200)
PPP1R12C	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PPP6R1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PPP6R3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PRAME	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PREB	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(31/518),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(11/113),REACTOME_MEMBRANE_TRAFFICKING(9/129)
PRELID1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PREP	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PRMT5	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),HALLMARK_G2M_CHECKPOINT(25/200),REACTOME_METABOLISM_OF_NON_CODING_RNA(6/49)
PRPF3	TH34_1447_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(29/128),HALLMARK_UV_RESPONSE_UP(9/158)
PRPF31	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),KEGG_SPLICEOSOME(29/128)
PRPF40A	TH34_1447_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(29/128)
PRPSAP2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PRR11	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PRRC2C	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PSMA2	TH34_1447_S01	v9	BORTEZOMIB,CARFILZOMIB	lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(17/65),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(16/56),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(18/84),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(15/49),REACTOME_HIV_INFECTION(25/207),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(15/53),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(16/65),REACTOME_S_PHASE(19/109),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(16/67),REACTOME_G1_S_TRANSITION(19/112),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(15/57),KEGG_PROTEASOME(14/48),REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES(14/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(14/48),REACTOME_MITOTIC_M_M_G1_PHASES(22/172),REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT(14/51),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(14/51),REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1(14/51),REACTOME_CELL_CYCLE_CHECKPOINTS(19/124),REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G(14/52),REACTOME_M_G1_TRANSITION(16/81),REACTOME_DNA_REPLICATION(22/192),REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX(14/56),REACTOME_REGULATION_OF_APOPTOSIS(14/58),REACTOME_MITOTIC_G1_G1_S_PHASES(19/137),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(15/73),REACTOME_ER_PHAGOSOME_PATHWAY(14/61),REACTOME_SYNTHESIS_OF_DNA(16/92),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(14/64),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_SIGNALING_BY_WNT(14/65),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(18/132),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_APOPTOSIS(18/148),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),BIOCARTA_PROTEASOME_PATHWAY(10/28),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(15/97),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(20/212),REACTOME_CELL_CYCLE(27/421),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(15/126),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),REACTOME_IMMUNE_SYSTEM(33/933)
PSMA3	TH34_1447_S01	v9	BORTEZOMIB,CARFILZOMIB	lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(17/65),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(16/56),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(18/84),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(15/49),REACTOME_HIV_INFECTION(25/207),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(15/53),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(16/65),REACTOME_S_PHASE(19/109),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(16/67),REACTOME_G1_S_TRANSITION(19/112),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(15/57),KEGG_PROTEASOME(14/48),REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES(14/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(14/48),REACTOME_MITOTIC_M_M_G1_PHASES(22/172),HALLMARK_MTORC1_SIGNALING(23/200),REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT(14/51),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(14/51),REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1(14/51),REACTOME_CELL_CYCLE_CHECKPOINTS(19/124),REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G(14/52),REACTOME_M_G1_TRANSITION(16/81),REACTOME_DNA_REPLICATION(22/192),REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX(14/56),REACTOME_REGULATION_OF_APOPTOSIS(14/58),REACTOME_MITOTIC_G1_G1_S_PHASES(19/137),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(15/73),REACTOME_ER_PHAGOSOME_PATHWAY(14/61),REACTOME_SYNTHESIS_OF_DNA(16/92),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(14/64),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_SIGNALING_BY_WNT(14/65),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(18/132),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_APOPTOSIS(18/148),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),BIOCARTA_PROTEASOME_PATHWAY(10/28),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(15/97),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(20/212),REACTOME_CELL_CYCLE(27/421),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(15/126),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),REACTOME_IMMUNE_SYSTEM(33/933)
PSMA3-AS1	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PSMA6	TH34_1447_S01	v9	BORTEZOMIB,CARFILZOMIB	lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(17/65),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(16/56),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(18/84),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(15/49),REACTOME_HIV_INFECTION(25/207),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(15/53),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(16/65),REACTOME_S_PHASE(19/109),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(16/67),REACTOME_G1_S_TRANSITION(19/112),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(15/57),KEGG_PROTEASOME(14/48),REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES(14/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(14/48),REACTOME_MITOTIC_M_M_G1_PHASES(22/172),REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT(14/51),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(14/51),REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1(14/51),REACTOME_CELL_CYCLE_CHECKPOINTS(19/124),REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G(14/52),REACTOME_M_G1_TRANSITION(16/81),REACTOME_DNA_REPLICATION(22/192),REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX(14/56),REACTOME_REGULATION_OF_APOPTOSIS(14/58),REACTOME_MITOTIC_G1_G1_S_PHASES(19/137),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(15/73),REACTOME_ER_PHAGOSOME_PATHWAY(14/61),REACTOME_SYNTHESIS_OF_DNA(16/92),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(14/64),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_SIGNALING_BY_WNT(14/65),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(18/132),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_APOPTOSIS(18/148),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),BIOCARTA_PROTEASOME_PATHWAY(10/28),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(15/97),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(20/212),REACTOME_CELL_CYCLE(27/421),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(15/126),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),REACTOME_IMMUNE_SYSTEM(33/933)
PSMB3	TH34_1447_S01	v9	BORTEZOMIB,CARFILZOMIB	lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(17/65),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(16/56),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(18/84),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(15/49),REACTOME_HIV_INFECTION(25/207),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(15/53),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(16/65),REACTOME_S_PHASE(19/109),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(16/67),REACTOME_G1_S_TRANSITION(19/112),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(15/57),KEGG_PROTEASOME(14/48),REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES(14/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(14/48),REACTOME_MITOTIC_M_M_G1_PHASES(22/172),REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT(14/51),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(14/51),REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1(14/51),REACTOME_CELL_CYCLE_CHECKPOINTS(19/124),REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G(14/52),REACTOME_M_G1_TRANSITION(16/81),REACTOME_DNA_REPLICATION(22/192),REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX(14/56),REACTOME_REGULATION_OF_APOPTOSIS(14/58),REACTOME_MITOTIC_G1_G1_S_PHASES(19/137),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(15/73),REACTOME_ER_PHAGOSOME_PATHWAY(14/61),REACTOME_SYNTHESIS_OF_DNA(16/92),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(14/64),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_SIGNALING_BY_WNT(14/65),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(18/132),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_APOPTOSIS(18/148),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),BIOCARTA_PROTEASOME_PATHWAY(10/28),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(15/97),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(20/212),REACTOME_CELL_CYCLE(27/421),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(15/126),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),REACTOME_IMMUNE_SYSTEM(33/933)
PSMB4	TH34_1447_S01	v9	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(17/65),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(16/56),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(18/84),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(15/49),REACTOME_HIV_INFECTION(25/207),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(15/53),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(16/65),REACTOME_S_PHASE(19/109),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(16/67),REACTOME_G1_S_TRANSITION(19/112),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(15/57),KEGG_PROTEASOME(14/48),REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES(14/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(14/48),REACTOME_MITOTIC_M_M_G1_PHASES(22/172),REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT(14/51),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(14/51),REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1(14/51),REACTOME_CELL_CYCLE_CHECKPOINTS(19/124),REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G(14/52),REACTOME_M_G1_TRANSITION(16/81),REACTOME_DNA_REPLICATION(22/192),REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX(14/56),REACTOME_REGULATION_OF_APOPTOSIS(14/58),REACTOME_MITOTIC_G1_G1_S_PHASES(19/137),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(15/73),REACTOME_ER_PHAGOSOME_PATHWAY(14/61),REACTOME_SYNTHESIS_OF_DNA(16/92),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(14/64),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_SIGNALING_BY_WNT(14/65),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(18/132),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_APOPTOSIS(18/148),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),BIOCARTA_PROTEASOME_PATHWAY(10/28),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(15/97),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(20/212),REACTOME_CELL_CYCLE(27/421),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(15/126),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),REACTOME_IMMUNE_SYSTEM(33/933)
PSMB5	TH34_1447_S01	v9	Bortezomib,Carfilzomib,CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(17/65),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(16/56),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(18/84),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(15/49),REACTOME_HIV_INFECTION(25/207),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(15/53),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(16/65),REACTOME_S_PHASE(19/109),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(16/67),REACTOME_G1_S_TRANSITION(19/112),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(15/57),KEGG_PROTEASOME(14/48),REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES(14/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(14/48),REACTOME_MITOTIC_M_M_G1_PHASES(22/172),HALLMARK_MTORC1_SIGNALING(23/200),REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT(14/51),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(14/51),REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1(14/51),REACTOME_CELL_CYCLE_CHECKPOINTS(19/124),REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G(14/52),REACTOME_M_G1_TRANSITION(16/81),REACTOME_DNA_REPLICATION(22/192),REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX(14/56),REACTOME_REGULATION_OF_APOPTOSIS(14/58),REACTOME_MITOTIC_G1_G1_S_PHASES(19/137),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(15/73),REACTOME_ER_PHAGOSOME_PATHWAY(14/61),REACTOME_SYNTHESIS_OF_DNA(16/92),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(14/64),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_SIGNALING_BY_WNT(14/65),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(18/132),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_APOPTOSIS(18/148),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),BIOCARTA_PROTEASOME_PATHWAY(10/28),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(15/97),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(20/212),REACTOME_CELL_CYCLE(27/421),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(15/126),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),REACTOME_IMMUNE_SYSTEM(33/933)
PSMC1	TH34_1447_S01	v9	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(17/65),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(16/56),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(18/84),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(15/49),REACTOME_HIV_INFECTION(25/207),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(15/53),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(16/65),REACTOME_S_PHASE(19/109),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(16/67),REACTOME_G1_S_TRANSITION(19/112),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(15/57),KEGG_PROTEASOME(14/48),REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES(14/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(14/48),REACTOME_MITOTIC_M_M_G1_PHASES(22/172),REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT(14/51),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(14/51),REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1(14/51),REACTOME_CELL_CYCLE_CHECKPOINTS(19/124),REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G(14/52),REACTOME_M_G1_TRANSITION(16/81),REACTOME_DNA_REPLICATION(22/192),REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX(14/56),REACTOME_REGULATION_OF_APOPTOSIS(14/58),REACTOME_MITOTIC_G1_G1_S_PHASES(19/137),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(15/73),REACTOME_ER_PHAGOSOME_PATHWAY(14/61),REACTOME_SYNTHESIS_OF_DNA(16/92),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(14/64),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_SIGNALING_BY_WNT(14/65),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(18/132),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_APOPTOSIS(18/148),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(15/97),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(20/212),REACTOME_CELL_CYCLE(27/421),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(15/126),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),REACTOME_IMMUNE_SYSTEM(33/933)
PSMC2	TH34_1447_S01	v9	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(17/65),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(16/56),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(18/84),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(15/49),REACTOME_HIV_INFECTION(25/207),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(15/53),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(16/65),REACTOME_S_PHASE(19/109),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(16/67),REACTOME_G1_S_TRANSITION(19/112),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(15/57),KEGG_PROTEASOME(14/48),REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES(14/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(14/48),REACTOME_MITOTIC_M_M_G1_PHASES(22/172),HALLMARK_MTORC1_SIGNALING(23/200),REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT(14/51),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(14/51),REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1(14/51),REACTOME_CELL_CYCLE_CHECKPOINTS(19/124),REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G(14/52),REACTOME_M_G1_TRANSITION(16/81),REACTOME_DNA_REPLICATION(22/192),REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX(14/56),REACTOME_REGULATION_OF_APOPTOSIS(14/58),REACTOME_MITOTIC_G1_G1_S_PHASES(19/137),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(15/73),REACTOME_ER_PHAGOSOME_PATHWAY(14/61),REACTOME_SYNTHESIS_OF_DNA(16/92),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(14/64),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_SIGNALING_BY_WNT(14/65),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(18/132),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_APOPTOSIS(18/148),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),BIOCARTA_PROTEASOME_PATHWAY(10/28),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(15/97),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(20/212),REACTOME_CELL_CYCLE(27/421),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(15/126),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),REACTOME_IMMUNE_SYSTEM(33/933)
PSMC6	TH34_1447_S01	v9	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(17/65),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(16/56),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(18/84),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(15/49),REACTOME_HIV_INFECTION(25/207),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(15/53),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(16/65),REACTOME_S_PHASE(19/109),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(16/67),REACTOME_G1_S_TRANSITION(19/112),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(15/57),KEGG_PROTEASOME(14/48),REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES(14/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(14/48),REACTOME_MITOTIC_M_M_G1_PHASES(22/172),HALLMARK_MTORC1_SIGNALING(23/200),REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT(14/51),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(14/51),REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1(14/51),REACTOME_CELL_CYCLE_CHECKPOINTS(19/124),REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G(14/52),REACTOME_M_G1_TRANSITION(16/81),REACTOME_DNA_REPLICATION(22/192),REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX(14/56),REACTOME_REGULATION_OF_APOPTOSIS(14/58),REACTOME_MITOTIC_G1_G1_S_PHASES(19/137),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(15/73),REACTOME_ER_PHAGOSOME_PATHWAY(14/61),REACTOME_SYNTHESIS_OF_DNA(16/92),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(14/64),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_SIGNALING_BY_WNT(14/65),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(18/132),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_APOPTOSIS(18/148),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),BIOCARTA_PROTEASOME_PATHWAY(10/28),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(15/97),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(20/212),REACTOME_CELL_CYCLE(27/421),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(15/126),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),REACTOME_IMMUNE_SYSTEM(33/933)
PSMD11	TH34_1447_S01	v9	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(17/65),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(16/56),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(18/84),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(15/49),REACTOME_HIV_INFECTION(25/207),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(15/53),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(16/65),REACTOME_S_PHASE(19/109),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(16/67),REACTOME_G1_S_TRANSITION(19/112),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(15/57),KEGG_PROTEASOME(14/48),REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES(14/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(14/48),REACTOME_MITOTIC_M_M_G1_PHASES(22/172),REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT(14/51),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(14/51),REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1(14/51),REACTOME_CELL_CYCLE_CHECKPOINTS(19/124),REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G(14/52),REACTOME_M_G1_TRANSITION(16/81),REACTOME_DNA_REPLICATION(22/192),REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX(14/56),REACTOME_REGULATION_OF_APOPTOSIS(14/58),REACTOME_MITOTIC_G1_G1_S_PHASES(19/137),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(15/73),REACTOME_ER_PHAGOSOME_PATHWAY(14/61),REACTOME_SYNTHESIS_OF_DNA(16/92),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(14/64),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_SIGNALING_BY_WNT(14/65),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(18/132),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_APOPTOSIS(18/148),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),BIOCARTA_PROTEASOME_PATHWAY(10/28),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(15/97),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(20/212),REACTOME_CELL_CYCLE(27/421),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(15/126),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),REACTOME_IMMUNE_SYSTEM(33/933)
PSMD12	TH34_1447_S01	v9	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(17/65),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(16/56),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(18/84),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(15/49),REACTOME_HIV_INFECTION(25/207),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(15/53),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(16/65),REACTOME_S_PHASE(19/109),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(16/67),REACTOME_G1_S_TRANSITION(19/112),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(15/57),KEGG_PROTEASOME(14/48),REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES(14/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(14/48),REACTOME_MITOTIC_M_M_G1_PHASES(22/172),HALLMARK_MTORC1_SIGNALING(23/200),REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT(14/51),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(14/51),REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1(14/51),REACTOME_CELL_CYCLE_CHECKPOINTS(19/124),REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G(14/52),REACTOME_M_G1_TRANSITION(16/81),REACTOME_DNA_REPLICATION(22/192),REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX(14/56),REACTOME_REGULATION_OF_APOPTOSIS(14/58),REACTOME_MITOTIC_G1_G1_S_PHASES(19/137),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(15/73),REACTOME_ER_PHAGOSOME_PATHWAY(14/61),REACTOME_SYNTHESIS_OF_DNA(16/92),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(14/64),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_SIGNALING_BY_WNT(14/65),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(18/132),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_APOPTOSIS(18/148),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),BIOCARTA_PROTEASOME_PATHWAY(10/28),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(15/97),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(20/212),REACTOME_CELL_CYCLE(27/421),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(15/126),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),REACTOME_IMMUNE_SYSTEM(33/933)
PSMD3	TH34_1447_S01	v9	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(17/65),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(16/56),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(18/84),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(15/49),REACTOME_HIV_INFECTION(25/207),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(15/53),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(16/65),REACTOME_S_PHASE(19/109),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(16/67),REACTOME_G1_S_TRANSITION(19/112),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(15/57),KEGG_PROTEASOME(14/48),REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES(14/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(14/48),REACTOME_MITOTIC_M_M_G1_PHASES(22/172),REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT(14/51),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(14/51),REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1(14/51),REACTOME_CELL_CYCLE_CHECKPOINTS(19/124),REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G(14/52),REACTOME_M_G1_TRANSITION(16/81),REACTOME_DNA_REPLICATION(22/192),REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX(14/56),REACTOME_REGULATION_OF_APOPTOSIS(14/58),REACTOME_MITOTIC_G1_G1_S_PHASES(19/137),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(15/73),REACTOME_ER_PHAGOSOME_PATHWAY(14/61),REACTOME_SYNTHESIS_OF_DNA(16/92),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(14/64),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_SIGNALING_BY_WNT(14/65),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(18/132),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_APOPTOSIS(18/148),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(15/97),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(20/212),REACTOME_CELL_CYCLE(27/421),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(15/126),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),REACTOME_IMMUNE_SYSTEM(33/933)
PSMD4	TH34_1447_S01	v9	BORTEZOMIB,TALAZOPARIB,CARFILZOMIB	lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(17/65),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(16/56),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(18/84),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(15/49),REACTOME_HIV_INFECTION(25/207),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(15/53),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(16/65),REACTOME_S_PHASE(19/109),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(16/67),REACTOME_G1_S_TRANSITION(19/112),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(15/57),KEGG_PROTEASOME(14/48),REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES(14/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(14/48),REACTOME_MITOTIC_M_M_G1_PHASES(22/172),REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT(14/51),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(14/51),REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1(14/51),REACTOME_CELL_CYCLE_CHECKPOINTS(19/124),REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G(14/52),REACTOME_M_G1_TRANSITION(16/81),REACTOME_DNA_REPLICATION(22/192),REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX(14/56),REACTOME_REGULATION_OF_APOPTOSIS(14/58),REACTOME_MITOTIC_G1_G1_S_PHASES(19/137),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(15/73),REACTOME_ER_PHAGOSOME_PATHWAY(14/61),REACTOME_SYNTHESIS_OF_DNA(16/92),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(14/64),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_SIGNALING_BY_WNT(14/65),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(18/132),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_APOPTOSIS(18/148),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(15/97),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(20/212),REACTOME_CELL_CYCLE(27/421),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(15/126),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),REACTOME_IMMUNE_SYSTEM(33/933)
PSMD7	TH34_1447_S01	v9	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(17/65),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(16/56),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(18/84),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(15/49),REACTOME_HIV_INFECTION(25/207),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(15/53),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(16/65),REACTOME_S_PHASE(19/109),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(16/67),REACTOME_G1_S_TRANSITION(19/112),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(15/57),KEGG_PROTEASOME(14/48),REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES(14/48),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(14/48),REACTOME_MITOTIC_M_M_G1_PHASES(22/172),REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT(14/51),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(14/51),REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1(14/51),REACTOME_CELL_CYCLE_CHECKPOINTS(19/124),REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G(14/52),REACTOME_M_G1_TRANSITION(16/81),REACTOME_DNA_REPLICATION(22/192),REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX(14/56),REACTOME_REGULATION_OF_APOPTOSIS(14/58),REACTOME_MITOTIC_G1_G1_S_PHASES(19/137),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(15/73),REACTOME_ER_PHAGOSOME_PATHWAY(14/61),REACTOME_SYNTHESIS_OF_DNA(16/92),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(14/64),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(14/64),REACTOME_SIGNALING_BY_WNT(14/65),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(18/132),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(15/85),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(14/72),REACTOME_APOPTOSIS(18/148),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(14/76),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(15/97),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(20/212),REACTOME_CELL_CYCLE(27/421),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(15/126),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(15/200),REACTOME_IMMUNE_SYSTEM(33/933)
PSMG1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(23/200)
PSMG3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PTBP1	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(28/111),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140)
PTH1R	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
PTMA	TH34_1447_S01	v9		lowstringency_pd_outliers	PID_MYC_ACTIV_PATHWAY(13/79)
PTPN2	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(33/933)
PXDN	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
QPRT	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
RAD51C	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200)
RALA	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_DNA_REPAIR(11/150)
RARS	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_TRNA_AMINOACYLATION(9/42),KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(8/41),REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION(6/24)
RARS2	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_TRNA_AMINOACYLATION(9/42),KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(8/41),REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION(4/21)
RBM28	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
RBM34	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
RBM39	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
RBM8A	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(28/111),KEGG_SPLICEOSOME(29/128),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_RNA_POL_II_TRANSCRIPTION(17/105),REACTOME_TRANSCRIPTION(21/210),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),REACTOME_MRNA_3_END_PROCESSING(9/35),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(7/54)
RDH14	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
RECQL5	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
REEP4	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
RFC1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200),KEGG_DNA_REPLICATION(5/36)
RHNO1	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RNASEH1	TH34_1447_S01	v9		lowstringency_pd_outliers	KEGG_DNA_REPLICATION(5/36)
RNF212	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
RNF25	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(20/212),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_IMMUNE_SYSTEM(33/933)
RNF31	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
RNF44	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
RP11-14P20.1	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-423H2.1	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-632C17__A.1	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-70C1.3	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-669L17.10	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-765C7.2	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP9	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
RPF2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
RPL26L1	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_TRANSLATION(11/222)
RPL36A	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_TRANSLATION(11/222)
RPL39P3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
RPL7L1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
RPP21	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
RPS6KB2	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(15/97),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(15/126),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_IMMUNE_SYSTEM(33/933)
RPS7	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_TRANSLATION(11/222)
RPUSD3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
RRP36	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
RRP9	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),HALLMARK_MTORC1_SIGNALING(23/200),HALLMARK_MYC_TARGETS_V2(14/58),HALLMARK_UNFOLDED_PROTEIN_RESPONSE(11/113)
RSL1D1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200)
S100B	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(33/933)
SAMD11	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SAP25	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SCFD1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SCNM1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SDC1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SEC13	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MITOTIC_M_M_G1_PHASES(22/172),REACTOME_DNA_REPLICATION(22/192),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_CELL_CYCLE(27/421),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_IMMUNE_SYSTEM(33/933),REACTOME_MEMBRANE_TRAFFICKING(9/129)
SEC23A	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_IMMUNE_SYSTEM(33/933),REACTOME_MEMBRANE_TRAFFICKING(9/129)
SEMA3A	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SEMA4C	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SEPT6	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SEPT7	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SERBP1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200)
SERPINA3	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SETDB1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SF3A3	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(28/111),KEGG_SPLICEOSOME(29/128),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),HALLMARK_DNA_REPAIR(11/150)
SF3B3	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_MRNA_SPLICING(28/111),KEGG_SPLICEOSOME(29/128),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(7/45)
SF3B4	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(28/111),KEGG_SPLICEOSOME(29/128),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(7/45)
SF3B5	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(28/111),KEGG_SPLICEOSOME(29/128),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(7/45)
SF3B6	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SFPQ	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(25/200)
SFXN1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SKA2	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MITOTIC_M_M_G1_PHASES(22/172),REACTOME_DNA_REPLICATION(22/192),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_CELL_CYCLE(27/421)
SLC11A1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SLC2A3	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(23/200)
SLC4A1AP	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SLC50A1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SLC5A6	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SLIT2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SMARCD2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SMARCE1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SMEK1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SMPD4	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SNCG	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SNHG15	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SNHG16	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SNRPA1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_MRNA_SPLICING(28/111),KEGG_SPLICEOSOME(29/128),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140)
SNRPC	TH34_1447_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(29/128)
SNRPD1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_MRNA_SPLICING(28/111),KEGG_SPLICEOSOME(29/128),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),REACTOME_METABOLISM_OF_RNA(34/330),HALLMARK_G2M_CHECKPOINT(25/200),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(7/45),REACTOME_METABOLISM_OF_NON_CODING_RNA(6/49)
SNRPD3	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_MRNA_SPLICING(28/111),KEGG_SPLICEOSOME(29/128),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_RNA_POL_II_TRANSCRIPTION(17/105),REACTOME_TRANSCRIPTION(21/210),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA(7/23),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(7/45),REACTOME_METABOLISM_OF_NON_CODING_RNA(6/49)
SNRPF	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(28/111),KEGG_SPLICEOSOME(29/128),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_RNA_POL_II_TRANSCRIPTION(17/105),REACTOME_TRANSCRIPTION(21/210),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA(7/23),REACTOME_MRNA_SPLICING_MINOR_PATHWAY(7/45),REACTOME_METABOLISM_OF_NON_CODING_RNA(6/49)
SNW1	TH34_1447_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(29/128),REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION(5/46)
SNX8	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SPAG5	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200)
SPDL1	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SPP1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SRP54	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_TRANSLATION(11/222)
SRP68	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_TRANSLATION(11/222)
SRSF11	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(28/111),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),REACTOME_RNA_POL_II_TRANSCRIPTION(17/105),REACTOME_TRANSCRIPTION(21/210),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),REACTOME_MRNA_3_END_PROCESSING(9/35),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(7/54)
SS18	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(25/200)
SSB	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_TRANSCRIPTION(21/210)
SSBP1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),KEGG_DNA_REPLICATION(5/36)
SSU72	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
STARD3	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(9/158)
STARD3NL	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
STK19	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
STOML2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
STRA6	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
STX4	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MEMBRANE_TRAFFICKING(9/129)
SUPT16H	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_HIV_INFECTION(25/207),REACTOME_RNA_POL_II_TRANSCRIPTION(17/105),REACTOME_TRANSCRIPTION(21/210),REACTOME_HIV_LIFE_CYCLE(10/125),REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS(6/61),REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE(7/104)
SUPT6H	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
SUPT7L	TH34_1447_S01	v9		lowstringency_pd_outliers	PID_MYC_ACTIV_PATHWAY(13/79)
SYNCRIP	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),HALLMARK_E2F_TARGETS(29/200),HALLMARK_G2M_CHECKPOINT(25/200)
TAF11	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_HIV_INFECTION(25/207),REACTOME_RNA_POL_II_TRANSCRIPTION(17/105),REACTOME_TRANSCRIPTION(21/210),REACTOME_HIV_LIFE_CYCLE(10/125),REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS(6/61),REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING(5/41),REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE(7/104)
TAF15	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
TARS2	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_TRNA_AMINOACYLATION(9/42),KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(8/41),REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION(4/21)
TBRG4	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200),HALLMARK_MYC_TARGETS_V2(14/58)
TCOF1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(14/58)
TCP1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS(4/27)
TES	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(23/200)
TF	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
TFPT	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
THOC2	TH34_1447_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(29/128)
THOC3	TH34_1447_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(29/128)
TIMM17A	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT(8/58),HALLMARK_OXIDATIVE_PHOSPHORYLATION(13/200)
TIMM17B	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT(8/58)
TIMM44	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT(8/58)
TIMM9	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT(8/58),HALLMARK_OXIDATIVE_PHOSPHORYLATION(13/200)
TM2D2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
TMEM11	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
TMEM18	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
TMEM214	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
TMEM237	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
TMEM261	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TOMM40	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(23/200),REACTOME_METABOLISM_OF_PROTEINS(31/518),REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT(8/58)
TOMM6	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
TOP3A	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
TOX4	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
TRA2A	TH34_1447_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(29/128)
TRAPPC2B	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TRIM28	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200)
TRIM52-AS1	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TRIP12	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(20/212),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_IMMUNE_SYSTEM(33/933)
TRIP13	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200)
TRMU	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
TUBB	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_CELL_CYCLE(27/421)
TWIST1	TH34_1447_S01	v9		lowstringency_pd_outliers	PID_HES_HEY_PATHWAY(5/48)
TXNDC5	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MEMBRANE_TRAFFICKING(9/129)
TXNDC9	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
U2AF2	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(28/111),KEGG_SPLICEOSOME(29/128),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),REACTOME_RNA_POL_II_TRANSCRIPTION(17/105),REACTOME_TRANSCRIPTION(21/210),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),REACTOME_MRNA_3_END_PROCESSING(9/35),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(7/54)
UBAP2L	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
UBE2M	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(20/212),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_IMMUNE_SYSTEM(33/933),BIOCARTA_P27_PATHWAY(4/13)
UBE2S	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_E2F_TARGETS(29/200),HALLMARK_G2M_CHECKPOINT(25/200),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(22/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(20/212),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(25/539),REACTOME_IMMUNE_SYSTEM(33/933)
UCHL5	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(23/200)
UCK2	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(25/200),REACTOME_METABOLISM_OF_NUCLEOTIDES(7/72),KEGG_PYRIMIDINE_METABOLISM(7/98)
UGDH	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
UPF3B	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(28/111),REACTOME_MRNA_PROCESSING(31/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(29/140),REACTOME_METABOLISM_OF_RNA(34/330),REACTOME_METABOLISM_OF_MRNA(28/284),REACTOME_RNA_POL_II_TRANSCRIPTION(17/105),REACTOME_TRANSCRIPTION(21/210),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(11/44),REACTOME_MRNA_3_END_PROCESSING(9/35),HALLMARK_DNA_REPAIR(11/150),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(7/54)
UTP11L	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
UTP18	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
UTP6	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
VARS	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_TRNA_AMINOACYLATION(9/42),KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(8/41),REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION(6/24),KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS(3/11)
VPS41	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
VPS45	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
VPS72	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
WDR12	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
WDR26	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
WDR43	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(14/58)
WDR46	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
WDR74	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(14/58)
WDR75	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
WRNIP1	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
WT1	TH34_1447_S01	v9	CYTARABINE,DAUNORUBICIN	lowstringency_pd_outliers	PID_TELOMERASE_PATHWAY(7/68)
XPO5	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
XRCC6	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(48/200),HALLMARK_E2F_TARGETS(29/200),REACTOME_HIV_INFECTION(25/207),REACTOME_HIV_LIFE_CYCLE(10/125),PID_TELOMERASE_PATHWAY(7/68),REACTOME_DNA_REPAIR(8/112)
YAE1D1	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
YIPF2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
YKT6	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(23/200),HALLMARK_UV_RESPONSE_UP(9/158)
YY1	TH34_1447_S01	v9		lowstringency_pd_outliers	PID_HES_HEY_PATHWAY(5/48)
ZBTB8OS	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ZC3H18	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ZMAT2	TH34_1447_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(29/128)
ZMIZ2	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ZNF274	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ZNF362	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ZNF444	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ZNF544	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ZNF580	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ZNF581	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ZNF787	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ZNF814	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ZNRD1	TH34_1447_S01	v9		lowstringency_pd_outliers	HALLMARK_DNA_REPAIR(11/150),KEGG_PURINE_METABOLISM(9/159),KEGG_PYRIMIDINE_METABOLISM(7/98)
ZPR1	TH34_1447_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZSWIM7	TH34_1447_S01	v9		lowstringency_pd_outliers	NA
ZWINT	TH34_1447_S01	v9		lowstringency_pd_outliers	REACTOME_MITOTIC_M_M_G1_PHASES(22/172),REACTOME_DNA_REPLICATION(22/192),REACTOME_CELL_CYCLE_MITOTIC(26/325),REACTOME_CELL_CYCLE(27/421),HALLMARK_DNA_REPAIR(11/150)
ABCF1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
ABCF2	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(8/200)
AC074289.1	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACP1	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(10/200),KEGG_RIBOFLAVIN_METABOLISM(2/16)
ADAM8	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
ADCY4	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
ADGRG3	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AKIRIN2	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
AL662801.1	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ALDH1A2	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
ALOX5AP	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
AP1G2	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
ATG16L2	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
ATG2A	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
AVL9	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
BCL2A1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
BOLA2	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
BPHL	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
BRD9	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
BRMS1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
BTN2A1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
C11orf98	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
C15orf48	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
C1orf35	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
CBWD1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
CBWD7	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
CCDC86	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
CDC37	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
CDK11A	TH34_1447_S02	v9		lowstringency_pd_outliers	BIOCARTA_HIVNEF_PATHWAY(3/58)
CDK11B	TH34_1447_S02	v9		lowstringency_pd_outliers	BIOCARTA_HIVNEF_PATHWAY(3/58)
CHD8	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
CHMP2A	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
CIAPIN1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
CNOT11	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CNOT3	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(12/330),REACTOME_METABOLISM_OF_MRNA(10/284),KEGG_RNA_DEGRADATION(3/59)
COMMD9	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
COX5B	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
CPSF3	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_3_END_PROCESSING(5/35),REACTOME_MRNA_PROCESSING(8/161),REACTOME_MRNA_SPLICING(7/111),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(5/44),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(7/140),REACTOME_RNA_POL_II_TRANSCRIPTION(6/105),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(4/54),REACTOME_TRANSCRIPTION(6/210),REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS(2/14)
CSF3R	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
CSNK1D	TH34_1447_S02	v9		lowstringency_pd_outliers	PID_P53_REGULATION_PATHWAY(4/59),REACTOME_CELL_CYCLE(8/421),REACTOME_CELL_CYCLE_MITOTIC(7/325)
CWC25	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
CXCL8	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
CYCS	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_APOPTOSIS(7/148),BIOCARTA_HIVNEF_PATHWAY(3/58)
DDIT3	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(8/200),PID_MYC_REPRESS_PATHWAY(4/63)
DDX41	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
DENND3	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
DHX16	TH34_1447_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(10/128)
DHX34	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
DKC1	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(8/421),HALLMARK_G2M_CHECKPOINT(5/200)
DMAP1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
DRG2	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
DUS1L	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
EEF1E1	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_TRNA_AMINOACYLATION(5/42),HALLMARK_MTORC1_SIGNALING(8/200)
EIF2B2	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
EIF3B	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(10/200)
EIF5B	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
ELFN1-AS1	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ERAL1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
ERVK3-1	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
EXOSC3	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(12/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(7/84),REACTOME_METABOLISM_OF_MRNA(10/284),KEGG_RNA_DEGRADATION(3/59)
FAM136A	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
FAM192A	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
FBRS	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
FCGR3B	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
FGR	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
FIP1L1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
FKBP4	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(5/158),HALLMARK_GLYCOLYSIS(5/200)
FLAD1	TH34_1447_S02	v9		lowstringency_pd_outliers	KEGG_RIBOFLAVIN_METABOLISM(2/16)
FLOT1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
FTSJ2	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
GALE	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(5/200)
GET4	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
GGCT	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
GNPDA1	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(5/200)
GPATCH4	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
GTF2H4	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(8/161),REACTOME_RNA_POL_II_TRANSCRIPTION(6/105),REACTOME_HIV_INFECTION(7/207),REACTOME_TRANSCRIPTION(6/210)
HARS2	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_TRNA_AMINOACYLATION(5/42),KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(4/41),REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION(3/21)
HBA1	TH34_1447_S02	v9		lowstringency_pd_outliers	BIOCARTA_AHSP_PATHWAY(2/13)
HBA2	TH34_1447_S02	v9		lowstringency_pd_outliers	BIOCARTA_AHSP_PATHWAY(2/13)
HCAR2	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
HCAR3	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
HDAC3	TH34_1447_S02	v9		lowstringency_pd_outliers	PID_MYC_REPRESS_PATHWAY(4/63)
HMGN3	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
HMOX1	TH34_1447_S02	v9	SUNITINIB,SORAFENIB	lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(5/158)
HOXA-AS2	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HOXA3	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
HOXA4	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
HSPA6	TH34_1447_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(10/128)
HSPBP1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
ID2	TH34_1447_S02	v9		lowstringency_pd_outliers	PID_MYC_REPRESS_PATHWAY(4/63)
ID2-AS1	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
IL11	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
ILF2	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(10/200)
IMP4	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(6/58)
INPP5F	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
IPO4	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(6/58)
ITGAX	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
IVNS1ABP	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
KLHL7	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
KRI1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
LCP2	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(14/933)
LILRB3	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(14/933)
LINC01272	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LPCAT1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
LRCH4	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
LRWD1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
LTV1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
LYPLA2	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
MAGEA9B	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
MALSU1	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MAP4K2	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
MAPK1IP1L	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
METTL22	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
MIA3	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
MIR671	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MRPL2	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
MRPL32	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
MRPL38	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
MRPS9	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
MT-CO2	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MXD1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
MYO1F	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
NADK	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
NBEAL2	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
NCF2	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(7/76),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(11/251),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(14/933)
NDUFA3	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
NECAP1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
NEDD8	TH34_1447_S02	v9		lowstringency_pd_outliers	PID_P53_REGULATION_PATHWAY(4/59),BIOCARTA_P27_PATHWAY(2/13),PID_ERB_GENOMIC_PATHWAY(2/15)
NELFE	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NGDN	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
NOL10	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
NOL7	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
NRBP1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
PABPN1	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_3_END_PROCESSING(5/35),REACTOME_MRNA_PROCESSING(8/161),REACTOME_MRNA_SPLICING(7/111),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(5/44),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(7/140),REACTOME_RNA_POL_II_TRANSCRIPTION(6/105),REACTOME_TRANSCRIPTION(6/210),REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS(2/14)
PBDC1	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PFDN6	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
PHACTR1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
PHKG2	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
PPIF	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(5/158)
PPM1G	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(10/200)
PPP1R12C	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
PPP4C	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
PPP6R1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
PRMT5	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(12/330),PID_P53_REGULATION_PATHWAY(4/59),HALLMARK_G2M_CHECKPOINT(5/200)
PRPF31	TH34_1447_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(10/128),HALLMARK_MYC_TARGETS_V1(10/200)
PSMB5	TH34_1447_S02	v9	Bortezomib,Carfilzomib,CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	KEGG_PROTEASOME(6/48),REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES(6/48),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(7/76),REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT(6/51),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(6/48),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(6/49),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(6/51),REACTOME_METABOLISM_OF_RNA(12/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(7/84),REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1(6/51),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(11/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(10/212),REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G(6/52),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(6/53),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX(6/56),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(6/56),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(6/57),REACTOME_REGULATION_OF_APOPTOSIS(6/58),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(7/97),REACTOME_ER_PHAGOSOME_PATHWAY(6/61),REACTOME_SIGNALING_BY_WNT(6/65),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(6/64),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(6/65),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(6/65),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(6/64),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(6/67),REACTOME_METABOLISM_OF_MRNA(10/284),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(6/72),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(6/73),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(7/126),REACTOME_M_G1_TRANSITION(6/81),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(6/85),HALLMARK_MTORC1_SIGNALING(8/200),REACTOME_SYNTHESIS_OF_DNA(6/92),REACTOME_APOPTOSIS(7/148),REACTOME_S_PHASE(6/109),REACTOME_G1_S_TRANSITION(6/112),REACTOME_CELL_CYCLE_CHECKPOINTS(6/124),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(6/132),REACTOME_MITOTIC_G1_G1_S_PHASES(6/137),REACTOME_HIV_INFECTION(7/207),REACTOME_IMMUNE_SYSTEM(14/933),REACTOME_MITOTIC_M_M_G1_PHASES(6/172),REACTOME_DNA_REPLICATION(6/192),BIOCARTA_PROTEASOME_PATHWAY(3/28),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(6/200),REACTOME_CELL_CYCLE(8/421),REACTOME_CELL_CYCLE_MITOTIC(7/325)
PSMC1	TH34_1447_S02	v9	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	KEGG_PROTEASOME(6/48),REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES(6/48),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(7/76),REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT(6/51),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(6/48),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(6/49),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(6/51),REACTOME_METABOLISM_OF_RNA(12/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(7/84),REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1(6/51),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(11/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(10/212),REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G(6/52),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(6/53),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX(6/56),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(6/56),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(6/57),REACTOME_REGULATION_OF_APOPTOSIS(6/58),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(7/97),REACTOME_ER_PHAGOSOME_PATHWAY(6/61),REACTOME_SIGNALING_BY_WNT(6/65),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(6/64),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(6/65),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(6/65),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(6/64),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(6/67),REACTOME_METABOLISM_OF_MRNA(10/284),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(6/72),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(6/73),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(7/126),REACTOME_M_G1_TRANSITION(6/81),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(6/85),REACTOME_SYNTHESIS_OF_DNA(6/92),REACTOME_APOPTOSIS(7/148),REACTOME_S_PHASE(6/109),REACTOME_G1_S_TRANSITION(6/112),REACTOME_CELL_CYCLE_CHECKPOINTS(6/124),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(6/132),REACTOME_MITOTIC_G1_G1_S_PHASES(6/137),REACTOME_HIV_INFECTION(7/207),REACTOME_IMMUNE_SYSTEM(14/933),REACTOME_MITOTIC_M_M_G1_PHASES(6/172),REACTOME_DNA_REPLICATION(6/192),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(6/200),REACTOME_CELL_CYCLE(8/421),REACTOME_CELL_CYCLE_MITOTIC(7/325)
PSMD11	TH34_1447_S02	v9	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	KEGG_PROTEASOME(6/48),REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES(6/48),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(7/76),REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT(6/51),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(6/48),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(6/49),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(6/51),REACTOME_METABOLISM_OF_RNA(12/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(7/84),REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1(6/51),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(11/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(10/212),REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G(6/52),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(6/53),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX(6/56),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(6/56),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(6/57),REACTOME_REGULATION_OF_APOPTOSIS(6/58),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(7/97),REACTOME_ER_PHAGOSOME_PATHWAY(6/61),REACTOME_SIGNALING_BY_WNT(6/65),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(6/64),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(6/65),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(6/65),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(6/64),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(6/67),REACTOME_METABOLISM_OF_MRNA(10/284),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(6/72),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(6/73),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(7/126),REACTOME_M_G1_TRANSITION(6/81),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(6/85),REACTOME_SYNTHESIS_OF_DNA(6/92),REACTOME_APOPTOSIS(7/148),REACTOME_S_PHASE(6/109),REACTOME_G1_S_TRANSITION(6/112),REACTOME_CELL_CYCLE_CHECKPOINTS(6/124),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(6/132),REACTOME_MITOTIC_G1_G1_S_PHASES(6/137),REACTOME_HIV_INFECTION(7/207),REACTOME_IMMUNE_SYSTEM(14/933),REACTOME_MITOTIC_M_M_G1_PHASES(6/172),REACTOME_DNA_REPLICATION(6/192),BIOCARTA_PROTEASOME_PATHWAY(3/28),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(6/200),REACTOME_CELL_CYCLE(8/421),REACTOME_CELL_CYCLE_MITOTIC(7/325)
PSMD12	TH34_1447_S02	v9	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	KEGG_PROTEASOME(6/48),REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES(6/48),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(7/76),REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT(6/51),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(6/48),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(6/49),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(6/51),REACTOME_METABOLISM_OF_RNA(12/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(7/84),REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1(6/51),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(11/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(10/212),REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G(6/52),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(6/53),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX(6/56),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(6/56),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(6/57),REACTOME_REGULATION_OF_APOPTOSIS(6/58),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(7/97),REACTOME_ER_PHAGOSOME_PATHWAY(6/61),REACTOME_SIGNALING_BY_WNT(6/65),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(6/64),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(6/65),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(6/65),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(6/64),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(6/67),REACTOME_METABOLISM_OF_MRNA(10/284),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(6/72),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(6/73),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(7/126),REACTOME_M_G1_TRANSITION(6/81),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(6/85),HALLMARK_MTORC1_SIGNALING(8/200),REACTOME_SYNTHESIS_OF_DNA(6/92),REACTOME_APOPTOSIS(7/148),REACTOME_S_PHASE(6/109),REACTOME_G1_S_TRANSITION(6/112),REACTOME_CELL_CYCLE_CHECKPOINTS(6/124),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(6/132),REACTOME_MITOTIC_G1_G1_S_PHASES(6/137),REACTOME_HIV_INFECTION(7/207),REACTOME_IMMUNE_SYSTEM(14/933),REACTOME_MITOTIC_M_M_G1_PHASES(6/172),REACTOME_DNA_REPLICATION(6/192),BIOCARTA_PROTEASOME_PATHWAY(3/28),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(6/200),REACTOME_CELL_CYCLE(8/421),REACTOME_CELL_CYCLE_MITOTIC(7/325)
PSMD4	TH34_1447_S02	v9	BORTEZOMIB,TALAZOPARIB,CARFILZOMIB	lowstringency_pd_outliers	KEGG_PROTEASOME(6/48),REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES(6/48),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(7/76),REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT(6/51),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(6/48),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(6/49),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(6/51),REACTOME_METABOLISM_OF_RNA(12/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(7/84),REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1(6/51),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(11/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(10/212),REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G(6/52),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(6/53),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX(6/56),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(6/56),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(6/57),REACTOME_REGULATION_OF_APOPTOSIS(6/58),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(7/97),REACTOME_ER_PHAGOSOME_PATHWAY(6/61),REACTOME_SIGNALING_BY_WNT(6/65),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(6/64),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(6/65),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(6/65),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(6/64),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(6/67),REACTOME_METABOLISM_OF_MRNA(10/284),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(6/72),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(6/73),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(7/126),REACTOME_M_G1_TRANSITION(6/81),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(6/85),REACTOME_SYNTHESIS_OF_DNA(6/92),REACTOME_APOPTOSIS(7/148),REACTOME_S_PHASE(6/109),REACTOME_G1_S_TRANSITION(6/112),REACTOME_CELL_CYCLE_CHECKPOINTS(6/124),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(6/132),REACTOME_MITOTIC_G1_G1_S_PHASES(6/137),REACTOME_HIV_INFECTION(7/207),REACTOME_IMMUNE_SYSTEM(14/933),REACTOME_MITOTIC_M_M_G1_PHASES(6/172),REACTOME_DNA_REPLICATION(6/192),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(6/200),REACTOME_CELL_CYCLE(8/421),REACTOME_CELL_CYCLE_MITOTIC(7/325)
PSMD7	TH34_1447_S02	v9	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(10/200),KEGG_PROTEASOME(6/48),REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES(6/48),REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION(7/76),REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT(6/51),REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6(6/48),REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC(6/49),REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1(6/51),REACTOME_METABOLISM_OF_RNA(12/330),REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS(7/84),REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1(6/51),REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(11/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(10/212),REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G(6/52),REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0(6/53),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX(6/56),REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21(6/56),REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE(6/57),REACTOME_REGULATION_OF_APOPTOSIS(6/58),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(7/97),REACTOME_ER_PHAGOSOME_PATHWAY(6/61),REACTOME_SIGNALING_BY_WNT(6/65),REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS(6/64),REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_(6/65),REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX(6/65),REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C(6/64),REACTOME_ORC1_REMOVAL_FROM_CHROMATIN(6/67),REACTOME_METABOLISM_OF_MRNA(10/284),REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1(6/72),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS(6/73),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(7/126),REACTOME_M_G1_TRANSITION(6/81),REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE(6/85),REACTOME_SYNTHESIS_OF_DNA(6/92),REACTOME_APOPTOSIS(7/148),REACTOME_S_PHASE(6/109),REACTOME_G1_S_TRANSITION(6/112),REACTOME_CELL_CYCLE_CHECKPOINTS(6/124),REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS(6/132),REACTOME_MITOTIC_G1_G1_S_PHASES(6/137),REACTOME_HIV_INFECTION(7/207),REACTOME_IMMUNE_SYSTEM(14/933),REACTOME_MITOTIC_M_M_G1_PHASES(6/172),REACTOME_DNA_REPLICATION(6/192),REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES(6/200),REACTOME_CELL_CYCLE(8/421),REACTOME_CELL_CYCLE_MITOTIC(7/325)
RABGGTA	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
RARS	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_TRNA_AMINOACYLATION(5/42),KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(4/41),HALLMARK_GLYCOLYSIS(5/200)
RARS2	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_TRNA_AMINOACYLATION(5/42),KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(4/41),REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION(3/21)
RBM28	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
RBM8A	TH34_1447_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(10/128),REACTOME_METABOLISM_OF_RNA(12/330),REACTOME_MRNA_3_END_PROCESSING(5/35),REACTOME_MRNA_PROCESSING(8/161),REACTOME_MRNA_SPLICING(7/111),REACTOME_METABOLISM_OF_MRNA(10/284),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(5/44),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(7/140),REACTOME_RNA_POL_II_TRANSCRIPTION(6/105),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(4/54),REACTOME_TRANSCRIPTION(6/210)
RNASEH1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
RNF166	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
RNF25	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(11/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(10/212),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(14/933)
RNF31	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
RNF40	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
RP11-14P20.1	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-323N12.5	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-343H5.4	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-423H2.1	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-632C17__A.1	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-70C1.3	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-765C7.2	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP9	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
RPF2	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
RPS6KB2	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR(7/97),REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR(7/126),REACTOME_IMMUNE_SYSTEM(14/933)
RRP36	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
RRP9	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(10/200),HALLMARK_MYC_TARGETS_V2(6/58),HALLMARK_MTORC1_SIGNALING(8/200)
S100P	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
SAP25	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
SCNM1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
SEC14L1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
SF3A3	TH34_1447_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(10/128),REACTOME_MRNA_PROCESSING(8/161),REACTOME_MRNA_SPLICING(7/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(7/140)
SF3B6	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SFXN1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
SKIV2L	TH34_1447_S02	v9		lowstringency_pd_outliers	KEGG_RNA_DEGRADATION(3/59)
SLC11A1	TH34_1447_S02	v9		lowstringency_pd_outliers	PID_MYC_REPRESS_PATHWAY(4/63)
SLC25A37	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
SLX1B	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
SNCG	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
SNRPC	TH34_1447_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(10/128)
SNRPD1	TH34_1447_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(10/128),HALLMARK_MYC_TARGETS_V1(10/200),REACTOME_METABOLISM_OF_RNA(12/330),REACTOME_MRNA_PROCESSING(8/161),REACTOME_MRNA_SPLICING(7/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(7/140),HALLMARK_G2M_CHECKPOINT(5/200)
SRP54	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
SS18	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(5/200)
SSBP1	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(10/200)
STARD3	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(5/158)
STK19	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
STOML2	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
STX4	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
SUPT6H	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
TARS2	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_TRNA_AMINOACYLATION(5/42),KEGG_AMINOACYL_TRNA_BIOSYNTHESIS(4/41),REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION(3/21)
TBRG4	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(6/58)
TCOF1	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(6/58)
TFPT	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
THOC3	TH34_1447_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(10/128)
TIMM9	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
TMEM18	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
TOMM6	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
TPI1	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(8/200),HALLMARK_GLYCOLYSIS(5/200)
TRAPPC2B	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TREM1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
TRIM11	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(11/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(10/212),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(14/933)
TRIM28	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V1(10/200),PID_P53_REGULATION_PATHWAY(4/59)
TTC1	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
TXNDC9	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
U2AF2	TH34_1447_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(10/128),REACTOME_MRNA_3_END_PROCESSING(5/35),REACTOME_MRNA_PROCESSING(8/161),REACTOME_MRNA_SPLICING(7/111),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(5/44),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(7/140),REACTOME_RNA_POL_II_TRANSCRIPTION(6/105),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(4/54),REACTOME_TRANSCRIPTION(6/210)
UBE2M	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(11/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(10/212),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(14/933),BIOCARTA_P27_PATHWAY(2/13),PID_ERB_GENOMIC_PATHWAY(2/15)
UBE2S	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION(11/251),REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION(10/212),REACTOME_ADAPTIVE_IMMUNE_SYSTEM(14/539),REACTOME_IMMUNE_SYSTEM(14/933),HALLMARK_G2M_CHECKPOINT(5/200)
UPF3B	TH34_1447_S02	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_RNA(12/330),REACTOME_MRNA_3_END_PROCESSING(5/35),REACTOME_MRNA_PROCESSING(8/161),REACTOME_MRNA_SPLICING(7/111),REACTOME_METABOLISM_OF_MRNA(10/284),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(5/44),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(7/140),REACTOME_RNA_POL_II_TRANSCRIPTION(6/105),REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM(4/54),REACTOME_TRANSCRIPTION(6/210)
VPS72	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
WDR74	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_MYC_TARGETS_V2(6/58)
YKT6	TH34_1447_S02	v9		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(8/200),HALLMARK_UV_RESPONSE_UP(5/158)
ZC3H18	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
ZDHHC11	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
ZFAND2A	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
ZMAT2	TH34_1447_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(10/128)
ZMIZ2	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
ZNF274	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
ZNF544	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
ZNF579	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
ZNF580	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
ZNF787	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
ZNF814	TH34_1447_S02	v9		lowstringency_pd_outliers	NA
ZPR1	TH34_1447_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ABTB1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
AC008623.1	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC009065.4	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACAD11	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ACIN1	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(12/128)
ACSF3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ADAM33	TH34_1452_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(29/1028)
ADAMTS2	TH34_1452_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(29/1028)
ADAMTSL2	TH34_1452_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(29/1028)
ADAMTSL4	TH34_1452_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(29/1028)
ADAP1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ADAR	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(16/161)
ADGRB1	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADGRG2	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADGRL2	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AFG3L1P	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
AGA	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
AIF1L	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
AKT1	TH34_1452_S01	v9	Everolimus,MK-2206,GSK2126458,PERIFOSINE,AZD5363,AZD-5363,MK2206,IPATASERTIB,Vemurafenib,VEMURAFENIB,Perifosine,EVEROLIMUS,AZD4547,GDC-0068,Ipatasertib	lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),PID_ERBB2_ERBB3_PATHWAY(8/44),KEGG_INSULIN_SIGNALING_PATHWAY(12/137),KEGG_MAPK_SIGNALING_PATHWAY(16/267),REACTOME_SIGNALING_BY_ERBB2(10/101),BIOCARTA_PTEN_PATHWAY(5/18),KEGG_PATHWAYS_IN_CANCER(16/328),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(9/100),BIOCARTA_IGF1R_PATHWAY(5/23),PID_SMAD2_3NUCLEAR_PATHWAY(8/82),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(9/109),REACTOME_SIGNALING_BY_FGFR(9/112),KEGG_PROSTATE_CANCER(8/89),PID_BCR_5PATHWAY(7/65),ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS(6/45),PID_INSULIN_PATHWAY(6/45),PID_HEDGEHOG_GLI_PATHWAY(6/48),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(8/97),PID_RETINOIC_ACID_PATHWAY(5/30),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(9/127),PID_AURORA_A_PATHWAY(5/31),KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY(7/75),KEGG_ENDOMETRIAL_CANCER(6/52),PID_KIT_PATHWAY(6/52),BIOCARTA_HCMV_PATHWAY(4/17),SA_PTEN_PATHWAY(4/17),PID_FGF_PATHWAY(6/55),BIOCARTA_NFAT_PATHWAY(6/56),PID_REG_GR_PATHWAY(7/82),BIOCARTA_TFF_PATHWAY(4/21),PID_FCER1_PATHWAY(6/62),REACTOME_SIGNALING_BY_ERBB4(7/90),REACTOME_SIGNALING_BY_PDGF(8/122),BIOCARTA_MTOR_PATHWAY(4/23),BIOCARTA_PTDINS_PATHWAY(4/23),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(7/95),BIOCARTA_EIF4_PATHWAY(4/24),PID_VEGFR1_2_PATHWAY(6/69),KEGG_FOCAL_ADHESION(10/201),PID_LYMPH_ANGIOGENESIS_PATHWAY(4/25),SIG_BCR_SIGNALING_PATHWAY(5/46),PID_A6B1_A6B4_INTEGRIN_PATHWAY(5/46),KEGG_CHRONIC_MYELOID_LEUKEMIA(6/73),BIOCARTA_CREB_PATHWAY(4/27),SIG_IL4RECEPTOR_IN_B_LYPHOCYTES(4/27),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(8/137),BIOCARTA_TRKA_PATHWAY(3/12)
AL603831.1	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL662801.1	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AMOTL2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
AMZ2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ANGPTL6	TH34_1452_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(29/1028)
ANK2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ANKRD11	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ANKRD13B	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ANKRD65	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ANKZF1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
AP003041.1	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ARHGAP4	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ARL16	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ARL8A	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ASNSD1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ASPSCR1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ASXL1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ATF6B	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ATN1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ATP11A	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ATXN2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ATXN2L	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
AXIN2	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(16/328),PID_ERA_GENOMIC_PATHWAY(7/65),KEGG_ENDOMETRIAL_CANCER(6/52),KEGG_WNT_SIGNALING_PATHWAY(9/151)
B9D1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
BAIAP2	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_CDC42_PATHWAY(8/70),HALLMARK_P53_PATHWAY(11/200),KEGG_ADHERENS_JUNCTION(6/75)
BAZ2A	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
BBS1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
BCL9L	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
BCLAF1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
BECN1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
BEGAIN	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
BIRC2	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(16/328),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(10/138),KEGG_FOCAL_ADHESION(10/201)
BIRC6	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(10/138)
BMPER	TH34_1452_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(29/1028)
BOP1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
BPTF	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
BRD2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
BRF1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_TRANSCRIPTION(11/210)
BRINP2	TH34_1452_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(29/1028)
BSCL2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
C11orf57	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
C11orf84	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
C11orf95	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
C17orf85	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
C1orf194	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
C2orf72	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
C5orf49	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
C7orf55-LUC7L2	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
C9orf117	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CACNA1H	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),REACTOME_AXON_GUIDANCE(17/251),KEGG_MAPK_SIGNALING_PATHWAY(16/267),REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH(7/64),REACTOME_NCAM1_INTERACTIONS(5/39)
CACNA1I	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),REACTOME_AXON_GUIDANCE(17/251),KEGG_MAPK_SIGNALING_PATHWAY(16/267),REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH(7/64),REACTOME_NCAM1_INTERACTIONS(5/39)
CACNA2D2	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(16/267)
CACNB1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),REACTOME_AXON_GUIDANCE(17/251),KEGG_MAPK_SIGNALING_PATHWAY(16/267),REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH(7/64),REACTOME_NCAM1_INTERACTIONS(5/39)
CAMSAP3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CARS2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CASC3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CASKIN2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CASZ1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CBWD3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CBX1	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(13/200)
CBX2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CBX4	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CBX8	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CCDC114	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CCDC12	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(12/128)
CCDC13	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CCDC159	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CCDC24	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CCDC37	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CCDC40	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CCDC57	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CCDC74A	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CCDC74B	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CCDC84	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CCNK	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_P53_DOWNSTREAM_PATHWAY(10/137),HALLMARK_P53_PATHWAY(11/200)
CDC27	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(13/200),HALLMARK_HEME_METABOLISM(12/200),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(10/138)
CDC37	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_ERBB2(10/101),PID_LKB1_PATHWAY(7/47),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(9/109)
CDCA7	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CDH22	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CDK5R1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),REACTOME_AXON_GUIDANCE(17/251),HALLMARK_P53_PATHWAY(11/200),PID_REG_GR_PATHWAY(7/82),HALLMARK_HEDGEHOG_SIGNALING(5/36)
CDKAL1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CELSR1	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_HEDGEHOG_SIGNALING(5/36)
CELSR3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CERK	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_PHOSPHOLIPID_METABOLISM(10/198)
CES2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CFAP126	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFAP20	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFAP43	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFAP44	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CHD2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CHD5	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CHKB	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_PHOSPHOLIPID_METABOLISM(10/198)
CHRNA4	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CIR1	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(12/200),KEGG_NOTCH_SIGNALING_PATHWAY(6/47)
CIZ1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CLK2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CLK3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CMIP	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CNIH2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CNOT1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CNOT2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CNOT7	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CNRIP1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
COL18A1	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_P53_DOWNSTREAM_PATHWAY(10/137),PID_ERA_GENOMIC_PATHWAY(7/65),NABA_MATRISOME(29/1028)
COL6A1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),REACTOME_AXON_GUIDANCE(17/251),REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH(7/64),NABA_MATRISOME(29/1028),REACTOME_NCAM1_INTERACTIONS(5/39),REACTOME_SIGNALING_BY_PDGF(8/122),KEGG_FOCAL_ADHESION(10/201)
COMP	TH34_1452_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(29/1028),KEGG_FOCAL_ADHESION(10/201)
CORO1B	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CPSF3L	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CPSF7	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(16/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(13/140),REACTOME_MRNA_SPLICING(12/111),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(7/44),REACTOME_MRNA_3_END_PROCESSING(6/35),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105),REACTOME_TRANSCRIPTION(11/210)
CRABP2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CREBBP	TH34_1452_S01	v9	C646	lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),PID_HDAC_CLASSI_PATHWAY(9/66),REACTOME_SIGNALING_BY_NOTCH(10/103),REACTOME_SIGNALING_BY_NOTCH1(8/70),KEGG_PATHWAYS_IN_CANCER(16/328),PID_SMAD2_3NUCLEAR_PATHWAY(8/82),PID_P53_DOWNSTREAM_PATHWAY(10/137),BIOCARTA_VDR_PATHWAY(4/12),KEGG_PROSTATE_CANCER(8/89),ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS(6/45),REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION(6/46),KEGG_NOTCH_SIGNALING_PATHWAY(6/47),PID_HEDGEHOG_GLI_PATHWAY(6/48),PID_RETINOIC_ACID_PATHWAY(5/30),PID_KIT_PATHWAY(6/52),PID_NFAT_3PATHWAY(6/54),BIOCARTA_NFAT_PATHWAY(6/56),PID_REG_GR_PATHWAY(7/82),REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION(5/36),BIOCARTA_PPARA_PATHWAY(6/58),KEGG_WNT_SIGNALING_PATHWAY(9/151),REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA(4/23),REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION(4/24),PID_AJDISS_2PATHWAY(5/48),KEGG_ADHERENS_JUNCTION(6/75)
CROCC	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CRTC1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CRTC2	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_LKB1_PATHWAY(7/47)
CSNK1G2	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_HEDGEHOG_GLI_PATHWAY(6/48),REACTOME_PHOSPHOLIPID_METABOLISM(10/198)
CSPG5	TH34_1452_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(29/1028)
CTD-2537I9.12	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-2545G14.4	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-2587H19.2	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTNND1	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_FGF_PATHWAY(6/55),PID_AJDISS_2PATHWAY(5/48),KEGG_ADHERENS_JUNCTION(6/75)
CYB5R3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
CYP27C1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
DAZAP1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
DCAF11	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(12/200)
DCAF5	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
DCAF8	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
DDRGK1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
DDX5	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(12/128),PID_P53_DOWNSTREAM_PATHWAY(10/137)
DENND6B	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DGAT1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_PHOSPHOLIPID_METABOLISM(10/198)
DGCR8	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_P53_DOWNSTREAM_PATHWAY(10/137)
DHX38	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(16/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(13/140),REACTOME_MRNA_SPLICING(12/111),KEGG_SPLICEOSOME(12/128),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(7/44),REACTOME_MRNA_3_END_PROCESSING(6/35),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105),REACTOME_TRANSCRIPTION(11/210)
DIO2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
DKC1	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(13/200)
DLX1	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_SMAD2_3NUCLEAR_PATHWAY(8/82)
DMPK	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
DMTF1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
DMWD	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
DNAJB6	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
DNALI1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
DNM1L	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(8/97)
DOC2B	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
DPP9	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
DROSHA	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_P53_DOWNSTREAM_PATHWAY(10/137)
DTX4	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_NOTCH(10/103),REACTOME_SIGNALING_BY_NOTCH1(8/70),KEGG_NOTCH_SIGNALING_PATHWAY(6/47)
DVL3	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(16/328),KEGG_NOTCH_SIGNALING_PATHWAY(6/47),KEGG_WNT_SIGNALING_PATHWAY(9/151)
DYRK1A	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
DYRK1B	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
DZIP1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ECE1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ECEL1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
EDF1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
EFCAB1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
EFCAB2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
EHMT1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
EIF2B5	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
EIF4G1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE(9/87),REACTOME_SIGNALING_BY_INSULIN_RECEPTOR(9/108),BIOCARTA_MTOR_PATHWAY(4/23),BIOCARTA_EIF4_PATHWAY(4/24)
ELL3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ELN	TH34_1452_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(29/1028)
EMC6	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
EPHB2	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_AXON_GUIDANCE(11/129)
EPHB4	TH34_1452_S01	v9	TESEVATINIB,XL647	lowstringency_pd_outliers	KEGG_AXON_GUIDANCE(11/129)
ERBB2	TH34_1452_S01	v9	CAPECITABINE,TYKERB,Capecitabine,MUBRITINIB,T-DM1,HERCEPTIN,Afatinib,ADO-TRASTUZUMAB EMTANSINE,trastuzumab,TAK165,AC480,TRASTUZUMAB EMTANSINE,HKI-272,Poziotinib,BMS-690514,CANERTINIB,BIBW 2992,Neratinib,Gefitinib,GW2016,PICTILISIB,IRINOTECAN,AEE788,DOCETAXEL,Lapatinib,ARRY-380,IRESSA,XL647,Trastuzumab emtansine,poziotinib,AEE-788,PLATINUM,Docetaxel,Canertinib,TESEVATINIB,BMS-599626,Ado-trastuzumab emtansine,LAPATINIB,PERTUZUMAB,Trastuzumab,Dacomitinib,AC-480,RAPAMYCIN (SIROLIMUS),trastuzumab emtansine,Cetuximab,CETUXIMAB,GDC-0941,NERATINIB,LAPATINIB DITOSYLATE,Pertuzumab,GEFITINIB,AFATINIB,Irbinitinib,TRASTUZUMAB,DACOMITINIB,Ado-Trastuzumab Emtansine,ARRY380,POZIOTINIB,PELITINIB	lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),REACTOME_AXON_GUIDANCE(17/251),PID_ERBB2_ERBB3_PATHWAY(8/44),REACTOME_SIGNALING_BY_ERBB2(10/101),KEGG_PATHWAYS_IN_CANCER(16/328),KEGG_PROSTATE_CANCER(8/89),KEGG_ENDOMETRIAL_CANCER(6/52),PID_ERBB4_PATHWAY(5/38),KEGG_FOCAL_ADHESION(10/201),PID_A6B1_A6B4_INTEGRIN_PATHWAY(5/46),KEGG_ADHERENS_JUNCTION(6/75)
ERBB2IP	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
EWSR1	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(13/200)
EXOC7	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_INSULIN_SIGNALING_PATHWAY(12/137),PID_CDC42_PATHWAY(8/70),PID_INSULIN_PATHWAY(6/45)
EZR	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),REACTOME_AXON_GUIDANCE(17/251),PID_LKB1_PATHWAY(7/47),PID_RHOA_PATHWAY(5/45),BIOCARTA_CFTR_PATHWAY(3/12)
FABP5P7	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
FAM118A	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
FAM131A	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
FAM133B	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
FAM189A1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
FAM193A	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
FAM193B	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
FAM21A	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
FAM53B	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
FBP2	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_INSULIN_SIGNALING_PATHWAY(12/137)
FBRS	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
FBRSL1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
FBXO31	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
FBXW7	TH34_1452_S01	v9	Sirolimus,RAPAMYCIN (SIROLIMUS)	lowstringency_pd_outliers	REACTOME_SIGNALING_BY_NOTCH(10/103),REACTOME_SIGNALING_BY_NOTCH1(8/70),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(10/138),REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION(6/46),HALLMARK_P53_PATHWAY(11/200)
FGFBP3	TH34_1452_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(29/1028)
FGFR3	TH34_1452_S01	v9	BGJ-398,SU-5402,XL228,Dovitinib,PD173074,Nintedanib,JNJ-42756493,Ponatinib,INFIGRATINIB,PONATINIB,DOVITINIB,AZD-4547,MASITINIB,ERDAFITINIB,ENMD-2076,AZD4547,TKI258,NINTEDANIB,BGJ398,SU5402	lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(16/267),REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE(9/87),KEGG_PATHWAYS_IN_CANCER(16/328),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(9/100),REACTOME_SIGNALING_BY_INSULIN_RECEPTOR(9/108),REACTOME_SIGNALING_BY_FGFR(9/112),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(9/127),PID_FGF_PATHWAY(6/55)
FGFRL1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
FKBP2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
FMNL3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
FN3K	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(12/200)
FNBP4	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
FOXG1	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_SMAD2_3NUCLEAR_PATHWAY(8/82)
FOXJ1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
FPGS	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
FRZB	TH34_1452_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(29/1028)
FUBP3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
GALNT9	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
GAREML	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GART	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
GAS8	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
GIT1	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_AURORA_A_PATHWAY(5/31)
GLCCI1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
GNG3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
GOLGA2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
GON4L	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
GP1BB	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
GPATCH8	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
GPC1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),REACTOME_AXON_GUIDANCE(17/251),NABA_MATRISOME(29/1028)
GPC4	TH34_1452_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(29/1028)
GPR153	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
GPS2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
GPSM1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
GRAMD4	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
GRB10	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE(9/87),REACTOME_SIGNALING_BY_INSULIN_RECEPTOR(9/108),PID_INSULIN_PATHWAY(6/45),REACTOME_SIGNAL_ATTENUATION(4/14),PID_KIT_PATHWAY(6/52),PID_RET_PATHWAY(5/39),PID_VEGFR1_2_PATHWAY(6/69)
GSE1	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GTF2H4	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(16/161),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105),REACTOME_TRANSCRIPTION(11/210)
GUCY1B2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
HAUS7	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
HDAC4	TH34_1452_S01	v9	VORINOSTAT,ROMIDEPSIN,BELINOSTAT,PANOBINOSTAT,Romidepsin	lowstringency_pd_outliers	PID_HDAC_CLASSI_PATHWAY(9/66),REACTOME_SIGNALING_BY_NOTCH(10/103),REACTOME_SIGNALING_BY_NOTCH1(8/70),PID_RANBP2_PATHWAY(4/11),PID_ERA_GENOMIC_PATHWAY(7/65),REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION(6/46)
HDGF	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(12/200)
HDHD2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
HES3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
HES4	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
HIPK1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
HMGN3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
HNRNPA2B1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(16/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(13/140),REACTOME_MRNA_SPLICING(12/111)
HNRNPDL	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HNRNPH3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
HNRNPUL1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(16/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(13/140),REACTOME_MRNA_SPLICING(12/111)
HP1BP3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
HSF1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
HUWE1	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(10/138)
HYDIN	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ICA1L	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
IDH3G	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
IDUA	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
IFT140	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
IFT80	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
IGF2	TH34_1452_S01	v9	CABAZITAXEL,DOCETAXEL,OSI-906 (LINSITINIB)	lowstringency_pd_outliers	NABA_MATRISOME(29/1028),PID_AJDISS_2PATHWAY(5/48)
ILF3	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(13/200)
IMPDH1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
INHBB	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(11/200),NABA_MATRISOME(29/1028)
INPP5A	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
INTS1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
INTS3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
IPO9	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
IQCE	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
IQCG	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
IQSEC1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ITFG2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
JAG1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_NOTCH(10/103),REACTOME_SIGNALING_BY_NOTCH1(8/70),KEGG_NOTCH_SIGNALING_PATHWAY(6/47),BIOCARTA_PTDINS_PATHWAY(4/23)
JPH4	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
KCNG1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
KCNK3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
KDM2A	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
KIAA0430	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
KIAA0907	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
KIF26B	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
KMT2D	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
KNDC1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
KRI1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
KRR1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
L1CAM	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),REACTOME_AXON_GUIDANCE(17/251),KEGG_AXON_GUIDANCE(11/129),HALLMARK_HEDGEHOG_SIGNALING(5/36)
LAMA5	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(16/328),NABA_MATRISOME(29/1028),KEGG_FOCAL_ADHESION(10/201),PID_A6B1_A6B4_INTEGRIN_PATHWAY(5/46)
LARP7	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
LDB2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
LEMD2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
LENG8	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
LHX2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
LIMK1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),REACTOME_AXON_GUIDANCE(17/251),KEGG_AXON_GUIDANCE(11/129),PID_CDC42_PATHWAY(8/70),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(8/97),PID_RHOA_PATHWAY(5/45)
LINC01002	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01278	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LMO1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
LMX1B	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
LPCAT1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_PHOSPHOLIPID_METABOLISM(10/198)
LRRC23	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
LRRC37B	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
LRRC45	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
LRRC48	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
LTBP3	TH34_1452_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(29/1028)
LUC7L3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MAEA	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MALAT1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MAMDC4	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MAMLD1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_NOTCH(10/103),REACTOME_SIGNALING_BY_NOTCH1(8/70),REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION(6/46)
MAP2K3	TH34_1452_S01	v9	GDC-0973,AZD6244,BAY869766,MEK162,TRAMETINIB,SELUMETINIB,PD 0325901,DABRAFENIB MESYLATE	lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(16/267),PID_CDC42_PATHWAY(8/70),HALLMARK_HEME_METABOLISM(12/200),BIOCARTA_HCMV_PATHWAY(4/17),BIOCARTA_FMLP_PATHWAY(5/39),PID_VEGFR1_2_PATHWAY(6/69),PID_RHOA_PATHWAY(5/45)
MAPK15	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MAPK1IP1L	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MAPK3	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),REACTOME_AXON_GUIDANCE(17/251),PID_ERBB2_ERBB3_PATHWAY(8/44),KEGG_INSULIN_SIGNALING_PATHWAY(12/137),KEGG_MAPK_SIGNALING_PATHWAY(16/267),REACTOME_SIGNALING_BY_ERBB2(10/101),KEGG_AXON_GUIDANCE(11/129),REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE(9/87),BIOCARTA_PTEN_PATHWAY(5/18),PID_CDC42_PATHWAY(8/70),KEGG_PATHWAYS_IN_CANCER(16/328),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(9/100),BIOCARTA_IGF1R_PATHWAY(5/23),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(9/109),REACTOME_SIGNALING_BY_INSULIN_RECEPTOR(9/108),REACTOME_SIGNALING_BY_FGFR(9/112),REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH(7/64),KEGG_PROSTATE_CANCER(8/89),PID_BCR_5PATHWAY(7/65),ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS(6/45),REACTOME_SIGNAL_ATTENUATION(4/14),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(8/97),BIOCARTA_TCR_PATHWAY(6/49),PID_RETINOIC_ACID_PATHWAY(5/30),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(9/127),KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY(7/75),KEGG_ENDOMETRIAL_CANCER(6/52),PID_KIT_PATHWAY(6/52),BIOCARTA_HCMV_PATHWAY(4/17),SA_PTEN_PATHWAY(4/17),PID_NFAT_3PATHWAY(6/54),PID_FGF_PATHWAY(6/55),BIOCARTA_NFAT_PATHWAY(6/56),REACTOME_TRANSCRIPTION(11/210),PID_REG_GR_PATHWAY(7/82),BIOCARTA_PPARA_PATHWAY(6/58),BIOCARTA_BCR_PATHWAY(5/37),PID_ERBB4_PATHWAY(5/38),BIOCARTA_FMLP_PATHWAY(5/39),BIOCARTA_TFF_PATHWAY(4/21),PID_RET_PATHWAY(5/39),PID_FCER1_PATHWAY(6/62),REACTOME_SIGNALING_BY_ERBB4(7/90),BIOCARTA_FCER1_PATHWAY(5/41),REACTOME_SIGNALING_BY_PDGF(8/122),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(7/95),BIOCARTA_EIF4_PATHWAY(4/24),SA_B_CELL_RECEPTOR_COMPLEXES(4/24),PID_VEGFR1_2_PATHWAY(6/69),KEGG_FOCAL_ADHESION(10/201),PID_LYMPH_ANGIOGENESIS_PATHWAY(4/25),SIG_BCR_SIGNALING_PATHWAY(5/46),KEGG_CHRONIC_MYELOID_LEUKEMIA(6/73),BIOCARTA_CREB_PATHWAY(4/27),SIG_IL4RECEPTOR_IN_B_LYPHOCYTES(4/27),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(8/137),KEGG_ADHERENS_JUNCTION(6/75),BIOCARTA_ERK_PATHWAY(4/28)
MAPK8IP1	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(16/267),ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS(6/45)
MARCH7	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MAU2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MBD6	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MCMBP	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MDC1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MDM2	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_ERBB2(10/101),KEGG_PATHWAYS_IN_CANCER(16/328),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(9/100),PID_RANBP2_PATHWAY(4/11),PID_P53_DOWNSTREAM_PATHWAY(10/137),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(9/109),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(10/138),REACTOME_SIGNALING_BY_FGFR(9/112),KEGG_PROSTATE_CANCER(8/89),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(9/127),PID_AURORA_A_PATHWAY(5/31),HALLMARK_P53_PATHWAY(11/200),PID_REG_GR_PATHWAY(7/82),PID_ERBB4_PATHWAY(5/38),REACTOME_SIGNALING_BY_ERBB4(7/90),REACTOME_SIGNALING_BY_PDGF(8/122),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(7/95),KEGG_CHRONIC_MYELOID_LEUKEMIA(6/73),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(8/137)
MED25	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396)
MEG3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MEGF6	TH34_1452_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(29/1028)
METRNL	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
METTL17	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MFGE8	TH34_1452_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(29/1028)
MGRN1	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(10/138)
MIA3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MICALL2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MKNK2	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_INSULIN_SIGNALING_PATHWAY(12/137),KEGG_MAPK_SIGNALING_PATHWAY(16/267),HALLMARK_P53_PATHWAY(11/200),BIOCARTA_ERK_PATHWAY(4/28)
MLLT1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MOK	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MORF4L1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MOV10	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_NOTCH(10/103)
MRPS25	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MRPS5	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MSH5	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MSI1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MTA1	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_ERA_GENOMIC_PATHWAY(7/65)
MTA2	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_HDAC_CLASSI_PATHWAY(9/66)
MTA3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MTERF4	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTMR4	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(7/63),REACTOME_PHOSPHOLIPID_METABOLISM(10/198)
MTSS1	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_HEDGEHOG_GLI_PATHWAY(6/48)
MTSS1L	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MUC1	TH34_1452_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(29/1028)
MXRA8	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MYO15B	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MYO19	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MYO3A	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MYO7A	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
MZF1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
NAA40	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
NCOR1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),PID_HDAC_CLASSI_PATHWAY(9/66),REACTOME_SIGNALING_BY_NOTCH(10/103),REACTOME_SIGNALING_BY_NOTCH1(8/70),PID_SMAD2_3NUCLEAR_PATHWAY(8/82),BIOCARTA_VDR_PATHWAY(4/12),REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(7/63),PID_ERA_GENOMIC_PATHWAY(7/65),REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION(6/46),REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION(5/36),BIOCARTA_PPARA_PATHWAY(6/58),REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY(4/20),PID_ERBB4_PATHWAY(5/38),REACTOME_SIGNALING_BY_ERBB4(7/90),REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA(4/23),REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION(4/24)
NDEL1	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_AURORA_A_PATHWAY(5/31)
NEK11	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
NEMF	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
NFATC4	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_ERBB2_ERBB3_PATHWAY(8/44),KEGG_MAPK_SIGNALING_PATHWAY(16/267),KEGG_AXON_GUIDANCE(11/129),BIOCARTA_TCR_PATHWAY(6/49),KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY(7/75),BIOCARTA_NFAT_PATHWAY(6/56),BIOCARTA_BCR_PATHWAY(5/37),BIOCARTA_FMLP_PATHWAY(5/39),KEGG_WNT_SIGNALING_PATHWAY(9/151),BIOCARTA_FCER1_PATHWAY(5/41)
NFE2L1	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(12/200)
NFIX	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
NISCH	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
NMT1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
NOL4L	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NOLC1	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(13/200)
NONO	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
NOTCH1	TH34_1452_S01	v9	REGN421,PF-03084014	lowstringency_pd_outliers	KEGG_NOTCH_SIGNALING_PATHWAY(6/47),HALLMARK_P53_PATHWAY(11/200)
NOTUM	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
NPAS2	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION(5/36),REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA(4/23),REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION(4/24)
NPIPA5	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB3	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB4	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB5	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPP1	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPTXR	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
NR2C1	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_HDAC_CLASSI_PATHWAY(9/66)
NRARP	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
NSRP1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
NTN1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),REACTOME_AXON_GUIDANCE(17/251),KEGG_AXON_GUIDANCE(11/129),NABA_MATRISOME(29/1028)
NUP214	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(16/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(13/140),PID_NFAT_3PATHWAY(6/54)
NYAP1	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
OARD1	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
OBSL1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ODF2	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(13/200)
OSBPL2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
OSGEP	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
P2RX5	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PABPN1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(16/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(13/140),REACTOME_MRNA_SPLICING(12/111),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(7/44),REACTOME_MRNA_3_END_PROCESSING(6/35),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105),REACTOME_TRANSCRIPTION(11/210)
PACSIN3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PAGR1	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PALM	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PAX6	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),PID_CDC42_PATHWAY(8/70)
PAXBP1	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PBX2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PC	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(12/200)
PCBP1-AS1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PCGF5	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PCP4L1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PCYT1B	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_PHOSPHOLIPID_METABOLISM(10/198)
PDCD4	TH34_1452_S01	v9	PACLITAXEL	lowstringency_pd_outliers	NA
PDK2	TH34_1452_S01	v9		lowstringency_pd_outliers	BIOCARTA_PTEN_PATHWAY(5/18),BIOCARTA_MTOR_PATHWAY(4/23),BIOCARTA_EIF4_PATHWAY(4/24)
PDS5B	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(13/200)
PER1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION(5/36)
PFKL	TH34_1452_S01	v9		lowstringency_pd_outliers	BIOCARTA_PTDINS_PATHWAY(4/23)
PHACTR1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PHC1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PHF23	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PI4KAP2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PIAS3	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(16/328),PID_SMAD2_3NUCLEAR_PATHWAY(8/82),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(10/138)
PIGG	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PIP5K1A	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(8/97),PID_RHOA_PATHWAY(5/45)
PITPNA	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),REACTOME_AXON_GUIDANCE(17/251)
PKD1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PKD2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PKDCC	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PLA2G6	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(16/267),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(8/97),REACTOME_PHOSPHOLIPID_METABOLISM(10/198)
PLCH2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PLD2	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(8/97),PID_FCER1_PATHWAY(6/62),REACTOME_PHOSPHOLIPID_METABOLISM(10/198),PID_RHOA_PATHWAY(5/45)
PLEKHG5	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PLXNA3	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),REACTOME_AXON_GUIDANCE(17/251),KEGG_AXON_GUIDANCE(11/129),NABA_MATRISOME(29/1028)
PLXNB2	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_AXON_GUIDANCE(11/129),HALLMARK_P53_PATHWAY(11/200),NABA_MATRISOME(29/1028)
PMEPA1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(7/63)
PNMA3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PNN	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PNRC2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
POGZ	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
POLR2J3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
POM121C	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PP7080	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PPAN	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PPIL6	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PPP1R10	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PPP1R16A	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PPP1R2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PPP3CB	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_ERBB2_ERBB3_PATHWAY(8/44),KEGG_MAPK_SIGNALING_PATHWAY(16/267),KEGG_AXON_GUIDANCE(11/129),PID_BCR_5PATHWAY(7/65),BIOCARTA_TCR_PATHWAY(6/49),KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY(7/75),PID_NFAT_3PATHWAY(6/54),BIOCARTA_NFAT_PATHWAY(6/56),BIOCARTA_BCR_PATHWAY(5/37),BIOCARTA_FMLP_PATHWAY(5/39),KEGG_WNT_SIGNALING_PATHWAY(9/151),BIOCARTA_FCER1_PATHWAY(5/41),SIG_BCR_SIGNALING_PATHWAY(5/46)
PPP4R1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PRAF2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PRDX5	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PRKAA1	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_INSULIN_SIGNALING_PATHWAY(12/137),REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE(9/87),PID_LKB1_PATHWAY(7/47),REACTOME_SIGNALING_BY_INSULIN_RECEPTOR(9/108),PID_VEGFR1_2_PATHWAY(6/69)
PRKACA	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_ERBB2_ERBB3_PATHWAY(8/44),PID_HDAC_CLASSI_PATHWAY(9/66),KEGG_INSULIN_SIGNALING_PATHWAY(12/137),KEGG_MAPK_SIGNALING_PATHWAY(16/267),REACTOME_SIGNALING_BY_ERBB2(10/101),PID_LKB1_PATHWAY(7/47),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(9/100),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(9/109),REACTOME_SIGNALING_BY_FGFR(9/112),PID_HEDGEHOG_GLI_PATHWAY(6/48),PID_RETINOIC_ACID_PATHWAY(5/30),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(9/127),PID_AURORA_A_PATHWAY(5/31),PID_NFAT_3PATHWAY(6/54),PID_REG_GR_PATHWAY(7/82),PID_RET_PATHWAY(5/39),KEGG_WNT_SIGNALING_PATHWAY(9/151),REACTOME_SIGNALING_BY_PDGF(8/122),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(7/95),PID_VEGFR1_2_PATHWAY(6/69),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(8/137)
PRKAR1A	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_INSULIN_SIGNALING_PATHWAY(12/137),REACTOME_SIGNALING_BY_ERBB2(10/101),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(9/100),BIOCARTA_IGF1R_PATHWAY(5/23),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(9/109),REACTOME_SIGNALING_BY_FGFR(9/112),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(9/127),BIOCARTA_NFAT_PATHWAY(6/56),BIOCARTA_PPARA_PATHWAY(6/58),REACTOME_SIGNALING_BY_PDGF(8/122),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(7/95),BIOCARTA_CREB_PATHWAY(4/27),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(8/137),BIOCARTA_CFTR_PATHWAY(3/12)
PRR14	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PRRT2	TH34_1452_S01	v9	BRYOSTATIN	lowstringency_pd_outliers	NA
PRSS35	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PSMA3-AS1	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PSMC6	TH34_1452_S01	v9	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	NA
PTBP2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PTP4A3	TH34_1452_S01	v9	CETUXIMAB	lowstringency_pd_outliers	NA
PTPRS	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
PYCR1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
QRICH1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
R3HDM2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RAB5C	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RAB7A	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_AJDISS_2PATHWAY(5/48)
RABL2A	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RABL2B	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RANBP1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RAP1GAP	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(12/200)
RBBP6	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RBM12	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RBM17	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(12/128)
RBM23	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RBM25	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(12/128)
RBM26	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RBM33	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RBM5	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(16/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(13/140),REACTOME_MRNA_SPLICING(12/111),HALLMARK_HEME_METABOLISM(12/200)
RBM6	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RCOR2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RCOR3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RELA	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),PID_HDAC_CLASSI_PATHWAY(9/66),KEGG_MAPK_SIGNALING_PATHWAY(16/267),KEGG_PATHWAYS_IN_CANCER(16/328),KEGG_PROSTATE_CANCER(8/89),PID_BCR_5PATHWAY(7/65),BIOCARTA_TCR_PATHWAY(6/49),KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY(7/75),BIOCARTA_HCMV_PATHWAY(4/17),PID_REG_GR_PATHWAY(7/82),BIOCARTA_PPARA_PATHWAY(6/58),BIOCARTA_FMLP_PATHWAY(5/39),PID_FCER1_PATHWAY(6/62),KEGG_CHRONIC_MYELOID_LEUKEMIA(6/73)
RERE	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
REXO1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RFX2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RGL2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RIMKLB	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RMST	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RNF103	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RNF212	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RNF31	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RNPC3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ROBO4	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ROGDI	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RP11-1212A22.4	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-1246C19.1	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-138I1.4	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-158M2.3	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-223I10.1	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-231C14.4	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-242D8.3	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-274B21.2	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-274B21.4	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-311C24.1	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-386G11.10	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-575L7.8	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-611O2.3	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-616M22.12	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-618K13.2	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-70C1.3	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-849I19.1	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP13-766D20.4	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP13-870H17.3	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP3-525N10.2	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-613B23.5	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-669L17.10	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP5-857K21.6	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RPGR	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RSPH1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RSRC2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RUNDC3A	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
RXRA	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),KEGG_PATHWAYS_IN_CANCER(16/328),BIOCARTA_VDR_PATHWAY(4/12),PID_RETINOIC_ACID_PATHWAY(5/30),HALLMARK_P53_PATHWAY(11/200),REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION(5/36),BIOCARTA_PPARA_PATHWAY(6/58),REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA(4/23),REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION(4/24),PID_A6B1_A6B4_INTEGRIN_PATHWAY(5/46)
RYK	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SAFB	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_ERA_GENOMIC_PATHWAY(7/65)
SART3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SCAF11	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SCMH1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SCRN1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SEL1L3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SENP2	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_WNT_SIGNALING_PATHWAY(9/151)
SENP6	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SF1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SF3A1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(16/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(13/140),REACTOME_MRNA_SPLICING(12/111),KEGG_SPLICEOSOME(12/128)
SFSWAP	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SH3BP2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SHC1	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_ERBB2_ERBB3_PATHWAY(8/44),KEGG_INSULIN_SIGNALING_PATHWAY(12/137),REACTOME_SIGNALING_BY_ERBB2(10/101),REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE(9/87),BIOCARTA_PTEN_PATHWAY(5/18),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(9/100),BIOCARTA_IGF1R_PATHWAY(5/23),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(9/109),REACTOME_SIGNALING_BY_INSULIN_RECEPTOR(9/108),REACTOME_SIGNALING_BY_FGFR(9/112),PID_BCR_5PATHWAY(7/65),ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS(6/45),PID_INSULIN_PATHWAY(6/45),REACTOME_SIGNAL_ATTENUATION(4/14),BIOCARTA_TCR_PATHWAY(6/49),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(9/127),PID_KIT_PATHWAY(6/52),SA_PTEN_PATHWAY(4/17),PID_FGF_PATHWAY(6/55),BIOCARTA_BCR_PATHWAY(5/37),PID_ERBB4_PATHWAY(5/38),BIOCARTA_TFF_PATHWAY(4/21),PID_RET_PATHWAY(5/39),PID_FCER1_PATHWAY(6/62),REACTOME_SIGNALING_BY_ERBB4(7/90),BIOCARTA_FCER1_PATHWAY(5/41),SA_B_CELL_RECEPTOR_COMPLEXES(4/24),KEGG_FOCAL_ADHESION(10/201),PID_LYMPH_ANGIOGENESIS_PATHWAY(4/25),SIG_BCR_SIGNALING_PATHWAY(5/46),PID_A6B1_A6B4_INTEGRIN_PATHWAY(5/46),KEGG_CHRONIC_MYELOID_LEUKEMIA(6/73),SIG_IL4RECEPTOR_IN_B_LYPHOCYTES(4/27),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(8/137),BIOCARTA_ERK_PATHWAY(4/28),BIOCARTA_TRKA_PATHWAY(3/12)
SKI	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_SMAD2_3NUCLEAR_PATHWAY(8/82),REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(7/63),REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY(4/20)
SLC12A7	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SLC25A29	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SLC35C2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SLC9A3R1	TH34_1452_S01	v9		lowstringency_pd_outliers	BIOCARTA_CFTR_PATHWAY(3/12)
SLIT1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),REACTOME_AXON_GUIDANCE(17/251),KEGG_AXON_GUIDANCE(11/129),NABA_MATRISOME(29/1028),HALLMARK_HEDGEHOG_SIGNALING(5/36),PID_AJDISS_2PATHWAY(5/48)
SLITRK2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SLTM	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SMEK1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SMG7	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SMPD4	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_PHOSPHOLIPID_METABOLISM(10/198)
SNAP29	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SNORA22	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SNRNP70	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(16/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(13/140),REACTOME_MRNA_SPLICING(12/111),KEGG_SPLICEOSOME(12/128)
SNRPD3	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(16/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(13/140),REACTOME_MRNA_SPLICING(12/111),KEGG_SPLICEOSOME(12/128),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(7/44),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105),REACTOME_TRANSCRIPTION(11/210)
SORBS2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SOS1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),REACTOME_AXON_GUIDANCE(17/251),PID_ERBB2_ERBB3_PATHWAY(8/44),KEGG_INSULIN_SIGNALING_PATHWAY(12/137),KEGG_MAPK_SIGNALING_PATHWAY(16/267),REACTOME_SIGNALING_BY_ERBB2(10/101),REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE(9/87),BIOCARTA_PTEN_PATHWAY(5/18),KEGG_PATHWAYS_IN_CANCER(16/328),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(9/100),BIOCARTA_IGF1R_PATHWAY(5/23),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(9/109),REACTOME_SIGNALING_BY_INSULIN_RECEPTOR(9/108),REACTOME_SIGNALING_BY_FGFR(9/112),REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH(7/64),KEGG_PROSTATE_CANCER(8/89),PID_BCR_5PATHWAY(7/65),PID_INSULIN_PATHWAY(6/45),REACTOME_SIGNAL_ATTENUATION(4/14),BIOCARTA_TCR_PATHWAY(6/49),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(9/127),KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY(7/75),KEGG_ENDOMETRIAL_CANCER(6/52),PID_KIT_PATHWAY(6/52),SA_PTEN_PATHWAY(4/17),PID_FGF_PATHWAY(6/55),BIOCARTA_BCR_PATHWAY(5/37),BIOCARTA_TFF_PATHWAY(4/21),PID_RET_PATHWAY(5/39),PID_FCER1_PATHWAY(6/62),REACTOME_SIGNALING_BY_ERBB4(7/90),BIOCARTA_FCER1_PATHWAY(5/41),REACTOME_SIGNALING_BY_PDGF(8/122),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(7/95),SA_B_CELL_RECEPTOR_COMPLEXES(4/24),KEGG_FOCAL_ADHESION(10/201),PID_LYMPH_ANGIOGENESIS_PATHWAY(4/25),SIG_BCR_SIGNALING_PATHWAY(5/46),KEGG_CHRONIC_MYELOID_LEUKEMIA(6/73),BIOCARTA_CREB_PATHWAY(4/27),SIG_IL4RECEPTOR_IN_B_LYPHOCYTES(4/27),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(8/137),BIOCARTA_ERK_PATHWAY(4/28),BIOCARTA_TRKA_PATHWAY(3/12)
SP2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SPA17	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SPECC1L	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SPG11	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SPG20	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SRCAP	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SRP14	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SRPK3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SRRM1	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(16/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(13/140),REACTOME_MRNA_SPLICING(12/111),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(7/44),REACTOME_MRNA_3_END_PROCESSING(6/35),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105),REACTOME_TRANSCRIPTION(11/210)
SRRM2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SRRT	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SRSF11	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(16/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(13/140),REACTOME_MRNA_SPLICING(12/111),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(7/44),REACTOME_MRNA_3_END_PROCESSING(6/35),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105),REACTOME_TRANSCRIPTION(11/210)
SRSF5	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(16/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(13/140),REACTOME_MRNA_SPLICING(12/111),KEGG_SPLICEOSOME(12/128),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(7/44),REACTOME_MRNA_3_END_PROCESSING(6/35),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105),REACTOME_TRANSCRIPTION(11/210)
SS18	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(13/200)
SSBP3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ST8SIA2	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(24/396),REACTOME_AXON_GUIDANCE(17/251),REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH(7/64),REACTOME_NCAM1_INTERACTIONS(5/39)
STAG3L5P	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
STAT2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
STIM2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
STK38L	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
STRA13	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
STRADA	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE(9/87),PID_LKB1_PATHWAY(7/47),REACTOME_SIGNALING_BY_INSULIN_RECEPTOR(9/108)
SUMO1	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_HDAC_CLASSI_PATHWAY(9/66),PID_RANBP2_PATHWAY(4/11)
SUPT20H	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SUPT5H	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(16/161),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105),REACTOME_TRANSCRIPTION(11/210)
SUPT7L	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
SYNGAP1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TAF15	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TBX1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TCF25	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TCF7L2	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(16/328),KEGG_PROSTATE_CANCER(8/89),KEGG_ENDOMETRIAL_CANCER(6/52),KEGG_WNT_SIGNALING_PATHWAY(9/151),KEGG_ADHERENS_JUNCTION(6/75)
TESK1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TFDP2	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(12/200)
TGIF2	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_SMAD2_3NUCLEAR_PATHWAY(8/82),REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(7/63),REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY(4/20)
TINF2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TLE3	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_NOTCH(10/103),HALLMARK_G2M_CHECKPOINT(13/200),REACTOME_SIGNALING_BY_NOTCH1(8/70),REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION(6/46),HALLMARK_HEDGEHOG_SIGNALING(5/36)
TLX1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TMEM131	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TMEM231	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TMEM256-PLSCR3	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TMEM67	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TMSB4XP6	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TMTC2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TNFRSF25	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TNK2	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_CDC42_PATHWAY(8/70)
TNPO2	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(13/200)
TNRC18	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TNRC6A	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_NOTCH(10/103)
TNS1	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(12/200)
TOB1	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(11/200)
TP53BP2	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_P53_DOWNSTREAM_PATHWAY(10/137)
TP73	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_P53_DOWNSTREAM_PATHWAY(10/137)
TPBG	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TPPP3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TPSG1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TRA2A	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(12/128)
TRAF7	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TRIM33	TH34_1452_S01	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(7/63),REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY(4/20)
TRIP10	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_INSULIN_SIGNALING_PATHWAY(12/137),PID_INSULIN_PATHWAY(6/45)
TRMT2A	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TRO	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TSC2	TH34_1452_S01	v9	Everolimus,EVEROLIMUS	lowstringency_pd_outliers	KEGG_INSULIN_SIGNALING_PATHWAY(12/137),REACTOME_SIGNALING_BY_ERBB2(10/101),REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE(9/87),PID_LKB1_PATHWAY(7/47),REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR(9/100),PID_P53_DOWNSTREAM_PATHWAY(10/137),REACTOME_SIGNALING_BY_EGFR_IN_CANCER(9/109),REACTOME_SIGNALING_BY_INSULIN_RECEPTOR(9/108),BIOCARTA_VDR_PATHWAY(4/12),REACTOME_SIGNALING_BY_FGFR(9/112),REACTOME_SIGNALING_BY_FGFR_IN_DISEASE(9/127),REACTOME_SIGNALING_BY_ERBB4(7/90),REACTOME_SIGNALING_BY_PDGF(8/122),BIOCARTA_MTOR_PATHWAY(4/23),REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION(7/95),REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE(8/137)
TSNARE1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TSPAN33	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TTC17	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TTLL10	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TTLL3	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
TUBA1A	TH34_1452_S01	v9		lowstringency_pd_outliers	ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS(6/45)
U2AF1L4	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
UBA3	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(10/138),PID_ERA_GENOMIC_PATHWAY(7/65)
UBAP2L	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
UBP1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
UBR5	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(10/138)
UBXN11	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
UCKL1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
UNC119	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
UPF1	TH34_1452_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(13/200)
USP40	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
USP5	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
VAV2	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_CDC42_PATHWAY(8/70),PID_BCR_5PATHWAY(7/65),KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS(8/97),KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY(7/75),BIOCARTA_PTDINS_PATHWAY(4/23),SA_B_CELL_RECEPTOR_COMPLEXES(4/24),KEGG_FOCAL_ADHESION(10/201)
VEZT	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
VPS52	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
VPS9D1	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
VWA3A	TH34_1452_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(29/1028)
WDR60	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
WDR90	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
WIPF2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
WNT7B	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(16/328),NABA_MATRISOME(29/1028),KEGG_WNT_SIGNALING_PATHWAY(9/151)
WSB1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
XAB2	TH34_1452_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(12/128)
XPNPEP1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
XPO1	TH34_1452_S01	v9		lowstringency_pd_outliers	PID_HDAC_CLASSI_PATHWAY(9/66),HALLMARK_G2M_CHECKPOINT(13/200),PID_RANBP2_PATHWAY(4/11),REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(7/63),PID_HEDGEHOG_GLI_PATHWAY(6/48),PID_NFAT_3PATHWAY(6/54)
XXbac-BPG252P9.9	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
Y_RNA	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZC3H18	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ZCCHC11	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ZDHHC11	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ZDHHC8	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ZFYVE21	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ZMIZ1	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ZMIZ2	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ZMYND10	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ZNF185	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ZNF385C	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ZNF423	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ZNF521	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ZNF532	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ZNF589	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ZNF644	TH34_1452_S01	v9		lowstringency_pd_outliers	NA
ZSWIM8	TH34_1452_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AASDHPPT	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ABCA5	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_BILE_ACID_METABOLISM(10/112)
ABR	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(12/217)
AC027612.6	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC055736.1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC132217.4	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC159540.1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACAD11	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ACADVL	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478),HALLMARK_FATTY_ACID_METABOLISM(10/158)
ACIN1	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(11/128)
ADAM15	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(37/1028)
ADAMTS2	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(37/1028)
ADAMTSL4	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(37/1028)
ADCK4	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ADGB	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADIPOR1	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(16/200)
AGBL2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
AHCTF1	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(23/421),REACTOME_CELL_CYCLE_MITOTIC(17/325)
AHDC1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
AK1	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_PURINE_METABOLISM(11/159),HALLMARK_DNA_REPAIR(10/150)
AK7	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_PURINE_METABOLISM(11/159)
AKAP14	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
AKAP9	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MITOTIC_G2_G2_M_PHASES(11/81),REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES(9/59),REACTOME_CELL_CYCLE(23/421),REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES(9/66),REACTOME_CELL_CYCLE_MITOTIC(17/325)
AKIRIN1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
AKNA	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
AKR7A2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
AL662801.1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ALDH3A1	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(10/158)
ALDH3A2	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(12/200),HALLMARK_FATTY_ACID_METABOLISM(10/158)
ALDH9A1	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_BILE_ACID_METABOLISM(10/112),HALLMARK_PEROXISOME(9/104),HALLMARK_FATTY_ACID_METABOLISM(10/158)
AMIGO2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
AMT	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
AMZ2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ANAPC13	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(11/138)
ANAPC7	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(23/421),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(11/138),REACTOME_CELL_CYCLE_MITOTIC(17/325)
ANKMY1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ANKRD13D	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ANKRD29	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ANKRD42	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ANKRD45	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ANKRD54	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ANKRD66	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ANKZF1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ANXA11	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(37/1028)
ANXA4	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(37/1028)
AP003041.1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ARFIP2	TH34_1455_S01	v9		lowstringency_pd_outliers	PID_ARF_3PATHWAY(4/19)
ARHGAP18	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ARHGAP5	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ARIH1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ARL1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ARL2BP	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(16/200)
ARMC2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ARMC3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ARMC4	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ASXL1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ATF6B	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ATP2C1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ATP6V1D	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ATPIF1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ATXN2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ATXN7L3B	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
AUTS2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
AZI2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
B9D1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
BAALC-AS1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
BBS1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
BBS4	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
BBS5	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
BCLAF1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
BCO2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
BDH2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
BECN1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
BIN3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
BNIP3L	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(16/200)
BOC	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
BOP1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C10orf105	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
C10orf107	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C11orf58	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C11orf70	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C11orf74	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C11orf88	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C11orf97	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
C14orf142	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C14orf159	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C14orf79	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C15orf26	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C16orf71	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C16orf93	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C1QBP	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C1orf158	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C1orf194	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C1orf228	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C20orf96	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C21orf59	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C2orf81	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C4orf22	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C4orf47	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C5orf45	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C5orf49	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C6	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C6orf118	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C6orf165	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C7orf57	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C8orf34	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C8orf76	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C9orf116	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C9orf117	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C9orf135	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C9orf171	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C9orf24	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C9orf72	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
C9orf9	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CA4	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(10/158)
CAB39L	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CADM1	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(13/200),HALLMARK_PEROXISOME(9/104)
CALCOCO1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CALM1	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_ERBB2(8/101),REACTOME_SIGNALLING_BY_NGF(12/217)
CAPN10	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CAPN2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CAPRIN1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CAPS	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CAPS2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CAPSL	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CASC1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CAST	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(16/200)
CAT	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(16/200),HALLMARK_BILE_ACID_METABOLISM(10/112),HALLMARK_PEROXISOME(9/104),HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY(6/49),KEGG_PEROXISOME(7/78)
CATIP	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CBY1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CC2D2A	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC103	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC108	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC113	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC114	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC13	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC146	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC153	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC162P	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC170	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CCDC176	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CCDC180	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CCDC181	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CCDC24	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC30	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC33	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC34	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC37	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC39	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC40	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC42B	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC53	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC57	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC65	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC74A	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC74B	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC78	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC81	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC82	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC89	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCDC93	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCND1	TH34_1455_S01	v9	TAMOXIFEN	lowstringency_pd_outliers	REACTOME_CELL_CYCLE(23/421),REACTOME_CELL_CYCLE_MITOTIC(17/325),KEGG_PROSTATE_CANCER(8/89),HALLMARK_G2M_CHECKPOINT(12/200),HALLMARK_ESTROGEN_RESPONSE_LATE(12/200),KEGG_PATHWAYS_IN_CANCER(15/328),WNT_SIGNALING(7/89),PID_ILK_PATHWAY(5/45),KEGG_THYROID_CANCER(4/29)
CCNL1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CCPG1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CD163	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CD164	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CD46	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CD84	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CDK9	TH34_1455_S01	v9	SCH 727965,ALVOCIDIB,SELICICLIB,SCH727965,Roniciclib,Flavopiridol,DINACICLIB,SNS-032,BMS-387032,BAY1000394	lowstringency_pd_outliers	REACTOME_RNA_POL_II_TRANSCRIPTION(9/105),REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(7/63),REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_(5/45)
CEBPG	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CEP126	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CEP41	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MITOTIC_G2_G2_M_PHASES(11/81),REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES(9/59),REACTOME_CELL_CYCLE(23/421),REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES(9/66),REACTOME_CELL_CYCLE_MITOTIC(17/325)
CEP83	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CEP95	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CETN2	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MITOTIC_G2_G2_M_PHASES(11/81),REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES(9/59),REACTOME_CELL_CYCLE(23/421),REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES(9/66),REACTOME_CELL_CYCLE_MITOTIC(17/325),HALLMARK_DNA_REPAIR(10/150),KEGG_NUCLEOTIDE_EXCISION_REPAIR(5/44)
CETN3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CFAP126	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFAP221	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFAP36	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFAP43	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFAP44	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFAP45	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFAP46	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFAP47	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFAP52	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFAP53	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFAP57	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFAP61	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFAP69	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFAP70	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFAP74	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFAP99	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CH17-13I23.3	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CH17-232I21.1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CHD1L	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CHORDC1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CHURC1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CIPC	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CIR1	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(16/200)
CIT	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CLEC3B	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(37/1028)
CLHC1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CLK2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CLN5	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CLUAP1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CMSS1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CNDP2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CNOT1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
COL16A1	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_CORE_MATRISOME(18/275),NABA_MATRISOME(37/1028),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(13/200),PID_AVB3_INTEGRIN_PATHWAY(7/75),NABA_COLLAGENS(5/44)
COL18A1	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_CORE_MATRISOME(18/275),NABA_MATRISOME(37/1028),NABA_COLLAGENS(5/44)
COL21A1	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_CORE_MATRISOME(18/275),NABA_MATRISOME(37/1028),NABA_COLLAGENS(5/44)
COL4A5	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_CORE_MATRISOME(18/275),NABA_MATRISOME(37/1028),PID_AVB3_INTEGRIN_PATHWAY(7/75),NABA_COLLAGENS(5/44)
COL5A3	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_CORE_MATRISOME(18/275),NABA_MATRISOME(37/1028),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(13/200),NABA_COLLAGENS(5/44)
COLEC12	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(37/1028)
COLQ	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_CORE_MATRISOME(18/275),NABA_MATRISOME(37/1028),NABA_ECM_GLYCOPROTEINS(11/196)
COPA	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(13/200),PID_ARF_3PATHWAY(4/19)
COPB1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
COPRS	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
COQ4	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
COX11	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CPNE2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CRB2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CRIP1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CROCC	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CROCC2	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CRYZL1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CSPG4	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(37/1028)
CSPP1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CSTB	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(37/1028)
CSTF3	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(13/161),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105),REACTOME_MRNA_SPLICING(9/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(10/140),HALLMARK_DNA_REPAIR(10/150),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(5/44)
CTC-260F20.3	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CUL3	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(11/138),HALLMARK_G2M_CHECKPOINT(12/200)
CUL4A	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(11/138),HALLMARK_G2M_CHECKPOINT(12/200),KEGG_NUCLEOTIDE_EXCISION_REPAIR(5/44)
CXCL12	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(37/1028),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(13/200),HALLMARK_ESTROGEN_RESPONSE_LATE(12/200),REACTOME_NUCLEAR_SIGNALING_BY_ERBB4(5/38),REACTOME_SIGNALING_BY_ERBB4(7/90)
CYB561	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CYB561A3	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CYB5D1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CYB5R1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
CYSTM1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DAAM1	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(16/200),WNT_SIGNALING(7/89)
DALRD3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DAW1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DCAF8	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DDB1	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(11/138),HALLMARK_DNA_REPAIR(10/150),KEGG_NUCLEOTIDE_EXCISION_REPAIR(5/44)
DDB2	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(11/138),HALLMARK_DNA_REPAIR(10/150),KEGG_NUCLEOTIDE_EXCISION_REPAIR(5/44)
DDX17	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DDX42	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(11/128)
DDX5	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(11/128)
DEDD	TH34_1455_S01	v9		lowstringency_pd_outliers	PID_P73PATHWAY(9/79)
DENND6B	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DERL2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DFNA5	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_DNA_REPAIR(10/150)
DHX40	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DLEC1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DLGAP1-AS1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DMKN	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DNAAF1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DNAAF3	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DNAH1	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_HUNTINGTONS_DISEASE(12/185)
DNAH11	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DNAH12	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DNAH2	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_HUNTINGTONS_DISEASE(12/185)
DNAH3	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_HUNTINGTONS_DISEASE(12/185)
DNAH7	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DNAH9	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DNAI1	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_HUNTINGTONS_DISEASE(12/185)
DNAI2	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_HUNTINGTONS_DISEASE(12/185)
DNAJA1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DNAJB13	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DNAJB4	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DNAJC10	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DNAL1	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_HUNTINGTONS_DISEASE(12/185)
DNAL4	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_HUNTINGTONS_DISEASE(12/185),REACTOME_SIGNALLING_BY_NGF(12/217)
DNALI1	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_HUNTINGTONS_DISEASE(12/185)
DOC2A	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DPCD	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DPY30	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DRC1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DRC7	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DTHD1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DUSP14	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(15/267)
DUSP3	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(15/267),REACTOME_SIGNALLING_BY_NGF(12/217)
DYDC2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DYNC2H1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DYNC2LI1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DYNLL1	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MITOTIC_G2_G2_M_PHASES(11/81),REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES(9/59),REACTOME_CELL_CYCLE(23/421),REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES(9/66),REACTOME_CELL_CYCLE_MITOTIC(17/325)
DYNLRB2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DYX1C1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DZIP1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DZIP1L	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
DZIP3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ECHDC2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ECM2	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_CORE_MATRISOME(18/275),NABA_MATRISOME(37/1028),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(13/200),NABA_ECM_GLYCOPROTEINS(11/196)
EFCAB1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
EFCAB10	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
EFCAB12	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
EFCAB2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
EFHC1	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_BILE_ACID_METABOLISM(10/112)
EFHC2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
EHBP1L1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
EIF2D	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
EIF4E	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(13/161),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(10/140),PID_MYC_ACTIV_PATHWAY(7/79)
EIF4G3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ELAVL1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ELN	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_CORE_MATRISOME(18/275),NABA_MATRISOME(37/1028),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(13/200),NABA_ECM_GLYCOPROTEINS(11/196)
EMD	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ENKD1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ENKUR	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ENOSF1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ENPP5	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ENSA	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ENTPD2	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_PURINE_METABOLISM(11/159)
EPHX2	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_BILE_ACID_METABOLISM(10/112),HALLMARK_PEROXISOME(9/104),KEGG_PEROXISOME(7/78)
ERBB2	TH34_1455_S01	v9	CAPECITABINE,TYKERB,Capecitabine,MUBRITINIB,T-DM1,HERCEPTIN,Afatinib,ADO-TRASTUZUMAB EMTANSINE,trastuzumab,TAK165,AC480,TRASTUZUMAB EMTANSINE,HKI-272,Poziotinib,BMS-690514,CANERTINIB,BIBW 2992,Neratinib,Gefitinib,GW2016,PICTILISIB,IRINOTECAN,AEE788,DOCETAXEL,Lapatinib,ARRY-380,IRESSA,XL647,Trastuzumab emtansine,poziotinib,AEE-788,PLATINUM,Docetaxel,Canertinib,TESEVATINIB,BMS-599626,Ado-trastuzumab emtansine,LAPATINIB,PERTUZUMAB,Trastuzumab,Dacomitinib,AC-480,RAPAMYCIN (SIROLIMUS),trastuzumab emtansine,Cetuximab,CETUXIMAB,GDC-0941,NERATINIB,LAPATINIB DITOSYLATE,Pertuzumab,GEFITINIB,AFATINIB,Irbinitinib,TRASTUZUMAB,DACOMITINIB,Ado-Trastuzumab Emtansine,ARRY380,POZIOTINIB,PELITINIB	lowstringency_pd_outliers	KEGG_PROSTATE_CANCER(8/89),KEGG_ADHERENS_JUNCTION(7/75),REACTOME_SIGNALING_BY_ERBB2(8/101),KEGG_PATHWAYS_IN_CANCER(15/328),REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING(3/12)
ERF	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ERGIC3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ERI3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ERICH3	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ERLIN2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ESYT1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ETF1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
EWSR1	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(12/200)
EXD3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
EXOC5	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
F11R	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(7/63),PID_AVB3_INTEGRIN_PATHWAY(7/75)
FAM118A	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FAM131A	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FAM160B2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FAM166B	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FAM174A	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FAM179A	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FAM183A	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FAM187A	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FAM216B	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FAM219B	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FAM229B	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FAM53C	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FAM81B	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FAM92A1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FAM92B	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FAM98A	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FANK1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FAR2P1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FASTKD3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FBF1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FBLN1	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_CORE_MATRISOME(18/275),NABA_MATRISOME(37/1028),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(13/200),NABA_ECM_GLYCOPROTEINS(11/196)
FBRS	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FBXO15	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FCF1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FGFR1	TH34_1455_S01	v9	[Lucitanib],INFIGRATINIB,AZD-4547,BGJ-398,ORANTINIB,SU-6668,Regorafenib,LUCITANIB,PD173074,PONATINIB,MIDOSTAURIN,Ponatinib,Dovitinib,MASITINIB,AZD4547,Nintedanib,FGF/VEGF RECEPTOR TYROSINE KINASE INHIBITOR, PD173074,XL228,DOVITINIB,1058137-23-7,4-HYDROXYTAMOXIFEN,REGORAFENIB,NINTEDANIB,BGJ398,Lucitanib	lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(15/267),KEGG_PROSTATE_CANCER(8/89),KEGG_ADHERENS_JUNCTION(7/75),KEGG_PATHWAYS_IN_CANCER(15/328)
FGFR3	TH34_1455_S01	v9	BGJ-398,SU-5402,XL228,Dovitinib,PD173074,Nintedanib,JNJ-42756493,Ponatinib,INFIGRATINIB,PONATINIB,DOVITINIB,AZD-4547,MASITINIB,ERDAFITINIB,ENMD-2076,AZD4547,TKI258,NINTEDANIB,BGJ398,SU5402	lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(15/267),HALLMARK_ESTROGEN_RESPONSE_LATE(12/200),KEGG_PATHWAYS_IN_CANCER(15/328),KEGG_ENDOCYTOSIS(10/183)
FHAD1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FHL1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FHOD3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FLCN	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FLNB	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(15/267),HALLMARK_ESTROGEN_RESPONSE_LATE(12/200)
FLNC	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(15/267)
FOLR1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FOSB	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FOXJ1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FRMD3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FRMPD2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
FRZB	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(37/1028),WNT_SIGNALING(7/89)
FSTL1	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(37/1028),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(13/200)
FXR1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
GABRG1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
GALC	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478)
GALNS	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
GALNT16	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GAS8	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
GDPD2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
GEM	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(13/200)
GEMIN8	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
GGPS1	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478)
GLB1L	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
GLB1L2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
GLT8D1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
GLYR1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
GMPR	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_PURINE_METABOLISM(11/159)
GMPR2	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_PURINE_METABOLISM(11/159),HALLMARK_DNA_REPAIR(10/150)
GNPAT	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_BILE_ACID_METABOLISM(10/112),KEGG_GLYCEROPHOSPHOLIPID_METABOLISM(8/77),HALLMARK_PEROXISOME(9/104),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478),KEGG_PEROXISOME(7/78)
GNS	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
GOLGA2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
GOLGA2P5	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
GOLGA8B	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
GOLPH3L	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
GON4L	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
GPBP1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
GRAMD4	TH34_1455_S01	v9		lowstringency_pd_outliers	PID_P73PATHWAY(9/79)
GRSF1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
GSTM2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
HADH	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478),HALLMARK_FATTY_ACID_METABOLISM(10/158)
HAGHL	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
HDAC3	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478),REACTOME_SIGNALLING_BY_NGF(12/217),PID_HDAC_CLASSI_PATHWAY(6/66)
HDGF	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(16/200)
HDLBP	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
HIPK1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
HLA-E	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_ENDOCYTOSIS(10/183)
HMGN2P15	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HMGN3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
HMGXB3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
HMOX1	TH34_1455_S01	v9	SUNITINIB,SORAFENIB	lowstringency_pd_outliers	NA
HNRNPF	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(13/161),REACTOME_MRNA_SPLICING(9/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(10/140)
HNRNPH2	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(13/161),REACTOME_MRNA_SPLICING(9/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(10/140)
HR	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(12/200)
HSBP1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
HSD17B4	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_BILE_ACID_METABOLISM(10/112),HALLMARK_PEROXISOME(9/104),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478),KEGG_PEROXISOME(7/78),HALLMARK_FATTY_ACID_METABOLISM(10/158)
HSF1	TH34_1455_S01	v9		lowstringency_pd_outliers	PID_P73PATHWAY(9/79)
HSP90AA1	TH34_1455_S01	v9	GANETESPIB,AUY922,XL888,RETASPIMYCIN,AT13387,TANESPIMYCIN,STA-9090	lowstringency_pd_outliers	REACTOME_MITOTIC_G2_G2_M_PHASES(11/81),REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES(9/59),REACTOME_CELL_CYCLE(23/421),REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES(9/66),REACTOME_CELL_CYCLE_MITOTIC(17/325),KEGG_PROSTATE_CANCER(8/89),PID_AVB3_INTEGRIN_PATHWAY(7/75),REACTOME_SIGNALING_BY_ERBB2(8/101),PID_MYC_ACTIV_PATHWAY(7/79),HALLMARK_FATTY_ACID_METABOLISM(10/158),BIOCARTA_P53HYPOXIA_PATHWAY(4/23),KEGG_PATHWAYS_IN_CANCER(15/328),PID_ILK_PATHWAY(5/45)
HSPA1A	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(11/128),KEGG_MAPK_SIGNALING_PATHWAY(15/267),BIOCARTA_P53HYPOXIA_PATHWAY(4/23),KEGG_ENDOCYTOSIS(10/183)
HSPA4	TH34_1455_S01	v9		lowstringency_pd_outliers	PID_MYC_ACTIV_PATHWAY(7/79)
HSPBP1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
HSPH1	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_FATTY_ACID_METABOLISM(10/158)
HYDIN	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IARS2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ICA1L	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IFT122	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IFT140	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IFT172	TH34_1455_S01	v9		lowstringency_pd_outliers	PID_HEDGEHOG_GLI_PATHWAY(7/48)
IFT20	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IFT22	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
IFT27	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IFT43	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IFT46	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IFT57	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_HUNTINGTONS_DISEASE(12/185)
IFT74	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IFT80	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IFT81	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IFT88	TH34_1455_S01	v9		lowstringency_pd_outliers	PID_HEDGEHOG_GLI_PATHWAY(7/48)
IGF2	TH34_1455_S01	v9	CABAZITAXEL,DOCETAXEL,OSI-906 (LINSITINIB)	lowstringency_pd_outliers	NABA_MATRISOME(37/1028)
IGF2-AS	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IGHA1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IGHG1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IGKC	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IGSF1	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(12/200)
IK	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IKBKB	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(15/267),KEGG_PROSTATE_CANCER(8/89),REACTOME_SIGNALLING_BY_NGF(12/217),KEGG_PATHWAYS_IN_CANCER(15/328)
IL13RA2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IMPA1	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_INOSITOL_PHOSPHATE_METABOLISM(6/54)
INTS3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IP6K3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IQCA1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IQCD	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IQCG	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IQCK	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
IRF2BP2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ISCU	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ISYNA1	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_INOSITOL_PHOSPHATE_METABOLISM(6/54)
ITIH5	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(37/1028)
ITPKB	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_INOSITOL_PHOSPHATE_METABOLISM(6/54)
IWS1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
JKAMP	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
KATNB1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
KCNG1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
KCNH3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
KCTD17	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
KIAA0556	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
KIAA1407	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
KIAA2013	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
KIF19	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
KIF9	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
KIFAP3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
KLF10	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
KLHDC8A	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
KLHDC9	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
KNDC1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
KRT5	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
LAMA3	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_CORE_MATRISOME(18/275),NABA_MATRISOME(37/1028),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(13/200),NABA_ECM_GLYCOPROTEINS(11/196),KEGG_PATHWAYS_IN_CANCER(15/328)
LAPTM4A	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
LARP7	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
LCA5L	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
LCAT	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM(8/77),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478)
LEF1	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_PROSTATE_CANCER(8/89),KEGG_ADHERENS_JUNCTION(7/75),KEGG_PATHWAYS_IN_CANCER(15/328),WNT_SIGNALING(7/89),KEGG_THYROID_CANCER(4/29)
LGR6	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
LIMK2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
LINC00094	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
LINC01002	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01088	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LLNLF-187D8.1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LMNTD1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LONP2	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_BILE_ACID_METABOLISM(10/112),HALLMARK_PEROXISOME(9/104)
LRRC17	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
LRRC23	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
LRRC43	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
LRRC46	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
LRRC48	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
LRRC6	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
LRRC71	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
LRRC74B	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LRRFIP2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
LRRIQ1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
LRRN2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
LRTOMT	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
LSP1	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY(6/49)
LTBP1	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_CORE_MATRISOME(18/275),NABA_MATRISOME(37/1028),NABA_ECM_GLYCOPROTEINS(11/196)
LYPLA2	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM(8/77)
LYPLAL1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
LYRM1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
LZTFL1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MAATS1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MALAT1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MAP3K12	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(15/267)
MAP3K19	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MAP6	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MAPK10	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(15/267),KEGG_PATHWAYS_IN_CANCER(15/328)
MAPK15	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MAPRE3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MATN2	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_CORE_MATRISOME(18/275),NABA_MATRISOME(37/1028),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(13/200),NABA_ECM_GLYCOPROTEINS(11/196)
MDH1B	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MDM1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MDM2	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(23/421),PID_P73PATHWAY(9/79),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(11/138),KEGG_PROSTATE_CANCER(8/89),REACTOME_SIGNALING_BY_ERBB2(8/101),REACTOME_SIGNALLING_BY_NGF(12/217),BIOCARTA_P53HYPOXIA_PATHWAY(4/23),PID_RANBP2_PATHWAY(3/11),KEGG_PATHWAYS_IN_CANCER(15/328),REACTOME_SIGNALING_BY_ERBB4(7/90),KEGG_ENDOCYTOSIS(10/183)
MEAF6	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MED25	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478)
MFAP4	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_CORE_MATRISOME(18/275),NABA_MATRISOME(37/1028),NABA_ECM_GLYCOPROTEINS(11/196)
MGAT5	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MIA3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MICALL2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MICU2	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MINA	TH34_1455_S01	v9		lowstringency_pd_outliers	PID_MYC_ACTIV_PATHWAY(7/79)
MIR34C	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MKS1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MLF1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MLLT1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MLLT4	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_ADHERENS_JUNCTION(7/75)
MNAT1	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MITOTIC_G2_G2_M_PHASES(11/81),REACTOME_CELL_CYCLE(23/421),REACTOME_MRNA_PROCESSING(13/161),REACTOME_CELL_CYCLE_MITOTIC(17/325),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105),HALLMARK_G2M_CHECKPOINT(12/200),KEGG_NUCLEOTIDE_EXCISION_REPAIR(5/44),REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_(5/45),REACTOME_MRNA_CAPPING(4/30)
MNS1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MOK	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MORN1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MORN2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MORN3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MORN5	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MOSPD1	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(16/200)
MPC2	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MPZL1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MRPL38	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MRPS14	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MRPS25	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MRPS33	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MSI2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MSTO1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MTMR11	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MTRR	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MYCBP	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MYCBPAP	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MYEF2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
MZF1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
NCBP1	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(13/161),KEGG_SPLICEOSOME(11/128),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105),REACTOME_MRNA_SPLICING(9/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(10/140),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(5/44),REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_(5/45),REACTOME_MRNA_CAPPING(4/30)
NCSTN	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_NUCLEAR_SIGNALING_BY_ERBB4(5/38),REACTOME_SIGNALLING_BY_NGF(12/217),REACTOME_SIGNALING_BY_ERBB4(7/90)
NEAT1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
NEIL1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
NEK11	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
NEK4	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
NEK5	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
NISCH	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
NIT1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
NME5	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_PURINE_METABOLISM(11/159)
NME7	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_PURINE_METABOLISM(11/159)
NME9	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
NPHP1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
NPR2	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_PURINE_METABOLISM(11/159),HALLMARK_DNA_REPAIR(10/150)
NQO1	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY(6/49),BIOCARTA_P53HYPOXIA_PATHWAY(4/23)
NR4A1	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(15/267),REACTOME_SIGNALING_BY_ERBB2(8/101),REACTOME_SIGNALLING_BY_NGF(12/217),REACTOME_SIGNALING_BY_ERBB4(7/90)
NR4A3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
NRAV	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NRBP1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
NRG2	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(37/1028),REACTOME_SIGNALING_BY_ERBB2(8/101),REACTOME_NUCLEAR_SIGNALING_BY_ERBB4(5/38),REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING(3/12),REACTOME_SIGNALING_BY_ERBB4(7/90)
NSMF	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NT5DC1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
NUCB2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
NUCKS1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
NUDC	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(23/421),REACTOME_CELL_CYCLE_MITOTIC(17/325)
NUDT5	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_PURINE_METABOLISM(11/159)
NXN	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
OBSL1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ODF2	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(12/200)
ODF2L	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ODF3B	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
OSCP1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
OSGEP	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
P3H2	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(37/1028)
P4HTM	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(37/1028)
PACRG	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PAIP2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PARD3	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(7/63),KEGG_ADHERENS_JUNCTION(7/75),KEGG_ENDOCYTOSIS(10/183)
PASK	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PBX2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PCM1	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MITOTIC_G2_G2_M_PHASES(11/81),REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES(9/59),REACTOME_CELL_CYCLE(23/421),REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES(9/66),REACTOME_CELL_CYCLE_MITOTIC(17/325)
PCNXL4	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PCYT1A	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM(8/77),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478)
PDCD4	TH34_1455_S01	v9	PACLITAXEL	lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(12/200)
PDDC1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PDIA4	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PDLIM1	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY(6/49)
PDXK	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PEX19	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_BILE_ACID_METABOLISM(10/112),KEGG_PEROXISOME(7/78)
PFKFB2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PHACTR1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PHC1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PHYKPL	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PI4KB	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478),KEGG_INOSITOL_PHOSPHATE_METABOLISM(6/54),PID_AVB3_INTEGRIN_PATHWAY(7/75)
PIAS1	TH34_1455_S01	v9		lowstringency_pd_outliers	PID_HEDGEHOG_GLI_PATHWAY(7/48),KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(11/138),PID_RANBP2_PATHWAY(3/11),KEGG_PATHWAYS_IN_CANCER(15/328)
PIAS3	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(11/138),KEGG_PATHWAYS_IN_CANCER(15/328)
PIFO	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PIH1D2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PIH1D3	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PILRB	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PIP5K1A	TH34_1455_S01	v9		lowstringency_pd_outliers	PID_ARF_3PATHWAY(4/19),KEGG_INOSITOL_PHOSPHATE_METABOLISM(6/54),KEGG_ENDOCYTOSIS(10/183)
PITPNA	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PITPNM1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PLA2G4A	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM(8/77),KEGG_MAPK_SIGNALING_PATHWAY(15/267),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478)
PLA2G6	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM(8/77),KEGG_MAPK_SIGNALING_PATHWAY(15/267),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478)
PLCD1	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_INOSITOL_PHOSPHATE_METABOLISM(6/54)
PLD2	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_GLYCEROPHOSPHOLIPID_METABOLISM(8/77),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478),PID_ARF_3PATHWAY(4/19),KEGG_ENDOCYTOSIS(10/183)
PLEKHA5	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PLEKHG5	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PLTP	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478)
PLXNB2	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(37/1028)
PNISR	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PNKP	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PNMA2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PODN	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_CORE_MATRISOME(18/275),NABA_MATRISOME(37/1028)
POFUT2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
POGZ	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
POLR2L	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(13/161),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105),KEGG_HUNTINGTONS_DISEASE(12/185),KEGG_PURINE_METABOLISM(11/159),REACTOME_MRNA_SPLICING(9/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(10/140),REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_(5/45),REACTOME_MRNA_CAPPING(4/30)
POMT2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PPAP2A	TH34_1455_S01	v9		lowstringency_pd_outliers	PID_P73PATHWAY(9/79),KEGG_GLYCEROPHOSPHOLIPID_METABOLISM(8/77),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478)
PPID	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_HUNTINGTONS_DISEASE(12/185)
PPIL4	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PPIL6	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PPM1J	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PPOX	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(16/200)
PPP1R12B	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PPP1R15A	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(7/63)
PPP1R16A	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PPP1R32	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PPP1R42	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PPP1R7	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PPP5C	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(15/267)
PQLC1	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(16/200)
PRDX5	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_BILE_ACID_METABOLISM(10/112),HALLMARK_PEROXISOME(9/104),KEGG_PEROXISOME(7/78)
PRKAR1A	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_ERBB2(8/101),REACTOME_SIGNALLING_BY_NGF(12/217)
PRKRA	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PRMT5	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(12/200),PID_HDAC_CLASSI_PATHWAY(6/66)
PRNP	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY(6/49)
PRPF4B	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(12/200)
PRPS1	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_PURINE_METABOLISM(11/159)
PRR29	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PSENEN	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_NUCLEAR_SIGNALING_BY_ERBB4(5/38),REACTOME_SIGNALLING_BY_NGF(12/217),REACTOME_SIGNALING_BY_ERBB4(7/90)
PSMA3-AS1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PSMD9	TH34_1455_S01	v9	CARFILZOMIB,BORTEZOMIB	lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(16/200),REACTOME_CELL_CYCLE(23/421),REACTOME_CELL_CYCLE_MITOTIC(17/325)
PSPH	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PTBP1	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(13/161),REACTOME_MRNA_SPLICING(9/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(10/140)
PTCD3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
PTK2B	TH34_1455_S01	v9	PF00562271,PF-562271	lowstringency_pd_outliers	PID_AVB3_INTEGRIN_PATHWAY(7/75)
PTPRM	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_ADHERENS_JUNCTION(7/75)
PYCR2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RAB36	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RAB4A	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_ENDOCYTOSIS(10/183)
RABL2A	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RABL2B	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RAMP2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RAMP2-AS1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RBM24	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RBM25	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(11/128)
RBM38	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(16/200)
RBM5	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(16/200),REACTOME_MRNA_PROCESSING(13/161),REACTOME_MRNA_SPLICING(9/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(10/140)
RERG	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RFX2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RFX5	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RGL2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RHOU	TH34_1455_S01	v9		lowstringency_pd_outliers	WNT_SIGNALING(7/89)
RIBC1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RIBC2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RIIAD1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RIMKLB	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RMST	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RMST_10	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RNF220	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RNF43	TH34_1455_S01	v9		lowstringency_pd_outliers	PID_P73PATHWAY(9/79)
RNPEP	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RNU5B-3P	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ROPN1L	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RP11-1212A22.1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-1212A22.4	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-14N7.2	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-259K15.2	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-263K19.4	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-356K23.1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-424M24.5	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-445L6.3	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-503N18.1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-545G3.1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-620J15.3	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-863K10.4	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-669L17.10	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-717I23.3	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RPGR	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RPL32P3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RPS6KA2	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_MAPK_SIGNALING_PATHWAY(15/267),HALLMARK_ESTROGEN_RESPONSE_LATE(12/200),REACTOME_SIGNALLING_BY_NGF(12/217)
RRNAD1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RSPH1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RSPH10B	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RSPH10B2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RSPH4A	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
RUFY1	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_ENDOCYTOSIS(10/183)
RUVBL1	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(23/421),PID_MYC_ACTIV_PATHWAY(7/79),PID_ILK_PATHWAY(5/45)
RUVBL2	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(23/421),PID_MYC_ACTIV_PATHWAY(7/79),PID_ILK_PATHWAY(5/45)
SAP30	TH34_1455_S01	v9		lowstringency_pd_outliers	PID_HEDGEHOG_GLI_PATHWAY(7/48),HALLMARK_G2M_CHECKPOINT(12/200),PID_HDAC_CLASSI_PATHWAY(6/66)
SARAF	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SAXO2	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SCAMP4	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SCCPDH	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SCPEP1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SCX	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SDC1	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_MATRISOME(37/1028),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(13/200),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478),PID_AVB3_INTEGRIN_PATHWAY(7/75)
SDCCAG8	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MITOTIC_G2_G2_M_PHASES(11/81),REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES(9/59),REACTOME_CELL_CYCLE(23/421),REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES(9/66),REACTOME_CELL_CYCLE_MITOTIC(17/325)
SDHC	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_HUNTINGTONS_DISEASE(12/185),HALLMARK_FATTY_ACID_METABOLISM(10/158)
SENP2	TH34_1455_S01	v9		lowstringency_pd_outliers	WNT_SIGNALING(7/89)
SENP6	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SF1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SFSWAP	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SH3BGR	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SIN3B	TH34_1455_S01	v9		lowstringency_pd_outliers	PID_HEDGEHOG_GLI_PATHWAY(7/48),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478),PID_HDAC_CLASSI_PATHWAY(6/66)
SIRT3	TH34_1455_S01	v9		lowstringency_pd_outliers	PID_HDAC_CLASSI_PATHWAY(6/66)
SKA2	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(23/421),REACTOME_CELL_CYCLE_MITOTIC(17/325)
SLC12A4	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SLC16A1	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(12/200)
SLC16A4	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SLC25A17	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_PEROXISOME(9/104),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478),KEGG_PEROXISOME(7/78)
SLC25A37	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(16/200)
SLC27A3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SLC38A3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SLC39A12	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SLC40A1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SLC41A1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SLC46A1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SLC47A2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SLFN13	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SLTM	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SMARCA1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SMEK1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SMEK2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SMG7	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SMYD2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SNAPIN	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SNCAIP	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SNHG14	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SNRPGP10	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SNTN	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SNW1	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(11/128)
SNX14	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SOCS2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SON	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SORBS2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SPA17	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SPAG1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SPAG16	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SPAG17	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SPAG6	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SPAG8	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SPATA17	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SPATA18	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SPATA33	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SPEF1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SPEF2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SPG20	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SPIN1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SPINT2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SQLE	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478),HALLMARK_G2M_CHECKPOINT(12/200)
SRCIN1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SREK1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SRGN	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_CORE_MATRISOME(18/275),NABA_MATRISOME(37/1028)
SRP14	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SRP19	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SRP9	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SRRT	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SRSF5	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(13/161),KEGG_SPLICEOSOME(11/128),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105),REACTOME_MRNA_SPLICING(9/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(10/140),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(5/44)
SRSF6	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(13/161),KEGG_SPLICEOSOME(11/128),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105),REACTOME_MRNA_SPLICING(9/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(10/140),HALLMARK_DNA_REPAIR(10/150),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(5/44)
SRXN1	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY(6/49)
SS18	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_G2M_CHECKPOINT(12/200)
SSB	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SSBP3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SSBP4	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ST3GAL6	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
STAG3L5P	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
STAT2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
STIM1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
STK11IP	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
STK33	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
STK36	TH34_1455_S01	v9		lowstringency_pd_outliers	PID_HEDGEHOG_GLI_PATHWAY(7/48),KEGG_PATHWAYS_IN_CANCER(15/328)
STK38L	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
STOML3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
STPG1	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
STRADA	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
STRBP	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
STX16	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SUN1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SUPT5H	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(13/161),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105),HALLMARK_DNA_REPAIR(10/150),REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_(5/45),REACTOME_MRNA_CAPPING(4/30)
SUPT7L	TH34_1455_S01	v9		lowstringency_pd_outliers	PID_MYC_ACTIV_PATHWAY(7/79)
SVOPL	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SWI5	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SYNC	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SYNE1	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(23/421)
SYNE2	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(23/421)
SYNGAP1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
SYTL3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TARBP1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TCF15	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TCF7	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_PROSTATE_CANCER(8/89),KEGG_ADHERENS_JUNCTION(7/75),KEGG_PATHWAYS_IN_CANCER(15/328),WNT_SIGNALING(7/89),KEGG_THYROID_CANCER(4/29)
TCTEX1D1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TCTEX1D2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TCTN1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TCTN2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TEKT1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TEKT2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TEKT4	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TELO2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TEX26	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TEX9	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TGIF1	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(7/63)
THBS3	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_CORE_MATRISOME(18/275),NABA_MATRISOME(37/1028),NABA_ECM_GLYCOPROTEINS(11/196)
TKFC	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TM9SF1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TM9SF2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TMCO1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TMEM106C	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TMEM107	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TMEM110	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TMEM123	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TMEM138	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TMEM150C	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TMEM218	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TMEM231	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TMEM232	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TMEM234	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TMEM237	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TMEM248	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TMEM254	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TMEM50B	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TMEM67	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TNFRSF10B	TH34_1455_S01	v9	APOMAB,DULANERMIN,LEXATUMUMAB,RHAPO2L/TRAIL,LBY135,CONATUMUMAB	lowstringency_pd_outliers	NA
TNFRSF25	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TNRC6C	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TOB1	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(12/200)
TP53BP1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TP73	TH34_1455_S01	v9		lowstringency_pd_outliers	PID_P73PATHWAY(9/79)
TPM3	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(15/328),KEGG_THYROID_CANCER(4/29)
TPPP3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TPRG1L	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TRA2A	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(11/128)
TRAF3IP1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TRDN	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TRIM22	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TRIM41	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TSGA10	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TSNAX	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TSNAXIP1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TSPAN6	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TTC17	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TTC21A	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TTC25	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TTC26	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TTC29	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TTC8	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TTLL3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TTLL4	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TTLL7	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TTLL9	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TUBA1A	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MITOTIC_G2_G2_M_PHASES(11/81),REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES(9/59),REACTOME_CELL_CYCLE(23/421),REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES(9/66),PID_P73PATHWAY(9/79),REACTOME_CELL_CYCLE_MITOTIC(17/325)
TUBB4B	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MITOTIC_G2_G2_M_PHASES(11/81),REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES(9/59),REACTOME_CELL_CYCLE(23/421),REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES(9/66),REACTOME_CELL_CYCLE_MITOTIC(17/325)
TUSC3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
TVP23B	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
U2SURP	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(11/128)
UBAC2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
UBAP2L	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
UBE2D3	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(11/138),REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(7/63)
UBL3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
UBR5	TH34_1455_S01	v9		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(11/138)
UBXN10	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
UBXN11	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
UFC1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
UNC119B	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
USF1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
USP2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
USP21	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
USP8	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_ERBB2(8/101),REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING(3/12),KEGG_ENDOCYTOSIS(10/183)
UXS1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
VANGL2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
VPS39	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
VWA3A	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_CORE_MATRISOME(18/275),NABA_MATRISOME(37/1028),NABA_ECM_GLYCOPROTEINS(11/196)
VWA3B	TH34_1455_S01	v9		lowstringency_pd_outliers	NABA_CORE_MATRISOME(18/275),NABA_MATRISOME(37/1028),NABA_ECM_GLYCOPROTEINS(11/196)
WDR19	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
WDR26	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
WDR27	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
WDR38	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
WDR49	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
WDR54	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
WDR60	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
WDR61	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
WDR63	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
WDR66	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
WDR73	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
WDR78	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
WDR90	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
WDR92	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
WFS1	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(12/200)
WNK2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
WRAP53	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_CELL_CYCLE(23/421)
WRB	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
XPO1	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MITOTIC_G2_G2_M_PHASES(11/81),REACTOME_CELL_CYCLE(23/421),PID_HEDGEHOG_GLI_PATHWAY(7/48),REACTOME_CELL_CYCLE_MITOTIC(17/325),REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX(7/63),HALLMARK_G2M_CHECKPOINT(12/200),PID_RANBP2_PATHWAY(3/11),PID_ILK_PATHWAY(5/45),PID_HDAC_CLASSI_PATHWAY(6/66)
XPR1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
XRN2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
XXbac-BPG308J9.3	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
YAP1	TH34_1455_S01	v9		lowstringency_pd_outliers	PID_P73PATHWAY(9/79),REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS(21/478),REACTOME_NUCLEAR_SIGNALING_BY_ERBB4(5/38),REACTOME_SIGNALING_BY_ERBB4(7/90)
YIF1B	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
YJEFN3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
YPEL5	TH34_1455_S01	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(16/200)
ZBBX	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ZC2HC1C	TH34_1455_S01	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZC3H11A	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ZC3H14	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ZDHHC1	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ZDHHC14	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ZDHHC17	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ZFR	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ZMYND10	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ZMYND12	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ZNF273	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ZNF3	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ZNF326	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ZNF423	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ZNF473	TH34_1455_S01	v9		lowstringency_pd_outliers	REACTOME_MRNA_PROCESSING(13/161),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(5/44)
ZNF664	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ZRANB2	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
ZSCAN18	TH34_1455_S01	v9		lowstringency_pd_outliers	NA
A2M	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_MATRISOME_ASSOCIATED(35/753),REACTOME_HEMOSTASIS(26/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(16/208),REACTOME_SIGNALING_BY_RHO_GTPASES(12/113),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(9/89),HALLMARK_COAGULATION(10/138),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(7/69)
ABCA8	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ABI3BP	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_GLYCOPROTEINS(15/196),NABA_CORE_MATRISOME(17/275),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(12/200)
ABLIM1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200),REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),HALLMARK_ESTROGEN_RESPONSE_EARLY(17/200),REACTOME_AXON_GUIDANCE(18/251)
ABR	TH34_1456_S02	v9		lowstringency_pd_outliers	PID_RHOA_REG_PATHWAY(10/46),HALLMARK_MITOTIC_SPINDLE(16/200),REACTOME_SIGNALING_BY_RHO_GTPASES(12/113),REACTOME_SIGNALLING_BY_NGF(15/217)
AC002398.12	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC005154.6	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC008623.1	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACADVL	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ACE	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(17/200),KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM(9/85)
ACKR1	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACSS2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ACVRL1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ADAMTS7P3	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADCY4	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_SIGNALLING_BY_NGF(15/217),KEGG_CHEMOKINE_SIGNALING_PATHWAY(14/190),KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(11/115),PID_LYSOPHOSPHOLIPID_PATHWAY(8/66),KEGG_DILATED_CARDIOMYOPATHY(9/92)
ADD1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_APOPTOSIS(15/161),HALLMARK_HEME_METABOLISM(13/200)
ADGRL2	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADH1B	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ADIRF-AS1	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AGAP3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
AGER	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(15/200),REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE(9/72),REACTOME_IMMUNE_SYSTEM(35/933),REACTOME_TRIF_MEDIATED_TLR3_SIGNALING(9/74),REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION(9/77),REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE(9/83),REACTOME_INNATE_IMMUNE_SYSTEM(16/279),REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION(5/21),REACTOME_ACTIVATED_TLR4_SIGNALLING(9/93),REACTOME_TOLL_RECEPTOR_CASCADES(9/118)
AKAP1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(17/200),REACTOME_HEMOSTASIS(26/466),PID_VEGFR1_2_PATHWAY(7/69)
AKAP2	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(15/200)
AKAP8L	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
AKT2	TH34_1456_S02	v9	MK-2206,GSK2126458,IPATASERTIB,MK2206,TRASTUZUMAB,AZD4547,GDC-0068,EVEROLIMUS	lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200),KEGG_FOCAL_ADHESION(24/201),HALLMARK_APICAL_JUNCTION(23/200),REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),KEGG_PATHWAYS_IN_CANCER(24/328),KEGG_TIGHT_JUNCTION(15/134),PID_MET_PATHWAY(12/80),HALLMARK_KRAS_SIGNALING_UP(17/200),REACTOME_HEMOSTASIS(26/466),ST_INTEGRIN_SIGNALING_PATHWAY(11/82),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(16/208),REACTOME_SIGNALLING_BY_NGF(15/217),REACTOME_IMMUNE_SYSTEM(35/933),KEGG_CHEMOKINE_SIGNALING_PATHWAY(14/190),KEGG_SMALL_CELL_LUNG_CANCER(9/84),PID_ECADHERIN_KERATINOCYTE_PATHWAY(5/21),KEGG_MAPK_SIGNALING_PATHWAY(15/267),KEGG_RENAL_CELL_CARCINOMA(7/70)
AL603831.1	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ALDH1A1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ALOX5	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ALS2CL	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ANKRD1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ANKRD11	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ANKRD29	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ANKZF1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ANXA3	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_AFFILIATED(18/171),NABA_MATRISOME_ASSOCIATED(35/753)
ANXA8	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_AFFILIATED(18/171),NABA_MATRISOME_ASSOCIATED(35/753)
ANXA8L1	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_AFFILIATED(18/171),NABA_MATRISOME_ASSOCIATED(35/753)
AP003041.1	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AP3S1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
APOL3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
APP	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200),REACTOME_HEMOSTASIS(26/466),HALLMARK_APOPTOSIS(15/161),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(16/208),REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE(9/72),REACTOME_IMMUNE_SYSTEM(35/933),REACTOME_TRIF_MEDIATED_TLR3_SIGNALING(9/74),REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION(9/77),REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE(9/83),REACTOME_INNATE_IMMUNE_SYSTEM(16/279),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(9/89),REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION(5/21),REACTOME_ACTIVATED_TLR4_SIGNALLING(9/93),HALLMARK_P53_PATHWAY(12/200),REACTOME_TOLL_RECEPTOR_CASCADES(9/118)
APPL1	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(24/328)
AQP4	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ARAP1	TH34_1456_S02	v9		lowstringency_pd_outliers	PID_RHOA_REG_PATHWAY(10/46),KEGG_ENDOCYTOSIS(16/183),REACTOME_SIGNALING_BY_RHO_GTPASES(12/113)
ARAP3	TH34_1456_S02	v9		lowstringency_pd_outliers	PID_RHOA_REG_PATHWAY(10/46),KEGG_ENDOCYTOSIS(16/183),HALLMARK_MITOTIC_SPINDLE(16/200),REACTOME_SIGNALING_BY_RHO_GTPASES(12/113)
ARGLU1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ARHGAP17	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_RHO_GTPASES(12/113)
ARHGAP21	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ARHGAP35	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(24/201),REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(19/216),PID_RHOA_REG_PATHWAY(10/46),ST_INTEGRIN_SIGNALING_PATHWAY(11/82),REACTOME_AXON_GUIDANCE(18/251),REACTOME_SIGNALING_BY_RHO_GTPASES(12/113),KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION(12/118),PID_FAK_PATHWAY(7/59)
ARHGAP44	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_RHO_GTPASES(12/113)
ARHGEF1	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(19/216),PID_RHOA_REG_PATHWAY(10/46),REACTOME_SIGNALLING_BY_NGF(15/217),KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(11/115),PID_LYSOPHOSPHOLIPID_PATHWAY(8/66)
ARHGEF10	TH34_1456_S02	v9		lowstringency_pd_outliers	PID_RHOA_REG_PATHWAY(10/46)
ARHGEF15	TH34_1456_S02	v9		lowstringency_pd_outliers	PID_RHOA_REG_PATHWAY(10/46)
ARHGEF2	TH34_1456_S02	v9		lowstringency_pd_outliers	PID_RHOA_REG_PATHWAY(10/46),HALLMARK_MITOTIC_SPINDLE(16/200),REACTOME_SIGNALING_BY_RHO_GTPASES(12/113),REACTOME_SIGNALLING_BY_NGF(15/217)
ARL8A	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(16/200)
ARRB1	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(26/466),KEGG_ENDOCYTOSIS(16/183),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(16/208),KEGG_CHEMOKINE_SIGNALING_PATHWAY(14/190),KEGG_MAPK_SIGNALING_PATHWAY(15/267)
ARRDC1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ASAP1	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_ENDOCYTOSIS(16/183),ST_INTEGRIN_SIGNALING_PATHWAY(11/82),PID_FAK_PATHWAY(7/59)
ASAP2	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_ENDOCYTOSIS(16/183),PID_ARF6_TRAFFICKING_PATHWAY(7/49)
ASNSD1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ATF7	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ATHL1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ATN1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ATP13A4	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ATP5SL	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ATP6V0A1	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION(8/68),HALLMARK_HEME_METABOLISM(13/200)
ATXN2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ATXN2L	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
BANF1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
BAZ2A	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
BBS2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
BCAM	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(13/200)
BCAR1	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(24/201),KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(19/216),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(12/79),PID_MET_PATHWAY(12/80),BIOCARTA_INTEGRIN_PATHWAY(9/38),REACTOME_HEMOSTASIS(26/466),ST_INTEGRIN_SIGNALING_PATHWAY(11/82),HALLMARK_MITOTIC_SPINDLE(16/200),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(16/208),KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION(12/118),KEGG_CHEMOKINE_SIGNALING_PATHWAY(14/190),PID_LYSOPHOSPHOLIPID_PATHWAY(8/66),PID_FAK_PATHWAY(7/59),BIOCARTA_CELL2CELL_PATHWAY(4/14),PID_AVB3_OPN_PATHWAY(5/31),PID_CDC42_PATHWAY(7/70)
BCL2L2	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_APOPTOSIS(15/161)
BCL6B	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
BCL7B	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
BCL9L	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
BECN1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
BMI1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
BPTF	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
BRD2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
BRD7	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
BTN2A1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
BTN3A1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
BTNL9	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
BUD31	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(12/128)
C14orf166	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
C15orf52	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
C16orf89	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
C19orf33	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
C19orf66	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
C1D	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
C1orf116	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
C4BPA	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(35/933),REACTOME_INNATE_IMMUNE_SYSTEM(16/279),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(7/69),PID_CD40_PATHWAY(5/31)
C7	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(35/933),REACTOME_INNATE_IMMUNE_SYSTEM(16/279),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(7/69)
C7orf55-LUC7L2	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
C8orf4	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CA4	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CAB39	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CABIN1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CACNA2D2	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(18/200),KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC(10/76),KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM(9/85),KEGG_DILATED_CARDIOMYOPATHY(9/92),KEGG_MAPK_SIGNALING_PATHWAY(15/267)
CADM1	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_CELL_JUNCTION_ORGANIZATION(12/78),REACTOME_CELL_CELL_COMMUNICATION(14/120),REACTOME_CELL_CELL_JUNCTION_ORGANIZATION(8/56),KEGG_CELL_ADHESION_MOLECULES_CAMS(11/134),REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS(5/27),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(12/200)
CALCOCO1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CALCRL	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_INFLAMMATORY_RESPONSE(17/200),KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(11/115)
CAMK2N1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CAMTA2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CAPN2	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(24/201),PID_FAK_PATHWAY(7/59),BIOCARTA_MCALPAIN_PATHWAY(5/25),PID_ERBB1_DOWNSTREAM_PATHWAY(9/105),HALLMARK_COAGULATION(10/138)
CAPNS1	TH34_1456_S02	v9		lowstringency_pd_outliers	BIOCARTA_INTEGRIN_PATHWAY(9/38),BIOCARTA_MCALPAIN_PATHWAY(5/25)
CARD8	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY(8/62)
CASC3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CAT	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(13/200)
CAV1	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(24/201),HALLMARK_ESTROGEN_RESPONSE_LATE(18/200),BIOCARTA_INTEGRIN_PATHWAY(9/38),REACTOME_HEMOSTASIS(26/466),HALLMARK_APOPTOSIS(15/161),ST_INTEGRIN_SIGNALING_PATHWAY(11/82),REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL(9/91),KEGG_VIRAL_MYOCARDITIS(8/73),HALLMARK_UV_RESPONSE_DN(10/144),PID_VEGFR1_2_PATHWAY(7/69)
CAV2	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(24/201)
CBWD3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CC2D1B	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CCDC12	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(12/128)
CCDC57	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CCDC69	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CCDC84	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CCDC92	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CCL19	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_MATRISOME_ASSOCIATED(35/753),KEGG_CHEMOKINE_SIGNALING_PATHWAY(14/190)
CCNK	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(12/200)
CCRL2	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200),HALLMARK_INFLAMMATORY_RESPONSE(17/200)
CD52	TH34_1456_S02	v9	ALEMTUZUMAB,Alemtuzumab,CAMPATH	lowstringency_pd_outliers	NA
CD55	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_INFLAMMATORY_RESPONSE(17/200),REACTOME_IMMUNE_SYSTEM(35/933),REACTOME_INNATE_IMMUNE_SYSTEM(16/279),KEGG_VIRAL_MYOCARDITIS(8/73),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(7/69)
CDC42BPG	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CDH1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(23/200),KEGG_PATHWAYS_IN_CANCER(24/328),HALLMARK_ESTROGEN_RESPONSE_LATE(18/200),REACTOME_CELL_JUNCTION_ORGANIZATION(12/78),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(12/79),PID_MET_PATHWAY(12/80),REACTOME_CELL_CELL_COMMUNICATION(14/120),REACTOME_IMMUNE_SYSTEM(35/933),REACTOME_CELL_CELL_JUNCTION_ORGANIZATION(8/56),PID_A6B1_A6B4_INTEGRIN_PATHWAY(7/46),KEGG_CELL_ADHESION_MOLECULES_CAMS(11/134),PID_ARF6_TRAFFICKING_PATHWAY(7/49),PID_ECADHERIN_KERATINOCYTE_PATHWAY(5/21),HALLMARK_TGF_BETA_SIGNALING(7/54),REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS(5/27),PID_CDC42_PATHWAY(7/70)
CDH5	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_CELL_JUNCTION_ORGANIZATION(12/78),REACTOME_CELL_CELL_COMMUNICATION(14/120),KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION(12/118),REACTOME_CELL_CELL_JUNCTION_ORGANIZATION(8/56),KEGG_CELL_ADHESION_MOLECULES_CAMS(11/134),REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS(5/27),PID_VEGFR1_2_PATHWAY(7/69)
CDK11B	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CEACAM6	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CENPT	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CES1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CFAP20	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CFD	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200),REACTOME_HEMOSTASIS(26/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(16/208),REACTOME_IMMUNE_SYSTEM(35/933),REACTOME_INNATE_IMMUNE_SYSTEM(16/279),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(9/89),HALLMARK_COAGULATION(10/138),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(7/69)
CFL2	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(19/216)
CFLAR	TH34_1456_S02	v9	BICALUTAMIDE	lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200),HALLMARK_APOPTOSIS(15/161),BIOCARTA_DEATH_PATHWAY(6/33),ST_TUMOR_NECROSIS_FACTOR_PATHWAY(5/29)
CGN	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_TIGHT_JUNCTION(15/134)
CGNL1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CH17-219N22.1	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CHD2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CHD8	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CHKA	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CHMP3	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_ENDOCYTOSIS(16/183)
CHMP4A	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_ENDOCYTOSIS(16/183)
CHRDL1	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_MATRISOME_ASSOCIATED(35/753)
CIR1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(13/200)
CITED2	TH34_1456_S02	v9		lowstringency_pd_outliers	BIOCARTA_PPARA_PATHWAY(7/58),HALLMARK_UV_RESPONSE_DN(10/144)
CIZ1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CLDN18	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(23/200),KEGG_TIGHT_JUNCTION(15/134),REACTOME_CELL_JUNCTION_ORGANIZATION(12/78),REACTOME_CELL_CELL_COMMUNICATION(14/120),KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION(12/118),REACTOME_CELL_CELL_JUNCTION_ORGANIZATION(8/56),KEGG_CELL_ADHESION_MOLECULES_CAMS(11/134)
CLDN7	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(23/200),KEGG_TIGHT_JUNCTION(15/134),REACTOME_CELL_JUNCTION_ORGANIZATION(12/78),REACTOME_CELL_CELL_COMMUNICATION(14/120),HALLMARK_ESTROGEN_RESPONSE_EARLY(17/200),KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION(12/118),REACTOME_CELL_CELL_JUNCTION_ORGANIZATION(8/56),KEGG_CELL_ADHESION_MOLECULES_CAMS(11/134)
CLEC14A	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_AFFILIATED(18/171),NABA_MATRISOME_ASSOCIATED(35/753)
CLEC2B	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_AFFILIATED(18/171),NABA_MATRISOME_ASSOCIATED(35/753)
CLEC3B	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_AFFILIATED(18/171),NABA_MATRISOME_ASSOCIATED(35/753)
CLIC5	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CLK3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CNOT2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CNOT3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
COL13A1	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_CORE_MATRISOME(17/275)
CPM	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CPNE2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CPSF7	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(16/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(16/140),REACTOME_MRNA_PROCESSING(16/161),REACTOME_MRNA_3_END_PROCESSING(8/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(8/44),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105)
CRACR2B	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CRTC2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CRTC3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CRYAB	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200)
CSF3R	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(24/328),HALLMARK_INFLAMMATORY_RESPONSE(17/200)
CTD-2562J17.6	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTNNA1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(23/200),REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),KEGG_PATHWAYS_IN_CANCER(24/328),KEGG_TIGHT_JUNCTION(15/134),REACTOME_CELL_JUNCTION_ORGANIZATION(12/78),PID_MET_PATHWAY(12/80),REACTOME_CELL_CELL_COMMUNICATION(14/120),KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC(10/76),KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION(12/118),REACTOME_CELL_CELL_JUNCTION_ORGANIZATION(8/56),PID_ARF6_TRAFFICKING_PATHWAY(7/49),PID_ECADHERIN_KERATINOCYTE_PATHWAY(5/21),BIOCARTA_CELL2CELL_PATHWAY(4/14),REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS(5/27),PID_VEGFR1_2_PATHWAY(7/69),PID_CDC42_PATHWAY(7/70)
CXCL16	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_CHEMOKINE_SIGNALING_PATHWAY(14/190)
CXCL17	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CXCL2	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200),NABA_MATRISOME(52/1028),NABA_MATRISOME_ASSOCIATED(35/753),KEGG_CHEMOKINE_SIGNALING_PATHWAY(14/190),KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY(8/62)
CYFIP1	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(19/216),HALLMARK_IL2_STAT5_SIGNALING(15/200)
CYP2B7P	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CYP4B1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
CYTH1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
DAB2IP	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
DAG1	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC(10/76),KEGG_ECM_RECEPTOR_INTERACTION(10/84),BIOCARTA_AGR_PATHWAY(7/36),KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM(9/85),KEGG_DILATED_CARDIOMYOPATHY(9/92),KEGG_VIRAL_MYOCARDITIS(8/73)
DAZAP1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
DBN1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
DCAF8	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
DCTN2	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(35/933)
DCTN6	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(35/933)
DDR1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
DDX5	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(12/128)
DENND3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
DES	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200),KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC(10/76),KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM(9/85),KEGG_DILATED_CARDIOMYOPATHY(9/92)
DGKA	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(26/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(16/208),HALLMARK_P53_PATHWAY(12/200)
DHX16	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(23/200),KEGG_SPLICEOSOME(12/128)
DHX38	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(16/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(16/140),REACTOME_MRNA_PROCESSING(16/161),REACTOME_MRNA_3_END_PROCESSING(8/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(8/44),KEGG_SPLICEOSOME(12/128),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105)
DLC1	TH34_1456_S02	v9		lowstringency_pd_outliers	PID_RHOA_REG_PATHWAY(10/46),HALLMARK_ESTROGEN_RESPONSE_EARLY(17/200),REACTOME_SIGNALING_BY_RHO_GTPASES(12/113),HALLMARK_UV_RESPONSE_DN(10/144)
DMKN	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
DMPK	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200)
DMTN	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DNAJB6	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
DNAJC1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(18/200)
DROSHA	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
DUOX1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
DUSP6	TH34_1456_S02	v9	TRAMETINIB	lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(17/200),REACTOME_SIGNALLING_BY_NGF(15/217),REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE(9/72),REACTOME_IMMUNE_SYSTEM(35/933),REACTOME_TRIF_MEDIATED_TLR3_SIGNALING(9/74),REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION(9/77),REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE(9/83),REACTOME_INNATE_IMMUNE_SYSTEM(16/279),REACTOME_ACTIVATED_TLR4_SIGNALLING(9/93),KEGG_MAPK_SIGNALING_PATHWAY(15/267),PID_ERBB1_DOWNSTREAM_PATHWAY(9/105),HALLMARK_COAGULATION(10/138),REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES(5/30),REACTOME_TOLL_RECEPTOR_CASCADES(9/118)
DVL3	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(24/328)
DYNC2LI1	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(35/933)
ECHDC2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ECSCR	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
EDN1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200),HALLMARK_INFLAMMATORY_RESPONSE(17/200),PID_AP1_PATHWAY(7/70)
EDNRB	TH34_1456_S02	v9		lowstringency_pd_outliers	PID_ARF6_TRAFFICKING_PATHWAY(7/49)
EFNB2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
EGR1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200),PID_MET_PATHWAY(12/80),REACTOME_IMMUNE_SYSTEM(35/933),PID_AR_TF_PATHWAY(7/53),PID_ERBB1_DOWNSTREAM_PATHWAY(9/105),PID_AP1_PATHWAY(7/70)
EHBP1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
EID1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
EIF2B1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
EIF2B5	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
EIF4ENIF1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
EIF4G2	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(35/933),KEGG_VIRAL_MYOCARDITIS(8/73)
ELF3	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(17/200)
EMC7	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
EMCN	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_AFFILIATED(18/171),NABA_MATRISOME_ASSOCIATED(35/753)
EML1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
EMP2	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(18/200)
EOGT	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
EPAS1	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(24/328),KEGG_RENAL_CELL_CARCINOMA(7/70)
EPB41L2	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(23/200),KEGG_TIGHT_JUNCTION(15/134),HALLMARK_MITOTIC_SPINDLE(16/200)
EPB41L3	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_TIGHT_JUNCTION(15/134),HALLMARK_KRAS_SIGNALING_UP(17/200)
EPB41L5	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
EPN2	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_ENDOCYTOSIS(16/183)
EPS8L2	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(12/200)
ERBB2IP	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY(8/62)
ERBB3	TH34_1456_S02	v9	AV-203,LAPATINIB,CETUXIMAB,U3-1287,MEHD7945A,CP724714,MM121,Pertuzumab,MEHD7945 A,GEFITINIB,AFATINIB,SELUMETINIB (AZD6244),CHEMBL2109402,AV203,Afatinib,MM-121,DACOMITINIB,POZIOTINIB,PERTUZUMAB,Lapatinib,Poziotinib	lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200),KEGG_ENDOCYTOSIS(16/183),HALLMARK_APOPTOSIS(15/161),PID_A6B1_A6B4_INTEGRIN_PATHWAY(7/46)
ERCC5	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(12/200)
ERG	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ESAM	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(26/466),KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION(12/118),KEGG_CELL_ADHESION_MOLECULES_CAMS(11/134),REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL(9/91)
EWSR1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
EZH1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(13/200)
F11R	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_TIGHT_JUNCTION(15/134),REACTOME_CELL_JUNCTION_ORGANIZATION(12/78),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(12/79),REACTOME_CELL_CELL_COMMUNICATION(14/120),REACTOME_HEMOSTASIS(26/466),KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION(12/118),REACTOME_CELL_CELL_JUNCTION_ORGANIZATION(8/56),KEGG_CELL_ADHESION_MOLECULES_CAMS(11/134),KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION(8/68),REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL(9/91)
FABP4	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),PID_AP1_PATHWAY(7/70)
FADS3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FAM107B	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FAM111A	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FAM133B	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FAM189A2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FAM192A	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FAM193B	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FAM21C	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FAM65A	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FAXDC2	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FBLN5	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_GLYCOPROTEINS(15/196),NABA_CORE_MATRISOME(17/275),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(12/200),HALLMARK_UV_RESPONSE_DN(10/144)
FBRS	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FBXW4	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FCN3	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_AFFILIATED(18/171),NABA_MATRISOME_ASSOCIATED(35/753)
FENDRR	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FERMT2	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_CELL_JUNCTION_ORGANIZATION(12/78),REACTOME_CELL_CELL_COMMUNICATION(14/120),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(12/200)
FGD5	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FGF7	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),KEGG_PATHWAYS_IN_CANCER(24/328),KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(19/216),NABA_MATRISOME_ASSOCIATED(35/753),KEGG_MAPK_SIGNALING_PATHWAY(15/267)
FGFR4	TH34_1456_S02	v9	BGJ-398,FGF/VEGF RECEPTOR TYROSINE KINASE INHIBITOR, PD173074,BGJ398,INFIGRATINIB,DOVITINIB	lowstringency_pd_outliers	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(19/216),KEGG_ENDOCYTOSIS(16/183),KEGG_MAPK_SIGNALING_PATHWAY(15/267)
FHL1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200)
FIGF	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(24/201),NABA_MATRISOME(52/1028),KEGG_PATHWAYS_IN_CANCER(24/328),NABA_MATRISOME_ASSOCIATED(35/753),REACTOME_HEMOSTASIS(26/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(16/208),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(9/89),KEGG_RENAL_CELL_CARCINOMA(7/70)
FIP1L1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FKBP2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FLI1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FMO2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FN3K	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(13/200)
FNBP1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FNBP4	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FOSB	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200),PID_AP1_PATHWAY(7/70)
FOXP1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FRG1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FRY	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FUBP3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FXR2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FXYD1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200)
FXYD3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
FXYD6	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
G0S2	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200),HALLMARK_KRAS_SIGNALING_UP(17/200)
GABBR1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_INFLAMMATORY_RESPONSE(17/200)
GABRE	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
GATA2	TH34_1456_S02	v9	bortezomib,fasudil,BORTEZOMIB,FASUDIL	lowstringency_pd_outliers	REACTOME_HEMOSTASIS(26/466),PID_HDAC_CLASSI_PATHWAY(9/66),PID_AR_TF_PATHWAY(7/53),PID_AP1_PATHWAY(7/70)
GBP3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
GBP4	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(15/200),REACTOME_IMMUNE_SYSTEM(35/933)
GDI1	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_RHO_GTPASES(12/113)
GGA2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
GGA3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
GGNBP2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
GGT1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
GIMAP4	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
GIMAP5	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
GIMAP6	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
GIMAP7	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
GIMAP8	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
GIT1	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(19/216),KEGG_ENDOCYTOSIS(16/183),KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION(8/68)
GJA5	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200)
GKN2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
GOLGA8B	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
GPM6A	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
GPR137	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
GPRC5A	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
GPS2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
GPX3	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200),HALLMARK_APOPTOSIS(15/161)
GRASP	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
GRIPAP1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
GRK5	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_ENDOCYTOSIS(16/183),KEGG_CHEMOKINE_SIGNALING_PATHWAY(14/190),HALLMARK_UV_RESPONSE_DN(10/144)
GSAP	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GSE1	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GTPBP1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
HBA1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
HBEGF	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200),HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200),NABA_MATRISOME(52/1028),NABA_MATRISOME_ASSOCIATED(35/753),HALLMARK_INFLAMMATORY_RESPONSE(17/200),HALLMARK_KRAS_SIGNALING_UP(17/200),PID_LYSOPHOSPHOLIPID_PATHWAY(8/66),KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION(8/68),HALLMARK_P53_PATHWAY(12/200)
HDAC7	TH34_1456_S02	v9	ROMIDEPSIN,BELINOSTAT,PANOBINOSTAT,VORINOSTAT	lowstringency_pd_outliers	PID_HDAC_CLASSI_PATHWAY(9/66),PID_AR_TF_PATHWAY(7/53)
HDHD2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
HERC2P9	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
HERPUD2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
HIF3A	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
HLX	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
HNRNPA2B1	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(16/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(16/140),REACTOME_MRNA_PROCESSING(16/161)
HNRNPH3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
HNRNPM	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(16/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(16/140),REACTOME_MRNA_PROCESSING(16/161),KEGG_SPLICEOSOME(12/128)
HNRNPR	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(16/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(16/140),REACTOME_MRNA_PROCESSING(16/161)
HNRNPUL1	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(16/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(16/140),REACTOME_MRNA_PROCESSING(16/161)
HOPX	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(15/200)
HOXA4	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
HPGD	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
HRCT1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
HSD17B4	TH34_1456_S02	v9		lowstringency_pd_outliers	BIOCARTA_PPARA_PATHWAY(7/58)
HSPA9	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
HSPB6	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
HYAL1	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_MATRISOME_ASSOCIATED(35/753)
ICA1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_DN(10/144)
IGHA2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
IGKV2-30	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
IGSF10	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_GLYCOPROTEINS(15/196),NABA_CORE_MATRISOME(17/275)
IL15RA	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200),HALLMARK_INFLAMMATORY_RESPONSE(17/200)
IL17RE	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
IL18	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200),NABA_MATRISOME(52/1028),NABA_MATRISOME_ASSOCIATED(35/753),HALLMARK_INFLAMMATORY_RESPONSE(17/200),HALLMARK_APOPTOSIS(15/161),REACTOME_IMMUNE_SYSTEM(35/933),KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY(8/62)
IL1RL1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(15/200)
IL7R	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200),HALLMARK_INFLAMMATORY_RESPONSE(17/200),HALLMARK_KRAS_SIGNALING_UP(17/200),REACTOME_IMMUNE_SYSTEM(35/933)
INMT	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
INPP1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
INPP5K	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ITFG2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ITGA3	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(24/201),HALLMARK_APICAL_JUNCTION(23/200),KEGG_PATHWAYS_IN_CANCER(24/328),KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(19/216),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(12/79),REACTOME_HEMOSTASIS(26/466),ST_INTEGRIN_SIGNALING_PATHWAY(11/82),KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC(10/76),KEGG_ECM_RECEPTOR_INTERACTION(10/84),KEGG_SMALL_CELL_LUNG_CANCER(9/84),KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM(9/85),PID_ARF6_TRAFFICKING_PATHWAY(7/49),REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL(9/91),KEGG_DILATED_CARDIOMYOPATHY(9/92)
ITGAL	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(19/216),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(12/79),REACTOME_HEMOSTASIS(26/466),KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION(12/118),REACTOME_IMMUNE_SYSTEM(35/933),KEGG_CELL_ADHESION_MOLECULES_CAMS(11/134),REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL(9/91),KEGG_VIRAL_MYOCARDITIS(8/73)
ITGB4	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200),KEGG_FOCAL_ADHESION(24/201),HALLMARK_APICAL_JUNCTION(23/200),KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(19/216),REACTOME_CELL_JUNCTION_ORGANIZATION(12/78),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(12/79),REACTOME_CELL_CELL_COMMUNICATION(14/120),KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC(10/76),PID_INTEGRIN4_PATHWAY(5/11),KEGG_ECM_RECEPTOR_INTERACTION(10/84),PID_A6B1_A6B4_INTEGRIN_PATHWAY(7/46),KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM(9/85),KEGG_DILATED_CARDIOMYOPATHY(9/92),HALLMARK_P53_PATHWAY(12/200)
ITGB6	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(24/201),KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(19/216),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(12/79),KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC(10/76),KEGG_ECM_RECEPTOR_INTERACTION(10/84),KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM(9/85),KEGG_DILATED_CARDIOMYOPATHY(9/92)
ITLN2	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_AFFILIATED(18/171),NABA_MATRISOME_ASSOCIATED(35/753)
JUN	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200),KEGG_FOCAL_ADHESION(24/201),KEGG_PATHWAYS_IN_CANCER(24/328),PID_MET_PATHWAY(12/80),BIOCARTA_INTEGRIN_PATHWAY(9/38),HALLMARK_APOPTOSIS(15/161),BIOCARTA_AGR_PATHWAY(7/36),REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE(9/72),REACTOME_IMMUNE_SYSTEM(35/933),REACTOME_TRIF_MEDIATED_TLR3_SIGNALING(9/74),REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION(9/77),PID_ILK_PATHWAY(7/45),REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE(9/83),PID_LYSOPHOSPHOLIPID_PATHWAY(8/66),BIOCARTA_MAPK_PATHWAY(9/87),REACTOME_INNATE_IMMUNE_SYSTEM(16/279),KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION(8/68),REACTOME_ACTIVATED_TLR4_SIGNALLING(9/93),PID_AR_TF_PATHWAY(7/53),KEGG_MAPK_SIGNALING_PATHWAY(15/267),BIOCARTA_PPARA_PATHWAY(7/58),PID_FAK_PATHWAY(7/59),PID_ERBB1_DOWNSTREAM_PATHWAY(9/105),PID_FCER1_PATHWAY(7/62),PID_HNF3A_PATHWAY(6/44),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(12/200),HALLMARK_P53_PATHWAY(12/200),ST_TUMOR_NECROSIS_FACTOR_PATHWAY(5/29),BIOCARTA_CDMAC_PATHWAY(4/16),REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES(5/30),REACTOME_TOLL_RECEPTOR_CASCADES(9/118),KEGG_RENAL_CELL_CARCINOMA(7/70),PID_CD40_PATHWAY(5/31),PID_AVB3_OPN_PATHWAY(5/31),PID_CDC42_PATHWAY(7/70),PID_AP1_PATHWAY(7/70)
JUP	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(23/200),KEGG_PATHWAYS_IN_CANCER(24/328),REACTOME_CELL_JUNCTION_ORGANIZATION(12/78),REACTOME_CELL_CELL_COMMUNICATION(14/120),HALLMARK_KRAS_SIGNALING_UP(17/200),KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC(10/76),REACTOME_CELL_CELL_JUNCTION_ORGANIZATION(8/56),PID_ECADHERIN_KERATINOCYTE_PATHWAY(5/21),REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS(5/27)
KANK2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
KDR	TH34_1456_S02	v9	Vandetanib,RAF265,VANDETANIB,MGCD-265,PTK787/ZK 222584,SORAFENIB,BRIVANIB,XL880,CHIR-265,ABT-869,ENMD 2076,BMS-690514,CABOZANTINIB,ORANTINIB,Vatalanib,LENVATINIB,TESEVATINIB,Axitinib,SUNITINIB,TELATINIB,BAY-57-9352,FORETINIB,AEE788,X-82,ENMD-2076,MGCD265,Regorafenib,XL647,IMC-1121B,AEE-788,SU-6668,AXITINIB,Ponatinib,MIDOSTAURIN,PONATINIB,Sorafenib,Motesanib,1058137-23-7,PAZOPANIB,Nintedanib,CEDIRANIB,XL-820,Cabozantinib,MOTESANIB,RAMUCIRUMAB,VATALANIB,TIVOZANIB,Sunitinib,LINIFANIB,XL820,LUCITANIB,SORAFENIB TOSYLATE,Ramucirumab,E 7080,REGORAFENIB,NINTEDANIB,Lucitanib,Pazopanib	lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(24/201),KEGG_ENDOCYTOSIS(16/183),PID_VEGFR1_2_PATHWAY(7/69)
KIAA0368	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
KIAA0430	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
KIAA1462	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
KIF1C	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
KLC1	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(26/466),HALLMARK_MITOTIC_SPINDLE(16/200),REACTOME_IMMUNE_SYSTEM(35/933),PID_ARF6_TRAFFICKING_PATHWAY(7/49)
KLF13	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
KLF2	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200)
KLF5	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200),REACTOME_DEVELOPMENTAL_BIOLOGY(27/396)
KLF6	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200),HALLMARK_INFLAMMATORY_RESPONSE(17/200),HALLMARK_IL2_STAT5_SIGNALING(15/200)
KLF9	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200)
KLK11	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(18/200)
KMT2E	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
KRT18	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(17/200),HALLMARK_APOPTOSIS(15/161)
KRT19	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(18/200),HALLMARK_ESTROGEN_RESPONSE_EARLY(17/200)
KRT7	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
KRT8	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(17/200)
KSR1	TH34_1456_S02	v9		lowstringency_pd_outliers	PID_ERBB1_DOWNSTREAM_PATHWAY(9/105)
KXD1	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LAMA2	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200),KEGG_FOCAL_ADHESION(24/201),NABA_MATRISOME(52/1028),KEGG_PATHWAYS_IN_CANCER(24/328),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(12/79),KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC(10/76),PID_INTEGRIN4_PATHWAY(5/11),NABA_ECM_GLYCOPROTEINS(15/196),KEGG_ECM_RECEPTOR_INTERACTION(10/84),BIOCARTA_AGR_PATHWAY(7/36),NABA_CORE_MATRISOME(17/275),KEGG_SMALL_CELL_LUNG_CANCER(9/84),PID_A6B1_A6B4_INTEGRIN_PATHWAY(7/46),KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM(9/85),KEGG_DILATED_CARDIOMYOPATHY(9/92),KEGG_VIRAL_MYOCARDITIS(8/73),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(12/200)
LAMA3	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(24/201),HALLMARK_APICAL_JUNCTION(23/200),NABA_MATRISOME(52/1028),KEGG_PATHWAYS_IN_CANCER(24/328),REACTOME_CELL_JUNCTION_ORGANIZATION(12/78),REACTOME_CELL_CELL_COMMUNICATION(14/120),PID_INTEGRIN4_PATHWAY(5/11),NABA_ECM_GLYCOPROTEINS(15/196),KEGG_ECM_RECEPTOR_INTERACTION(10/84),BIOCARTA_AGR_PATHWAY(7/36),NABA_CORE_MATRISOME(17/275),KEGG_SMALL_CELL_LUNG_CANCER(9/84),PID_A6B1_A6B4_INTEGRIN_PATHWAY(7/46),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(12/200)
LAMB2	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(24/201),NABA_MATRISOME(52/1028),KEGG_PATHWAYS_IN_CANCER(24/328),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(12/79),PID_INTEGRIN4_PATHWAY(5/11),NABA_ECM_GLYCOPROTEINS(15/196),KEGG_ECM_RECEPTOR_INTERACTION(10/84),NABA_CORE_MATRISOME(17/275),KEGG_SMALL_CELL_LUNG_CANCER(9/84),PID_A6B1_A6B4_INTEGRIN_PATHWAY(7/46)
LAMC2	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(24/201),HALLMARK_APICAL_JUNCTION(23/200),NABA_MATRISOME(52/1028),KEGG_PATHWAYS_IN_CANCER(24/328),HALLMARK_ESTROGEN_RESPONSE_LATE(18/200),REACTOME_CELL_JUNCTION_ORGANIZATION(12/78),REACTOME_CELL_CELL_COMMUNICATION(14/120),PID_INTEGRIN4_PATHWAY(5/11),NABA_ECM_GLYCOPROTEINS(15/196),KEGG_ECM_RECEPTOR_INTERACTION(10/84),NABA_CORE_MATRISOME(17/275),KEGG_SMALL_CELL_LUNG_CANCER(9/84),PID_A6B1_A6B4_INTEGRIN_PATHWAY(7/46),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(12/200)
LAMP3	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_INFLAMMATORY_RESPONSE(17/200)
LCAT	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
LDB2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
LEMD2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
LENG8	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
LEPROTL1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
LHFP	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
LIMS2	TH34_1456_S02	v9		lowstringency_pd_outliers	PID_ILK_PATHWAY(7/45)
LINC01002	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01272	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LLGL2	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(18/200),KEGG_TIGHT_JUNCTION(15/134)
LMO2	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(13/200)
LMO7	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
LPCAT4	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
LRP5	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
LRRFIP1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
LSR	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(18/200)
LTA4H	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_COAGULATION(10/138)
LTBP3	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_GLYCOPROTEINS(15/196),NABA_CORE_MATRISOME(17/275)
LTBP4	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_GLYCOPROTEINS(15/196),NABA_CORE_MATRISOME(17/275)
LUC7L3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MACF1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MAGEH1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MAGI2-AS3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MAL2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MAMDC2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MAML1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MAOA	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MAP3K3	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(35/933),BIOCARTA_MAPK_PATHWAY(9/87),KEGG_MAPK_SIGNALING_PATHWAY(15/267),ST_TUMOR_NECROSIS_FACTOR_PATHWAY(5/29)
MAP4	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MAPK1IP1L	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MAPK3	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(24/201),REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),KEGG_PATHWAYS_IN_CANCER(24/328),KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(19/216),PID_MET_PATHWAY(12/80),BIOCARTA_INTEGRIN_PATHWAY(9/38),REACTOME_HEMOSTASIS(26/466),REACTOME_AXON_GUIDANCE(18/251),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(16/208),BIOCARTA_AGR_PATHWAY(7/36),REACTOME_SIGNALLING_BY_NGF(15/217),REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE(9/72),REACTOME_IMMUNE_SYSTEM(35/933),KEGG_CHEMOKINE_SIGNALING_PATHWAY(14/190),KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(11/115),REACTOME_TRIF_MEDIATED_TLR3_SIGNALING(9/74),REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION(9/77),KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY(8/62),REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE(9/83),BIOCARTA_MAPK_PATHWAY(9/87),REACTOME_INNATE_IMMUNE_SYSTEM(16/279),REACTOME_ACTIVATED_TLR4_SIGNALLING(9/93),KEGG_MAPK_SIGNALING_PATHWAY(15/267),BIOCARTA_PPARA_PATHWAY(7/58),BIOCARTA_MCALPAIN_PATHWAY(5/25),PID_ERBB1_DOWNSTREAM_PATHWAY(9/105),PID_FCER1_PATHWAY(7/62),BIOCARTA_CDMAC_PATHWAY(4/16),REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES(5/30),PID_VEGFR1_2_PATHWAY(7/69),REACTOME_TOLL_RECEPTOR_CASCADES(9/118),KEGG_RENAL_CELL_CARCINOMA(7/70),PID_AVB3_OPN_PATHWAY(5/31),PID_CDC42_PATHWAY(7/70)
MAPRE2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MARC2	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MARCO	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_INFLAMMATORY_RESPONSE(17/200)
MATR3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MAX	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(24/328),PID_HDAC_CLASSI_PATHWAY(9/66),KEGG_SMALL_CELL_LUNG_CANCER(9/84),BIOCARTA_MAPK_PATHWAY(9/87),KEGG_MAPK_SIGNALING_PATHWAY(15/267)
MBD6	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MCEMP1	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MDC1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MEF2A	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200),REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),REACTOME_SIGNALLING_BY_NGF(15/217),REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE(9/72),REACTOME_IMMUNE_SYSTEM(35/933),REACTOME_TRIF_MEDIATED_TLR3_SIGNALING(9/74),REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION(9/77),REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE(9/83),BIOCARTA_MAPK_PATHWAY(9/87),REACTOME_INNATE_IMMUNE_SYSTEM(16/279),REACTOME_ACTIVATED_TLR4_SIGNALLING(9/93),REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES(5/30),REACTOME_TOLL_RECEPTOR_CASCADES(9/118)
MEF2D	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200),REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),BIOCARTA_MAPK_PATHWAY(9/87)
MEIS1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MEIS2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MFAP4	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_GLYCOPROTEINS(15/196),NABA_CORE_MATRISOME(17/275)
MGEA5	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MIA3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MINK1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MIR675	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MITD1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MKRN1	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(35/933),HALLMARK_HEME_METABOLISM(13/200)
MLLT6	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MLPH	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(17/200)
MLXIP	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MMP28	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_MATRISOME_ASSOCIATED(35/753)
MNT	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MOB2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MOCS2	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(18/200)
MORC3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MORF4L1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MPHOSPH8	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MPZL2	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(23/200),HALLMARK_KRAS_SIGNALING_UP(17/200)
MRPL22	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MS4A15	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MT-ATP8	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND1	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND2	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND5	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND6	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTATP6P1	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTERF4	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTND2P28	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MUC1	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_AFFILIATED(18/171),NABA_MATRISOME_ASSOCIATED(35/753),HALLMARK_ESTROGEN_RESPONSE_EARLY(17/200),HALLMARK_IL2_STAT5_SIGNALING(15/200)
MUM1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MXD4	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(12/200)
MYH11	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200),REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),KEGG_TIGHT_JUNCTION(15/134),REACTOME_AXON_GUIDANCE(18/251),KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(11/115),KEGG_VIRAL_MYOCARDITIS(8/73)
MYH14	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(19/216),KEGG_TIGHT_JUNCTION(15/134),REACTOME_AXON_GUIDANCE(18/251),KEGG_VIRAL_MYOCARDITIS(8/73)
MYL9	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(24/201),HALLMARK_APICAL_JUNCTION(23/200),REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(19/216),KEGG_TIGHT_JUNCTION(15/134),REACTOME_AXON_GUIDANCE(18/251),KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION(12/118),KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(11/115),PID_ILK_PATHWAY(7/45),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(12/200)
MYO15B	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
MYO1C	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200),HALLMARK_IL2_STAT5_SIGNALING(15/200)
MYRF	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MYZAP	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
N4BP1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
N4BP2L2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
NAA60	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
NADSYN1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(17/200)
NAP1L4	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
NAPSA	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
NASP	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
NBEAL2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
NDEL1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
NDFIP1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
NDNF	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_GLYCOPROTEINS(15/196),NABA_CORE_MATRISOME(17/275)
NDRG2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
NDRG4	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
NECAP1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
NEDD9	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_APOPTOSIS(15/161),HALLMARK_MITOTIC_SPINDLE(16/200)
NEO1	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),REACTOME_AXON_GUIDANCE(18/251),KEGG_CELL_ADHESION_MOLECULES_CAMS(11/134)
NEXN	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(23/200)
NFE2L1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(13/200)
NFKBIA	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200),KEGG_PATHWAYS_IN_CANCER(24/328),HALLMARK_INFLAMMATORY_RESPONSE(17/200),PID_HDAC_CLASSI_PATHWAY(9/66),REACTOME_SIGNALLING_BY_NGF(15/217),REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE(9/72),REACTOME_IMMUNE_SYSTEM(35/933),KEGG_CHEMOKINE_SIGNALING_PATHWAY(14/190),REACTOME_TRIF_MEDIATED_TLR3_SIGNALING(9/74),REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION(9/77),KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY(8/62),REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE(9/83),KEGG_SMALL_CELL_LUNG_CANCER(9/84),PID_LYSOPHOSPHOLIPID_PATHWAY(8/66),BIOCARTA_MAPK_PATHWAY(9/87),REACTOME_INNATE_IMMUNE_SYSTEM(16/279),KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION(8/68),BIOCARTA_DEATH_PATHWAY(6/33),REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION(5/21),REACTOME_ACTIVATED_TLR4_SIGNALLING(9/93),BIOCARTA_PPARA_PATHWAY(7/58),ST_TUMOR_NECROSIS_FACTOR_PATHWAY(5/29),BIOCARTA_CDMAC_PATHWAY(4/16),REACTOME_TOLL_RECEPTOR_CASCADES(9/118),PID_CD40_PATHWAY(5/31),PID_AVB3_OPN_PATHWAY(5/31)
NFKBIZ	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(15/200)
NFU1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
NIPBL	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_DN(10/144)
NISCH	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
NKX2-1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
NMT1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
NOSTRIN	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
NOTCH4	TH34_1456_S02	v9	REGN421,PF-03084014	lowstringency_pd_outliers	NA
NPIPA5	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB3	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB4	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPNT	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_GLYCOPROTEINS(15/196),NABA_CORE_MATRISOME(17/275)
NR2C1	TH34_1456_S02	v9		lowstringency_pd_outliers	PID_HDAC_CLASSI_PATHWAY(9/66),PID_AR_TF_PATHWAY(7/53)
NR2F2	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),PID_HNF3A_PATHWAY(6/44)
NRBP2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
NRGN	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
NSRP1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
NTAN1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
NTM	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(12/200)
NUMB	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),PID_MET_PATHWAY(12/80),REACTOME_AXON_GUIDANCE(18/251)
OLR1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200),HALLMARK_INFLAMMATORY_RESPONSE(17/200),REACTOME_HEMOSTASIS(26/466),REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL(9/91),HALLMARK_COAGULATION(10/138)
ORMDL1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PABPN1	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(16/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(16/140),REACTOME_MRNA_PROCESSING(16/161),REACTOME_MRNA_3_END_PROCESSING(8/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(8/44),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105)
PAK4	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(24/201),REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(19/216),PID_MET_PATHWAY(12/80),ST_INTEGRIN_SIGNALING_PATHWAY(11/82),REACTOME_AXON_GUIDANCE(18/251),BIOCARTA_AGR_PATHWAY(7/36),KEGG_RENAL_CELL_CARCINOMA(7/70),PID_CDC42_PATHWAY(7/70)
PARP14	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PARP6	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PBX2	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(23/200)
PCAT19	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PCBD1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PCF11	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(16/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(16/140),REACTOME_MRNA_PROCESSING(16/161),REACTOME_MRNA_3_END_PROCESSING(8/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(8/44),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105)
PCGF3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PCYT1A	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PDK2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PEBP4	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PECAM1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(23/200),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(12/79),HALLMARK_KRAS_SIGNALING_UP(17/200),REACTOME_HEMOSTASIS(26/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(16/208),KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION(12/118),KEGG_CELL_ADHESION_MOLECULES_CAMS(11/134),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(9/89),REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL(9/91),BIOCARTA_CELL2CELL_PATHWAY(4/14),HALLMARK_COAGULATION(10/138)
PER1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200)
PGC	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PHC1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PHF21A	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PIGR	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(17/200)
PKD1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(23/200)
PLA2G1B	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(11/115),KEGG_MAPK_SIGNALING_PATHWAY(15/267),PID_FCER1_PATHWAY(7/62)
PLA2G6	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(11/115),KEGG_MAPK_SIGNALING_PATHWAY(15/267)
PLEKHH2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PLLP	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PMPCB	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PNN	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PODXL	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(17/200)
POLR2J3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
POM121C	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PPFIBP1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PPIL3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PPP1R10	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PPP1R13B	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PPP1R13L	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PPP1R14A	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(11/115),PID_ILK_PATHWAY(7/45)
PPP1R15A	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200),HALLMARK_KRAS_SIGNALING_UP(17/200),HALLMARK_TGF_BETA_SIGNALING(7/54),HALLMARK_P53_PATHWAY(12/200)
PPP1R2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PPP1R9B	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PRAF2	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(15/200)
PRKAR1A	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(26/466),REACTOME_SIGNALLING_BY_NGF(15/217),BIOCARTA_PPARA_PATHWAY(7/58),BIOCARTA_MCALPAIN_PATHWAY(5/25)
PRKCZ	TH34_1456_S02	v9	SOPHORETIN	lowstringency_pd_outliers	KEGG_TIGHT_JUNCTION(15/134),PID_MET_PATHWAY(12/80),REACTOME_HEMOSTASIS(26/466),KEGG_ENDOCYTOSIS(16/183),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(16/208),KEGG_CHEMOKINE_SIGNALING_PATHWAY(14/190),PID_ERBB1_DOWNSTREAM_PATHWAY(9/105),PID_CDC42_PATHWAY(7/70)
PRODH	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PRR14	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PRR4	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PRSS8	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PSIP1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PSMA3-AS1	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PTMS	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PTPN12	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PTPN18	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
PXN	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(24/201),KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(19/216),PID_MET_PATHWAY(12/80),BIOCARTA_INTEGRIN_PATHWAY(9/38),HALLMARK_MITOTIC_SPINDLE(16/200),KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION(12/118),BIOCARTA_AGR_PATHWAY(7/36),KEGG_CHEMOKINE_SIGNALING_PATHWAY(14/190),PID_ILK_PATHWAY(7/45),PID_LYSOPHOSPHOLIPID_PATHWAY(8/66),PID_FAK_PATHWAY(7/59),BIOCARTA_MCALPAIN_PATHWAY(5/25),PID_FCER1_PATHWAY(7/62),BIOCARTA_CELL2CELL_PATHWAY(4/14),PID_VEGFR1_2_PATHWAY(7/69)
R3HDM2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RAB11FIP1	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_ENDOCYTOSIS(16/183)
RAB12	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RAB14	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RAB25	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RAB6A	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RAB7A	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(35/933)
RAB8A	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RAB8B	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RABGAP1L	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(17/200),HALLMARK_IL2_STAT5_SIGNALING(15/200)
RAI2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RALA	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(24/328),ST_INTEGRIN_SIGNALING_PATHWAY(11/82),REACTOME_SIGNALLING_BY_NGF(15/217),PID_ARF6_TRAFFICKING_PATHWAY(7/49),PID_ERBB1_DOWNSTREAM_PATHWAY(9/105)
RAMP2	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(11/115)
RAMP3	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION(11/115)
RASIP1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RBM12	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RBM17	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(12/128)
RBM23	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RBM5	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(16/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(16/140),REACTOME_MRNA_PROCESSING(16/161),HALLMARK_HEME_METABOLISM(13/200)
RBM6	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RBMS2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RBP1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RDX	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(19/216),REACTOME_AXON_GUIDANCE(18/251)
RELA	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200),REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),KEGG_PATHWAYS_IN_CANCER(24/328),HALLMARK_INFLAMMATORY_RESPONSE(17/200),HALLMARK_APOPTOSIS(15/161),PID_HDAC_CLASSI_PATHWAY(9/66),REACTOME_SIGNALLING_BY_NGF(15/217),REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE(9/72),REACTOME_IMMUNE_SYSTEM(35/933),KEGG_CHEMOKINE_SIGNALING_PATHWAY(14/190),REACTOME_TRIF_MEDIATED_TLR3_SIGNALING(9/74),REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION(9/77),KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY(8/62),REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE(9/83),KEGG_SMALL_CELL_LUNG_CANCER(9/84),PID_LYSOPHOSPHOLIPID_PATHWAY(8/66),BIOCARTA_MAPK_PATHWAY(9/87),REACTOME_INNATE_IMMUNE_SYSTEM(16/279),KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION(8/68),BIOCARTA_DEATH_PATHWAY(6/33),REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION(5/21),REACTOME_ACTIVATED_TLR4_SIGNALLING(9/93),KEGG_MAPK_SIGNALING_PATHWAY(15/267),BIOCARTA_PPARA_PATHWAY(7/58),PID_FCER1_PATHWAY(7/62),BIOCARTA_CDMAC_PATHWAY(4/16),REACTOME_TOLL_RECEPTOR_CASCADES(9/118),PID_CD40_PATHWAY(5/31),PID_AVB3_OPN_PATHWAY(5/31)
RERE	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
REXO1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RFC1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(16/200)
RGCC	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RIMKLB	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RNF19A	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_HEME_METABOLISM(13/200)
RNF44	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RNU6-817P	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ROBO3	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),REACTOME_AXON_GUIDANCE(18/251)
ROBO4	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ROGDI	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RP1-261G23.7	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-1100L3.8	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-1212A22.4	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-159D12.5	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-196G11.5	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-242D8.3	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-274B21.2	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-27M24.1	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-326C3.2	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-386G11.10	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-386I14.4	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-433J22.2	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-466H18.1	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-478C6.4	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-488C13.7	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-498C9.3	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-693N9.2	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-78A19.3	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-927P21.5	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-613B23.5	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RPL36AL	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RPS25	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RPS6KA2	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),HALLMARK_ESTROGEN_RESPONSE_LATE(18/200),HALLMARK_ESTROGEN_RESPONSE_EARLY(17/200),REACTOME_AXON_GUIDANCE(18/251),REACTOME_SIGNALLING_BY_NGF(15/217),REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE(9/72),REACTOME_IMMUNE_SYSTEM(35/933),REACTOME_TRIF_MEDIATED_TLR3_SIGNALING(9/74),REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION(9/77),REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE(9/83),BIOCARTA_MAPK_PATHWAY(9/87),REACTOME_INNATE_IMMUNE_SYSTEM(16/279),REACTOME_ACTIVATED_TLR4_SIGNALLING(9/93),KEGG_MAPK_SIGNALING_PATHWAY(15/267),REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES(5/30),REACTOME_TOLL_RECEPTOR_CASCADES(9/118)
RSRC2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
RTKN2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
S100A14	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_MATRISOME_ASSOCIATED(35/753)
S1PR1	TH34_1456_S02	v9		lowstringency_pd_outliers	PID_FCER1_PATHWAY(7/62)
SAR1A	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SBDS	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SCEL	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SCFD1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SCGB1A1	TH34_1456_S02	v9		lowstringency_pd_outliers	PID_HNF3A_PATHWAY(6/44)
SCGB3A2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SCNN1A	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(18/200),HALLMARK_ESTROGEN_RESPONSE_EARLY(17/200)
SCNN1B	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SDPR	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SEL1L3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SELP	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(26/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(16/208),HALLMARK_IL2_STAT5_SIGNALING(15/200),KEGG_CELL_ADHESION_MOLECULES_CAMS(11/134),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(9/89),REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL(9/91)
SEMA6A	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),NABA_ECM_AFFILIATED(18/171),NABA_MATRISOME_ASSOCIATED(35/753),REACTOME_AXON_GUIDANCE(18/251)
SENP2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SENP3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SEPT7	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SERPING1	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_MATRISOME_ASSOCIATED(35/753),REACTOME_HEMOSTASIS(26/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(16/208),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(9/89),HALLMARK_COAGULATION(10/138),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(7/69)
SETD5	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SETD8	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SF1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SF3A1	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(16/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(16/140),REACTOME_MRNA_PROCESSING(16/161),KEGG_SPLICEOSOME(12/128)
SFSWAP	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SFTA1P	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SFTA2	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_AFFILIATED(18/171),NABA_MATRISOME_ASSOCIATED(35/753)
SFTA3	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_AFFILIATED(18/171),NABA_MATRISOME_ASSOCIATED(35/753)
SFTPA1	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_AFFILIATED(18/171),NABA_MATRISOME_ASSOCIATED(35/753),PID_HNF3A_PATHWAY(6/44)
SFTPA2	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_AFFILIATED(18/171),NABA_MATRISOME_ASSOCIATED(35/753),PID_HNF3A_PATHWAY(6/44)
SFTPB	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_AFFILIATED(18/171),NABA_MATRISOME_ASSOCIATED(35/753)
SFTPC	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_AFFILIATED(18/171),NABA_MATRISOME_ASSOCIATED(35/753)
SFTPD	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_ECM_AFFILIATED(18/171),NABA_MATRISOME_ASSOCIATED(35/753),PID_HNF3A_PATHWAY(6/44)
SH2D3C	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SH3BP2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SH3BP5	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(17/200)
SH3D19	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SH3GLB2	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_ENDOCYTOSIS(16/183)
SIPA1L3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SIRT2	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200),PID_HDAC_CLASSI_PATHWAY(9/66),HALLMARK_COAGULATION(10/138)
SLC25A27	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SLC34A2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SLC39A8	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(15/200)
SLC44A2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SLC6A4	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SLCO2A1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SLIT2	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(23/200),NABA_MATRISOME(52/1028),REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),REACTOME_AXON_GUIDANCE(18/251),NABA_ECM_GLYCOPROTEINS(15/196),NABA_CORE_MATRISOME(17/275),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(12/200)
SLTM	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SMAD3	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200),REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),KEGG_PATHWAYS_IN_CANCER(24/328),HALLMARK_TGF_BETA_SIGNALING(7/54),HALLMARK_UV_RESPONSE_DN(10/144)
SMAD6	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TGF_BETA_SIGNALING(7/54)
SMAD7	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_APOPTOSIS(15/161),PID_HDAC_CLASSI_PATHWAY(9/66),HALLMARK_TGF_BETA_SIGNALING(7/54),HALLMARK_UV_RESPONSE_DN(10/144)
SMARCC2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SMN1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SMN2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SMTN	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200)
SNAP29	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SNORA44	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SNRNP70	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(16/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(16/140),REACTOME_MRNA_PROCESSING(16/161),KEGG_SPLICEOSOME(12/128)
SNRPGP10	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SORBS3	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200),HALLMARK_APICAL_JUNCTION(23/200)
SOS1	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(24/201),REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),KEGG_PATHWAYS_IN_CANCER(24/328),KEGG_REGULATION_OF_ACTIN_CYTOSKELETON(19/216),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(12/79),PID_MET_PATHWAY(12/80),BIOCARTA_INTEGRIN_PATHWAY(9/38),REACTOME_HEMOSTASIS(26/466),ST_INTEGRIN_SIGNALING_PATHWAY(11/82),REACTOME_AXON_GUIDANCE(18/251),HALLMARK_MITOTIC_SPINDLE(16/200),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(16/208),REACTOME_SIGNALING_BY_RHO_GTPASES(12/113),REACTOME_SIGNALLING_BY_NGF(15/217),REACTOME_IMMUNE_SYSTEM(35/933),KEGG_CHEMOKINE_SIGNALING_PATHWAY(14/190),REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL(9/91),KEGG_MAPK_SIGNALING_PATHWAY(15/267),PID_FAK_PATHWAY(7/59),PID_ERBB1_DOWNSTREAM_PATHWAY(9/105),PID_FCER1_PATHWAY(7/62),KEGG_RENAL_CELL_CARCINOMA(7/70)
SP2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SPG11	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SPG20	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SPINT2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SPOCK2	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_CORE_MATRISOME(17/275)
SPTAN1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200),REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),KEGG_TIGHT_JUNCTION(15/134),REACTOME_CELL_CELL_COMMUNICATION(14/120),HALLMARK_APOPTOSIS(15/161),REACTOME_AXON_GUIDANCE(18/251),HALLMARK_MITOTIC_SPINDLE(16/200),BIOCARTA_DEATH_PATHWAY(6/33)
SPTBN1	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),REACTOME_CELL_CELL_COMMUNICATION(14/120),REACTOME_AXON_GUIDANCE(18/251),HALLMARK_MITOTIC_SPINDLE(16/200),HALLMARK_TGF_BETA_SIGNALING(7/54)
SRP14	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SRRM1	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(16/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(16/140),REACTOME_MRNA_PROCESSING(16/161),REACTOME_MRNA_3_END_PROCESSING(8/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(8/44),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105)
SRRM2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SRSF11	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(16/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(16/140),REACTOME_MRNA_PROCESSING(16/161),REACTOME_MRNA_3_END_PROCESSING(8/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(8/44),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105)
SRSF4	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(16/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(16/140),REACTOME_MRNA_PROCESSING(16/161),REACTOME_MRNA_3_END_PROCESSING(8/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(8/44),KEGG_SPLICEOSOME(12/128),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105)
SRSF5	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(16/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(16/140),REACTOME_MRNA_PROCESSING(16/161),REACTOME_MRNA_3_END_PROCESSING(8/35),REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_(8/44),KEGG_SPLICEOSOME(12/128),REACTOME_RNA_POL_II_TRANSCRIPTION(9/105)
SS18	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SSB	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SSFA2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ST14	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),HALLMARK_ESTROGEN_RESPONSE_LATE(18/200),NABA_MATRISOME_ASSOCIATED(35/753),HALLMARK_P53_PATHWAY(12/200)
ST7	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
STIM2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
STX3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
STXBP1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
STXBP2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SUGP1	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_MRNA_SPLICING(16/111),REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA(16/140),REACTOME_MRNA_PROCESSING(16/161)
SUMO1	TH34_1456_S02	v9		lowstringency_pd_outliers	PID_HDAC_CLASSI_PATHWAY(9/66),REACTOME_IMMUNE_SYSTEM(35/933)
SUMO3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SUPT20H	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SUSD2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SYNE2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
SYNPO	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(16/200)
TACC2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TACSTD2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TAF10	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_RNA_POL_II_TRANSCRIPTION(9/105)
TAF1C	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TAPBPL	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TBC1D2B	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TBC1D3L	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TBX2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TBX3	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TBX4	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TCEAL4	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TCF7L2	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_PATHWAYS_IN_CANCER(24/328),KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC(10/76),PID_AP1_PATHWAY(7/70)
TERF2IP	TH34_1456_S02	v9		lowstringency_pd_outliers	ST_INTEGRIN_SIGNALING_PATHWAY(11/82)
THRA	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TIE1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TJP1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(23/200),KEGG_TIGHT_JUNCTION(15/134),KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION(8/68),HALLMARK_TGF_BETA_SIGNALING(7/54),HALLMARK_UV_RESPONSE_DN(10/144)
TLE2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TMA7	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TMC4	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TMEM100	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(17/200)
TMEM125	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TMEM256-PLSCR3	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TMEM50B	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TMEM63A	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TMEM88	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TMPRSS2	TH34_1456_S02	v9		lowstringency_pd_outliers	PID_AR_TF_PATHWAY(7/53)
TNFAIP3	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200),HALLMARK_KRAS_SIGNALING_UP(17/200),REACTOME_IMMUNE_SYSTEM(35/933),KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY(8/62),REACTOME_INNATE_IMMUNE_SYSTEM(16/279),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(12/200),ST_TUMOR_NECROSIS_FACTOR_PATHWAY(5/29),PID_CD40_PATHWAY(5/31)
TNFSF10	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_MATRISOME_ASSOCIATED(35/753),HALLMARK_INFLAMMATORY_RESPONSE(17/200),HALLMARK_APOPTOSIS(15/161),HALLMARK_IL2_STAT5_SIGNALING(15/200),BIOCARTA_DEATH_PATHWAY(6/33)
TNFSF12	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_MATRISOME_ASSOCIATED(35/753),BIOCARTA_DEATH_PATHWAY(6/33)
TNFSF13	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_MATRISOME_ASSOCIATED(35/753)
TNNC1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200),HALLMARK_ESTROGEN_RESPONSE_LATE(18/200),KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM(9/85),KEGG_DILATED_CARDIOMYOPATHY(9/92)
TNS1	TH34_1456_S02	v9		lowstringency_pd_outliers	BIOCARTA_INTEGRIN_PATHWAY(9/38),PID_ILK_PATHWAY(7/45),HALLMARK_HEME_METABOLISM(13/200)
TNS2	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TNXB	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(24/201),NABA_MATRISOME(52/1028),NABA_ECM_GLYCOPROTEINS(15/196),KEGG_ECM_RECEPTOR_INTERACTION(10/84),NABA_CORE_MATRISOME(17/275)
TOB1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(18/200),HALLMARK_ESTROGEN_RESPONSE_EARLY(17/200),HALLMARK_P53_PATHWAY(12/200)
TOM1L2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TRA2A	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_SPLICEOSOME(12/128)
TRIB1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200),HALLMARK_KRAS_SIGNALING_UP(17/200)
TRIM25	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(35/933),REACTOME_INNATE_IMMUNE_SYSTEM(16/279),REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION(5/21)
TRIO	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(27/396),PID_RHOA_REG_PATHWAY(10/46),REACTOME_AXON_GUIDANCE(18/251),HALLMARK_MITOTIC_SPINDLE(16/200),REACTOME_SIGNALING_BY_RHO_GTPASES(12/113),REACTOME_SIGNALLING_BY_NGF(15/217)
TRIP10	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(24/200)
TSPAN12	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TSPAN13	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(18/200),HALLMARK_KRAS_SIGNALING_UP(17/200)
TSPAN18	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TSTD1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
TUBA4A	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(26/466),HALLMARK_MITOTIC_SPINDLE(16/200),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(16/208),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(9/89)
UACA	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
UBA7	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(35/933),REACTOME_INNATE_IMMUNE_SYSTEM(16/279)
UBAP2L	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
UBE2Q1	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(35/933)
UBP1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
UBXN1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
UGP2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
UIMC1	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
UNC13D	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
UPF3A	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
UPK3B	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
UQCRB	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
USP40	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
USP47	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
USP54	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
VAMP2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
VIPAS39	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
VIPR1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(26/200)
VPS29	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
VSIG2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
VTI1B	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
VWF	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(24/201),HALLMARK_APICAL_JUNCTION(23/200),NABA_MATRISOME(52/1028),REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS(12/79),REACTOME_HEMOSTASIS(26/466),REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION(16/208),NABA_ECM_GLYCOPROTEINS(15/196),KEGG_ECM_RECEPTOR_INTERACTION(10/84),NABA_CORE_MATRISOME(17/275),REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_(9/89),HALLMARK_COAGULATION(10/138),KEGG_COMPLEMENT_AND_COAGULATION_CASCADES(7/69)
WAC	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
WASH5P	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
WASH6P	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
WASH7P	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
WBP2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
WDR13	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
WDR45	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
WDR60	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
WFS1	TH34_1456_S02	v9		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(18/200),HALLMARK_ESTROGEN_RESPONSE_EARLY(17/200)
WIF1	TH34_1456_S02	v9		lowstringency_pd_outliers	NABA_MATRISOME(52/1028),NABA_MATRISOME_ASSOCIATED(35/753)
WIPF2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
WWC2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
XAF1	TH34_1456_S02	v9		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(35/933)
Y_RNA	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZBTB4	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ZC3H7A	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ZCCHC11	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ZMIZ2	TH34_1456_S02	v9		lowstringency_pd_outliers	PID_AR_TF_PATHWAY(7/53)
ZMYND11	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ZNF219	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ZNF331	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ZNF358	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ZNF384	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ZNF580	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ZRSR2	TH34_1456_S02	v9		lowstringency_pd_outliers	NA
ZSWIM8	TH34_1456_S02	v9		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZYX	TH34_1456_S02	v9		lowstringency_pd_outliers	KEGG_FOCAL_ADHESION(24/201),HALLMARK_APICAL_JUNCTION(23/200),BIOCARTA_INTEGRIN_PATHWAY(9/38),ST_INTEGRIN_SIGNALING_PATHWAY(11/82),PID_ILK_PATHWAY(7/45),PID_ECADHERIN_KERATINOCYTE_PATHWAY(5/21)
AC003688.1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACSF2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
ADAM8	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(19/1028),NABA_MATRISOME_ASSOCIATED(16/753),HALLMARK_KRAS_SIGNALING_UP(8/200)
ADARB2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
ADGRG3	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL132780.1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ALDOC	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(14/200),REACTOME_GLYCOLYSIS(4/29),KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM(4/34),REACTOME_METABOLISM_OF_CARBOHYDRATES(7/247),REACTOME_GLUCOSE_METABOLISM(4/69),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(3/62)
ALOX5	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
ALOX5AP	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
ANKZF1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(14/200),HALLMARK_GLYCOLYSIS(6/200)
AP003041.1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AP1M2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(11/933)
AP2A2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(11/933)
APOBEC3A	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
APOBR	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
AQP9	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(7/200),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(9/413),HALLMARK_INFLAMMATORY_RESPONSE(5/200)
ARAP1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
ARG1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(8/200),HALLMARK_XENOBIOTIC_METABOLISM(7/200)
ARG2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(7/200)
ARHGAP26	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
ARRB2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(9/466),PID_CXCR4_PATHWAY(4/102),KEGG_CHEMOKINE_SIGNALING_PATHWAY(5/190)
ATG16L2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
ATG2A	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
BCL2A1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(8/200),PID_P53_DOWNSTREAM_PATHWAY(4/137)
BPI	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
C15orf48	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
C6orf141	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
CALB2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
CCDC88B	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
CD177	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
CD300A	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
CDA	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_COMPLEMENT(7/200),HALLMARK_XENOBIOTIC_METABOLISM(7/200)
CES1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(7/200)
CLDN1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION(5/118),REACTOME_CELL_CELL_COMMUNICATION(4/120)
CLK3	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
COL9A1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(19/1028)
COLEC11	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(19/1028),NABA_MATRISOME_ASSOCIATED(16/753)
CP	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(14/200),PID_HIF1_TFPATHWAY(8/66),HALLMARK_COMPLEMENT(7/200),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(9/413),REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS(5/89),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(7/241)
CPNE5	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
CRH	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
CRHBP	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(19/1028),NABA_MATRISOME_ASSOCIATED(16/753),NABA_SECRETED_FACTORS(10/344)
CSF3R	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(8/267),HALLMARK_INFLAMMATORY_RESPONSE(5/200)
CST7	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(19/1028),NABA_MATRISOME_ASSOCIATED(16/753),HALLMARK_IL2_STAT5_SIGNALING(6/200)
CTD-2012M11.3	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-2370N5.3	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CXCL1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(19/1028),NABA_MATRISOME_ASSOCIATED(16/753),NABA_SECRETED_FACTORS(10/344),HALLMARK_TNFA_SIGNALING_VIA_NFKB(8/200),KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(8/267),HALLMARK_COMPLEMENT(7/200),KEGG_CHEMOKINE_SIGNALING_PATHWAY(5/190)
CXCL8	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(19/1028),NABA_MATRISOME_ASSOCIATED(16/753),NABA_SECRETED_FACTORS(10/344)
DARS-AS1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DEFA1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(11/933),REACTOME_DEFENSINS(3/51)
DEFA1B	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(11/933),REACTOME_DEFENSINS(3/51)
DEFA3	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(11/933),REACTOME_DEFENSINS(3/51)
DENND3	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
DIO3	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
DIO3OS	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
DOCK5	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(9/466)
DOK3	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
ERO1L	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(14/200),HALLMARK_KRAS_SIGNALING_UP(8/200),HALLMARK_MTORC1_SIGNALING(6/200),HALLMARK_GLYCOLYSIS(6/200)
ETV4	TH34_2292_S01	v10_polya	TRAMETINIB	lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(8/200),HALLMARK_IL2_STAT5_SIGNALING(6/200)
ETV5	TH34_2292_S01	v10_polya	TRAMETINIB	lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(8/200)
EVI2B	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
FABP7	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
FAM193B	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
FAM210A	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FCAR	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
FCGR3B	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY(5/137),KEGG_LEISHMANIA_INFECTION(4/72)
FCN1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(19/1028),NABA_MATRISOME_ASSOCIATED(16/753),HALLMARK_COMPLEMENT(7/200)
FER1L4	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
FGF23	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(19/1028),NABA_MATRISOME_ASSOCIATED(16/753),NABA_SECRETED_FACTORS(10/344)
FGGY	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
FGR	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(9/466),PID_CXCR4_PATHWAY(4/102),KEGG_CHEMOKINE_SIGNALING_PATHWAY(5/190)
FLT4	TH34_2292_S01	v10_polya	MGCD265,MGCD-265,SORAFENIB,MOTESANIB,ABT-869,ENMD 2076,ORANTINIB,Vatalanib,LENVATINIB,TESEVATINIB,Axitinib,SUNITINIB,TELATINIB,FORETINIB,ENMD-2076,Regorafenib,XL647,LUCITANIB,AXITINIB,X-82,Sorafenib,PAZOPANIB,Nintedanib,VATALANIB,VANDETANIB,TIVOZANIB,Sunitinib,LINIFANIB,SORAFENIB TOSYLATE,1058137-23-7,REGORAFENIB,NINTEDANIB,Pazopanib	lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(8/200),KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(8/267),PID_VEGF_VEGFR_PATHWAY(2/10),REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS(2/10)
GABRE	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
GRPEL1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(7/200)
HBA1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	BIOCARTA_AHSP_PATHWAY(3/13)
HBA2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	BIOCARTA_AHSP_PATHWAY(3/13)
HBB	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	BIOCARTA_AHSP_PATHWAY(3/13),REACTOME_HEMOSTASIS(9/466)
HBG2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(9/466)
HCAR2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
HCAR3	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
HILPDA	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HK2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(14/200),PID_HIF1_TFPATHWAY(8/66),KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM(4/34),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(9/413),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(7/241),REACTOME_METABOLISM_OF_CARBOHYDRATES(7/247),HALLMARK_MTORC1_SIGNALING(6/200),HALLMARK_GLYCOLYSIS(6/200),HALLMARK_IL2_STAT5_SIGNALING(6/200),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(3/62)
HMOX1	TH34_2292_S01	v10_polya	SUNITINIB,SORAFENIB	lowstringency_pd_outliers	HALLMARK_HYPOXIA(14/200),PID_HIF1_TFPATHWAY(8/66),HALLMARK_XENOBIOTIC_METABOLISM(7/200),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(9/413)
HPCAL1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
HSPA6	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
ICOSLG	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(8/200),REACTOME_IMMUNE_SYSTEM(11/933),HALLMARK_INFLAMMATORY_RESPONSE(5/200)
INPP5D	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	PID_CXCR4_PATHWAY(4/102)
IRX1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
ITGAX	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(9/466)
IVNS1ABP	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
KCNAB2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
LA16c-361A3.3	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LCN2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
LEP	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	PID_HIF1_TFPATHWAY(8/66),NABA_MATRISOME(19/1028),NABA_MATRISOME_ASSOCIATED(16/753),NABA_SECRETED_FACTORS(10/344),KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(8/267),HALLMARK_ADIPOGENESIS(7/200)
LIF	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(19/1028),NABA_MATRISOME_ASSOCIATED(16/753),NABA_SECRETED_FACTORS(10/344),HALLMARK_TNFA_SIGNALING_VIA_NFKB(8/200),HALLMARK_KRAS_SIGNALING_UP(8/200),KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(8/267),HALLMARK_IL2_STAT5_SIGNALING(6/200),HALLMARK_INFLAMMATORY_RESPONSE(5/200),PID_P53_DOWNSTREAM_PATHWAY(4/137)
LILRA2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
LILRA6	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
LILRB3	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(11/933)
LINC01272	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01393	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LPCAT1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
LRG1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(19/1028)
LTF	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_COMPLEMENT(7/200),REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS(3/33)
MAPK13	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION(5/118),KEGG_LEISHMANIA_INFECTION(4/72),REACTOME_IMMUNE_SYSTEM(11/933),REACTOME_CELL_CELL_COMMUNICATION(4/120)
MCC	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
MCEMP1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MEG8_2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MIR142	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
MIR210HG	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
MIR433	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MIR671	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MMP25	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(19/1028),NABA_MATRISOME_ASSOCIATED(16/753)
MTMR4	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
MYBPC2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
MYO1F	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
NADSYN1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS(3/51)
NAMPT	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(8/200),HALLMARK_MTORC1_SIGNALING(6/200),HALLMARK_INFLAMMATORY_RESPONSE(5/200),REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS(3/51)
NBEAL2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
NCF1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION(5/118),KEGG_LEISHMANIA_INFECTION(4/72),KEGG_CHEMOKINE_SIGNALING_PATHWAY(5/190)
NCF1B	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
NCF1C	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
NCF2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION(5/118),KEGG_LEISHMANIA_INFECTION(4/72),REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS(3/33),REACTOME_IMMUNE_SYSTEM(11/933)
NEAT1_2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPTX1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
ORM1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(7/200)
OSBPL11	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
P2RY11	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
PADI4	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
PCNX	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
PDE8B	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
PFKFB3	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(14/200),PID_HIF1_TFPATHWAY(8/66),HALLMARK_TNFA_SIGNALING_VIA_NFKB(8/200),REACTOME_GLYCOLYSIS(4/29),HALLMARK_ADIPOGENESIS(7/200),KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM(4/34),REACTOME_METABOLISM_OF_CARBOHYDRATES(7/247),REACTOME_GLUCOSE_METABOLISM(4/69)
PFKFB4	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	REACTOME_GLYCOLYSIS(4/29),KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM(4/34),REACTOME_METABOLISM_OF_CARBOHYDRATES(7/247),REACTOME_GLUCOSE_METABOLISM(4/69)
PGK1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(14/200),PID_HIF1_TFPATHWAY(8/66),REACTOME_GLYCOLYSIS(4/29),REACTOME_METABOLISM_OF_CARBOHYDRATES(7/247),HALLMARK_MTORC1_SIGNALING(6/200),HALLMARK_GLYCOLYSIS(6/200),REACTOME_GLUCOSE_METABOLISM(4/69),KEGG_GLYCOLYSIS_GLUCONEOGENESIS(3/62)
PGLYRP1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
PHACTR1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
PIM3	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(7/200)
PISD	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
PLAC8	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(14/200)
PLIN2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(14/200),PID_HIF1_TFPATHWAY(8/66),HALLMARK_ADIPOGENESIS(7/200),HALLMARK_IL2_STAT5_SIGNALING(6/200)
PLIN5	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
PTK2B	TH34_2292_S01	v10_polya	PF00562271,PF-562271	lowstringency_pd_outliers	KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION(5/118),KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY(5/137),REACTOME_IMMUNE_SYSTEM(11/933),PID_CXCR4_PATHWAY(4/102),KEGG_CHEMOKINE_SIGNALING_PATHWAY(5/190),REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS(2/12),REACTOME_CELL_CELL_COMMUNICATION(4/120)
RNU11	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
RP1-261G23.7	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-148L24.1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-20I20.4	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-82L18.2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-841O20.2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-555D20.2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP5-857K21.6	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP6-159A1.4	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
S100A12	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(19/1028),NABA_MATRISOME_ASSOCIATED(16/753),NABA_SECRETED_FACTORS(10/344),HALLMARK_COMPLEMENT(7/200),REACTOME_IMMUNE_SYSTEM(11/933)
S100A8	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(19/1028),NABA_MATRISOME_ASSOCIATED(16/753),NABA_SECRETED_FACTORS(10/344)
S100A9	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(19/1028),NABA_MATRISOME_ASSOCIATED(16/753),NABA_SECRETED_FACTORS(10/344),HALLMARK_COMPLEMENT(7/200)
SCNN1B	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
SERPINA3	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(19/1028),NABA_MATRISOME_ASSOCIATED(16/753),HALLMARK_KRAS_SIGNALING_UP(8/200)
SH3BP2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY(5/137)
SH3D21	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
SHISA3	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
SIRPB1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS(2/12),REACTOME_CELL_CELL_COMMUNICATION(4/120)
SLC11A1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(9/413),REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS(5/89),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(7/241),REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS(3/33)
SLC25A37	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
SLC26A6	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(9/413),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(7/241)
SLC2A3	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(14/200),HALLMARK_TNFA_SIGNALING_VIA_NFKB(8/200),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(9/413),REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS(5/89),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(7/241),REACTOME_METABOLISM_OF_CARBOHYDRATES(7/247),HALLMARK_MTORC1_SIGNALING(6/200),HALLMARK_IL2_STAT5_SIGNALING(6/200),REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS(3/51),REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS(2/12)
SLC2A5	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(14/200),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(9/413),REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS(5/89),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(7/241),REACTOME_METABOLISM_OF_CARBOHYDRATES(7/247),REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS(2/12)
SLC6A6	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(14/200),HALLMARK_XENOBIOTIC_METABOLISM(7/200),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(9/413),REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS(5/89),REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT(7/241),HALLMARK_MTORC1_SIGNALING(6/200)
SNORA40	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
SOD1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ADIPOGENESIS(7/200),REACTOME_HEMOSTASIS(9/466),HALLMARK_GLYCOLYSIS(6/200)
SPON2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(19/1028)
SPRED3	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
ST20	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
STK10	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
STK32B	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
STXBP5-AS1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TARSL2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
TESC	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
TMEM114	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
TMEM145	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
TNFRSF10C	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(8/267),KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY(5/137),PID_P53_DOWNSTREAM_PATHWAY(4/137)
TNFRSF10D	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(8/267),KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY(5/137),PID_P53_DOWNSTREAM_PATHWAY(4/137)
TREM1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(9/466)
UAP1L1	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
UBALD2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
UNC13D	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
VAT1L	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
VEGFA	TH34_2292_S01	v10_polya	AFLIBERCEPT,VEGF TRAP,BEVACIZUMAB,SORAFENIB TOSYLATE,Aflibercept,ZALTRAP,ZIV-AFLIBERCEPT,Bevacizumab	lowstringency_pd_outliers	HALLMARK_HYPOXIA(14/200),PID_HIF1_TFPATHWAY(8/66),NABA_MATRISOME(19/1028),NABA_MATRISOME_ASSOCIATED(16/753),NABA_SECRETED_FACTORS(10/344),HALLMARK_TNFA_SIGNALING_VIA_NFKB(8/200),KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(8/267),REACTOME_HEMOSTASIS(9/466),HALLMARK_GLYCOLYSIS(6/200),PID_VEGF_VEGFR_PATHWAY(2/10),REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS(2/10)
VGF	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
VNN2	TH34_2292_S01	v10_polya		lowstringency_pd_outliers	NA
ABCA3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(9/200),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413),HALLMARK_ESTROGEN_RESPONSE_LATE(8/200)
ABCA8	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413)
AC132217.4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACIN1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
ACSL3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
ADAMTS14	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(6/87),NABA_ECM_REGULATORS(9/238),REACTOME_COLLAGEN_FORMATION(5/58)
ADGRB1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AGER	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(16/933)
AGR2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(8/200)
AGT	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),NABA_ECM_REGULATORS(9/238)
AHSA2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
AL442127.1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL589743.1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL603831.1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL662801.1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ANAPC4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(7/138),REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE(3/22),REACTOME_PHOSPHORYLATION_OF_THE_APC_C(3/23),REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS(3/24),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B(3/26),REACTOME_IMMUNE_SYSTEM(16/933),REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A(3/28)
ANAPC5	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(7/138),REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE(3/22),REACTOME_PHOSPHORYLATION_OF_THE_APC_C(3/23),REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS(3/24),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B(3/26),REACTOME_IMMUNE_SYSTEM(16/933),REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A(3/28)
ANGPTL1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753)
ANGPTL2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753)
ANKRD11	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
AP3S1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	KEGG_LYSOSOME(7/121)
AQP3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(9/200),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413)
AQP5	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413)
ARGLU1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
ARHGEF10	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	PID_RHOA_REG_PATHWAY(5/46),BIOCARTA_MYOSIN_PATHWAY(3/31)
ARHGEF12	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(9/200),PID_RHOA_REG_PATHWAY(5/46),REACTOME_AXON_GUIDANCE(9/251),REACTOME_DEVELOPMENTAL_BIOLOGY(11/396),REACTOME_SIGNALLING_BY_NGF(8/217),REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK(4/43),REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE(4/60),REACTOME_SIGNALING_BY_RHO_GTPASES(5/113),BIOCARTA_MYOSIN_PATHWAY(3/31),REACTOME_G_ALPHA1213_SIGNALLING_EVENTS(4/74)
ARHGEF7	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(9/200),PID_CDC42_REG_PATHWAY(4/30),PID_RAC1_REG_PATHWAY(4/38),BIOCARTA_MYOSIN_PATHWAY(3/31)
ARRDC2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
ARSE	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
ASPN	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_CORE_MATRISOME(13/275),NABA_PROTEOGLYCANS(3/35)
ATG12	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(16/933)
ATP11A	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413)
ATP6V1G1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413),KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION(4/68)
ATP9A	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413)
BCAS1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
BLOC1S5-TXNDC5	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
BTNL9	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
C16orf89	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
C1QTNF6	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),NABA_ECM_AFFILIATED(12/171)
C1orf123	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
C4BPA	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(16/933)
C8orf4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
CACNA1B	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
CACNG4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
CARD16	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
CASC4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
CBFA2T3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(9/200)
CCAR1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
CCDC102B	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
CCDC14	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
CCNL2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
CD86	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(8/200),REACTOME_IMMUNE_SYSTEM(16/933)
CDH13	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
CEP95	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
CFAP36	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CHFR	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
CHST1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(7/200),REACTOME_KERATAN_SULFATE_BIOSYNTHESIS(3/26),REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM(3/30),REACTOME_METABOLISM_OF_CARBOHYDRATES(7/247)
CLDN10	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
CLEC11A	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),NABA_ECM_AFFILIATED(12/171)
CLEC2B	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),NABA_ECM_AFFILIATED(12/171)
CNBP	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
CNTN4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
COL16A1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_CORE_MATRISOME(13/275),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(6/87),REACTOME_COLLAGEN_FORMATION(5/58),HALLMARK_APICAL_JUNCTION(8/200),NABA_COLLAGENS(4/44)
COL23A1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_CORE_MATRISOME(13/275),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(6/87),REACTOME_COLLAGEN_FORMATION(5/58),NABA_COLLAGENS(4/44)
COL4A1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_CORE_MATRISOME(13/275),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(6/87),REACTOME_COLLAGEN_FORMATION(5/58),REACTOME_AXON_GUIDANCE(9/251),REACTOME_DEVELOPMENTAL_BIOLOGY(11/396),NABA_COLLAGENS(4/44)
COL5A1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_CORE_MATRISOME(13/275),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(6/87),REACTOME_COLLAGEN_FORMATION(5/58),REACTOME_AXON_GUIDANCE(9/251),REACTOME_DEVELOPMENTAL_BIOLOGY(11/396),NABA_COLLAGENS(4/44),HALLMARK_HYPOXIA(7/200),HALLMARK_GLYCOLYSIS(7/200)
CPZ	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
CREBZF	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
CSGALNACT2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_METABOLISM_OF_CARBOHYDRATES(7/247)
CSNK1E	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
CTDP1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
CTSE	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),KEGG_LYSOSOME(7/121),NABA_ECM_REGULATORS(9/238)
CUL4A	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(7/138)
CXCL17	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
CXCL2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753)
CYB5A	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(7/200),HALLMARK_GLYCOLYSIS(7/200)
D4S234E	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
DBNDD2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
DDB2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(7/138)
DENND3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
DIDO1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
DIO3OS	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
DLK1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_NOTCH1(5/70),PID_NOTCH_PATHWAY(4/59),REACTOME_SIGNALING_BY_NOTCH(5/103),REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS(3/27)
DLL1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_NOTCH1(5/70),PID_NOTCH_PATHWAY(4/59),REACTOME_SIGNALING_BY_NOTCH(5/103),REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS(3/27)
DMBT1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_CORE_MATRISOME(13/275)
DMTF1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
DNM1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_AXON_GUIDANCE(9/251),REACTOME_DEVELOPMENTAL_BIOLOGY(11/396),REACTOME_SIGNALLING_BY_NGF(8/217),PID_NOTCH_PATHWAY(4/59),REACTOME_IMMUNE_SYSTEM(16/933)
DOCK6	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	PID_CDC42_REG_PATHWAY(4/30),PID_RAC1_REG_PATHWAY(4/38)
DPP6	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
DPYSL4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_AXON_GUIDANCE(9/251),REACTOME_DEVELOPMENTAL_BIOLOGY(11/396),HALLMARK_HYPOXIA(7/200),HALLMARK_GLYCOLYSIS(7/200)
DUSP22	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
DUXAP8	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
DUXAP9	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
DZIP1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
EBF3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
ECM2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_CORE_MATRISOME(13/275),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200)
EEF1E1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
ELN	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_CORE_MATRISOME(13/275),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200)
ENTPD1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
ENTPD4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	KEGG_LYSOSOME(7/121)
ERICH1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
FAM111A	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
FAM150B	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
FAM156A	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
FAM159B	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
FARP1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(9/200),HALLMARK_ESTROGEN_RESPONSE_EARLY(9/200),PID_RHOA_REG_PATHWAY(5/46),HALLMARK_ESTROGEN_RESPONSE_LATE(8/200)
FBXO11	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
FIBIN	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
FLCN	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
FLJ16779	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FLRT2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
FMOD	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_CORE_MATRISOME(13/275),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200),REACTOME_KERATAN_SULFATE_BIOSYNTHESIS(3/26),REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM(3/30),REACTOME_METABOLISM_OF_CARBOHYDRATES(7/247),NABA_PROTEOGLYCANS(3/35)
FNBP4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
FOLR1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
FOXC1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(9/200),HALLMARK_ESTROGEN_RESPONSE_LATE(8/200)
FOXC2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200)
FOXL1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
FRMD4A	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
GAD1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(7/200)
GALNS	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	KEGG_LYSOSOME(7/121)
GALNT9	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
GAS7	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
GOLGA2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
GPR137B	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
GPSM1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
H19	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
HECTD1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
HELZ2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HEYL	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_NOTCH1(5/70),REACTOME_SIGNALING_BY_NOTCH(5/103)
HNRNPDL	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HNRNPH1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
HP	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
HSBP1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
ICOSLG	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(16/933)
IDI1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
IGF2	TH34_2293_S01	v10_polya	CABAZITAXEL,DOCETAXEL,OSI-906 (LINSITINIB)	lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753)
IGHD	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
IQCG	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
ITIH5	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),NABA_ECM_REGULATORS(9/238)
ITM2B	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
JAM3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(8/200),KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION(4/68)
KCTD10	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
KCTD15	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
KLC1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(9/200),REACTOME_IMMUNE_SYSTEM(16/933)
KRT19	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(9/200),HALLMARK_ESTROGEN_RESPONSE_LATE(8/200)
KRT7	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
KSR1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
LAMP3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	KEGG_LYSOSOME(7/121)
LCAT	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(7/200)
LDB2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
LEMD2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
LHX5-AS1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC00969	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC00982	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01089	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LIPA	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	KEGG_LYSOSOME(7/121)
LL22NC03-N14H11.1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LOX	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200),NABA_ECM_REGULATORS(9/238),HALLMARK_HYPOXIA(7/200)
LPCAT1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
LRRN3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
LUC7L3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
MAP1LC3B	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
MAPK8IP3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
MARCH6	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(7/200)
MATN2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_CORE_MATRISOME(13/275),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200)
ME2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(7/200)
MEF2A	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_DEVELOPMENTAL_BIOLOGY(11/396),REACTOME_SIGNALLING_BY_NGF(8/217),REACTOME_IMMUNE_SYSTEM(16/933)
MEG3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
MFSD2A	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
MGAT5	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
MIR675	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MKNK1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
MLC1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
MMP13	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(6/87),NABA_ECM_REGULATORS(9/238)
MMP23B	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),NABA_ECM_REGULATORS(9/238)
MPC1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MUC4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),NABA_ECM_AFFILIATED(12/171)
MYOM2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
N4BP2L2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
NADSYN1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(9/200)
NAPSA	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	KEGG_LYSOSOME(7/121)
NDUFA4L2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
NDUFB1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
NEK3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
NFATC1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
NGEF	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	PID_RHOA_REG_PATHWAY(5/46),PID_CDC42_REG_PATHWAY(4/30),PID_RAC1_REG_PATHWAY(4/38),REACTOME_SIGNALLING_BY_NGF(8/217),REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK(4/43),REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE(4/60),REACTOME_SIGNALING_BY_RHO_GTPASES(5/113),REACTOME_G_ALPHA1213_SIGNALLING_EVENTS(4/74)
NISCH	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
NKAIN4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
NKTR	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
NKX6-2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
NOTUM	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
NPIPA1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPA5	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPA7	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPA8	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPB5	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPIPP1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPTX1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
NR2C1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
NT5DC2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
NUMB	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_AXON_GUIDANCE(9/251),REACTOME_DEVELOPMENTAL_BIOLOGY(11/396),REACTOME_SIGNALING_BY_NOTCH1(5/70),PID_NOTCH_PATHWAY(4/59),REACTOME_SIGNALING_BY_NOTCH(5/103),REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS(3/27)
OMD	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_CORE_MATRISOME(13/275),REACTOME_KERATAN_SULFATE_BIOSYNTHESIS(3/26),REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM(3/30),REACTOME_METABOLISM_OF_CARBOHYDRATES(7/247),NABA_PROTEOGLYCANS(3/35)
ORMDL1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
P3H1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),NABA_ECM_REGULATORS(9/238)
PAPSS2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(9/200),HALLMARK_ESTROGEN_RESPONSE_LATE(8/200),HALLMARK_XENOBIOTIC_METABOLISM(7/200)
PARP6	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
PASK	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
PCGF3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
PCNT	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(9/200)
PCP4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(8/200)
PCSK6	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),NABA_ECM_REGULATORS(9/238),REACTOME_DEVELOPMENTAL_BIOLOGY(11/396),REACTOME_SIGNALLING_BY_NGF(8/217)
PDIA2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
PDXDC2P	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
PFKL	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	BIOCARTA_PTDINS_PATHWAY(4/23),HALLMARK_HYPOXIA(7/200),KEGG_GALACTOSE_METABOLISM(3/26),KEGG_PENTOSE_PHOSPHATE_PATHWAY(3/27),REACTOME_METABOLISM_OF_CARBOHYDRATES(7/247)
PFKP	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	BIOCARTA_PTDINS_PATHWAY(4/23),HALLMARK_HYPOXIA(7/200),HALLMARK_GLYCOLYSIS(7/200),KEGG_GALACTOSE_METABOLISM(3/26),KEGG_PENTOSE_PHOSPHATE_PATHWAY(3/27),REACTOME_METABOLISM_OF_CARBOHYDRATES(7/247)
PGC	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
PGM2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(7/200),HALLMARK_GLYCOLYSIS(7/200),KEGG_GALACTOSE_METABOLISM(3/26),KEGG_PENTOSE_PHOSPHATE_PATHWAY(3/27),REACTOME_METABOLISM_OF_CARBOHYDRATES(7/247)
PHF10	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
PHF11	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
PHYKPL	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PKD1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(8/200)
PKD1P1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
PKD1P6	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
PKD2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(9/200)
PLAC9	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
PLCG1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	BIOCARTA_PTDINS_PATHWAY(4/23),PID_CDC42_REG_PATHWAY(4/30),REACTOME_AXON_GUIDANCE(9/251),HALLMARK_APICAL_JUNCTION(8/200),REACTOME_DEVELOPMENTAL_BIOLOGY(11/396),REACTOME_SIGNALLING_BY_NGF(8/217),REACTOME_IMMUNE_SYSTEM(16/933),KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION(4/68),PID_NEPHRIN_NEPH1_PATHWAY(3/31)
PLCH2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
PLEKHG2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(9/200),REACTOME_SIGNALLING_BY_NGF(8/217),REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK(4/43),REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE(4/60),REACTOME_SIGNALING_BY_RHO_GTPASES(5/113),REACTOME_G_ALPHA1213_SIGNALLING_EVENTS(4/74)
PLXNA1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),NABA_ECM_AFFILIATED(12/171),REACTOME_AXON_GUIDANCE(9/251),REACTOME_DEVELOPMENTAL_BIOLOGY(11/396)
PMP22	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200)
PNISR	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
PNN	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
POFUT2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
PP7080	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
PPIL3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
PPP1R2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
PRKCZ	TH34_2293_S01	v10_polya	SOPHORETIN	lowstringency_pd_outliers	BIOCARTA_PTDINS_PATHWAY(4/23),PID_NEPHRIN_NEPH1_PATHWAY(3/31)
PROCR	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
PTN	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753)
PXYLP1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
QPCT	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
RASA3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
RBM5	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
RBM6	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
RGL3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
RGS12	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
RHOBTB3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(9/200)
RHOJ	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_RHO_GTPASES(5/113)
RNASE4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
RNF144A	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
RNF146	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
RP11-101E13.5	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-1212A22.1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-1212A22.4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-20I20.4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-231C14.4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-295P9.3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-488L18.4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-638I2.6	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-693N9.2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
S1PR3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
SCUBE1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753)
SCUBE3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753)
SDCCAG8	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
SDF4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
SDHAP1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
SENP6	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
SFSWAP	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
SFTA2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),NABA_ECM_AFFILIATED(12/171)
SFTA3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),NABA_ECM_AFFILIATED(12/171)
SFTPA1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),NABA_ECM_AFFILIATED(12/171)
SFTPA2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),NABA_ECM_AFFILIATED(12/171)
SFTPB	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),NABA_ECM_AFFILIATED(12/171)
SFTPC	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),NABA_ECM_AFFILIATED(12/171)
SFTPD	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_MATRISOME_ASSOCIATED(28/753),NABA_ECM_AFFILIATED(12/171)
SH3BP4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
SIPA1L2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
SIPA1L3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
SLC12A4	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413),HALLMARK_XENOBIOTIC_METABOLISM(7/200)
SLC17A9	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
SLC1A3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413)
SLC25A29	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
SLC30A9	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
SLC34A2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413)
SLC6A13	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
SLC6A3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413)
SLC9A3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(12/413)
SNCA	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
SNRPGP10	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SNX14	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
SORCS2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
SPARC	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_CORE_MATRISOME(13/275),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(11/200)
SPON2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(41/1028),NABA_CORE_MATRISOME(13/275)
SRSF11	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
SS18L1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
SSR3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_XENOBIOTIC_METABOLISM(7/200)
STARD5	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
STAT1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(16/933)
SUGP2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
SUN1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
SUPT20H	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SYNDIG1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
TARBP1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
TBC1D2B	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
TBCD	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(9/200)
TBX18	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
TESC	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
THOC1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
THUMPD3-AS1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TIA1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
TIAL1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(8/200)
TJP1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(8/200),KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION(4/68),PID_NEPHRIN_NEPH1_PATHWAY(3/31)
TLE1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_NOTCH1(5/70),REACTOME_SIGNALING_BY_NOTCH(5/103)
TMCO3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
TMEM120A	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
TMEM184B	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
TMEM263	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TMEM52	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
TMEM63A	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
TMEM8A	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
TMSB15A	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
TNNT3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
TP53I13	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
TRAPPC2L	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
TRIO	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MITOTIC_SPINDLE(9/200),PID_RHOA_REG_PATHWAY(5/46),REACTOME_AXON_GUIDANCE(9/251),REACTOME_DEVELOPMENTAL_BIOLOGY(11/396),PID_RAC1_REG_PATHWAY(4/38),REACTOME_SIGNALLING_BY_NGF(8/217),REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK(4/43),REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE(4/60),REACTOME_SIGNALING_BY_RHO_GTPASES(5/113),REACTOME_G_ALPHA1213_SIGNALLING_EVENTS(4/74)
TRO	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(8/200)
TSPAN13	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(8/200)
TSPAN7	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
TSPAN9	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
TSPYL2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
TTLL3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
TWIST2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
UBE2E1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(7/138),REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE(3/22),REACTOME_PHOSPHORYLATION_OF_THE_APC_C(3/23),REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS(3/24),REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B(3/26),REACTOME_IMMUNE_SYSTEM(16/933),REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A(3/28)
UBE2G2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(7/138),REACTOME_IMMUNE_SYSTEM(16/933)
VAT1L	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
WDR13	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
WDR27	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
WDR41	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
WFDC1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
WSB1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(7/200),REACTOME_IMMUNE_SYSTEM(16/933)
WWP2	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS(7/138)
XAF1	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(16/933)
ZBTB21	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZDHHC3	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
ZNF207	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
ZNF266	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
ZNF83	TH34_2293_S01	v10_polya		lowstringency_pd_outliers	NA
A2ML1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_ECM_REGULATORS(14/238)
AARSD1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
AC055736.1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC055736.2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC055736.3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC055736.4	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACTC1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_DN(10/200),HALLMARK_MYOGENESIS(9/200),HALLMARK_APICAL_JUNCTION(8/200)
ADM	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(16/200),PID_HIF1_TFPATHWAY(11/66),REACTOME_GPCR_LIGAND_BINDING(8/408)
AGR2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(11/200)
ANGPTL4	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),HALLMARK_HYPOXIA(16/200),NABA_SECRETED_FACTORS(18/344),HALLMARK_GLYCOLYSIS(10/200),HALLMARK_KRAS_SIGNALING_UP(10/200)
ANXA1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),HALLMARK_APOPTOSIS(6/161),REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS(6/188),REACTOME_GPCR_LIGAND_BINDING(8/408)
AP4B1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
AQP3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(11/200),HALLMARK_UV_RESPONSE_UP(9/158),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(8/413)
ARHGEF10	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
ASAP1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
ATG12	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(14/933)
ATP6V1C1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(9/158),REACTOME_IRON_UPTAKE_AND_TRANSPORT(4/36),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(8/413)
BCL2A1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(13/200),PID_P53_DOWNSTREAM_PATHWAY(7/137)
BNIP3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	PID_HIF1_TFPATHWAY(11/66)
BNIP3L	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(16/200),PID_P53_DOWNSTREAM_PATHWAY(7/137),HALLMARK_APOPTOSIS(6/161)
BOD1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
BPIFA1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
BPIFB1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
C11orf31	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
C11orf74	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
C19orf33	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
C8orf59	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
CANX	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(10/200),REACTOME_IMMUNE_SYSTEM(14/933)
CCL3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_SECRETED_FACTORS(18/344),REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES(4/57),REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS(6/188),KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(7/267),REACTOME_GPCR_LIGAND_BINDING(8/408)
CCNL2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
CH17-232I21.1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CHRNA1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(9/200),BIOCARTA_NO1_PATHWAY(3/33)
CLDN4	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(8/200),REACTOME_CELL_JUNCTION_ORGANIZATION(4/78)
CNFN	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
COL11A2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),PID_SYNDECAN_1_PATHWAY(5/46),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(6/87),NABA_CORE_MATRISOME(9/275),PID_AVB3_INTEGRIN_PATHWAY(5/75),NABA_COLLAGENS(4/44),REACTOME_COLLAGEN_FORMATION(4/58),PID_INTEGRIN1_PATHWAY(4/66)
COL17A1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),PID_SYNDECAN_1_PATHWAY(5/46),PID_A6B1_A6B4_INTEGRIN_PATHWAY(5/46),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(6/87),HALLMARK_APICAL_JUNCTION(8/200),NABA_CORE_MATRISOME(9/275),PID_AVB3_INTEGRIN_PATHWAY(5/75),NABA_COLLAGENS(4/44),REACTOME_COLLAGEN_FORMATION(4/58),REACTOME_CELL_JUNCTION_ORGANIZATION(4/78)
COL9A1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),PID_SYNDECAN_1_PATHWAY(5/46),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(6/87),HALLMARK_APICAL_JUNCTION(8/200),NABA_CORE_MATRISOME(9/275),PID_AVB3_INTEGRIN_PATHWAY(5/75),NABA_COLLAGENS(4/44),REACTOME_COLLAGEN_FORMATION(4/58)
COL9A3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),PID_SYNDECAN_1_PATHWAY(5/46),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(6/87),NABA_CORE_MATRISOME(9/275),PID_AVB3_INTEGRIN_PATHWAY(5/75),NABA_COLLAGENS(4/44),REACTOME_COLLAGEN_FORMATION(4/58)
CP	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(16/200),PID_HIF1_TFPATHWAY(11/66),REACTOME_IRON_UPTAKE_AND_TRANSPORT(4/36),HALLMARK_COMPLEMENT(6/200),KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM(3/41),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(8/413)
CRNN	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_SECRETED_FACTORS(18/344)
CSTA	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_ECM_REGULATORS(14/238)
CSTB	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_ECM_REGULATORS(14/238)
CXCL1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_SECRETED_FACTORS(18/344),HALLMARK_TNFA_SIGNALING_VIA_NFKB(13/200),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(9/200),REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES(4/57),REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS(6/188),KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(7/267),HALLMARK_COMPLEMENT(6/200),HALLMARK_IL6_JAK_STAT3_SIGNALING(4/87),REACTOME_GPCR_LIGAND_BINDING(8/408)
CXCL17	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
CXCL2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_SECRETED_FACTORS(18/344),HALLMARK_TNFA_SIGNALING_VIA_NFKB(13/200),HALLMARK_UV_RESPONSE_UP(9/158),REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES(4/57),REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS(6/188),KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(7/267),REACTOME_GPCR_LIGAND_BINDING(8/408)
CXCL8	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_SECRETED_FACTORS(18/344)
CYTL1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
DCAF13	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
DDHD2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
DLK1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
DMTF1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	PID_FRA_PATHWAY(4/37)
DMWD	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
DNAJC2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
DSCR8	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
DSG3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS(4/40),REACTOME_APOPTOTIC_EXECUTION_PHASE(4/54),REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS(2/12)
DSP	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS(4/40),REACTOME_APOPTOTIC_EXECUTION_PHASE(4/54),REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS(2/12)
DUSP12	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
E2F5	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(9/158)
ECM1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(9/200),NABA_CORE_MATRISOME(9/275),HALLMARK_IL2_STAT5_SIGNALING(7/200)
EGLN3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),PID_HIF1_TFPATHWAY(11/66),NABA_ECM_REGULATORS(14/238),HALLMARK_MTORC1_SIGNALING(10/200),HALLMARK_GLYCOLYSIS(10/200),PID_HIF2PATHWAY(5/34),REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN(3/25),KEGG_PATHWAYS_IN_CANCER(8/328)
EHF	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
EIF3E	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	PID_HIF2PATHWAY(5/34)
EIF3H	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
ELF3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(11/200),HALLMARK_GLYCOLYSIS(10/200)
EMC2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ENPP2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
ENTPD4	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
ENY2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
EPS8L1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
ERO1L	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(16/200),HALLMARK_MTORC1_SIGNALING(10/200),HALLMARK_GLYCOLYSIS(10/200),HALLMARK_KRAS_SIGNALING_UP(10/200)
F3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(16/200),HALLMARK_TNFA_SIGNALING_VIA_NFKB(13/200),HALLMARK_COMPLEMENT(6/200),REACTOME_HEMOSTASIS(9/466)
FADS1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(10/200),HALLMARK_ANDROGEN_RESPONSE(5/101)
FAM129B	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
FAM160B2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
FAM91A1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
FAM98A	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
FAR2P1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FBN2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(9/200),NABA_CORE_MATRISOME(9/275)
FGFBP1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_SECRETED_FACTORS(18/344)
FNBP4	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
FNDC5	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
FNTA	TH34_2351_S01	v10_polya	TIPIFARNIB	lowstringency_pd_outliers	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS(4/40),REACTOME_APOPTOTIC_EXECUTION_PHASE(4/54)
FTH1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	REACTOME_IRON_UPTAKE_AND_TRANSPORT(4/36),KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM(3/41),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(8/413)
FXYD3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
GABRP	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
GAS2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS(4/40),REACTOME_APOPTOTIC_EXECUTION_PHASE(4/54)
GJB2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
HAX1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(10/200),HALLMARK_IL6_JAK_STAT3_SIGNALING(4/87)
HBA1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	BIOCARTA_AHSP_PATHWAY(3/13)
HBA2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	BIOCARTA_AHSP_PATHWAY(3/13)
HBB	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	BIOCARTA_AHSP_PATHWAY(3/13),REACTOME_HEMOSTASIS(9/466)
HBG2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	REACTOME_HEMOSTASIS(9/466)
HDAC3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(8/200)
HIF3A	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN(3/25)
HILPDA	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HK2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(16/200),PID_HIF1_TFPATHWAY(11/66),HALLMARK_MTORC1_SIGNALING(10/200),HALLMARK_GLYCOLYSIS(10/200),HALLMARK_IL2_STAT5_SIGNALING(7/200),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(8/413)
HMOX1	TH34_2351_S01	v10_polya	SUNITINIB,SORAFENIB	lowstringency_pd_outliers	HALLMARK_HYPOXIA(16/200),PID_HIF1_TFPATHWAY(11/66),HALLMARK_UV_RESPONSE_UP(9/158),HALLMARK_P53_PATHWAY(8/200),REACTOME_IRON_UPTAKE_AND_TRANSPORT(4/36),PID_FRA_PATHWAY(4/37),HALLMARK_APOPTOSIS(6/161),HALLMARK_IL6_JAK_STAT3_SIGNALING(4/87),KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM(3/41),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(8/413)
HNRNPH1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
HOPX	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(7/200)
HRSP12	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
HSPA4	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MTORC1_SIGNALING(10/200)
IFI27	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(14/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(7/270)
IL11RA	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(7/267)
IL1B	TH34_2351_S01	v10_polya	Canakinumab,CANAKINUMAB	lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_SECRETED_FACTORS(18/344),HALLMARK_TNFA_SIGNALING_VIA_NFKB(13/200),HALLMARK_KRAS_SIGNALING_UP(10/200),HALLMARK_APOPTOSIS(6/161),KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(7/267),REACTOME_IMMUNE_SYSTEM(14/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(7/270),PID_IL1_PATHWAY(3/34),REACTOME_IL1_SIGNALING(3/39),HALLMARK_IL6_JAK_STAT3_SIGNALING(4/87)
IL1RN	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_SECRETED_FACTORS(18/344),REACTOME_IMMUNE_SYSTEM(14/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(7/270),PID_IL1_PATHWAY(3/34),REACTOME_IL1_SIGNALING(3/39)
INTS8	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
IVL	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	PID_FRA_PATHWAY(4/37)
IVNS1ABP	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
KANSL1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
KDM3A	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(16/200)
KHDRBS3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
KIAA0907	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
KRT13	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(11/200),HALLMARK_ESTROGEN_RESPONSE_LATE(11/200),HALLMARK_KRAS_SIGNALING_DN(10/200)
KRT14	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	PID_REG_GR_PATHWAY(5/82),PID_DELTA_NP63_PATHWAY(4/47)
KRT15	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(11/200),HALLMARK_KRAS_SIGNALING_DN(10/200)
KRT16	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
KRT16P6	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
KRT17	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_P53_PATHWAY(8/200),PID_REG_GR_PATHWAY(5/82)
KRT19	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(11/200),HALLMARK_ESTROGEN_RESPONSE_LATE(11/200),HALLMARK_ANDROGEN_RESPONSE(5/101),PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY(3/38)
KRT4	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_DN(10/200)
KRT5	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_DN(10/200),PID_REG_GR_PATHWAY(5/82),PID_DELTA_NP63_PATHWAY(4/47)
KRT6A	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
KRT6B	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
KRT6C	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
KRT8	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(11/200),HALLMARK_ANDROGEN_RESPONSE(5/101),PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY(3/38)
KRTCAP2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
LAMB3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),HALLMARK_TNFA_SIGNALING_VIA_NFKB(13/200),PID_A6B1_A6B4_INTEGRIN_PATHWAY(5/46),HALLMARK_APICAL_JUNCTION(8/200),NABA_CORE_MATRISOME(9/275),PID_INTEGRIN1_PATHWAY(4/66),KEGG_PATHWAYS_IN_CANCER(8/328),REACTOME_CELL_JUNCTION_ORGANIZATION(4/78),PID_INTEGRIN4_PATHWAY(2/11)
LAMC2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),HALLMARK_ESTROGEN_RESPONSE_LATE(11/200),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(9/200),PID_A6B1_A6B4_INTEGRIN_PATHWAY(5/46),HALLMARK_APICAL_JUNCTION(8/200),NABA_CORE_MATRISOME(9/275),PID_INTEGRIN1_PATHWAY(4/66),KEGG_PATHWAYS_IN_CANCER(8/328),REACTOME_CELL_JUNCTION_ORGANIZATION(4/78),PID_INTEGRIN4_PATHWAY(2/11)
LAMTOR2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
LCN2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
LGALS7B	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
LY6D	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
LYNX1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
LYPD2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
LYPD3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_DN(10/200),HALLMARK_APICAL_SURFACE(3/44)
MAL	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_APICAL_SURFACE(3/44)
MEOX2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
MEST	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(11/200),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(9/200)
MKX	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
MMP1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_ECM_REGULATORS(14/238),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(9/200),PID_SYNDECAN_1_PATHWAY(5/46),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(6/87),PID_FRA_PATHWAY(4/37),PID_REG_GR_PATHWAY(5/82),KEGG_PATHWAYS_IN_CANCER(8/328),REACTOME_HEMOSTASIS(9/466)
MMP13	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_ECM_REGULATORS(14/238),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(6/87),HALLMARK_COMPLEMENT(6/200)
MPC2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MPZL2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(10/200),HALLMARK_APICAL_JUNCTION(8/200)
MRPL13	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
MSC	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(13/200)
MT1X	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
MTERF3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MUC1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),HALLMARK_ESTROGEN_RESPONSE_EARLY(11/200),HALLMARK_IL2_STAT5_SIGNALING(7/200)
MYH3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	REACTOME_STRIATED_MUSCLE_CONTRACTION(5/27),HALLMARK_MYOGENESIS(9/200),REACTOME_MUSCLE_CONTRACTION(5/48)
MYL1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	REACTOME_STRIATED_MUSCLE_CONTRACTION(5/27),HALLMARK_MYOGENESIS(9/200),REACTOME_MUSCLE_CONTRACTION(5/48)
MYL4	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	REACTOME_STRIATED_MUSCLE_CONTRACTION(5/27),HALLMARK_MYOGENESIS(9/200),REACTOME_MUSCLE_CONTRACTION(5/48)
MYLPF	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(9/200)
MYOF	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(11/200),HALLMARK_ESTROGEN_RESPONSE_LATE(11/200)
MYOG	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(9/200)
NAMPT	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(13/200),HALLMARK_MTORC1_SIGNALING(10/200)
NDRG1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(16/200),PID_HIF1_TFPATHWAY(11/66),PID_P53_DOWNSTREAM_PATHWAY(7/137),HALLMARK_P53_PATHWAY(8/200),HALLMARK_IL2_STAT5_SIGNALING(7/200),HALLMARK_ANDROGEN_RESPONSE(5/101)
NDUFS2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
NEAT1_1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NEFM	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
NNAT	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
NOP16	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
NOP56	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
NPTX2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(9/158)
NSMCE2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
OAF	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
PDE7A	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
PEG3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(10/200)
PERP	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(11/200),PID_P53_DOWNSTREAM_PATHWAY(7/137),HALLMARK_P53_PATHWAY(8/200),PID_DELTA_NP63_PATHWAY(4/47)
PFDN4	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
PGK1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(16/200),PID_HIF1_TFPATHWAY(11/66),HALLMARK_MTORC1_SIGNALING(10/200),HALLMARK_GLYCOLYSIS(10/200),PID_HIF2PATHWAY(5/34)
PHF20L1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
PHF21A	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
PI3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_ECM_REGULATORS(14/238)
PLCG1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(8/200),PID_S1P_S1P1_PATHWAY(3/21),KEGG_PATHWAYS_IN_CANCER(8/328),REACTOME_IMMUNE_SYSTEM(14/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(7/270),PID_PI3K_PLC_TRK_PATHWAY(3/36),REACTOME_HEMOSTASIS(9/466)
PLIN2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(16/200),PID_HIF1_TFPATHWAY(11/66),HALLMARK_IL2_STAT5_SIGNALING(7/200)
POLR3D	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
PPBP	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_SECRETED_FACTORS(18/344),HALLMARK_KRAS_SIGNALING_UP(10/200),REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES(4/57),REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS(6/188),KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(7/267),REACTOME_HEMOSTASIS(9/466),REACTOME_GPCR_LIGAND_BINDING(8/408)
PPIF	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(11/200),HALLMARK_ESTROGEN_RESPONSE_LATE(11/200),HALLMARK_UV_RESPONSE_UP(9/158)
PPL	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
PPP2R2A	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
PRDX5	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(16/200)
PRG4	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_CORE_MATRISOME(9/275)
PTGS2	TH34_2351_S01	v10_polya	ACETYLSALICYLIC ACID,ASPIRIN,CELECOXIB,Acetylsalicylic acid,Celecoxib	lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(13/200),HALLMARK_KRAS_SIGNALING_UP(10/200),PID_S1P_S1P1_PATHWAY(3/21),KEGG_PATHWAYS_IN_CANCER(8/328),PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY(3/38)
PTHLH	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(9/200),REACTOME_GPCR_LIGAND_BINDING(8/408)
RAB2A	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
RARS	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(10/200)
RBM28	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
RGS2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
RGS4	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(9/200)
RHCG	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_APICAL_SURFACE(3/44),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(8/413)
RMDN1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RNA5SP265	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RNF149	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
RP11-175B9.3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-20O24.4	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-343H5.4	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-423H2.1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-543P15.1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-761N21.2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-927P21.9	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-669L17.10	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-765C7.2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RPL12P4	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
RPL26L1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
RPL30	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
RPL7P9	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
S100A11	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_SECRETED_FACTORS(18/344)
S100A14	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_SECRETED_FACTORS(18/344)
S100A2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_SECRETED_FACTORS(18/344),PID_P53_DOWNSTREAM_PATHWAY(7/137)
S100A8	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_SECRETED_FACTORS(18/344)
S100A9	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_SECRETED_FACTORS(18/344),HALLMARK_ESTROGEN_RESPONSE_LATE(11/200),HALLMARK_COMPLEMENT(6/200)
S100P	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_SECRETED_FACTORS(18/344)
SBSN	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
SCEL	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
SCGB1A1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_DN(10/200)
SDHAF2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
SERPINB1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_ECM_REGULATORS(14/238)
SERPINB2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_ECM_REGULATORS(14/238),HALLMARK_TNFA_SIGNALING_VIA_NFKB(13/200),HALLMARK_KRAS_SIGNALING_DN(10/200),HALLMARK_COMPLEMENT(6/200),REACTOME_HEMOSTASIS(9/466)
SERPINB3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_ECM_REGULATORS(14/238)
SERPINB4	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_ECM_REGULATORS(14/238)
SERPINB5	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_ECM_REGULATORS(14/238),PID_P53_DOWNSTREAM_PATHWAY(7/137),HALLMARK_P53_PATHWAY(8/200)
SFN	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_EARLY(11/200),HALLMARK_ESTROGEN_RESPONSE_LATE(11/200),PID_A6B1_A6B4_INTEGRIN_PATHWAY(5/46),PID_P53_DOWNSTREAM_PATHWAY(7/137),HALLMARK_P53_PATHWAY(8/200),PID_REG_GR_PATHWAY(5/82),PID_DELTA_NP63_PATHWAY(4/47),PID_PI3K_PLC_TRK_PATHWAY(3/36)
SFXN1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
SIKE1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(14/933)
SIN3B	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
SLC2A1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(16/200),PID_HIF1_TFPATHWAY(11/66),HALLMARK_ESTROGEN_RESPONSE_EARLY(11/200),HALLMARK_MTORC1_SIGNALING(10/200),PID_HIF2PATHWAY(5/34),KEGG_PATHWAYS_IN_CANCER(8/328),REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES(8/413)
SLC39A14	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
SLC50A1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
SLPI	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_ECM_REGULATORS(14/238),HALLMARK_KRAS_SIGNALING_UP(10/200)
SNRPGP10	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SOD2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(13/200),HALLMARK_UV_RESPONSE_UP(9/158),HALLMARK_APOPTOSIS(6/161)
SPINK5	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
SPINT2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
SPRR1A	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
SPRR1B	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
SPRR2A	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
SPRR2D	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
SPRR3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_DN(10/200)
SQSTM1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_TNFA_SIGNALING_VIA_NFKB(13/200),HALLMARK_MTORC1_SIGNALING(10/200),HALLMARK_UV_RESPONSE_UP(9/158),HALLMARK_APOPTOSIS(6/161),REACTOME_IMMUNE_SYSTEM(14/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(7/270),PID_IL1_PATHWAY(3/34),REACTOME_IL1_SIGNALING(3/39)
STEAP1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
TAC1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS(6/188),REACTOME_GPCR_LIGAND_BINDING(8/408)
TACSTD2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
TAF2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
TATDN1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
TBX4	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
TCERG1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
TCN1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
TGM1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_ECM_REGULATORS(14/238),HALLMARK_KRAS_SIGNALING_DN(10/200)
THOC3	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
TIA1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
TMEM216	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
TMPRSS11D	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
TMPRSS4	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
TNMD	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
TNNI1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	REACTOME_STRIATED_MUSCLE_CONTRACTION(5/27),HALLMARK_MYOGENESIS(9/200),REACTOME_MUSCLE_CONTRACTION(5/48),HALLMARK_P53_PATHWAY(8/200),BIOCARTA_NO1_PATHWAY(3/33)
TNNT2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(10/200),REACTOME_STRIATED_MUSCLE_CONTRACTION(5/27),HALLMARK_MYOGENESIS(9/200),REACTOME_MUSCLE_CONTRACTION(5/48)
TRIM25	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(14/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(7/270)
TRIM29	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ESTROGEN_RESPONSE_LATE(11/200)
TSPAN1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_KRAS_SIGNALING_UP(10/200)
TWIST2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
TXN	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_GLYCOLYSIS(10/200),REACTOME_IMMUNE_SYSTEM(14/933)
UAP1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_ANDROGEN_RESPONSE(5/101)
UBE2Q1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(14/933)
UBE2V2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	REACTOME_IMMUNE_SYSTEM(14/933)
UBR5	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
UCK2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_IL2_STAT5_SIGNALING(7/200)
UPK1B	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
UQCRB	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
VEGFA	TH34_2351_S01	v10_polya	AFLIBERCEPT,VEGF TRAP,BEVACIZUMAB,SORAFENIB TOSYLATE,Aflibercept,ZALTRAP,ZIV-AFLIBERCEPT,Bevacizumab	lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),HALLMARK_HYPOXIA(16/200),PID_HIF1_TFPATHWAY(11/66),NABA_SECRETED_FACTORS(18/344),HALLMARK_TNFA_SIGNALING_VIA_NFKB(13/200),HALLMARK_GLYCOLYSIS(10/200),PID_HIF2PATHWAY(5/34),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(9/200),PID_AVB3_INTEGRIN_PATHWAY(5/75),PID_S1P_S1P1_PATHWAY(3/21),REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN(3/25),PID_INTEGRIN1_PATHWAY(4/66),KEGG_PATHWAYS_IN_CANCER(8/328),KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION(7/267),BIOCARTA_NO1_PATHWAY(3/33),REACTOME_HEMOSTASIS(9/466)
VMO1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
WDR27	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
WDYHV1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
WFDC2	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
WFDC21P	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
WIF1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(43/1028),NABA_MATRISOME_ASSOCIATED(34/753),NABA_SECRETED_FACTORS(18/344)
WSB1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_HYPOXIA(16/200),REACTOME_IMMUNE_SYSTEM(14/933)
YWHAZ	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	PID_A6B1_A6B4_INTEGRIN_PATHWAY(5/46),REACTOME_IMMUNE_SYSTEM(14/933),REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM(7/270),PID_PI3K_PLC_TRK_PATHWAY(3/36),REACTOME_HEMOSTASIS(9/466)
ZFAND1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
ZFHX4-AS1	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZNF395	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
ZNF7	TH34_2351_S01	v10_polya		lowstringency_pd_outliers	NA
ABCB1	TH34_2410_S01	v11_polya	PACLITAXEL	lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(6/158)
ABCB8	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
AC034198.1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACADVL	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
ADAM33	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NABA_MATRISOME(16/1028),NABA_ECM_REGULATORS(7/238),NABA_MATRISOME_ASSOCIATED(10/753)
ADAMTS19	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NABA_MATRISOME(16/1028),NABA_ECM_REGULATORS(7/238),NABA_MATRISOME_ASSOCIATED(10/753)
ADCY4	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
ADGRB1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ADRA2C	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
AFAP1L2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
AL662801.1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ALDH1A1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
ANKRD19P	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
AP000349.2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ASTN2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
ATP1B2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
ATP1B3	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
BCHE	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
BLOC1S5-TXNDC5	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
C17orf58	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NABA_MATRISOME(16/1028),NABA_ECM_REGULATORS(7/238),NABA_MATRISOME_ASSOCIATED(10/753)
C19orf60	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
C1orf123	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
C21orf2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
C4orf48	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
CDC37	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
CDKN1C	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(6/158)
CHKB	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
CHST8	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
CITED1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
CLEC11A	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NABA_MATRISOME(16/1028),NABA_MATRISOME_ASSOCIATED(10/753)
COL26A1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NABA_MATRISOME(16/1028),NABA_CORE_MATRISOME(6/275),NABA_COLLAGENS(3/44)
COL27A1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NABA_MATRISOME(16/1028),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(4/87),NABA_CORE_MATRISOME(6/275),NABA_COLLAGENS(3/44)
COL2A1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NABA_MATRISOME(16/1028),HALLMARK_UV_RESPONSE_UP(6/158),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(4/87),NABA_CORE_MATRISOME(6/275),NABA_COLLAGENS(3/44)
CRELD1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NABA_MATRISOME(16/1028),NABA_CORE_MATRISOME(6/275)
CRHR1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
CRYBB2P1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
CTSV	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NABA_MATRISOME(16/1028),NABA_ECM_REGULATORS(7/238),NABA_MATRISOME_ASSOCIATED(10/753)
CTXN1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
CXorf36	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
DENND2A	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
DKK1	TH34_2410_S01	v11_polya	IRINOTECAN,L-FOLINIC ACID,5-FLUOROURACIL,OXALIPLATIN	lowstringency_pd_outliers	NA
DPH7	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DPP6	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
ECEL1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
EEF1A1P13	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
EFNA3	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
EMX2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
EMX2OS	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
ENPP2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
EPHB6	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
ERF	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
ESR1	TH34_2410_S01	v11_polya	Letrozole,Palbociclib,PALBOCICLIB (PD0332991),TAMOXIFEN,Fluvestrant,LETROZOLE,Tamoxifen,FULVESTRANT,Fulvestrant	lowstringency_pd_outliers	REACTOME_SIGNALING_BY_ERBB4(4/90),REACTOME_NUCLEAR_SIGNALING_BY_ERBB4(3/38)
FAM173A	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
FAM19A5	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
FAM89A	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
FBXO18	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
FCGRT	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
FZD10-AS1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
GAS6	TH34_2410_S01	v11_polya	DOCETAXEL	lowstringency_pd_outliers	NABA_MATRISOME(16/1028),NABA_CORE_MATRISOME(6/275)
GFRA2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
HAGHL	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
HAND2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
HES4	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
HES6	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
HOXA11	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
HOXA11-AS	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
HOXA5	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
HOXD10	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
HOXD11	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
HOXD3	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
HOXD4	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
HOXD9	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
HPCAL1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
HYAL2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NABA_MATRISOME(16/1028),HALLMARK_UV_RESPONSE_UP(6/158),NABA_ECM_REGULATORS(7/238),KEGG_GLYCOSAMINOGLYCAN_DEGRADATION(3/21),NABA_MATRISOME_ASSOCIATED(10/753)
IDUA	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	KEGG_GLYCOSAMINOGLYCAN_DEGRADATION(3/21)
IFITM2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
IFITM3	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
IFT43	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
IGSF21	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
IMMP1L	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
ISOC1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
ITM2B	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
KCNK6	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
KIAA0895L	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
KLF2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
LAMA3	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NABA_MATRISOME(16/1028),NABA_CORE_MATRISOME(6/275)
LCN6	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
LEF1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
LINC01089	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MAN2C1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
MAPK11	TH34_2410_S01	v11_polya	Regorafenib,REGORAFENIB	lowstringency_pd_outliers	NA
MDK	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NABA_MATRISOME(16/1028),NABA_MATRISOME_ASSOCIATED(10/753)
MED25	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
MED4	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
MEI1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
METRN	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
MIR1282	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MIR5047	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MIR671	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MMP11	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NABA_MATRISOME(16/1028),NABA_ECM_REGULATORS(7/238),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(4/87),NABA_MATRISOME_ASSOCIATED(10/753)
MMP15	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NABA_MATRISOME(16/1028),NABA_ECM_REGULATORS(7/238),REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION(4/87),NABA_MATRISOME_ASSOCIATED(10/753)
MTND2P28	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MUS81	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
MYO15B	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
NEAT1_2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NPDC1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
NPR2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
NPTX1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
NR4A1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(6/158),REACTOME_SIGNALING_BY_ERBB4(4/90)
NRGN	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
NSUN5P2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
NUTM2B	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
NXF1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	HALLMARK_UV_RESPONSE_UP(6/158)
OAZ2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
OSBPL1A	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
OSR2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
PAGE4	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
PCDHGC3	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
PDZD4	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
PGR	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_ERBB4(4/90),REACTOME_NUCLEAR_SIGNALING_BY_ERBB4(3/38)
PPP1R12C	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
PPP2R2C	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
PPP2R3B	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
PSD	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
PTH1R	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
RAMP1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
RASL11B	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
RBM6	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
ROBO3	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
RP1-20B21.4	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-1100L3.8	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-342I1.2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-638I2.6	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-680F20.6	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-732A19.5	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RPL13P12	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
RPRM	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
SGSH	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	KEGG_GLYCOSAMINOGLYCAN_DEGRADATION(3/21)
SGSM3	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
SH2B1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	REACTOME_SIGNALING_BY_ERBB4(4/90),REACTOME_NUCLEAR_SIGNALING_BY_ERBB4(3/38)
SLC22A1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
SLC47A1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
SNHG25	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SNX1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
SPSB3	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
SSR2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
TELO2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
TMEM120B	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
TMEM132E	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
TRAF3IP2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
TRIM7	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
TRMT2A	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
TRPT1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
TTC1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
TUBGCP6	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
TWIST2	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
UXS1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
VCAN-AS1	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
VGF	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
VPS25	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
WNT11	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NABA_MATRISOME(16/1028),NABA_MATRISOME_ASSOCIATED(10/753)
WT1	TH34_2410_S01	v11_polya	CYTARABINE,DAUNORUBICIN	lowstringency_pd_outliers	NA
Y_RNA	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZBTB48	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
ZCCHC12	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
ZNF516	TH34_2410_S01	v11_polya		lowstringency_pd_outliers	NA
ABCC10	TH34_2411_S01	v10_polya	PACLITAXEL	lowstringency_pd_outliers	NA
AC034198.1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC096559.1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACAN	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(17/1028),NABA_CORE_MATRISOME(9/275)
ACTA1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(17/200),HALLMARK_APICAL_JUNCTION(5/200)
ACTC1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(17/200),HALLMARK_APICAL_JUNCTION(5/200)
ADAMTS10	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(17/1028)
AGAP2-AS1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL132780.1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AL662801.1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AP003041.1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ARHGEF25	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
AVIL	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
B4GALNT1	TH34_2411_S01	v10_polya	DINUTUXIMAB	lowstringency_pd_outliers	NA
BGLAP	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(17/1028),NABA_CORE_MATRISOME(9/275),PID_RB_1PATHWAY(5/65),NABA_ECM_GLYCOPROTEINS(6/196),PID_FGF_PATHWAY(3/55)
BPIFB4	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
C6orf226	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
CCDC101	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
CCDC159	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
CCL13	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(17/1028)
CCT2	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
CDH15	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(5/200)
CDK4	TH34_2411_S01	v10_polya	CS1229,Ribociclib,PD 0332991,ALVOCIDIB,Flavopiridol,Abemaciclib,PALBOCICLIB (PD0332991),PD-0332991,PD-332991,LY2835219,ABEMACICLIB,Roniciclib,Palbociclib,LEE011,CID 5330286,RIBOCICLIB,BAY1000394,PD0332991,PALBOCICLIB	lowstringency_pd_outliers	PID_RB_1PATHWAY(5/65),KEGG_CHRONIC_MYELOID_LEUKEMIA(4/73),KEGG_BLADDER_CANCER(3/42),KEGG_CELL_CYCLE(4/128)
CDK5RAP3	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
CDKN2D	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	KEGG_CELL_CYCLE(4/128)
CERCAM	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(5/200)
CHAD	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(17/1028),NABA_CORE_MATRISOME(9/275),KEGG_ECM_RECEPTOR_INTERACTION(4/84),KEGG_FOCAL_ADHESION(5/201)
CKM	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(17/200),PID_RB_1PATHWAY(5/65)
CLEC11A	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(17/1028)
CMKLR1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
CNOT2	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
COL13A1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(17/1028),NABA_CORE_MATRISOME(9/275)
COMP	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(17/1028),NABA_CORE_MATRISOME(9/275),NABA_ECM_GLYCOPROTEINS(6/196),KEGG_ECM_RECEPTOR_INTERACTION(4/84),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(5/200),KEGG_FOCAL_ADHESION(5/201)
COPZ2	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
COX6A2	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(17/200)
CRELD2	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(17/1028),NABA_CORE_MATRISOME(9/275),NABA_ECM_GLYCOPROTEINS(6/196)
CRLF1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(17/1028),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(5/200)
CTDSP2	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
CYP27B1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
DCAF15	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
DDB2	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
DLX3	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
DLX5	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
DTX3	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
DYSF	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
EEF1A2	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
EHMT1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
ENKD1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ENO3	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(17/200)
FAM20C	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(17/1028)
FOXS1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
FRG2FP	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FRS2	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	PID_FGF_PATHWAY(3/55)
GPR108	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
HSF4	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
IBSP	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(17/1028),NABA_CORE_MATRISOME(9/275),NABA_ECM_GLYCOPROTEINS(6/196),KEGG_ECM_RECEPTOR_INTERACTION(4/84),KEGG_FOCAL_ADHESION(5/201)
IGFN1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
INPPL1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_APICAL_JUNCTION(5/200)
IPO13	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
ISYNA1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
KAT2A	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
KCNF1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
KCNMB4	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
KIAA1462	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
KLK4	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
LAMP5	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LCAT	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
LCMT1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
LIME1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
LINC01481	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MAP2K2	TH34_2411_S01	v10_polya	MEK162,TRAMETINIB,PD 0325901,PD0325901,AZD-8330,ARRY-162,PD-0325901,GDC-0973,REFAMETINIB,SELUMETINIB,CI-1040,AZD8330,BINIMETINIB,PD325901,BAY 869766,RDEA119,PIMASERTIB,COBIMETINIB,DABRAFENIB MESYLATE,TAK-733,AZD6244,BAY869766,Refametinib,XL518	lowstringency_pd_outliers	KEGG_CHRONIC_MYELOID_LEUKEMIA(4/73),KEGG_BLADDER_CANCER(3/42)
MARCH9	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
MB	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(17/200)
MDM2	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	PID_RB_1PATHWAY(5/65),KEGG_CHRONIC_MYELOID_LEUKEMIA(4/73),KEGG_BLADDER_CANCER(3/42),KEGG_CELL_CYCLE(4/128)
MEG3	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
METTL1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
METTL21B	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
MFAP5	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(17/1028),NABA_CORE_MATRISOME(9/275),NABA_ECM_GLYCOPROTEINS(6/196),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(5/200)
MIB2	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
MICALL2	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
MIR671	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MIR675	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MMP17	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(17/1028)
MSX1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(5/200)
MUSTN1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
MYBPC2	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	REACTOME_STRIATED_MUSCLE_CONTRACTION(7/27),REACTOME_MUSCLE_CONTRACTION(7/48)
MYH1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(17/200)
MYL1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(17/200),REACTOME_STRIATED_MUSCLE_CONTRACTION(7/27),REACTOME_MUSCLE_CONTRACTION(7/48)
MYLPF	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(17/200),KEGG_FOCAL_ADHESION(5/201)
NEB	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	REACTOME_STRIATED_MUSCLE_CONTRACTION(7/27),REACTOME_MUSCLE_CONTRACTION(7/48)
NOMO2	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
OCEL1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(17/200)
OLFML2B	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
ORMDL3	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
OS9	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
OSR1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
P4HA3	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(17/1028)
PET100	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
PHF1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
PLA2G5	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
PRR14	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
PTH1R	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
RAB3IP	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
RGS3	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
RHBDF1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
RNA5SP216	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RNA5SP244	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP1-20B21.4	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-1212A22.4	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-343H5.4	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-571M6.17	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-571M6.18	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-588H23.3	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-611O2.3	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-620J15.3	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-632C17__A.1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-785D18.3	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-802E16.3	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-867G23.4	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP3-508I15.18	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-583P15.14	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-738P15.6	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP4-765C7.2	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RUNX2	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	PID_RB_1PATHWAY(5/65),PID_FGF_PATHWAY(3/55)
SDCCAG8	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
SDF2	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
SH2B1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(17/200)
SLC17A9	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
SLC26A10	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
SLC29A1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
SLC39A13	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
SNAI1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
SNHG25	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SNHG9	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
SNORD89	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
SP7	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
STAC3	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
STMN3	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
SUGCT	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TCAP	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(17/200),REACTOME_STRIATED_MUSCLE_CONTRACTION(7/27),REACTOME_MUSCLE_CONTRACTION(7/48)
TGFB1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(17/200),NABA_MATRISOME(17/1028),KEGG_CHRONIC_MYELOID_LEUKEMIA(4/73),HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION(5/200),KEGG_CELL_CYCLE(4/128)
THBS4	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NABA_MATRISOME(17/1028),NABA_CORE_MATRISOME(9/275),NABA_ECM_GLYCOPROTEINS(6/196),KEGG_ECM_RECEPTOR_INTERACTION(4/84),KEGG_FOCAL_ADHESION(5/201)
TMEM259	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
TNFRSF6B	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
TNNC2	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(17/200),REACTOME_STRIATED_MUSCLE_CONTRACTION(7/27),REACTOME_MUSCLE_CONTRACTION(7/48)
TNNI2	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(17/200),REACTOME_STRIATED_MUSCLE_CONTRACTION(7/27),REACTOME_MUSCLE_CONTRACTION(7/48)
TNNT1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(17/200),REACTOME_STRIATED_MUSCLE_CONTRACTION(7/27),REACTOME_MUSCLE_CONTRACTION(7/48)
TNNT3	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	HALLMARK_MYOGENESIS(17/200)
TPRG1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
TSFM	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
TSPAN31	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
TYK2	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
WASH3P	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
XRCC6BP1	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
YEATS4	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
YPEL3	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
Y_RNA	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZGPAT	TH34_2411_S01	v10_polya		lowstringency_pd_outliers	NA
ABCC8	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
AC002523.1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC005606.15	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC006116.20	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AC104451.2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ACSF2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
AHRR	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
ALX1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
AMDHD1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
AP000580.1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AP001059.6	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
AP1M2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
ARHGAP8	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
ARVCF	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
BCO2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
BCYRN1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
CAMK1G	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
CBLN2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NABA_MATRISOME_ASSOCIATED(8/753)
CD99P1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
CEMP1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
CHD5	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
CLDN1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
CNGB1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
CRH	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
CSAG1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
CSAG3	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
CTB-12A17.3	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTB-191K22.5	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTB-36O1.7	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-2308N23.2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-2349P21.7	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-2545M3.2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
CTD-2659N19.10	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
DNAAF1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
EP400	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
ERVH48-1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
FABP7	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
FAR2P1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
FLT4	TH34_2666_S01	v11_polya	MGCD265,MGCD-265,SORAFENIB,MOTESANIB,ABT-869,ENMD 2076,ORANTINIB,Vatalanib,LENVATINIB,TESEVATINIB,Axitinib,SUNITINIB,TELATINIB,FORETINIB,ENMD-2076,Regorafenib,XL647,LUCITANIB,AXITINIB,X-82,Sorafenib,PAZOPANIB,Nintedanib,VATALANIB,VANDETANIB,TIVOZANIB,Sunitinib,LINIFANIB,SORAFENIB TOSYLATE,1058137-23-7,REGORAFENIB,NINTEDANIB,Pazopanib	lowstringency_pd_outliers	NA
FMN2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
FOXB1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
GGN	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
GK	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
GLIS3-AS1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
GNRH1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
GTSF1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
GYG2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
GYG2P1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
IGLON5	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
LA16c-361A3.3	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LDLRAD2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
LINC00473	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
LINC01150	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LINC01393	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
LPCAT1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
MDM2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
MEIOB	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ATP6	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CO1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CO2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CO3	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-CYB	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND3	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND4	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-ND4L	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MT-RNR2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTATP6P1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MTRNR2L12	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
MUC2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NABA_ECM_AFFILIATED(7/171),REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS(3/24),NABA_MATRISOME_ASSOCIATED(8/753),REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS(3/59)
MUC5AC	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NABA_ECM_AFFILIATED(7/171),REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS(3/24),NABA_MATRISOME_ASSOCIATED(8/753),REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS(3/59)
MUC6	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NABA_ECM_AFFILIATED(7/171),REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS(3/24),NABA_MATRISOME_ASSOCIATED(8/753),REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS(3/59)
NHSL1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
NPIPB3	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
OBP2A	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
PAEP	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
PIGG	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
POLE	TH34_2666_S01	v11_polya	PEMBROLIZUMAB	lowstringency_pd_outliers	NA
RALYL	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
RBPJ	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
RGS20	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
RHPN1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
RNA5SP425	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RNA5SP466	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP1-20B21.4	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP1-56K13.3	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-1079K10.4	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-109M17.2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-110I1.6	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-126K1.8	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-134D3.2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-159D12.5	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-179G8.1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-192H23.5	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-20I20.4	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-231C14.4	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-244F12.2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-307C12.12	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-323N12.5	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-380M21.2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-385F7.1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-390P2.4	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-473E2.4	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-496I9.1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-498C9.2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-498P14.3	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-580I16.2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-627K11.6	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-676J15.1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-802E16.3	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-804A23.4	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-809N8.5	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-82L18.2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP11-977G19.5	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP3-508I15.18	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP5-857K21.11	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP5-857K21.7	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RP5-940J5.9	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
RPL13AP2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
SCNN1B	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
SFTPA1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NABA_ECM_AFFILIATED(7/171),NABA_MATRISOME_ASSOCIATED(8/753)
SFTPA2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NABA_ECM_AFFILIATED(7/171),NABA_MATRISOME_ASSOCIATED(8/753)
SFTPB	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NABA_ECM_AFFILIATED(7/171),NABA_MATRISOME_ASSOCIATED(8/753)
SFTPC	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NABA_ECM_AFFILIATED(7/171),NABA_MATRISOME_ASSOCIATED(8/753)
SHC3	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
SLC12A5	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
SLC13A4	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
SLC1A6	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
SNHG25	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
SNORA77	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
SNORD13	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
SPRED3	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
SPRR2A	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
SPTBN4	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
SULT1E1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
SYCE1L	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
SYCP2L	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
T	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
VCAN-AS1	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
VGF	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
Vault	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
WNK2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
WNK4	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
WT1-AS	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
WT1-AS_7	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
WT1-AS_8	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
Y_RNA	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
ZFHX2	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NA
snoU13	TH34_2666_S01	v11_polya		lowstringency_pd_outliers	NO_PATHWAY_SUPPORT_RESULTS
